Table of Contents 

Table of Contents 3 Preface 438 Acknowledgements 439 
1 Apoptosis (Pathway) 440 
1.1 Extrinsic Pathway for Apoptosis (Pathway) 442 
1.1.1 Death Receptor Signalling (Pathway) 444 
1.1.1.1 FasL/ CD95L signaling (Pathway) 445 
1.1.1.1.1 FASL binds FAS Receptor (Reaction) 447 
1.1.1.1.2 Trimerization of the FASL:FAS receptor complex (Reaction) 448 
1.1.1.1.3 FasL:Fas binds FADD (Reaction) 449 
1.1.1.1.4 FASL:FAS Receptor Trimer:FADD complex binds pro-Caspase-8 (Reaction) 451 
1.1.1.1.5 FASL:FAS Receptor Trimer:FADD complex binds pro-Caspase-10 (Reaction) 452 
1.1.1.2 TNF signaling (Pathway) 454 
1.1.1.2.1 TNF-alpha cleavage by TACE (Reaction) 455 
1.1.1.2.2 Soluble TNF-alpha binds TNF-R1 (Reaction) 456 
1.1.1.2.3 Membrane-anchored TNF-alpha binds TNF-R1 (Reaction) 457 
1.1.1.2.4 TNF:TNF-R1 binds TRADD, TRAF2 and RIP (Reaction) 459 
1.1.1.2.5 TRADD:TRAF2:RIP1 complex dissociates from the TNF-alpha:TNF-R1 460 complex. (Reaction) 
1.1.1.3 TRAIL signaling (Pathway) 461 
1.1.1.3.1 TRAIL Binds TRAIL-Receptor2 (Reaction) 462 
1.1.1.3.2 Trimerization of TRAIL: TRAIL receptor-2 complex (Reaction) 463 
1.1.1.3.3 TRAIL:TRAIL receptor-2 Trimer Binds FADD (Reaction) 464 
1.1.1.3.4 TRAIL:TRAIL-Receptor2 Trimer:FADD complex binds Caspase-8 (Reaction) 465 
1.1.1.3.5 TRAIL:TRAIL-Receptor2 Trimer:FADD complex binds Caspase-10 (Reaction) 466 
1.1.2 Caspase-8 activation by cleavage (Pathway) 467 
1.1.2.1 Dimerization of procaspase-8 (Pathway) 468 
1.1.2.1.1 FAS-mediated dimerization of procaspase-8 (Reaction) 469 
1.1.2.1.2 TRAIL-mediated dimerization of procaspase-8 (Reaction) 471 
1.1.2.1.3 TNF-mediated dimerization of procaspase-8 (Reaction) 472 
1.1.2.2 Caspase-8 processing in the DISC (BlackBoxEvent) 474 
1.1.2.3 Regulation by c-FLIP (Pathway) 475 
1.1.2.3.1 FLIP(L) and procaspase-8 form heterodimer in TNF signaling (Reaction) 478 
1.1.2.3.2 FLIP(L) and procaspase-8 form heterodimer in TRAIL signaling (Reaction) 480 
1.1.2.3.3 FLIP(L) and procaspase-8 form heterodimer in FasL/CD95 signaling (Reaction)482 
1.1.2.3.4 Caspase-8 and FLIP(L) processing at DISC (BlackBoxEvent) 484 
1.1.2.3.5 FLIP(S) and procaspase-8 form heterodimer (Reaction) 486 
1.1.3 Regulation by c-FLIP (Pathway) 488 
1.1.3.1 FLIP(L) and procaspase-8 form heterodimer in TNF signaling (Reaction) 488 
1.1.3.2 FLIP(L) and procaspase-8 form heterodimer in TRAIL signaling (Reaction) 488 
1.1.3.3 FLIP(L) and procaspase-8 form heterodimer in FasL/CD95 signaling (Reaction) 489 
1.1.3.4 Caspase-8 and FLIP(L) processing at DISC (BlackBoxEvent) 489 
1.1.3.5 FLIP(S) and procaspase-8 form heterodimer (Reaction) 489 
1.2 Intrinsic Pathway for Apoptosis (Pathway) 490 
1.2.1 Activation, myristolyation of BID and translocation to mitochondria (Pathway) 492 
1.2.1.1 Caspase-8 activates BID by cleavage (Reaction) 494 
1.2.1.2 Granzyme-B activates BID by cleavage (Reaction) 495 
1.2.1.3 Myristoylation of tBID by NMT1 (Reaction) 496 
1.2.1.4 Translocation of tBID to mitochondria (Reaction) 497 
1.2.2 Activation of BH3-only proteins (Pathway) 498 
1.2.2.1 Activation of BAD and translocation to mitochondria (Pathway) 500 
1.2.2.1.1 AKT phosphorylates BAD (Reaction) 501 
1.2.2.1.2 Sequestration of BAD protein by 14-3-3 (Reaction) 503 
1.2.2.1.3 Activation of BAD by calcineurin (Reaction) 504 
1.2.2.1.4 Translocation of activated BAD protein to mitochondria (Reaction) 504 
1.2.2.1.5 BAD displaces tBID from BCL-2 sequestration (Reaction) 505 
1.2.2.2 Activation of NOXA and translocation to mitochondria (Pathway) 506 
1.2.2.2.1 TP53 binds PMAIP1 (NOXA) promoter (Reaction) 506 
1.2.2.2.2 Transactivation of PMAIP1 (NOXA) by p53 (BlackBoxEvent) 507 
1.2.2.2.3 E2F1 binds PMAIP1 (NOXA) promoter (Reaction) 508 
1.2.2.2.4 Transactivation of PMAIP1 (NOXA) by E2F1 (BlackBoxEvent) 509 
1.2.2.2.5 Translocation of PMAIP1 (NOXA) to mitochondria (Reaction) 510 
1.2.2.3 Activation of PUMA and translocation to mitochondria (Pathway) 510 
1.2.2.3.1 TP53 binds BBC3 (PUMA) promoter (Reaction) 511 
1.2.2.3.2 Transactivation of BBC3 (PUMA) by p53 (BlackBoxEvent) 512 
1.2.2.3.3 E2F1 binds BBC3 (PUMA) promoter (Reaction) 513 
1.2.2.3.4 Transactivation of BBC3 (PUMA) by E2F1 (BlackBoxEvent) 513 
1.2.2.3.5 Translocation of BBC3 (PUMA) protein to mitochondria (Reaction) 514 
1.2.2.4 Activation of BIM and translocation to mitochondria (Pathway) 515 
1.2.2.4.1 Phosphorylation of BIM by JNK (Reaction) 516 
1.2.2.4.2 Translocation of BIM to mitochondria (Reaction) 517 
1.2.2.5 Activation of BMF and translocation to mitochondria (Pathway) 518 
1.2.2.5.1 Phosphorylation of DLC2 by MAPK8 (Reaction) 519 
1.2.2.5.2 Translocation of BMF to mitochondria (Reaction) 520 
1.2.3 BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members 520 (Pathway) 
1.2.3.1 BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 (Reaction) 521 
1.2.3.2 Sequestration of tBID by BCL-2 (Reaction) 522 
1.2.3.3 BH3 only proteins associate with and inactivate anti-apoptotic BCL-XL (Reaction) 522 
1.2.4 Activation, translocation and oligomerization of BAX (Pathway) 524 
1.2.4.1 tBID binds to inactive BAX protein (Reaction) 524 
1.2.4.2 tBID activates BAX protein (Reaction) 525 
1.2.4.3 Translocation of activated BAX to the mitochondria (Reaction) 526 
1.2.4.4 Oligomerization of BAX at the mitochondrial membrane (Reaction) 527 
1.2.5 Activation and oligomerization of BAK protein (Pathway) 527 
1.2.5.1 tBID binds to inactive BAK protein (Reaction) 528 1.2.5.2 tBID activates BAK protein (Reaction) 528 
1.2.5.3 Oligomerization of BAK at the mitochondrial membrane (Reaction) 529 
1.2.6 Release of apoptotic factors from the mitochondria (Pathway) 530 
1.2.6.1 Release of Cytochrome c from mitochondria (Reaction) 531 
1.2.6.2 Release of SMAC from mitochondria (Reaction) 532 
1.2.7 Apoptotic factor-mediated response (Pathway) 533 
1.2.7.1 Cytochrome c-mediated apoptotic response (Pathway) 534 
1.2.7.1.1 Formation of apoptosome (Pathway) 536 
1.2.7.1.1.1 Cytochrome C Binds to Apaf-1 (Reaction) 536 
1.2.7.1.1.2 Cytochrome C:Apaf-1 binds Procaspase-9 (Reaction) 537 
1.2.7.1.1.3 Cleavage of Procaspase-9 to Caspase-9 (Reaction) 538 
1.2.7.1.2 Activation of caspases through apoptosome-mediated cleavage (Pathway) 538 
1.2.7.1.2.1 Cleavage of Procaspase-3 by the apoptosome (Reaction) 539 
1.2.7.1.2.2 Cleavage of Procaspase-7 by the apoptosome (Reaction) 541 
1.2.7.2 SMAC-mediated apoptotic response (Pathway) 542 
1.2.7.2.1 SMAC binds to IAPs (Pathway) 544 
1.2.7.2.1.1 SMAC binds XIAP:Caspase-3 (Reaction) 544 
1.2.7.2.1.2 SMAC binds XIAP:Caspase-7 (Reaction) 546 
1.2.7.2.1.3 SMAC binds XIAP:Caspase-9 (Reaction) 546 
1.2.7.2.2 SMAC-mediated dissociation of IAP:caspase complexes (Pathway) 548 
1.2.7.2.2.1 Dissociation of Caspase-3 from SMAC:XIAP:Caspase-3 (Reaction) 548 
1.2.7.2.2.2 Dissociation of Caspase-7 from SMAC:XIAP:Caspase-7 (Reaction) 550 
1.2.7.2.2.3 Dissociation of Caspase-9 from SMAC:XIAP:Caspase-9 (Reaction) 551 
1.3 Apoptotic execution phase (Pathway) 552 
1.3.1 Apoptotic cleavage of cellular proteins (Pathway) 555 
1.3.1.1 Caspase-mediated cleavage of cytoskeletal proteins (Pathway) 556 
1.3.1.1.1 Caspase-mediated cleavage of alpha adducin (Reaction) 557 
1.3.1.1.2 Caspase mediated cleavage of alpha-II-Fodrin (Reaction) 558 
1.3.1.1.3 Caspase-mediated cleavage of GAS2 (Reaction) 560 
1.3.1.1.4 Caspase mediated cleavage of HIP-55 (Reaction) 561 
1.3.1.1.5 Caspase-mediated cleavage of vimentin at DSVD (85) (Reaction) 562 
1.3.1.1.6 Caspase mediated cleavage of vimentin at IDVD (259) (Reaction) 564 
1.3.1.1.7 Caspase-mediated cleavage of vimentin at TNLD (429) (Reaction) 565 
1.3.1.1.8 Caspase-mediated cleavage of gelsolin (Reaction) 566 
1.3.1.1.9 Caspase-mediated cleavage of plectin-1 (Reaction) 568 
1.3.1.1.10 Caspase-mediated cleavage of Tau (Reaction) 569 
1.3.1.2 Apoptotic cleavage of cell adhesion proteins (Pathway) 570 
1.3.1.2.1 Caspase-mediated cleavage of E-Cadherin (Reaction) 571 
1.3.1.2.2 Caspase mediated cleavage of beta-catenin (Reaction) 573 
1.3.1.2.3 Caspase-mediated cleavage of Desmoglein 3 (Reaction) 574 
1.3.1.2.4 Caspase-mediated cleavage of Desmoglein 2 (Reaction) 575 
1.3.1.2.5 Caspase-mediated cleavage of Desmoglein 1 (Reaction) 577 
1.3.1.2.6 Caspase-mediated cleavage of Desmoplakin (Reaction) 578 
1.3.1.2.7 Caspase-mediated cleavage of plakophilin-1 (Reaction) 579 
1.3.1.2.8 Caspase-mediated cleavage of TJP1 (Reaction) 581 
1.3.1.2.9 Caspase-mediated cleavage of Z0-2 (Reaction) 582 
1.3.1.2.10 Caspase-mediated cleavage of occludin (Reaction) 583 
1.3.1.3 Breakdown of the nuclear lamina (Pathway) 585 
1.3.1.3.1 Caspase-mediated cleavage of Lamin A (Reaction) 586 
1.3.1.3.2 Caspase-mediated cleavage of Lamin B1 (Reaction) 587 
1.3.1.4 Caspase mediated cleavage of APC (Reaction) 589 
1.3.1.5 Caspase mediated cleavage of C-IAP1 (Reaction) 590 
1.3.1.6 Caspase-mediated cleavage of FADK 1 (Reaction) 591 
1.3.1.7 Caspase 3-mediated cleavage of PKC delta (Reaction) 593 
1.3.1.8 Caspase-mediated cleavage of PKC theta (Reaction) 594 
1.3.1.9 Caspase-mediated cleavage of Acinus (Reaction) 595 
1.3.1.10 Caspase-mediated cleavage of Rock-1 (Reaction) 597 
1.3.1.11 Caspase-mediated cleavage of farnesyltransferase/geranyl- geranyltransferase 598 subunit alpha (Reaction) 
1.3.1.12 Caspase mediated cleavage of BAP31 (Reaction) 600 
1.3.1.13 Caspase-mediated cleavage of Etk (Reaction) 601 
1.3.1.14 Caspase-mediated cleavage of MASK (Reaction) 602 
1.3.1.15 Caspase-mediated cleavage of MST3 (Reaction) 603 
1.3.1.16 Caspase-mediated cleavage of claspin (Reaction) 605 
1.3.1.17 Cleavage of Satb1 (Reaction) 606 
1.3.2 Apoptosis induced DNA fragmentation (Pathway) 608 
1.3.2.1 Activation of DNA fragmentation factor (Pathway) 609 
1.3.2.1.1 Association of DFF40 with DFF45 (Reaction) 610 
1.3.2.1.2 Association of DFF with alpha:beta importin (Reaction) 612 
1.3.2.1.3 Translocation of DFF to the nucleus (Reaction) 613 
1.3.2.1.4 Translocation of caspase-3 to the nucleus (Reaction) 614 
1.3.2.1.5 Caspase 3-mediated cleavage of DFF45 (117) (Reaction) 615 
1.3.2.1.6 Cleavage of DFF45 (224) by caspase-3 (Reaction) 616 
1.3.2.1.7 Cleaved fragments of DFF45 dissociate from DFF40 (Reaction) 617 
1.3.2.1.8 Homodimerization of DFF40 (Reaction) 618 
1.3.2.1.9 Association of DFF40 with chromatin (Reaction) 620 
1.3.2.1.10 Association of HMGB1/HMGB2 with chromatin (Reaction) 621 
1.3.2.1.11 Cleavage of DNA by DFF40 (Reaction) 623 
1.3.3 Stimulation of the cell death response by PAK-2p34 (Pathway) 624 
1.3.3.1 Cleavage of PAK-2 at 212 (Reaction) 626 
1.3.3.2 Autophosphorylation of PAK-2p34 in the activation loop (Reaction) 628 
1.3.3.3 Proteolytic PAK-2p34 fragment translocates to the nucleus (Reaction) 629 
1.3.3.4 Partial autophosphorylation of PAK-2 at Ser-19, Ser-20, Ser-55, Ser-192, and 631 Ser-197 (Reaction) 
1.3.4 Translocation of active caspase-8 to the mitochondrial membrane (Reaction) 633 
1.3.5 Mitochondrial recruitment of Drp1 (Reaction) 635 
1.3.6 Nuclear translocation of catalytic domain of Mst3 (Reaction) 636 
1.4 Regulation of Apoptosis (Pathway) 637 
1.4.1 Regulation of activated PAK-2p34 by proteasome mediated degradation (Pathway) 638 
1.4.1.1 Ubiquitination of PAK-2p34 (BlackBoxEvent) 639 
1.4.1.2 Proteasome mediated degradation of PAK-2p34 (BlackBoxEvent) 641 
1.4.2 Regulation of PAK-2p34 activity by PS-GAP/RHG10 (Pathway) 643 
1.4.2.1 Rho GTPase-activating protein 10 (RHG10) interacts with caspase-activated 644 PAK-2p34 (Reaction) 
1.4.2.2 Interaction of PAK-2p34 with RGH10/ PS-GAP results in accumulation of 646 PAK-2p34 in the perinuclear region (Reaction) 
1.4.3 Role of DCC in regulating apoptosis (Pathway) 648 
1.4.3.1 Caspase cleavage of DCC (Reaction) 649 
1.4.3.2 DCC interacts with DIP13alpha (Reaction) 651 
1.4.3.3 Caspase-9 binds DCC:DIP13alpha complex (Reaction) 652 
1.4.3.4 Activation of caspase-3 (Reaction) 653 
1.4.3.5 Caspase cleavage of UNC5B (Reaction) 654 
1.4.3.6 DAPK binds UNC5B (Reaction) 657 
1.4.3.7 Caspase cleavage of UNC5A (Reaction) 659 
1.4.3.8 UNC5A binds NRAGE (Reaction) 660 2 Binding and Uptake of Ligands by Scavenger Receptors (Pathway) 663 
2.1 Scavenging of heme from plasma (Pathway) 664 
2.1.1 Haptoglobin binds Hemoglobin (Reaction) 666 
2.1.2 Haptoglobin:Hemoglobin binds CD163 (Reaction) 668 
2.1.3 Hemoglobin:Haptoglobin:CD163 is endocytosed (BlackBoxEvent) 669 
2.1.4 Haptoglobin-related Protein binds Hemoglobin (Reaction) 671 
2.1.5 Ferriheme is transferred from Albumin to Hemopexin (Reaction) 672 
2.1.6 Ferriheme is transferred from Methemoglobin to Hemopexin (Reaction) 674 
2.1.7 Hemopexin binds Heme b (Reaction) 675 
2.1.8 LRP1 (CD91) binds Hemopexin:heme (Reaction) 677 
2.1.9 LRP1:Hemopexin:heme is endocytosed (BlackBoxEvent) 679 
2.1.10 Alpha1-Microglobulin binds heme (Reaction) 680 
2.1.11 Alpha-1-Microglobulin is cleaved (BlackBoxEvent) 682 
2.1.12 Truncated Alpha-1-Microglobulin binds heme (Reaction) 683 
2.2 Scavenging by Class A Receptors (Pathway) 684 
2.2.1 MSR1 (SCARA1, SR-A) binds ligands (Reaction) 686 
2.2.2 MSR1:ligand (SCARA1:ligand, SR-A:ligand) is endocytosed (BlackBoxEvent) 690 
2.2.3 MSR1 (SCARA1) binds collagen (Reaction) 691 
2.2.4 MARCO (SCARA2) binds ligands (Reaction) 693 
2.2.5 MARCO:ligand is endocytosed (BlackBoxEvent) 696 
2.2.6 COLEC12 (SCARA4) binds ligands (Reaction) 698 
2.2.7 COLEC12:ligand is endocytosed (BlackBoxEvent) 699 
2.2.8 SCARA5 binds ligands (Reaction) 700 
2.2.9 SCARA5:ligand is endocytosed (BlackBoxEvent) 702 
2.2.10 COLEC11 binds ligands (Reaction) 703 
2.3 Scavenging by Class B Receptors (Pathway) 705 
2.3.1 Platelet glycoprotein IV (CD36) binds ligands (Reaction) 706 
2.3.2 Platelet glycoprotein IV:ligand (CD36:ligand) is endocytosed (BlackBoxEvent) 709 
2.3.3 SCARB1 (SR-BI, CLA-1) binds ligands (Reaction) 711 
2.3.4 SCARB1:ligand is endocytosed (BlackBoxEvent) 713 2.4 Scavenging by Class F Receptors (Pathway) 715 
2.4.1 SCARF1 (SREC-I) binds ligands (Reaction) 716 
2.4.2 SCARF1:ligand is endocytosed (BlackBoxEvent) 718 
2.5 Scavenging by Class H Receptors (Pathway) 720 
2.5.1 STAB1 (FEEL-1) binds ligands (Reaction) 721 
2.5.2 STAB1:ligand is endocytosed (BlackBoxEvent) 722 
2.5.3 STAB2 (FEEL-2) binds ligands (Reaction) 724 
2.5.4 STAB2:ligand is endocytosed (BlackBoxEvent) 726 3 Cell Cycle (Pathway) 728 
3.1 Cell Cycle Checkpoints (Pathway) 729 
3.1.1 G1/S DNA Damage Checkpoints (Pathway) 730 
3.1.1.1 p53-Dependent G1/S DNA damage checkpoint (Pathway) 731 
3.1.1.1.1 p53-Dependent G1 DNA Damage Response (Pathway) 732 
3.1.1.1.1.1 Stabilization of p53 (Pathway) 733 
3.1.1.1.1.1.1 Phosphorylation of p53 at ser-15 by ATM kinase (Reaction) 735 
3.1.1.1.1.1.2 Phosphorylation of MDM2 at serine-395 by ATM kinase (Reaction) 736 
3.1.1.1.1.1.3 Autodegradation of the E3 ubiquitin ligase COP1 (Pathway) 737 
3.1.1.1.1.1.3.1 Phosphorylation of COP1 at Ser-387 by ATM (Reaction) 738 
3.1.1.1.1.1.3.2 Dissociation of the COP1-p53 complex (Reaction) 739 
3.1.1.1.1.1.3.3 Translocation of COP1 from the nucleus to the cytoplasm (Reaction) 741 
3.1.1.1.1.1.3.4 Autoubiquitination of phospho-COP1(Ser-387 ) (Reaction) 742 
3.1.1.1.1.1.3.5 Proteasome mediated degradation of COP1 (BlackBoxEvent) 743 
3.1.1.1.1.2 Transcriptional activation of p53 responsive genes (Pathway) 744 
3.1.1.1.1.2.1 Transcriptional activation of cell cycle inhibitor p21 (Pathway) 745 
3.1.1.1.1.2.1.1 TP53 binds CDKN1A promoter (Reaction) 745 
3.1.1.1.1.2.1.2 Transcriptional activation of p21 by p53 after DNA damage 746 (BlackBoxEvent) 
3.1.1.1.1.3 Inactivation of Cyclin E:Cdk2 complexes by p27/p21 (Reaction) 748 
3.1.1.2 p53-Independent G1/S DNA damage checkpoint (Pathway) 750 
3.1.1.2.1 p53-Independent DNA Damage Response (Pathway) 750 
3.1.1.2.1.1 Phosphorylation of Cdc25A at Ser-123 in response to DNA damage 751 (Reaction) 
3.1.1.2.1.2 Ubiquitin Mediated Degradation of Phosphorylated Cdc25A (Pathway) 753 
3.1.1.2.1.2.1 Phosphorylation of Cdc25A at Ser-123 by Chk2 (Reaction) 753 
3.1.1.2.1.2.2 Ubiquitination of phosphorylated Cdc25A (Reaction) 754 
3.1.1.2.1.2.3 Proteolytic degradation of ubiquitinated-Cdc25A (BlackBoxEvent) 755 
3.1.1.2.1.2.4 Phosphorylation and activation of Chk1 by ATM (Reaction) 755 
3.1.1.2.1.2.5 Phosphorylation of Cdc25A at Ser-123 by Chk1 (Reaction) 756 
3.1.2 G2/M Checkpoints (Pathway) 757 
3.1.2.1 G2/M DNA damage checkpoint (Pathway) 757 
3.1.2.1.1 Recruitment and activation of Chk1 (Reaction) 758 
3.1.2.1.2 Phosphorylation and activation of CHK2 by ATM (Reaction) 761 
3.1.2.1.3 Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex (Pathway) 762 
3.1.2.1.3.1 Phosphorylation of Cdc25C at Ser216 (Reaction) 762 
3.1.2.1.3.2 Association of phospho-Cdc25C(Ser 216) with 14-3-3 proteins (Reaction) 764 
3.1.2.1.3.3 Retention of phospho-Cdc25C:14-3-3 complexes within the cytoplasm 765 (Reaction) 
3.1.2.1.3.4 Phosphorylation of Wee1 kinase by Chk1 (Reaction) 766 
3.1.2.1.3.5 Wee1-mediated phosphorylation of Cyclin B1:phospho-Cdc2 complexes 767 (Reaction) 
3.1.2.2 G2/M DNA replication checkpoint (Pathway) 768 
3.1.2.2.1 Myt-1 mediated phosphorylation of Cyclin B:Cdc2 complexes (Reaction) 769 
3.1.2.2.2 Wee1-mediated phosphorylation of Cyclin B1:phospho-Cdc2 complexes 770 (Reaction) 
3.1.2.3 Activation of ATR in response to replication stress (Pathway) 770 
3.1.2.3.1 Stalling of DNA replication fork and RPA binding (Reaction) 773 
3.1.2.3.2 Binding of ATR-ATRIP to the RPA-ssDNA complex (Reaction) 775 
3.1.2.3.3 Recruitment of Rad17-RFC complex to DNA (Reaction) 777 
3.1.2.3.4 Recruitment of the Rad9-Hus1-Rad1 complex to DNA (Reaction) 779 
3.1.2.3.5 Loading of claspin onto DNA during replication origin firing (Reaction) 781 
3.1.2.3.6 Activation of claspin (Reaction) 783 
3.1.2.3.7 Recruitment and activation of Chk1 (Reaction) 784 
3.1.2.3.8 Phosphorylation of Cdc25A at Ser-123 by Chk1 (Reaction) 784 
3.1.2.3.9 Phosphorylation of Cdc25C at Ser 216 by Chk1 (Reaction) 785 
3.1.3 Mitotic Spindle Checkpoint (Pathway) 786 
3.1.3.1 Amplification of signal from the kinetochores (Pathway) 787 
3.1.3.1.1 Amplification of signal from unattached kinetochores via a MAD2 inhibitory 788 signal (Pathway) 
3.1.3.1.1.1 Mad1 binds kinetochore (Reaction) 789 
3.1.3.1.1.2 MAD2 associates with the Mad1 kinetochore complex (Reaction) 789 
3.1.3.1.1.3 MAD2 converted to an inhibitory state via interaction with Mad1 (Reaction) 790 
3.1.3.1.1.4 Release of activated MAD2 from kinetochores (Reaction) 791 
3.1.3.2 Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by792 mitotic spindle checkpoint components (Pathway) 
3.1.3.2.1 Inactivation of APC/C via CDC20 sequestration (Reaction) 794 
3.1.3.2.2 Inactivation of APC/C via direct inhibition of the APC/C complex (Pathway) 795 
3.1.3.2.2.1 Formation of the MCC complex (Reaction) 796 
3.1.3.2.2.2 Binding of the MCC complex to the APC/C complex (Reaction) 797 
3.2 Cell Cycle, Mitotic (Pathway) 798 
3.2.1 Mitotic G1-G1/S phases (Pathway) 799 
3.2.1.1 G0 and Early G1 (Pathway) 800 
3.2.1.1.1 Phosphorylation of LIN52 component of MuvB by DYRK1A (Reaction) 801 
3.2.1.1.2 p130 (RBL2) associates with MuvB to form DREAM complex (Reaction) 802 
3.2.1.1.3 Transcription of E2F targets under negative control by DREAM complex 803 (BlackBoxEvent) 
3.2.1.1.4 Recruitment of HDAC1 by p107 (RBL1) (Reaction) 804 
3.2.1.1.5 Recruitment of HDAC1 by p130 (RBL2) (Reaction) 805 
3.2.1.1.6 Transcription of E2F targets under negative control by p107 (RBL1) and p130 806 (RBL2) in complex with HDAC1 (BlackBoxEvent) 
3.2.1.1.7 p107 (RBL1) binds CyclinE/A:CDK2 (Reaction) 
3.2.1.1.8 p107 (RBL1) in complex with E2F4:DP1/2 binds to cyclin E/A:CDK2 (Reaction)809 
3.2.1.1.9 p130 (RBL2) binds Cyclin E/A:CDK2 (Reaction) 810 
3.2.1.1.10 p130 (RBL2) in complex with E2F4/5:DP1/2 binds to cyclin E/A:CDK2 811 (Reaction) 
3.2.1.2 G1 Phase (Pathway) 812 
3.2.1.2.1 Cyclin D associated events in G1 (Pathway) 813 
3.2.1.2.1.1 Formation of Cyclin D:Cdk4/6 complexes (Reaction) 814 
3.2.1.2.1.2 Translocation of Cyclin D:Cdk4/6 complexes from the cytoplasm to the 816 nucleus (Reaction) 
3.2.1.2.1.3 Phosphorylation of Cyclin D:Cdk4/6 complexes (Reaction) 817 
3.2.1.2.1.4 Cyclin D:Cdk4/6 mediated phosphorylation of Rb and dissociation of 819 phospho-Rb from the E2F1/2/3:DP-1 complexes (Reaction) 
3.2.1.2.1.5 Association of INK4A with Cdk4/6 (Reaction) 820 
3.2.1.2.1.6 Cyclin D:CDK4/6 mediated phosphorylation of p107 (RBL1) and dissociation821 of phosphorylated p107 (p-RBL1) from DP1:E2F4 complex (Reaction) 
3.2.1.2.1.7 Dephosphorylation of p107 (RBL1) by PP2A (Reaction) 823 
3.2.1.2.1.8 Cyclin D:Cdk4/6 mediated phosphorylation of p130 (RBL2) and dissociation824 of phosphorylated p130 (RBL2) from DP1:E2F4/5 complex (Reaction) 
3.2.1.2.1.9 Dephosphorylation of p130 (RBL2) by PP2A (Reaction) 825 
3.2.1.2.1.10 Phosphorylated p130 (RBL2) binds SCF(Skp2):Cks1 complex (Reaction) 826 
3.2.1.2.1.11 Ubiquitination of p130 (RBL2) by SCF (Skp2) (Reaction) 827 
3.2.1.3 G1/S Transition (Pathway) 828 
3.2.1.3.1 Cyclin E associated events during G1/S transition (Pathway) 829 
3.2.1.3.1.1 Formation of Cyclin E:Cdk2 complexes (Reaction) 830 
3.2.1.3.1.2 Translocation of Cyclin E:Cdk2 complex to the nucleus (Reaction) 831 
3.2.1.3.1.3 Translocation of p21 to the nucleus (Reaction) 831 
3.2.1.3.1.4 Translocation of p27 to the nucleoplasm (Reaction) 832 
3.2.1.3.1.5 Inactivation of Cyclin E:Cdk2 complexes by p27/p21 (Reaction) 833 
3.2.1.3.1.6 SCF(Skp2)-mediated degradation of p27/p21 (Pathway) 834 
3.2.1.3.1.6.1 Cyclin E/A:Cdk2-mediated phosphorylation of p27/p21 (Reaction) 837 
3.2.1.3.1.6.2 Association of Cks1 with SCF(Skp2) complex (Reaction) 839 
3.2.1.3.1.6.3 Binding of phospho-p27/p21:Cdk2:Cyclin E/A to the SCF(Skp2):Cks1 840 complex (Reaction) 
3.2.1.3.1.6.4 Ubiquitination of phospho-p27/p21 (Reaction) 842 
3.2.1.3.1.6.5 Degradation of ubiquitinated p27/p21 by the 26S proteasome 843 (BlackBoxEvent) 
3.2.1.3.1.7 Phosphorylation of Cyclin E:Cdk2 complexes by Wee-1 (Reaction) 844 
3.2.1.3.1.8 Phosphorylation of Cyclin E1:Cdk2 complexes by Myt1 (Reaction) 846 
3.2.1.3.1.9 Phosphorylation of Cyclin E2:Cdk2 complexes by Myt1 (Reaction) 847 
3.2.1.3.1.10 Activation of Cdc25A by c-myc (BlackBoxEvent) 847 
3.2.1.3.1.11 Dephosphorylation of Cyclin E:Cdk2 complexes by Cdc25A (Reaction) 849 
3.2.1.3.1.12 CAK-mediated phosphorylation of Cyclin E:Cdk2 (Reaction) 851 
3.2.1.3.1.13 Association of Rb with Cyclin E:Cdk2 complexes (Reaction) 852 
3.2.1.3.1.14 Phosphorylation of proteins involved in G1/S transition by active Cyclin 853 E:Cdk2 complexes (Pathway) 
3.2.1.3.1.14.1 Cyclin E:Cdk2-mediated phosphorylation of Rb (Reaction) 854 
3.2.1.3.2 G1/S-Specific Transcription (Pathway) 855 
3.2.1.3.2.1 Activation of E2F target genes at G1/S (BlackBoxEvent) 855 
3.2.1.3.3 Activation of the pre-replicative complex (Pathway) 858 
3.2.1.3.3.1 Mcm10 associates with the pre-replicative complex, stabilizing Mcm2-7 859 (Reaction) 
3.2.1.3.3.2 Cdt1 is displaced from the pre-replicative complex. (Reaction) 861 
3.2.1.3.3.3 CDK and DDK associate with the Mcm10:pre-replicative complex (Reaction)862 
3.2.1.3.3.4 Mcm2-7 is phosphorylated by DDK (Reaction) 862 
3.2.1.3.3.5 Cdc45 associates with the pre-replicative complex at the origin (Reaction) 863 
3.2.1.3.3.6 DNA Replication Factor A (RPA) associates with the pre-replicative complex865 at the origin (Reaction) 
3.2.1.3.3.7 DNA polymerase alpha:primase binds at the origin (Reaction) 866 
3.2.1.3.3.8 DNA polymerase epsilon binds at the origin (Reaction) 867 
3.2.1.3.4 E2F mediated regulation of DNA replication (Pathway) 868 
3.2.1.3.4.1 Inhibition of replication initiation of damaged DNA by RB1/E2F1 (Pathway) 869 
3.2.1.3.4.1.1 Detection of damage during initiation of DNA synthesis in S-phase 869 (Reaction) 
3.2.1.3.4.1.2 PP2A mediated localization of RB1 protein in chromatin (Reaction) 870 
3.2.1.3.4.1.3 Replication initiation regulation by Rb1/E2F1 (Reaction) 871 
3.2.1.3.4.2 E2F-enabled inhibition of pre-replication complex formation (Pathway) 872 
3.2.1.3.4.2.1 Activation of Cyclin B/Cdk1 by Cdc25a (string) protein (BlackBoxEvent) 872 
3.2.1.3.4.2.2 Association of Cyclin B/Cdk1 with replicative origin inhibits pre-RC 873 formation (Reaction) 
3.2.1.3.4.3 Activation of E2F target genes at G1/S (BlackBoxEvent) 874 
3.2.2 S Phase (Pathway) 874 
3.2.2.1 Cyclin A:Cdk2-associated events at S phase entry (Pathway) 875 
3.2.2.1.1 Formation of Cyclin A:Cdk2 complexes (Reaction) 877 
3.2.2.1.2 Translocation of Cyclin A:Cdk2 complexes to the nucleus (Reaction) 878 
3.2.2.1.3 Translocation of p21 to the nucleus (Reaction) 879 
3.2.2.1.4 Translocation of p27 to the nucleoplasm (Reaction) 879 
3.2.2.1.5 SCF(Skp2)-mediated degradation of p27/p21 (Pathway) 879 
3.2.2.1.5.1 Cyclin E/A:Cdk2-mediated phosphorylation of p27/p21 (Reaction) 880 
3.2.2.1.5.2 Association of Cks1 with SCF(Skp2) complex (Reaction) 880 
3.2.2.1.5.3 Binding of phospho-p27/p21:Cdk2:Cyclin E/A to the SCF(Skp2):Cks1 880 complex (Reaction) 
3.2.2.1.5.4 Ubiquitination of phospho-p27/p21 (Reaction) 880 
3.2.2.1.5.5 Degradation of ubiquitinated p27/p21 by the 26S proteasome 881 (BlackBoxEvent) 
3.2.2.1.6 Phosphorylation of Cyclin A:Cdk2 at Tyr 15 (Reaction) 881 
3.2.2.1.7 Activation of Cdc25A by c-myc (BlackBoxEvent) 882 
3.2.2.1.8 Cdc25A mediated dephosphorylation of Cyclin A:phospho-Cdk2 (Reaction) 882 
3.2.2.1.9 CAK-mediated phosphorylation of Cyclin A:Cdk2 (Reaction) 883 
3.2.2.1.10 Cyclin A:Cdk2 mediated phosphorylation of p27/p21 (Reaction) 885 
3.2.2.1.11 Inactivation of Cyclin A:Cdk2 complexes by p27/p21 (Reaction) 886 
3.2.2.1.12 Phosphorylation of proteins involved in the G1/S transition by Cyclin A:Cdk2 888 (Reaction) 
3.2.2.2 Synthesis of DNA (Pathway) 889 
3.2.2.2.1 DNA replication initiation (Pathway) 889 
3.2.2.2.1.1 The primase component of DNA polymerase:primase synthesizes a 6-10 890 nucleotide RNA primer at the origin (Reaction) 
3.2.2.2.1.2 The polymerase component of DNA polymerase alpha:primase synthesizes891 a 20-nucleotide primer at the origin (Reaction) 
3.2.2.2.2 Switching of origins to a post-replicative state (Pathway) 892 
3.2.2.2.2.1 Orc1 removal from chromatin (Pathway) 892 
3.2.2.2.2.1.1 Orc1 is phosphorylated by cyclin A/CDK2 (Reaction) 892 
3.2.2.2.2.1.2 Phosphorylated Orc1 is ubiquitinated while still associated with chromatin893 (Reaction) 
3.2.2.2.2.1.3 Ubiquitinated Orc1 enters the cytosol (Reaction) 894 
3.2.2.2.2.1.4 Ubiquitinated Orc1 is degraded by the proteasome (BlackBoxEvent) 895 
3.2.2.2.2.2 CDK-mediated phosphorylation and removal of Cdc6 (Pathway) 896 
3.2.2.2.2.2.1 Cdc6 protein is phosphorylated by CDK (Reaction) 896 
3.2.2.2.2.2.2 Phosphorylated Cdc6 is exported from the nucleus (Reaction) 897 
3.2.2.2.2.2.3 Cytoplasmic phosphorylated Cdc6 is ubiquitinated by the 898 anaphase-promoting complex (Reaction) 
3.2.2.2.2.2.4 Ubiquitinated Cdc6 is degraded by the proteasome (BlackBoxEvent) 899 
3.2.2.2.2.3 Mcm4,6,7 trimer forms and associates with the replication fork (Reaction) 900 
3.2.2.2.3 DNA strand elongation (Pathway) 902 
3.2.2.2.3.1 Unwinding of DNA (Pathway) 903 
3.2.2.2.3.1.1 MCM2-7 mediated fork unwinding (Reaction) 904 
3.2.2.2.3.1.2 MCM8 mediated fork unwinding (Reaction) 906 
3.2.2.2.3.1.3 Formation of GINS complex (Reaction) 907 
3.2.2.2.3.1.4 Multiple proteins are localized at replication fork (Reaction) 908 
3.2.2.2.3.2 Leading Strand Synthesis (Pathway) 909 
3.2.2.2.3.2.1 Polymerase switching (Pathway) 910 
3.2.2.2.3.2.1.1 RFC binding displaces Pol Alpha (Reaction) 912 
3.2.2.2.3.2.1.2 Loading of PCNA - Sliding Clamp Formation (Reaction) 913 
3.2.2.2.3.2.1.3 RFC dissociates after sliding clamp formation (Reaction) 913 
3.2.2.2.3.2.1.4 Formation of Processive Complex (Reaction) 914 
3.2.2.2.3.2.2 Processive synthesis on the leading strand (BlackBoxEvent) 915 
3.2.2.2.3.3 Lagging Strand Synthesis (Pathway) 916 
3.2.2.2.3.3.1 Polymerase switching (Pathway) 916 
3.2.2.2.3.3.1.1 RFC binding displaces Pol Alpha (Reaction) 916 
3.2.2.2.3.3.1.2 Loading of PCNA - Sliding Clamp Formation (Reaction) 917 
3.2.2.2.3.3.1.3 RFC dissociates after sliding clamp formation (Reaction) 917 
3.2.2.2.3.3.1.4 Formation of Processive Complex (Reaction) 917 
3.2.2.2.3.3.2 Processive synthesis on the lagging strand (Pathway) 917 
3.2.2.2.3.3.2.1 Formation of Okazaki fragments (Reaction) 919 
3.2.2.2.3.3.2.2 Formation of the Flap Intermediate (Reaction) 920 
3.2.2.2.3.3.2.3 Removal of the Flap Intermediate (Pathway) 920 
3.2.2.2.3.3.2.3.1 RPA binds to the Flap (Reaction) 921 
3.2.2.2.3.3.2.3.2 Recruitment of Dna2 endonuclease (Reaction) 922 
3.2.2.2.3.3.2.3.3 Removal of RNA primer and dissociation of RPA and Dna2 922 (Reaction) 
3.2.2.2.3.3.2.3.4 Removal of remaining Flap (Reaction) 923 
3.2.2.2.3.3.2.4 Joining of adjacent Okazaki fragments (Reaction) 924 
3.2.2.3 Ubiquitin-dependent degradation of Cyclin D (Pathway) 925 
3.2.2.3.1 Ubiquitin-dependent degradation of Cyclin D1 (Pathway) 926 
3.2.2.3.1.1 Phosphorylation of Cyclin D1 at T286 by glycogen synthase kinase-3 beta 926 (Reaction) 
3.2.2.3.1.2 Relocalization of nuclearly localized phospho-(T286):cyclin D1:Cdk4 to 927 cytoplasm (Reaction) 
3.2.2.3.1.3 Relocalization of nuclearly localized Cyclin D1 to the cytoplasm (Reaction) 928 
3.2.2.3.1.4 Ubiquitination of Cyclin D1 (Reaction) 928 
3.2.2.3.1.5 Proteasome mediated degradation of Cyclin D1 (BlackBoxEvent) 929 
3.2.2.4 Establishment of Sister Chromatid Cohesion (Pathway) 930 
3.2.2.4.1 Acetylation of SMC3 subunit of chromosomal arm associated cohesin by 932 ESCO1 or ESCO2 (Reaction) 
3.2.2.4.2 Acetylation of SMC3 subunit of centromeric chromatin associated cohesin by 933 ESCO1 or ESCO2 (Reaction) 
3.2.2.4.3 CDCA5 (Sororin) enables cohesion of sister chromosomal arms (Reaction) 936 
3.2.2.4.4 CDCA5 (Sororin) enables cohesion of sister centromeres (Reaction) 937 
3.2.3 Regulation of DNA replication (Pathway) 938 
3.2.3.1 Association of licensing factors with the pre-replicative complex (Pathway) 939 
3.2.3.1.1 Orc1 associates with Orc4:Orc5:Orc3:Orc2:origin complexes (Reaction) 939 
3.2.3.1.2 CDC6 protein is synthesized under the control of E2F transcription factors 940 (BlackBoxEvent) 
3.2.3.1.3 The geminin component of geminin:Cdt1 complexes is ubiquitinated, releasing941 Cdt1 (Reaction) 
3.2.3.2 Removal of licensing factors from origins (Pathway) 941 
3.2.3.2.1 Orc1 removal from chromatin (Pathway) 942 
3.2.3.2.1.1 Orc1 is phosphorylated by cyclin A/CDK2 (Reaction) 942 
3.2.3.2.1.2 Phosphorylated Orc1 is ubiquitinated while still associated with chromatin 942 (Reaction) 
3.2.3.2.1.3 Ubiquitinated Orc1 enters the cytosol (Reaction) 942 
3.2.3.2.1.4 Ubiquitinated Orc1 is degraded by the proteasome (BlackBoxEvent) 943 
3.2.3.2.2 Cdt1 is displaced from the pre-replicative complex. (Reaction) 943 
3.2.3.2.3 Cdt1 associates with geminin (Reaction) 943 
3.2.3.2.4 CDK-mediated phosphorylation and removal of Cdc6 (Pathway) 944 
3.2.3.2.4.1 Cdc6 protein is phosphorylated by CDK (Reaction) 944 
3.2.3.2.4.2 Phosphorylated Cdc6 is exported from the nucleus (Reaction) 944 
3.2.3.2.4.3 Cytoplasmic phosphorylated Cdc6 is ubiquitinated by the 945 anaphase-promoting complex (Reaction) 
3.2.3.2.4.4 Ubiquitinated Cdc6 is degraded by the proteasome (BlackBoxEvent) 945 
3.2.3.2.5 Mcm4,6,7 trimer forms and associates with the replication fork (Reaction) 945 
3.2.4 Mitotic G2-G2/M phases (Pathway) 946 
3.2.4.1 G2 Phase (Pathway) 946 
3.2.4.1.1 Association of Cyclin A:phospho-Cdk2(Thr 160) with E2F1/E2F3 (Reaction) 947 
3.2.4.1.2 Phosphorylation of E2F1/E2F3 by Cyclin A:phosph-Cdk2(Thr 160) (Reaction) 948 
3.2.4.2 G2/M Transition (Pathway) 949 
3.2.4.2.1 Cyclin A/B1 associated events during G2/M transition (Pathway) 950 
3.2.4.2.1.1 Formation of Cyclin A:Cdc2 complexes (Reaction) 951 
3.2.4.2.1.2 Myt-1 mediated phosphorylation of Cyclin A:Cdc2 (Reaction) 953 
3.2.4.2.1.3 Translocation of Cyclin A:phospho-Cdc2 (Thr 14) to the nucleus (Reaction) 955 
3.2.4.2.1.4 CAK-mediated phosphorylation of Cyclin A:Cdc2 complexes (Reaction) 955 
3.2.4.2.1.5 Wee1-mediated phosphorylation of Cyclin A:phospho-Cdc2 complexes 956 (Reaction) 
3.2.4.2.1.6 Translocation of active Cdc25C to the nucleus (Reaction) 958 
3.2.4.2.1.7 Dephosphorylation of nuclear Cyclin A:phospho-Cdc2 complexes (Reaction)958 
3.2.4.2.1.8 Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2961 complexes (Pathway) 
3.2.4.2.1.8.1 Phosphorylation of proteins involved in G2/M transition by active Cyclin 962 A1:Cdc2 complexes (Reaction) 
3.2.4.2.1.8.2 Phosphorylation of proteins involved in G2/M transition by active Cyclin 963 A2:Cdc2 complexes (Reaction) 
3.2.4.2.1.9 Formation of Cyclin B:Cdc2 complexes (Reaction) 963 
3.2.4.2.1.10 Myt-1 mediated phosphorylation of Cyclin B:Cdc2 complexes (Reaction) 965 
3.2.4.2.1.11 Translocation of Cyclin B1:phospho-Cdc2 complexes to the nucleus 965 (Reaction) 
3.2.4.2.1.12 CAK-mediated phosphorylation of Cyclin B1:Cdc2 complexes (Reaction) 966 
3.2.4.2.1.13 Wee1-mediated phosphorylation of Cyclin B1:phospho-Cdc2 complexes 966 (Reaction) 
3.2.4.2.1.14 Translocation of Cyclin B1:phospho-Cdc2 to the cytoplasm (Reaction) 967 
3.2.4.2.1.15 Translocation of Cdc25B to the cytoplasm (Reaction) 968 
3.2.4.2.1.16 Dephosphorylation of cytoplasmic Cyclin B1:phospho-Cdc2 (Thr 14, Tyr 15) 968 complexes by Cdc25 phosphatases (Reaction) 
3.2.4.2.1.17 Phosphorylation of Cyclin B1 in the CRS domain (Reaction) 970 
3.2.4.2.1.18 Translocation of CRS phosphorylated Cyclin B1:Cdc2 complexes 971 (Reaction) 
3.2.4.2.1.19 Translocation of Cdc25 to the nucleus (Reaction) 972 
3.2.4.2.1.20 Dephosphorylation of nuclear Cyclin B1:phospho-Cdc2 (Thr 14, Tyr15) 973 complexes by Cdc25 phosphatases (Reaction) 
3.2.4.2.1.21 Phosphorylation of M phase proteins by active Cyclin B1:Cdc2 complexes974 (Reaction) 
3.2.4.2.1.22 CCNA:CDK1/2 complexes and CCNB:CDK1 complexes phosphorylate 975 FOXM1 (Reaction) 
3.2.4.2.1.23 PP2A-PPP2R2A dephosphorylates FOXM1 (Reaction) 977 
3.2.4.2.2 Cyclin B2 mediated events (Pathway) 978 
3.2.4.2.2.1 Dephosphorylation of cyclin B2:phospho-Cdc2 (Thr 14) by Cdc25 (Reaction)979 
3.2.4.2.2.2 Phosphorylation of proteins involved in G2/M transition by active Cyclin B2:Cdc2 complexes (Reaction) 
3.2.4.2.3 Regulation of PLK1 Activity at G2/M Transition (Pathway) 983 
3.2.4.2.3.1 AJUBA binds centrosome-associated AURKA (Reaction) 985 
3.2.4.2.3.2 AJUBA facilitates AURKA autophosphorylation (Reaction) 986 
3.2.4.2.3.3 CDK1 phosphorylates BORA (Reaction) 987 
3.2.4.2.3.4 BORA binds PLK1 and AURKA (Reaction) 988 
3.2.4.2.3.5 AURKA phosphorylates PLK1 (Reaction) 990 
3.2.4.2.3.6 PLK1 phosphorylates BORA (Reaction) 991 
3.2.4.2.3.7 Phosphorylated BORA binds SCF-beta-TrCp1/2 (Reaction) 992 
3.2.4.2.3.8 SCF-beta-TrCp1/2 ubiquitinates phosphorylated BORA (Reaction) 993 
3.2.4.2.3.9 PLK1 phosphorylates OPTN (Reaction) 994 
3.2.4.2.3.10 Phosphorylated OPTN translocates to the nucleus (Reaction) 995 
3.2.4.2.3.11 Cytosolic PLK1 translocates to the nucleus (Reaction) 996 
3.2.4.2.3.12 Myosin phosphatase dephosphorylates PLK1 (Reaction) 997 
3.2.4.2.4 Polo-like kinase mediated events (Pathway) 999 
3.2.4.2.4.1 Inactivation of Wee1 kinase (Reaction) 1002 
3.2.4.2.4.2 Activation of Cdc25C (Reaction) 1004 
3.2.4.2.4.3 Inactivation of Myt1 kinase (Reaction) 1006 
3.2.4.2.4.4 PLK1 binds FOXM1 (Reaction) 1008 
3.2.4.2.4.5 PLK1 phosphorylates FOXM1 (Reaction) 1009 
3.2.4.2.4.6 FOXM1 binds CDC25A promoter (Reaction) 1010 
3.2.4.2.4.7 FOXM1 stimulates CDC25A transcription (BlackBoxEvent) 1011 
3.2.4.2.4.8 FOXM1 binds PLK1 promoter (Reaction) 1013 
3.2.4.2.4.9 FOXM1 stimulates PLK1 transcription (BlackBoxEvent) 1014 
3.2.4.2.4.10 FOXM1 binds CCNB1 promoter (Reaction) 1016 
3.2.4.2.4.11 FOXM1 stimulates CCNB1 transcription (BlackBoxEvent) 1017 
3.2.4.2.4.12 FOXM1 binds CCNB2 promoter (Reaction) 1018 
3.2.4.2.4.13 FOXM1 stimulates CCNB2 transcription (BlackBoxEvent) 1019 
3.2.4.2.4.14 FOXM1 binds CENPF promoter (Reaction) 1021 
3.2.4.2.4.15 FOXM1 stimulates CENPF transcription (BlackBoxEvent) 1022 
3.2.4.2.5 Centrosome maturation (Pathway) 1023 
3.2.4.2.5.1 Recruitment of mitotic centrosome proteins and complexes (Pathway) 1024 
3.2.4.2.5.1.1 Recruitment of CDK11p58 to the centrosomes (Reaction) 1026 
3.2.4.2.5.1.2 Recruitment of Plk1 to centrosomes (Reaction) 1027 
3.2.4.2.5.1.3 Recruitment of NuMA to mitotic centrosomes (Pathway) 1029 
3.2.4.2.5.1.3.1 Cyclin B/Cdk1 mediate phosphorylation of NuMA (Reaction) 1031 
3.2.4.2.5.1.3.2 Translocation of NuMA to the centrosomes (Reaction) 1032 
3.2.4.2.5.1.3.3 Association of NuMA with microtubules (Reaction) 1033 
3.2.4.2.5.1.4 Recruitment of additional gamma tubulin/ gamma TuRC to the 1035 centrosome (Reaction) 
3.2.4.2.5.2 Loss of proteins required for interphase microtubule organizationÂ from the 1037 centrosome (Pathway) 
3.2.4.2.5.2.1 Loss of C-Nap-1 from centrosomes (Reaction) 1038 
3.2.4.2.5.2.2 Loss of Nlp from mitotic centrosomes (Pathway) 1039 
3.2.4.2.5.2.2.1 Plk1-mediated phosphorylation of Nlp (Reaction) 981 1040 
3.2.4.2.5.2.2.2 Dissociation of Phospho-Nlp from the centrosome (Reaction) 1041 
3.2.5 M Phase (Pathway) 1042 
3.2.5.1 Mitotic Prophase (Pathway) 1043 
3.2.5.1.1 Golgi Cisternae Pericentriolar Stack Reorganization (Pathway) 1043 
3.2.5.1.1.1 Phosphorylation of GORASP1, GOLGA2 and RAB1A by CDK1:CCNB 1046 (Reaction) 
3.2.5.1.1.2 GOLGA2 phosphorylated by CDK1 is unable to promote fusion of ER to 1049 Golgi transport vesicles with cis-Golgi (BlackBoxEvent) 
3.2.5.1.1.3 Recruitment of PLK1 to phosphorylated GORASP1 (GRASP65) (Reaction)1051 
3.2.5.1.1.4 PLK1 phosphorylates GORASP1 (Reaction) 1053 
3.2.5.1.1.5 MAPK3-3 or MAPK1 phosphorylate GORASP2 (Reaction) 1055 
3.2.5.1.1.6 GORASP1 phosphorylated by PLK1 and GORASP2 phosphorylated by 1057 MAPK3-3/MAPK1 are unable to promote Golgi cisternae stacking (BlackBoxEvent) 
3.2.5.1.2 Condensation of Prophase Chromosomes (Pathway) 1059 
3.2.5.1.2.1 SETD8 monomethylates histone H4 (Reaction) 1060 
3.2.5.1.2.2 PHF8 demethylates histone H4K20me1 (Reaction) 1062 
3.2.5.1.2.3 CDK1 phosphorylates PHF8 (Reaction) 1063 
3.2.5.1.2.4 RB1 binds condensin II (Reaction) 1064 
3.2.5.1.2.5 Condensin II complex binds H4K20me1-containing nucleosomes (Reaction)1066 
3.2.5.1.2.6 CDK1 phosphorylates condensin II subunit NCAPD3 (Reaction) 1068 
3.2.5.1.2.7 PLK1 binds phosphorylated condensin II complex (Reaction) 1069 
3.2.5.1.2.8 PLK1 hyperphosphorylates Condensin II complex (Reaction) 1070 
3.2.5.1.2.9 Condensin II-mediated condensation of prophase chromosomes 1072 (BlackBoxEvent) 
3.2.5.1.2.10 MCPH1 sequesters condensin II (Reaction) 1073 
3.2.5.1.3 MASTL Facilitates Mitotic Progression (Pathway) 1075 
3.2.5.1.3.1 CDK1 phosphorylates MASTL (Reaction) 1076 
3.2.5.1.3.2 MASTL (GWL) phosphorylates ARPP19 (Reaction) 1079 
3.2.5.1.3.3 MASTL phosphorylates ENSA (Reaction) 1080 
3.2.5.1.3.4 p-S62-ARPP19/p-S67-ENSA binds PP2A-PPP2R2D (Reaction) 1081 
3.2.5.1.4 Nuclear Envelope Breakdown (Pathway) 1083 
3.2.5.1.4.1 Activation of NIMA Kinases NEK9, NEK6, NEK7 (Pathway) 1084 
3.2.5.1.4.1.1 CDK1:CCNB phosphorylates NEK9 (Reaction) 1085 
3.2.5.1.4.1.2 PLK1 phosphorylates NEK9 (Reaction) 1087 
3.2.5.1.4.1.3 NEK9 binds NEK6/NEK7 in the cytosol (Reaction) 1088 
3.2.5.1.4.1.4 NEK9 phosphorylates NEK6/NEK7 (Reaction) 1089 
3.2.5.1.4.2 Nuclear Pore Complex (NPC) Disassembly (Pathway) 1091 
3.2.5.1.4.2.1 CDK1 phosphorylates NUP98 (Reaction) 1092 
3.2.5.1.4.2.2 NEK6/NEK7 phosphorylates NUP98 (Reaction) 1094 
3.2.5.1.4.3 Clearance of Nuclear Envelope Membranes from Chromatin (Pathway) 1095 
3.2.5.1.4.3.1 VRK1/VRK2 phosphorylate BANF1 (Reaction) 1097 
3.2.5.1.4.4 Depolymerisation of the Nuclear Lamina (Pathway) 1100 
3.2.5.1.4.4.1 CDK1 phosphorylates LPIN (Reaction) 1102 
3.2.5.1.4.4.2 CTDNEP1:CNEP1R1 dephosphorylates LPIN (Reaction) 1103 
3.2.5.1.4.4.3 LPIN catalyzes conversion of phosphatidic acid to diacylglycerol (Reaction) 
3.2.5.1.4.4.4 DAG and Ca+2 bind to PKC and tether it to membrane (Reaction) 1107 
3.2.5.1.4.4.5 Depolymerization of lamin filaments after PKC-mediated phosphorylation 1109 (Depolymerisation) 
3.2.5.1.4.4.6 CDK1 phosphorylates lamins and facilitates depolymerization of lamin 1110 filaments (Reaction) 
3.2.5.2 Mitotic Prometaphase (Pathway) 1112 
3.2.5.2.1 Kinetochore capture of astral microtubules (Reaction) 1112 
3.2.5.2.2 Resolution of Sister Chromatid Cohesion (Pathway) 1114 
3.2.5.2.2.1 CDK1 phosphorylates CDCA5 (Sororin) at chromosomal arms (Reaction) 1116 
3.2.5.2.2.2 Phosphorylation of cohesin by PLK1 at chromosomal arms (Reaction) 1117 
3.2.5.2.2.3 Resolution of sister chromatids (Reaction) 1119 
3.2.5.2.2.4 Deacetylation of cohesin (Reaction) 1122 
3.2.5.2.2.5 Kinetochore assembly (BlackBoxEvent) 1123 
3.2.5.2.2.6 CDK1 phosphorylates CDCA5 (Sororin) at centromeres (Reaction) 1124 
3.2.5.2.2.7 Phosphorylation of cohesin by PLK1 at centromeres (Reaction) 1126 
3.2.5.2.2.8 PP2A-B56 dephosphorylates centromeric cohesin (Reaction) 1127 
3.2.5.2.3 Condensation of Prometaphase Chromosomes (Pathway) 1129 
3.2.5.2.3.1 CK2 phosphorylates condensin I subunits (Reaction) 1131 
3.2.5.2.3.2 Dephosphorylation of CK2-modified condensin I (Reaction) 1133 
3.2.5.2.3.3 CDK1 phosphorylates condensin I (Reaction) 1134 
3.2.5.2.3.4 Phosphorylated condensin I promotes condensation of prometaphase 1136 chromosomes (BlackBoxEvent) 
3.2.5.3 Mitotic Metaphase and Anaphase (Pathway) 1139 
3.2.5.3.1 Mitotic Metaphase/Anaphase Transition (Pathway) 1139 
3.2.5.3.1.1 Down Regulation of Emi1 through Phosphorylation of Emi1 (Reaction) 1140 
3.2.5.3.2 Mitotic Anaphase (Pathway) 1142 
3.2.5.3.2.1 Separation of Sister Chromatids (Pathway) 1142 
3.2.5.3.2.1.1 Association of Securin with Cdc20:APC/C complex (Reaction) 1143 
3.2.5.3.2.1.2 Ubiquitination of Securin by phospho-APC/C:Cdc20 complex (Reaction)1144 
3.2.5.3.2.1.3 Degradation of multiubiquitinated Securin (BlackBoxEvent) 1146 
3.2.5.3.2.1.4 PTTG1 (Securin) sequesters ESPL1 (Separase) (Reaction) 1147 
3.2.5.3.2.1.5 Autocleavage of ESPL1 (Separase) (Reaction) 1149 
3.2.5.3.2.1.6 ESPL1 (Separase) cleaves centromeric cohesin (Reaction) 1150 
3.2.5.3.2.1.7 Separation of sister chromatids (Reaction) 1152 
3.2.5.3.2.1.8 Deacetylation of cleaved cohesin (Reaction) 1153 
3.2.5.3.2.2 Nuclear Envelope Reassembly (Pathway) 1154 
3.2.5.3.2.2.1 Initiation of Nuclear Envelope Reformation (Pathway) 1155 
3.2.5.3.2.2.1.1 ANKLE2 binds VRK1 or VRK2 (Reaction) 1157 
3.2.5.3.2.2.1.2 PP2A dephosphorylates BANF1 (Reaction) 1158 
3.2.5.3.2.2.1.3 BANF1 binds chromatin, EMD/TMPO/LEMD3/LEMD2 and lamins 1160 (Reaction) 
3.2.5.4 Mitotic Telophase/Cytokinesis (Pathway) 1161 
3.2.5.4.1 Regulation of KIF23 (MKLP1) by phosphorylation (Reaction) 1161 
3.2.5.4.2 Regulation of KIF20A (MKL2) by phosphorylation (Reaction) 1106
3.2.5.4.3 Regulation of NUDC by phosphorylation (Reaction) 1163 
3.2.5.4.4 Cohesin Loading onto Chromatin (Pathway) 1163 
3.2.5.4.4.1 Cohesin binds PDS5 and WAPAL (Reaction) 1165 
3.2.5.4.4.2 Cohesin binding to decondensed chromatin is facilitated by NIPBL:MAU2 1167 (Reaction) 
3.2.6 M/G1 Transition (Pathway) 1168 
3.2.6.1 DNA Replication Pre-Initiation (Pathway) 1168 
3.2.6.1.1 Assembly of the pre-replicative complex (Pathway) 1169 
3.2.6.1.1.1 Assembly of the ORC complex at the origin of replication (Pathway) 1171 
3.2.6.1.1.1.1 Orc3 associates with Orc2 constitutively bound at origins of replication 1173 (Reaction) 
3.2.6.1.1.1.2 Orc5 associates with Orc3:Orc2:origin complexes (Reaction) 1174 
3.2.6.1.1.1.3 Orc4 associates with Orc5:Orc3:Orc2:origin complexes (Reaction) 1174 
3.2.6.1.1.1.4 Orc1 associates with Orc4:Orc5:Orc3:Orc2:origin complexes (Reaction)1175 
3.2.6.1.1.1.5 Orc6 associates with Orc1:Orc4:Orc5:Orc3:Orc2:origin complexes, 1175 forming ORC:origin complexes (Reaction) 
3.2.6.1.1.2 Association of MCM8 with ORC:origin complex (Reaction) 1176 
3.2.6.1.1.3 CDC6 association with the ORC:origin complex (Pathway) 1177 
3.2.6.1.1.3.1 CDC6 protein is synthesized under the control of E2F transcription factors 1179 (BlackBoxEvent) 
3.2.6.1.1.3.2 CDC6 association with ORC:origin complexes mediated by MCM8 1179 (Reaction) 
3.2.6.1.1.4 CDT1 association with the CDC6:ORC:origin complex (Pathway) 1180 
3.2.6.1.1.4.1 The geminin component of geminin:Cdt1 complexes is ubiquitinated, 1182 releasing Cdt1 (Reaction) 
3.2.6.1.1.4.2 Ubiquitinated geminin is degraded by the proteasome (BlackBoxEvent)1182 
3.2.6.1.1.4.3 Free CDT1 associates with CDC6:ORC:origin complexes (Reaction) 1183 
3.2.6.1.1.5 Mcm2-7 associates with the Cdt1:CDC6:ORC:origin complex, forming the 1184 pre-replicative complex (preRC) (Reaction) 
3.2.6.1.2 Activation of the pre-replicative complex (Pathway) 1186 
3.2.6.1.2.1 Mcm10 associates with the pre-replicative complex, stabilizing Mcm2-7 1186 (Reaction) 
3.2.6.1.2.2 Cdt1 is displaced from the pre-replicative complex. (Reaction) 1186 
3.2.6.1.2.3 CDK and DDK associate with the Mcm10:pre-replicative complex (Reaction)1186 
3.2.6.1.2.4 Mcm2-7 is phosphorylated by DDK (Reaction) 1187 
3.2.6.1.2.5 Cdc45 associates with the pre-replicative complex at the origin (Reaction) 1187 
3.2.6.1.2.6 DNA Replication Factor A (RPA) associates with the pre-replicative complex 1187 at the origin (Reaction) 
3.2.6.1.2.7 DNA polymerase alpha:primase binds at the origin (Reaction) 1187 
3.2.6.1.2.8 DNA polymerase epsilon binds at the origin (Reaction) 1188 
3.2.7 Regulation of mitotic cell cycle (Pathway) 1188 
3.2.7.1 APC/C-mediated degradation of cell cycle proteins (Pathway) 1188 
3.2.7.1.1 Regulation of APC/C activators between G1/S and early anaphase (Pathway)1192 
3.2.7.1.1.1 Association of Cyclin A:Cdk2 with Cdh1 (Reaction) 1194 
3.2.7.1.1.2 Phosphorylation of Cdh1 by Cyclin A:Cdk2 (Reaction) 1195 
3.2.7.1.1.3 Dissociation of phospho-Cdh1 from the APC/C complex (Reaction) 1197 
3.2.7.1.1.4 Association of Emi1 with Cdh1 (Reaction) 1198 
3.2.7.1.1.5 Association of Emi1 with Cdc20 (Reaction) 1199 
3.2.7.1.1.6 Phosphorylation of Emi1 (Pathway) 1200 
3.2.7.1.1.6.1 Phosphorylation of the Emi1 DSGxxS degron by Cyclin B:Cdc2 1201 (Reaction) 
3.2.7.1.1.6.2 Phosphorylation of the Emi1 DSGxxS degron by Plk1 (Reaction) 1202 
3.2.7.1.1.7 SCF-beta-TrCP mediated degradation of Emi1 (Pathway) 1204 
3.2.7.1.1.7.1 Phosphorylated Emi1 binds the beta-TrCP in the SCF complex (Reaction)
 
3.2.7.1.1.7.2 Ubiquitination of Emi1 by SCF-beta-TrCP (Reaction) 1206 
3.2.7.1.1.7.3 SCF-mediated degradation of Emi1 (BlackBoxEvent) 1207 
3.2.7.1.1.8 Phosphorylation of Cdh1 by Cyclin B1:Cdc2 (Reaction) 1208 
3.2.7.1.1.9 Inhibition of the proteolytic activity of APC/C required for the onset of 1209 anaphase by mitotic spindle checkpoint components (Pathway) 
3.2.7.1.1.9.1 Inactivation of APC/C via CDC20 sequestration (Reaction) 1210 
3.2.7.1.1.9.2 Inactivation of APC/C via direct inhibition of the APC/C complex 1210 (Pathway) 
3.2.7.1.1.9.2.1 Formation of the MCC complex (Reaction) 1210 
3.2.7.1.1.9.2.2 Binding of the MCC complex to the APC/C complex (Reaction) 1210 
3.2.7.1.2 Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins (Pathway) 
3.2.7.1.2.1 Phosphorylation of the APC/C (Pathway) 1212 
3.2.7.1.2.1.1 Free APC/C phosphorylated by Plk1 (Reaction) 1212 
3.2.7.1.2.1.2 Free APC/C phosphorylated by Cyclin B:Cdc2 (Reaction) 1214 
3.2.7.1.2.2 APC/C:Cdc20 mediated degradation of mitotic proteins (Pathway) 1215 
3.2.7.1.2.2.1 Activation of APC/C:Cdc20 by dissociation of Cdc20:phospho-APC/C 1217 from Cdc20:phospho-APC/C:Mad2:Bub3:BubR1 (Reaction) 
3.2.7.1.2.2.2 APC/C:Cdc20 mediated degradation of Cyclin B (Pathway) 1218 
3.2.7.1.2.2.2.1 Association of Cyclin B:Cdc2 with Cdc20:APC/C complex (Reaction)1219 
3.2.7.1.2.2.2.2 Ubiquitination of Cyclin B by phospho-APC/C:Cdc20 complex 1220 (Reaction) 
3.2.7.1.2.2.2.3 Degradation of multiubiquitinated Cyclin B (BlackBoxEvent) 1221 
3.2.7.1.2.2.3 APC/C:Cdc20 mediated degradation of Securin (Pathway) 1222 
3.2.7.1.2.2.3.1 Association of Securin with Cdc20:APC/C complex (Reaction) 1224 
3.2.7.1.2.2.3.2 Ubiquitination of Securin by phospho-APC/C:Cdc20 complex 1224 (Reaction) 
3.2.7.1.2.2.3.3 Degradation of multiubiquitinated Securin (BlackBoxEvent) 1225 
3.2.7.1.3 Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase (Pathway) 1225 
3.2.7.1.3.1 Dephosphorylation of phospho-Cdh1 (Reaction) 1226 
3.2.7.1.3.2 Dissociation of Cdc20 from APC/C complex (Reaction) 1227 
3.2.7.1.3.3 Association of Cdh1 with the APC/C (Reaction) 1228 
3.2.7.1.4 APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted1229 proteins in late mitosis/early G1 (Pathway) 
3.2.7.1.4.1 Association of cell cycle proteins with the APC/C:Cdh1 complex (Reaction)1232 
3.2.7.1.4.2 Ubiquitination of cell cycle proteins targeted by the APC/C:Cdh1complex (Reaction) 
3.2.7.1.4.3 Degradation of multiubiquitinated cell cycle proteins (BlackBoxEvent) 1234 
3.2.7.1.4.4 APC/C:Cdh1-mediated degradation of Skp2 (BlackBoxEvent) 1235 
3.2.7.1.5 Autodegradation of Cdh1 by Cdh1:APC/C (Pathway) 1238 
3.2.7.1.5.1 Multiubiquitination of APC/C-associated Cdh1 (Reaction) 1239 
3.2.7.1.5.2 Degradation of multiubiquitinated Cdh1 (BlackBoxEvent) 1240 
3.3 Chromosome Maintenance (Pathway) 1241 
3.3.1 Nucleosome assembly (Pathway) 1242 
3.3.1.1 Deposition of new CENPA-containing nucleosomes at the centromere (Pathway)1243 
3.3.1.1.1 Mis18 complex binds the centromere (Reaction) 1244 
3.3.1.1.2 HJURP:CENPA complex localizes to the centromere (Reaction) 1246 
3.3.1.1.3 New CENPA-containing nucleosomes are deposited at the centromere 1247 (BlackBoxEvent) 
3.3.1.1.4 RSF complex binds the centromere (BlackBoxEvent) 1249 
3.3.2 Telomere Maintenance (Pathway) 1250 
3.3.2.1 Extension of Telomeres (Pathway) 1254 
3.3.2.1.1 Telomere Extension By Telomerase (Pathway) 1254 
3.3.2.1.1.1 Biogenesis And Assembly Of The Telomerase RNP (Reaction) 1257 
3.3.2.1.1.2 Recruitment of Telomerase RNP to the Telomeric Chromosome End 1262 (Reaction) 
3.3.2.1.1.3 Alignment Of The RNA Template On The Telomeric Chromosome End 1264 (Reaction) 
3.3.2.1.1.4 Elongation Of The Telomeric Chromosome End (Reaction) 1266 
3.3.2.1.1.5 Translocation Of Telomerase RNP And Alignment Of RNA Template (TERC)
1268 To Extended Single Stranded Telomeric Chromosome-End (Reaction) 
3.3.2.1.1.6 Elongation of Extended Telomeric Chromosome End (Reaction) 1269 
3.3.2.1.1.7 Disassociation of Telomerase RNP and the Chromosome End (Reaction) 1271 
3.3.2.1.2 Telomere C-strand (Lagging Strand) Synthesis (Pathway) 1273 
3.3.2.1.2.1 Telomere C-strand synthesis initiation (Pathway) 1274 
3.3.2.1.2.1.1 The primase component of DNA polymerase:primase synthesizes a 6-10
1276 nucleotide RNA primer on the G strand of the telomere (Reaction) 
3.3.2.1.2.1.2 The polymerase component of DNA polymerase alpha:primase 1277 synthesizes a 20-nucleotide primer on the G strand of the telomere (Reaction) 
3.3.2.1.2.2 Polymerase switching on the C-strand of the telomere (Pathway) 1278 
3.3.2.1.2.2.1 RFC binding displaces Pol Alpha on the C-strand of the telomere 1280 (Reaction) 
3.3.2.1.2.2.2 Loading of PCNA - Sliding Clamp Formation on the C-strand of the 1281 telomere (Reaction) 
3.3.2.1.2.2.3 RFC dissociates after sliding clamp formation on the C-strand of the 1282 telomere (Reaction) 
3.3.2.1.2.2.4 Formation of Processive Complex on the C-strand of the telomere 1283 (Reaction) 
3.3.2.1.2.3 Processive synthesis on the C-strand of the telomere (Pathway) 1285 
3.3.2.1.2.3.1 Formation of C-strand Okazaki fragments (Reaction) 1287 
3.3.2.1.2.3.2 Formation of the Flap Intermediate on the C-strand (Reaction) 1233
1288 
3.3.2.1.2.3.3 Removal of the Flap Intermediate from the C-strand (Pathway) 1290 
3.3.2.1.2.3.3.1 RPA binds to the Flap on the C-strand (Reaction) 1291 
3.3.2.1.2.3.3.2 Recruitment of Dna2 endonuclease to the C strand (Reaction) 1292 
3.3.2.1.2.3.3.3 Removal of RNA primer and dissociation of RPA and Dna2 from the1293 
C-strand (Reaction) 
3.3.2.1.2.3.3.4 Removal of remaining Flap from the C-strand (Reaction) 1294 
3.3.2.1.2.3.4 Joining of adjacent Okazaki fragments of the C-strand (Reaction) 1295 
3.3.2.1.2.4 Disassociation of Processive Complex and Completed Telomere End 1297 (Reaction) 
3.3.2.2 Packaging Of Telomere Ends (Pathway) 1298 
3.3.2.2.1 Incorporation Of Extended And Processed Telomere End Into Associated 1300 Protein Structure (Reaction) 
3.3.2.2.2 Incorporation Of Extended And Processed Telomere End Into Higher Order 1302 T-Loop And Associated Protein Structure (Reaction) 
3.4 Meiosis (Pathway) 1306 
3.4.1 Meiotic recombination (Pathway) 1307 
3.4.1.1 PRDM9 binds recombination hotspot motifs in DNA (Reaction) 1309 
3.4.1.2 PRDM9 trimethylates histone H3 (Reaction) 1311 
3.4.1.3 SPO11 hydrolyzes DNA forming double-strand breaks (Reaction) 1312 
3.4.1.4 MRN:CtIP hydrolyzes single-strand DNA 3' to SPO11 and SPO11:double-strand1314 break dissociates to SPO11:oligonucleotide and resected 5' end (BlackBoxEvent) 
3.4.1.5 Formation of meiotic single-stranded DNA invasion complex (BlackBoxEvent) 1317 
3.4.1.6 Formation of meiotic heteroduplex (BlackBoxEvent) 1322 
3.4.1.7 Formation of meiotic holliday junction (BlackBoxEvent) 1325 
3.4.1.8 Resolution of meiotic holliday junction (BlackBoxEvent) 1328 
3.4.2 Meiotic synapsis (Pathway) 1332 
3.4.2.1 Formation of axial/lateral elements of Synaptonemal Complex (BlackBoxEvent) 1334 
3.4.2.2 Telomeres cluster at the nuclear membrane (BlackBoxEvent) 1336 
3.4.2.3 Synapsis (BlackBoxEvent) 1339 
3.4.2.4 BRCA1 is recruited to unsynapsed regions (Reaction) 1342 
3.4.2.5 ATR Kinase is recruited to unsynapsed regions (Reaction) 1344 
3.4.2.6 ATR phosphorylates Histone H2A.X at unsynapsed regions (Reaction) 1346 4 Cell-Cell communication (Pathway) 1348 
4.1 Cell junction organization (Pathway) 1349 
4.1.1 Cell-cell junction organization (Pathway) 1349 
4.1.1.1 Adherens junctions interactions (Pathway) 1351 
4.1.1.1.1 Connection of adjacent cells through calcium-dependent trans-dimerization of1352 cadherin (Reaction) 
4.1.1.1.2 Interaction of cadherin with Beta/gamma catenin, alpha catenin and p120 1354 catenin (Reaction) 
4.1.1.1.3 Interaction of Afadin with F-actin (Reaction) 1355 
4.1.1.1.4 Interaction of Nectins with Afadin (Reaction) 1357 
4.1.1.1.5 Cis-homodimerization of nectins (Reaction) 1358 
4.1.1.1.6 Transhomodimerization of Nectins (Reaction) 1359 
4.1.1.1.7 Transhomodimerization of Nectin-like (Necl) proteins (Reaction) 1361 
4.1.1.1.8 Nectin/Necl trans heterodimerization (Pathway) 1362 
4.1.1.1.8.1 Nectin-1:PVRL3 trans heterodimer formation (Reaction) 1364 
4.1.1.1.8.2 Nectin-1:Nectin-4 trans heterodimer formation (Reaction) 1365 
4.1.1.1.8.3 Nectin-2:Nectin 3 trans heterodimer interaction (Reaction) 1366 
4.1.1.1.8.4 Necl-1:Nectin-1 trans heterodimer interaction (Reaction) 1367 
4.1.1.1.8.5 Necl-1:Nectin 3 trans heterodimer interaction (Reaction) 1369 
4.1.1.1.8.6 Necl-1:Necl-2 trans heterodimer interaction (Reaction) 1370 
4.1.1.1.8.7 Necl-2:Nectin 3 trans heterodimer interaction (Reaction) 1371 
4.1.1.1.8.8 PVR:PVRL3 trans heterodimer interaction (Reaction) 1372 
4.1.1.2 Tight junction interactions (Pathway) 1373 
4.1.1.2.1 Claudins create paired strands through homophilic and heterophilic cis and 1376 trans interactions (Reaction) 
4.1.1.2.2 Recruitment of PAR-3:PAR-6:aPKC complex to tight junctions (Reaction) 1379 
4.1.1.2.3 Crumbs forms a ternary complex with Pals1 and PATJ at tight junctions 1381 (Reaction) 
4.1.2 Cell-extracellular matrix interactions (Pathway) 1383 
4.1.2.1 Formation of the PINCH-ILK-parvin complex (Reaction) 1384 
4.1.2.2 Localization of the PINCH-ILK-PARVIN complex to focal adhesions (Pathway) 1386 
4.1.2.2.1 ILK interacts with beta-1 integrin (Reaction) 1387 
4.1.2.2.2 PARVA associates with Paxillin (Reaction) 1388 
4.1.2.3 Regulation of cytoskeletal remodeling and cell spreading by IPP complex 1389 components (Pathway) 
4.1.2.3.1 PARVB/Affixin interacts with alpha PIX (Reaction) 1390 
4.1.2.3.2 PARVA associates with Paxillin (Reaction) 1392 
4.1.2.3.3 Rsu-1 interacts with Pinch1 (Reaction) 1392 
4.1.2.3.4 Association of PARVA with TESK1 (Reaction) 1393 
4.1.2.3.5 PARVB interacts with Alpha-actinin (Reaction) 1395 
4.1.2.4 Mig-2 recruits Migfilin to the cell-ECM adhesions (Reaction) 1396 
4.1.2.5 MigFilin associates with Filamin and F-actin (Reaction) 1397 
4.1.2.6 Migfilin interacts with VASP (Reaction) 1398 
4.1.3 Type I hemidesmosome assembly (Pathway) 1400 
4.1.3.1 Interaction of Plectin with Integrin beta 4 (Reaction) 1401 
4.1.3.2 BP180 interacts intracellularly with plectin and integrin beta4 (Reaction) 1403 
4.1.3.3 BP180 interacts extracellularly with Laminin 332 (Reaction) 1404 
4.1.3.4 BP230 is recruited to the hemidesmosome (Reaction) 1405 
4.1.3.5 BP230 interacts with keretin K5/K14 (Reaction) 1406 
4.1.3.6 CD151 interacts with BP180 and the integrin alpha 6 subunit (Reaction) 1407 
4.2 Signal regulatory protein (SIRP) family interactions (Pathway) 1408 
4.2.1 SIRP alpha binds CD47 (Reaction) 1410 
4.2.2 Phosphorylation of ITIM in SIRP alpha (Reaction) 1412 
4.2.3 Recruitment of SHP-2 and SHP-1 to pSIRP alpha (Reaction) 1414 
4.2.4 Recruitment of SCAP2 to pSIRP alpha (Reaction) 1417 
4.2.5 Recruitment of FYB to pSIRP alpha (Reaction) 1418 
4.2.6 Recruitment of PYK2 to pSIRP alpha (Reaction) 1419 
4.2.7 Recruitment of Grb2 to pSIRP alpha (Reaction) 1421 4.2.8 SP-A/SP-D binds SIRP alpha (Reaction) 1422 
4.2.9 Interaction of DAP12 and SIRP beta (Reaction) 1423 
4.2.10 SIRP gamma binds CD47 (Reaction) 1425 
4.3 DSCAM interactions (Pathway) 1426 
4.3.1 DSCAM/DSCAML1 homodimerization (Reaction) 1427 
4.3.2 DSCAM binds DCC (Reaction) 1429 
4.3.3 DSCAM binds Netrin-1 (Reaction) 1430 
4.3.4 DSCAM associates with Rac1-GTP:pPAK1 (Reaction) 1432 
4.3.5 Activation of JNK by DSCAM (Reaction) 1433 
4.3.6 Activation of p38MAPK by DSCAM (BlackBoxEvent) 1435 
4.4 Nephrin interactions (Pathway) 1436 
4.4.1 Nephrin trans-homophilic interaction (Reaction) 1438 
4.4.2 Cis-Heterodimerization of nephrin and NEPH1 (Reaction) 1439 
4.4.3 Heterodimerization of nephrin and NEPH2/NEPH3 (Reaction) 1441 
4.4.4 Phosphorylation of nephrin by the Src family kinase Fyn (Reaction) 1442 
4.4.5 Nephrin binds NCK (Reaction) 1444 
4.4.6 Nephrin mediated activation of N-WASP (Reaction) 1445 
4.4.7 Nephrin interacts with Podocin (Reaction) 1447 
4.4.8 Nephrin binds CD2AP (Reaction) 1448 
4.4.9 p85 associates with both p-Nephrin and CD2AP (Reaction) 1450 
4.4.10 Nephrin binds CASK (Reaction) 1452 
4.4.11 Interaction of IQGAP1 with nephrin (Reaction) 1454 
4.4.12 Interaction of nephrin with adherens junction-associated proteins (Reaction) 1455 5 Cellular responses to stress (Pathway) 1458 
5.1 Cellular response to hypoxia (Pathway) 1459 
5.1.1 Regulation of Hypoxia-inducible Factor (HIF) by oxygen (Pathway) 1460 
5.1.1.1 Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha 1461 (Pathway) 
5.1.1.1.1 Cytosolic hydroxylation of asparagine residue in HIF alpha (Reaction) 1463 
5.1.1.2 Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha 1465 (Pathway) 
5.1.1.2.1 Cytosolic PHD2,3 hydroxylates proline residues on EPAS1 (HIF2A) (Reaction)1467 
5.1.1.2.2 Cytosolic PHD2,3 hydroxylates proline residues on HIF1A (Reaction) 1470 
5.1.1.2.3 Cytosolic PHD2,3 hydroxylates proline residues on HIF3A (Reaction) 1473 
5.1.1.2.4 Nuclear PHD1,3 hydroxylates proline residues on EPAS1 (HIF2A) (Reaction)1474 
5.1.1.2.5 Nuclear PHD1,3 hydroxylates proline residues on HIF1A (Reaction) 1477 
5.1.1.2.6 Nuclear PHD1,3 hydroxylates proline residues on HIF3A (Reaction) 1479 
5.1.1.2.7 Cytosolic VHL:EloB,C:CUL2:RBX1 binds hydroxyprolyl-HIF-alpha (Reaction) 1481 
5.1.1.2.8 Nuclear VHL:EloB,C:CUL2:RBX1 binds hydroxyprolyl-HIF-alpha (Reaction) 1483 
5.1.1.2.9 Cytosolic VCB complex ubiquitinylates hydroxyprolyl-HIF-alpha (Reaction) 1485 
5.1.1.2.10 Nuclear VCB complex ubiquitinylates HIF-alpha (Reaction) 1487 
5.1.1.2.11 ub-HIF-alpha:VHL:EloB,C:CUL2:RBX1 translocates from the nucleus to the 1489 cytosol (BlackBoxEvent) 
5.1.1.2.12 Proteasome proteolyzes ub-HIF-alpha (BlackBoxEvent) 1490 
5.1.1.3 Regulation of gene expression by Hypoxia-inducible Factor (Pathway) 1492 5.1.1.3.1 HIF-alpha translocates from cytosol to nucleus (BlackBoxEvent) 1494 
5.1.1.3.2 HIF-alpha binds ARNT (HIF1-beta) forming HIF-alpha:ARNT (Reaction) 1495 
5.1.1.3.3 Formation of HIF:CBP:p300 complex at promoters (BlackBoxEvent) 1497 
5.1.1.3.4 Expression of Carbonic Anhydrase IX (CA9) (BlackBoxEvent) 1499 
5.1.1.3.5 Expression of VEGFA (BlackBoxEvent) 1500 
5.1.1.3.6 Expression of Erythropoietin (EPO) (BlackBoxEvent) 1502 
5.2 Detoxification of Reactive Oxygen Species (Pathway) 1504 
5.2.1 SOD1 apoenzyme binds CCS:Cu1+ (Reaction) 1506 
5.2.2 CCS transfers Cu to SOD1 (Reaction) 1507 
5.2.3 SOD1 apoenzyme binds CCS:Cu1+ (mitochondrial) (Reaction) 1509 
5.2.4 CCS transfers Cu to SOD1 (mitochondrial) (Reaction) 1512 
5.2.5 ATP7A transfers Cu from ATOX1 to SOD3 (BlackBoxEvent) 1514 
5.2.6 Secretion of SOD3 (BlackBoxEvent) 1516 
5.2.7 SOD1 catalyzes 2H+ + 2O2.- => O2 + H2O2 (cytosol) (Reaction) 1518 
5.2.8 SOD1 catalyzes 2H+ + O2.- => O2 + H2O2 (mitochondrial intermembrane space) 1519 (Reaction) 
5.2.9 SOD2 catalyzes 2H+ + 2O2.- => O2 + H2O2 (mitochondrial matrix) (Reaction) 1521 
5.2.10 SOD3 catalyzes 2H+ + 2O2.- => O2 + H2O2 (extracellular) (Reaction) 1523 
5.2.11 H2O2 diffuses from the mitochondrial matrix to the cytosol (Reaction) 1524 
5.2.12 2 H2O2 => O2 + 2 H2O (Reaction) 1526 
5.2.13 GPX1 catalyzes 2 glutathione, reduced + H2O2 => glutathione, oxidized + 2 H2O 1528 (Reaction) 
5.2.14 GSR catalyzes glutathione (oxidized) + NADPH + H+ => 2 glutathione (reduced) +1529 NADP+ (Reaction) 
5.2.15 2 glutathione, reduced + H2O2 => glutathione, oxidized + 2 H2O (Reaction) 1531 
5.2.16 glutathione (oxidized) + NADPH + H+ => 2 glutathione (reduced) + NADP+ 1532 (Reaction) 
5.2.17 GPX2 catalyzes 2 glutathione, reduced + H2O2 => glutathione, oxidized + 2 H2O 1533 (Reaction) 
5.2.18 GPX3 catalyzes 2 glutathione, reduced + H2O2 => glutathione, oxidized + 2 H2O 1534 (Reaction) 
5.2.19 PRDX3,5 catalyze TXN2 reduced + H2O2 => TXN2 oxidized + 2H2O (Reaction) 1536 
5.2.20 TXNRD2 catalyzes the reduction of TXN2 by NADPH (Reaction) 1537 
5.2.21 Superoxide reduces cytochrome c (Reaction) 1539 
5.2.22 PRDX1,2,5 catalyze TXN reduced + H2O2 => TXN oxidized + 2H2O (Reaction) 1540 
5.2.23 thioredoxin, oxidized + NADPH + H+ => thioredoxin, reduced + NADP+ (Reaction)1542 
5.2.24 GPX7,8 catalyze peroxidation of P4HB (PDI) (Reaction) 1543 
5.2.25 PRDX6:GSTP1 catalyzes 2 glutathione, reduced + H2O2 => glutathione, oxidized +1544 2 H2O (Reaction) 
5.2.26 Superoxide and nitric oxide react to peroxynitrite (Reaction) 1546 
5.2.27 PRDX5 reduces peroxynitrite to nitrite using TXN (Reaction) 1547 
5.2.28 Superoxide and nitric oxide react to form peroxynitrite in mitochondria (Reaction) 1548 
5.2.29 PRDX5 reduces peroxynitrite to nitrite using TXN2 (Reaction) 1550 
5.3 Cellular response to heat stress (Pathway) 1551 
5.3.1 HSF1 activation (Pathway) 1555 5.3.1.1 Dissociation of cytosolic HSF1:HSP90 complex (Reaction) 1557 
5.3.1.2 Dissociation of cytosolic HSF1:HSP90:HDAC6:PTGES3 upon sensing protein 1559 aggregates (Reaction) 
5.3.1.3 Trimerization of cytosolic HSF1 (Reaction) 1561 
5.3.1.4 HSF1 trimer translocates to the nucleus (BlackBoxEvent) 1563 
5.3.1.5 Dissociation of HSF1:HSP90 complex in the nucleus (Reaction) 1566 
5.3.1.6 Trimerization of HSF1 in the nucleus (Reaction) 1568 
5.3.1.7 HSF1 trimer binds HSE on the target gene (Reaction) 1570 
5.3.2 HSF1-dependent transactivation (Pathway) 1573 
5.3.2.1 Phosphorylation of HSF1 at Ser326 induces transactivation (Reaction) 1576 
5.3.2.2 Phosphorylation of HSF1 at Ser230 induces transactivation (Reaction) 1577 
5.3.2.3 HSF1-mediated gene expression (BlackBoxEvent) 1579 
5.3.2.4 Attenuation phase (Pathway) 1581 
5.3.2.4.1 HSP70:DNAJB1 binds HSF1 (Reaction) 1582 
5.3.2.4.2 HSF1 acetylation at Lys80 (Reaction) 1584 
5.3.2.4.3 Acetylated HSF1 dissociates from DNA (Reaction) 1585 
5.3.2.4.4 HSBP1 binds HSF1 trimer (Reaction) 1586 
5.3.2.4.5 HSP90:FKBP4:PTGES3 binds HSF1 trimer (Reaction) 1588 
5.3.3 Regulation of HSF1-mediated heat shock response (Pathway) 1589 
5.3.3.1 Constitutive phosphorylation by pERK1/2 (Reaction) 1590 
5.3.3.2 Constitutive phosphorylation by GSK3 (Reaction) 1592 
5.3.3.3 p-S303,307-HSF1 binds YWHAE (14-3-3) (Reaction) 1594 
5.3.3.4 MAPKAPK2 phosphorylates HSF1 (Reaction) 1595 
5.3.3.5 RPA1 binds HSF1 (Reaction) 1596 
5.3.3.6 DBC-1 is phosphorylated by ATM/ART (Reaction) 1598 
5.3.3.7 DBC1 binds SIRT1 (Reaction) 1599 
5.3.3.8 SIRT1 binds to HSF1 (Reaction) 1601 
5.3.3.9 SIRT1 deacetylates HSF1 (Reaction) 1603 
5.4 Cellular Senescence (Pathway) 1604 
5.4.1 Oncogene Induced Senescence (Pathway) 1607 
5.4.1.1 MAPKs phosphorylate ETS1 and ETS2 (Reaction) 1610 
5.4.1.2 Phosphorylated ETS1/ETS2 binds p16-INK4A promoter (Reaction) 1612 
5.4.1.3 p-T38-ETS1/p-T72-ETS2 stimulates transcription of p16-INK4A mRNA 1613 (BlackBoxEvent) 
5.4.1.4 ID1 sequesters ETS2 (Reaction) 1614 
5.4.1.5 ERF binds ETS2 promoter (Reaction) 1615 
5.4.1.6 ERF inhibits ETS2 expression (BlackBoxEvent) 1616 
5.4.1.7 Activated ERKs phosphorylate ERF (Reaction) 1618 
5.4.1.8 Phosphorylated ERF translocates to the cytosol (Reaction) 1620 
5.4.1.9 Association of INK4A with Cdk4/6 (Reaction) 1621 
5.4.1.10 E2F1, E2F2, or E2F3 and SP1 bind p14-ARF promoter (Reaction) 1621 
5.4.1.11 E2F1/E2F2/E2F3 and SP1 stimulate transcription of p14-ARF mRNA 1623 (BlackBoxEvent) 
5.4.1.12 miR-24 binds p16-INK4a and p14-ARF mRNAs (Reaction) 1624 
5.4.1.13 Translation of p14-ARF mRNA is inhibited by miR-24 (BlackBoxEvent) 1626 5.4.1.14 Translation of p16-INK4a mRNA is inhibited by miR-24 (BlackBoxEvent) 1627 
5.4.1.15 MDM2 ubiquitinates TP53 (Reaction) 1629 
5.4.1.16 p14-ARF forms a ternary complex with MDM2 and TP53 (Reaction) 1630 
5.4.1.17 p14-ARF sequesters MDM2 (Reaction) 1631 
5.4.2 Oxidative Stress Induced Senescence (Pathway) 1633 
5.4.2.1 RAS signaling and prolonged interferon-beta stimulation promote generation of 1638 reactive oxygen species (ROS) (BlackBoxEvent) 
5.4.2.2 ROS oxidize thioredoxin and activate MAP3K5 (Reaction) 1640 
5.4.2.3 Expression of MINK1/TNIK is positively regulated by ROS (BlackBoxEvent) 1642 
5.4.2.4 MAP3K5 phosphorylates MKK3 and MKK6 (Reaction) 1643 
5.4.2.5 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 1645 
5.4.2.6 Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with 1646 MAPKAPK2 or MAPKAPK3 (Reaction) 
5.4.2.7 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 1647 
5.4.2.8 MAP3K5 (ASK1) phosphorylates MAP2K4 (SEK1) (Reaction) 1650 
5.4.2.9 Phosphorylation of human JNKs by activated MKK4/MKK7 (Reaction) 1652 
5.4.2.10 Activated human JNKs migrate to nucleoplasm (Reaction) 1653 
5.4.2.11 Activated JNKs phosphorylate c-JUN (Reaction) 1655 
5.4.2.12 c-FOS activation by phospho ERK1/2 (Reaction) 1656 
5.4.2.13 Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. 1658 (Reaction) 
5.4.2.14 E2F1/2/3:DP1/2 binds EED gene promoter (Reaction) 1659 
5.4.2.15 E2F1/2/3 stimulates EED transcription (BlackBoxEvent) 1660 
5.4.2.16 E2F1/2/3:DP1/2 binds EZH2 gene promoter (Reaction) 1662 
5.4.2.17 E2F1/2/3 stimulates EZH2 transcription (BlackBoxEvent) 1663 
5.4.2.18 E2F1/2/3:DP1/2 binds SUZ12 gene promoter (Reaction) 1664 
5.4.2.19 E2F1/2/3 stimulates SUZ12 transcription (BlackBoxEvent) 1665 
5.4.2.20 Formation of PRC2-EZH2 complex (Reaction) 1667 
5.4.2.21 PRC2-EZH2 trimethylates nucleosomes associated with CDKN2A promoter 1668 (Reaction) 
5.4.2.22 PRC1.4 complex binds H3K27Me3 nucleosomes on CDKN2A promoter 1670 (Reaction) 
5.4.2.23 p-MAPKAPK3 phosphorylates BMI1 (Reaction) 1671 
5.4.2.24 MAPKAPK2/3-mediated removal of PRC1.4 complex stimulates p14-ARF 1673 transcription (BlackBoxEvent) 
5.4.2.25 ERK1/2-activated AP1 complex binds KDM6B promoter (Reaction) 1674 
5.4.2.26 AP-1 complex stimulates KDM6B transcription (BlackBoxEvent) 1676 
5.4.2.27 KDM6B demethylates H3K27me3 on p16-INK4A promoter (Reaction) 1677 
5.4.2.28 Demethylation of H3K27Me3 by KDM6B stimulates p16-INK4A transcription, while1679 
binding of PRC1.4 complex to H3K27Me3 represses p16-INK4A transcription 
(BlackBoxEvent) 
5.4.2.29 Translation of p16-INK4a mRNA is inhibited by miR-24 (BlackBoxEvent) 1681 
5.4.2.30 Association of INK4A with Cdk4/6 (Reaction) 1681 
5.4.2.31 Translation of p14-ARF mRNA is inhibited by miR-24 (BlackBoxEvent) 1681 
5.4.2.32 miR-24 binds p16-INK4a and p14-ARF mRNAs (Reaction) 1681 
5.4.2.33 MDM2 ubiquitinates TP53 (Reaction) 1682 
5.4.2.34 p14-ARF forms a ternary complex with MDM2 and TP53 (Reaction) 1682 
5.4.2.35 p14-ARF sequesters MDM2 (Reaction) 1682 
5.4.2.36 Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with 1682 MAPKAPK5 (Reaction) 
5.4.2.37 Active p38 MAPK phosphorylates MAPKAPK5 (Reaction) 1684 
5.4.2.38 MAPKAPK5 phosphorylates TP53 (Reaction) 1685 
5.4.3 DNA Damage/Telomere Stress Induced Senescence (Pathway) 1686 
5.4.3.1 ROS induce double strand DNA breaks (BlackBoxEvent) 1689 
5.4.3.2 Telomere shortening during replicative exhaustion (BlackBoxEvent) 1690 
5.4.3.3 MRN complex binds DNA double strand breaks and shortened telomeres 1691 (Reaction) 
5.4.3.4 MRN complex bound to DNA ends recruits ATM (Reaction) 1693 
5.4.3.5 MRN activates ATM (Reaction) 1694 
5.4.3.6 Phosphorylation of p53 at ser-15 by ATM kinase (Reaction) 1695 
5.4.3.7 TP53 binds CDKN1A promoter (Reaction) 1696 
5.4.3.8 EP400 binds CDKN1A promoter (Reaction) 1696 
5.4.3.9 Transcriptional activation of CDKN1A by TP53 is inhibited by EP400 1697 (BlackBoxEvent) 
5.4.3.10 Inactivation of Cyclin A:Cdk2 complexes by p27/p21 (Reaction) 1699 
5.4.3.11 Inactivation of Cyclin E:Cdk2 complexes by p27/p21 (Reaction) 1699 
5.4.3.12 Formation of Senescence-Associated Heterochromatin Foci (SAHF) (Pathway)1700 
5.4.3.12.1 Initiation of SAHF formation (Reaction) 1702 
5.4.3.12.2 SAHF formation (Reaction) 1704 
5.4.4 Senescence-Associated Secretory Phenotype (SASP) (Pathway) 1706 
5.4.4.1 CDKN1A (p21) prevents association of Cyclin A:Cdk2 with Cdh1 (Reaction) 1710 
5.4.4.2 CDKN1A (p21) prevents phosphorylation of Cdh1 by Cyclin A:Cdk2 (Reaction) 1712 
5.4.4.3 Cdh1:APC/C complex binds EHMT1:EHMT2 (Reaction) 1713 
5.4.4.4 Cdh1:APC/C ubiquitinates EHMT1 and EHMT2 (Reaction) 1715 
5.4.4.5 EHMT1:EHMT2 methylates IL6 promoter (Reaction) 1716 
5.4.4.6 EHMT1:EHMT2 methylates IL8 promoter (Reaction) 1717 
5.4.4.7 ERK1/2/5 activate RSK1/2/3 (Reaction) 1719 
5.4.4.8 MAPK3 (ERK1) and MAPK1 (ERK2) phosphorylate CEBPB (Reaction) 1720 
5.4.4.9 RPS6KA1/2/3 phosphorylates CEBPB on S321 (Reaction) 1722 
5.4.4.10 CEBPB homodimerization (Reaction) 1723 
5.4.4.11 Activated CEBPB and NFKB complex bind IL6 promoter (Reaction) 1725 
5.4.4.12 Stimulation of IL6 transcription in senescent cells (BlackBoxEvent) 1727 
5.4.4.13 Activated STAT3 positively regulates CEBPB transcription (BlackBoxEvent) 1730 
5.4.4.14 Activated CEBPB and NFKB complex bind IL8 promoter (Reaction) 1731 
5.4.4.15 Stimulation of IL8 transcription in senescent cells (BlackBoxEvent) 1733 
5.4.4.16 Activated CEBPB binds CDKN2B promoter (Reaction) 1736 
5.4.4.17 Activated CEBPB stimulates transcription of CDKN2B (BlackBoxEvent) 1737 
5.4.4.18 Association of INK4A with Cdk4/6 (Reaction) 1738 
5.4.4.19 AP-1 transcription factor binds IGFBP7 promoter (Reaction) 1739 
5.4.4.20 AP-1 stimulates transcription of IGFBP7 (BlackBoxEvent) 1740 
5.4.4.21 AP-1 transcription factor binds IL1A promoter (Reaction) 1742 
5.4.4.22 AP-1 stimulates IL1A transcription (BlackBoxEvent) 1743 6 Chromatin organization (Pathway) 1746 
6.1 Chromatin modifying enzymes (Pathway) 1747 
6.1.1 HATs acetylate histones (Pathway) 1749 
6.1.1.1 Type B histone acetlytransferase complex acetylates histone H4 (Reaction) 1751 
6.1.1.2 KAT2 complexes acetylate replicative histone H3 (Reaction) 1753 
6.1.1.3 EP300 acetylates replicative histone H2A, H2B, H3, H4 (Reaction) 1758 
6.1.1.4 CREBBP acetylates replicative histone H2B, H3, H4 (Reaction) 1760 
6.1.1.5 Elongator complex acetylates replicative histone H3, H4 (Reaction) 1763 
6.1.1.6 ATF2 acetylates replicative histone H2B, H4 (Reaction) 1768 
6.1.1.7 KAT6A, KAT6B-containing ING5 complexes acetylate replicative histone H3 1770 (Reaction) 
6.1.1.8 KAT7-containing ING4/5 complexes acetylate Me3K-histone H3 (Reaction) 1772 
6.1.1.9 MSL acetylates histone H4 (Reaction) 1774 
6.1.1.10 NSL acetylates histone H4 (Reaction) 1776 
6.1.1.11 NuA4 complex acetylates replicative histone H2A, H4 (Reaction) 1778 
6.1.1.12 CLOCK acetylates lysine-10 of replicative histone H3, H4 (Reaction) 1780 
6.1.1.13 CLOCK acetylates lysine-15 of replicative histone H3, H4 (Reaction) 1783 
6.1.2 HDACs deacetylate histones (Pathway) 1785 
6.1.2.1 HDAC1/2 containing-complexes deacetylate histones (Reaction) 1789 
6.1.2.2 HDAC3 containing complexes deacetylate histone (Reaction) 1794 
6.1.2.3 HDAC8 deacetylates histones (Reaction) 1797 
6.1.2.4 HDAC10 deacetylates histone (Reaction) 1798 
6.1.3 HDMs demethylate histones (Pathway) 1800 
6.1.3.1 KDM1A, KDM1B demethylate MeK5/Me2K5 histone H3 (Reaction) 1804 
6.1.3.2 KDM2A, KDM2B, KDM4A demethylate MeK37/Me2K37 histone H3 (Reaction) 1806 
6.1.3.3 KDM3A, KDM3B, KDM7A, PHF2:ARID5B, PHF8 demethylate MeK10/Me2K10 1807 histone H3 (Reaction) 
6.1.3.4 KDM4A, KDM4B, KDM4C, KDM4D demethylate Me2K10/Me3K10 histone H3 1810 (Reaction) 
6.1.3.5 KDM5A-D demethylate Me2K5/Me3K5 histone H3 (Reaction) 1812 
6.1.3.6 KDM6A, KDM6B, KDM7A demethylate Me2K28/Me3K28 histone H3 (Reaction) 1813 
6.1.3.7 PHF8 demethylates MeK21 histone H4 (Reaction) 1815 
6.1.4 RMTs methylate histone arginines (Pathway) 1817 
6.1.4.1 PRMT5 is tyrosine phosphorylated by JAK2 V617F (Reaction) 1819 
6.1.4.2 PRMT5 binds WDR77 (Reaction) 1821 
6.1.4.3 CDK4 in CCND1:CDK4:PRMT5:WDR77 phosphorylates WDR77 (Reaction) 1822 
6.1.4.4 CCND1:CDK4:PRMT5:pT5-WDR77 methylates histone H3 arginine-9 (H3R8) 1824 (Reaction) 
6.1.4.5 COPRS binds CCND1:CDK4:PRMT5:pT5-WDR77 (Reaction) 1825 
6.1.4.6 COPRS:CCND1:CDK4:PRMT5:pT5-WDR77 methylates histone H4 arginine-4 1827 (H4R3) (Reaction) 
6.1.4.7 PRMT5:pT5-WDR77 methylates histone H2A arginine-4 (H2AR3) (BlackBoxEvent)1828 
6.1.4.8 PRMT5:WDR77, PRMT7 methylate histone H3 arginine-3 (H3R2) (Reaction) 1830 6.1.4.9 RBBP7 binds histone H3 arginine-3 (H3R2). (Reaction) 1831 
6.1.4.10 WDR5 binds Me2sR3-replicative histone H3 (Reaction) 1833 
6.1.4.11 DNMT3A binds Me2sR4-HIST1H4 (Reaction) 1834 
6.1.4.12 SWI/SNF chromatin remodelling complex enhances MEP50:PRMT5 1835 methyltransferase activity (Reaction) 
6.1.4.13 PRMT1,PRMT6 methylate histone H4 arginine-4 (H4R3) (Reaction) 1838 
6.1.4.14 CARM1 methylates histone H3 arginine-18 (H3R17) (Reaction) 1840 
6.1.4.15 CARM1 methylates histone H3 arginine-27 (H3R26) (Reaction) 1841 
6.1.4.16 CARM1, PRMT6 methylate histone H3 arginine-3 (H3R2) (Reaction) 1843 
6.1.4.17 PRMT6 methylates histone H2A arginine-4 (H2AR3) (Reaction) 1844 
6.1.4.18 PRMT1 methylates histone H2A arginine-12 (H2AR11) (Reaction) 1846 
6.1.4.19 PRMT6 methylates histone H2A arginine-30 (H2AR29) (Reaction) 1847 7 Circadian Clock (Pathway) 1849 
7.1 Expression of BMAL1 (ARNTL). (BlackBoxEvent) 1851 
7.2 Expression of CLOCK (BlackBoxEvent) 1854 
7.3 Expression of NPAS2 (BlackBoxEvent) 1855 
7.4 BMAL1 binds CLOCK,NPAS2 forming BMAL1:CLOCK,NPAS2 heterodimer (Reaction)1857 
7.5 BMAL1:CLOCK,NPAS2 heterodimer is phosphorylated and translocates to the nucleus1859 (BlackBoxEvent) 
7.6 BMAL1:CLOCK,NPAS2 activates circadian gene expression (Pathway) 1861 
7.6.1 Expression of AVP (BlackBoxEvent) 1863 
7.6.2 Expression of DBP (BlackBoxEvent) 1865 
7.6.3 Expression of DEC1 (BHLHE40, BHLHB2) (BlackBoxEvent) 1867 
7.6.4 Expression of DEC2 (BHLHE41, BHLHB3) (BlackBoxEvent) 1869 
7.6.5 Expression of FACTOR VII (F7) (BlackBoxEvent) 1871 
7.6.6 Expression of NOCTURNIN (BlackBoxEvent) 1873 
7.6.7 Expression of PAI-1 (BlackBoxEvent) 1874 
7.6.8 Expression of PPARA (BlackBoxEvent) 1876 
7.6.9 Expression of NAMPT (NamPRT, PBEF, Visfatin) (BlackBoxEvent) 1879 
7.6.10 Expression of CRYPTOCHROME-1 (BlackBoxEvent) 1880 
7.6.11 Expression of CRYPTOCHROME-2 (BlackBoxEvent) 1883 
7.6.12 Expression of PERIOD-1 (BlackBoxEvent) 1885 
7.6.13 Expression of PERIOD-2 (BlackBoxEvent) 1888 
7.6.14 Expression of NR1D1 (REV-ERBA) (BlackBoxEvent) 1890 
7.7 NR1D1 (REV-ERBA) binds heme and corepressors (BlackBoxEvent) 1893 
7.8 REV-ERBA represses gene expression (Pathway) 1894 
7.8.1 Expression of ELOVL3 (BlackBoxEvent) 1895 
7.8.2 Expression of BMAL1 (ARNTL). (BlackBoxEvent) 1897 
7.8.3 Expression of CLOCK (BlackBoxEvent) 1897 
7.8.4 Expression of NPAS2 (BlackBoxEvent) 1897 
7.9 CRY proteins stabilize unphosphorylated BMAL1:CLOCK,NPAS2 (Reaction) 1898 
7.10 Formation of CRY:PER:Kinase complex (BlackBoxEvent) 1899 
7.11 CSNK1E,CSNK1D phosphorylate CRY and PER proteins (Reaction) 1902 
7.12 CRY:PER:Kinase complex translocates to the nucleus (BlackBoxEvent) 1906 
7.13 CRY:PER heterodimer binds the BMAL1:CLOCK/NPAS2 heterodimer (Reaction) 1908 7.14 Beta-TrCP1 binds phosphorylated PER proteins (Reaction) 1911 
7.15 FBXL3 binds phosphorylated CRY proteins (Reaction) 1913 
7.16 CRY proteins are ubiquitinylated (BlackBoxEvent) 1915 
7.17 BTRC:CUL1:SKP1 (SCF-beta-TrCP1) ubiquitinylates PER proteins (BlackBoxEvent) 1917 
7.18 Expression of PPARGC1A (PGC-1alpha) (BlackBoxEvent) 1919 
7.19 Expression of RORA (ROR-alpha) (BlackBoxEvent) 1921 
7.20 Formation of ROR-alpha coactivator complex (Reaction) 1923 
7.21 RORA activates circadian gene expression (Pathway) 1924 
7.21.1 Expression of BMAL1 (ARNTL). (BlackBoxEvent) 1926 
7.21.2 Expression of NPAS2 (BlackBoxEvent) 1926 
7.21.3 Expression of NR1D1 (REV-ERBA) (BlackBoxEvent) 1926 
7.21.4 Expression of SREBF1 (SREBP1) (BlackBoxEvent) 1926 
7.21.5 Expression of CPT1A (BlackBoxEvent) 1928 8 Developmental Biology (Pathway) 1930 
8.1 Axon guidance (Pathway) 1930 
8.1.1 Semaphorin interactions (Pathway) 1931 
8.1.1.1 Sema4D in semaphorin signaling (Pathway) 1933 
8.1.1.1.1 Sema4D mediated inhibition of cell attachment and migration (Pathway) 1934 
8.1.1.1.1.1 SEMA4D interacts with Plexin-B1:Met (Reaction) 1936 
8.1.1.1.1.2 Active Rac1 interacts with Plexin-B1:Sema4D (Reaction) 1937 
8.1.1.1.1.3 Rnd1 interacts with Plexin-B1:Sema4D (Reaction) 1938 
8.1.1.1.1.4 Inactivation of R-Ras by Sema4D-Plexin-B1 GAP activity (Reaction) 1940 
8.1.1.1.1.5 p190RhoGAP binds Plexin-B1 (Reaction) 1941 

8.1.1.1.1.6 Inactivation of Rho-GTP by p190RhoGAP (Reaction) 1942 
8.1.1.1.2 Sema4D induced cell migration and growth-cone collapse (Pathway) 1944 
8.1.1.1.2.1 SEMA4D interacts with Plexin-B1:ErbB2 (Reaction) 1946 
8.1.1.1.2.2 LARG and PDZ-RhoGEF binds to Plexin-B1 (Reaction) 1947 
8.1.1.1.2.3 Activation of Rho by LARG and PDZ-RhoGEF (Reaction) 1949 
8.1.1.1.2.4 ROCK activation by Rho (Reaction) 1950 
8.1.1.1.2.5 Myosin regulatory light chain phosphorylation by ROCK (Reaction) 1952 
8.1.1.1.2.6 LIM kinase phosphorylation by ROCK (Reaction) 1954 
8.1.1.2 SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion (Pathway) 1956 
8.1.1.2.1 Plexin-A1-4 binds NRP1 (Reaction) 1958 
8.1.1.2.2 Sema3A binds Nrp-1 bound to PlexinA (Reaction) 1960 
8.1.1.2.3 Phosphorylation of Plexin-A (Reaction) 1961 
8.1.1.2.4 Activation of Rac1 by FARP2 (Reaction) 1963 
8.1.1.2.5 Rac1 binds PlexinA (Reaction) 1965 
8.1.1.2.6 Recruitment of Rnd1 to Plexin A (Reaction) 1966 
8.1.1.2.7 Inactivation of R-Ras by Sema3A-Plexin-A GAP activity (Reaction) 1968 
8.1.1.2.8 Inhibition of integrin activation by sequestering PIP5KIgamma (Reaction) 1969 
8.1.1.3 Sema3A PAK dependent Axon repulsion (Pathway) 1971 
8.1.1.3.1 Activation of PAK by Rac1 (Reaction) 1973 
8.1.1.3.2 Autophosphorylation of PAK (Reaction) 1974 
8.1.1.3.3 Phosphorylation of LIMK-1 by PAK (Reaction) 1975 
8.1.1.3.4 Dimerization of LIMK1 by Hsp90 (Reaction) 1977 
8.1.1.3.5 Transphosphorylation of pLIMK1 (BlackBoxEvent) 1978 
8.1.1.3.6 Phosphorylation of cofilin by LIMK-1 (Reaction) 1979 
8.1.1.4 CRMPs in Sema3A signaling (Pathway) 1982 
8.1.1.4.1 Activation of Fyn (Reaction) 1983 
8.1.1.4.2 Recruitment and activation of Cdk5 (Reaction) 1984 
8.1.1.4.3 Phosphorylation of CRMPs by Cdk5 (Reaction) 1986 
8.1.1.4.4 Phosphorylation of CRMPs by GSK3beta (Reaction) 1987 
8.1.1.4.5 Tyrosine phosphorylation of CRMPs by Fes (Reaction) 1989 
8.1.1.5 Other semaphorin interactions (Pathway) 1990 
8.1.1.5.1 SEMA3E binds to PLXND1 (Reaction) 1991 
8.1.1.5.2 SEMA4A binds to PLXND1 (Reaction) 1992 
8.1.1.5.3 SEMA4D interacts with CD45 (Reaction) 1993 
8.1.1.5.4 SEMA4D interacts with CD72 (Reaction) 1995 
8.1.1.5.5 SEMA5A binds to PLXNB3 (Reaction) 1996 
8.1.1.5.6 SEMA6A binds to PLXNA2 and PLXNA4 (Reaction) 1997 
8.1.1.5.7 SEMA6D binds to PLXNA1:TREM2:DAP12 (Reaction) 1999 
8.1.1.5.8 SEMA7A binds to PLXNC1 (Reaction) 2000 
8.1.1.5.9 SEMA7A binds to integrin alpha1beta1 (Reaction) 2001 
8.1.2 NCAM signaling for neurite out-growth (Pathway) 2003 
8.1.2.1 NCAM1 cis-homophilic interaction (Reaction) 2006 
8.1.2.2 NCAM1 trans-homophilic interaction (Reaction) 2008 
8.1.2.3 NCAM1 binds FGFR-1 (Reaction) 2010 
8.1.2.4 Fyn binds NCAM1 (Reaction) 2013 
8.1.2.5 Dephosphorylation of NCAM1 bound pFyn (Reaction) 2015 
8.1.2.6 Autophosphorylation of NCAM1 bound Fyn (Reaction) 2017 
8.1.2.7 Recruitment of FAK to NCAM1:Fyn in lipid rafts (Reaction) 2019 
8.1.2.8 Phosphorylation of FAK by Src kinase (Reaction) 2020 
8.1.2.9 Recruitment of Grb2 to pFAK:NCAM1 (Reaction) 2022 
8.1.2.10 SOS binds Grb2 bound to pFAK:NCAM1 (Reaction) 2024 
8.1.2.11 NCAM1:pFAK:Grb2:Sos-mediated nucleotide exchange of Ras (Reaction) 2025 
8.1.2.12 RAF/MAP kinase cascade (Pathway) 2026 
8.1.2.12.1 RAF activation (Pathway) 2028 
8.1.2.12.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 2029 
8.1.2.12.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 2030 
8.1.2.12.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 2032 
8.1.2.12.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 2033 
8.1.2.12.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 2035 
8.1.2.12.2 MEK activation (Pathway) 2037 
8.1.2.12.2.1 Activated RAF1 complex binds MEK (Reaction) 2037 
8.1.2.12.2.2 RAF phosphorylates MEK (Pathway) 2039 
8.1.2.12.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 2041 
8.1.2.12.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 2043 
8.1.2.12.3 ERK activation (Pathway) 2045 
8.1.2.12.3.1 ERK1 activation (Pathway) 2045 
8.1.2.12.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 2046 
8.1.2.12.3.1.2 MEK1 binds ERK-1 (Reaction) 2046 
8.1.2.12.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 2048 
8.1.2.12.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 2049 
8.1.2.12.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 2051 
8.1.2.12.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 2053 
8.1.2.12.3.2 ERK2 activation (Pathway) 2055 
8.1.2.12.3.2.1 MEK2 binds ERK-2 (Reaction) 2055 
8.1.2.12.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 2057 
8.1.2.12.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 2058 
8.1.2.12.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 2060 
8.1.2.12.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 2062 
8.1.2.13 ERK1/2 phosphorylates MSK1 (Reaction) 2064 
8.1.2.14 MSK1 activates CREB (Reaction) 2065 
8.1.2.15 NCAM1 interactions (Pathway) 2066 
8.1.2.15.1 Interaction of NCAM1 with GFRalpha-1 (Reaction) 2067 
8.1.2.15.2 Interaction of NCAM1:GFRalpha-1 with GDNF (Reaction) 2069 
8.1.2.15.3 Interaction of NCAM1 with Neurocan (Reaction) 2071 
8.1.2.15.4 Interaction of NCAM1 with collagens (Reaction) 2072 
8.1.2.15.5 Interaction of NCAM1 with Major prion protein (PrP) (Reaction) 2074 
8.1.2.15.6 Interaction of NCAM1 with agrin (Reaction) 2075 
8.1.2.15.7 Interaction of NCAM1 with contactin-2 (Reaction) 2077 
8.1.2.15.8 NCAM1 binds to ATP (Reaction) 2079 
8.1.2.15.9 Polysialylation of NCAM1 (Reaction) 2080 
8.1.2.15.10 NCAM1 interacts with T- and L-type VDCC (Reaction) 2082 
8.1.3 Netrin-1 signaling (Pathway) 2083 
8.1.3.1 DCC mediated attractive signaling (Pathway) 2084 
8.1.3.1.1 DCC interaction with Netrin-1 (Reaction) 2086 
8.1.3.1.2 Netrin-1 induced DCC clustering (Reaction) 2087 
8.1.3.1.3 FADK1 interaction with DCC (Reaction) 2088 
8.1.3.1.4 Phosphorylation of FADK1 (Reaction) 2090 
8.1.3.1.5 Recruitment of Src and Fyn to DCC:FADK1 (Reaction) 2092 
8.1.3.1.6 Phosphorylation of DCC by Fyn (Reaction) 2093 
8.1.3.1.7 DCC interacting NCK-1 (Reaction) 2095 
8.1.3.1.8 RhoGTPase GEF's recruited to DCC (Reaction) 2096 
8.1.3.1.9 Activation of Cdc42 (Reaction) 2097 
8.1.3.1.10 Activation of Rac1 (Reaction) 2099 
8.1.3.1.11 Recruitment and activation of N-WASP by Cdc42 (Reaction) 2100 
8.1.3.1.12 Recruitment of ABLIM to the plasma membrane (Reaction) 2101 
8.1.3.2 Netrin mediated repulsion signals (Pathway) 2103 
8.1.3.2.1 UNC-5 binds Netrin-1 (Reaction) 2104 
8.1.3.2.2 DCC heterodimerizes with UNC-5:Netrin-1 (Reaction) 2106 
8.1.3.2.3 Phosphorylation of Unc5C (Reaction) 2107 
8.1.3.2.4 Shp2 binds pUnc5C (Reaction) 2109 
8.1.3.3 DCC interaction with ROBO-1 (Reaction) 2111 
8.1.3.4 DCC interaction with SIAH1 (Reaction) 2113 8.1.3.5 DCC interaction with SIAH2 (Reaction) 2114 
8.1.3.6 Translocation of Ezrin to plasma membrane (Reaction) 2115 
8.1.3.7 Phosphorylation and activation of Ezrin (Reaction) 2117 
8.1.3.8 DCC interaction with Ezrin (Reaction) 2118 
8.1.3.9 Netrin-4 binds DCC/UNC5A (Reaction) 2119 
8.1.3.10 Neogenin binds Netrin-1 (Reaction) 2120 
8.1.3.11 Neogenin binds repulsive guidance molecules (RGDs) (Reaction) 2122 
8.1.3.12 Myosin-X binds DCC/Neogenin (Reaction) 2124 
8.1.3.13 PIKE-L interaction with UNC5B (Reaction) 2125 
8.1.3.14 Role of second messengers in netrin-1 signaling (Pathway) 2127 
8.1.3.14.1 PITPalpha binds DCC (Reaction) 2128 
8.1.3.14.2 Phosphorylation of PLCgamma by Netrin-1 (BlackBoxEvent) 2130 
8.1.3.14.3 PIP2 hydrolysis (Reaction) 2132 
8.1.3.14.4 Activation of TRPC channels by Netrin-1 (BlackBoxEvent) 2134 
8.1.4 Signaling by Robo receptor (Pathway) 2136 
8.1.4.1 Regulation of Commissural axon pathfinding by Slit and Robo (Pathway) 2138 
8.1.4.1.1 Proteolytic processing of Slit (Reaction) 2139 
8.1.4.1.2 Robo3 antagonizes Robo1/Robo2 to allow floor plate crossing (Reaction) 2141 
8.1.4.2 Glypican-1 binds Slit2 (Reaction) 2143 
8.1.4.3 Robo1 binds Slit2 (Reaction) 2144 
8.1.4.4 Ena/VASP binds Robo1:Slit2 complex (Reaction) 2146 
8.1.4.5 Recruitment of Profilin by Ena/Vasp proteins (Reaction) 2148 
8.1.4.6 Inactivation of Cdc42 and Rac (Pathway) 2149 
8.1.4.6.1 SrGAP binds Robo1:Slit2 (Reaction) 2150 
8.1.4.6.2 Inactivation of Cdc42 (Reaction) 2152 
8.1.4.6.3 KIAA1688/Vilse binds Robo1:Slit2 (Reaction) 2154 
8.1.4.6.4 Inactivation of Rac1 (Reaction) 2156 
8.1.4.7 Activation of Rac (Pathway) 2158 
8.1.4.7.1 Nck binds Robo1:Slit2 (Reaction) 2158 
8.1.4.7.2 Recruitment of PAK to Nck (Reaction) 2160 
8.1.4.7.3 Recruitment of Sos to plasma membrane (Reaction) 2162 
8.1.4.7.4 Activation of Rac by Sos (Reaction) 2164 
8.1.4.8 Role of Abl in Robo-Slit signaling (Pathway) 2165 
8.1.4.8.1 Interaction of Abl with Robo1:Slit2 (Reaction) 2166 
8.1.4.8.2 Phosphorylation of Rob1 by Abl kinase (Reaction) 2167 
8.1.4.8.3 Activation of CLASP (Reaction) 2168 
8.1.4.8.4 Recruitment of CAP to Abl (Reaction) 2170 
8.1.5 L1CAM interactions (Pathway) 2172 
8.1.5.1 Recycling pathway of L1 (Pathway) 2174 
8.1.5.1.1 Phosphorylation of L1 by SRC (Reaction) 2175 
8.1.5.1.2 L1 binds ERM family members (Reaction) 2177 
8.1.5.1.3 L1 trans-homophilic interaction (Reaction) 2179 
8.1.5.1.4 Linkage of L1 with treadmilling F-actin (Reaction) 2180 
8.1.5.1.5 Shootin-1 links L1 and retrograde actin flow (Reaction) 2182 
8.1.5.1.6 Dephosphorylation of pL1 (Y1176) (Reaction) 2183 8.1.5.1.7 L1 binds to AP-2 Clathrin complex (Reaction) 2185 
8.1.5.1.8 Formation of clathrin coated vesicle (Reaction) 2186 
8.1.5.1.9 Interaction of NUMB with L1 (Reaction) 2187 
8.1.5.1.10 Transport of L1 into endosomes (Reaction) 2189 
8.1.5.1.11 Phosphorylation of L1 by p90rsk (Reaction) 2190 
8.1.5.1.12 Phosphorylation of L1 by ERK (Reaction) 2192 
8.1.5.1.13 Transport of L1 from C-domain to P-domain (Reaction) 2193 
8.1.5.1.14 Reinsertion of L1 into the plasma membrane (Reaction) 2195 
8.1.5.2 Interaction between L1 and Ankyrins (Pathway) 2196 
8.1.5.2.1 L1 dimer binds Ankyrin (Reaction) 2197 
8.1.5.2.2 L1 linked to actin cytoskeleton by ankyrin (Reaction) 2200 
8.1.5.2.3 Ankyrins link voltage-gated sodium and potassium channels to spectrin and L12201 (Reaction) 
8.1.5.2.4 Phosphorylation of Y1229 in L1 (Reaction) 2203 
8.1.5.3 Signal transduction by L1 (Pathway) 2204 
8.1.5.3.1 L1 and NCAM1 engaged in cis-interaction (Reaction) 2206 
8.1.5.3.2 L1-FGFR cis-heterodimerization (Reaction) 2208 
8.1.5.3.3 L1-EGFR trans-heterodimerization (Reaction) 2209 
8.1.5.3.4 L1 binds NRP1 (Reaction) 2210 
8.1.5.3.5 L1 interaction with Integrins (Reaction) 2211 
8.1.5.3.6 Phosphorylation of VAV2 (BlackBoxEvent) 2213 
8.1.5.3.7 Activation of Rac1 by VAV2 (Reaction) 2214 
8.1.5.3.8 Interaction of PAK1 with Rac1-GTP (Reaction) 2215 
8.1.5.3.9 MEK1 phosphorylates ERK-1 (Reaction) 2217 
8.1.5.3.10 MEK2 phosphorylates ERK-2 (Reaction) 2217 
8.1.5.3.11 Phosphorylation of L1 by CK-II (Reaction) 2217 
8.1.5.4 Interaction of L1 with Neurocan (Reaction) 2218 
8.1.5.5 Interaction of L1 with Laminin-1 (Reaction) 2220 
8.1.5.6 Cis-heterodimerization of L1 and Axonin-1 (Reaction) 2222 
8.1.5.7 Cis-heterodimerization of L1 and Contactin-1/F3/F11 (Reaction) 2224 
8.1.5.8 Cis-heterodimerization of L1 and DM-GRASP/ALCAM/BEN (Reaction) 2225 
8.1.5.9 L1 binds RanBPM (Reaction) 2227 
8.1.5.10 Heat-Stable Antigen binds L1 (Reaction) 2229 
8.1.5.11 Phosphorylation of L1 by EPHB2 (Reaction) 2230 
8.1.5.12 CHL1 interactions (Pathway) 2232 
8.1.5.12.1 CHL1 interacts with Ankyrin-G (Reaction) 2234 
8.1.5.12.2 CHL1 interacts with HSP7C (Reaction) 2235 
8.1.5.12.3 CHL1 interacts with NRP1 (Reaction) 2237 
8.1.5.12.4 CHL1 interacts with beta1 integrins (Reaction) 2238 
8.1.5.12.5 CHL1 interacts with contactin-6 (Reaction) 2240 
8.1.5.13 Neurofascin interactions (Pathway) 2242 
8.1.5.13.1 Neurofascin binds Ankyrin-G (Reaction) 2244 
8.1.5.13.2 Trans-homodimerization of Neurofascin (Reaction) 2245 
8.1.5.13.3 Neurofascin and NrCAM heterodimerization (Reaction) 2247 
8.1.5.13.4 Phosphorylation of Neurofascin (Reaction) 2248 8.1.5.13.5 Doublecortin binds phosphorylated neurofascin (Reaction) 2250 
8.1.5.13.6 Neurofascin interacts with syntenin-1 (Reaction) 2251 
8.1.5.13.7 Neurofascin binds contactin-1:CASPR complex (Reaction) 2252 
8.1.5.14 NrCAM interactions (Pathway) 2254 
8.1.5.14.1 NrCAM binds Ankyrin-G (Reaction) 2255 
8.1.5.14.2 NrCAM binds axonin-1 (Reaction) 2257 
8.1.5.14.3 NrCAM binds synapse-associated proteins (Reaction) 2258 
8.1.5.14.4 NrCAM binds Neuropilin-2 (Reaction) 2260 
8.1.6 EPH-Ephrin signaling (Pathway) 2262 
8.1.6.1 EPHAs bind EFNAs (Reaction) 2264 
8.1.6.2 EPHBs bind EFNBs (Reaction) 2265 
8.1.6.3 EPH:EFN dimers tetramerise (Reaction) 2267 
8.1.6.4 EPH:EFN tetramers oligomerise (Polymerisation) 2268 
8.1.6.5 EPH receptors autophosphorylate (Reaction) 2269 
8.1.6.6 p-EPHs bind SRC,FYN,YES,LYN (Reaction) 2271 
8.1.6.7 EPHA-mediated growth cone collapse (Pathway) 2274 
8.1.6.7.1 NGEF binds EPHA (Reaction) 2275 
8.1.6.7.2 SFKs phosphorylate NGEF (Reaction) 2278 
8.1.6.7.3 NGEF exchanges GTP for GDP on RHOA (Reaction) 2280 
8.1.6.7.4 RHOA:GTP:Mg2+ binds ROCK1,ROCK2 (Reaction) 2282 
8.1.6.7.5 Activated ROCK phosphorylates MRLCs (Reaction) 2284 
8.1.6.8 EPHB-mediated forward signaling (Pathway) 2286 
8.1.6.8.1 EPHB binds ITSN1 (Reaction) 2287 
8.1.6.8.2 N-WASP binds ITSN1 (Reaction) 2289 
8.1.6.8.3 ITSN1 exchanges GTP for GDP on CDC42, activating it (Reaction) 2291 
8.1.6.8.4 CDC42 and PIP2 bind WASL, activating it (Reaction) 2292 
8.1.6.8.5 N-WASP binds ARP2/3 and G-actin (Reaction) 2294 
8.1.6.8.6 EPHB2 binds KALRN (Reaction) 2295 
8.1.6.8.7 KALRN exchanges GTP for GDP on RAC1, activating it (Reaction) 2297 
8.1.6.8.8 PAK1 binds RAC1:GTP (Reaction) 2298 
8.1.6.8.9 PAK1 autophosphorylates (Reaction) 2299 
8.1.6.8.10 EPHBs binds PTK2 (Reaction) 2301 
8.1.6.8.11 PTK2 autophosporylates at Y397 (Reaction) 2303 
8.1.6.8.12 Recruitment of p190RhoGEF to p-FAK (Reaction) 2305 
8.1.6.8.13 p190RhoGEF exchanges GTP for GDP on RHOA, activating it (Reaction) 2306 
8.1.6.8.14 RHOA:GTP binds ROCK, activating it (Reaction) 2307 
8.1.6.8.15 ROCK phosphorylates LIMK1,2 (Reaction) 2309 
8.1.6.8.16 LIMK phosphorylates CFL1, inactivating it (Reaction) 2311 
8.1.6.8.17 EPHBs bind NMDARs (Reaction) 2313 
8.1.6.8.18 FYN phosphorylates NMDAR2B (Reaction) 2315 
8.1.6.8.19 EPHB:NMDAR binds TIAM1 (Reaction) 2317 
8.1.6.8.20 EPHB phosphorylates TIAM1 (Reaction) 2318 
8.1.6.8.21 p-TIAM1 exchanges GTP for GDP on RAC1, activating it (Reaction) 2319 
8.1.6.8.22 EPHB binds p120-RasGAP (Reaction) 2321 
8.1.6.8.23 Ras:GTP binds p120-RasGAP (Reaction) 2323 
8.1.6.8.24 p120-RasGAP exchanges GTP for GDP on RAS, inactivating it (Reaction) 2324 
8.1.6.8.25 p-EPHB phosphorylates SDC2 (Reaction) 2325 
8.1.6.8.26 SDC2 multimerises (BlackBoxEvent) 2327 
8.1.6.9 Ephrin signaling (Pathway) 2328 
8.1.6.9.1 EFNBs bind SFKs (Reaction) 2329 
8.1.6.9.2 SFKs phosphorylate EFNBs (Reaction) 2330 
8.1.6.9.3 p-EFNB binds GRB4 (Reaction) 2333 
8.1.6.9.4 SFKs phosphorylate GIT1 (Reaction) 2334 
8.1.6.9.5 EFNB:GRB4 binds GIT1 (Reaction) 2336 
8.1.6.9.6 GIT1 binds bPIX (Reaction) 2338 
8.1.6.9.7 bPIX exchanges GTP for GDP on RAC, activating it (Reaction) 2339 
8.1.6.9.8 PAK binds RAC and bPIX (Reaction) 2340 
8.1.6.9.9 PAKs autophosphorylate (Reaction) 2341 
8.1.6.9.10 PAKs phosphorylate MLC (Reaction) 2342 
8.1.6.9.11 EFNBs bind SDCBP (Reaction) 2343 
8.1.6.10 EPH-ephrin mediated repulsion of cells (Pathway) 2345 
8.1.6.10.1 ADAM10 cleaves EFNAs (BlackBoxEvent) 2346 
8.1.6.10.2 MMP2,9 cleave EPHB (BlackBoxEvent) 2348 
8.1.6.10.3 gamma-secretase cleaves EPHB2 (BlackBoxEvent) 2350 
8.1.6.10.4 Clathrin internalises EPH:EFN complexes (BlackBoxEvent) 2351 
8.1.6.10.5 p-EPHs bind VAV2,3 (Reaction) 2353 
8.1.6.10.6 SFKs phosphorylate VAV2,3 (Reaction) 2354 
8.1.6.10.7 VAV exchanges GTP for GDP on RAC1, activating it (Reaction) 2355 
8.1.6.10.8 EPHA binds TIAM1 (Reaction) 2356 
8.1.6.10.9 TIAM1 exchanges GTP for GDP on RAC1, activating it (Reaction) 2358 
8.2 Myogenesis (Pathway) 2359 
8.2.1 CDO in myogenesis (Pathway) 2360 
8.2.1.1 CDO binds BOC (Reaction) 2361 
8.2.1.2 CDO binds promyogenic cadherins (Reaction) 2362 
8.2.1.3 Bnip2 interacts with CDO complex (Reaction) 2364 
8.2.1.4 Interaction of Bnip-2 with Cdc42 (Reaction) 2365 
8.2.1.5 JLP interacts with CDO complex (Reaction) 2367 
8.2.1.6 Interaction of ABL1 with CDO complex (Reaction) 2369 
8.2.1.7 Interaction of p38 MAPK with JLP (Reaction) 2370 
8.2.1.8 Activation of p38 alpha/beta MAPK (BlackBoxEvent) 2372 
8.2.1.9 Nuclear translocation of p38 MAPK (BlackBoxEvent) 2373 
8.2.1.10 Phosphorylation of E proteins by p38 MAPK (Reaction) 2375 
8.2.1.11 Heterodimerization of E proteins with Myod (Reaction) 2376 
8.2.1.12 Phosphorylation of MEF2 proteins by p38 (Reaction) 2378 
8.2.1.13 Interaction of MyoD:E protein with MEF2 (Reaction) 2380 
8.2.1.14 Neogenin:Netrin-3 binds CDO complex (Reaction) 2381 
8.3 Regulation of beta-cell development (Pathway) 2383 
8.3.1 Regulation of gene expression in early pancreatic precursor cells (Pathway) 2385 
8.3.1.1 HNF1B-dependent synthesis of HNF6 protein (BlackBoxEvent) 2386 
8.3.1.2 HNF1B- and FGF10-dependent synthesis of PTF1A protein (BlackBoxEvent) 2388 
8.3.1.3 HNF6-dependent synthesis of ONECUT3 protein during early pancreas 2390 specification (BlackBoxEvent) 
8.3.1.4 HNF6- and FGF10-dependent synthesis of PDX1 protein (BlackBoxEvent) 2392 
8.3.1.5 PDX1-dependent synthesis of NR5A2 protein (BlackBoxEvent) 2394 
8.3.1.6 PDX1-dependent synthesis of NKX6-1 protein (BlackBoxEvent) 2396 
8.3.2 Regulation of gene expression in late stage (branching morphogenesis) pancreatic 2398 bud precursor cells (Pathway) 
8.3.2.1 HNF6-dependent synthesis of HNF1B protein (BlackBoxEvent) 2400 
8.3.2.2 HNF6-dependent synthesis of ONECUT3 protein during morphogenesis 2401 (BlackBoxEvent) 
8.3.2.3 HNF6-dependent synthesis of NEUROG3 protein during morphogenesis 2403 (BlackBoxEvent) 
8.3.2.4 RBPJ- and NOTCH1-dependent synthesis of HES1 protein during morphogenesis
2405 (BlackBoxEvent) 
8.3.3 Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
2407 (Pathway) 
8.3.3.1 NEUROG3-dependent synthesis of PAX4 protein (BlackBoxEvent) 2408 
8.3.3.2 NEUROG3-dependent synthesis of NEUROD1 (BlackBoxEvent) 2410 
8.3.3.3 NEUROG3-dependent synthesis of NKX2-2 (BlackBoxEvent) 2411 
8.3.3.4 NEUROG3-dependent synthesis of INSM1 (BlackBoxEvent) 2413 
8.3.4 Regulation of gene expression in beta cells (Pathway) 2414 
8.3.4.1 AKT-mediated inactivation of FOXO1A (Pathway) 2415 
8.3.4.1.1 AKT phosphorylates FOXO1A (Reaction) 2416 
8.3.4.1.2 Phosphorylated FOXO1A is excluded from the nucleus (Reaction) 2418 
8.3.4.2 FOXOA2-, MAFA-, and PAX6-dependent synthesis of PDX1 protein 2419 (BlackBoxEvent) 
8.3.4.3 MAFA-, NKX2-2-, PAX6-, and PDX1-dependent synthesis of insulin precursor 2422 protein (BlackBoxEvent) 
8.3.4.4 PDX1-dependent synthesis of IAPP protein (BlackBoxEvent) 2425 
8.3.4.5 PDX1-dependent synthesis of NKX6-1 protein (BlackBoxEvent) 2427 
8.3.4.6 NEUROD1- and PDX1-dependent synthesis of glucokinase (GCK) protein 2429 (BlackBoxEvent) 
8.3.4.7 HNF1A-dependent synthesis of GLUT2 protein (BlackBoxEvent) 2431 
8.3.4.8 HNF1A-dependent synthesis of the L isoform of PKLR protein (BlackBoxEvent) 2434 
8.3.4.9 HNF1A-dependent synthesis of HNF4A (BlackBoxEvent) 2436 
8.3.4.10 HNF1A-dependent synthesis of HNF4G protein (BlackBoxEvent) 2438 
8.3.4.11 HNF1A-dependent synthesis of FOXA3 (BlackBoxEvent) 2440 
8.4 Signaling by NODAL (Pathway) 2442 
8.4.1 Cleavage of NODAL proprotein (Reaction) 2443 
8.4.2 The NODAL Receptor binds NODAL ligands (Reaction) 2445 
8.4.3 Type II Activin Receptor (ActRII/ACVR2) phosphorylates Type I Activin Receptor 2447 (ActRIB/ACVR1B) in response to NODAL (Reaction) 
8.4.4 Type II Activin Receptor (ActRIIB/ACVR2B) phosphorylates Type I Activin Receptor2449 (ActRIC/ACVR1C) in response to NODAL (Reaction) 
8.4.5 Phosphorylation of R-SMAD2/3 by NODAL receptor (Reaction) 
8.4.6 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 (Reaction) 2454 
8.4.7 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction) 2455 
8.4.8 Phospho R-SMAD(SMAD2/3):CO-SMAD(SMAD4):FOXH1 binds Activin Response 2458 Element (Reaction) 
8.4.9 Phospho R-SMAD(SMAD2/3):CO-SMAD(SMAD4):FOXO3 binds FoxO3a-binding 2460 elements (Reaction) 
8.4.10 Regulation of signaling by NODAL (Pathway) 2461 
8.4.10.1 CERBERUS binds NODAL (Reaction) 2462 
8.4.10.2 LEFTY binds NODAL (Reaction) 2464 
8.4.10.3 LEFTY binds the EGF-CFC coreceptor in the NODAL receptor (Reaction) 2465 
8.5 Transcriptional regulation of white adipocyte differentiation (Pathway) 2467 
8.5.1 Expression of CEBPB (BlackBoxEvent) 2470 
8.5.2 Expression of CEBPD (BlackBoxEvent) 2473 
8.5.3 Expression of KLF5 (BlackBoxEvent) 2476 
8.5.4 Expression of EBF1 (BlackBoxEvent) 2478 
8.5.5 Expression of PPARG (BlackBoxEvent) 2479 
8.5.6 Formation of PPARG:RXRA heterodimer (ARF6 complex) (Reaction) 2483 
8.5.7 PPARG:RXRA heterodimer binds to PPARG corepressors (Reaction) 2485 
8.5.8 PPARG:RXRA heterodimer binds to fatty acid-like ligands (Reaction) 2487 
8.5.9 Expression of FABP4 (aP2) (BlackBoxEvent) 2491 
8.5.10 Expression of Perilipin (PLIN) (BlackBoxEvent) 2493 
8.5.11 Expression of Phosphoenolpyruvate carboxykinase 1 (PEPCK-C) (BlackBoxEvent)2495 
8.5.12 Expression of ANGPTL4 (BlackBoxEvent) 2496 
8.5.13 Expression of Lipoprotein lipase (LPL) (BlackBoxEvent) 2498 
8.5.14 Expression of CEBPA (BlackBoxEvent) 2499 
8.5.15 Expression of CD36 (platelet glycoprotein IV, FAT) (BlackBoxEvent) 2502 
8.5.16 Maintenance of PPARG expression in differentiated adipocytes (BlackBoxEvent) 2503 
8.5.17 Expression of Leptin (BlackBoxEvent) 2505 
8.5.18 Expression of Adiponectin (BlackBoxEvent) 2507 
8.5.19 Expression of GLUT4 (BlackBoxEvent) 2509 
8.6 Transcriptional regulation of pluripotent stem cells (Pathway) 2511 
8.6.1 Expression of EPAS1 (HIF2A) (BlackBoxEvent) 2515 
8.6.2 Transcription of POU5F1 (OCT4) (BlackBoxEvent) 2517 
8.6.3 LIN28 binds POU5F1 (OCT4) mRNA (Reaction) 2521 
8.6.4 Translation of OCT4 mRNA (BlackBoxEvent) 2522 
8.6.5 Expression of SOX2 (BlackBoxEvent) 2525 
8.6.6 Expression of NANOG (BlackBoxEvent) 2528 
8.6.7 POU5F1 (OCT4), SOX2, NANOG bind the SOX2 promoter (Reaction) 2532 
8.6.8 POU5F1 (OCT4), SOX2, NANOG, ZSCAN10, PRDM14, SMAD2 bind the OCT4 2534 promoter (Reaction) 
8.6.9 POU5F1 (OCT4), SOX2, NANOG, KLF4, PBX1, SMAD2 bind the NANOG promoter2536 (Reaction) 
8.6.10 POU5F1 (OCT4), STAT3 bind the SALL4 promoter (Reaction) 2539 
8.6.11 Expression of SALL4 (BlackBoxEvent) 2540 
8.6.12 SALL4 binds the SALL4 promoter (Reaction) 2542 
8.6.13 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation (Pathway)2543 
8.6.13.1 POU5F1 (OCT4), SOX2, NANOG bind the EPHA1 promoter (Reaction) 2545 
8.6.13.2 Expression of EPHA1 (BlackBoxEvent) 2547 
8.6.13.3 POU5F1 (OCT4), SOX2, NANOG bind the FGF2 promoter (Reaction) 2549 
8.6.13.4 Expression of FGF2 (BlackBoxEvent) 2550 
8.6.13.5 POU5F1 (OCT4), SOX2, NANOG bind the FOXD3 promoter (Reaction) 2552 
8.6.13.6 Expression of FOXD3 (BlackBoxEvent) 2554 
8.6.13.7 POU5F1 (OCT4), SOX2, NANOG bind the STAT3 promoter (Reaction) 2555 
8.6.13.8 Expression of STAT3 (BlackBoxEvent) 2557 
8.6.13.9 POU5F1 (OCT4), SOX2, NANOG bind the TDGF1 promoter (Reaction) 2558 
8.6.13.10 Expression of TDGF1 (CRIPTO) (BlackBoxEvent) 2560 
8.6.13.11 POU5F1 (OCT4), SOX2, NANOG bind the ZIC3 promoter (Reaction) 2563 
8.6.13.12 Expression of ZIC3 (BlackBoxEvent) 2564 
8.6.14 POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation (Pathway)
2566 
8.6.14.1 POU5F1 (OCT4), NANOG bind the CDX2 promoter (Reaction) 2568 
8.6.14.2 POU5F1 (OCT4), SOX2, NANOG bind the DKK1 promoter (Reaction) 2570 
8.6.14.3 POU5F1 (OCT4), SOX2, NANOG bind the EOMES promoter (Reaction) 2572 
8.6.14.4 POU5F1 (OCT4), NANOG bind the GATA6 promoter (Reaction) 2574 
8.6.14.5 POU5F1 (OCT4), SOX2, NANOG bind the GSC promoter (Reaction) 2576 
8.6.14.6 POU5F1 (OCT4), SOX2, NANOG bind the HHEX promoter (Reaction) 2578 
8.6.14.7 POU5F1 (OCT4), SOX2, NANOG bind the TSC22D1 promoter (Reaction) 2580 9 Disease (Pathway) 2582 
9.1 HIV Infection (Pathway) 2583 
9.1.1 HIV Life Cycle (Pathway) 2584 
9.1.1.1 Early Phase of HIV Life Cycle (Pathway) 2586 
9.1.1.1.1 Binding and entry of HIV virion (Pathway) 2587 
9.1.1.1.1.1 Binding of gp120 of ENV oligomer to the host CD4 (Reaction) 2589 
9.1.1.1.1.2 Conformational change in gp120 of Env oligomer (Reaction) 2591 
9.1.1.1.1.3 CD4:gp120 binds to chemokine co-receptor CCR5/CXCR4 (Reaction) 2593 
9.1.1.1.1.4 Conformational changes in gp120 exposes gp41 (Reaction) 2595 
9.1.1.1.1.5 Fusogenic activation of gp41 (Reaction) 2597 
9.1.1.1.1.6 Insertion of gp41 fusion peptide into the target membrane (Reaction) 2598 
9.1.1.1.1.7 N and C terminal heptad repeat helices of gp41 form six-helix bundle 2600 (Reaction) 
9.1.1.1.1.8 Fusion of viral membrane with host cell membrane (Reaction) 2602 
9.1.1.1.2 Uncoating of the HIV Virion (Pathway) 2604 
9.1.1.1.2.1 Disintegration of matrix layer (Depolymerisation) 2605 
9.1.1.1.2.2 Disassembly of viral capsid (Reaction) 2607 
9.1.1.1.3 Formation of RTC (Reverse Transcription Complex) (Reaction) 2608 
9.1.1.1.4 Annealing of 3'-end of unwound transfer RNA primer with genomic RNA 2610 (Reaction) 
9.1.1.1.5 Reverse Transcription of HIV RNA (Pathway) 2612 
9.1.1.1.5.1 Minus-strand DNA synthesis (Pathway) 2614 
9.1.1.1.5.1.1 Synthesis of minus strand strong stop DNA (-sssDNA) (Reaction) 2617 
9.1.1.1.5.1.2 RNase H-mediated cleavage of the RNA strand of the -sssDNA:RNA duplex (Reaction) 
9.1.1.1.5.1.3 RNase H-mediated degradation of the RNA strand of the -sssDNA:RNA2622 duplex (Reaction) 
9.1.1.1.5.1.4 First strand transfer mediated by Repeated (R) sequence (Reaction) 2624 
9.1.1.1.5.1.5 Minus strand DNA synthesis resumes (Reaction) 2626 
9.1.1.1.5.1.6 RNase H-mediated cleavage of the template strand (Reaction) 2628 
9.1.1.1.5.1.7 RNase H-mediated degradation of the template strand (Reaction) 2630 
9.1.1.1.5.2 Plus-strand DNA synthesis (Pathway) 2633 
9.1.1.1.5.2.1 3' PPT-primed initiation of plus-strand DNA synthesis (Reaction) 2635 
9.1.1.1.5.2.2 RNase H-mediated digestion of tRNA, 3'PPT and cPPT RNA primers 2637 (Reaction) 
9.1.1.1.5.2.3 Second strand transfer by annealing complementary PBS sequences 2639 (Reaction) 
9.1.1.1.5.2.4 Synthesis of full-length duplex viral DNA with a discontinuous plus strand
2641 (Reaction) 
9.1.1.1.6 Removal of plus-strand flap and gap closure complete synthesis of linear duplex
2643 viral DNA (Reaction) 
9.1.1.1.7 Integration of provirus (Pathway) 2645 
9.1.1.1.7.1 Formation of Pre-Integration Complex (PIC) (Reaction) 2650 
9.1.1.1.7.2 Integrase binds viral DNA ends (Reaction) 2652 
9.1.1.1.7.3 Terminal (3' end) cleavage of viral DNA (Reaction) 2654 
9.1.1.1.7.4 Import of PIC to the Host Nucleus (Reaction) 2655 
9.1.1.1.7.5 Integration of viral DNA into host genomic DNA (Pathway) 2657 
9.1.1.1.7.5.1 Target DNA binding (Reaction) 2659 
9.1.1.1.7.5.2 Transesterification to connect viral DNA 3' ends to host DNA 5' ends 2662 (Reaction) 
9.1.1.1.7.5.3 Gap repair completes provirus integration (Reaction) 2664 
9.1.1.1.7.6 1-LTR circle formation (Reaction) 2666 
9.1.1.1.7.7 2-LTR circle formation (Pathway) 2668 
9.1.1.1.7.7.1 Association of Ku heterodimer with viral DNA ends (Reaction) 2669 
9.1.1.1.7.7.2 Association of XRCC4:DNA ligase IV complex with viral DNA ends 2670 (Reaction) 
9.1.1.1.7.7.3 2-LTR formation due to circularization of viral DNA (Reaction) 2671 
9.1.1.1.7.8 Autointegration results in viral DNA circles (Pathway) 2673 
9.1.1.1.7.8.1 Suicidal integration leading to inverted circle formation (Reaction) 2674 
9.1.1.1.7.8.2 Suicidal integration leading to smaller circles of viral DNA (Reaction) 2676 
9.1.1.2 Late Phase of HIV Life Cycle (Pathway) 2677 
9.1.1.2.1 Transcription of the HIV genome (Pathway) 2678 
9.1.1.2.1.1 HIV Promoter Opening: First Transition (Reaction) 2681 
9.1.1.2.1.2 Fall Back to Closed Pre-initiation Complex (Reaction) 2683 
9.1.1.2.1.3 HIV Transcription Initiation (Pathway) 2684 
9.1.1.2.1.3.1 NTP binds active site of RNA Polymerase II in HIV-1 open pre-initiation2686 complex (Reaction) 
9.1.1.2.1.3.2 Nucleophillic attack by 3'-hydroxyl oxygen of nascent HIV-1 transcript on2687 
the Alpha phosphate of NTP (Reaction) 9.1.1.2.1.3.3 Newly formed phosphodiester bond stabilized and PPi released 2688 (Reaction) 
9.1.1.2.1.3.4 Abortive HIV-1 initiation after formation of the first phosphodiester bond2690 (Reaction) 
9.1.1.2.1.4 RNA Polymerase II HIV Promoter Escape (Pathway) 2691 
9.1.1.2.1.4.1 Addition of the third nucleotide on the nascent HIV-1 transcript 2692 (BlackBoxEvent) 
9.1.1.2.1.4.2 Addition of the fourth nucleotide on the nascent HIV-1 transcript: Second
2694 Transition (BlackBoxEvent) 
9.1.1.2.1.4.3 Abortive HIV-1 Initiation Before Second Transition (Reaction) 2695 
9.1.1.2.1.4.4 Addition of nucleotides 5 through 9 on the growing HIV-1 transcript 2697 (Reaction) 
9.1.1.2.1.4.5 Abortive HIV-1 Initiation After Second Transition (Reaction) 2699 
9.1.1.2.1.4.6 Addition of nucleotides 10 and 11 on the growing HIV-1 transcript: Third2700 Transition (Reaction) 
9.1.1.2.1.4.7 Addition of nucleotides between position +11 and +30 on HIV-1 transcript
2701 (Reaction) 
9.1.1.2.1.5 RNA Pol II CTD phosphorylation and interaction with CE (Pathway) 2703 
9.1.1.2.1.5.1 Extrusion of 5'-end of 30 nt long HIV-1 transcript through the pore in Pol II
2704 complex (Reaction) 
9.1.1.2.1.5.2 Phosphorylation (Ser5) of RNA pol II CTD (Reaction) 2705 
9.1.1.2.1.5.3 RNA Polymerase II CTD (phosphorylated) binds to CE (Reaction) 2706 
9.1.1.2.1.5.4 Activation of GT (Reaction) 2708 
9.1.1.2.1.5.5 SPT5 subunit of Pol II binds the RNA triphosphatase (RTP) (Reaction) 2709 
9.1.1.2.1.6 HIV Transcription Elongation (Pathway) 2710 
9.1.1.2.1.6.1 Formation of the HIV-1 Early Elongation Complex (Pathway) 2712 
9.1.1.2.1.6.1.1 Hypophosphorylation of RNA Pol II CTD by FCP1P protein (Reaction)
2714 
9.1.1.2.1.6.1.2 DSIF complex binds to RNA Pol II (hypophosphorylated) (Reaction)2715 
9.1.1.2.1.6.1.3 Formation of DSIF:NELF:HIV-1 early elongation complex (Reaction)2717 
9.1.1.2.1.6.1.4 Abortive termination of HIV-1 early transcription elongation by 2719 DSIF:NELF (Reaction) 
9.1.1.2.1.6.1.5 Recognition and binding of the HIV-1 mRNA cap by the cap-binding2721 complex (Reaction) 
9.1.1.2.1.6.2 Tat-mediated elongation of the HIV-1 transcript (Pathway) 2722 
9.1.1.2.1.6.2.1 Formation of HIV-1 elongation complex containing HIV-1 Tat 2724 (Pathway) 
9.1.1.2.1.6.2.1.1 Association of Tat with P-TEFb(Cyclin T1:Cdk9) (Reaction) 2727 
9.1.1.2.1.6.2.1.2 Hyperphosphorylation (Ser2) of RNA Pol II CTD by the 2728 P-TEFb(Cyclin T1:Cdk9) complex (Reaction) 
9.1.1.2.1.6.2.1.3 Phosphorylation of NEFL by the P-TEFb(Cyclin T1:Cdk9) complex
2730 (Reaction) 
9.1.1.2.1.6.2.1.4 Phosphorylation of DSIF by the P-TEFb(Cyclin T1:Cdk9) complex2731 (Reaction) 
9.1.1.2.1.6.2.1.5 Recruitment of elongation factors to form HIV-1 elongation complex
2732 (Reaction) 
9.1.1.2.1.6.2.2 Addition of nucleotides leads to HIV-1 transcript elongation (Reaction)
2733 
9.1.1.2.1.6.2.3 Pol II elongation complex moves on the HIV-1 template as transcript2736 elongates (Reaction) 
9.1.1.2.1.6.2.4 Separation of elongating HIV-1 transcript from template (Reaction) 2737 
9.1.1.2.1.6.3 Abortive elongation of HIV-1 transcript in the absence of Tat (Pathway)2738 
9.1.1.2.1.6.3.1 Limited elongation of the HIV-1 transcript (Reaction) 2739 
9.1.1.2.1.6.3.2 Separation of abortive HIV-1 transcript from template (Reaction) 2741 
9.1.1.2.1.7 HIV elongation arrest and recovery (Pathway) 2742 
9.1.1.2.1.7.1 7-14 nt. Backtracking of Pol II complex on the HIV-1 template leading to2743 elongation arrest (Reaction) 
9.1.1.2.1.7.2 Abortive termination of HIV-1 elongation after arrest (Reaction) 2744 
9.1.1.2.1.7.3 TFIIS-mediated recovery of HIV-1 elongation from arrest (Reaction) 2746 
9.1.1.2.1.8 Formation of HIV elongation complex in the absence of HIV Tat (Pathway)2747 
9.1.1.2.1.8.1 Hyperphosphorylation (Ser2) of RNA Pol II CTD by P-TEFb complex 2749 (Reaction) 
9.1.1.2.1.8.2 Recruitment of elongation factors to form HIV-1 elongation complex 2751 (Reaction) 
9.1.1.2.1.9 Pausing and recovery of HIV elongation (Pathway) 2752 
9.1.1.2.1.9.1 2-4 nt.backtracking of Pol II complex on the HIV-1 template leading to 2752 elongation pausing (Reaction) 
9.1.1.2.1.9.2 Resumption of elongation of HIV-1 transcript after recovery from pausing
2754 (Reaction) 
9.1.1.2.1.10 Tat-mediated HIV elongation arrest and recovery (Pathway) 2755 
9.1.1.2.1.10.1 TFIIS-mediated recovery of elongation from arrest (Reaction) 2756 
9.1.1.2.1.10.2 Abortive termination of HIV-1 elongation after arrest (Tat-containing 2757 elongation complex) (Reaction) 
9.1.1.2.1.10.3 7-14 nt. Backtracking of Pol II complex on the HIV-1 template leading to
2759 elongation arrest (Reaction) 
9.1.1.2.1.11 Pausing and recovery of Tat-mediated HIV elongation (Pathway) 2760 
9.1.1.2.1.11.1 2-4 nt.backtracking of Pol II complex on the HIV-1 template leading to2760 elongation pausing (Reaction) 
9.1.1.2.1.11.2 Resumption of elongation of HIV-1 transcript after recovery from pausing
2762 (Reaction) 
9.1.1.2.1.12 HIV Transcription Termination (Pathway) 2763 
9.1.1.2.2 Rev-mediated nuclear export of HIV RNA (Pathway) 2764 
9.1.1.2.2.1 Rev molecules assemble onto the RRE RNA sequence through their ARM2766 sequence (Reaction) 
9.1.1.2.2.2 Multimerization of Rev (Reaction) 2767 
9.1.1.2.2.3 Rev multimer-bound HIV mRNA associates with Crm1 (Reaction) 2768 
9.1.1.2.2.4 Conversion of Ran-GDP to Ran-GTP (Reaction) 2769 
9.1.1.2.2.5 Rev multimer-bound HIV mRNA:CRM1 complex associates with Ran:GTP2771 (Reaction) 
9.1.1.2.2.6 Rev multimer-bound HIV mRNA:Crm1:Ran:GTP complex associates with the
2772 NPC (Reaction) 
9.1.1.2.2.7 Translocation of nuclear RNA transport complex to cytoplasm (Reaction) 2773 
9.1.1.2.2.8 Association of RanBP1 with Ran-GTP:CRM1:Rev:mRNA complex (Reaction)2774 
9.1.1.2.2.9 Release of the HIV mRNA and Crm1 from Rev in the cytoplasm (Reaction)2775 
9.1.1.2.2.10 Hydrolysis of Ran:GTP to Ran:GDP (Reaction) 2776 
9.1.1.2.3 Myristoylation of Nef (Reaction) 2778 
9.1.1.2.4 Assembly Of The HIV Virion (Pathway) 2779 
9.1.1.2.4.1 Synthesis And Processing Of GAG, GAGPOL Polyproteins (Pathway) 2780 
9.1.1.2.4.1.1 Synthesis of GAG polyprotein (BlackBoxEvent) 2781 
9.1.1.2.4.1.2 Membrane binding and targetting of GAG proteins (Pathway) 2782 
9.1.1.2.4.1.2.1 N-myristoylation of GAG polyprotein by NMT2 (Reaction) 2783 
9.1.1.2.4.1.2.2 Monoubiquitination of N-myristoyl GAG polyprotein (BlackBoxEvent)2784 
9.1.1.2.4.1.2.3 Monoubiquitinated N-myristoyl GAG polyprotein is targeted to the late
2786 endosomal vesicle membrane by the ESCRT-I complex (Reaction) 
9.1.1.2.4.1.2.4 Transport of GAG to the Plasma Membrane (Reaction) 2787 
9.1.1.2.4.2 Synthesis and processing of ENV and VPU (Pathway) 2788 
9.1.1.2.4.2.1 Splicing of HIV RNA transcript (BlackBoxEvent) 2789 
9.1.1.2.4.2.2 Synthesis of ENV polyprotein (BlackBoxEvent) 2790 
9.1.1.2.4.2.3 Glycosylation of ENV polyprotein (Reaction) 2791 
9.1.1.2.4.2.4 Folding and Oligomerization of ENV glycoprotein (Reaction) 2792 
9.1.1.2.4.2.5 Transport of trimeric ENV precursor to Golgi apparatus (Reaction) 2793 
9.1.1.2.4.2.6 Cleavage of the viral Env gp160 precursor polyprotein (Reaction) 2794 
9.1.1.2.4.2.7 Transport of trimeric gp41:gp120 to plasma membrane (Reaction) 2796 
9.1.1.2.4.2.8 Synthesis of VPU protein (BlackBoxEvent) 2797 
9.1.1.2.4.2.9 Transport of VPU to Golgi apparatus (Reaction) 2798 
9.1.1.2.4.2.10 Transport of VPU to Plasma Membrane (Reaction) 2799 
9.1.1.2.4.3 Packaging of HIV virion on the host cell plasma membrane (Reaction) 2800 
9.1.1.2.5 Budding and maturation of HIV virion (Pathway) 2802 
9.1.1.2.5.1 Recruitment Of HIV Virion Budding Machinery (Reaction) 2803 
9.1.1.2.5.2 HIV Virion Budding (BlackBoxEvent) 2804 
9.1.1.2.5.3 Maturation of HIV Virion (Reaction) 2805 
9.2 Influenza Infection (Pathway) 2807 
9.2.1 Influenza Life Cycle (Pathway) 2809 
9.2.1.1 Binding of the influenza virion to the host cell (Reaction) 2811 
9.2.1.2 Entry of Influenza Virion into Host Cell via Endocytosis (Pathway) 2813 
9.2.1.2.1 Clathrin-Mediated Pit Formation And Endocytosis Of The Influenza Virion 2814 (Reaction) 
9.2.1.3 Fusion and Uncoating of the Influenza Virion (Pathway) 2815 
9.2.1.3.1 Fusion of the Influenza Virion to the Host Cell Endosome (Pathway) 2816 
9.2.1.3.1.1 Conformation change in hemagglutinin freeing the fusion peptide of HA2 2817 (Reaction) 
9.2.1.3.1.2 Fusion of the influenza virion HA2 protein transmembrane domain to the host
2818 cell endosome membrane (Reaction) 
9.2.1.3.1.3 Concerted hemagglutinin pore formation (Reaction) 2818 
9.2.1.3.2 Uncoating of the Influenza Virion (Pathway) 2819 
9.2.1.3.2.1 Virion-associated M2 protein mediated ion infusion (Reaction) 2820 
9.2.1.3.2.2 Ribonucleoprotein release from M1 proteins (Reaction) 2821 9.2.1.4 Transport of Ribonucleoproteins into the Host Nucleus (Pathway) 2822 
9.2.1.4.1 Recognition of the Nuclear Localization Signal (NLS) by a Karyopherin Alpha2824 Family Protein (Reaction) 
9.2.1.4.2 Recruitment of Karyopherin Beta to form a Trimeric Complex (Reaction) 2825 
9.2.1.4.3 Docking and transport of the RNP:Karyopherin complex through the nuclear 2826 pore (Reaction) 
9.2.1.4.4 Release of the RNP into the host cell nucleus (Reaction) 2827 
9.2.1.5 Influenza Viral RNA Transcription and Replication (Pathway) 2828 
9.2.1.5.1 vRNP Assembly (Pathway) 2830 
9.2.1.5.1.1 Viral Polymerase Assembly (Reaction) 2831 
9.2.1.5.1.2 NP binds vRNA (Reaction) 2833 
9.2.1.5.2 Viral Messenger RNA Synthesis (Pathway) 2835 
9.2.1.5.2.1 Assembly of an Active Transcription Complex (Reaction) 2837 
9.2.1.5.2.2 Priming and Initiation of Transcription (Reaction) 2839 
9.2.1.5.2.3 Elongation of viral mRNA (Reaction) 2841 
9.2.1.5.2.4 Polyadenylation and Termination (Reaction) 2842 
9.2.1.5.2.5 Viral mRNA Splicing (M, NS segments) (Reaction) 2844 
9.2.1.5.2.6 Export of Spliced Viral mRNA (Reaction) 2846 
9.2.1.5.2.7 Viral mRNA Export (Reaction) 2847 
9.2.1.5.3 cRNA Synthesis (Pathway) 2849 
9.2.1.5.3.1 Initiation of cRNA Synthesis (Reaction) 2850 
9.2.1.5.3.2 cRNA Extension (Reaction) 2852 
9.2.1.5.4 vRNA Synthesis (Pathway) 2853 
9.2.1.5.4.1 Initiation of vRNA Synthesis (Reaction) 2854 
9.2.1.5.4.2 vRNA Extension (Reaction) 2855 
9.2.1.5.5 Viral mRNA Translation (Pathway) 2856 
9.2.1.5.5.1 Synthesis of PB1-F2 (BlackBoxEvent) 2858 
9.2.1.5.5.2 Viral Protein Synthesis (BlackBoxEvent) 2859 
9.2.1.6 Export of Viral Ribonucleoproteins from Nucleus (Pathway) 2861 
9.2.1.6.1 Viral RNP Complexes in the Host Cell Nucleus (Pathway) 2863 
9.2.1.6.1.1 Newly synthesized vRNP for export (Reaction) 2864 
9.2.1.6.1.2 Binding of M1 to vRNP (Reaction) 2866 
9.2.1.6.1.3 Binding of NEP/NS2 to vRNP:M1 (Reaction) 2867 
9.2.1.6.2 NEP/NS2 Interacts with the Cellular Export Machinery (Pathway) 2868 
9.2.1.6.2.1 Binding of vRNP:M1:NEP complex to CRM1 export receptor (Reaction) 2869 
9.2.1.6.2.2 vRNP Export through the nuclear pore (Reaction) 2870 
9.2.1.7 Virus Assembly and Release (Pathway) 2872 
9.2.1.7.1 Assembly of Viral Components at the Budding Site (Pathway) 2874 
9.2.1.7.1.1 Entry of M2 into the endoplasmic reticulum (Reaction) 2875 
9.2.1.7.1.2 Assembly of M2 tetramers (Reaction) 2876 
9.2.1.7.1.3 Entry of NA into the endoplasmic reticulum (Reaction) 2877 
9.2.1.7.1.4 Glycosylation of NA (Reaction) 2878 
9.2.1.7.1.5 Assembly of NA tetramers (Reaction) 2879 
9.2.1.7.1.6 Entry of HA into the endoplasmic reticulum (Reaction) 2880 
9.2.1.7.1.7 Glycosylation and Folding of HA (Reaction) 2881 
9.2.1.7.1.8 Trimerization of HA (Reaction) 2883 
9.2.1.7.1.9 Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic2884 reticulum to the Golgi Apparatus (Pathway) 
9.2.1.7.1.9.1 Budding of vesicle with the HA trimer, NA tetramer and M2 tetramer from
2885 the endoplasmic reticulum into the cytosol (Reaction) 
9.2.1.7.1.9.2 Fusion of vesicle containing the HA trimer, NA tetramer and M2 tetramer2886 to the Golgi apparatus (Reaction) 
9.2.1.7.1.10 Palmitoylation of cysteine residues on HA in the cis-Golgi network 2887 (Reaction) 
9.2.1.7.1.11 Palmitoylation of cysteine residues on M2 in the cis-golgi network 2889 (Reaction) 
9.2.1.7.1.12 Association of HA into rafts (Reaction) 2890 
9.2.1.7.1.13 Association of NP into rafts (Reaction) 2891 
9.2.1.7.1.14 Association of NA into rafts (Reaction) 2892 
9.2.1.7.1.15 Transport of processed viral proteins to the cell membrane (Reaction) 2894 
9.2.1.7.1.16 Accumulation of M1 at the inner leaflet of the lipid bilayer (Reaction) 2895 
9.2.1.7.2 Packaging of Eight RNA Segments (Pathway) 2896 
9.2.1.7.2.1 RNP association (Reaction) 2898 
9.2.1.7.2.2 Association with M1 at cell membrane (Reaction) 2900 
9.2.1.7.3 Budding (Pathway) 2901 
9.2.1.7.3.1 Membrane fusion (Reaction) 2902 
9.2.1.7.4 Release (Pathway) 2903 
9.2.1.7.4.1 Neuraminidase enzymatic release from sialic acid (Reaction) 2904 
9.2.2 Host Interactions with Influenza Factors (Pathway) 2906 
9.2.2.1 NS1 Mediated Effects on Host Pathways (Pathway) 2906 
9.2.2.1.1 Inhibition of Host mRNA Processing and RNA Silencing (Pathway) 2907 
9.2.2.1.1.1 Binding of NS1 to cleavage and host polyadenylation specificity factor 2908 (CPSF) (Reaction) 
9.2.2.1.1.2 Binding of NS1 to poly(A)-binding protein II (PABII) (Reaction) 2909 
9.2.2.1.2 Inhibition of Interferon Synthesis (Pathway) 2909 
9.2.2.1.2.1 Inhibition of IFN-beta (Pathway) 2910 
9.2.2.1.2.1.1 Binding of NS1 to dsRNA (Reaction) 2910 
9.2.2.1.3 Inhibition of PKR (Pathway) 2911 
9.2.2.1.3.1 Binding of NS1 to dsRNA (Reaction) 2911 
9.2.2.1.3.2 Binding of NS1 to PKR (Reaction) 2911 
9.2.2.2 Influenza Virus Induced Apoptosis (Pathway) 2912 
9.2.2.2.1 NA activation of TGF-beta (Reaction) 2913 
9.2.2.2.2 PB1-F2 binds to the mitochondrial adenine nucleotide translocator 3 ANT3, 2914 inducing apoptosis (Reaction) 
9.3 Latent infection of Homo sapiens with Mycobacterium tuberculosis (Pathway) 2915 
9.3.1 Phagosomal maturation (early endosomal stage) (Pathway) 2916 
9.3.1.1 Nitric Oxide Synthase (NOS) produces Nitric Oxide (NO) (Reaction) 2917 
9.3.1.2 Nitric oxide oxidizes to nitrosyl (Reaction) 2919 
9.3.1.3 Nitric oxide diffuses into the phagosome (Reaction) 2920 
9.3.1.4 Nitric oxide enters the bacterium (BlackBoxEvent) 2922 
9.3.1.5 NOX2 generates superoxide from oxygen (Reaction) 2923 
9.3.1.6 Intraphagosomal pH is lowered to 5 by V-ATPase (Reaction) 2924 
9.3.1.7 Protonation of superoxide (Reaction) 2926 
9.3.1.8 Hydroperoxyl enters the bacterium (BlackBoxEvent) 2927 
9.3.1.9 Superoxide and nitric oxide react to peroxynitrite (Reaction) 2928 
9.3.1.10 Peroxynitrite enters the bacterium (BlackBoxEvent) 2929 
9.3.1.11 Peroxynitrite oxidizes methionine residues (Reaction) 2930 
9.3.1.12 Glutathione scavenges nitrosyl (Reaction) 2931 
9.3.1.13 Glutathione is taken up by the bacterium (Reaction) 2932 
9.3.1.14 Lactoferrin scavenges iron ions (Reaction) 2933 
9.3.1.15 NRAMP1 transports divalent metal ions across phagosomal membranes of 2935 macrophages (Reaction) 
9.3.1.16 Cathelicidin LL-37 localizes to bacterial cell wall (BlackBoxEvent) 2936 
9.3.2 Response of Mtb to phagocytosis (Pathway) 2937 
9.3.2.1 Tolerance by Mtb to nitric oxide produced by macrophages (Pathway) 2939 
9.3.2.1.1 Nitrogen dioxide is reduced to NO by F420 (Reaction) 2940 
9.3.2.1.2 Nitric oxide is oxidized to nitrate (Reaction) 2941 
9.3.2.1.3 Peroxynitrite is reduced to nitrite by AhpC (Reaction) 2942 
9.3.2.1.4 Peroxynitrite is reduced by AhpE (Reaction) 2944 
9.3.2.1.5 Peroxynitrite is reduced to nitrite by Tpx (Reaction) 2945 
9.3.2.1.6 Mycothiol scavenges nitrosyl (Reaction) 2946 
9.3.2.1.7 MscR reduces nitrosomycothiol to ammonia (Reaction) 2947 
9.3.2.1.8 MsrA/B reduces peptide-methionine S/R-sulfoxides (Reaction) 2949 
9.3.2.1.9 Nitrosoglutathione gets cleaved to Cys(NO)-Gly (Reaction) 2950 
9.3.2.2 Tolerance of reactive oxygen produced by macrophages (Pathway) 2951 
9.3.2.2.1 SodB gets secreted (Reaction) 2952 
9.3.2.2.2 SodB reduces superoxide to H2O2 (Reaction) 2953 
9.3.2.2.3 SodC reduces superoxide to H2O2 (Reaction) 2955 
9.3.2.2.4 AhpC reduces H2O2 (Reaction) 2956 
9.3.2.2.5 KatG reduces H2O2 (Reaction) 2957 
9.3.2.2.6 H2O2 gets scavenged by unsaturated lipid (Reaction) 2958 
9.3.2.2.7 AhpC reduces peroxidated lipids (Reaction) 2960 
9.3.2.3 Cell redox homeostasis (Pathway) 2961 
9.3.2.3.1 AhpD reactivates AhpC (Reaction) 2962 
9.3.2.3.2 DlaT reactivates AhpD (Reaction) 2963 
9.3.2.3.3 Lpd reactivates dlaT (Reaction) 2964 
9.3.2.3.4 TrxA reactivates AhpC (Reaction) 2966 
9.3.2.3.5 TrxB reactivates TrxA (Reaction) 2967 
9.3.2.3.6 TrxA/B1 reactivates Tpx (Reaction) 2968 
9.3.2.3.7 Fgd1 reactivates F420 (Reaction) 2969 
9.3.2.4 Mtb iron assimilation by chelation (Pathway) 2971 
9.3.2.4.1 Carboxymycobactin gets secreted (BlackBoxEvent) 2972 
9.3.2.4.2 Mycobactin is exported (Reaction) 2973 
9.3.2.4.3 Carboxymycobactin binds iron from lactoferrin (Reaction) 2974 
9.3.2.4.4 Carboxymycobactin and mycobactin exchange their iron load (Reaction) 2976 
9.3.2.4.5 Loaded mycobactin gets imported (Reaction) 2977 
9.3.2.4.6 Iron is reduced and separates from mycobactin (Reaction) 2978 
9.3.2.4.7 BfrA stores iron (Reaction) 2980 
9.3.2.4.8 BfrB stores iron (Reaction) 2981 
9.4 Uptake and actions of bacterial toxins (Pathway) 2982 
9.4.1 Neurotoxicity of clostridium toxins (Pathway) 2983 
9.4.1.1 Toxicity of botulinum toxin type A (BoNT/A) (Pathway) 2985 
9.4.1.1.1 Transcytosis and dissociation of BoNT/A:NTNHA:HA (BlackBoxEvent) 2987 
9.4.1.1.2 BoNT/A HC:LC binds SV2A, B, or C and GT1b on the target cell surface 2988 (Reaction) 
9.4.1.1.3 BoNT/A:SV2:GT1b internalized from target cell plasma membrane to synaptic2989 vesicle membrane (BlackBoxEvent) 
9.4.1.1.4 BoNT/A HC transports BoNT/A LC from target cell synaptic vesicle membrane2990 into cytosol (BlackBoxEvent) 
9.4.1.1.5 BoNT/A LC cleaves target cell SNAP25 (Reaction) 2992 
9.4.1.2 Toxicity of botulinum toxin type B (BoNT/B) (Pathway) 2994 
9.4.1.2.1 Transcytosis and dissociation of BoNT/B:NTNHA:HA (BlackBoxEvent) 2996 
9.4.1.2.2 BoNT/B HC:LC binds SYT1 or 2 and GT1b on the target cell surface (Reaction)2997 
9.4.1.2.3 BoNT/B:SYT:GT1b internalized from target cell plasma membrane to synaptic2998 vesicle membrane (BlackBoxEvent) 
9.4.1.2.4 BoNT/B HC transports BoNT/B LC from target cell synaptic vesicle membrane2999 into cytosol (BlackBoxEvent) 
9.4.1.2.5 BoNT/B LC cleaves target cell VAMP2 (Reaction) 3001 
9.4.1.3 Toxicity of botulinum toxin type E (BoNT/E) (Pathway) 3002 
9.4.1.3.1 Transcytosis and dissociation of BoNT/E:NTNHA (BlackBoxEvent) 3005 
9.4.1.3.2 BoNT/E HC:LC binds SV2A or B and GT1b on the target cell surface (Reaction)3006 
9.4.1.3.3 BoNT/E:SV2:GT1b internalized from target cell plasma membrane to synaptic3007 vesicle membrane (BlackBoxEvent) 
9.4.1.3.4 BoNT/E HC transports BoNT/E LC from target cell synaptic vesicle membrane3008 into cytosol (BlackBoxEvent) 
9.4.1.3.5 BoNT/E LC cleaves target cell SNAP25 (Reaction) 3010 
9.4.1.4 Toxicity of botulinum toxin type C (BoNT/C) (Pathway) 3012 
9.4.1.4.1 BoNT/C HC:LC binds GT1b on the target cell surface (Reaction) 3013 
9.4.1.4.2 BoNT/C:GT1b internalized from target cell plasma membrane to synaptic 3014 vesicle membrane (BlackBoxEvent) 
9.4.1.4.3 BoNT/C HC transports BoNT/C LC from target cell synaptic vesicle membrane3015 to cytosol (BlackBoxEvent) 
9.4.1.4.4 BoNT/C LC cleaves target cell STX1 (Reaction) 3017 
9.4.1.4.5 BoNT/C LC cleaves target cell SNAP25 (Reaction) 3018 
9.4.1.5 Toxicity of botulinum toxin type D (BoNT/D) (Pathway) 3020 
9.4.1.5.1 BoNT/D HC:LC binds SV2A or B or C and GD2 on the target cell surface 3021 (Reaction) 
9.4.1.5.2 BoNT/D:SV2:GD2 internalized from target cell plasma membrane to synaptic3022 vesicle membrane (BlackBoxEvent) 
9.4.1.5.3 BoNT/D HC transports BoNT/D LC from target cell synaptic vesicle membrane 
into cytosol (BlackBoxEvent) 
9.4.1.5.4 BoNT/D LC cleaves target cell VAMP1 (Reaction) 	3025 
9.4.1.5.5 BoNT/D LC cleaves target cell VAMP2 (Reaction) 	3026 
9.4.1.6 Toxicity of botulinum toxin type F (BoNT/F) (Pathway) 	3028 
9.4.1.6.1 BoNT/F HC:LC binds SV2A or B or C and GT1b on the target cell surface 3029 (Reaction) 
9.4.1.6.2 BoNT/F:SV2:GT1b internalized from target cell plasma membrane to synaptic3031 vesicle membrane (BlackBoxEvent) 
9.4.1.6.3 BoNT/F HC transports BoNT/F LC from target cell synaptic vesicle membrane3032 into cytosol (BlackBoxEvent) 
9.4.1.6.4 BoNT/F LC cleaves target cell VAMP1 (Reaction) 	3033 
9.4.1.6.5 BoNT/F LC cleaves target cell VAMP2 (Reaction) 	3035 
9.4.1.7 Toxicity of botulinum toxin type G (BoNT/G) (Pathway) 	3036 
9.4.1.7.1 BoNT/G HC:LC binds SYT1 and GT1b on the target cell surface (Reaction) 3037 
9.4.1.7.2 BoNT/G:SYT1:GT1b internalized from target cell plasma membrane to synaptic
3039 vesicle membrane (BlackBoxEvent) 
9.4.1.7.3 BoNT/G HC transports BoNT/G LC from target cell synaptic vesicle membrane3040 into cytosol (BlackBoxEvent) 
9.4.1.7.4 BoNT/G LC cleaves target cell VAMP1 (Reaction) 	3041 
9.4.1.7.5 BoNT/G LC cleaves target cell VAMP2 (Reaction) 	3042 
9.4.2 Uptake and function of anthrax toxins (Pathway) 	3044 
9.4.2.1 PA83 binds ANTXR1 (Reaction) 	3045 
9.4.2.2 PA83 binds ANTXR2 (Reaction) 	3047 
9.4.2.3 Furin cleaves ANTXR1-bound PA83 to yield PA63 (Reaction) 	3048 
9.4.2.4 Furin cleaves ANTXR2-bound PA83 to yield PA63 (Reaction) 	3049 
9.4.2.5 ANTXR1-bound PA63 forms oligomers (Reaction) 	3051 
9.4.2.6 ANTXR2-bound PA63 forms oligomers (Reaction) 	3052 
9.4.2.7 EF and LF bind to PA63:ANTXR1 oligomer (Reaction) 	3053 
9.4.2.8 EF and LF bind to PA63:ANTXR2 oligomer (Reaction) 	3055 
9.4.2.9 Endocytosis of EF:LF:PA63:ANTXR1 (plasma membrane to endosome membrane)
3056 (BlackBoxEvent) 
9.4.2.10 Endocytosis of EF:LF:PA63:ANTXR2 (plasma membrane to endosome 3057 membrane) (BlackBoxEvent) 
9.4.2.11 PA63:ANTRX1 oligomer transports EF and LF (target cell endosome to cytosol)3058 (BlackBoxEvent) 
9.4.2.12 PA63:ANTRX2 oligomer transports EF and LF (target cell endosome to cytosol)3060 (BlackBoxEvent) 
9.4.2.13 Anthrax EF catalyzes the conversion of ATP to cAMP (Reaction) 	3062 
9.4.2.14 Anthrax LF cleaves target cell MAP2K1 (MEK1) (Reaction) 	3064 
9.4.2.15 Anthrax LF cleaves target cell MAP2K2 (MEK2) (Reaction) 	3065 
9.4.2.16 Anthrax LF cleaves target cell MAP2K3 (MEK3) (Reaction) 	3066 
9.4.2.17 Anthrax LF cleaves target cell MAP2K4 (MEK4) (Reaction) 	3067 
9.4.2.18 Anthrax LF cleaves target cell MAP2K6 (MEK6) (Reaction) 	3068 
9.4.2.19 Anthrax LF cleaves target cell MAP2K7 (MEK7) (Reaction) 	3069 
9.5 Signaling by EGFR in Cancer (Pathway) 	30233071 9.5.1 Signaling by constitutively active EGFR (Pathway) 3072 
9.5.1.1 Binding of ligand-responsive EGFR mutants to chaperoning proteins HSP90 and3076 CDC37 (Reaction) 
9.5.1.2 Binding of EGF to ligand-responsive EGFR mutants (Reaction) 3077 
9.5.1.3 EGF-induced dimerization of ligand-responsive EGFR mutants (Reaction) 3079 
9.5.1.4 Spontaneous dimerization of ligand-responsive EGFR mutants (Reaction) 3080 
9.5.1.5 Trans-autophosphorylation of activated ligand-responsive EGFR mutant dimers 3082 (Reaction) 
9.5.1.6 EGFRvIII mutant binds chaperone proteins HSP90 and CDC37. (Reaction) 3083 
9.5.1.7 Ligand-independent dimerization of EGFRvIII mutant (Reaction) 3084 
9.5.1.8 Trans-autophosphorylation of EGFRvIII mutant dimers (Reaction) 3086 
9.5.1.9 Binding of GRB2:SOS1 complex to phosphorylated EGFR mutants (Reaction) 3087 
9.5.1.10 SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in 3090 complex with p-EGFR mutants) (Reaction) 
9.5.1.11 Binding of SHC1 to p-EGFR mutants (Reaction) 3092 
9.5.1.12 Phosphorylation of SHC1 by p-EGFR mutants (Reaction) 3094 
9.5.1.13 Phosphorylated SHC1 in complex with p-EGFR mutants recruits GRB2:SOS1 3095 complex (Reaction) 
9.5.1.14 SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in 3097 complex with phosphorylated SHC1 and p-EGFR mutants) (Reaction) 
9.5.1.15 Binding of GRB2:GAB1:PIK3R1 complex to p-EGFR mutants (Reaction) 3099 
9.5.1.16 Binding of PI3K p110 subunit alpha (PIK3CA) to complex of GRB2:GAB1:PIK3R1
3102 and p-EGFR mutants (Reaction) 
9.5.1.17 Conversion of PIP2 to PIP3 by PI3K bound to phosphorylated EGFR mutants 3103 (Reaction) 
9.5.1.18 PLC-gamma 1 binds to p-EGFR mutants (Reaction) 3106 
9.5.1.19 Phosphorylation of PLC-gamma 1 by p-EGFR mutants (Reaction) 3108 
9.5.1.20 Dissociation of phosphorylated PLC-gamma 1 from p-EGFR mutants (Reaction)3109 
9.5.1.21 Binding of CBL to phosphorylated ligand-responsive EGFR mutants (Reaction) 3111 
9.5.1.22 Phosphorylation of CBL by ligand-responsive p-6Y-EGFR mutants (Reaction) 3113 
9.5.1.23 Inefficient ubiquitination of ligand-responsive EGFR mutants by phosphorylated3115 CBL (Reaction) 
9.5.1.24 HSP90 is inactivated by binding to benzaquinoid ansamycins (Reaction) 3117 
9.5.1.25 Non-covalent tyrosine kinase inhibitors bind and inactivate sensitive 3118 ligand-responsive EGFR cancer mutants (Reaction) 
9.5.1.26 Covalent tyrosine kinase inhibitors bind and inactivate EGFR kinase domain 3120 mutant dimers resistant to non-covalent tyrosine kinase inhibitors (Reaction) 
9.5.1.27 Covalent tyrosine kinase inhibitors bind and inhibit wild-type EGF:EGFR dimers3121 (Reaction) 
9.5.1.28 Inactivation of over-expressed wild type EGFR by Cetuximab recombinant 3122 antibody (Reaction) 
9.6 Amyloids (Pathway) 3124 
9.6.1 Serum amyloid P-component forms homopentamers (Reaction) 3126 
9.6.2 Amyloid precursor proteins form ordered fibrils (Polymerisation) 3127 
9.6.3 Amyloid fibrils have additional components (Reaction) 
9.6.4 Formation of serum amyloid P decamer (Reaction) 3134 
9.6.5 Serum amyloid P binds DNA and chromatin (Reaction) 3135 
9.7 Signaling by FGFR in disease (Pathway) 3137 
9.7.1 Signaling by FGFR mutants (Pathway) 3138 
9.7.1.1 Signaling by FGFR1 mutants (Pathway) 3142 
9.7.1.1.1 Signaling by FGFR1 amplification mutants (Pathway) 3145 
9.7.1.1.1.1 Ligand-independent dimerization of overexpressed FGFR1 (Reaction) 3148 
9.7.1.1.1.2 Ligand-independent phosphorylation of overexpressed FGFR1 (Reaction) 3150 
9.7.1.1.1.3 Tyrosine kinase inhibitors bind and inhibit overexpressed FGFR1 dimers 3151 (Reaction) 
9.7.1.1.2 Signaling by FGFR1 fusion mutants (Pathway) 3153 
9.7.1.1.2.1 Dimerization of FGFR1 fusion proteins (Reaction) 3156 
9.7.1.1.2.2 Phosphorylation of FGFR1 fusion dimers (Reaction) 3158 
9.7.1.1.2.3 Tyrosine kinase inhibitors bind and inhibit FGFR1 fusion dimer 3160 phosphorylation (Reaction) 
9.7.1.1.2.4 FGFR1 fusions bind PLCgamma (Reaction) 3162 
9.7.1.1.2.5 PLCgamma is phosphorylated by FGFR1-fusions (Reaction) 3164 
9.7.1.1.2.6 p-PLCgamma dissociates from FGFR1 fusions (Reaction) 3165 
9.7.1.1.2.7 FGFR1 fusion proteins recruit PIK3R1 (BlackBoxEvent) 3166 
9.7.1.1.2.8 Recruitment of the catalytic subunit of PI3K to activated FGFR1 fusions 3168 (Reaction) 
9.7.1.1.2.9 FGFR1 fusion protein-associated PI3K phosphorylates PIP2 to PIP3 3170 (Reaction) 
9.7.1.1.2.10 Phosphorylation of BCR moiety of BCR-FGFR1 (Reaction) 3171 
9.7.1.1.2.11 p-BCR-pFGFR1 recruits GRB2:GAB2 (Reaction) 3173 
9.7.1.1.2.12 GAB2 is phosphorylated by p-BCR-p-FGFR1 (Reaction) 3174 
9.7.1.1.2.13 Recruitment of the p85 regulatory subunit of PI3K to the BCR-FGFR1 3176 complex. (Reaction) 
9.7.1.1.2.14 The catalytic subunit of PI3K is recruited to the BCR-FGFR1 fusion. 3177 (Reaction) 
9.7.1.1.2.15 BCR-FGFR1-associated PI3K phosphorylates PIP2 to PIP3. (Reaction) 3179 
9.7.1.1.2.16 Phosphorylation of STAT5 by FGFR1 fusions (Reaction) 3180 
9.7.1.1.2.17 FGFR1OP-FGFR1 phosphorylates STAT1 and STAT3 (Reaction) 3182 
9.7.1.1.3 Signaling by activated point mutants of FGFR1 (Pathway) 3183 
9.7.1.1.3.1 FGFR1 P252X mutants bind ligand with enhanced affinity (Reaction) 3185 
9.7.1.1.3.2 Autocatalytic phosphorylation of FGFR1 P252X mutant dimers (Reaction) 3187 
9.7.1.1.3.3 Dimerization of FGFR1 point mutants with enhanced kinase activity 3189 (Reaction) 
9.7.1.1.3.4 Autocatalytic phosphorylation of FGFR1 mutants with enhanced kinase 3190 activity (Reaction) 
9.7.1.2 Signaling by FGFR2 mutants (Pathway) 3193 
9.7.1.2.1 Activated point mutants of FGFR2 (Pathway) 3195 
9.7.1.2.1.1 Dimerization of FGFR2 ligand-independent mutants (Reaction) 3198 
9.7.1.2.1.2 Autocatalytic phosphorylation of FGFR2 ligand-independent mutants 3200 (Reaction) 
9.7.1.2.1.3 FGFR2b mutants bind an expanded range of ligands (Reaction) 3202 
9.7.1.2.1.4 Autocatalytic phosphorylation of FGFR2b mutants with enhanced ligand 3205 binding (Reaction) 
9.7.1.2.1.5 FP-1039 acts as a ligand-trap for FGFR2b-binding ligands in endometrial 3206 cancer (Reaction) 
9.7.1.2.1.6 FGFR2c mutants bind an expanded range of ligands (Reaction) 3207 
9.7.1.2.1.7 Autocatalytic phosphorylation of FGFR2c mutants with enhanced ligand 3210 binding (Reaction) 
9.7.1.2.1.8 Dimerization of FGFR2 point mutants with enhanced kinase activity 3211 (Reaction) 
9.7.1.2.1.9 Autocatalytic phosphorylation of FGFR2 point mutants with enhanced kinase
3213 activity (Reaction) 
9.7.1.2.1.10 Point mutants of FGFR2 bind and are inactivated by tyrosine kinase 3216 inhibitors (Reaction) 
9.7.1.2.2 Signaling by FGFR2 amplification mutants (Pathway) 3217 
9.7.1.2.2.1 Dimerization of overexpressed FGFR2 (Reaction) 3219 
9.7.1.2.2.2 Autocatalytic phosphorylation of overexpressed FGFR2 variants (Reaction)3221 
9.7.1.2.2.3 Tyrosine kinase inhibitors bind to overexpressed FGFR2 variants (Reaction)3223 
9.7.1.2.2.4 GP369 inhibits activation of amplified FGFR2 signaling (Reaction) 3224 
9.7.1.3 Signaling by FGFR3 mutants (Pathway) 3225 
9.7.1.3.1 Signaling by activated point mutants of FGFR3 (Pathway) 3229 
9.7.1.3.1.1 Constitutive dimerization of FGFR3 cysteine mutants (Reaction) 3231 
9.7.1.3.1.2 Autocatalytic phosphorylation of FGFR3 cysteine mutants (Reaction) 3233 
9.7.1.3.1.3 Dimerization of FGFR3 point mutants with enhanced kinase activity 3234 (Reaction) 
9.7.1.3.1.4 Autocatalytic phosphorylation of FGFR3 point mutants with enhanced kinase
3236 activity (Reaction) 
9.7.1.3.1.5 FGFR3c P250R mutant binds to ligand with enhanced affinity (Reaction) 3238 
9.7.1.3.1.6 Autocatalytic phosphorylation of FGFR3c P250R mutant (Reaction) 3240 
9.7.1.3.2 t(4;14) translocations of FGFR3 (Pathway) 3241 
9.7.1.3.2.1 Dimerization of FGFR3 t(4;14) translocation mutants (Reaction) 3243 
9.7.1.3.2.2 Autocatalytic phosphorylation of FGFR3 t(4;14) translocation mutants 3245 (Reaction) 
9.7.1.3.3 FGFR3 mutants bind and are inactivated by tyrosine kinase inhibitors (Reaction)
3247 
9.7.1.4 Signaling by FGFR4 mutants (Pathway) 3249 
9.7.1.4.1 Constitutive dimerization of FGFR4 Y367C mutant (Reaction) 3251 
9.7.1.4.2 Autocatalytic phosphorylation of FGFR4 Y367C mutant (Reaction) 3253 
9.7.1.4.3 Dimerization of FGFR4 mutants with enhanced kinase activity (Reaction) 3254 
9.7.1.4.4 Autocatalytic phosphorylation of FGFR4 mutants with enhanced kinase activity3255 (Reaction) 
9.7.1.4.5 FGFR4 kinase mutants are inhibited by PD170734 (Reaction) 3257 
9.7.1.5 Activated FGFR mutants bind FRS2alpha (Reaction) 3258 
9.7.1.6 FGFR mutants phosphorylate FRS2alpha (Reaction) 3260 
9.7.1.7 GRB2-SOS1 is recruited by activated FGFR mutants (Reaction) 3263 
9.7.1.8 Ras nucleotide exchange mediated by GRB2-SOS1 bound to FGFR mutants (Reaction) 
9.7.1.9 GRB2:GAB1:PI3Kreg binds to p-FRS2:activated FGFR mutants (Reaction) 3267 
9.7.1.10 Recruitment of the catalytic subunit of PI3K by activated FGFR1 mutants 3270 (Reaction) 
9.7.1.11 Conversion of PIP2 to PIP3 by PI3K associated with FGFR mutants (Reaction) 3273 
9.7.1.12 Activated FGFR mutants bind PLC-gamma (Reaction) 3275 
9.7.1.13 PLC-gamma phosphorylation by FGFR mutants (Reaction) 3278 
9.7.1.14 Activated PLC-gamma release by activated FGFR mutants (Reaction) 3279 
9.8 Abnormal metabolism in phenylketonuria (Pathway) 3281 
9.8.1 phenylalanine + tetrahydrobiopterin + O2 => tyrosine + 4a-hydroxytetrahydrobiopterin
3282 
+ H2O (Reaction) 
9.8.2 phenylalanine + H2O + O2 => phenylpyruvate + NH3 + H2O2 (Reaction) 3284 
9.8.3 phenylalanine + oxaloacetate => phenylpyruvate + aspartate [CCBL1] (Reaction) 3285 
9.8.4 phenylpyruvate + NADH + H+ => phenyllactate + NAD+ (Reaction) 3287 
9.8.5 kynurenine + pyruvate => 4-(2-aminophenyl)-2,4-dioxobutanoic acid + alanine 3288 [CCBL1] (Reaction) 
9.9 Mucopolysaccharidoses (Pathway) 3291 
9.9.1 MPS I - Hurler syndrome (Pathway) 3292 
9.9.1.1 Defective IDUA does not hydrolyse Lido (BlackBoxEvent) 3294 
9.9.1.2 Glycosaminoglycan metabolism (Pathway) 3297 
9.9.1.2.1 Hyaluronan metabolism (Pathway) 3298 
9.9.1.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3299 
9.9.1.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3300 
9.9.1.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3302 
9.9.1.2.1.2 Hyaluronan uptake and degradation (Pathway) 3303 
9.9.1.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3304 
9.9.1.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3306 
9.9.1.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3308 (BlackBoxEvent) 
9.9.1.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3309 
9.9.1.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3310 (BlackBoxEvent) 
9.9.1.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3312 tetrasaccharides (Reaction) 
9.9.1.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3313 
9.9.1.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3314 disaccharides (Reaction) 
9.9.1.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3316 cytosol (BlackBoxEvent) 
9.9.1.2.2 Transport and synthesis of PAPS (Pathway) 3317 
9.9.1.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3318 
9.9.1.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3320 
9.9.1.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3321 (Reaction) 
9.9.1.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3265
3322 
9.9.1.2.3 Keratan sulfate/keratin metabolism (Pathway) 3324 
9.9.1.2.3.1 Keratan sulfate biosynthesis (Pathway) 3326 
9.9.1.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3327 
9.9.1.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3329 
9.9.1.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3330 
9.9.1.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3332 
9.9.1.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3334 
9.9.1.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3336 
9.9.1.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3337 
9.9.1.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3339 
9.9.1.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3340 
9.9.1.2.3.2 Keratan sulfate degradation (Pathway) 3341 
9.9.1.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3342 (BlackBoxEvent) 
9.9.1.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3343 galactosidase (BlackBoxEvent) 
9.9.1.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3345 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.1.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3346 glycosaminoglycan (Reaction) 
9.9.1.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3348 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.1.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3349 
9.9.1.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3351 
9.9.1.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3352 
9.9.1.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3353 
9.9.1.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3355 
9.9.1.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3356 
9.9.1.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3357 
9.9.1.2.4.2 HS-GAG biosynthesis (Pathway) 3359 
9.9.1.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3360 
9.9.1.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3360 heparan (Reaction) 
9.9.1.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3361 
9.9.1.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3363 
9.9.1.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3364 
9.9.1.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3366 
9.9.1.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3367 sulfate (HS) (Reaction) 
9.9.1.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3369 
9.9.1.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3371 
9.9.1.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3372 
9.9.1.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3373 
9.9.1.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3375 
9.9.1.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3377 9.9.1.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3378 
9.9.1.2.4.3 HS-GAG degradation (Pathway) 3380 
9.9.1.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3381 
9.9.1.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3382 (lysosome) (Reaction) 
9.9.1.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3383 (plasma membrane) (Reaction) 
9.9.1.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3385 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.1.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from3386 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.1.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3387 (Reaction) 
9.9.1.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3389 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.1.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3390 units of heparan sulfate (Reaction) 
9.9.1.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3392 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.1.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3393 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.1.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3394 (Reaction) 
9.9.1.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3396 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.1.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3397 chain (Reaction) 
9.9.1.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3399 (Reaction) 
9.9.1.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3400 
9.9.1.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3402 
9.9.1.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3402 
9.9.1.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3402 
9.9.1.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3402 
9.9.1.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3403 
9.9.1.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3403 
9.9.1.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3404 chondroitin (Reaction) 
9.9.1.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3405 
9.9.1.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3407 
9.9.1.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123409 and 13 (Reaction) 
9.9.1.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3410 CHST15 (Reaction) 
9.9.1.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 
(Reaction) 
9.9.1.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3413 
9.9.1.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3414 
9.9.1.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3415 dermatan sulfate (DS) (Reaction) 
9.9.1.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3417 (Reaction) 
9.9.1.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3418 
9.9.1.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3419 
9.9.1.2.5.4 CS/DS degradation (Pathway) 3420 
9.9.1.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3422 (BlackBoxEvent) 
9.9.1.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3423 
9.9.1.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3424 
9.9.1.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3426 units of DS (Reaction) 
9.9.1.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3427 units of dermatan sulfate (Reaction) 
9.9.1.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3429 
9.9.1.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3430 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.1.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate

3431 units of CS (Reaction) 
9.9.1.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3433 D-glucuronate residues in CS. (Reaction) 
9.9.2 MPS II - Hunter syndrome (Pathway) 3434 
9.9.2.1 Defective IDS does not hydrolyse sulfates from Lido (BlackBoxEvent) 3436 
9.9.2.2 Glycosaminoglycan metabolism (Pathway) 3438 
9.9.2.2.1 Hyaluronan metabolism (Pathway) 3438 
9.9.2.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3438 
9.9.2.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3438 
9.9.2.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3439 
9.9.2.2.1.2 Hyaluronan uptake and degradation (Pathway) 3439 
9.9.2.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3439 
9.9.2.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3439 
9.9.2.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3440 (BlackBoxEvent) 
9.9.2.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3440 
9.9.2.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3440 (BlackBoxEvent) 
9.9.2.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3441 tetrasaccharides (Reaction) 
9.9.2.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3441 
9.9.2.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3441 disaccharides (Reaction) 3412 9.9.2.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3442 cytosol (BlackBoxEvent) 
9.9.2.2.2 Transport and synthesis of PAPS (Pathway) 3442 
9.9.2.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3442 
9.9.2.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3442 
9.9.2.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3443 (Reaction) 
9.9.2.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3443 
9.9.2.2.3 Keratan sulfate/keratin metabolism (Pathway) 3443 
9.9.2.2.3.1 Keratan sulfate biosynthesis (Pathway) 3443 
9.9.2.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3444 
9.9.2.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3444 
9.9.2.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3444 
9.9.2.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3444 
9.9.2.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3445 
9.9.2.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3445 
9.9.2.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3445 
9.9.2.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3446 
9.9.2.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3446 
9.9.2.2.3.2 Keratan sulfate degradation (Pathway) 3446 
9.9.2.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3446 (BlackBoxEvent) 
9.9.2.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3447 galactosidase (BlackBoxEvent) 
9.9.2.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3447 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.2.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3447 glycosaminoglycan (Reaction) 
9.9.2.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3448 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.2.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3448 
9.9.2.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3448 
9.9.2.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3449 
9.9.2.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3449 
9.9.2.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3449 
9.9.2.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3449 
9.9.2.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3450 
9.9.2.2.4.2 HS-GAG biosynthesis (Pathway) 3450 
9.9.2.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3450 
9.9.2.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3450 heparan (Reaction) 
9.9.2.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3451 
9.9.2.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3451 
9.9.2.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3451 
9.9.2.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3451 
9.9.2.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan 3452 
sulfate (HS) (Reaction)  
9.9.2.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction)  3452  
9.9.2.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction)  3452  
9.9.2.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction)  3452  
9.9.2.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction)  3453  

9.9.2.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3453 
9.9.2.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3453 
9.9.2.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3454 
9.9.2.2.4.3 HS-GAG degradation (Pathway) 3454 
9.9.2.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3454 
9.9.2.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3454 (lysosome) (Reaction) 
9.9.2.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3455 (plasma membrane) (Reaction) 
9.9.2.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3455 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.2.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from 3455 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.2.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3456 (Reaction) 
9.9.2.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3456 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.2.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate 
3456 units of heparan sulfate (Reaction) 
9.9.2.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3457 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.2.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3457 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.2.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3457 (Reaction) 
9.9.2.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3458 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.2.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3458 chain (Reaction) 
9.9.2.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain 3458 (Reaction) 
9.9.2.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3459 
9.9.2.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3459 
9.9.2.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3459 
9.9.2.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3459 
9.9.2.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3460 
9.9.2.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3460 
9.9.2.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3460 
9.9.2.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms chondroitin (Reaction) 
9.9.2.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3461 
9.9.2.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3461 
9.9.2.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123461 and 13 (Reaction) 
9.9.2.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3461 CHST15 (Reaction) 
9.9.2.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3462 (Reaction) 
9.9.2.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3462 
9.9.2.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3462 
9.9.2.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3462 dermatan sulfate (DS) (Reaction) 
9.9.2.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3463 (Reaction) 
9.9.2.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3463 
9.9.2.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3463 
9.9.2.2.5.4 CS/DS degradation (Pathway) 3463 
9.9.2.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3464 (BlackBoxEvent) 
9.9.2.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3464 
9.9.2.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3464 
9.9.2.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3464 units of DS (Reaction) 
9.9.2.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3465 units of dermatan sulfate (Reaction) 
9.9.2.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3465 
9.9.2.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3465 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.2.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3466 units of CS (Reaction) 
9.9.2.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3466 D-glucuronate residues in CS. (Reaction) 
9.9.3 MPS IIIA - Sanfilippo syndrome A (Pathway) 3466 
9.9.3.1 Defective SGSH does not hydrolyse sulfates from SGlcN (BlackBoxEvent) 3468 
9.9.3.2 Glycosaminoglycan metabolism (Pathway) 3470 
9.9.3.2.1 Hyaluronan metabolism (Pathway) 3470 
9.9.3.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3471 
9.9.3.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3471 
9.9.3.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3471 
9.9.3.2.1.2 Hyaluronan uptake and degradation (Pathway) 3471 
9.9.3.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3472 
9.9.3.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3472 
9.9.3.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3472 (BlackBoxEvent) 3460 9.9.3.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3472 
9.9.3.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3473 (BlackBoxEvent) 
9.9.3.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3473 tetrasaccharides (Reaction) 
9.9.3.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3473 
9.9.3.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3474 disaccharides (Reaction) 
9.9.3.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3474 cytosol (BlackBoxEvent) 
9.9.3.2.2 Transport and synthesis of PAPS (Pathway) 3474 
9.9.3.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3474 
9.9.3.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3475 
9.9.3.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3475 (Reaction) 
9.9.3.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3475 
9.9.3.2.3 Keratan sulfate/keratin metabolism (Pathway) 3476 
9.9.3.2.3.1 Keratan sulfate biosynthesis (Pathway) 3476 
9.9.3.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3476 
9.9.3.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3476 
9.9.3.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3477 
9.9.3.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3477 
9.9.3.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3477 
9.9.3.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3477 
9.9.3.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3478 
9.9.3.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3478 
9.9.3.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3478 
9.9.3.2.3.2 Keratan sulfate degradation (Pathway) 3478 
9.9.3.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3479 (BlackBoxEvent) 
9.9.3.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3479 galactosidase (BlackBoxEvent) 
9.9.3.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3479 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.3.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3480 glycosaminoglycan (Reaction) 
9.9.3.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3480 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.3.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3480 
9.9.3.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3481 
9.9.3.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3481 
9.9.3.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3481 
9.9.3.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3481 
9.9.3.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3482 
9.9.3.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3482 9.9.3.2.4.2 HS-GAG biosynthesis (Pathway) 3482 
9.9.3.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3482 
9.9.3.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3483 heparan (Reaction) 
9.9.3.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3483 
9.9.3.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3483 
9.9.3.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3483 
9.9.3.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3484 
9.9.3.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3484 sulfate (HS) (Reaction) 
9.9.3.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3484 
9.9.3.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3484 
9.9.3.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3485 
9.9.3.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3485 
9.9.3.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3485 
9.9.3.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3486 
9.9.3.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3486 
9.9.3.2.4.3 HS-GAG degradation (Pathway) 3486 
9.9.3.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3486 
9.9.3.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3487 (lysosome) (Reaction) 
9.9.3.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3487 (plasma membrane) (Reaction) 
9.9.3.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3487 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.3.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from3488 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.3.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3488 (Reaction) 
9.9.3.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3488 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.3.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3489 units of heparan sulfate (Reaction) 
9.9.3.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3489 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.3.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3489 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.3.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3490 (Reaction) 
9.9.3.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3490 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.3.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3490 chain (Reaction) 
9.9.3.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3491 (Reaction) 
9.9.3.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3491 
9.9.3.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3491 
9.9.3.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3491 
9.9.3.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3492 
9.9.3.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3492 
9.9.3.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3492 
9.9.3.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3492 
9.9.3.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3493 chondroitin (Reaction) 
9.9.3.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3493 
9.9.3.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3493 
9.9.3.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123493 and 13 (Reaction) 
9.9.3.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3494 CHST15 (Reaction) 
9.9.3.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3494 (Reaction) 
9.9.3.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3494 
9.9.3.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3494 
9.9.3.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3495 dermatan sulfate (DS) (Reaction) 
9.9.3.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3495 (Reaction) 
9.9.3.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3495 
9.9.3.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3495 
9.9.3.2.5.4 CS/DS degradation (Pathway) 3496 
9.9.3.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3496 (BlackBoxEvent) 
9.9.3.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3496 
9.9.3.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3496 
9.9.3.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3497 units of DS (Reaction) 
9.9.3.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3497 units of dermatan sulfate (Reaction) 
9.9.3.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3497 
9.9.3.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3498 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.3.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3498 units of CS (Reaction) 
9.9.3.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3498 D-glucuronate residues in CS. (Reaction) 
9.9.4 MPS IIIB - Sanfilippo syndrome B (Pathway) 3499 
9.9.4.1 Defective NAGLU does not hydrolyse GlcNAc (BlackBoxEvent) 3500 
9.9.4.2 Glycosaminoglycan metabolism (Pathway) 3502 
9.9.4.2.1 Hyaluronan metabolism (Pathway) 3502 9.9.4.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3503 
9.9.4.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3503 
9.9.4.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3503 
9.9.4.2.1.2 Hyaluronan uptake and degradation (Pathway) 3503 
9.9.4.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3504 
9.9.4.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3504 
9.9.4.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3504 (BlackBoxEvent) 
9.9.4.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3504 
9.9.4.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3505 (BlackBoxEvent) 
9.9.4.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3505 tetrasaccharides (Reaction) 
9.9.4.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3505 
9.9.4.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3506 disaccharides (Reaction) 
9.9.4.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3506 cytosol (BlackBoxEvent) 
9.9.4.2.2 Transport and synthesis of PAPS (Pathway) 3506 
9.9.4.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3506 
9.9.4.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3507 
9.9.4.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3507 (Reaction) 
9.9.4.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3507 
9.9.4.2.3 Keratan sulfate/keratin metabolism (Pathway) 3508 
9.9.4.2.3.1 Keratan sulfate biosynthesis (Pathway) 3508 
9.9.4.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3508 
9.9.4.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3508 
9.9.4.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3509 
9.9.4.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3509 
9.9.4.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3509 
9.9.4.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3509 
9.9.4.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3510 
9.9.4.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3510 
9.9.4.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3510 
9.9.4.2.3.2 Keratan sulfate degradation (Pathway) 3510 
9.9.4.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3511 (BlackBoxEvent) 
9.9.4.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3511 galactosidase (BlackBoxEvent) 
9.9.4.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3511 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.4.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3512 glycosaminoglycan (Reaction) 
9.9.4.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of 
the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.4.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3512 
9.9.4.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3513 
9.9.4.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3513 
9.9.4.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3513 
9.9.4.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3513 
9.9.4.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3514 
9.9.4.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3514 
9.9.4.2.4.2 HS-GAG biosynthesis (Pathway) 3514 
9.9.4.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3514 
9.9.4.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3515 heparan (Reaction) 
9.9.4.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3515 
9.9.4.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3515 
9.9.4.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3515 
9.9.4.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3516 
9.9.4.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3516 sulfate (HS) (Reaction) 
9.9.4.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3516 
9.9.4.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3516 
9.9.4.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3517 
9.9.4.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3517 
9.9.4.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3517 
9.9.4.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3518 
9.9.4.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3518 
9.9.4.2.4.3 HS-GAG degradation (Pathway) 3518 
9.9.4.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3518 
9.9.4.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3519 (lysosome) (Reaction) 
9.9.4.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3519 (plasma membrane) (Reaction) 
9.9.4.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3519 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.4.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from3520 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.4.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3520 (Reaction) 
9.9.4.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3520 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.4.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3521 units of heparan sulfate (Reaction) 
9.9.4.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3521 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.4.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3521 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 3512 9.9.4.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3522 (Reaction) 
9.9.4.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3522 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.4.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3522 chain (Reaction) 
9.9.4.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3523 (Reaction) 
9.9.4.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3523 
9.9.4.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3523 
9.9.4.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3523 
9.9.4.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3524 
9.9.4.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3524 
9.9.4.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3524 
9.9.4.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3524 
9.9.4.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3525 chondroitin (Reaction) 
9.9.4.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3525 
9.9.4.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3525 
9.9.4.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123525 and 13 (Reaction) 
9.9.4.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3526 CHST15 (Reaction) 
9.9.4.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3526 (Reaction) 
9.9.4.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3526 
9.9.4.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3526 
9.9.4.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3527 dermatan sulfate (DS) (Reaction) 
9.9.4.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3527 (Reaction) 
9.9.4.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3527 
9.9.4.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3527 
9.9.4.2.5.4 CS/DS degradation (Pathway) 3528 
9.9.4.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3528 (BlackBoxEvent) 
9.9.4.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3528 
9.9.4.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3528 
9.9.4.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3529 units of DS (Reaction) 
9.9.4.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3529 units of dermatan sulfate (Reaction) 
9.9.4.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3529 
9.9.4.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3530 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.4.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3530 units of CS (Reaction) 
9.9.4.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3530 D-glucuronate residues in CS. (Reaction) 
9.9.5 MPS IIIC - Sanfilippo syndrome C (Pathway) 3531 
9.9.5.1 Defective HGSNAT does not acetylate GlcN (BlackBoxEvent) 3532 
9.9.5.2 Glycosaminoglycan metabolism (Pathway) 3535 
9.9.5.2.1 Hyaluronan metabolism (Pathway) 3535 
9.9.5.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3535 
9.9.5.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3535 
9.9.5.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3535 
9.9.5.2.1.2 Hyaluronan uptake and degradation (Pathway) 3536 
9.9.5.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3536 
9.9.5.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3536 
9.9.5.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3536 (BlackBoxEvent) 
9.9.5.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3537 
9.9.5.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3537 (BlackBoxEvent) 
9.9.5.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3537 tetrasaccharides (Reaction) 
9.9.5.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3538 
9.9.5.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3538 disaccharides (Reaction) 
9.9.5.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3538 cytosol (BlackBoxEvent) 
9.9.5.2.2 Transport and synthesis of PAPS (Pathway) 3539 
9.9.5.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3539 
9.9.5.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3539 
9.9.5.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3539 (Reaction) 
9.9.5.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3540 
9.9.5.2.3 Keratan sulfate/keratin metabolism (Pathway) 3540 
9.9.5.2.3.1 Keratan sulfate biosynthesis (Pathway) 3540 
9.9.5.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3540 
9.9.5.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3541 
9.9.5.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3541 
9.9.5.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3541 
9.9.5.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3541 
9.9.5.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3542 
9.9.5.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3542 
9.9.5.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3542 
9.9.5.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3543 
9.9.5.2.3.2 Keratan sulfate degradation (Pathway) 3543 
9.9.5.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation (BlackBoxEvent) 
9.9.5.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3543 galactosidase (BlackBoxEvent) 
9.9.5.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3544 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.5.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3544 glycosaminoglycan (Reaction) 
9.9.5.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3544 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.5.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3545 
9.9.5.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3545 
9.9.5.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3545 
9.9.5.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3545 
9.9.5.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3546 
9.9.5.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3546 
9.9.5.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3546 
9.9.5.2.4.2 HS-GAG biosynthesis (Pathway) 3546 
9.9.5.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3547 
9.9.5.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3547 heparan (Reaction) 
9.9.5.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3547 
9.9.5.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3547 
9.9.5.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3548 
9.9.5.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3548 
9.9.5.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3548 sulfate (HS) (Reaction) 
9.9.5.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3548 
9.9.5.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3549 
9.9.5.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3549 
9.9.5.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3549 
9.9.5.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3549 
9.9.5.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3550 
9.9.5.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3550 
9.9.5.2.4.3 HS-GAG degradation (Pathway) 3550 
9.9.5.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3550 
9.9.5.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3551 (lysosome) (Reaction) 
9.9.5.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3551 (plasma membrane) (Reaction) 
9.9.5.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3551 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.5.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from3552 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.5.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3552 (Reaction) 3543 9.9.5.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3552 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.5.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3553 units of heparan sulfate (Reaction) 
9.9.5.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3553 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.5.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3553 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.5.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3554 (Reaction) 
9.9.5.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3554 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.5.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3554 chain (Reaction) 
9.9.5.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3555 (Reaction) 
9.9.5.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3555 
9.9.5.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3555 
9.9.5.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3555 
9.9.5.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3556 
9.9.5.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3556 
9.9.5.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3556 
9.9.5.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3556 
9.9.5.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3557 chondroitin (Reaction) 
9.9.5.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3557 
9.9.5.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3557 
9.9.5.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123557 and 13 (Reaction) 
9.9.5.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3558 CHST15 (Reaction) 
9.9.5.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3558 (Reaction) 
9.9.5.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3558 
9.9.5.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3558 
9.9.5.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3559 dermatan sulfate (DS) (Reaction) 
9.9.5.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3559 (Reaction) 
9.9.5.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3559 
9.9.5.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3559 
9.9.5.2.5.4 CS/DS degradation (Pathway) 3560 
9.9.5.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3560 (BlackBoxEvent) 
9.9.5.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 
9.9.5.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3560 
9.9.5.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3561 units of DS (Reaction) 
9.9.5.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3561 units of dermatan sulfate (Reaction) 
9.9.5.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3561 
9.9.5.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3562 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.5.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3562 units of CS (Reaction) 
9.9.5.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3562 D-glucuronate residues in CS. (Reaction) 
9.9.6 MPS IIID - Sanfilippo syndrome D (Pathway) 3563 
9.9.6.1 Defective GNS does not hydrolyse 6-sulfate from GlcNAc6S (BlackBoxEvent) 3564 
9.9.6.2 Glycosaminoglycan metabolism (Pathway) 3566 
9.9.6.2.1 Hyaluronan metabolism (Pathway) 3567 
9.9.6.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3567 
9.9.6.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3567 
9.9.6.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3567 
9.9.6.2.1.2 Hyaluronan uptake and degradation (Pathway) 3568 
9.9.6.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3568 
9.9.6.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3568 
9.9.6.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3568 (BlackBoxEvent) 
9.9.6.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3569 
9.9.6.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3569 (BlackBoxEvent) 
9.9.6.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3569 tetrasaccharides (Reaction) 
9.9.6.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3570 
9.9.6.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3570 disaccharides (Reaction) 
9.9.6.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3570 cytosol (BlackBoxEvent) 
9.9.6.2.2 Transport and synthesis of PAPS (Pathway) 3571 
9.9.6.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3571 
9.9.6.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3571 
9.9.6.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3571 (Reaction) 
9.9.6.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3572 
9.9.6.2.3 Keratan sulfate/keratin metabolism (Pathway) 3572 
9.9.6.2.3.1 Keratan sulfate biosynthesis (Pathway) 3572 
9.9.6.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3572 
9.9.6.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3573 
9.9.6.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3573 9.9.6.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3573 
9.9.6.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3573 
9.9.6.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3574 
9.9.6.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3574 
9.9.6.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3574 
9.9.6.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3575 
9.9.6.2.3.2 Keratan sulfate degradation (Pathway) 3575 
9.9.6.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3575 (BlackBoxEvent) 
9.9.6.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3575 galactosidase (BlackBoxEvent) 
9.9.6.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3576 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.6.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3576 glycosaminoglycan (Reaction) 
9.9.6.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3576 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.6.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3577 
9.9.6.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3577 
9.9.6.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3577 
9.9.6.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3577 
9.9.6.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3578 
9.9.6.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3578 
9.9.6.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3578 
9.9.6.2.4.2 HS-GAG biosynthesis (Pathway) 3578 
9.9.6.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3579 
9.9.6.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3579 heparan (Reaction) 
9.9.6.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3579 
9.9.6.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3579 
9.9.6.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3580 
9.9.6.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3580 
9.9.6.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3580 sulfate (HS) (Reaction) 
9.9.6.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3580 
9.9.6.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3581 
9.9.6.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3581 
9.9.6.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3581 
9.9.6.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3581 
9.9.6.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3582 
9.9.6.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3582 
9.9.6.2.4.3 HS-GAG degradation (Pathway) 3582 
9.9.6.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3582 
9.9.6.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3583 (lysosome) (Reaction) 
9.9.6.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3583 (plasma membrane) (Reaction) 
9.9.6.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3583 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.6.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from3584 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.6.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3584 (Reaction) 
9.9.6.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3584 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.6.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3585 units of heparan sulfate (Reaction) 
9.9.6.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3585 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.6.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3585 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.6.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3586 (Reaction) 
9.9.6.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3586 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.6.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3586 chain (Reaction) 
9.9.6.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3587 (Reaction) 
9.9.6.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3587 
9.9.6.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3587 
9.9.6.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3587 
9.9.6.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3588 
9.9.6.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3588 
9.9.6.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3588 
9.9.6.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3588 
9.9.6.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3589 chondroitin (Reaction) 
9.9.6.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3589 
9.9.6.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3589 
9.9.6.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123589 and 13 (Reaction) 
9.9.6.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3590 CHST15 (Reaction) 
9.9.6.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3590 (Reaction) 
9.9.6.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3590 
9.9.6.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3590 
9.9.6.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3591 dermatan sulfate (DS) (Reaction) 
9.9.6.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3591 (Reaction) 
9.9.6.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3591 
9.9.6.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3591 
9.9.6.2.5.4 CS/DS degradation (Pathway) 3592 
9.9.6.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3592 (BlackBoxEvent) 
9.9.6.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3592 
9.9.6.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3592 
9.9.6.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3593 units of DS (Reaction) 
9.9.6.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3593 units of dermatan sulfate (Reaction) 
9.9.6.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3593 
9.9.6.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3594 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.6.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3594 units of CS (Reaction) 
9.9.6.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3594 D-glucuronate residues in CS. (Reaction) 
9.9.7 MPS IV - Morquio syndrome A (Pathway) 3595 
9.9.7.1 Defective GALNS does not hydrolyse sulfate from Gal6S (BlackBoxEvent) 3596 
9.9.7.2 Glycosaminoglycan metabolism (Pathway) 3598 
9.9.7.2.1 Hyaluronan metabolism (Pathway) 3598 
9.9.7.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3598 
9.9.7.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3599 
9.9.7.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3599 
9.9.7.2.1.2 Hyaluronan uptake and degradation (Pathway) 3599 
9.9.7.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3599 
9.9.7.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3600 
9.9.7.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3600 (BlackBoxEvent) 
9.9.7.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3600 
9.9.7.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3601 (BlackBoxEvent) 
9.9.7.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3601 tetrasaccharides (Reaction) 
9.9.7.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3601 
9.9.7.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3602 disaccharides (Reaction) 
9.9.7.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3602 cytosol (BlackBoxEvent) 
9.9.7.2.2 Transport and synthesis of PAPS (Pathway) 3602 
9.9.7.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3602 
9.9.7.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3603 9.9.7.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3603 (Reaction) 
9.9.7.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3603 
9.9.7.2.3 Keratan sulfate/keratin metabolism (Pathway) 3604 
9.9.7.2.3.1 Keratan sulfate biosynthesis (Pathway) 3604 
9.9.7.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3604 
9.9.7.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3604 
9.9.7.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3605 
9.9.7.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3605 
9.9.7.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3605 
9.9.7.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3605 
9.9.7.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3606 
9.9.7.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3606 
9.9.7.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3606 
9.9.7.2.3.2 Keratan sulfate degradation (Pathway) 3606 
9.9.7.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3607 (BlackBoxEvent) 
9.9.7.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3607 galactosidase (BlackBoxEvent) 
9.9.7.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3607 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.7.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3608 glycosaminoglycan (Reaction) 
9.9.7.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3608 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.7.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3608 
9.9.7.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3609 
9.9.7.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3609 
9.9.7.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3609 
9.9.7.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3609 
9.9.7.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3610 
9.9.7.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3610 
9.9.7.2.4.2 HS-GAG biosynthesis (Pathway) 3610 
9.9.7.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3610 
9.9.7.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3611 heparan (Reaction) 
9.9.7.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3611 
9.9.7.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3611 
9.9.7.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3611 
9.9.7.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3612 
9.9.7.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3612 sulfate (HS) (Reaction) 
9.9.7.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3612 
9.9.7.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3612 
9.9.7.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3613 9.9.7.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3613 
9.9.7.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3613 
9.9.7.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3614 
9.9.7.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3614 
9.9.7.2.4.3 HS-GAG degradation (Pathway) 3614 
9.9.7.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3614 
9.9.7.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3615 (lysosome) (Reaction) 
9.9.7.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3615 (plasma membrane) (Reaction) 
9.9.7.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3615 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.7.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from 3616 
the N-sulphoglucosamine residue of heparan sulfate (Reaction)  
9.9.7.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate  3616  
(Reaction)  
9.9.7.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses  3616  
N-acetyl-D-glucosamine residues from heparan sulfate (Reaction)  

9.9.7.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate 
3617 units of heparan sulfate (Reaction) 
9.9.7.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3617 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.7.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3617 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.7.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3618 (Reaction) 
9.9.7.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3618 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.7.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3618 chain (Reaction) 
9.9.7.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain 3619 (Reaction) 
9.9.7.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3619 
9.9.7.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3619 
9.9.7.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3619 
9.9.7.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3620 
9.9.7.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3620 
9.9.7.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3620 
9.9.7.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3620 
9.9.7.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3621 chondroitin (Reaction) 
9.9.7.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3621 
9.9.7.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3621 
9.9.7.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 12 3621 and 13 (Reaction) 
9.9.7.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3622 CHST15 (Reaction) 
9.9.7.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3622 (Reaction) 
9.9.7.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3622 
9.9.7.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3622 
9.9.7.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3623 dermatan sulfate (DS) (Reaction) 
9.9.7.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3623 (Reaction) 
9.9.7.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3623 
9.9.7.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3623 
9.9.7.2.5.4 CS/DS degradation (Pathway) 3624 
9.9.7.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3624 (BlackBoxEvent) 
9.9.7.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3624 
9.9.7.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3624 
9.9.7.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3625 units of DS (Reaction) 
9.9.7.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3625 units of dermatan sulfate (Reaction) 
9.9.7.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3625 
9.9.7.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3626 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.7.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3626 units of CS (Reaction) 
9.9.7.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3626 D-glucuronate residues in CS. (Reaction) 
9.9.8 MPS IV - Morquio syndrome B (Pathway) 3627 
9.9.8.1 Defective GLB1 does not hydrolyse Gal (BlackBoxEvent) 3628 
9.9.8.2 Glycosaminoglycan metabolism (Pathway) 3631 
9.9.8.2.1 Hyaluronan metabolism (Pathway) 3631 
9.9.8.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3631 
9.9.8.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3631 
9.9.8.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3631 
9.9.8.2.1.2 Hyaluronan uptake and degradation (Pathway) 3632 
9.9.8.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3632 
9.9.8.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3632 
9.9.8.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3632 (BlackBoxEvent) 
9.9.8.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3633 
9.9.8.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3633 (BlackBoxEvent) 
9.9.8.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3633 tetrasaccharides (Reaction) 
9.9.8.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)
3634 
9.9.8.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3634 disaccharides (Reaction) 
9.9.8.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3634 cytosol (BlackBoxEvent) 
9.9.8.2.2 Transport and synthesis of PAPS (Pathway) 3635 
9.9.8.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3635 
9.9.8.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3635 
9.9.8.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3635 (Reaction) 
9.9.8.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3636 
9.9.8.2.3 Keratan sulfate/keratin metabolism (Pathway) 3636 
9.9.8.2.3.1 Keratan sulfate biosynthesis (Pathway) 3636 
9.9.8.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3636 
9.9.8.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3637 
9.9.8.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3637 
9.9.8.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3637 
9.9.8.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3637 
9.9.8.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3638 
9.9.8.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3638 
9.9.8.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3638 
9.9.8.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3639 
9.9.8.2.3.2 Keratan sulfate degradation (Pathway) 3639 
9.9.8.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3639 (BlackBoxEvent) 
9.9.8.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3639 galactosidase (BlackBoxEvent) 
9.9.8.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3640 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.8.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3640 glycosaminoglycan (Reaction) 
9.9.8.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3640 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.8.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3641 
9.9.8.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3641 
9.9.8.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3641 
9.9.8.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3641 
9.9.8.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3642 
9.9.8.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3642 
9.9.8.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3642 
9.9.8.2.4.2 HS-GAG biosynthesis (Pathway) 3642 
9.9.8.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3643 
9.9.8.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3643 heparan (Reaction) 
9.9.8.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 
9.9.8.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction)  3643  
9.9.8.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction)  3644  
9.9.8.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction)  3644  

9.9.8.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan 3644 sulfate (HS) (Reaction) 
9.9.8.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3644 
9.9.8.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3645 
9.9.8.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3645 
9.9.8.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3645 
9.9.8.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3645 
9.9.8.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3646 
9.9.8.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3646 
9.9.8.2.4.3 HS-GAG degradation (Pathway) 3646 
9.9.8.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3646 
9.9.8.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3647 (lysosome) (Reaction) 
9.9.8.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3647 (plasma membrane) (Reaction) 
9.9.8.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3647 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.8.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from 3648 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.8.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3648 (Reaction) 
9.9.8.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3648 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.8.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate 
3649 units of heparan sulfate (Reaction) 
9.9.8.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3649 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.8.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3649 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.8.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3650 (Reaction) 
9.9.8.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3650 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.8.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3650 chain (Reaction) 
9.9.8.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain 3651 (Reaction) 
9.9.8.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3651 
9.9.8.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3651 
9.9.8.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3651 
9.9.8.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3652 
9.9.8.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3652 9.9.8.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3652 
9.9.8.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3652 
9.9.8.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3653 chondroitin (Reaction) 
9.9.8.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3653 
9.9.8.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3653 
9.9.8.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123653 and 13 (Reaction) 
9.9.8.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3654 CHST15 (Reaction) 
9.9.8.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3654 (Reaction) 
9.9.8.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3654 
9.9.8.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3654 
9.9.8.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3655 dermatan sulfate (DS) (Reaction) 
9.9.8.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3655 (Reaction) 
9.9.8.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3655 
9.9.8.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3655 
9.9.8.2.5.4 CS/DS degradation (Pathway) 3656 
9.9.8.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3656 (BlackBoxEvent) 
9.9.8.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3656 
9.9.8.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3656 
9.9.8.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3657 units of DS (Reaction) 
9.9.8.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3657 units of dermatan sulfate (Reaction) 
9.9.8.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3657 
9.9.8.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3658 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.8.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3658 units of CS (Reaction) 
9.9.8.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3658 D-glucuronate residues in CS. (Reaction) 
9.9.9 MPS VI - Maroteaux-Lamy syndrome (Pathway) 3659 
9.9.9.1 Defective ARSB does not hydrolyse sulfate from GalNAc4S (BlackBoxEvent) 3660 
9.9.9.2 Glycosaminoglycan metabolism (Pathway) 3663 
9.9.9.2.1 Hyaluronan metabolism (Pathway) 3663 
9.9.9.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3663 
9.9.9.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3663 
9.9.9.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3663 
9.9.9.2.1.2 Hyaluronan uptake and degradation (Pathway) 3664 
9.9.9.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3664 9.9.9.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3664 
9.9.9.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3664 (BlackBoxEvent) 
9.9.9.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3665 
9.9.9.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments
3665 (BlackBoxEvent) 
9.9.9.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3665 tetrasaccharides (Reaction) 
9.9.9.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)3666 
9.9.9.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3666 disaccharides (Reaction) 
9.9.9.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the
3666 cytosol (BlackBoxEvent) 
9.9.9.2.2 Transport and synthesis of PAPS (Pathway) 3667 
9.9.9.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3667 
9.9.9.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3667 
9.9.9.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3667 (Reaction) 
9.9.9.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3668 
9.9.9.2.3 Keratan sulfate/keratin metabolism (Pathway) 3668 
9.9.9.2.3.1 Keratan sulfate biosynthesis (Pathway) 3668 
9.9.9.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3668 
9.9.9.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3669 
9.9.9.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3669 
9.9.9.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3669 
9.9.9.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3669 
9.9.9.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3670 
9.9.9.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3670 
9.9.9.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3670 
9.9.9.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3671 
9.9.9.2.3.2 Keratan sulfate degradation (Pathway) 3671 
9.9.9.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3671 (BlackBoxEvent) 
9.9.9.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3671 galactosidase (BlackBoxEvent) 
9.9.9.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3672 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.9.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3672 glycosaminoglycan (Reaction) 
9.9.9.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3672 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.9.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3673 
9.9.9.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3673 
9.9.9.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3673 
9.9.9.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 
9.9.9.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3674 
9.9.9.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3674 
9.9.9.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3674 
9.9.9.2.4.2 HS-GAG biosynthesis (Pathway) 3674 
9.9.9.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3675 
9.9.9.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3675 heparan (Reaction) 
9.9.9.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3675 
9.9.9.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3675 
9.9.9.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3676 
9.9.9.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3676 
9.9.9.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan3676 sulfate (HS) (Reaction) 
9.9.9.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3676 
9.9.9.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3677 
9.9.9.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3677 
9.9.9.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3677 
9.9.9.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)3677 
9.9.9.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3678 
9.9.9.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3678 
9.9.9.2.4.3 HS-GAG degradation (Pathway) 3678 
9.9.9.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)3678 
9.9.9.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3679 (lysosome) (Reaction) 
9.9.9.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 3679 (plasma membrane) (Reaction) 
9.9.9.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3679 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.9.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from3680 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.9.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3680 (Reaction) 
9.9.9.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3680 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.9.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3681 units of heparan sulfate (Reaction) 
9.9.9.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3681 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.9.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3681 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.9.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3682 (Reaction) 
9.9.9.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3682 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.9.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 
chain (Reaction) 
9.9.9.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3683 (Reaction) 
9.9.9.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 	3683 
9.9.9.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)3683 
9.9.9.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 	3683 
9.9.9.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3684 
9.9.9.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3684 
9.9.9.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3684 
9.9.9.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 	3684 
9.9.9.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3685 chondroitin (Reaction) 
9.9.9.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 	3685 
9.9.9.2.5.2.3 GalNAc is added to chondroitin (Reaction) 	3685 
9.9.9.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123685 and 13 (Reaction) 
9.9.9.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3686 CHST15 (Reaction) 
9.9.9.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3686 (Reaction) 
9.9.9.2.5.2.7 CSPG is secreted (BlackBoxEvent) 	3686 
9.9.9.2.5.3 Dermatan sulfate biosynthesis (Pathway) 	3686 
9.9.9.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to3687 dermatan sulfate (DS) (Reaction) 
9.9.9.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3687 (Reaction) 
9.9.9.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 	3687 
9.9.9.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 	3687 
9.9.9.2.5.4 CS/DS degradation (Pathway) 	3688 
9.9.9.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3688 (BlackBoxEvent) 
9.9.9.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 	3688 
9.9.9.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 	3688 
9.9.9.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3689 units of DS (Reaction) 
9.9.9.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate
3689 units of dermatan sulfate (Reaction) 
9.9.9.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3689 
9.9.9.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3690 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.9.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3690 units of CS (Reaction) 
9.9.9.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and3690 D-glucuronate residues in CS. (Reaction) 
9.9.10 MPS VII - Sly syndrome (Pathway) 	36823691 9.9.10.1 Defective GUSB does not hydrolyse glucuronate (BlackBoxEvent) 3692 
9.9.10.2 Glycosaminoglycan metabolism (Pathway) 3695 
9.9.10.2.1 Hyaluronan metabolism (Pathway) 3695 
9.9.10.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3695 
9.9.10.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3695 
9.9.10.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3695 
9.9.10.2.1.2 Hyaluronan uptake and degradation (Pathway) 3696 
9.9.10.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3696 
9.9.10.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3696 
9.9.10.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3696 (BlackBoxEvent) 
9.9.10.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3697 
9.9.10.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da 3697 fragments (BlackBoxEvent) 
9.9.10.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3697 tetrasaccharides (Reaction) 
9.9.10.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments 3698 (Reaction) 
9.9.10.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3698 disaccharides (Reaction) 
9.9.10.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to3698 the cytosol (BlackBoxEvent) 
9.9.10.2.2 Transport and synthesis of PAPS (Pathway) 3699 
9.9.10.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3699 
9.9.10.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3699 
9.9.10.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3699 (Reaction) 
9.9.10.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3700 
9.9.10.2.3 Keratan sulfate/keratin metabolism (Pathway) 3700 
9.9.10.2.3.1 Keratan sulfate biosynthesis (Pathway) 3700 
9.9.10.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3700 
9.9.10.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3701 
9.9.10.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3701 
9.9.10.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3701 
9.9.10.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3701 
9.9.10.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3702 
9.9.10.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3702 
9.9.10.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3702 
9.9.10.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3703 
9.9.10.2.3.2 Keratan sulfate degradation (Pathway) 3703 
9.9.10.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3703 (BlackBoxEvent) 
9.9.10.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3703 galactosidase (BlackBoxEvent) 
9.9.10.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 
groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.10.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3704 glycosaminoglycan (Reaction) 
9.9.10.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3704 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.10.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3705 
9.9.10.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3705 
9.9.10.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)
3705 
9.9.10.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3705 
9.9.10.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3706 
9.9.10.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3706 
9.9.10.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3706 
9.9.10.2.4.2 HS-GAG biosynthesis (Pathway) 3706 
9.9.10.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3707 
9.9.10.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3707 heparan (Reaction) 
9.9.10.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3707 
9.9.10.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3707 
9.9.10.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3708 
9.9.10.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3708 
9.9.10.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan
3708 sulfate (HS) (Reaction) 
9.9.10.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3709 
9.9.10.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3709 
9.9.10.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3709 
9.9.10.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3709 
9.9.10.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises 3710 (Reaction) 
9.9.10.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3710 
9.9.10.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3710 
9.9.10.2.4.3 HS-GAG degradation (Pathway) 3711 
9.9.10.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)
3711 
9.9.10.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3711 (lysosome) (Reaction) 
9.9.10.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan3711 (plasma membrane) (Reaction) 
9.9.10.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3712 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.10.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from
3712 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.10.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3712 (Reaction) 
9.9.10.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3713 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.10.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 3704 2-sulfate units of heparan sulfate (Reaction) 
9.9.10.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3713 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.10.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3714 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.10.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3714 (Reaction) 
9.9.10.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3714 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.10.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3715 chain (Reaction) 
9.9.10.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3715 (Reaction) 
9.9.10.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3715 
9.9.10.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)
3715 
9.9.10.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3716 
9.9.10.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3716 
9.9.10.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3716 
9.9.10.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3716 
9.9.10.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3717 
9.9.10.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3717 chondroitin (Reaction) 
9.9.10.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3717 
9.9.10.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3717 
9.9.10.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123718 and 13 (Reaction) 
9.9.10.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3718 CHST15 (Reaction) 
9.9.10.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3718 (Reaction) 
9.9.10.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3719 
9.9.10.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3719 
9.9.10.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to
3719 dermatan sulfate (DS) (Reaction) 
9.9.10.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3719 (Reaction) 
9.9.10.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3720 
9.9.10.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3720 
9.9.10.2.5.4 CS/DS degradation (Pathway) 3720 
9.9.10.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3720 (BlackBoxEvent) 
9.9.10.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3721 
9.9.10.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3721 
9.9.10.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3721 units of DS (Reaction) 3713 9.9.10.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 3721 2-sulfate units of dermatan sulfate (Reaction) 
9.9.10.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3722 
9.9.10.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3722 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.10.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate

3722 units of CS (Reaction) 
9.9.10.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and
3723 D-glucuronate residues in CS. (Reaction) 
9.9.11 MPS IX - Natowicz syndrome (Pathway) 3723 
9.9.11.1 Defective HYAL1 does not hydrolyse 1-4-linkages between GlcNAc and GlcA 3724 (BlackBoxEvent) 
9.9.11.2 Glycosaminoglycan metabolism (Pathway) 3726 
9.9.11.2.1 Hyaluronan metabolism (Pathway) 3726 
9.9.11.2.1.1 Hyaluronan biosynthesis and export (Pathway) 3726 
9.9.11.2.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 3727 
9.9.11.2.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 3727 
9.9.11.2.1.2 Hyaluronan uptake and degradation (Pathway) 3727 
9.9.11.2.1.2.1 Receptor-mediated uptake of HA (Reaction) 3727 
9.9.11.2.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 3728 
9.9.11.2.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 3728 (BlackBoxEvent) 
9.9.11.2.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 3728 
9.9.11.2.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da 3729 fragments (BlackBoxEvent) 
9.9.11.2.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 3729 tetrasaccharides (Reaction) 
9.9.11.2.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments 3729 (Reaction) 
9.9.11.2.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 3730 disaccharides (Reaction) 
9.9.11.2.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to3730 the cytosol (BlackBoxEvent) 
9.9.11.2.2 Transport and synthesis of PAPS (Pathway) 3730 
9.9.11.2.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 3730 
9.9.11.2.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 3731 
9.9.11.2.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 3731 (Reaction) 
9.9.11.2.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 3731 
9.9.11.2.3 Keratan sulfate/keratin metabolism (Pathway) 3732 
9.9.11.2.3.1 Keratan sulfate biosynthesis (Pathway) 3732 
9.9.11.2.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3732 
9.9.11.2.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 3732 
9.9.11.2.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 3733 
9.9.11.2.3.1.4 B4GALTs add another galactose to the chain (Reaction) 3733 9.9.11.2.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 3733 
9.9.11.2.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction)3733 
9.9.11.2.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 3734 
9.9.11.2.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 3734 
9.9.11.2.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 3734 
9.9.11.2.3.2 Keratan sulfate degradation (Pathway) 3734 
9.9.11.2.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 3735 (BlackBoxEvent) 
9.9.11.2.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 3735 galactosidase (BlackBoxEvent) 
9.9.11.2.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate 3735 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.9.11.2.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 3736 glycosaminoglycan (Reaction) 
9.9.11.2.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of3736 the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.9.11.2.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 3736 
9.9.11.2.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 3737 
9.9.11.2.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)
3737 
9.9.11.2.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3737 
9.9.11.2.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3737 
9.9.11.2.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3738 
9.9.11.2.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3738 
9.9.11.2.4.2 HS-GAG biosynthesis (Pathway) 3738 
9.9.11.2.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 3738 
9.9.11.2.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates 3739 heparan (Reaction) 
9.9.11.2.4.2.3 Glucuronate is added to the heparan chain (Reaction) 3739 
9.9.11.2.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 3739 
9.9.11.2.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 3739 
9.9.11.2.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 3740 
9.9.11.2.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan
3740 sulfate (HS) (Reaction) 
9.9.11.2.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 3740 
9.9.11.2.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 3740 
9.9.11.2.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 3741 
9.9.11.2.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 3741 
9.9.11.2.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises 3741 (Reaction) 
9.9.11.2.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 3742 
9.9.11.2.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent)3742 
9.9.11.2.4.3 HS-GAG degradation (Pathway) 3742 
9.9.11.2.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent)
3742 
9.9.11.2.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 3743 (lysosome) (Reaction) 
9.9.11.2.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan3743 (plasma membrane) (Reaction) 
9.9.11.2.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3743 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.11.2.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from
3744 the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.11.2.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate 3744 (Reaction) 
9.9.11.2.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 3744 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.9.11.2.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 3745 2-sulfate units of heparan sulfate (Reaction) 
9.9.11.2.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 3745 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.9.11.2.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another 3745 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.9.11.2.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 3746 (Reaction) 
9.9.11.2.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 3746 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.9.11.2.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker 3746 chain (Reaction) 
9.9.11.2.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain3747 (Reaction) 
9.9.11.2.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 3747 
9.9.11.2.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway)
3747 
9.9.11.2.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 3747 
9.9.11.2.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 3748 
9.9.11.2.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 3748 
9.9.11.2.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 3748 
9.9.11.2.5.2 Chondroitin sulfate biosynthesis (Pathway) 3748 
9.9.11.2.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 3749 chondroitin (Reaction) 
9.9.11.2.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 3749 
9.9.11.2.5.2.3 GalNAc is added to chondroitin (Reaction) 3749 
9.9.11.2.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 123749 and 13 (Reaction) 
9.9.11.2.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 3750 CHST15 (Reaction) 
9.9.11.2.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 3750 (Reaction) 
9.9.11.2.5.2.7 CSPG is secreted (BlackBoxEvent) 3750 
9.9.11.2.5.3 Dermatan sulfate biosynthesis (Pathway) 3750 
9.9.11.2.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to
3751 dermatan sulfate (DS) (Reaction) 
9.9.11.2.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 3751 (Reaction) 
9.9.11.2.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 3751 
9.9.11.2.5.3.4 DSPGs are secreted (BlackBoxEvent) 3751 
9.9.11.2.5.4 CS/DS degradation (Pathway) 3752 
9.9.11.2.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 3752 (BlackBoxEvent) 
9.9.11.2.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 3752 
9.9.11.2.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 3752 
9.9.11.2.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3753 units of DS (Reaction) 
9.9.11.2.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 3753 2-sulfate units of dermatan sulfate (Reaction) 
9.9.11.2.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 3753 
9.9.11.2.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 3754 alpha-L-iduronosidic linkage in DS (Reaction) 
9.9.11.2.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate
3754 units of CS (Reaction) 
9.9.11.2.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and
3754 D-glucuronate residues in CS. (Reaction) 
9.10 Diseases associated with visual transduction (Pathway) 3755 
9.10.1 Retinoid cycle disease events (Pathway) 3756 
9.10.1.1 Defective STRA6 does not transport atROL (BlackBoxEvent) 3757 
9.10.1.2 Defective LRAT does not esterify atROL and PALM to RPALM (BlackBoxEvent)3759 
9.10.1.3 Defective ABCA4 does not transport atRAL or NRPE from disc membranes 3761 (BlackBoxEvent) 
9.10.1.4 Defective OPN1SW causes tritanopia (BlackBoxEvent) 3764 
9.10.1.5 Defective OPN1MW causes DCB and BCM (BlackBoxEvent) 3766 
9.10.1.6 Defective OPN1MW causes COD5 (BlackBoxEvent) 3770 
9.10.1.7 Defective OPN1LW causes BCM (BlackBoxEvent) 3772 
9.10.1.8 Defective OPN1LW causes CBP (BlackBoxEvent) 3775 
9.10.1.9 Defective RDH12 does not reduce atRAL to atROL and causes LCA13 3777 (BlackBoxEvent) 
9.10.1.10 Defective RDH12 does not reduce atRAL to atROL and causes RP53 3779 (BlackBoxEvent) 
9.10.1.11 Defective RDH5 does not oxidise 11cROL to 11cRAL and causes RPA 3781 (BlackBoxEvent) 
9.10.1.12 Defective RBP4 does not bind atROL (BlackBoxEvent) 3783 
9.10.1.13 Biosynthesis of A2E, implicated in retinal degradation (Pathway) 3785 
9.10.1.13.1 atRAL can spontaneously react with PE to form NRPE (Reaction) 3787 
9.10.1.13.2 NRPE condenses with atRAL to form A2PE (Reaction) 3788 
9.10.1.13.3 A2PE hydrolyses to A2E (Reaction) 3789 
9.10.1.13.4 A2E is phagocytosed (Reaction) 3791 
9.10.1.13.5 A2E translocates to RPE cells (Reaction) 3792 
9.11 PI3K/AKT Signaling in Cancer (Pathway) 3794 
9.11.1 Constitutive PI3K/AKT Signaling in Cancer (Pathway) 3795 
9.11.1.1 PI3K gain of function mutants phosphorylate PIP2 to PIP3 (Reaction) 3798 
9.11.1.2 PTEN cancer mutants do not dephosphorylate PIP3 (BlackBoxEvent) 3803 
9.11.1.3 AKT1 E17K mutant binds PIP2 (Reaction) 3807 
9.11.1.4 AKT1 E17K mutant is phosphorylated by TORC2 complex (Reaction) 3809 
9.11.1.5 PIP2-bound p-S473-AKT1 mutant binds PIP2-bound PDPK1 (Reaction) 3811 
9.11.1.6 PDPK1 phosphorylates AKT1 E17K mutant (Reaction) 3813 
9.11.1.7 AKT1 E17K mutant phosphorylates GSK3 (Reaction) 3815 
9.11.1.8 AKT1 E17K mutant phosphorylates p21Cip1 and p27Kip1 (Reaction) 3817 
9.11.1.9 AKT1 E17K mutant phosphorylates BAD (Reaction) 3819 
9.11.1.10 AKT1 E17K mutant phosphorylates AKT1S1 (PRAS40) (Reaction) 3821 
9.11.1.11 AKT1 E17K mutant phosphorylates MDM2 (Reaction) 3823 
9.11.1.12 AKT1 E17K mutant phosphorylates TSC2, inhibiting it (Reaction) 3825 
9.11.1.13 AKT1 E17K mutant phosphorylates CHUK (IKKalpha) (Reaction) 3827 
9.11.1.14 AKT1 E17K mutant phosphorylates caspase-9 (Reaction) 3828 
9.11.1.15 AKT1 E17K mutant translocates to the nucleus (Reaction) 3830 
9.11.1.16 AKT1 E17K mutant phosphorylates forkhead box transcription factors (Reaction)
3832 
9.11.1.17 AKT1 E17K mutant phosphorylates CREB1 (Reaction) 3834 
9.11.1.18 AKT1 E17K mutant phosphorylates RSK (Reaction) 3835 
9.11.1.19 AKT1 E17K mutant phosphorylates NR4A1 (NUR77) (Reaction) 3837 
9.11.1.20 PI3K inhibitors block PI3K catalytic activity (Reaction) 3839 
9.11.1.21 AKT inhibitors block AKT membrane recruitment (Reaction) 3861 
9.12 Signaling by NOTCH1 in Cancer (Pathway) 3863 
9.12.1 Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant 3866 (Pathway) 
9.12.1.1 Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation
3867 Mutant (Pathway) 
9.12.1.1.1 NOTCH1 t(7;9)(NOTCH1:M1580_K2555) does not bind DLL1 (BlackBoxEvent)
3868 
9.12.1.1.2 NOTCH1 t(7;9)(NOTCH1:M1580_K2555) does not bind DLL4 (BlackBoxEvent)
3870 
9.12.1.1.3 NOTCH1 t(7;9)(NOTCH1:M1580_K2555) does not bind JAG1 3872 (BlackBoxEvent) 
9.12.1.1.4 NOTCH1 t(7;9)(NOTCH1:M1580_K2555) does not bind JAG2 3873 (BlackBoxEvent) 
9.12.1.1.5 NOTCH1 t(7;9)(NOTCH1:M1580_K2555) is cleaved to produce NEXT1 3875 (Reaction) 
9.12.2 Signaling by NOTCH1 HD Domain Mutants in Cancer (Pathway) 3877 
9.12.2.1 Constitutive Signaling by NOTCH1 HD Domain Mutants (Pathway) 3878 
9.12.2.1.1 NOTCH1 HD domain mutants bind DLL1 (Reaction) 3879 
9.12.2.1.2 NOTCH1 HD domain mutants bind DLL4 (Reaction) 3881 
9.12.2.1.3 NOTCH1 HD domain mutants bind JAG1 (Reaction) 3883 
9.12.2.1.4 NOTCH1 HD domain mutants bind JAG2 (Reaction) 3884 
9.12.2.1.5 Ubiquitination of DLL/JAG ligands upon binding to NOTCH1 HD domain 3886 mutants (Reaction) 
9.12.2.1.6 NOTCH1 HD domain mutants are cleaved to produce NEXT1 irrespective of3887 
ligand binding (Reaction) 9.12.3 Signaling by NOTCH1 PEST Domain Mutants in Cancer (Pathway) 3889 
9.12.3.1 Constitutive Signaling by NOTCH1 PEST Domain Mutants (Pathway) 3890 
9.12.3.1.1 NOTCH1 PEST domain mutants bind DLL1 (Reaction) 3892 
9.12.3.1.2 NOTCH1 PEST domain mutants bind DLL4 (Reaction) 3893 
9.12.3.1.3 NOTCH1 PEST domain mutants bind JAG1 (Reaction) 3895 
9.12.3.1.4 NOTCH1 PEST domain mutants bind JAG2 (Reaction) 3896 
9.12.3.1.5 Ubiquitination of DLL/JAG ligands upon binding to NOTCH1 PEST domain 3898 mutants (Reaction) 
9.12.3.1.6 ADAM10/17 cleaves ligand-bound NOTCH1 PEST domain mutants to produce
3900 NEXT1 PEST domain mutants (Reaction) 
9.12.3.1.7 NEXT1 PEST domain mutants are cleaved to produce NICD1 PEST domain3902 mutants (Reaction) 
9.12.3.1.8 NICD1 PEST domain mutants translocate from cytosol to nucleus (Reaction)3903 
9.12.3.1.9 NICD1 PEST domain mutants displace co-repressor complex from RBPJ 3905 (CSL) (Reaction) 
9.12.3.1.10 NICD1 PEST domain mutants in complex with RBPJ (CSL) bind MAML 3907 (Reaction) 
9.12.3.1.11 NOTCH1 PEST domain mutants bind HES1 promoter (Reaction) 3909 
9.12.3.1.12 NOTCH1 PEST domain mutants stimulate HES1 transcription 3910 (BlackBoxEvent) 
9.12.3.1.13 NOTCH1 PEST domain mutants bind HES5 promoter (Reaction) 3912 
9.12.3.1.14 NOTCH1 PEST domain mutants stimulate HES5 transcription 3913 (BlackBoxEvent) 
9.12.3.1.15 NOTCH1 PEST domain mutants bind promoters of HEY genes (Reaction) 3915 
9.12.3.1.16 NOTCH1 PEST domain mutants stimulate HEY transcription (BlackBoxEvent)3916 
9.12.3.1.17 NOTCH1 PEST domain mutants bind MYC promoter (Reaction) 3918 
9.12.3.1.18 NOTCH1 PEST domain mutants stimulate MYC transcription 3919 (BlackBoxEvent) 
9.12.3.1.19 NOTCH1 PEST domain mutants coactivator complex binds CDK8:CCNC 3921 (Reaction) 
9.12.3.1.20 CDK8 phosphorylates NICD1 PEST domain mutants (Reaction) 3922 
9.12.3.1.21 p-NICD1 PEST domain mutants do not bind FBXW7 (BlackBoxEvent) 3924 
9.12.4 Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer (Pathway) 3926 
9.12.4.1 Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants (Pathway) 3927 
9.12.4.1.1 NOTCH1 HD+PEST domain mutants bind DLL1 (Reaction) 3928 
9.12.4.1.2 NOTCH1 HD+PEST domain mutants bind DLL4 (Reaction) 3930 
9.12.4.1.3 NOTCH1 HD+PEST domain mutants bind JAG1 (Reaction) 3932 
9.12.4.1.4 NOTCH1 HD+PEST domain mutants bind JAG2 (Reaction) 3934 
9.12.4.1.5 Ubiquitination of DLL/JAG ligands upon binding to NOTCH1 HD+PEST domain
3935 mutants (Reaction) 
9.12.4.1.6 NOTCH1 HD+PEST domain mutants are cleaved by ADAM10/17 irrespective
3936 of ligand binding (Reaction) 
9.12.4.1.7 NEXT1 PEST domain mutants are cleaved to produce NICD1 PEST domain3938 mutants (Reaction) 
9.12.4.1.8 NICD1 PEST domain mutants translocate from cytosol to nucleus (Reaction)3938 
9.12.4.1.9 NICD1 PEST domain mutants displace co-repressor complex from RBPJ 3938 (CSL) (Reaction) 
9.12.4.1.10 NICD1 PEST domain mutants in complex with RBPJ (CSL) bind MAML 3939 (Reaction) 
9.12.4.1.11 NOTCH1 PEST domain mutants bind HES1 promoter (Reaction) 3939 
9.12.4.1.12 NOTCH1 PEST domain mutants stimulate HES1 transcription 3939 (BlackBoxEvent) 
9.12.4.1.13 NOTCH1 PEST domain mutants bind HES5 promoter (Reaction) 3940 
9.12.4.1.14 NOTCH1 PEST domain mutants stimulate HES5 transcription 3940 (BlackBoxEvent) 
9.12.4.1.15 NOTCH1 PEST domain mutants bind promoters of HEY genes (Reaction) 3940 
9.12.4.1.16 NOTCH1 PEST domain mutants stimulate HEY transcription (BlackBoxEvent)3941 
9.12.4.1.17 NOTCH1 PEST domain mutants bind MYC promoter (Reaction) 3941 
9.12.4.1.18 NOTCH1 PEST domain mutants stimulate MYC transcription 3941 (BlackBoxEvent) 
9.12.4.1.19 NOTCH1 PEST domain mutants coactivator complex binds CDK8:CCNC 3942 (Reaction) 
9.12.4.1.20 CDK8 phosphorylates NICD1 PEST domain mutants (Reaction) 3942 
9.12.4.1.21 p-NICD1 PEST domain mutants do not bind FBXW7 (BlackBoxEvent) 3942 
9.12.5 FBXW7 Mutants and NOTCH1 in Cancer (Pathway) 3943 
9.12.5.1 Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling (Pathway) 3944 
9.12.5.1.1 FBXW7 WD mutants do not bind NICD1 (BlackBoxEvent) 3946 
9.13 Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate (Pathway) 3948 
9.13.1 2-oxoglutarate + NADPH + H+ => (R)-2-hydroxyglutarate + NADP+ [mutant IDH1]3949 (Reaction) 
9.14 Glycogen storage diseases (Pathway) 3951 
9.14.1 Myoclonic epilepsy of Lafora (Pathway) 3952 
9.14.1.1 Defective EPM2A does not dephosphorylate phosphoglycogen (type 2A disease)
3954 (FailedReaction) 
9.14.1.2 Defective NHLRC1 does not ubiquitinate EPM2A (laforin) and PPP1R3C (PTG)3957 (type 2B disease) (FailedReaction) 
9.14.1.3 Metabolism of carbohydrates (Pathway) 3959 
9.14.1.3.1 Digestion of dietary carbohydrate (Pathway) 3960 
9.14.1.3.1.1 Digestion of linear starch (amylose) by extracellular amylase (Reaction) 3961 
9.14.1.3.1.2 Digestion of branched starch (amylopectin) by extracellular amylase 3963 (Reaction) 
9.14.1.3.1.3 Digestion of 1-6 linkages of limit dextrins to yield maltose, maltotriose, 3965 longer maltosides, and glucose (Reaction) 
9.14.1.3.1.4 maltotriose + H2O => maltose + D-glucose (maltase-glucoamylase) 3966 (Reaction) 
9.14.1.3.1.5 maltotriose + H2O => maltose + D-glucose (sucrase-isomaltase) (Reaction)3968 
9.14.1.3.1.6 maltose + H2O => 2 D-glucose (maltase-glucoamylase) (Reaction) 3969 
9.14.1.3.1.7 maltose + H2O => 2 D-glucose (sucrase-isomaltase) (Reaction) 3970 
9.14.1.3.1.8 lactose + H2O => D-glucose + D-galactose (Reaction) 3972 
9.14.1.3.1.9 sucrose + H2O => glucose + fructose (Reaction) 3973 9.14.1.3.1.10 trehalose + H2O => 2 D-glucose (Reaction) 3975 
9.14.1.3.2 Hexose transport (Pathway) 3977 
9.14.1.3.2.1 Transport (influx) of fructose by GLUT5 (Reaction) 3978 
9.14.1.3.2.2 Transport (influx) of glucose, galactose, and sodium ions by SGLT1 3980 (Reaction) 
9.14.1.3.2.3 Transport (efflux) of fructose, galactose, and glucose by GLUT2 (Reaction)3982 
9.14.1.3.2.4 Glucose transport (Pathway) 3983 
9.14.1.3.2.4.1 GLUT tetramers transport Glc from extracellular region to cytosol 3985 (Reaction) 
9.14.1.3.2.4.2 alpha-D-glucose (cytosol) alpha-D-glucose (extracellular) (Reaction) 3987 
9.14.1.3.2.4.3 GLUT1 + ATP GLUT1:ATP (Reaction) 3988 
9.14.1.3.2.4.4 GLUT1:ATP GLUT1 + ATP (Reaction) 3989 
9.14.1.3.2.4.5 alpha-D-Glucose + ATP => alpha-D-glucose 6-phosphate + ADP 3990 (Reaction) 
9.14.1.3.2.4.6 Regulation of Glucokinase by Glucokinase Regulatory Protein (Pathway)3992 
9.14.1.3.2.4.6.1 glucokinase (GCK1) + glucokinase regulatory protein (GKRP) 3993 GCK1:GKRP complex (Reaction) 
9.14.1.3.2.4.6.2 cytosolic GCK1:GKRP complex glucokinase (GCK1) + glucokinase3994 regulatory protein (GKRP) (Reaction) 
9.14.1.3.2.4.6.3 GCK1:GKRP [cytosol] => GCK1:GKRP [nucleoplasm] (Reaction) 3995 
9.14.1.3.2.4.6.4 nucleoplasmic GCK1:GKRP complex => glucokinase (GCK1) + 3996 glucokinase regulatory protein (GKRP) (Reaction) 
9.14.1.3.2.4.6.5 glucokinase [nucleoplasm] => glucokinase [cytosol] (Reaction) 3997 
9.14.1.3.2.4.7 Cytosolic glucose 6-phosphate is exchanged for orthophosphate from3998 the endoplasmic reticulum lumen by SLC37A4 (Reaction) 
9.14.1.3.2.4.8 G6PC hydrolyzes glucose 6-phosphate to form glucose and 3999 orthophosphate (liver) (Reaction) 
9.14.1.3.2.4.9 G6PC2 hydrolyzes glucose 6-phosphate to form glucose and 4000 orthophosphate (islet) (Reaction) 
9.14.1.3.2.4.10 G6PC3 hydrolyzes glucose 6-phosphate to form glucose and 4001 orthophosphate (ubiquitous) (Reaction) 
9.14.1.3.2.4.11 Efflux of glucose from the endoplasmic reticulum (BlackBoxEvent) 4002 
9.14.1.3.3 Glucose metabolism (Pathway) 4004 
9.14.1.3.3.1 Glycolysis (Pathway) 4006 
9.14.1.3.3.1.1 alpha-D-glucose 6-phosphate D-fructose 6-phosphate (Reaction) 4006 
9.14.1.3.3.1.2 Dephosphorylation of phosphoPFKFB1 by PP2A complex (Reaction) 4008 
9.14.1.3.3.1.3 D-fructose 6-phosphate + ATP => D-fructose 2,6-bisphosphate + ADP4009 (Reaction) 
9.14.1.3.3.1.4 D-fructose 6-phosphate + ATP => D-fructose 1,6-bisphosphate + ADP4011 (Reaction) 
9.14.1.3.3.1.5 D-fructose 1,6-bisphosphate dihydroxyacetone phosphate + 4012 D-glyceraldehyde 3-phosphate (Reaction) 
9.14.1.3.3.1.6 dihydroxyacetone phosphate D-glyceraldehyde 3-phosphate (Reaction)4013 
9.14.1.3.3.1.7 D-glyceraldehyde 3-phosphate + orthophosphate + NAD+ 4014 1,3-bisphospho-D-glycerate + NADH + H+ (Reaction) 
9.14.1.3.3.1.8 1,3-bisphospho-D-glycerate + ADP 3-phospho-D-glycerate + ADP 4015 (Reaction) 
9.14.1.3.3.1.9 3-Phospho-D-glycerate 2-Phospho-D-glycerate (Reaction) 4016 
9.14.1.3.3.1.10 2-Phospho-D-glycerate Phosphoenolpyruvate + H2O (Reaction) 4017 
9.14.1.3.3.1.11 phosphoenolpyruvate + ADP => pyruvate + ATP (Reaction) 4019 
9.14.1.3.3.2 Gluconeogenesis (Pathway) 4021 
9.14.1.3.3.2.1 Pyruvate + CO2 + ATP => ADP + Orthophosphate + Oxaloacetate 4023 (Reaction) 
9.14.1.3.3.2.2 Oxaloacetate + NADH + H+ (S)-Malate + NAD+ (Reaction) 4024 
9.14.1.3.3.2.3 malate [mitochondrial matrix] + orthophosphate [cytosol] malate [cytosol]
4025 + orthophosphate [mitochondrial matrix] (Reaction) 
9.14.1.3.3.2.4 malate + NAD+ oxaloacetate + NADH + H+ (Reaction) 4026 
9.14.1.3.3.2.5 oxaloacetate + glutamate aspartate + alpha-ketoglutarate [GOT2] 4027 (Reaction) 
9.14.1.3.3.2.6 malate [mitochondrial matrix] + alpha-ketoglutarate [cytosol] malate 4028 [cytosol] + alpha-ketoglutarate [mitochondrial matrix] (Reaction) 
9.14.1.3.3.2.7 aspartate [mitochondrial matrix] + glutamate [cytosol] => aspartate 4029 [cytosol] + glutamate [mitochondrial matrix] (Reaction) 
9.14.1.3.3.2.8 aspartate + alpha-ketoglutarate oxaloacetate + glutamate [GOT1] 4031 (Reaction) 
9.14.1.3.3.2.9 oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [cytosol]4032 (Reaction) 
9.14.1.3.3.2.10 oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 4033 [mitochondrial matrix] (Reaction) 
9.14.1.3.3.2.11 phosphoenolpyruvate [mitochondrial matrix] + citrate [cytosol] => 4034 phosphoenolpyruvate [cytosol] + citrate [mitochondrial matrix] (Reaction) 
9.14.1.3.3.2.12 Phosphoenolpyruvate + H2O 2-Phospho-D-glycerate (Reaction) 4036 
9.14.1.3.3.2.13 2-Phospho-D-glycerate 3-Phospho-D-glycerate (Reaction) 4037 
9.14.1.3.3.2.14 ATP + 3-Phospho-D-glycerate ADP + 1,3-bisphospho-D-glycerate 4038 (Reaction) 
9.14.1.3.3.2.15 1,3-bisphospho-D-glycerate + NADH + H+ D-glyceraldehyde 4039 3-phosphate + Orthophosphate + NAD+ (Reaction) 
9.14.1.3.3.2.16 D-glyceraldehyde 3-phosphate dihydroxyacetone phosphate (Reaction)4041 
9.14.1.3.3.2.17 dihydroxyacetone phosphate + D-glyceraldehyde 3-phosphate 4042 D-fructose 1,6-bisphosphate (Reaction) 
9.14.1.3.3.2.18 D-fructose 1,6-bisphosphate + H2O => D-fructose 6-phosphate + 4043 orthophosphate (Reaction) 
9.14.1.3.3.2.19 Phosphorylation of PF2K-Pase by PKA catalytic subunit (Reaction) 4044 
9.14.1.3.3.2.20 Fructose 2,6-bisphosphate is hydrolyzed to form fructose-6-phosphate
4045 and orthophosphate (Reaction) 
9.14.1.3.3.2.21 D-fructose 6-phosphate alpha-D-Glucose 6-phosphate (Reaction) 4047 
9.14.1.3.3.3 Glycogen synthesis (Pathway) 4048 
9.14.1.3.3.3.1 alpha-D-Glucose 6-phosphate D-Glucose 1-phosphate (Reaction) 4049 
9.14.1.3.3.3.2 UTP + D-glucose 1-phosphate pyrophosphate + UDP-glucose 4050 (Reaction) 
9.14.1.3.3.3.3 Autoglucosylation of GYG1 complexed with GYS1-a (Reaction) 4051 
9.14.1.3.3.3.4 Autoglucosylation of GYG1 complexed with GYS1-b (Reaction) 4052 
9.14.1.3.3.3.5 Autoglucosylation of GYG2 complexed with GYS2-a (Reaction) 4053 
9.14.1.3.3.3.6 Autoglucosylation of GYG2 complexed with GYS2-b (Reaction) 4054 
9.14.1.3.3.3.7 GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1 (Reaction) 4055 
9.14.1.3.3.3.8 Phosphorylated GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1
4056 (Reaction) 
9.14.1.3.3.3.9 GYS2 catalyzes the polyglucosylation of oligoGlc-GYG2 (Reaction) 4058 
9.14.1.3.3.3.10 GBE1 catalyzes branch formation in polyGlc-GYG1 complexed with 4059 GYS1-a (Reaction) 
9.14.1.3.3.3.11 GBE1 catalyzes branch formation in polyGlc-GYG1 complexed with 4060 GYS1-b (Reaction) 
9.14.1.3.3.3.12 GBE1 catalyzes branch formation in polyGlc-GYG2 complexed with 4061 GYS2-a (Reaction) 
9.14.1.3.3.3.13 PPP1R3C binds to glycogen:GYG1:GYS1 (Reaction) 4062 
9.14.1.3.3.3.14 PPP1R3C binds to glycogen:GYG2:GYS2 (Reaction) 4063 
9.14.1.3.3.3.15 GYS1 catalyzes the incorporation of phosphoglucose into 4064 glycogen-GYG1 (Reaction) 
9.14.1.3.3.3.16 GYS2 catalyzes the incorporation of phosphoglucose into 4065 glycogen-GYG2 (Reaction) 
9.14.1.3.3.3.17 EPM2A binds PPP1R3C:phosphoglycogen-GYG1 complex (Reaction)4066 
9.14.1.3.3.3.18 EPM2A binds PPP1R3C:phosphoglycogen-GYG2 complex (Reaction)
4067 
9.14.1.3.3.3.19 EPM2A dephosphorylates phosphoglycogen-GYG1 (Reaction) 4068 
9.14.1.3.3.3.20 EPM2A dephosphorylates phosphoglycogen-GYG2 (Reaction) 4069 
9.14.1.3.3.3.21 NHLRC1 mediated ubiquitination of EPM2A and PPP1RC3 associated
4070 with glycogen-GYG1 (BlackBoxEvent) 
9.14.1.3.3.3.22 NHLRC1 mediated ubiquitination of EPM2A (laforin) and PPP1RC3 4071 (PTG) associated with glycogen-GYG2 (BlackBoxEvent) 
9.14.1.3.3.4 Glycogen breakdown (glycogenolysis) (Pathway) 4073 
9.14.1.3.3.4.1 glycogen phosphorylase (PYGB) dimer b + 2 ATP => glycogen 4075 phosphorylase (PYGB) dimer a + 2 ADP (Reaction) 
9.14.1.3.3.4.2 glycogen phosphorylase (PYGM) dimer b + 2 ATP => glycogen 4077 phosphorylase (PYGM) dimer a + 2 ADP (Reaction) 
9.14.1.3.3.4.3 glycogen phosphorylase (PYGL) dimer b + 2 ATP => glycogen 4078 phosphorylase (PYGL) dimer a + 2 ADP (Reaction) 
9.14.1.3.3.4.4 PGYB dimer, b form + 2 AMP PGYB b dimer:AMP complex (Reaction)4080 
9.14.1.3.3.4.5 PGYB b dimer:AMP complex PGYB dimer, b form + 2 AMP (Reaction)4081 
9.14.1.3.3.4.6 PGYM dimer, b form + 2 AMP PGYM b dimer:AMP complex (Reaction)4082 
9.14.1.3.3.4.7 PGYM b dimer:AMP complex PGYM dimer, b form + 2 AMP (Reaction)4083 
9.14.1.3.3.4.8 glycogen-glycogenin-1 + n orthophosphate => limit dextrin-glycogenin-14084 
+ n D-glucose 1-phosphate [PYGM,PYGB] (Reaction) 
9.14.1.3.3.4.9 glycogen-glycogenin-2 + n orthophosphate => limit dextrin-glycogenin-24086 
+ n D-glucose 1-phosphate [PYGL] (Reaction) 
9.14.1.3.3.4.10 limit dextrin-glycogenin => 4087 ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl) glycogenin (Reaction) 
9.14.1.3.3.4.11 ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => 4087 poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose (Reaction) 
9.14.1.3.3.4.12 poly((1,4)-alpha-glycosyl) glycogenin-1 + n orthophosphate => 4088 glycogenin-1 + n D-glucose 1-phosphate [PYGM,PYGB] (Reaction) 
9.14.1.3.3.4.13 poly((1,4)-alpha-glucosyl) glycogenin-2 + n orthophosphate => 4090 glycogenin-2 + n D-glucose 1-phosphate [PYGL] (Reaction) 
9.14.1.3.3.4.14 D-Glucose 1-phosphate alpha-D-Glucose 6-phosphate (Reaction) 4091 
9.14.1.3.4 Fructose catabolism (Pathway) 4092 
9.14.1.3.4.1 ATP + beta-D-fructose => ADP + D-fructose 1-phosphate (Reaction) 4094 
9.14.1.3.4.2 D-fructose 1-phosphate D-glyceraldehyde + dihydroxyacetone phosphate4095 (Reaction) 
9.14.1.3.4.3 ATP + D-glyceraldehyde => ADP + D-glyceraldehyde 3-phosphate 4096 (Reaction) 
9.14.1.3.5 Galactose catabolism (Pathway) 4097 
9.14.1.3.5.1 ATP + D-galactose => ADP + D-galactose 1-phosphate (Reaction) 4098 
9.14.1.3.5.2 D-galactose 1-phosphate + UDP-glucose D-glucose 1-phosphate + 4099 UDP-galactose (Reaction) 
9.14.1.3.5.3 D-Glucose 1-phosphate alpha-D-Glucose 6-phosphate (Reaction) 4100 
9.14.1.3.5.4 UDP-galactose UDP-glucose (Reaction) 4100 
9.14.1.3.6 Pentose phosphate pathway (hexose monophosphate shunt) (Pathway) 4101 
9.14.1.3.6.1 alpha-D-glucose 6-phosphate + NADP+ => D-glucono-1,5-lactone 4102 6-phosphate + NADPH + H+ (Reaction) 
9.14.1.3.6.2 D-glucono-1,5-lactone 6-phosphate + H2O => 6-phospho-D-gluconate 4103 (Reaction) 
9.14.1.3.6.3 6-phospho-D-gluconate + NADP+ => D-ribulose 5-phosphate + CO2 + 4104 NADPH + H+ (Reaction) 
9.14.1.3.6.4 D-ribulose 5-phosphate xylulose 5-phosphate (Reaction) 4105 
9.14.1.3.6.5 xylulose 5-phosphate D-ribulose 5-phosphate (Reaction) 4105 
9.14.1.3.6.6 ribose 5-phosphate + xylulose 5-phosphate sedoheptulose 7-phosphate +4106 D-glyceraldehyde 3-phosphate (Reaction) 
9.14.1.3.6.7 D-glyceraldehyde 3-phosphate + sedoheptulose 7-phosphate xylulose 4107 5-phosphate+ribose 5-phosphate (Reaction) 
9.14.1.3.6.8 sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate D-erythrose4108 4-phosphate + D-fructose 6-phosphate (Reaction) 
9.14.1.3.6.9 D-fructose 6-phosphate + D-erythrose 4-phosphate sedoheptulose 4109 7-phosphate + D-glyceraldehyde 3-phosphate (Reaction) 
9.14.1.3.6.10 xylulose 5-phosphate + D-erythrose 4-phosphate D-glyceraldehyde 4110 3-phosphate + D-fructose 6-phosphate (Reaction) 
9.14.1.3.6.11 D-glyceraldehyde 3-phosphate + D-fructose 6-phosphate xylulose 4110 5-phosphate + D-erythrose 4-phosphate (Reaction) 
9.14.1.3.6.12 D-ribulose 5-phosphate ribose 5-phosphate (Reaction) 4111 
9.14.1.3.6.13 ribose 5-phosphate D-ribulose 5-phosphate (Reaction) 4112 
9.14.1.3.7 5-Phosphoribose 1-diphosphate biosynthesis (Pathway) 4113 
9.14.1.3.7.1 D-ribose 5-phosphate + 2'-deoxyadenosine 5'-triphosphate (dATP) => 
5-Phospho-alpha-D-ribose 1-diphosphate (PRPP) + 2'-deoxyadenosine 

5'-monophosphate (Reaction) 
9.14.1.3.7.2 D-ribose 5-phosphate + ATP => 5-phospho-alpha-D-ribose 1-diphosphate4116 (PRPP) + adenosine 5'-monophosphate (Reaction) 
9.14.1.3.8 Glycosaminoglycan metabolism (Pathway) 4116 
9.14.1.3.8.1 Hyaluronan metabolism (Pathway) 4117 
9.14.1.3.8.1.1 Hyaluronan biosynthesis and export (Pathway) 4117 
9.14.1.3.8.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 4117 
9.14.1.3.8.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 4117 
9.14.1.3.8.1.2 Hyaluronan uptake and degradation (Pathway) 4118 
9.14.1.3.8.1.2.1 Receptor-mediated uptake of HA (Reaction) 4118 
9.14.1.3.8.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 4118 
9.14.1.3.8.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 4118 (BlackBoxEvent) 
9.14.1.3.8.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent)4119 
9.14.1.3.8.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da 4119 fragments (BlackBoxEvent) 
9.14.1.3.8.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 4119 tetrasaccharides (Reaction) 
9.14.1.3.8.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments 4120 (Reaction) 
9.14.1.3.8.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 4120 disaccharides (Reaction) 
9.14.1.3.8.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to
4120 the cytosol (BlackBoxEvent) 
9.14.1.3.8.2 Transport and synthesis of PAPS (Pathway) 4121 
9.14.1.3.8.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 4121 
9.14.1.3.8.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 4121 
9.14.1.3.8.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 4121 (Reaction) 
9.14.1.3.8.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 4122 
9.14.1.3.8.3 Keratan sulfate/keratin metabolism (Pathway) 4122 
9.14.1.3.8.3.1 Keratan sulfate biosynthesis (Pathway) 4122 
9.14.1.3.8.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 4122 
9.14.1.3.8.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 4123 
9.14.1.3.8.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 4123 
9.14.1.3.8.3.1.4 B4GALTs add another galactose to the chain (Reaction) 4123 
9.14.1.3.8.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 4123 
9.14.1.3.8.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid 4124 (Reaction) 
9.14.1.3.8.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction)4124 
9.14.1.3.8.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction)4124 
9.14.1.3.8.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 4125 
9.14.1.3.8.3.2 Keratan sulfate degradation (Pathway) 4125 
9.14.1.3.8.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 4115
4125 (BlackBoxEvent) 
9.14.1.3.8.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 4125 galactosidase (BlackBoxEvent) 
9.14.1.3.8.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate4126 groups of galactose 6-sulfate units of keratan sulfate (Reaction) 
9.14.1.3.8.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a 4126 glycosaminoglycan (Reaction) 
9.14.1.3.8.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups4126 of the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
9.14.1.3.8.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction)4127 
9.14.1.3.8.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 4127 
9.14.1.3.8.4.1 A tetrasaccharide linker sequence is required for GAG synthesis 4127 (Pathway) 
9.14.1.3.8.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 4127 
9.14.1.3.8.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 4128 
9.14.1.3.8.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 4128 
9.14.1.3.8.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 4128 
9.14.1.3.8.4.2 HS-GAG biosynthesis (Pathway) 4129 
9.14.1.3.8.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 4129 
9.14.1.3.8.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates4129 heparan (Reaction) 
9.14.1.3.8.4.2.3 Glucuronate is added to the heparan chain (Reaction) 4129 
9.14.1.3.8.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 4130 
9.14.1.3.8.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 4130 
9.14.1.3.8.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 4130 
9.14.1.3.8.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form 4131 heparan sulfate (HS) (Reaction) 
9.14.1.3.8.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 4131 
9.14.1.3.8.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 4131 
9.14.1.3.8.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 4131 
9.14.1.3.8.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 4132 
9.14.1.3.8.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises 4132 (Reaction) 
9.14.1.3.8.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction)4132 
9.14.1.3.8.4.2.14 Some HSPGs are secreted to the plasma membrane 4133 (BlackBoxEvent) 
9.14.1.3.8.4.3 HS-GAG degradation (Pathway) 4133 
9.14.1.3.8.4.3.1 HS-GAGs translocate to the lysosome for degradation 4133 (BlackBoxEvent) 
9.14.1.3.8.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan4133 (lysosome) (Reaction) 
9.14.1.3.8.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its 4134 proteoglycan (plasma membrane) (Reaction) 
9.14.1.3.8.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 4134 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.14.1.3.8.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate 
from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.14.1.3.8.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate4135 (Reaction) 
9.14.1.3.8.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses 4135 N-acetyl-D-glucosamine residues from heparan sulfate (Reaction) 
9.14.1.3.8.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 4135 2-sulfate units of heparan sulfate (Reaction) 
9.14.1.3.8.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 4136 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
9.14.1.3.8.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another
4136 sulfate from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
9.14.1.3.8.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 4136 (Reaction) 
9.14.1.3.8.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 4137 N-acetyl-D-glucosamine residue from heparan (Reaction) 
9.14.1.3.8.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker
4137 chain (Reaction) 
9.14.1.3.8.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker 4137 chain (Reaction) 
9.14.1.3.8.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 4138 
9.14.1.3.8.5.1 A tetrasaccharide linker sequence is required for GAG synthesis 4138 (Pathway) 
9.14.1.3.8.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 4138 
9.14.1.3.8.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 4138 
9.14.1.3.8.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 4139 
9.14.1.3.8.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 4139 
9.14.1.3.8.5.2 Chondroitin sulfate biosynthesis (Pathway) 4139 
9.14.1.3.8.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 4139 chondroitin (Reaction) 
9.14.1.3.8.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 4140 
9.14.1.3.8.5.2.3 GalNAc is added to chondroitin (Reaction) 4140 
9.14.1.3.8.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11,4140 12 and 13 (Reaction) 
9.14.1.3.8.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by4140 CHST15 (Reaction) 
9.14.1.3.8.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 4141 (Reaction) 
9.14.1.3.8.5.2.7 CSPG is secreted (BlackBoxEvent) 4141 
9.14.1.3.8.5.3 Dermatan sulfate biosynthesis (Pathway) 4141 
9.14.1.3.8.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS)
4141 to dermatan sulfate (DS) (Reaction) 
9.14.1.3.8.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate4142 (Reaction) 
9.14.1.3.8.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 4142 
9.14.1.3.8.5.3.4 DSPGs are secreted (BlackBoxEvent) 4134
4142 
9.14.1.3.8.5.4 CS/DS degradation (Pathway) 4142 
9.14.1.3.8.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 4143 (BlackBoxEvent) 
9.14.1.3.8.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 4143 
9.14.1.3.8.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 4143 
9.14.1.3.8.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4143 4-sulfate units of DS (Reaction) 
9.14.1.3.8.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 4144 2-sulfate units of dermatan sulfate (Reaction) 
9.14.1.3.8.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 4144 
9.14.1.3.8.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated 4144 alpha-L-iduronosidic linkage in DS (Reaction) 
9.14.1.3.8.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4145 4-sulfate units of CS (Reaction) 
9.14.1.3.8.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc4145 and D-glucuronate residues in CS. (Reaction) 
9.15 Defects in vitamin and cofactor metabolism (Pathway) 4145 
9.15.1 Defects in cobalamin (B12) metabolism (Pathway) 4146 
9.15.1.1 Defective AMN causes hereditary megaloblastic anemia 1 (Pathway) 4148 
9.15.1.1.1 Defective AMN does not transport GIF:Cbl (BlackBoxEvent) 4149 
9.15.1.1.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4151 
9.15.1.1.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4152 
9.15.1.1.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4152 
9.15.1.1.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4153 
9.15.1.1.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4155 
9.15.1.1.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4156 
9.15.1.1.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4157 
9.15.1.1.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4158 
9.15.1.1.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4158 
9.15.1.1.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4160 
9.15.1.1.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4161 
9.15.1.1.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4162 
9.15.1.1.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4164 
9.15.1.1.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4164 
9.15.1.1.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4166 
9.15.1.1.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4167 
9.15.1.1.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4167 
9.15.1.1.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4168 
9.15.1.1.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4169 
9.15.1.1.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)4169 
9.15.1.1.2.4.2 Coenzyme A biosynthesis (Pathway) 4171 
9.15.1.1.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4172 
9.15.1.1.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4173 
9.15.1.1.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4174 
9.15.1.1.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4175 9.15.1.1.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4176 
9.15.1.1.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4177 
9.15.1.1.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4178 (Reaction) 
9.15.1.1.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4179 
9.15.1.1.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4180 
9.15.1.1.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4181 
9.15.1.1.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4183 
9.15.1.1.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4184 
9.15.1.1.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4185 
9.15.1.1.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4186 
9.15.1.1.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4188 
9.15.1.1.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4189 
9.15.1.1.2.6.1 TCN1 binds Cbl (Reaction) 4191 
9.15.1.1.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4192 
9.15.1.1.2.6.3 GIF binds Cbl (Reaction) 4193 
9.15.1.1.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4195 
9.15.1.1.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4197 
9.15.1.1.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4198 
9.15.1.1.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4199 
9.15.1.1.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4200 
9.15.1.1.2.6.9 MMACHC reduces Cbl (Reaction) 4201 
9.15.1.1.2.6.10 MMACHC decyanates CNCbl (Reaction) 4203 
9.15.1.1.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4204 
9.15.1.1.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4206 
9.15.1.1.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4207 
9.15.1.1.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4209 
9.15.1.1.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4211 
9.15.1.1.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4212 
9.15.1.1.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4213 (BlackBoxEvent) 
9.15.1.1.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4215 
9.15.1.1.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4216 
9.15.1.1.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4218 
9.15.1.1.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4219 
9.15.1.1.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4222 
9.15.1.1.2.6.23 TCII binds Cbl in the circulation (Reaction) 4223 
9.15.1.1.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4224 
9.15.1.1.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4226 
9.15.1.1.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4227 
9.15.1.1.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4228 
9.15.1.1.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4230 
9.15.1.1.2.7 Biotin transport and metabolism (Pathway) 4231 
9.15.1.1.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4232 
9.15.1.1.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4233 
9.15.1.1.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4235 
9.15.1.1.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4236 
9.15.1.1.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4238 (BlackBoxEvent) 
9.15.1.1.2.7.6 HLCS biotinylates ACACA (Reaction) 4239 
9.15.1.1.2.7.7 HLCS biotinylates ACACB (Reaction) 4241 
9.15.1.1.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4243 
9.15.1.1.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4244 
9.15.1.1.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4245 
9.15.1.1.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4247 
9.15.1.1.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4248 
9.15.1.1.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4249 
9.15.1.1.2.8 Nicotinate metabolism (Pathway) 4251 
9.15.1.1.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4251 non-enzymatically to quinolinate (Reaction) 
9.15.1.1.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4252 
9.15.1.1.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4253 [NMNAT1] (Reaction) 
9.15.1.1.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4254 [NMNAT2] (Reaction) 
9.15.1.1.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4255 [NMNAT3] (Reaction) 
9.15.1.1.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4256 
9.15.1.1.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4256 
9.15.1.1.2.8.8 Nicotinamide salvaging (Pathway) 4257 
9.15.1.1.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4258 
9.15.1.1.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4259 (NMN) (Reaction) 
9.15.1.1.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4259 mononucleotide (NaMN) (Reaction) 
9.15.1.1.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4260 
9.15.1.1.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4262 
9.15.1.1.2.9 Metabolism of folate and pterines (Pathway) 4263 
9.15.1.1.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4264 
9.15.1.1.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4265 
9.15.1.1.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4266 membrane (Reaction) 
9.15.1.1.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4267 
9.15.1.1.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4267 
9.15.1.1.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4268 
9.15.1.1.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4269 5-methylTHF-polyglutamate (Reaction) 
9.15.1.1.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4270 membrane (Reaction) 
9.15.1.1.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 
membrane (Reaction) 
9.15.1.1.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4272 
9.15.1.1.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4273 ADP + orthophosphate (Reaction) 
9.15.1.1.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4274 (Reaction) 
9.15.1.1.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4275 polyglutamate + NADP+ (Reaction) 
9.15.1.1.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4276 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.1.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4277 polyglutamate + NADP+ (Reaction) 
9.15.1.1.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4278 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.1.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4278 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.1.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4279 (Reaction) 
9.15.1.1.2.10 Molybdenum cofactor biosynthesis (Pathway) 4280 
9.15.1.1.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4281 
9.15.1.1.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4282 
9.15.1.1.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4284 
9.15.1.1.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4285 
9.15.1.1.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4286 
9.15.1.1.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4288 
9.15.1.2 Defective CUBN causes hereditary megaloblastic anemia 1 (Pathway) 4289 
9.15.1.2.1 Defective CUBN does not transport GIF:Cbl (BlackBoxEvent) 4290 
9.15.1.2.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4292 
9.15.1.2.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4292 
9.15.1.2.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4293 
9.15.1.2.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4293 
9.15.1.2.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4293 
9.15.1.2.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4293 
9.15.1.2.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4294 
9.15.1.2.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4294 
9.15.1.2.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4294 
9.15.1.2.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4294 
9.15.1.2.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4295 
9.15.1.2.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4295 
9.15.1.2.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4295 
9.15.1.2.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4295 
9.15.1.2.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4296 
9.15.1.2.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4296 
9.15.1.2.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4296 
9.15.1.2.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4271
4296 
9.15.1.2.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4297 
9.15.1.2.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4297 
9.15.1.2.2.4.2 Coenzyme A biosynthesis (Pathway) 4297 
9.15.1.2.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4297 
9.15.1.2.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4298 
9.15.1.2.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4298 
9.15.1.2.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4298 
9.15.1.2.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4298 
9.15.1.2.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4299 
9.15.1.2.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4299 (Reaction) 
9.15.1.2.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4299 
9.15.1.2.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4299 
9.15.1.2.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4300 
9.15.1.2.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4300 
9.15.1.2.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4300 
9.15.1.2.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4300 
9.15.1.2.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4301 
9.15.1.2.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4301 
9.15.1.2.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4301 
9.15.1.2.2.6.1 TCN1 binds Cbl (Reaction) 4301 
9.15.1.2.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4302 
9.15.1.2.2.6.3 GIF binds Cbl (Reaction) 4302 
9.15.1.2.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4302 
9.15.1.2.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4302 
9.15.1.2.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4303 
9.15.1.2.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4303 
9.15.1.2.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4303 
9.15.1.2.2.6.9 MMACHC reduces Cbl (Reaction) 4303 
9.15.1.2.2.6.10 MMACHC decyanates CNCbl (Reaction) 4304 
9.15.1.2.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4304 
9.15.1.2.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4304 
9.15.1.2.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4304 
9.15.1.2.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4305 
9.15.1.2.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4305 
9.15.1.2.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4305 
9.15.1.2.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4305 (BlackBoxEvent) 
9.15.1.2.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4306 
9.15.1.2.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4306 
9.15.1.2.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4306 
9.15.1.2.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4306 
9.15.1.2.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4307 
9.15.1.2.2.6.23 TCII binds Cbl in the circulation (Reaction) 4307 
9.15.1.2.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4307 9.15.1.2.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4307 
9.15.1.2.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4308 
9.15.1.2.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4308 
9.15.1.2.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4308 
9.15.1.2.2.7 Biotin transport and metabolism (Pathway) 4308 
9.15.1.2.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4309 
9.15.1.2.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4309 
9.15.1.2.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4309 
9.15.1.2.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4309 
9.15.1.2.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4310 (BlackBoxEvent) 
9.15.1.2.2.7.6 HLCS biotinylates ACACA (Reaction) 4310 
9.15.1.2.2.7.7 HLCS biotinylates ACACB (Reaction) 4310 
9.15.1.2.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4310 
9.15.1.2.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4311 
9.15.1.2.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4311 
9.15.1.2.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4311 
9.15.1.2.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4311 
9.15.1.2.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4312 
9.15.1.2.2.8 Nicotinate metabolism (Pathway) 4312 
9.15.1.2.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4312 non-enzymatically to quinolinate (Reaction) 
9.15.1.2.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4312 
9.15.1.2.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4313 [NMNAT1] (Reaction) 
9.15.1.2.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4313 [NMNAT2] (Reaction) 
9.15.1.2.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4313 [NMNAT3] (Reaction) 
9.15.1.2.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4314 
9.15.1.2.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4314 
9.15.1.2.2.8.8 Nicotinamide salvaging (Pathway) 4314 
9.15.1.2.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4314 
9.15.1.2.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4315 (NMN) (Reaction) 
9.15.1.2.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4315 mononucleotide (NaMN) (Reaction) 
9.15.1.2.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4315 
9.15.1.2.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4315 
9.15.1.2.2.9 Metabolism of folate and pterines (Pathway) 4316 
9.15.1.2.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4316 
9.15.1.2.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4316 
9.15.1.2.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4316 membrane (Reaction) 
9.15.1.2.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 
9.15.1.2.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4317 
9.15.1.2.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4317 
9.15.1.2.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4317 5-methylTHF-polyglutamate (Reaction) 
9.15.1.2.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4318 membrane (Reaction) 
9.15.1.2.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4318 membrane (Reaction) 
9.15.1.2.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4318 
9.15.1.2.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4319 ADP + orthophosphate (Reaction) 
9.15.1.2.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4319 (Reaction) 
9.15.1.2.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4319 polyglutamate + NADP+ (Reaction) 
9.15.1.2.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4320 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.2.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4320 polyglutamate + NADP+ (Reaction) 
9.15.1.2.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4320 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.2.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4321 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.2.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4321 (Reaction) 
9.15.1.2.2.10 Molybdenum cofactor biosynthesis (Pathway) 4321 
9.15.1.2.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4321 
9.15.1.2.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4322 
9.15.1.2.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4322 
9.15.1.2.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4322 
9.15.1.2.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4322 
9.15.1.2.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4323 
9.15.1.3 Defective TCN2 causes hereditary megaloblastic anemia (Pathway) 4323 
9.15.1.3.1 Defective TCII does not bind Cbl in the circulation (BlackBoxEvent) 4324 
9.15.1.3.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4326 
9.15.1.3.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4326 
9.15.1.3.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4326 
9.15.1.3.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4327 
9.15.1.3.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4327 
9.15.1.3.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4327 
9.15.1.3.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4327 
9.15.1.3.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4328 
9.15.1.3.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4328 
9.15.1.3.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4328 
9.15.1.3.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4328 
9.15.1.3.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4329 
9.15.1.3.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4329 
9.15.1.3.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4329 
9.15.1.3.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4329 
9.15.1.3.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4330 
9.15.1.3.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4330 
9.15.1.3.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4330 
9.15.1.3.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4330 
9.15.1.3.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4331 
9.15.1.3.2.4.2 Coenzyme A biosynthesis (Pathway) 4331 
9.15.1.3.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4331 
9.15.1.3.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4331 
9.15.1.3.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4332 
9.15.1.3.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4332 
9.15.1.3.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4332 
9.15.1.3.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4332 
9.15.1.3.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4333 (Reaction) 
9.15.1.3.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4333 
9.15.1.3.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4333 
9.15.1.3.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4333 
9.15.1.3.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4334 
9.15.1.3.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4334 
9.15.1.3.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4334 
9.15.1.3.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4334 
9.15.1.3.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4335 
9.15.1.3.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4335 
9.15.1.3.2.6.1 TCN1 binds Cbl (Reaction) 4335 
9.15.1.3.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4335 
9.15.1.3.2.6.3 GIF binds Cbl (Reaction) 4336 
9.15.1.3.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4336 
9.15.1.3.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4336 
9.15.1.3.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4336 
9.15.1.3.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4337 
9.15.1.3.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4337 
9.15.1.3.2.6.9 MMACHC reduces Cbl (Reaction) 4337 
9.15.1.3.2.6.10 MMACHC decyanates CNCbl (Reaction) 4337 
9.15.1.3.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4338 
9.15.1.3.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4338 
9.15.1.3.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4338 
9.15.1.3.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4338 
9.15.1.3.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4339 
9.15.1.3.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4339 
9.15.1.3.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4339 
(BlackBoxEvent) 
9.15.1.3.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4340 
9.15.1.3.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4340 
9.15.1.3.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4340 
9.15.1.3.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4340 
9.15.1.3.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4341 
9.15.1.3.2.6.23 TCII binds Cbl in the circulation (Reaction) 4341 
9.15.1.3.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4341 
9.15.1.3.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4341 
9.15.1.3.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4342 
9.15.1.3.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4342 
9.15.1.3.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4342 
9.15.1.3.2.7 Biotin transport and metabolism (Pathway) 4342 
9.15.1.3.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4343 
9.15.1.3.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4343 
9.15.1.3.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4343 
9.15.1.3.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4343 
9.15.1.3.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4344 (BlackBoxEvent) 
9.15.1.3.2.7.6 HLCS biotinylates ACACA (Reaction) 4344 
9.15.1.3.2.7.7 HLCS biotinylates ACACB (Reaction) 4344 
9.15.1.3.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4344 
9.15.1.3.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4345 
9.15.1.3.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4345 
9.15.1.3.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4345 
9.15.1.3.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4345 
9.15.1.3.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4346 
9.15.1.3.2.8 Nicotinate metabolism (Pathway) 4346 
9.15.1.3.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4346 non-enzymatically to quinolinate (Reaction) 
9.15.1.3.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4346 
9.15.1.3.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4347 [NMNAT1] (Reaction) 
9.15.1.3.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4347 [NMNAT2] (Reaction) 
9.15.1.3.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4347 [NMNAT3] (Reaction) 
9.15.1.3.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4348 
9.15.1.3.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4348 
9.15.1.3.2.8.8 Nicotinamide salvaging (Pathway) 4348 
9.15.1.3.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4348 
9.15.1.3.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4349 (NMN) (Reaction) 
9.15.1.3.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4349 mononucleotide (NaMN) (Reaction) 
9.15.1.3.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 
9.15.1.3.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4349 
9.15.1.3.2.9 Metabolism of folate and pterines (Pathway) 4350 
9.15.1.3.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4350 
9.15.1.3.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4350 
9.15.1.3.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4350 membrane (Reaction) 
9.15.1.3.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4351 
9.15.1.3.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4351 
9.15.1.3.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4351 
9.15.1.3.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4351 5-methylTHF-polyglutamate (Reaction) 
9.15.1.3.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4352 membrane (Reaction) 
9.15.1.3.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4352 membrane (Reaction) 
9.15.1.3.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4352 
9.15.1.3.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4353 ADP + orthophosphate (Reaction) 
9.15.1.3.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4353 (Reaction) 
9.15.1.3.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4353 polyglutamate + NADP+ (Reaction) 
9.15.1.3.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4354 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.3.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4354 polyglutamate + NADP+ (Reaction) 
9.15.1.3.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4354 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.3.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4355 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.3.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4355 (Reaction) 
9.15.1.3.2.10 Molybdenum cofactor biosynthesis (Pathway) 4355 
9.15.1.3.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4355 
9.15.1.3.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4356 
9.15.1.3.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4356 
9.15.1.3.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4356 
9.15.1.3.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4356 
9.15.1.3.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4357 
9.15.1.4 Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF
4357 (Pathway) 
9.15.1.4.1 Defective LMBRD1 does not transport lysosomal Cbl to cytosol 4358 (BlackBoxEvent) 
9.15.1.4.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4360 
9.15.1.4.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4361 
9.15.1.4.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4361 
9.15.1.4.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)
4361 
9.15.1.4.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4361 
9.15.1.4.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4362 
9.15.1.4.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4362 
9.15.1.4.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4362 
9.15.1.4.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4362 
9.15.1.4.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4363 
9.15.1.4.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4363 
9.15.1.4.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4363 
9.15.1.4.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4363 
9.15.1.4.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4364 
9.15.1.4.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4364 
9.15.1.4.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4364 
9.15.1.4.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4364 
9.15.1.4.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4365 
9.15.1.4.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4365 
9.15.1.4.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4365 
9.15.1.4.2.4.2 Coenzyme A biosynthesis (Pathway) 4365 
9.15.1.4.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4366 
9.15.1.4.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4366 
9.15.1.4.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4366 
9.15.1.4.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4366 
9.15.1.4.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4367 
9.15.1.4.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4367 
9.15.1.4.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4367 (Reaction) 
9.15.1.4.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4368 
9.15.1.4.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4368 
9.15.1.4.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4368 
9.15.1.4.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4368 
9.15.1.4.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4369 
9.15.1.4.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4369 
9.15.1.4.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4369 
9.15.1.4.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4369 
9.15.1.4.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4370 
9.15.1.4.2.6.1 TCN1 binds Cbl (Reaction) 4370 
9.15.1.4.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4370 
9.15.1.4.2.6.3 GIF binds Cbl (Reaction) 4370 
9.15.1.4.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4371 
9.15.1.4.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4371 
9.15.1.4.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4371 
9.15.1.4.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4371 
9.15.1.4.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4372 
9.15.1.4.2.6.9 MMACHC reduces Cbl (Reaction) 4372 9.15.1.4.2.6.10 MMACHC decyanates CNCbl (Reaction) 4372 
9.15.1.4.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4372 
9.15.1.4.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4373 
9.15.1.4.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4373 
9.15.1.4.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4373 
9.15.1.4.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4373 
9.15.1.4.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4374 
9.15.1.4.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4374 (BlackBoxEvent) 
9.15.1.4.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4374 
9.15.1.4.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4375 
9.15.1.4.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4375 
9.15.1.4.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4375 
9.15.1.4.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4375 
9.15.1.4.2.6.23 TCII binds Cbl in the circulation (Reaction) 4376 
9.15.1.4.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4376 
9.15.1.4.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4376 
9.15.1.4.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4376 
9.15.1.4.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4377 
9.15.1.4.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4377 
9.15.1.4.2.7 Biotin transport and metabolism (Pathway) 4377 
9.15.1.4.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4377 
9.15.1.4.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4378 
9.15.1.4.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4378 
9.15.1.4.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4378 
9.15.1.4.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4378 (BlackBoxEvent) 
9.15.1.4.2.7.6 HLCS biotinylates ACACA (Reaction) 4379 
9.15.1.4.2.7.7 HLCS biotinylates ACACB (Reaction) 4379 
9.15.1.4.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4379 
9.15.1.4.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4379 
9.15.1.4.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4380 
9.15.1.4.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4380 
9.15.1.4.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4380 
9.15.1.4.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4380 
9.15.1.4.2.8 Nicotinate metabolism (Pathway) 4381 
9.15.1.4.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4381 non-enzymatically to quinolinate (Reaction) 
9.15.1.4.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4381 
9.15.1.4.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4381 [NMNAT1] (Reaction) 
9.15.1.4.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4382 [NMNAT2] (Reaction) 
9.15.1.4.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4382 
[NMNAT3] (Reaction) 
9.15.1.4.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4382 
9.15.1.4.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4382 
9.15.1.4.2.8.8 Nicotinamide salvaging (Pathway) 4383 
9.15.1.4.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4383 
9.15.1.4.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4383 (NMN) (Reaction) 
9.15.1.4.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4383 mononucleotide (NaMN) (Reaction) 
9.15.1.4.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4384 
9.15.1.4.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4384 
9.15.1.4.2.9 Metabolism of folate and pterines (Pathway) 4384 
9.15.1.4.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4384 
9.15.1.4.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4385 
9.15.1.4.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4385 membrane (Reaction) 
9.15.1.4.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4385 
9.15.1.4.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4385 
9.15.1.4.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4386 
9.15.1.4.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4386 5-methylTHF-polyglutamate (Reaction) 
9.15.1.4.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4386 membrane (Reaction) 
9.15.1.4.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4387 membrane (Reaction) 
9.15.1.4.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4387 
9.15.1.4.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4387 ADP + orthophosphate (Reaction) 
9.15.1.4.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4388 (Reaction) 
9.15.1.4.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4388 polyglutamate + NADP+ (Reaction) 
9.15.1.4.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4388 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.4.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4389 polyglutamate + NADP+ (Reaction) 
9.15.1.4.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4389 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.4.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4389 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.4.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4390 (Reaction) 
9.15.1.4.2.10 Molybdenum cofactor biosynthesis (Pathway) 4390 

9.15.1.4.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4390 
9.15.1.4.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4390 
9.15.1.4.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4391 9.15.1.4.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4391 
9.15.1.4.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4391 
9.15.1.4.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4391 
9.15.1.5 Defective GIF causes intrinsic factor deficiency (Pathway) 4392 
9.15.1.5.1 Defective GIF does not bind Cbl (BlackBoxEvent) 4393 
9.15.1.5.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4394 
9.15.1.5.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4395 
9.15.1.5.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4395 
9.15.1.5.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4395 
9.15.1.5.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4395 
9.15.1.5.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4396 
9.15.1.5.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4396 
9.15.1.5.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4396 
9.15.1.5.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4396 
9.15.1.5.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4397 
9.15.1.5.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4397 
9.15.1.5.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4397 
9.15.1.5.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4397 
9.15.1.5.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4398 
9.15.1.5.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4398 
9.15.1.5.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4398 
9.15.1.5.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4398 
9.15.1.5.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4399 
9.15.1.5.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4399 
9.15.1.5.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4399 
9.15.1.5.2.4.2 Coenzyme A biosynthesis (Pathway) 4399 
9.15.1.5.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4400 
9.15.1.5.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4400 
9.15.1.5.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4400 
9.15.1.5.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4400 
9.15.1.5.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4401 
9.15.1.5.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4401 
9.15.1.5.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4401 (Reaction) 
9.15.1.5.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4402 
9.15.1.5.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4402 
9.15.1.5.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4402 
9.15.1.5.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4402 
9.15.1.5.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4403 
9.15.1.5.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4403 
9.15.1.5.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4403 
9.15.1.5.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4403 
9.15.1.5.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4404 
9.15.1.5.2.6.1 TCN1 binds Cbl (Reaction) 4404 
9.15.1.5.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4404 
9.15.1.5.2.6.3 GIF binds Cbl (Reaction) 4404 
9.15.1.5.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4405 
9.15.1.5.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4405 
9.15.1.5.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4405 
9.15.1.5.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4405 
9.15.1.5.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4406 
9.15.1.5.2.6.9 MMACHC reduces Cbl (Reaction) 4406 
9.15.1.5.2.6.10 MMACHC decyanates CNCbl (Reaction) 4406 
9.15.1.5.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4406 
9.15.1.5.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4407 
9.15.1.5.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4407 
9.15.1.5.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4407 
9.15.1.5.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4407 
9.15.1.5.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4408 
9.15.1.5.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4408 (BlackBoxEvent) 
9.15.1.5.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4408 
9.15.1.5.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4409 
9.15.1.5.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4409 
9.15.1.5.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4409 
9.15.1.5.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4409 
9.15.1.5.2.6.23 TCII binds Cbl in the circulation (Reaction) 4410 
9.15.1.5.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4410 
9.15.1.5.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4410 
9.15.1.5.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4410 
9.15.1.5.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4411 
9.15.1.5.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4411 
9.15.1.5.2.7 Biotin transport and metabolism (Pathway) 4411 
9.15.1.5.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4411 
9.15.1.5.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4412 
9.15.1.5.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4412 
9.15.1.5.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4412 
9.15.1.5.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4412 (BlackBoxEvent) 
9.15.1.5.2.7.6 HLCS biotinylates ACACA (Reaction) 4413 
9.15.1.5.2.7.7 HLCS biotinylates ACACB (Reaction) 4413 
9.15.1.5.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4413 
9.15.1.5.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4413 
9.15.1.5.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4414 
9.15.1.5.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4414 
9.15.1.5.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4414 
9.15.1.5.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4414 
9.15.1.5.2.8 Nicotinate metabolism (Pathway) 4415 
9.15.1.5.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4415 non-enzymatically to quinolinate (Reaction) 
9.15.1.5.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4415 
9.15.1.5.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4415 [NMNAT1] (Reaction) 
9.15.1.5.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4416 [NMNAT2] (Reaction) 
9.15.1.5.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4416 [NMNAT3] (Reaction) 
9.15.1.5.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4416 
9.15.1.5.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4416 
9.15.1.5.2.8.8 Nicotinamide salvaging (Pathway) 4417 
9.15.1.5.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4417 
9.15.1.5.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4417 (NMN) (Reaction) 
9.15.1.5.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4417 mononucleotide (NaMN) (Reaction) 
9.15.1.5.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4418 
9.15.1.5.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4418 
9.15.1.5.2.9 Metabolism of folate and pterines (Pathway) 4418 
9.15.1.5.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4418 
9.15.1.5.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4419 
9.15.1.5.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4419 membrane (Reaction) 
9.15.1.5.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4419 
9.15.1.5.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4419 
9.15.1.5.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4420 
9.15.1.5.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4420 5-methylTHF-polyglutamate (Reaction) 
9.15.1.5.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4420 membrane (Reaction) 
9.15.1.5.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4421 membrane (Reaction) 
9.15.1.5.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4421 
9.15.1.5.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4421 ADP + orthophosphate (Reaction) 
9.15.1.5.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4422 (Reaction) 
9.15.1.5.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4422 polyglutamate + NADP+ (Reaction) 
9.15.1.5.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4422 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.5.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4423 polyglutamate + NADP+ (Reaction) 
9.15.1.5.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4423 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.5.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 
polyglutamate + NADPH + H+ (Reaction) 
9.15.1.5.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4424 (Reaction) 
9.15.1.5.2.10 Molybdenum cofactor biosynthesis (Pathway) 4424 
9.15.1.5.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4424 
9.15.1.5.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4424 
9.15.1.5.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4425 
9.15.1.5.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4425 
9.15.1.5.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4425 
9.15.1.5.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4425 
9.15.1.6 Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC
4426 (Pathway) 
9.15.1.6.1 Defective MMACHC does not decyanate CNCbl (BlackBoxEvent) 4427 
9.15.1.6.2 Defective MMACHC does not reduce Cbl (BlackBoxEvent) 4429 
9.15.1.6.3 Metabolism of water-soluble vitamins and cofactors (Pathway) 4432 
9.15.1.6.3.1 Vitamin C (ascorbate) metabolism (Pathway) 4432 
9.15.1.6.3.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4432 
9.15.1.6.3.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4433 
9.15.1.6.3.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4433 
9.15.1.6.3.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4433 
9.15.1.6.3.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4433 
9.15.1.6.3.2 Vitamin B1 (thiamin) metabolism (Pathway) 4434 
9.15.1.6.3.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4434 
9.15.1.6.3.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4434 
9.15.1.6.3.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4434 
9.15.1.6.3.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4435 
9.15.1.6.3.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4435 
9.15.1.6.3.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4435 
9.15.1.6.3.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4435 
9.15.1.6.3.3.3 FLAD1 phosphorylates FMN (Reaction) 4436 
9.15.1.6.3.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4436 
9.15.1.6.3.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4436 
9.15.1.6.3.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4436 
9.15.1.6.3.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4437 
9.15.1.6.3.4.2 Coenzyme A biosynthesis (Pathway) 4437 
9.15.1.6.3.4.2.1 PANK2 phosphorylates PanK (Reaction) 4437 
9.15.1.6.3.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4437 
9.15.1.6.3.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4438 
9.15.1.6.3.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4438 
9.15.1.6.3.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4438 
9.15.1.6.3.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4438 
9.15.1.6.3.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4439 (Reaction) 
9.15.1.6.3.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4439 
9.15.1.6.3.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4423
4439 
9.15.1.6.3.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4439 
9.15.1.6.3.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4440 
9.15.1.6.3.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4440 
9.15.1.6.3.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4440 
9.15.1.6.3.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4440 
9.15.1.6.3.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4441 
9.15.1.6.3.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4441 
9.15.1.6.3.6.1 TCN1 binds Cbl (Reaction) 4441 
9.15.1.6.3.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4441 
9.15.1.6.3.6.3 GIF binds Cbl (Reaction) 4442 
9.15.1.6.3.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4442 
9.15.1.6.3.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4442 
9.15.1.6.3.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4442 
9.15.1.6.3.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4443 
9.15.1.6.3.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4443 
9.15.1.6.3.6.9 MMACHC reduces Cbl (Reaction) 4443 
9.15.1.6.3.6.10 MMACHC decyanates CNCbl (Reaction) 4443 
9.15.1.6.3.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4444 
9.15.1.6.3.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4444 
9.15.1.6.3.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4444 
9.15.1.6.3.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4444 
9.15.1.6.3.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4445 
9.15.1.6.3.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4445 
9.15.1.6.3.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4445 (BlackBoxEvent) 
9.15.1.6.3.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4446 
9.15.1.6.3.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4446 
9.15.1.6.3.6.20 MMAA:MUT binds AdoCbl (Reaction) 4446 
9.15.1.6.3.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4446 
9.15.1.6.3.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4447 
9.15.1.6.3.6.23 TCII binds Cbl in the circulation (Reaction) 4447 
9.15.1.6.3.6.24 TCN1 binds Cbl in the circulation (Reaction) 4447 
9.15.1.6.3.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4447 
9.15.1.6.3.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4448 
9.15.1.6.3.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4448 
9.15.1.6.3.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4448 
9.15.1.6.3.7 Biotin transport and metabolism (Pathway) 4448 
9.15.1.6.3.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4449 
9.15.1.6.3.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4449 
9.15.1.6.3.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4449 
9.15.1.6.3.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4449 
9.15.1.6.3.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4450 (BlackBoxEvent) 
9.15.1.6.3.7.6 HLCS biotinylates ACACA (Reaction) 4450 
9.15.1.6.3.7.7 HLCS biotinylates ACACB (Reaction) 4450 9.15.1.6.3.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4450 
9.15.1.6.3.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4451 
9.15.1.6.3.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4451 
9.15.1.6.3.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4451 
9.15.1.6.3.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4451 
9.15.1.6.3.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4452 
9.15.1.6.3.8 Nicotinate metabolism (Pathway) 4452 
9.15.1.6.3.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4452 non-enzymatically to quinolinate (Reaction) 
9.15.1.6.3.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4452 
9.15.1.6.3.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4453 [NMNAT1] (Reaction) 
9.15.1.6.3.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4453 [NMNAT2] (Reaction) 
9.15.1.6.3.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4453 [NMNAT3] (Reaction) 
9.15.1.6.3.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4454 
9.15.1.6.3.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4454 
9.15.1.6.3.8.8 Nicotinamide salvaging (Pathway) 4454 
9.15.1.6.3.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4454 
9.15.1.6.3.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4455 (NMN) (Reaction) 
9.15.1.6.3.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4455 mononucleotide (NaMN) (Reaction) 
9.15.1.6.3.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4455 
9.15.1.6.3.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4455 
9.15.1.6.3.9 Metabolism of folate and pterines (Pathway) 4456 
9.15.1.6.3.9.1 Extracellular folate import across the plasma membrane (Reaction) 4456 
9.15.1.6.3.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4456 
9.15.1.6.3.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4456 membrane (Reaction) 
9.15.1.6.3.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4457 
9.15.1.6.3.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4457 
9.15.1.6.3.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4457 
9.15.1.6.3.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4457 5-methylTHF-polyglutamate (Reaction) 
9.15.1.6.3.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4458 membrane (Reaction) 
9.15.1.6.3.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4458 membrane (Reaction) 
9.15.1.6.3.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4458 
9.15.1.6.3.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4459 ADP + orthophosphate (Reaction) 
9.15.1.6.3.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4459 (Reaction) 
9.15.1.6.3.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4459 polyglutamate + NADP+ (Reaction) 
9.15.1.6.3.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4460 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.6.3.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4460 polyglutamate + NADP+ (Reaction) 
9.15.1.6.3.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4460 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.6.3.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4461 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.6.3.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4461 (Reaction) 
9.15.1.6.3.10 Molybdenum cofactor biosynthesis (Pathway) 4461 
9.15.1.6.3.10.1 Cyclisation of GTP to precursor Z (Reaction) 4461 
9.15.1.6.3.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4462 
9.15.1.6.3.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4462 
9.15.1.6.3.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4462 
9.15.1.6.3.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4462 
9.15.1.6.3.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4463 
9.15.1.7 Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD
4463 (Pathway) 
9.15.1.7.1 Defective MMADHC does not bind MMACHC:B12r (BlackBoxEvent) 4464 
9.15.1.7.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4466 
9.15.1.7.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4467 
9.15.1.7.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4467 
9.15.1.7.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4467 
9.15.1.7.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4467 
9.15.1.7.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4468 
9.15.1.7.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4468 
9.15.1.7.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4468 
9.15.1.7.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4468 
9.15.1.7.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4469 
9.15.1.7.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4469 
9.15.1.7.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4469 
9.15.1.7.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4469 
9.15.1.7.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4470 
9.15.1.7.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4470 
9.15.1.7.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4470 
9.15.1.7.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4470 
9.15.1.7.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4471 
9.15.1.7.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4471 
9.15.1.7.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4471 
9.15.1.7.2.4.2 Coenzyme A biosynthesis (Pathway) 4471 
9.15.1.7.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4472 
9.15.1.7.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4472 
9.15.1.7.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4472 
9.15.1.7.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4472 
9.15.1.7.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4473 
9.15.1.7.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4473 
9.15.1.7.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4473 (Reaction) 
9.15.1.7.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4474 
9.15.1.7.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4474 
9.15.1.7.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4474 
9.15.1.7.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4474 
9.15.1.7.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4475 
9.15.1.7.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4475 
9.15.1.7.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4475 
9.15.1.7.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4475 
9.15.1.7.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4476 
9.15.1.7.2.6.1 TCN1 binds Cbl (Reaction) 4476 
9.15.1.7.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4476 
9.15.1.7.2.6.3 GIF binds Cbl (Reaction) 4476 
9.15.1.7.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4477 
9.15.1.7.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4477 
9.15.1.7.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4477 
9.15.1.7.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4477 
9.15.1.7.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4478 
9.15.1.7.2.6.9 MMACHC reduces Cbl (Reaction) 4478 
9.15.1.7.2.6.10 MMACHC decyanates CNCbl (Reaction) 4478 
9.15.1.7.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4478 
9.15.1.7.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4479 
9.15.1.7.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4479 
9.15.1.7.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4479 
9.15.1.7.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4479 
9.15.1.7.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4480 
9.15.1.7.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4480 (BlackBoxEvent) 
9.15.1.7.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4480 
9.15.1.7.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4481 
9.15.1.7.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4481 
9.15.1.7.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4481 
9.15.1.7.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4481 
9.15.1.7.2.6.23 TCII binds Cbl in the circulation (Reaction) 4482 
9.15.1.7.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4482 
9.15.1.7.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4482 
9.15.1.7.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4482 
9.15.1.7.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4483 
9.15.1.7.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4483 
9.15.1.7.2.7 Biotin transport and metabolism (Pathway) 4483 
9.15.1.7.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4483 
9.15.1.7.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4484 
9.15.1.7.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4484 
9.15.1.7.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4484 
9.15.1.7.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4484 (BlackBoxEvent) 
9.15.1.7.2.7.6 HLCS biotinylates ACACA (Reaction) 4485 
9.15.1.7.2.7.7 HLCS biotinylates ACACB (Reaction) 4485 
9.15.1.7.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4485 
9.15.1.7.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4485 
9.15.1.7.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4486 
9.15.1.7.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4486 
9.15.1.7.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4486 
9.15.1.7.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4486 
9.15.1.7.2.8 Nicotinate metabolism (Pathway) 4487 
9.15.1.7.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4487 non-enzymatically to quinolinate (Reaction) 
9.15.1.7.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4487 
9.15.1.7.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4487 [NMNAT1] (Reaction) 
9.15.1.7.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4488 [NMNAT2] (Reaction) 
9.15.1.7.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4488 [NMNAT3] (Reaction) 
9.15.1.7.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4488 
9.15.1.7.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4488 
9.15.1.7.2.8.8 Nicotinamide salvaging (Pathway) 4489 
9.15.1.7.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4489 
9.15.1.7.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4489 (NMN) (Reaction) 
9.15.1.7.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4489 mononucleotide (NaMN) (Reaction) 
9.15.1.7.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4490 
9.15.1.7.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4490 
9.15.1.7.2.9 Metabolism of folate and pterines (Pathway) 4490 
9.15.1.7.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4490 
9.15.1.7.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4491 
9.15.1.7.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4491 membrane (Reaction) 
9.15.1.7.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4491 
9.15.1.7.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4491 
9.15.1.7.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4492 
9.15.1.7.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4492 5-methylTHF-polyglutamate (Reaction) 
9.15.1.7.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 
membrane (Reaction) 
9.15.1.7.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4493 membrane (Reaction) 
9.15.1.7.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4493 
9.15.1.7.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4493 ADP + orthophosphate (Reaction) 
9.15.1.7.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4494 (Reaction) 
9.15.1.7.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4494 polyglutamate + NADP+ (Reaction) 
9.15.1.7.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4494 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.7.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4495 polyglutamate + NADP+ (Reaction) 
9.15.1.7.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4495 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.7.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4495 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.7.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4496 (Reaction) 
9.15.1.7.2.10 Molybdenum cofactor biosynthesis (Pathway) 4496 
9.15.1.7.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4496 
9.15.1.7.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4496 
9.15.1.7.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4497 
9.15.1.7.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4497 
9.15.1.7.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4497 
9.15.1.7.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4497 
9.15.1.8 Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE 4498 (Pathway) 
9.15.1.8.1 Defective MTRR does not convert cob(II)alamin to MeCbl (BlackBoxEvent) 4499 
9.15.1.8.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4503 
9.15.1.8.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4503 
9.15.1.8.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4503 
9.15.1.8.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4503 
9.15.1.8.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4504 
9.15.1.8.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4504 
9.15.1.8.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4504 
9.15.1.8.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4504 
9.15.1.8.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4505 
9.15.1.8.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4505 
9.15.1.8.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4505 
9.15.1.8.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4505 
9.15.1.8.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4506 
9.15.1.8.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4506 
9.15.1.8.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4492
4506 
9.15.1.8.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4506 
9.15.1.8.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4507 
9.15.1.8.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4507 
9.15.1.8.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4507 
9.15.1.8.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4507 
9.15.1.8.2.4.2 Coenzyme A biosynthesis (Pathway) 4508 
9.15.1.8.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4508 
9.15.1.8.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4508 
9.15.1.8.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4508 
9.15.1.8.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4509 
9.15.1.8.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4509 
9.15.1.8.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4509 
9.15.1.8.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4509 (Reaction) 
9.15.1.8.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4510 
9.15.1.8.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4510 
9.15.1.8.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4510 
9.15.1.8.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4510 
9.15.1.8.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4511 
9.15.1.8.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4511 
9.15.1.8.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4511 
9.15.1.8.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4511 
9.15.1.8.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4512 
9.15.1.8.2.6.1 TCN1 binds Cbl (Reaction) 4512 
9.15.1.8.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4512 
9.15.1.8.2.6.3 GIF binds Cbl (Reaction) 4512 
9.15.1.8.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4513 
9.15.1.8.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4513 
9.15.1.8.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4513 
9.15.1.8.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4513 
9.15.1.8.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4514 
9.15.1.8.2.6.9 MMACHC reduces Cbl (Reaction) 4514 
9.15.1.8.2.6.10 MMACHC decyanates CNCbl (Reaction) 4514 
9.15.1.8.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4514 
9.15.1.8.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4515 
9.15.1.8.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4515 
9.15.1.8.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4515 
9.15.1.8.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4515 
9.15.1.8.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4516 
9.15.1.8.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4516 (BlackBoxEvent) 
9.15.1.8.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4516 
9.15.1.8.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4517 
9.15.1.8.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4517 
9.15.1.8.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4517 9.15.1.8.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4517 
9.15.1.8.2.6.23 TCII binds Cbl in the circulation (Reaction) 4518 
9.15.1.8.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4518 
9.15.1.8.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4518 
9.15.1.8.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4518 
9.15.1.8.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4519 
9.15.1.8.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4519 
9.15.1.8.2.7 Biotin transport and metabolism (Pathway) 4519 
9.15.1.8.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4519 
9.15.1.8.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4520 
9.15.1.8.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4520 
9.15.1.8.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4520 
9.15.1.8.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4520 (BlackBoxEvent) 
9.15.1.8.2.7.6 HLCS biotinylates ACACA (Reaction) 4521 
9.15.1.8.2.7.7 HLCS biotinylates ACACB (Reaction) 4521 
9.15.1.8.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4521 
9.15.1.8.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4521 
9.15.1.8.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4522 
9.15.1.8.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4522 
9.15.1.8.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4522 
9.15.1.8.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4522 
9.15.1.8.2.8 Nicotinate metabolism (Pathway) 4523 
9.15.1.8.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4523 non-enzymatically to quinolinate (Reaction) 
9.15.1.8.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4523 
9.15.1.8.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4523 [NMNAT1] (Reaction) 
9.15.1.8.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4524 [NMNAT2] (Reaction) 
9.15.1.8.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4524 [NMNAT3] (Reaction) 
9.15.1.8.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4524 
9.15.1.8.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4524 
9.15.1.8.2.8.8 Nicotinamide salvaging (Pathway) 4525 
9.15.1.8.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4525 
9.15.1.8.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4525 (NMN) (Reaction) 
9.15.1.8.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4525 mononucleotide (NaMN) (Reaction) 
9.15.1.8.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4526 
9.15.1.8.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4526 
9.15.1.8.2.9 Metabolism of folate and pterines (Pathway) 4526 
9.15.1.8.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4526 
9.15.1.8.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4527 9.15.1.8.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4527 membrane (Reaction) 
9.15.1.8.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4527 
9.15.1.8.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4527 
9.15.1.8.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4528 
9.15.1.8.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4528 5-methylTHF-polyglutamate (Reaction) 
9.15.1.8.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4528 membrane (Reaction) 
9.15.1.8.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4529 membrane (Reaction) 
9.15.1.8.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4529 
9.15.1.8.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4529 ADP + orthophosphate (Reaction) 
9.15.1.8.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4530 (Reaction) 
9.15.1.8.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4530 polyglutamate + NADP+ (Reaction) 
9.15.1.8.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4530 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.8.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4531 polyglutamate + NADP+ (Reaction) 
9.15.1.8.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4531 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.8.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4531 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.8.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4532 (Reaction) 
9.15.1.8.2.10 Molybdenum cofactor biosynthesis (Pathway) 4532 
9.15.1.8.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4532 
9.15.1.8.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4532 
9.15.1.8.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4533 
9.15.1.8.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4533 
9.15.1.8.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4533 
9.15.1.8.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4533 
9.15.1.9 Defective MTR causes methylmalonic aciduria and homocystinuria type cblG 4534 (Pathway) 
9.15.1.9.1 Defective MTR does not transfer CH3 group from MTHF to cob(I)alamin 4535 (BlackBoxEvent) 
9.15.1.9.2 Defective MTR does not transfer CH3 group from MeCbl to HCYS 4537 (BlackBoxEvent) 
9.15.1.9.3 Metabolism of water-soluble vitamins and cofactors (Pathway) 4539 
9.15.1.9.3.1 Vitamin C (ascorbate) metabolism (Pathway) 4539 
9.15.1.9.3.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4539 
9.15.1.9.3.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)
9.15.1.9.3.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4540 
9.15.1.9.3.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4540 
9.15.1.9.3.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4540 
9.15.1.9.3.2 Vitamin B1 (thiamin) metabolism (Pathway) 4540 
9.15.1.9.3.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4541 
9.15.1.9.3.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4541 
9.15.1.9.3.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4541 
9.15.1.9.3.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4541 
9.15.1.9.3.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4542 
9.15.1.9.3.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4542 
9.15.1.9.3.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4542 
9.15.1.9.3.3.3 FLAD1 phosphorylates FMN (Reaction) 4542 
9.15.1.9.3.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4543 
9.15.1.9.3.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4543 
9.15.1.9.3.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4543 
9.15.1.9.3.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4543 
9.15.1.9.3.4.2 Coenzyme A biosynthesis (Pathway) 4544 
9.15.1.9.3.4.2.1 PANK2 phosphorylates PanK (Reaction) 4544 
9.15.1.9.3.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4544 
9.15.1.9.3.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4544 
9.15.1.9.3.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4545 
9.15.1.9.3.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4545 
9.15.1.9.3.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4545 
9.15.1.9.3.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4545 (Reaction) 
9.15.1.9.3.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4546 
9.15.1.9.3.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4546 
9.15.1.9.3.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4546 
9.15.1.9.3.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4546 
9.15.1.9.3.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4547 
9.15.1.9.3.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4547 
9.15.1.9.3.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4547 
9.15.1.9.3.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4547 
9.15.1.9.3.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4548 
9.15.1.9.3.6.1 TCN1 binds Cbl (Reaction) 4548 
9.15.1.9.3.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4548 
9.15.1.9.3.6.3 GIF binds Cbl (Reaction) 4548 
9.15.1.9.3.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4549 
9.15.1.9.3.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4549 
9.15.1.9.3.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4549 
9.15.1.9.3.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4549 
9.15.1.9.3.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4550 
9.15.1.9.3.6.9 MMACHC reduces Cbl (Reaction) 4550 
9.15.1.9.3.6.10 MMACHC decyanates CNCbl (Reaction) 4550 
9.15.1.9.3.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4550 
9.15.1.9.3.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4551 
9.15.1.9.3.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4551 
9.15.1.9.3.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4551 
9.15.1.9.3.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4551 
9.15.1.9.3.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4552 
9.15.1.9.3.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4552 (BlackBoxEvent) 
9.15.1.9.3.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4552 
9.15.1.9.3.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4553 
9.15.1.9.3.6.20 MMAA:MUT binds AdoCbl (Reaction) 4553 
9.15.1.9.3.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4553 
9.15.1.9.3.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4553 
9.15.1.9.3.6.23 TCII binds Cbl in the circulation (Reaction) 4554 
9.15.1.9.3.6.24 TCN1 binds Cbl in the circulation (Reaction) 4554 
9.15.1.9.3.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4554 
9.15.1.9.3.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4554 
9.15.1.9.3.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4555 
9.15.1.9.3.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4555 
9.15.1.9.3.7 Biotin transport and metabolism (Pathway) 4555 
9.15.1.9.3.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4555 
9.15.1.9.3.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4556 
9.15.1.9.3.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4556 
9.15.1.9.3.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4556 
9.15.1.9.3.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4556 (BlackBoxEvent) 
9.15.1.9.3.7.6 HLCS biotinylates ACACA (Reaction) 4557 
9.15.1.9.3.7.7 HLCS biotinylates ACACB (Reaction) 4557 
9.15.1.9.3.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4557 
9.15.1.9.3.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4557 
9.15.1.9.3.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4558 
9.15.1.9.3.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4558 
9.15.1.9.3.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4558 
9.15.1.9.3.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4558 
9.15.1.9.3.8 Nicotinate metabolism (Pathway) 4559 
9.15.1.9.3.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4559 non-enzymatically to quinolinate (Reaction) 
9.15.1.9.3.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4559 
9.15.1.9.3.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4559 [NMNAT1] (Reaction) 
9.15.1.9.3.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4560 [NMNAT2] (Reaction) 
9.15.1.9.3.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4560 [NMNAT3] (Reaction) 
9.15.1.9.3.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4560 
9.15.1.9.3.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4560 9.15.1.9.3.8.8 Nicotinamide salvaging (Pathway) 4561 
9.15.1.9.3.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4561 
9.15.1.9.3.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4561 (NMN) (Reaction) 
9.15.1.9.3.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4561 mononucleotide (NaMN) (Reaction) 
9.15.1.9.3.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4562 
9.15.1.9.3.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4562 
9.15.1.9.3.9 Metabolism of folate and pterines (Pathway) 4562 
9.15.1.9.3.9.1 Extracellular folate import across the plasma membrane (Reaction) 4562 
9.15.1.9.3.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4563 
9.15.1.9.3.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4563 membrane (Reaction) 
9.15.1.9.3.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4563 
9.15.1.9.3.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4563 
9.15.1.9.3.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4564 
9.15.1.9.3.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4564 5-methylTHF-polyglutamate (Reaction) 
9.15.1.9.3.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4564 membrane (Reaction) 
9.15.1.9.3.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4565 membrane (Reaction) 
9.15.1.9.3.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4565 
9.15.1.9.3.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4565 ADP + orthophosphate (Reaction) 
9.15.1.9.3.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4566 (Reaction) 
9.15.1.9.3.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4566 polyglutamate + NADP+ (Reaction) 
9.15.1.9.3.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4566 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.9.3.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4567 polyglutamate + NADP+ (Reaction) 
9.15.1.9.3.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4567 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.9.3.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4567 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.9.3.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4568 (Reaction) 
9.15.1.9.3.10 Molybdenum cofactor biosynthesis (Pathway) 4568 
9.15.1.9.3.10.1 Cyclisation of GTP to precursor Z (Reaction) 4568 
9.15.1.9.3.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4568 
9.15.1.9.3.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4569 
9.15.1.9.3.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4569 
9.15.1.9.3.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4569 9.15.1.9.3.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4569 
9.15.1.10 Defective MMAB causes methylmalonic aciduria type cblB (Pathway) 4570 
9.15.1.10.1 Defective MMAB does not transfer adenosyl group from ATP to B12s 4571 (BlackBoxEvent) 
9.15.1.10.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4573 
9.15.1.10.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4573 
9.15.1.10.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4573 
9.15.1.10.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol 4573 (Reaction) 
9.15.1.10.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4574 
9.15.1.10.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction)4574 
9.15.1.10.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4574 
9.15.1.10.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4574 
9.15.1.10.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4575 
9.15.1.10.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4575 
9.15.1.10.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4575 
9.15.1.10.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4575 
9.15.1.10.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4576 
9.15.1.10.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4576 
9.15.1.10.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4576 
9.15.1.10.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4576 
9.15.1.10.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4577 
9.15.1.10.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4577 
9.15.1.10.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4577 
9.15.1.10.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol 4577 (Reaction) 
9.15.1.10.2.4.2 Coenzyme A biosynthesis (Pathway) 4578 
9.15.1.10.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4578 
9.15.1.10.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4578 
9.15.1.10.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4578 
9.15.1.10.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4579 
9.15.1.10.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4579 
9.15.1.10.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4579 
9.15.1.10.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4579 (Reaction) 
9.15.1.10.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4580 
9.15.1.10.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4580 
9.15.1.10.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4580 
9.15.1.10.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4580 
9.15.1.10.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4581 
9.15.1.10.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4581 
9.15.1.10.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4581 
9.15.1.10.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4581 
9.15.1.10.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4582 
9.15.1.10.2.6.1 TCN1 binds Cbl (Reaction) 4582 
9.15.1.10.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4582 
9.15.1.10.2.6.3 GIF binds Cbl (Reaction) 4582 
9.15.1.10.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4583 
9.15.1.10.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction)4583 
9.15.1.10.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4583 
9.15.1.10.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4583 
9.15.1.10.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4584 
9.15.1.10.2.6.9 MMACHC reduces Cbl (Reaction) 4584 
9.15.1.10.2.6.10 MMACHC decyanates CNCbl (Reaction) 4584 
9.15.1.10.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4584 
9.15.1.10.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)
4585 
9.15.1.10.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4585 
9.15.1.10.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4585 
9.15.1.10.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4585 
9.15.1.10.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4586 
9.15.1.10.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria
4586 (BlackBoxEvent) 
9.15.1.10.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4586 
9.15.1.10.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)
4587 
9.15.1.10.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4587 
9.15.1.10.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4587 
9.15.1.10.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4587 
9.15.1.10.2.6.23 TCII binds Cbl in the circulation (Reaction) 4588 
9.15.1.10.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4588 
9.15.1.10.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4588 
9.15.1.10.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4588 
9.15.1.10.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4589 
9.15.1.10.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4589 
9.15.1.10.2.7 Biotin transport and metabolism (Pathway) 4589 
9.15.1.10.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4589 
9.15.1.10.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4590 
9.15.1.10.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4590 
9.15.1.10.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4590 
9.15.1.10.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4590 (BlackBoxEvent) 
9.15.1.10.2.7.6 HLCS biotinylates ACACA (Reaction) 4591 
9.15.1.10.2.7.7 HLCS biotinylates ACACB (Reaction) 4591 
9.15.1.10.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4591 
9.15.1.10.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4591 
9.15.1.10.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4592 
9.15.1.10.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4592 
9.15.1.10.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4592 
9.15.1.10.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4592 
9.15.1.10.2.8 Nicotinate metabolism (Pathway) 4593 
9.15.1.10.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms non-enzymatically to quinolinate (Reaction) 
9.15.1.10.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4593 
9.15.1.10.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4593 [NMNAT1] (Reaction) 
9.15.1.10.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4594 [NMNAT2] (Reaction) 
9.15.1.10.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4594 [NMNAT3] (Reaction) 
9.15.1.10.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4594 
9.15.1.10.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4594 
9.15.1.10.2.8.8 Nicotinamide salvaging (Pathway) 4595 
9.15.1.10.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4595 
9.15.1.10.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4595 (NMN) (Reaction) 
9.15.1.10.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4595 mononucleotide (NaMN) (Reaction) 
9.15.1.10.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4596 
9.15.1.10.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4596 
9.15.1.10.2.9 Metabolism of folate and pterines (Pathway) 4596 
9.15.1.10.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4596 
9.15.1.10.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4597 
9.15.1.10.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4597 membrane (Reaction) 
9.15.1.10.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4597 
9.15.1.10.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4597 
9.15.1.10.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4598 
9.15.1.10.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4598 5-methylTHF-polyglutamate (Reaction) 
9.15.1.10.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4598 membrane (Reaction) 
9.15.1.10.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4599 membrane (Reaction) 
9.15.1.10.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4599 
9.15.1.10.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate4599 
+ ADP + orthophosphate (Reaction) 
9.15.1.10.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O
4600 (Reaction) 
9.15.1.10.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4600 polyglutamate + NADP+ (Reaction) 
9.15.1.10.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4600 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.10.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF4601 polyglutamate + NADP+ (Reaction) 
9.15.1.10.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4601 
polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.10.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4601 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.10.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate
4602 (Reaction) 
9.15.1.10.2.10 Molybdenum cofactor biosynthesis (Pathway) 4602 
9.15.1.10.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4602 
9.15.1.10.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4602 
9.15.1.10.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4603 
9.15.1.10.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4603 
9.15.1.10.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4603 
9.15.1.10.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4603 
9.15.1.11 Defective MMAA causes methylmalonic aciduria type cblA (Pathway) 4604 
9.15.1.11.1 Defective MMAA does not protect MUT (BlackBoxEvent) 4605 
9.15.1.11.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4607 
9.15.1.11.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4607 
9.15.1.11.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4608 
9.15.1.11.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol 4608 (Reaction) 
9.15.1.11.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4608 
9.15.1.11.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction)4608 
9.15.1.11.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4609 
9.15.1.11.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4609 
9.15.1.11.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4609 
9.15.1.11.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4609 
9.15.1.11.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4610 
9.15.1.11.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4610 
9.15.1.11.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4610 
9.15.1.11.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4610 
9.15.1.11.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4611 
9.15.1.11.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4611 
9.15.1.11.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4611 
9.15.1.11.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4611 
9.15.1.11.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4612 
9.15.1.11.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol 4612 (Reaction) 
9.15.1.11.2.4.2 Coenzyme A biosynthesis (Pathway) 4612 
9.15.1.11.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4612 
9.15.1.11.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4613 
9.15.1.11.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4613 
9.15.1.11.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4613 
9.15.1.11.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4613 
9.15.1.11.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4614 
9.15.1.11.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4614 (Reaction) 
9.15.1.11.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)9.15.1.11.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4614 
9.15.1.11.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4615 
9.15.1.11.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4615 
9.15.1.11.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4615 
9.15.1.11.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4615 
9.15.1.11.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4616 
9.15.1.11.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4616 
9.15.1.11.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4616 
9.15.1.11.2.6.1 TCN1 binds Cbl (Reaction) 4616 
9.15.1.11.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4617 
9.15.1.11.2.6.3 GIF binds Cbl (Reaction) 4617 
9.15.1.11.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4617 
9.15.1.11.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction)4617 
9.15.1.11.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4618 
9.15.1.11.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4618 
9.15.1.11.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4618 
9.15.1.11.2.6.9 MMACHC reduces Cbl (Reaction) 4618 
9.15.1.11.2.6.10 MMACHC decyanates CNCbl (Reaction) 4619 
9.15.1.11.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4619 
9.15.1.11.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)
4619 
9.15.1.11.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4619 
9.15.1.11.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4620 
9.15.1.11.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4620 
9.15.1.11.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4620 
9.15.1.11.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria
4620 (BlackBoxEvent) 
9.15.1.11.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4621 
9.15.1.11.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)
4621 
9.15.1.11.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4621 
9.15.1.11.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4621 
9.15.1.11.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4622 
9.15.1.11.2.6.23 TCII binds Cbl in the circulation (Reaction) 4622 
9.15.1.11.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4622 
9.15.1.11.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4622 
9.15.1.11.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4623 
9.15.1.11.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4623 
9.15.1.11.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4623 
9.15.1.11.2.7 Biotin transport and metabolism (Pathway) 4623 
9.15.1.11.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4624 
9.15.1.11.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4624 
9.15.1.11.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4624 
9.15.1.11.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4624 
9.15.1.11.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4625 (BlackBoxEvent) 
9.15.1.11.2.7.6 HLCS biotinylates ACACA (Reaction) 
9.15.1.11.2.7.7 HLCS biotinylates ACACB (Reaction) 4625 
9.15.1.11.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4625 
9.15.1.11.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4626 
9.15.1.11.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4626 
9.15.1.11.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4626 
9.15.1.11.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4626 
9.15.1.11.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4627 
9.15.1.11.2.8 Nicotinate metabolism (Pathway) 4627 
9.15.1.11.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4627 non-enzymatically to quinolinate (Reaction) 
9.15.1.11.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4627 
9.15.1.11.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4628 [NMNAT1] (Reaction) 
9.15.1.11.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4628 [NMNAT2] (Reaction) 
9.15.1.11.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4628 [NMNAT3] (Reaction) 
9.15.1.11.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4629 
9.15.1.11.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4629 
9.15.1.11.2.8.8 Nicotinamide salvaging (Pathway) 4629 
9.15.1.11.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4629 
9.15.1.11.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4630 (NMN) (Reaction) 
9.15.1.11.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4630 mononucleotide (NaMN) (Reaction) 
9.15.1.11.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4630 
9.15.1.11.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4630 
9.15.1.11.2.9 Metabolism of folate and pterines (Pathway) 4631 
9.15.1.11.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4631 
9.15.1.11.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4631 
9.15.1.11.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4631 membrane (Reaction) 
9.15.1.11.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4632 
9.15.1.11.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4632 
9.15.1.11.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4632 
9.15.1.11.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4632 5-methylTHF-polyglutamate (Reaction) 
9.15.1.11.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4633 membrane (Reaction) 
9.15.1.11.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4633 membrane (Reaction) 
9.15.1.11.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4633 
9.15.1.11.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate4634 
+ ADP + orthophosphate (Reaction) 
9.15.1.11.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O 
(Reaction) 
9.15.1.11.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4634 polyglutamate + NADP+ (Reaction) 
9.15.1.11.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4635 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.11.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF4635 polyglutamate + NADP+ (Reaction) 
9.15.1.11.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4635 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.11.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4636 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.11.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate
4636 (Reaction) 
9.15.1.11.2.10 Molybdenum cofactor biosynthesis (Pathway) 4636 
9.15.1.11.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4636 
9.15.1.11.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4637 
9.15.1.11.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4637 
9.15.1.11.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4637 
9.15.1.11.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4637 
9.15.1.11.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4638 
9.15.1.12 Defective MUT causes methylmalonic aciduria mut type (Pathway) 4638 
9.15.1.12.1 Defective MUT does not isomerise L-MM-CoA to SUCC-CoA 4639 (BlackBoxEvent) 
9.15.1.12.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4642 
9.15.1.12.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4642 
9.15.1.12.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4642 
9.15.1.12.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol 4643 (Reaction) 
9.15.1.12.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4643 
9.15.1.12.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction)4643 
9.15.1.12.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4643 
9.15.1.12.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4644 
9.15.1.12.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4644 
9.15.1.12.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4644 
9.15.1.12.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4644 
9.15.1.12.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4645 
9.15.1.12.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4645 
9.15.1.12.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4645 
9.15.1.12.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4645 
9.15.1.12.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4646 
9.15.1.12.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4646 
9.15.1.12.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4646 
9.15.1.12.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4646 
9.15.1.12.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol 4647 (Reaction) 4634 
9.15.1.12.2.4.2 Coenzyme A biosynthesis (Pathway) 4647 
9.15.1.12.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4647 
9.15.1.12.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4647 
9.15.1.12.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4648 
9.15.1.12.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4648 
9.15.1.12.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)
4648 
9.15.1.12.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4648 
9.15.1.12.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4649 (Reaction) 
9.15.1.12.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4649 
9.15.1.12.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4649 
9.15.1.12.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4649 
9.15.1.12.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4650 
9.15.1.12.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4650 
9.15.1.12.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4650 
9.15.1.12.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4650 
9.15.1.12.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4651 
9.15.1.12.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4651 
9.15.1.12.2.6.1 TCN1 binds Cbl (Reaction) 4651 
9.15.1.12.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4651 
9.15.1.12.2.6.3 GIF binds Cbl (Reaction) 4652 
9.15.1.12.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4652 
9.15.1.12.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction)4652 
9.15.1.12.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4652 
9.15.1.12.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4653 
9.15.1.12.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4653 
9.15.1.12.2.6.9 MMACHC reduces Cbl (Reaction) 4653 
9.15.1.12.2.6.10 MMACHC decyanates CNCbl (Reaction) 4653 
9.15.1.12.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4654 
9.15.1.12.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)
4654 
9.15.1.12.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4654 
9.15.1.12.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4654 
9.15.1.12.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4655 
9.15.1.12.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4655 
9.15.1.12.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria
4655 (BlackBoxEvent) 
9.15.1.12.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4656 
9.15.1.12.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)
4656 
9.15.1.12.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4656 
9.15.1.12.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4656 
9.15.1.12.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4657 
9.15.1.12.2.6.23 TCII binds Cbl in the circulation (Reaction) 4657 
9.15.1.12.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4657 
9.15.1.12.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4657 
9.15.1.12.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4658 
9.15.1.12.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4658 
9.15.1.12.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4658 
9.15.1.12.2.7 Biotin transport and metabolism (Pathway) 4658 
9.15.1.12.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4659 
9.15.1.12.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4659 
9.15.1.12.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4659 
9.15.1.12.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4659 
9.15.1.12.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4660 (BlackBoxEvent) 
9.15.1.12.2.7.6 HLCS biotinylates ACACA (Reaction) 4660 
9.15.1.12.2.7.7 HLCS biotinylates ACACB (Reaction) 4660 
9.15.1.12.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4660 
9.15.1.12.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4661 
9.15.1.12.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4661 
9.15.1.12.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4661 
9.15.1.12.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4661 
9.15.1.12.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4662 

9.15.1.12.2.8 Nicotinate metabolism (Pathway) 4662 
9.15.1.12.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4662 non-enzymatically to quinolinate (Reaction) 
9.15.1.12.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4662 
9.15.1.12.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4663 [NMNAT1] (Reaction) 
9.15.1.12.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4663 [NMNAT2] (Reaction) 
9.15.1.12.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4663 [NMNAT3] (Reaction) 
9.15.1.12.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4664 
9.15.1.12.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4664 
9.15.1.12.2.8.8 Nicotinamide salvaging (Pathway) 4664 
9.15.1.12.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4664 
9.15.1.12.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4665 (NMN) (Reaction) 
9.15.1.12.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4665 mononucleotide (NaMN) (Reaction) 
9.15.1.12.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4665 
9.15.1.12.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4665 
9.15.1.12.2.9 Metabolism of folate and pterines (Pathway) 4666 
9.15.1.12.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4666 
9.15.1.12.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4666 
9.15.1.12.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4666 membrane (Reaction) 
9.15.1.12.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4667 
9.15.1.12.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4667 
9.15.1.12.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4667 9.15.1.12.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4667 5-methylTHF-polyglutamate (Reaction) 
9.15.1.12.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4668 membrane (Reaction) 
9.15.1.12.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4668 membrane (Reaction) 
9.15.1.12.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4668 
9.15.1.12.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate4669 
+ ADP + orthophosphate (Reaction) 
9.15.1.12.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O
4669 (Reaction) 
9.15.1.12.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4669 polyglutamate + NADP+ (Reaction) 
9.15.1.12.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4670 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.12.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF4670 polyglutamate + NADP+ (Reaction) 
9.15.1.12.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4670 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.12.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4671 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.12.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate
4671 (Reaction) 
9.15.1.12.2.10 Molybdenum cofactor biosynthesis (Pathway) 4671 
9.15.1.12.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4671 
9.15.1.12.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4672 
9.15.1.12.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4672 
9.15.1.12.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4672 
9.15.1.12.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4672 
9.15.1.12.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4673 
9.15.1.13 Defective CD320 causes methylmalonic aciduria (Pathway) 4673 
9.15.1.13.1 Defective CD320 does not transport extracellular TCII:Cbl to endosome 4674 (BlackBoxEvent) 
9.15.1.13.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4676 
9.15.1.13.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4676 
9.15.1.13.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4676 
9.15.1.13.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol 4677 (Reaction) 
9.15.1.13.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4677 
9.15.1.13.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction)4677 
9.15.1.13.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4677 
9.15.1.13.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4678 
9.15.1.13.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4678 
9.15.1.13.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4678 
9.15.1.13.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4678 
9.15.1.13.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4679 
9.15.1.13.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4679 
9.15.1.13.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4679 
9.15.1.13.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4679 
9.15.1.13.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4680 
9.15.1.13.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4680 
9.15.1.13.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4680 
9.15.1.13.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4680 
9.15.1.13.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol 4681 (Reaction) 
9.15.1.13.2.4.2 Coenzyme A biosynthesis (Pathway) 4681 
9.15.1.13.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4681 
9.15.1.13.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4681 
9.15.1.13.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4682 
9.15.1.13.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4682 
9.15.1.13.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)
4682 
9.15.1.13.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4682 
9.15.1.13.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4683 (Reaction) 
9.15.1.13.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4683 
9.15.1.13.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4683 
9.15.1.13.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4683 
9.15.1.13.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4684 
9.15.1.13.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4684 
9.15.1.13.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4684 
9.15.1.13.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4684 
9.15.1.13.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4685 
9.15.1.13.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4685 
9.15.1.13.2.6.1 TCN1 binds Cbl (Reaction) 4685 
9.15.1.13.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4685 
9.15.1.13.2.6.3 GIF binds Cbl (Reaction) 4686 
9.15.1.13.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4686 
9.15.1.13.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction)4686 
9.15.1.13.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4686 
9.15.1.13.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4687 
9.15.1.13.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4687 
9.15.1.13.2.6.9 MMACHC reduces Cbl (Reaction) 4687 
9.15.1.13.2.6.10 MMACHC decyanates CNCbl (Reaction) 4687 
9.15.1.13.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4688 
9.15.1.13.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)
4688 
9.15.1.13.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4688 
9.15.1.13.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4688 
9.15.1.13.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4689 
9.15.1.13.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4689 
9.15.1.13.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria 
(BlackBoxEvent) 
9.15.1.13.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4690 
9.15.1.13.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)
4690 
9.15.1.13.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4690 
9.15.1.13.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4690 
9.15.1.13.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4691 
9.15.1.13.2.6.23 TCII binds Cbl in the circulation (Reaction) 4691 
9.15.1.13.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4691 
9.15.1.13.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4691 
9.15.1.13.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4692 
9.15.1.13.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4692 
9.15.1.13.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4692 
9.15.1.13.2.7 Biotin transport and metabolism (Pathway) 4692 
9.15.1.13.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4693 
9.15.1.13.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4693 
9.15.1.13.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4693 
9.15.1.13.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4693 
9.15.1.13.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4694 (BlackBoxEvent) 
9.15.1.13.2.7.6 HLCS biotinylates ACACA (Reaction) 4694 
9.15.1.13.2.7.7 HLCS biotinylates ACACB (Reaction) 4694 
9.15.1.13.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4694 
9.15.1.13.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4695 
9.15.1.13.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4695 
9.15.1.13.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4695 
9.15.1.13.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4695 
9.15.1.13.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4696 
9.15.1.13.2.8 Nicotinate metabolism (Pathway) 4696 
9.15.1.13.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4696 non-enzymatically to quinolinate (Reaction) 
9.15.1.13.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4696 
9.15.1.13.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4697 [NMNAT1] (Reaction) 
9.15.1.13.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4697 [NMNAT2] (Reaction) 
9.15.1.13.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate
4697 [NMNAT3] (Reaction) 
9.15.1.13.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4698 
9.15.1.13.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4698 
9.15.1.13.2.8.8 Nicotinamide salvaging (Pathway) 4698 
9.15.1.13.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4698 
9.15.1.13.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4699 (NMN) (Reaction) 
9.15.1.13.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4699 mononucleotide (NaMN) (Reaction) 4689 9.15.1.13.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4699 
9.15.1.13.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4699 
9.15.1.13.2.9 Metabolism of folate and pterines (Pathway) 4700 
9.15.1.13.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4700 
9.15.1.13.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4700 
9.15.1.13.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4700 membrane (Reaction) 
9.15.1.13.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4701 
9.15.1.13.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4701 
9.15.1.13.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4701 
9.15.1.13.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4701 5-methylTHF-polyglutamate (Reaction) 
9.15.1.13.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4702 membrane (Reaction) 
9.15.1.13.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4702 membrane (Reaction) 
9.15.1.13.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4702 
9.15.1.13.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate4703 
+ ADP + orthophosphate (Reaction) 
9.15.1.13.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O
4703 (Reaction) 
9.15.1.13.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4703 polyglutamate + NADP+ (Reaction) 
9.15.1.13.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4704 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.1.13.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF4704 polyglutamate + NADP+ (Reaction) 
9.15.1.13.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4704 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.1.13.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4705 polyglutamate + NADPH + H+ (Reaction) 
9.15.1.13.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate
4705 (Reaction) 
9.15.1.13.2.10 Molybdenum cofactor biosynthesis (Pathway) 4705 
9.15.1.13.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4705 
9.15.1.13.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4706 
9.15.1.13.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4706 
9.15.1.13.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4706 
9.15.1.13.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4706 
9.15.1.13.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4707 
9.15.2 Defects in biotin (Btn) metabolism (Pathway) 4707 
9.15.2.1 Defective HLCS causes multiple carboxylase deficiency (Pathway) 4708 
9.15.2.1.1 Defective HLCS does not biotinylate apo-CBXs (BlackBoxEvent) 4710 
9.15.2.1.2 Metabolism of water-soluble vitamins and cofactors (Pathway) 4715 
9.15.2.1.2.1 Vitamin C (ascorbate) metabolism (Pathway) 4715 
9.15.2.1.2.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4715 
9.15.2.1.2.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)
4715 
9.15.2.1.2.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4716 
9.15.2.1.2.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4716 
9.15.2.1.2.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4716 
9.15.2.1.2.2 Vitamin B1 (thiamin) metabolism (Pathway) 4716 
9.15.2.1.2.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4717 
9.15.2.1.2.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4717 
9.15.2.1.2.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4717 
9.15.2.1.2.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4717 
9.15.2.1.2.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4718 
9.15.2.1.2.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4718 
9.15.2.1.2.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4718 
9.15.2.1.2.3.3 FLAD1 phosphorylates FMN (Reaction) 4718 
9.15.2.1.2.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4719 
9.15.2.1.2.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4719 
9.15.2.1.2.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4719 
9.15.2.1.2.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4719 
9.15.2.1.2.4.2 Coenzyme A biosynthesis (Pathway) 4720 
9.15.2.1.2.4.2.1 PANK2 phosphorylates PanK (Reaction) 4720 
9.15.2.1.2.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4720 
9.15.2.1.2.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4720 
9.15.2.1.2.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4721 
9.15.2.1.2.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4721 
9.15.2.1.2.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4721 
9.15.2.1.2.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4721 (Reaction) 
9.15.2.1.2.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4722 
9.15.2.1.2.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4722 
9.15.2.1.2.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4722 
9.15.2.1.2.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4722 
9.15.2.1.2.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4723 
9.15.2.1.2.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4723 
9.15.2.1.2.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4723 
9.15.2.1.2.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4723 
9.15.2.1.2.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4724 
9.15.2.1.2.6.1 TCN1 binds Cbl (Reaction) 4724 
9.15.2.1.2.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4724 
9.15.2.1.2.6.3 GIF binds Cbl (Reaction) 4724 
9.15.2.1.2.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4725 
9.15.2.1.2.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4725 
9.15.2.1.2.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4725 
9.15.2.1.2.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4725 
9.15.2.1.2.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4726 
9.15.2.1.2.6.9 MMACHC reduces Cbl (Reaction) 4726 9.15.2.1.2.6.10 MMACHC decyanates CNCbl (Reaction) 4726 
9.15.2.1.2.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4726 
9.15.2.1.2.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4727 
9.15.2.1.2.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4727 
9.15.2.1.2.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4727 
9.15.2.1.2.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4727 
9.15.2.1.2.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4728 
9.15.2.1.2.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4728 (BlackBoxEvent) 
9.15.2.1.2.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4728 
9.15.2.1.2.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4729 
9.15.2.1.2.6.20 MMAA:MUT binds AdoCbl (Reaction) 4729 
9.15.2.1.2.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4729 
9.15.2.1.2.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4729 
9.15.2.1.2.6.23 TCII binds Cbl in the circulation (Reaction) 4730 
9.15.2.1.2.6.24 TCN1 binds Cbl in the circulation (Reaction) 4730 
9.15.2.1.2.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4730 
9.15.2.1.2.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4730 
9.15.2.1.2.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4731 
9.15.2.1.2.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4731 
9.15.2.1.2.7 Biotin transport and metabolism (Pathway) 4731 
9.15.2.1.2.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4731 
9.15.2.1.2.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4732 
9.15.2.1.2.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4732 
9.15.2.1.2.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4732 
9.15.2.1.2.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4732 (BlackBoxEvent) 
9.15.2.1.2.7.6 HLCS biotinylates ACACA (Reaction) 4733 
9.15.2.1.2.7.7 HLCS biotinylates ACACB (Reaction) 4733 
9.15.2.1.2.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4733 
9.15.2.1.2.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4733 
9.15.2.1.2.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4734 
9.15.2.1.2.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4734 
9.15.2.1.2.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4734 
9.15.2.1.2.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4734 
9.15.2.1.2.8 Nicotinate metabolism (Pathway) 4735 
9.15.2.1.2.8.1 2-amino 3-carboxymuconate semialdehyde transforms 4735 non-enzymatically to quinolinate (Reaction) 
9.15.2.1.2.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4735 
9.15.2.1.2.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4735 [NMNAT1] (Reaction) 
9.15.2.1.2.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4736 [NMNAT2] (Reaction) 
9.15.2.1.2.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4736 
[NMNAT3] (Reaction) 
9.15.2.1.2.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4736 
9.15.2.1.2.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4736 
9.15.2.1.2.8.8 Nicotinamide salvaging (Pathway) 4737 
9.15.2.1.2.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4737 
9.15.2.1.2.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4737 (NMN) (Reaction) 
9.15.2.1.2.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4737 mononucleotide (NaMN) (Reaction) 
9.15.2.1.2.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4738 
9.15.2.1.2.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4738 
9.15.2.1.2.9 Metabolism of folate and pterines (Pathway) 4738 
9.15.2.1.2.9.1 Extracellular folate import across the plasma membrane (Reaction) 4738 
9.15.2.1.2.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4739 
9.15.2.1.2.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4739 membrane (Reaction) 
9.15.2.1.2.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4739 
9.15.2.1.2.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4739 
9.15.2.1.2.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4740 
9.15.2.1.2.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4740 5-methylTHF-polyglutamate (Reaction) 
9.15.2.1.2.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4740 membrane (Reaction) 
9.15.2.1.2.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4741 membrane (Reaction) 
9.15.2.1.2.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4741 
9.15.2.1.2.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4741 ADP + orthophosphate (Reaction) 
9.15.2.1.2.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4742 (Reaction) 
9.15.2.1.2.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4742 polyglutamate + NADP+ (Reaction) 
9.15.2.1.2.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4742 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.2.1.2.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4743 polyglutamate + NADP+ (Reaction) 
9.15.2.1.2.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4743 polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.2.1.2.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4743 polyglutamate + NADPH + H+ (Reaction) 
9.15.2.1.2.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4744 (Reaction) 
9.15.2.1.2.10 Molybdenum cofactor biosynthesis (Pathway) 4744 
9.15.2.1.2.10.1 Cyclisation of GTP to precursor Z (Reaction) 4744 
9.15.2.1.2.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4744 
9.15.2.1.2.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4745 9.15.2.1.2.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4745 
9.15.2.1.2.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4745 
9.15.2.1.2.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4745 
9.15.2.2 Defective BTD causes biotidinase deficiency (Pathway) 4746 
9.15.2.2.1 Defective extracellular BTD does not hydrolyse BCTN (BlackBoxEvent) 4747 
9.15.2.2.2 Defective mitochondrial BTD does not hydrolyse BCTN (BlackBoxEvent) 4749 
9.15.2.2.3 Metabolism of water-soluble vitamins and cofactors (Pathway) 4751 
9.15.2.2.3.1 Vitamin C (ascorbate) metabolism (Pathway) 4752 
9.15.2.2.3.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 4752 
9.15.2.2.3.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction)4752 
9.15.2.2.3.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 4752 
9.15.2.2.3.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 4753 
9.15.2.2.3.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 4753 
9.15.2.2.3.2 Vitamin B1 (thiamin) metabolism (Pathway) 4753 
9.15.2.2.3.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 4753 
9.15.2.2.3.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 4754 
9.15.2.2.3.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 4754 
9.15.2.2.3.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 4754 
9.15.2.2.3.3 Vitamin B2 (riboflavin) metabolism (Pathway) 4754 
9.15.2.2.3.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 4755 
9.15.2.2.3.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 4755 
9.15.2.2.3.3.3 FLAD1 phosphorylates FMN (Reaction) 4755 
9.15.2.2.3.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 4755 
9.15.2.2.3.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 4756 
9.15.2.2.3.4 Vitamin B5 (pantothenate) metabolism (Pathway) 4756 
9.15.2.2.3.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction)
4756 
9.15.2.2.3.4.2 Coenzyme A biosynthesis (Pathway) 4756 
9.15.2.2.3.4.2.1 PANK2 phosphorylates PanK (Reaction) 4757 
9.15.2.2.3.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 4757 
9.15.2.2.3.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 4757 
9.15.2.2.3.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 4757 
9.15.2.2.3.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction)4758 
9.15.2.2.3.4.2.6 COASY phosphorylates DP-CoA (Reaction) 4758 
9.15.2.2.3.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix 4758 (Reaction) 
9.15.2.2.3.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction)
4759 
9.15.2.2.3.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 4759 
9.15.2.2.3.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 4759 
9.15.2.2.3.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 4759 
9.15.2.2.3.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 4760 
9.15.2.2.3.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 4760 
9.15.2.2.3.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 4760 
9.15.2.2.3.5.6 AOX1 oxidises PXL to PDXate (Reaction) 4760 
9.15.2.2.3.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 4761 
9.15.2.2.3.6.1 TCN1 binds Cbl (Reaction) 4761 
9.15.2.2.3.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 4761 
9.15.2.2.3.6.3 GIF binds Cbl (Reaction) 4761 
9.15.2.2.3.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 4762 
9.15.2.2.3.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 4762 
9.15.2.2.3.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 4762 
9.15.2.2.3.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 4762 
9.15.2.2.3.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 4763 
9.15.2.2.3.6.9 MMACHC reduces Cbl (Reaction) 4763 
9.15.2.2.3.6.10 MMACHC decyanates CNCbl (Reaction) 4763 
9.15.2.2.3.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 4763 
9.15.2.2.3.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent)4764 
9.15.2.2.3.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 4764 
9.15.2.2.3.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 4764 
9.15.2.2.3.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 4764 
9.15.2.2.3.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 4765 
9.15.2.2.3.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria4765 (BlackBoxEvent) 
9.15.2.2.3.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction)4765 
9.15.2.2.3.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction)4766 
9.15.2.2.3.6.20 MMAA:MUT binds AdoCbl (Reaction) 4766 
9.15.2.2.3.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 4766 
9.15.2.2.3.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 4766 
9.15.2.2.3.6.23 TCII binds Cbl in the circulation (Reaction) 4767 
9.15.2.2.3.6.24 TCN1 binds Cbl in the circulation (Reaction) 4767 
9.15.2.2.3.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 4767 
9.15.2.2.3.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 4767 
9.15.2.2.3.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 4768 
9.15.2.2.3.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 4768 
9.15.2.2.3.7 Biotin transport and metabolism (Pathway) 4768 
9.15.2.2.3.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction)
4768 
9.15.2.2.3.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 4769 
9.15.2.2.3.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 4769 
9.15.2.2.3.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 4769 
9.15.2.2.3.7.5 Cytoslic carboxylases translocate to mitochondrial matrix 4769 (BlackBoxEvent) 
9.15.2.2.3.7.6 HLCS biotinylates ACACA (Reaction) 4770 
9.15.2.2.3.7.7 HLCS biotinylates ACACB (Reaction) 4770 
9.15.2.2.3.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 4770 
9.15.2.2.3.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 4770 
9.15.2.2.3.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 4771 
9.15.2.2.3.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 4771 
9.15.2.2.3.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 4771 
9.15.2.2.3.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 4771 
9.15.2.2.3.8 Nicotinate metabolism (Pathway) 4772 
9.15.2.2.3.8.1 2-amino 3-carboxymuconate semialdehyde transforms non-enzymatically to quinolinate (Reaction) 
9.15.2.2.3.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 4772 
9.15.2.2.3.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4772 [NMNAT1] (Reaction) 
9.15.2.2.3.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4773 [NMNAT2] (Reaction) 
9.15.2.2.3.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate4773 [NMNAT3] (Reaction) 
9.15.2.2.3.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 4773 
9.15.2.2.3.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 4773 
9.15.2.2.3.8.8 Nicotinamide salvaging (Pathway) 4774 
9.15.2.2.3.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 4774 
9.15.2.2.3.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide 4774 (NMN) (Reaction) 
9.15.2.2.3.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 4774 mononucleotide (NaMN) (Reaction) 
9.15.2.2.3.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 4775 
9.15.2.2.3.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 4775 
9.15.2.2.3.9 Metabolism of folate and pterines (Pathway) 4775 
9.15.2.2.3.9.1 Extracellular folate import across the plasma membrane (Reaction) 4775 
9.15.2.2.3.9.2 Cytosolic folate export across the plasma membrane (Reaction) 4776 
9.15.2.2.3.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma 4776 membrane (Reaction) 
9.15.2.2.3.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 4776 
9.15.2.2.3.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 4776 
9.15.2.2.3.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 4777 
9.15.2.2.3.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 4777 5-methylTHF-polyglutamate (Reaction) 
9.15.2.2.3.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial 4777 membrane (Reaction) 
9.15.2.2.3.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial 4778 membrane (Reaction) 
9.15.2.2.3.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 4778 
9.15.2.2.3.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate +
4778 ADP + orthophosphate (Reaction) 
9.15.2.2.3.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O4779 (Reaction) 
9.15.2.2.3.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF
4779 polyglutamate + NADP+ (Reaction) 
9.15.2.2.3.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 4779 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
9.15.2.2.3.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 4780 polyglutamate + NADP+ (Reaction) 
9.15.2.2.3.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate 4780 
polyglutamate (THF polyglutamate) + serine (Reaction) 
9.15.2.2.3.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 4780 polyglutamate + NADPH + H+ (Reaction) 
9.15.2.2.3.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate4781 
(Reaction) 
9.15.2.2.3.10 Molybdenum cofactor biosynthesis (Pathway) 4781 
9.15.2.2.3.10.1 Cyclisation of GTP to precursor Z (Reaction) 4781 
9.15.2.2.3.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 4781 
9.15.2.2.3.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 4782 
9.15.2.2.3.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 4782 
9.15.2.2.3.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 4782 
9.15.2.2.3.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 4782 
9.16 Signaling by TGF-beta Receptor Complex in Cancer (Pathway) 4783 
9.16.1 Loss of Function of SMAD4 in Cancer (Pathway) 4786 
9.16.1.1 SMAD4 MH2 Domain Mutants in Cancer (Pathway) 4788 
9.16.1.1.1 SMAD4 MH2 Domain Mutants do not bind phosphorylated SMAD2 and 4789 SMAD3 (BlackBoxEvent) 
9.16.1.1.2 Signaling by TGF-beta Receptor Complex (Pathway) 4791 
9.16.1.1.2.1 TGF-beta receptor signaling activates SMADs (Pathway) 4795 
9.16.1.1.2.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 4798 
9.16.1.1.2.1.2 Secretion and activation of the latent large complex of TGF-beta-1 4800 (Reaction) 
9.16.1.1.2.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 4801 
9.16.1.1.2.1.4 TGFBR2 recruits TGFBR1 (Reaction) 4803 
9.16.1.1.2.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 4804 
9.16.1.1.2.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 4806 
9.16.1.1.2.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)4807 
9.16.1.1.2.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 4808 
9.16.1.1.2.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 4810 (Reaction) 
9.16.1.1.2.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 4810 
9.16.1.1.2.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 4814 (Reaction) 
9.16.1.1.2.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 4815 (Reaction) 
9.16.1.1.2.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 4817 complex with SMAD7 (Reaction) 
9.16.1.1.2.1.10.4 BAMBI interferes with the interaction of type I receptor with type II4818 receptor (Reaction) 
9.16.1.1.2.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)4820 
9.16.1.1.2.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 4821 
9.16.1.1.2.1.10.7 SMAD7 binds to SMURF2 (Reaction) 4823 
9.16.1.1.2.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 4825 
9.16.1.1.2.1.10.9 SMAD7 binds to SMURF1 (Reaction) 4826 
9.16.1.1.2.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 4828 
9.16.1.1.2.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 4830 9.16.1.1.2.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 
9.16.1.1.2.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)4834 
9.16.1.1.2.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 4836 (Reaction) 
9.16.1.1.2.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 4839 SMAD7 (Reaction) 
9.16.1.1.2.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 4841 
9.16.1.1.2.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 4843 (Reaction) 
9.16.1.1.2.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 4845 
9.16.1.1.2.1.10.19 SMURF2 binds SMAD2 (Reaction) 4847 
9.16.1.1.2.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 4848 
9.16.1.1.2.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 4849 
9.16.1.1.2.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 4850 
9.16.1.1.2.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 4852 
9.16.1.1.2.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 4853 
9.16.1.1.2.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 4854 
9.16.1.1.2.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 4856 
9.16.1.1.2.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 4857 
9.16.1.1.2.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 4858 
9.16.1.1.2.1.11 CBL binds TGFBR2 (Reaction) 4859 
9.16.1.1.2.1.12 CBL neddylates TGFBR2 (Reaction) 4861 
9.16.1.1.2.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)4862 (Pathway) 
9.16.1.1.2.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 4863 
9.16.1.1.2.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 4865 (Reaction) 
9.16.1.1.2.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 4867 
9.16.1.1.2.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 4869 
9.16.1.1.2.2.5 SMURF1 ubiquitinates RHOA (Reaction) 4870 
9.16.1.1.2.2.6 Disassembly of tight junctions (BlackBoxEvent) 4871 
9.16.1.1.2.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)4872 
9.16.1.1.2.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)4874 
9.16.1.1.2.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD44876 (Reaction) 
9.16.1.1.2.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)4876 
9.16.1.1.2.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or4877 CDK9 (Reaction) 
9.16.1.1.2.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4879 
9.16.1.1.2.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 4880 
9.16.1.1.2.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)4881 
9.16.1.1.2.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 4882 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.1.1.2.3.1.8 RNF111 binds SMAD7 (Reaction) 4884 
9.16.1.1.2.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 
9.16.1.1.2.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 4887 
9.16.1.1.2.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
4888 and DP1/2 (Reaction) 
9.16.1.1.2.3.1.12 MYC trancscription is negatively regulated by 4889 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
9.16.1.1.2.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 4891 
9.16.1.1.2.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
4892 (BlackBoxEvent) 
9.16.1.1.2.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4893 
9.16.1.1.2.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription4895 (BlackBoxEvent) 
9.16.1.1.2.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)4896 
9.16.1.1.2.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 4899 (Reaction) 
9.16.1.1.2.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 4900 SKI/SKIL (Reaction) 
9.16.1.1.2.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 4902 
9.16.1.1.2.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 4904 
9.16.1.1.2.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 4906 (Reaction) 
9.16.1.1.2.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 4907 
9.16.1.1.2.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 4909 (Reaction) 
9.16.1.1.2.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 4911 
9.16.1.1.2.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 4912 
9.16.1.1.2.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)4914 
9.16.1.1.2.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 4915 
9.16.1.1.2.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 4916 
9.16.1.1.2.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 4917 (Reaction) 
9.16.1.1.2.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 4918 
9.16.1.1.2.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)4920 
9.16.1.1.2.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4921 
9.16.1.1.2.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 4922 
9.16.1.1.2.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 4923 (Reaction) 
9.16.1.1.2.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 4924 
9.16.1.1.2.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)4926 
9.16.1.1.2.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates4927 TGF-beta signaling (BlackBoxEvent) 
9.16.2 Loss of Function of SMAD2/3 in Cancer (Pathway) 4929 
9.16.2.1 SMAD2/3 Phosphorylation Motif Mutants in Cancer (Pathway) 4930 
9.16.2.1.1 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 phosphorylation 4932 motif mutants (Reaction) 
9.16.2.1.2 Activated TGFBR1 cannot phosphorylate SMAD2 and SMAD3 
Phosphorylation Motif Mutants (BlackBoxEvent) 
9.16.2.1.3 Signaling by TGF-beta Receptor Complex (Pathway) 4935 
9.16.2.1.3.1 TGF-beta receptor signaling activates SMADs (Pathway) 4936 
9.16.2.1.3.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 4936 
9.16.2.1.3.1.2 Secretion and activation of the latent large complex of TGF-beta-1 4936 (Reaction) 
9.16.2.1.3.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 4936 
9.16.2.1.3.1.4 TGFBR2 recruits TGFBR1 (Reaction) 4937 
9.16.2.1.3.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 4937 
9.16.2.1.3.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 4937 
9.16.2.1.3.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)4937 
9.16.2.1.3.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 4938 
9.16.2.1.3.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 4938 (Reaction) 
9.16.2.1.3.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 4938 
9.16.2.1.3.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 4938 (Reaction) 
9.16.2.1.3.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 4939 (Reaction) 
9.16.2.1.3.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 4939 complex with SMAD7 (Reaction) 
9.16.2.1.3.1.10.4 BAMBI interferes with the interaction of type I receptor with type II4939 receptor (Reaction) 
9.16.2.1.3.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)4940 
9.16.2.1.3.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 4940 
9.16.2.1.3.1.10.7 SMAD7 binds to SMURF2 (Reaction) 4940 
9.16.2.1.3.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 4940 
9.16.2.1.3.1.10.9 SMAD7 binds to SMURF1 (Reaction) 4941 
9.16.2.1.3.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 4941 
9.16.2.1.3.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 4941 
9.16.2.1.3.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 4941 
9.16.2.1.3.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)4942 
9.16.2.1.3.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 4942 (Reaction) 
9.16.2.1.3.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 4942 SMAD7 (Reaction) 
9.16.2.1.3.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 4943 
9.16.2.1.3.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 4943 (Reaction) 
9.16.2.1.3.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 4943 
9.16.2.1.3.1.10.19 SMURF2 binds SMAD2 (Reaction) 4944 
9.16.2.1.3.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 4944 
9.16.2.1.3.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 4944 
9.16.2.1.3.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 4944 
9.16.2.1.3.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 4934
4945 
9.16.2.1.3.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 4945 
9.16.2.1.3.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 4945 
9.16.2.1.3.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 4945 
9.16.2.1.3.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 4946 
9.16.2.1.3.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 4946 
9.16.2.1.3.1.11 CBL binds TGFBR2 (Reaction) 4946 
9.16.2.1.3.1.12 CBL neddylates TGFBR2 (Reaction) 4946 
9.16.2.1.3.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)4947 (Pathway) 
9.16.2.1.3.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 4947 
9.16.2.1.3.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 4947 (Reaction) 
9.16.2.1.3.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 4947 
9.16.2.1.3.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 4948 
9.16.2.1.3.2.5 SMURF1 ubiquitinates RHOA (Reaction) 4948 
9.16.2.1.3.2.6 Disassembly of tight junctions (BlackBoxEvent) 4948 
9.16.2.1.3.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)4948 
9.16.2.1.3.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)4949 
9.16.2.1.3.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD44949 (Reaction) 
9.16.2.1.3.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)4949 
9.16.2.1.3.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or4950 CDK9 (Reaction) 
9.16.2.1.3.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4950 
9.16.2.1.3.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 4950 
9.16.2.1.3.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)4950 
9.16.2.1.3.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 4951 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.2.1.3.3.1.8 RNF111 binds SMAD7 (Reaction) 4951 
9.16.2.1.3.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 4951 
9.16.2.1.3.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 4951 
9.16.2.1.3.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
4952 and DP1/2 (Reaction) 
9.16.2.1.3.3.1.12 MYC trancscription is negatively regulated by 4952 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
9.16.2.1.3.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 4952 
9.16.2.1.3.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
4953 (BlackBoxEvent) 
9.16.2.1.3.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4953 
9.16.2.1.3.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription4953 (BlackBoxEvent) 
9.16.2.1.3.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)4954 
9.16.2.1.3.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 4954 (Reaction) 
9.16.2.1.3.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 
SKI/SKIL (Reaction) 
9.16.2.1.3.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 4954 
9.16.2.1.3.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 4955 
9.16.2.1.3.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 4955 (Reaction) 
9.16.2.1.3.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 4955 
9.16.2.1.3.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 4955 (Reaction) 
9.16.2.1.3.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 4956 
9.16.2.1.3.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 4956 
9.16.2.1.3.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)4956 
9.16.2.1.3.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 4956 
9.16.2.1.3.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 4957 
9.16.2.1.3.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 4957 (Reaction) 
9.16.2.1.3.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 4957 
9.16.2.1.3.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)4957 
9.16.2.1.3.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4958 
9.16.2.1.3.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 4958 
9.16.2.1.3.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 4958 (Reaction) 
9.16.2.1.3.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 4958 
9.16.2.1.3.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)4959 
9.16.2.1.3.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates4959 TGF-beta signaling (BlackBoxEvent) 
9.16.2.2 SMAD2/3 MH2 Domain Mutants in Cancer (Pathway) 4959 
9.16.2.2.1 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 MH2 domain 4961 mutants (Reaction) 
9.16.2.2.2 Activated type I receptor phosphorylates SMAD2/3 MH2 domain mutants 4963 directly (Reaction) 
9.16.2.2.3 Phosphorylated SMAD2/3 MH2 domain mutants dissociate from TGFBR 4965 (Reaction) 
9.16.2.2.4 Phosphorylated SMAD2/3 MH2 Domain Mutants do not bind SMAD4 4966 (BlackBoxEvent) 
9.16.2.2.5 Signaling by TGF-beta Receptor Complex (Pathway) 4968 
9.16.2.2.5.1 TGF-beta receptor signaling activates SMADs (Pathway) 4968 
9.16.2.2.5.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 4969 
9.16.2.2.5.1.2 Secretion and activation of the latent large complex of TGF-beta-1 4969 (Reaction) 
9.16.2.2.5.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 4969 
9.16.2.2.5.1.4 TGFBR2 recruits TGFBR1 (Reaction) 4969 
9.16.2.2.5.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 4970 
9.16.2.2.5.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 4970 
9.16.2.2.5.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)4970 
9.16.2.2.5.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 49544970 9.16.2.2.5.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 4971 (Reaction) 
9.16.2.2.5.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 4971 
9.16.2.2.5.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 4971 (Reaction) 
9.16.2.2.5.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 4971 (Reaction) 
9.16.2.2.5.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 4972 complex with SMAD7 (Reaction) 
9.16.2.2.5.1.10.4 BAMBI interferes with the interaction of type I receptor with type II4972 receptor (Reaction) 
9.16.2.2.5.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)4972 
9.16.2.2.5.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 4973 
9.16.2.2.5.1.10.7 SMAD7 binds to SMURF2 (Reaction) 4973 
9.16.2.2.5.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 4973 
9.16.2.2.5.1.10.9 SMAD7 binds to SMURF1 (Reaction) 4973 
9.16.2.2.5.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 4974 
9.16.2.2.5.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 4974 
9.16.2.2.5.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 4974 
9.16.2.2.5.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)4975 
9.16.2.2.5.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 4975 (Reaction) 
9.16.2.2.5.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 4975 SMAD7 (Reaction) 
9.16.2.2.5.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 4976 
9.16.2.2.5.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 4976 (Reaction) 
9.16.2.2.5.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 4976 
9.16.2.2.5.1.10.19 SMURF2 binds SMAD2 (Reaction) 4977 
9.16.2.2.5.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 4977 
9.16.2.2.5.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 4977 
9.16.2.2.5.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 4977 
9.16.2.2.5.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 4978 
9.16.2.2.5.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 4978 
9.16.2.2.5.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 4978 
9.16.2.2.5.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 4978 
9.16.2.2.5.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 4979 
9.16.2.2.5.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 4979 
9.16.2.2.5.1.11 CBL binds TGFBR2 (Reaction) 4979 
9.16.2.2.5.1.12 CBL neddylates TGFBR2 (Reaction) 4979 
9.16.2.2.5.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)4980 (Pathway) 
9.16.2.2.5.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 4980 
9.16.2.2.5.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 4980 (Reaction) 
9.16.2.2.5.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 4980 
9.16.2.2.5.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 4981 
9.16.2.2.5.2.5 SMURF1 ubiquitinates RHOA (Reaction) 4981 
9.16.2.2.5.2.6 Disassembly of tight junctions (BlackBoxEvent) 4981 
9.16.2.2.5.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)4981 
9.16.2.2.5.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)4982 
9.16.2.2.5.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD44982 (Reaction) 
9.16.2.2.5.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)4982 
9.16.2.2.5.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or4983 CDK9 (Reaction) 
9.16.2.2.5.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4983 
9.16.2.2.5.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 4983 
9.16.2.2.5.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)4983 
9.16.2.2.5.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 4984 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.2.2.5.3.1.8 RNF111 binds SMAD7 (Reaction) 4984 
9.16.2.2.5.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 4984 
9.16.2.2.5.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 4984 
9.16.2.2.5.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
4985 and DP1/2 (Reaction) 
9.16.2.2.5.3.1.12 MYC trancscription is negatively regulated by 4985 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
9.16.2.2.5.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 4985 
9.16.2.2.5.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
4986 (BlackBoxEvent) 
9.16.2.2.5.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4986 
9.16.2.2.5.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription4986 (BlackBoxEvent) 
9.16.2.2.5.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)4987 
9.16.2.2.5.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 4987 (Reaction) 
9.16.2.2.5.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 4987 SKI/SKIL (Reaction) 
9.16.2.2.5.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 4987 
9.16.2.2.5.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 4988 
9.16.2.2.5.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 4988 (Reaction) 
9.16.2.2.5.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 4988 
9.16.2.2.5.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 4988 (Reaction) 
9.16.2.2.5.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 4989 
9.16.2.2.5.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 4989 
9.16.2.2.5.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)4989 
9.16.2.2.5.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 4989 9.16.2.2.5.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 4990 
9.16.2.2.5.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 4990 (Reaction) 
9.16.2.2.5.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 4990 
9.16.2.2.5.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)4990 
9.16.2.2.5.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 4991 
9.16.2.2.5.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 4991 
9.16.2.2.5.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 4991 (Reaction) 
9.16.2.2.5.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 4991 
9.16.2.2.5.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)4992 
9.16.2.2.5.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates4992 TGF-beta signaling (BlackBoxEvent) 
9.16.3 Loss of Function of TGFBR2 in Cancer (Pathway) 4992 
9.16.3.1 TGFBR2 MSI Frameshift Mutants in Cancer (Pathway) 4994 
9.16.3.1.1 Dimeric TGFB1 does not bind TGFBR2 MSI frameshift mutants 4995 (BlackBoxEvent) 
9.16.3.1.2 Signaling by TGF-beta Receptor Complex (Pathway) 4998 
9.16.3.1.2.1 TGF-beta receptor signaling activates SMADs (Pathway) 4998 
9.16.3.1.2.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 4999 
9.16.3.1.2.1.2 Secretion and activation of the latent large complex of TGF-beta-1 4999 (Reaction) 
9.16.3.1.2.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 4999 
9.16.3.1.2.1.4 TGFBR2 recruits TGFBR1 (Reaction) 4999 
9.16.3.1.2.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 5000 
9.16.3.1.2.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 5000 
9.16.3.1.2.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)5000 
9.16.3.1.2.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 5000 
9.16.3.1.2.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 5001 (Reaction) 
9.16.3.1.2.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 5001 
9.16.3.1.2.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 5001 (Reaction) 
9.16.3.1.2.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 5001 (Reaction) 
9.16.3.1.2.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 5002 complex with SMAD7 (Reaction) 
9.16.3.1.2.1.10.4 BAMBI interferes with the interaction of type I receptor with type II5002 receptor (Reaction) 
9.16.3.1.2.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)5002 
9.16.3.1.2.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 5003 
9.16.3.1.2.1.10.7 SMAD7 binds to SMURF2 (Reaction) 5003 
9.16.3.1.2.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 5003 
9.16.3.1.2.1.10.9 SMAD7 binds to SMURF1 (Reaction) 5003 
9.16.3.1.2.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 5004 9.16.3.1.2.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 5004 
9.16.3.1.2.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 5004 
9.16.3.1.2.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)5005 
9.16.3.1.2.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 5005 (Reaction) 
9.16.3.1.2.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 5005 SMAD7 (Reaction) 
9.16.3.1.2.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 5006 
9.16.3.1.2.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 5006 (Reaction) 
9.16.3.1.2.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 5006 
9.16.3.1.2.1.10.19 SMURF2 binds SMAD2 (Reaction) 5007 
9.16.3.1.2.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 5007 
9.16.3.1.2.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 5007 
9.16.3.1.2.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 5007 
9.16.3.1.2.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 5008 
9.16.3.1.2.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 5008 
9.16.3.1.2.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 5008 
9.16.3.1.2.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 5008 
9.16.3.1.2.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 5009 
9.16.3.1.2.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 5009 
9.16.3.1.2.1.11 CBL binds TGFBR2 (Reaction) 5009 
9.16.3.1.2.1.12 CBL neddylates TGFBR2 (Reaction) 5009 
9.16.3.1.2.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)5010 (Pathway) 
9.16.3.1.2.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 5010 
9.16.3.1.2.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 5010 (Reaction) 
9.16.3.1.2.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 5010 
9.16.3.1.2.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 5011 
9.16.3.1.2.2.5 SMURF1 ubiquitinates RHOA (Reaction) 5011 
9.16.3.1.2.2.6 Disassembly of tight junctions (BlackBoxEvent) 5011 
9.16.3.1.2.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)5011 
9.16.3.1.2.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)5012 
9.16.3.1.2.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD45012 (Reaction) 
9.16.3.1.2.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)5012 
9.16.3.1.2.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or5013 CDK9 (Reaction) 
9.16.3.1.2.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5013 
9.16.3.1.2.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 5013 
9.16.3.1.2.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)5013 
9.16.3.1.2.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 5014 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.3.1.2.3.1.8 RNF111 binds SMAD7 (Reaction) 
9.16.3.1.2.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 5014 
9.16.3.1.2.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 5014 
9.16.3.1.2.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
5015 and DP1/2 (Reaction) 
9.16.3.1.2.3.1.12 MYC trancscription is negatively regulated by 5015 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
9.16.3.1.2.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 5015 
9.16.3.1.2.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
5016 (BlackBoxEvent) 
9.16.3.1.2.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5016 
9.16.3.1.2.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription5016 (BlackBoxEvent) 
9.16.3.1.2.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)5017 
9.16.3.1.2.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 5017 (Reaction) 
9.16.3.1.2.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 5017 SKI/SKIL (Reaction) 
9.16.3.1.2.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 5017 
9.16.3.1.2.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 5018 
9.16.3.1.2.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 5018 (Reaction) 
9.16.3.1.2.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 5018 
9.16.3.1.2.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 5018 (Reaction) 
9.16.3.1.2.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 5019 
9.16.3.1.2.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 5019 
9.16.3.1.2.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)5019 
9.16.3.1.2.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 5019 
9.16.3.1.2.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 5020 
9.16.3.1.2.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 5020 (Reaction) 
9.16.3.1.2.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 5020 
9.16.3.1.2.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)5020 
9.16.3.1.2.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5021 
9.16.3.1.2.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 5021 
9.16.3.1.2.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 5021 (Reaction) 
9.16.3.1.2.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 5021 
9.16.3.1.2.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)5022 
9.16.3.1.2.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates5022 TGF-beta signaling (BlackBoxEvent) 
9.16.3.2 TGFBR2 Kinase Domain Mutants in Cancer (Pathway) 5022 
9.16.3.2.1 TGFB1 binds TGFBR2 KD Mutant Dimers (Reaction) 5024 
9.16.3.2.2 TGFBR2 mutant dimers recruit TGFBR1 (Reaction) 5026 
9.16.3.2.3 TGFBR2 KD mutants do not phosphorylate TGFBR1 (BlackBoxEvent) 5028 9.16.3.2.4 Signaling by TGF-beta Receptor Complex (Pathway) 5030 
9.16.3.2.4.1 TGF-beta receptor signaling activates SMADs (Pathway) 5030 
9.16.3.2.4.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 5030 
9.16.3.2.4.1.2 Secretion and activation of the latent large complex of TGF-beta-1 5030 (Reaction) 
9.16.3.2.4.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 5031 
9.16.3.2.4.1.4 TGFBR2 recruits TGFBR1 (Reaction) 5031 
9.16.3.2.4.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 5031 
9.16.3.2.4.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 5031 
9.16.3.2.4.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)5032 
9.16.3.2.4.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 5032 
9.16.3.2.4.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 5032 (Reaction) 
9.16.3.2.4.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 5033 
9.16.3.2.4.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 5033 (Reaction) 
9.16.3.2.4.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 5033 (Reaction) 
9.16.3.2.4.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 5033 complex with SMAD7 (Reaction) 
9.16.3.2.4.1.10.4 BAMBI interferes with the interaction of type I receptor with type II5034 receptor (Reaction) 
9.16.3.2.4.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)5034 
9.16.3.2.4.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 5034 
9.16.3.2.4.1.10.7 SMAD7 binds to SMURF2 (Reaction) 5034 
9.16.3.2.4.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 5035 
9.16.3.2.4.1.10.9 SMAD7 binds to SMURF1 (Reaction) 5035 
9.16.3.2.4.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 5035 
9.16.3.2.4.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 5035 
9.16.3.2.4.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 5036 
9.16.3.2.4.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)5036 
9.16.3.2.4.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 5036 (Reaction) 
9.16.3.2.4.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 5037 SMAD7 (Reaction) 
9.16.3.2.4.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 5037 
9.16.3.2.4.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 5037 (Reaction) 
9.16.3.2.4.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 5038 
9.16.3.2.4.1.10.19 SMURF2 binds SMAD2 (Reaction) 5038 
9.16.3.2.4.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 5038 
9.16.3.2.4.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 5038 
9.16.3.2.4.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 5039 
9.16.3.2.4.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 5039 
9.16.3.2.4.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 5039 9.16.3.2.4.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 5039 
9.16.3.2.4.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 5040 
9.16.3.2.4.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 5040 
9.16.3.2.4.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 5040 
9.16.3.2.4.1.11 CBL binds TGFBR2 (Reaction) 5040 
9.16.3.2.4.1.12 CBL neddylates TGFBR2 (Reaction) 5041 
9.16.3.2.4.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)5041 (Pathway) 
9.16.3.2.4.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 5041 
9.16.3.2.4.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 5041 (Reaction) 
9.16.3.2.4.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 5042 
9.16.3.2.4.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 5042 
9.16.3.2.4.2.5 SMURF1 ubiquitinates RHOA (Reaction) 5042 
9.16.3.2.4.2.6 Disassembly of tight junctions (BlackBoxEvent) 5042 
9.16.3.2.4.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)5043 
9.16.3.2.4.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)5043 
9.16.3.2.4.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD45043 (Reaction) 
9.16.3.2.4.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)5043 
9.16.3.2.4.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or5044 CDK9 (Reaction) 
9.16.3.2.4.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5044 
9.16.3.2.4.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 5044 
9.16.3.2.4.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)5045 
9.16.3.2.4.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 5045 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.3.2.4.3.1.8 RNF111 binds SMAD7 (Reaction) 5045 
9.16.3.2.4.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 5045 
9.16.3.2.4.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 5046 
9.16.3.2.4.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
5046 and DP1/2 (Reaction) 
9.16.3.2.4.3.1.12 MYC trancscription is negatively regulated by 5046 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
9.16.3.2.4.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 5046 
9.16.3.2.4.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
5047 (BlackBoxEvent) 
9.16.3.2.4.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5047 
9.16.3.2.4.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription5047 (BlackBoxEvent) 
9.16.3.2.4.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)5048 
9.16.3.2.4.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 5048 (Reaction) 
9.16.3.2.4.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 5048 SKI/SKIL (Reaction) 
9.16.3.2.4.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 5048 
9.16.3.2.4.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 5049 
9.16.3.2.4.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 5049 (Reaction) 
9.16.3.2.4.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 5049 
9.16.3.2.4.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 5049 (Reaction) 
9.16.3.2.4.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 5050 
9.16.3.2.4.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 5050 
9.16.3.2.4.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)5050 
9.16.3.2.4.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 5050 
9.16.3.2.4.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 5051 
9.16.3.2.4.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 5051 (Reaction) 
9.16.3.2.4.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 5051 
9.16.3.2.4.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)5051 
9.16.3.2.4.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5052 
9.16.3.2.4.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 5052 
9.16.3.2.4.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 5052 (Reaction) 
9.16.3.2.4.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 5052 
9.16.3.2.4.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)5053 
9.16.3.2.4.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates5053 TGF-beta signaling (BlackBoxEvent) 
9.16.4 Loss of Function of TGFBR1 in Cancer (Pathway) 5053 
9.16.4.1 TGFBR1 LBD Mutants in Cancer (Pathway) 5055 
9.16.4.1.1 TGFBR2 does not recruit TGFBR1 LBD Mutants (BlackBoxEvent) 5056 
9.16.4.1.2 Signaling by TGF-beta Receptor Complex (Pathway) 5059 
9.16.4.1.2.1 TGF-beta receptor signaling activates SMADs (Pathway) 5059 
9.16.4.1.2.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 5059 
9.16.4.1.2.1.2 Secretion and activation of the latent large complex of TGF-beta-1 5059 (Reaction) 
9.16.4.1.2.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 5060 
9.16.4.1.2.1.4 TGFBR2 recruits TGFBR1 (Reaction) 5060 
9.16.4.1.2.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 5060 
9.16.4.1.2.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 5060 
9.16.4.1.2.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)5061 
9.16.4.1.2.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 5061 
9.16.4.1.2.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 5061 (Reaction) 
9.16.4.1.2.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 5062 
9.16.4.1.2.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 5062 (Reaction) 
9.16.4.1.2.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 5062 (Reaction) 
9.16.4.1.2.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 5062 complex with SMAD7 (Reaction) 
9.16.4.1.2.1.10.4 BAMBI interferes with the interaction of type I receptor with type II5063 receptor (Reaction) 
9.16.4.1.2.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)5063 
9.16.4.1.2.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 5063 
9.16.4.1.2.1.10.7 SMAD7 binds to SMURF2 (Reaction) 5063 
9.16.4.1.2.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 5064 
9.16.4.1.2.1.10.9 SMAD7 binds to SMURF1 (Reaction) 5064 
9.16.4.1.2.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 5064 
9.16.4.1.2.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 5064 
9.16.4.1.2.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 5065 
9.16.4.1.2.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)5065 
9.16.4.1.2.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 5065 (Reaction) 
9.16.4.1.2.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 5066 SMAD7 (Reaction) 
9.16.4.1.2.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 5066 
9.16.4.1.2.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 5066 (Reaction) 
9.16.4.1.2.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 5067 
9.16.4.1.2.1.10.19 SMURF2 binds SMAD2 (Reaction) 5067 
9.16.4.1.2.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 5067 
9.16.4.1.2.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 5067 
9.16.4.1.2.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 5068 
9.16.4.1.2.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 5068 
9.16.4.1.2.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 5068 
9.16.4.1.2.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 5068 
9.16.4.1.2.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 5069 
9.16.4.1.2.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 5069 
9.16.4.1.2.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 5069 
9.16.4.1.2.1.11 CBL binds TGFBR2 (Reaction) 5069 
9.16.4.1.2.1.12 CBL neddylates TGFBR2 (Reaction) 5070 
9.16.4.1.2.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)5070 (Pathway) 
9.16.4.1.2.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 5070 
9.16.4.1.2.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 5070 (Reaction) 
9.16.4.1.2.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 5071 
9.16.4.1.2.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 5071 
9.16.4.1.2.2.5 SMURF1 ubiquitinates RHOA (Reaction) 5071 
9.16.4.1.2.2.6 Disassembly of tight junctions (BlackBoxEvent) 5071 
9.16.4.1.2.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)5072 
9.16.4.1.2.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)5072 
9.16.4.1.2.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 
(Reaction) 
9.16.4.1.2.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)5072 
9.16.4.1.2.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or5073 CDK9 (Reaction) 
9.16.4.1.2.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5073 
9.16.4.1.2.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 5073 
9.16.4.1.2.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)5074 
9.16.4.1.2.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 5074 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.4.1.2.3.1.8 RNF111 binds SMAD7 (Reaction) 5074 
9.16.4.1.2.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 5074 
9.16.4.1.2.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 5075 
9.16.4.1.2.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
5075 and DP1/2 (Reaction) 
9.16.4.1.2.3.1.12 MYC trancscription is negatively regulated by 5075 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
9.16.4.1.2.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 5075 
9.16.4.1.2.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
5076 (BlackBoxEvent) 
9.16.4.1.2.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5076 
9.16.4.1.2.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription5076 (BlackBoxEvent) 
9.16.4.1.2.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)5077 
9.16.4.1.2.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 5077 (Reaction) 
9.16.4.1.2.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 5077 SKI/SKIL (Reaction) 
9.16.4.1.2.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 5077 
9.16.4.1.2.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 5078 
9.16.4.1.2.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 5078 (Reaction) 
9.16.4.1.2.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 5078 
9.16.4.1.2.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 5078 (Reaction) 
9.16.4.1.2.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 5079 

9.16.4.1.2.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 5079 
9.16.4.1.2.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)5079 
9.16.4.1.2.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 5079 
9.16.4.1.2.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 5080 
9.16.4.1.2.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 5080 (Reaction) 
9.16.4.1.2.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 5080 
9.16.4.1.2.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)5080 
9.16.4.1.2.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5081 
9.16.4.1.2.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 50725081 9.16.4.1.2.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 5081 (Reaction) 
9.16.4.1.2.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 5081 
9.16.4.1.2.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)5082 
9.16.4.1.2.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates5082 TGF-beta signaling (BlackBoxEvent) 
9.16.4.2 TGFBR1 KD Mutants in Cancer (Pathway) 5082 
9.16.4.2.1 TGFBR2 recruits TGFBR1 KD Mutants (Reaction) 5084 
9.16.4.2.2 TGFBR2 phosphorylates TGFBR1 KD Mutants (Reaction) 5086 
9.16.4.2.3 An anchoring protein ZFYVE9 (SARA) does not recruit SMAD2/3 to 5088 TGFB1:TGFBR2:p-TGFBR1 KD Mutants (BlackBoxEvent) 
9.16.4.2.4 Signaling by TGF-beta Receptor Complex (Pathway) 5090 
9.16.4.2.4.1 TGF-beta receptor signaling activates SMADs (Pathway) 5090 
9.16.4.2.4.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 5090 
9.16.4.2.4.1.2 Secretion and activation of the latent large complex of TGF-beta-1 5090 (Reaction) 
9.16.4.2.4.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 5091 
9.16.4.2.4.1.4 TGFBR2 recruits TGFBR1 (Reaction) 5091 
9.16.4.2.4.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 5091 
9.16.4.2.4.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 5091 
9.16.4.2.4.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction)5092 
9.16.4.2.4.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 5092 
9.16.4.2.4.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 5092 (Reaction) 
9.16.4.2.4.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 5093 
9.16.4.2.4.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) 5093 (Reaction) 
9.16.4.2.4.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex 5093 (Reaction) 
9.16.4.2.4.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor 5093 complex with SMAD7 (Reaction) 
9.16.4.2.4.1.10.4 BAMBI interferes with the interaction of type I receptor with type II5094 receptor (Reaction) 
9.16.4.2.4.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction)5094 
9.16.4.2.4.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 5094 
9.16.4.2.4.1.10.7 SMAD7 binds to SMURF2 (Reaction) 5094 
9.16.4.2.4.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 5095 
9.16.4.2.4.1.10.9 SMAD7 binds to SMURF1 (Reaction) 5095 
9.16.4.2.4.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 5095 
9.16.4.2.4.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 5095 
9.16.4.2.4.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 5096 
9.16.4.2.4.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction)5096 
9.16.4.2.4.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 5096 (Reaction) 
9.16.4.2.4.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and 
SMAD7 (Reaction) 
9.16.4.2.4.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 5097 
9.16.4.2.4.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 5097 (Reaction) 
9.16.4.2.4.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 5098 
9.16.4.2.4.1.10.19 SMURF2 binds SMAD2 (Reaction) 5098 
9.16.4.2.4.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 5098 
9.16.4.2.4.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 5098 
9.16.4.2.4.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 5099 
9.16.4.2.4.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 5099 
9.16.4.2.4.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 5099 
9.16.4.2.4.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 5099 
9.16.4.2.4.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 5100 
9.16.4.2.4.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 5100 
9.16.4.2.4.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 5100 
9.16.4.2.4.1.11 CBL binds TGFBR2 (Reaction) 5100 
9.16.4.2.4.1.12 CBL neddylates TGFBR2 (Reaction) 5101 
9.16.4.2.4.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)5101 (Pathway) 
9.16.4.2.4.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 5101 
9.16.4.2.4.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation 5101 (Reaction) 
9.16.4.2.4.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 5102 
9.16.4.2.4.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 5102 
9.16.4.2.4.2.5 SMURF1 ubiquitinates RHOA (Reaction) 5102 
9.16.4.2.4.2.6 Disassembly of tight junctions (BlackBoxEvent) 5102 
9.16.4.2.4.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway)5103 
9.16.4.2.4.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway)5103 
9.16.4.2.4.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD45103 (Reaction) 
9.16.4.2.4.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction)5103 
9.16.4.2.4.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or5104 CDK9 (Reaction) 
9.16.4.2.4.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5104 
9.16.4.2.4.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 5104 
9.16.4.2.4.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent)5105 
9.16.4.2.4.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while 5105 TGIF:SMAD and SMAD7 inhibit it (BlackBoxEvent) 
9.16.4.2.4.3.1.8 RNF111 binds SMAD7 (Reaction) 5105 
9.16.4.2.4.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 5105 
9.16.4.2.4.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 5106 
9.16.4.2.4.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5
5106 and DP1/2 (Reaction) 
9.16.4.2.4.3.1.12 MYC trancscription is negatively regulated by 5106 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 5097 9.16.4.2.4.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 5106 
9.16.4.2.4.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B
5107 (BlackBoxEvent) 
9.16.4.2.4.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5107 
9.16.4.2.4.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription5107 (BlackBoxEvent) 
9.16.4.2.4.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway)5108 
9.16.4.2.4.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling 5108 (Reaction) 
9.16.4.2.4.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to 5108 SKI/SKIL (Reaction) 
9.16.4.2.4.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 5108 
9.16.4.2.4.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 5109 
9.16.4.2.4.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus 5109 (Reaction) 
9.16.4.2.4.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 5109 
9.16.4.2.4.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol 5109 (Reaction) 
9.16.4.2.4.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 5110 
9.16.4.2.4.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 5110 
9.16.4.2.4.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction)5110 
9.16.4.2.4.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 5110 
9.16.4.2.4.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 5111 
9.16.4.2.4.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region 5111 (Reaction) 
9.16.4.2.4.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 5111 
9.16.4.2.4.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction)5111 
9.16.4.2.4.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 5112 
9.16.4.2.4.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 5112 
9.16.4.2.4.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 5112 (Reaction) 
9.16.4.2.4.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 5112 
9.16.4.2.4.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction)5113 
9.16.4.2.4.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates5113 TGF-beta signaling (BlackBoxEvent) 
9.17 Signaling by WNT in cancer (Pathway) 5113 
9.17.1 truncated APC mutants destabilize the destruction complex (Pathway) 5116 
9.17.1.1 APC truncation mutants are not K63 polyubiquitinated (Pathway) 5118 
9.17.1.1.1 APC truncation mutants are not K63 polyubiquitinated (FailedReaction) 5119 
9.17.1.1.2 Degradation of beta-catenin by the destruction complex (Pathway) 5121 
9.17.1.1.2.1 expression of AMER1 gene (BlackBoxEvent) 5122 
9.17.1.1.2.2 expression of AXIN1 gene (BlackBoxEvent) 5123 
9.17.1.1.2.3 APC is K63-polyubiquitinated (Reaction) 5124 
9.17.1.1.2.4 Assembly of the destruction complex (Reaction) 5126 
9.17.1.1.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5128 9.17.1.1.2.6 Association of beta-catenin with the destruction complex (Reaction) 5130 
9.17.1.1.2.7 Beta-catenin phosphorylation cascade (Pathway) 5131 
9.17.1.1.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5132 
9.17.1.1.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5133 
9.17.1.1.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5135 GSK-3 (Reaction) 
9.17.1.1.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5136 (Reaction) 
9.17.1.1.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5138 
9.17.1.1.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5139 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.1.1.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5141 ligase complex (Reaction) 
9.17.1.1.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5142 (Reaction) 
9.17.1.1.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5143 (BlackBoxEvent) 
9.17.1.1.2.13 repression of WNT target genes (Pathway) 5144 
9.17.1.1.2.13.1 TLE oligomerizes (Reaction) 5146 
9.17.1.1.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5149 
9.17.1.1.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5151 
9.17.1.1.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5153 
9.17.1.1.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5155 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.1.2 APC truncation mutants have impaired AXIN binding (Pathway) 5157 
9.17.1.2.1 APC truncation mutants have impaired AXIN binding (FailedReaction) 5158 
9.17.1.2.2 Degradation of beta-catenin by the destruction complex (Pathway) 5161 
9.17.1.2.2.1 expression of AMER1 gene (BlackBoxEvent) 5161 
9.17.1.2.2.2 expression of AXIN1 gene (BlackBoxEvent) 5161 
9.17.1.2.2.3 APC is K63-polyubiquitinated (Reaction) 5161 
9.17.1.2.2.4 Assembly of the destruction complex (Reaction) 5162 
9.17.1.2.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5162 
9.17.1.2.2.6 Association of beta-catenin with the destruction complex (Reaction) 5162 
9.17.1.2.2.7 Beta-catenin phosphorylation cascade (Pathway) 5162 
9.17.1.2.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5163 
9.17.1.2.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5163 
9.17.1.2.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5163 GSK-3 (Reaction) 
9.17.1.2.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5164 (Reaction) 
9.17.1.2.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5164 
9.17.1.2.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5164 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.1.2.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5165 ligase complex (Reaction) 
9.17.1.2.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5165 (Reaction) 
9.17.1.2.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5165 (BlackBoxEvent) 
9.17.1.2.2.13 repression of WNT target genes (Pathway) 5166 
9.17.1.2.2.13.1 TLE oligomerizes (Reaction) 5166 
9.17.1.2.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5166 
9.17.1.2.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5166 
9.17.1.2.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5167 
9.17.1.2.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5167 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.1.3 Degradation of beta-catenin by the destruction complex (Pathway) 5167 
9.17.1.3.1 expression of AMER1 gene (BlackBoxEvent) 5167 
9.17.1.3.2 expression of AXIN1 gene (BlackBoxEvent) 5168 
9.17.1.3.3 APC is K63-polyubiquitinated (Reaction) 5168 
9.17.1.3.4 Assembly of the destruction complex (Reaction) 5168 
9.17.1.3.5 AXIN is phosphorylated in the destruction complex (Reaction) 5168 
9.17.1.3.6 Association of beta-catenin with the destruction complex (Reaction) 5169 
9.17.1.3.7 Beta-catenin phosphorylation cascade (Pathway) 5169 
9.17.1.3.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5169 
9.17.1.3.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5169 
9.17.1.3.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by 5170 GSK-3 (Reaction) 
9.17.1.3.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5170 (Reaction) 
9.17.1.3.8 Phosphorylation of APC component of the destruction complex (Reaction) 5170 
9.17.1.3.9 Dissociation of beta-catenin from Axin and association of beta catenin with 5171 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.1.3.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase5171 complex (Reaction) 
9.17.1.3.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 5171 (Reaction) 
9.17.1.3.12 Degradation of ubiquitinated beta catenin by the proteasome 5172 (BlackBoxEvent) 
9.17.1.3.13 repression of WNT target genes (Pathway) 5172 
9.17.1.3.13.1 TLE oligomerizes (Reaction) 5172 
9.17.1.3.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5172 
9.17.1.3.13.3 TLE forms non-functional complexes with AES (Reaction) 5173 
9.17.1.3.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 5173 
9.17.1.3.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
5173 TCF/CTBP complexes (BlackBoxEvent) 
9.17.2 AXIN mutants destabilize the destruction complex, activating WNT signaling 5174 (Pathway) 
9.17.2.1 deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT5175 signaling (Pathway) 
9.17.2.1.1 deletions in the AXIN1 gene prevent expression of AXIN1 protein 5177 (FailedReaction) 
9.17.2.1.2 Degradation of beta-catenin by the destruction complex (Pathway) 5178 
9.17.2.1.2.1 expression of AMER1 gene (BlackBoxEvent) 5179 
9.17.2.1.2.2 expression of AXIN1 gene (BlackBoxEvent) 5179 
9.17.2.1.2.3 APC is K63-polyubiquitinated (Reaction) 5179 
9.17.2.1.2.4 Assembly of the destruction complex (Reaction) 5179 
9.17.2.1.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5180 
9.17.2.1.2.6 Association of beta-catenin with the destruction complex (Reaction) 5180 
9.17.2.1.2.7 Beta-catenin phosphorylation cascade (Pathway) 5180 
9.17.2.1.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5180 
9.17.2.1.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5181 
9.17.2.1.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5181 GSK-3 (Reaction) 
9.17.2.1.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5181 (Reaction) 
9.17.2.1.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5182 
9.17.2.1.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5182 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.2.1.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5182 ligase complex (Reaction) 
9.17.2.1.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5183 (Reaction) 
9.17.2.1.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5183 (BlackBoxEvent) 
9.17.2.1.2.13 repression of WNT target genes (Pathway) 5183 
9.17.2.1.2.13.1 TLE oligomerizes (Reaction) 5183 
9.17.2.1.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5184 
9.17.2.1.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5184 
9.17.2.1.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5184 
9.17.2.1.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5185 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.2.2 AXIN missense mutants destabilize the destruction complex (Pathway) 5185 
9.17.2.2.1 AXIN mutants destabilize the destruction complex (FailedReaction) 5186 
9.17.2.2.2 Degradation of beta-catenin by the destruction complex (Pathway) 5188 
9.17.2.2.2.1 expression of AMER1 gene (BlackBoxEvent) 5189 
9.17.2.2.2.2 expression of AXIN1 gene (BlackBoxEvent) 5189 
9.17.2.2.2.3 APC is K63-polyubiquitinated (Reaction) 5189 
9.17.2.2.2.4 Assembly of the destruction complex (Reaction) 5189 
9.17.2.2.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5190 
9.17.2.2.2.6 Association of beta-catenin with the destruction complex (Reaction) 5190 
9.17.2.2.2.7 Beta-catenin phosphorylation cascade (Pathway) 5190 
9.17.2.2.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5190 
9.17.2.2.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5191 
9.17.2.2.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by GSK-3 (Reaction) 
9.17.2.2.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5191 (Reaction) 
9.17.2.2.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5192 
9.17.2.2.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5192 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.2.2.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5192 ligase complex (Reaction) 
9.17.2.2.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5193 (Reaction) 
9.17.2.2.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5193 (BlackBoxEvent) 
9.17.2.2.2.13 repression of WNT target genes (Pathway) 5193 
9.17.2.2.2.13.1 TLE oligomerizes (Reaction) 5193 
9.17.2.2.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5194 
9.17.2.2.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5194 
9.17.2.2.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5194 
9.17.2.2.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5195 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.2.3 Degradation of beta-catenin by the destruction complex (Pathway) 5195 
9.17.2.3.1 expression of AMER1 gene (BlackBoxEvent) 5195 
9.17.2.3.2 expression of AXIN1 gene (BlackBoxEvent) 5195 
9.17.2.3.3 APC is K63-polyubiquitinated (Reaction) 5196 
9.17.2.3.4 Assembly of the destruction complex (Reaction) 5196 
9.17.2.3.5 AXIN is phosphorylated in the destruction complex (Reaction) 5196 
9.17.2.3.6 Association of beta-catenin with the destruction complex (Reaction) 5196 
9.17.2.3.7 Beta-catenin phosphorylation cascade (Pathway) 5197 
9.17.2.3.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5197 
9.17.2.3.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5197 
9.17.2.3.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by 5197 GSK-3 (Reaction) 
9.17.2.3.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5198 (Reaction) 
9.17.2.3.8 Phosphorylation of APC component of the destruction complex (Reaction) 5198 
9.17.2.3.9 Dissociation of beta-catenin from Axin and association of beta catenin with 5198 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.2.3.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase5199 complex (Reaction) 
9.17.2.3.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 5199 (Reaction) 
9.17.2.3.12 Degradation of ubiquitinated beta catenin by the proteasome 5199 (BlackBoxEvent) 
9.17.2.3.13 repression of WNT target genes (Pathway) 5200 
9.17.2.3.13.1 TLE oligomerizes (Reaction) 5200 
9.17.2.3.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5191
5200 
9.17.2.3.13.3 TLE forms non-functional complexes with AES (Reaction) 5200 
9.17.2.3.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 5201 
9.17.2.3.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
5201 
TCF/CTBP complexes (BlackBoxEvent) 
9.17.3 AMER1 mutants destabilize the destruction complex (Pathway) 5201 
9.17.3.1 deletions in the AMER1 gene destabilize the destruction complex (Pathway) 5203 
9.17.3.1.1 deletions of the AMER1 gene prevent expression of AMER1 protein 5204 (FailedReaction) 
9.17.3.1.2 Degradation of beta-catenin by the destruction complex (Pathway) 5206 
9.17.3.1.2.1 expression of AMER1 gene (BlackBoxEvent) 5206 
9.17.3.1.2.2 expression of AXIN1 gene (BlackBoxEvent) 5207 
9.17.3.1.2.3 APC is K63-polyubiquitinated (Reaction) 5207 
9.17.3.1.2.4 Assembly of the destruction complex (Reaction) 5207 
9.17.3.1.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5207 
9.17.3.1.2.6 Association of beta-catenin with the destruction complex (Reaction) 5208 
9.17.3.1.2.7 Beta-catenin phosphorylation cascade (Pathway) 5208 
9.17.3.1.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5208 
9.17.3.1.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5208 
9.17.3.1.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5209 GSK-3 (Reaction) 
9.17.3.1.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5209 (Reaction) 
9.17.3.1.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5209 
9.17.3.1.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5210 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.3.1.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5210 ligase complex (Reaction) 
9.17.3.1.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5210 (Reaction) 
9.17.3.1.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5211 (BlackBoxEvent) 
9.17.3.1.2.13 repression of WNT target genes (Pathway) 5211 
9.17.3.1.2.13.1 TLE oligomerizes (Reaction) 5211 
9.17.3.1.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5211 
9.17.3.1.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5212 
9.17.3.1.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5212 
9.17.3.1.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5212 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.3.2 truncations of AMER1 destabilize the destruction complex (Pathway) 5213 
9.17.3.2.1 truncated AMER1 mutants destabilize the destruction complex 5214 (FailedReaction) 
9.17.3.2.2 Degradation of beta-catenin by the destruction complex (Pathway) 5216 
9.17.3.2.2.1 expression of AMER1 gene (BlackBoxEvent) 5217 
9.17.3.2.2.2 expression of AXIN1 gene (BlackBoxEvent) 5217 
9.17.3.2.2.3 APC is K63-polyubiquitinated (Reaction) 5217 9.17.3.2.2.4 Assembly of the destruction complex (Reaction) 5217 
9.17.3.2.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5218 
9.17.3.2.2.6 Association of beta-catenin with the destruction complex (Reaction) 5218 
9.17.3.2.2.7 Beta-catenin phosphorylation cascade (Pathway) 5218 
9.17.3.2.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5218 
9.17.3.2.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5219 
9.17.3.2.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5219 GSK-3 (Reaction) 
9.17.3.2.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5219 (Reaction) 
9.17.3.2.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5220 
9.17.3.2.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5220 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.3.2.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5220 ligase complex (Reaction) 
9.17.3.2.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5221 (Reaction) 
9.17.3.2.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5221 (BlackBoxEvent) 
9.17.3.2.2.13 repression of WNT target genes (Pathway) 5221 
9.17.3.2.2.13.1 TLE oligomerizes (Reaction) 5221 
9.17.3.2.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5222 
9.17.3.2.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5222 
9.17.3.2.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5222 
9.17.3.2.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5223 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.3.3 Degradation of beta-catenin by the destruction complex (Pathway) 5223 
9.17.3.3.1 expression of AMER1 gene (BlackBoxEvent) 5223 
9.17.3.3.2 expression of AXIN1 gene (BlackBoxEvent) 5223 
9.17.3.3.3 APC is K63-polyubiquitinated (Reaction) 5224 
9.17.3.3.4 Assembly of the destruction complex (Reaction) 5224 
9.17.3.3.5 AXIN is phosphorylated in the destruction complex (Reaction) 5224 
9.17.3.3.6 Association of beta-catenin with the destruction complex (Reaction) 5224 
9.17.3.3.7 Beta-catenin phosphorylation cascade (Pathway) 5225 
9.17.3.3.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5225 
9.17.3.3.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5225 
9.17.3.3.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by 5225 GSK-3 (Reaction) 
9.17.3.3.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5226 (Reaction) 
9.17.3.3.8 Phosphorylation of APC component of the destruction complex (Reaction) 5226 
9.17.3.3.9 Dissociation of beta-catenin from Axin and association of beta catenin with 5226 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.3.3.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase5227 
complex (Reaction) 9.17.3.3.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 5227 (Reaction) 
9.17.3.3.12 Degradation of ubiquitinated beta catenin by the proteasome 5227 (BlackBoxEvent) 
9.17.3.3.13 repression of WNT target genes (Pathway) 5228 
9.17.3.3.13.1 TLE oligomerizes (Reaction) 5228 
9.17.3.3.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5228 
9.17.3.3.13.3 TLE forms non-functional complexes with AES (Reaction) 5228 
9.17.3.3.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 5229 
9.17.3.3.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
5229 TCF/CTBP complexes (BlackBoxEvent) 
9.17.4 phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the5229 destruction complex (Pathway) 
9.17.4.1 S45 mutants of beta-catenin aren't phosphorylated (Pathway) 5231 
9.17.4.1.1 CTNNB1 S45 mutants aren't phosphorylated by CK1alpha (FailedReaction) 5232 
9.17.4.1.2 Degradation of beta-catenin by the destruction complex (Pathway) 5234 
9.17.4.1.2.1 expression of AMER1 gene (BlackBoxEvent) 5235 
9.17.4.1.2.2 expression of AXIN1 gene (BlackBoxEvent) 5235 
9.17.4.1.2.3 APC is K63-polyubiquitinated (Reaction) 5235 
9.17.4.1.2.4 Assembly of the destruction complex (Reaction) 5235 
9.17.4.1.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5236 
9.17.4.1.2.6 Association of beta-catenin with the destruction complex (Reaction) 5236 
9.17.4.1.2.7 Beta-catenin phosphorylation cascade (Pathway) 5236 
9.17.4.1.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5236 
9.17.4.1.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5237 
9.17.4.1.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5237 GSK-3 (Reaction) 
9.17.4.1.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5237 (Reaction) 
9.17.4.1.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5238 
9.17.4.1.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5238 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.4.1.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5238 ligase complex (Reaction) 
9.17.4.1.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5239 (Reaction) 
9.17.4.1.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5239 (BlackBoxEvent) 
9.17.4.1.2.13 repression of WNT target genes (Pathway) 5239 
9.17.4.1.2.13.1 TLE oligomerizes (Reaction) 5239 
9.17.4.1.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5240 
9.17.4.1.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5240 
9.17.4.1.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5240 
9.17.4.1.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5241 
and TCF/CTBP complexes (BlackBoxEvent) 
9.17.4.2 T41 mutants of beta-catenin aren't phosphorylated (Pathway) 5241 
9.17.4.2.1 CTNNB1 T41 mutants aren't phosphorylated by GSK3beta (FailedReaction)5242 
9.17.4.2.2 Degradation of beta-catenin by the destruction complex (Pathway) 5244 
9.17.4.2.2.1 expression of AMER1 gene (BlackBoxEvent) 5244 
9.17.4.2.2.2 expression of AXIN1 gene (BlackBoxEvent) 5245 
9.17.4.2.2.3 APC is K63-polyubiquitinated (Reaction) 5245 
9.17.4.2.2.4 Assembly of the destruction complex (Reaction) 5245 
9.17.4.2.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5245 
9.17.4.2.2.6 Association of beta-catenin with the destruction complex (Reaction) 5246 
9.17.4.2.2.7 Beta-catenin phosphorylation cascade (Pathway) 5246 
9.17.4.2.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5246 
9.17.4.2.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5246 
9.17.4.2.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5247 GSK-3 (Reaction) 
9.17.4.2.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5247 (Reaction) 
9.17.4.2.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5247 
9.17.4.2.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5248 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.4.2.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5248 ligase complex (Reaction) 
9.17.4.2.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5248 (Reaction) 
9.17.4.2.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5249 (BlackBoxEvent) 
9.17.4.2.2.13 repression of WNT target genes (Pathway) 5249 
9.17.4.2.2.13.1 TLE oligomerizes (Reaction) 5249 
9.17.4.2.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5249 
9.17.4.2.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5250 
9.17.4.2.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5250 
9.17.4.2.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5250 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.4.3 S37 mutants of beta-catenin aren't phosphorylated (Pathway) 5251 
9.17.4.3.1 CTNNB1 S37 mutants aren't phosphorylated by GSK3beta (FailedReaction)5252 
9.17.4.3.2 Degradation of beta-catenin by the destruction complex (Pathway) 5253 
9.17.4.3.2.1 expression of AMER1 gene (BlackBoxEvent) 5254 
9.17.4.3.2.2 expression of AXIN1 gene (BlackBoxEvent) 5254 
9.17.4.3.2.3 APC is K63-polyubiquitinated (Reaction) 5254 
9.17.4.3.2.4 Assembly of the destruction complex (Reaction) 5254 
9.17.4.3.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5255 
9.17.4.3.2.6 Association of beta-catenin with the destruction complex (Reaction) 5255 
9.17.4.3.2.7 Beta-catenin phosphorylation cascade (Pathway) 5255 
9.17.4.3.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5255 
9.17.4.3.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5256 
9.17.4.3.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by GSK-3 (Reaction) 
9.17.4.3.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5256 (Reaction) 
9.17.4.3.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5257 
9.17.4.3.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5257 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.4.3.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5257 ligase complex (Reaction) 
9.17.4.3.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5258 (Reaction) 
9.17.4.3.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5258 (BlackBoxEvent) 
9.17.4.3.2.13 repression of WNT target genes (Pathway) 5258 
9.17.4.3.2.13.1 TLE oligomerizes (Reaction) 5258 
9.17.4.3.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5259 
9.17.4.3.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5259 
9.17.4.3.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5259 
9.17.4.3.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5260 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.4.4 S33 mutants of beta-catenin aren't phosphorylated (Pathway) 5260 
9.17.4.4.1 CTNNB1 S33 mutants aren't phosphorylated by GSK3beta (FailedReaction)5261 
9.17.4.4.2 Degradation of beta-catenin by the destruction complex (Pathway) 5263 
9.17.4.4.2.1 expression of AMER1 gene (BlackBoxEvent) 5263 
9.17.4.4.2.2 expression of AXIN1 gene (BlackBoxEvent) 5264 
9.17.4.4.2.3 APC is K63-polyubiquitinated (Reaction) 5264 
9.17.4.4.2.4 Assembly of the destruction complex (Reaction) 5264 
9.17.4.4.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5264 
9.17.4.4.2.6 Association of beta-catenin with the destruction complex (Reaction) 5265 
9.17.4.4.2.7 Beta-catenin phosphorylation cascade (Pathway) 5265 
9.17.4.4.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5265 
9.17.4.4.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5265 
9.17.4.4.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by5266 GSK-3 (Reaction) 
9.17.4.4.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5266 (Reaction) 
9.17.4.4.2.8 Phosphorylation of APC component of the destruction complex (Reaction)5266 
9.17.4.4.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with
5267 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.4.4.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin 5267 ligase complex (Reaction) 
9.17.4.4.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)5267 (Reaction) 
9.17.4.4.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5268 (BlackBoxEvent) 
9.17.4.4.2.13 repression of WNT target genes (Pathway) 5256
5268 
9.17.4.4.2.13.1 TLE oligomerizes (Reaction) 5268 
9.17.4.4.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5268 
9.17.4.4.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5269 
9.17.4.4.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction)5269 
9.17.4.4.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC5269 and TCF/CTBP complexes (BlackBoxEvent) 
9.17.4.5 Degradation of beta-catenin by the destruction complex (Pathway) 5270 
9.17.4.5.1 expression of AMER1 gene (BlackBoxEvent) 5270 
9.17.4.5.2 expression of AXIN1 gene (BlackBoxEvent) 5270 
9.17.4.5.3 APC is K63-polyubiquitinated (Reaction) 5270 
9.17.4.5.4 Assembly of the destruction complex (Reaction) 5271 
9.17.4.5.5 AXIN is phosphorylated in the destruction complex (Reaction) 5271 
9.17.4.5.6 Association of beta-catenin with the destruction complex (Reaction) 5271 
9.17.4.5.7 Beta-catenin phosphorylation cascade (Pathway) 5271 
9.17.4.5.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5272 
9.17.4.5.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5272 
9.17.4.5.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by 5272 GSK-3 (Reaction) 
9.17.4.5.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5273 (Reaction) 
9.17.4.5.8 Phosphorylation of APC component of the destruction complex (Reaction) 5273 
9.17.4.5.9 Dissociation of beta-catenin from Axin and association of beta catenin with 5273 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.4.5.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase5274 complex (Reaction) 
9.17.4.5.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 5274 (Reaction) 
9.17.4.5.12 Degradation of ubiquitinated beta catenin by the proteasome 5274 (BlackBoxEvent) 
9.17.4.5.13 repression of WNT target genes (Pathway) 5275 
9.17.4.5.13.1 TLE oligomerizes (Reaction) 5275 
9.17.4.5.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5275 
9.17.4.5.13.3 TLE forms non-functional complexes with AES (Reaction) 5275 
9.17.4.5.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 5276 
9.17.4.5.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
5276 TCF/CTBP complexes (BlackBoxEvent) 
9.17.5 misspliced GSK3beta mutants stabilize beta-catenin (Pathway) 5276 
9.17.5.1 misspliced GSK3beta mutants stabilize beta-catenin levels (FailedReaction) 5278 
9.17.5.2 Degradation of beta-catenin by the destruction complex (Pathway) 5279 
9.17.5.2.1 expression of AMER1 gene (BlackBoxEvent) 5280 
9.17.5.2.2 expression of AXIN1 gene (BlackBoxEvent) 5280 
9.17.5.2.3 APC is K63-polyubiquitinated (Reaction) 5280 
9.17.5.2.4 Assembly of the destruction complex (Reaction) 5280 
9.17.5.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5281 
9.17.5.2.6 Association of beta-catenin with the destruction complex (Reaction) 5281 9.17.5.2.7 Beta-catenin phosphorylation cascade (Pathway) 5281 
9.17.5.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5281 
9.17.5.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5282 
9.17.5.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by 5282 GSK-3 (Reaction) 
9.17.5.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5282 (Reaction) 
9.17.5.2.8 Phosphorylation of APC component of the destruction complex (Reaction) 5283 
9.17.5.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with 5283 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.5.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase5283 complex (Reaction) 
9.17.5.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 5284 (Reaction) 
9.17.5.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5284 (BlackBoxEvent) 
9.17.5.2.13 repression of WNT target genes (Pathway) 5284 
9.17.5.2.13.1 TLE oligomerizes (Reaction) 5284 
9.17.5.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5285 
9.17.5.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5285 
9.17.5.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 5285 
9.17.5.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
5286 TCF/CTBP complexes (BlackBoxEvent) 
9.17.6 TCF7L2 mutants don't bind CTBP (Pathway) 5286 
9.17.6.1 TFC7L2 mutants don't bind CTBP (FailedReaction) 5287 
9.17.6.2 Degradation of beta-catenin by the destruction complex (Pathway) 5289 
9.17.6.2.1 expression of AMER1 gene (BlackBoxEvent) 5290 
9.17.6.2.2 expression of AXIN1 gene (BlackBoxEvent) 5290 
9.17.6.2.3 APC is K63-polyubiquitinated (Reaction) 5290 
9.17.6.2.4 Assembly of the destruction complex (Reaction) 5290 
9.17.6.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 5291 
9.17.6.2.6 Association of beta-catenin with the destruction complex (Reaction) 5291 
9.17.6.2.7 Beta-catenin phosphorylation cascade (Pathway) 5291 
9.17.6.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 5291 
9.17.6.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 5292 
9.17.6.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by 5292 GSK-3 (Reaction) 
9.17.6.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 5292 (Reaction) 
9.17.6.2.8 Phosphorylation of APC component of the destruction complex (Reaction) 5293 
9.17.6.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with 5293 phospho-(20 aa) APC in the detruction complex (Reaction) 
9.17.6.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase5293 complex (Reaction) 
9.17.6.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 
(Reaction) 
9.17.6.2.12 Degradation of ubiquitinated beta catenin by the proteasome 5294 (BlackBoxEvent) 
9.17.6.2.13 repression of WNT target genes (Pathway) 5294 
9.17.6.2.13.1 TLE oligomerizes (Reaction) 5294 
9.17.6.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 5295 
9.17.6.2.13.3 TLE forms non-functional complexes with AES (Reaction) 5295 
9.17.6.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 5295 
9.17.6.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
5296 TCF/CTBP complexes (BlackBoxEvent) 
9.17.7 misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling 5296 (Pathway) 
9.17.7.1 misspliced mutants of LRP5 support enhanced beta-catenin-dependent signaling
5297 (FailedReaction) 
9.17.7.2 TCF dependent signaling in response to WNT (Pathway) 5299 
9.17.7.2.1 WNT binds to FZD and LRP5/6 (Reaction) 5301 
9.17.7.2.2 WNT mediated activation of DVL (Pathway) 5303 
9.17.7.2.2.1 CSNK2-mediated phosphorylation of DVL (Reaction) 5306 
9.17.7.2.2.2 WNT signaling stimulates CSNK1-dependent phosphorylation of DVL 5307 (Reaction) 
9.17.7.2.2.3 Phosphorylated DVL recruits PIP5K1B to the plasma membrane (Reaction)5309 
9.17.7.2.2.4 DVL-associated PIP5K1B phosphorylates PI4P to PI(4,5)P2 (Reaction) 5310 
9.17.7.2.3 FZD recruits DVL to the receptor complex (Reaction) 5312 
9.17.7.2.4 disassembly of the destruction complex and recruitment of AXIN to the 5314 membrane (Pathway) 
9.17.7.2.4.1 FRAT proteins bind GSK3beta (Reaction) 5316 
9.17.7.2.4.2 PP2A dephosphorylates AXIN in the destruction complex (BlackBoxEvent)5319 
9.17.7.2.4.3 DVL recruits GSK3beta:AXIN1 to the receptor complex (Reaction) 5322 
9.17.7.2.4.4 phosphorylation of LRP5/6 cytoplasmic domain by membrane-associated5324 GSK3beta (Reaction) 
9.17.7.2.4.5 phosphorylation of LRP5/6 cytoplasmic domain by CSNKI (Reaction) 5325 
9.17.7.2.4.6 WNT3A stimulates the caveolin-dependent internalization of FZD5:p-LRP6
5328 (BlackBoxEvent) 
9.17.7.2.4.7 beta-catenin is released from the destruction complex (Reaction) 5329 
9.17.7.2.5 beta-catenin translocates to the nucleus (BlackBoxEvent) 5331 
9.17.7.2.6 formation of the beta-catenin:TCF transactivating complex (Pathway) 5333 
9.17.7.2.6.1 binding of TCF/LEF:CTNNB1 to target gene promoters (Pathway) 5335 
9.17.7.2.6.1.1 TCF7L1/TCF7L2/LEF1:CTNNB1 bind the MYC gene (Reaction) 5337 
9.17.7.2.6.1.2 TCF7L1/TCF7L2/LEF1:CTNNB1 promote transcription of the MYC gene
5338 (BlackBoxEvent) 
9.17.7.2.6.1.3 TCF/LEF:CTNNB1 bind the AXIN2 gene (Reaction) 5340 
9.17.7.2.6.1.4 TCF/LEF:CTNNB1 promote transcription of AXIN2 (BlackBoxEvent) 5341 
9.17.7.2.6.2 beta-catenin displaces TLE:HDAC1 from TCF/LEF (Reaction) 5343 
9.17.7.2.6.3 beta-catenin:TCF associates with BCL9 and PYGO (Reaction) 5346 
9.17.7.2.6.4 beta-catenin recruits CBP/p300 (Reaction) 52945349 
9.17.7.2.6.5 beta-catenin recruits CDC73 and LEO1 (Reaction) 5351 
9.17.7.2.6.6 beta-catenin recruits SMARCA4 (Reaction) 5353 
9.17.7.2.6.7 Recruitment of SET1 methyltransferase complex (Reaction) 5354 
9.17.7.2.6.8 SET1 complex trimethylates H3K4 at the MYC gene (Reaction) 5356 
9.17.7.2.6.9 beta-catenin recruits TRRAP/KAT5 HAT components (Reaction) 5357 
9.17.7.2.6.10 KAT5 HAT complex acetylates TCF4 gene at histone H4 (Reaction) 5359 
9.17.7.2.7 deactivation of the beta-catenin transactivating complex (Pathway) 5360 
9.17.7.2.7.1 XIAP binds TLE (Reaction) 5362 
9.17.7.2.7.2 XIAP monoubiquinates TLE (Reaction) 5364 
9.17.7.2.7.3 XIAP dissociates from ub-TLE (Reaction) 5365 
9.17.7.2.7.4 APC promotes disassembly of beta-catenin transactivation complex 5367 (BlackBoxEvent) 
9.17.7.2.7.5 beta-catenin is replaced by repression complexes at the promoter 5368 (BlackBoxEvent) 
9.17.7.2.7.6 CBY1 binds beta-catenin (Reaction) 5370 
9.17.7.2.7.7 AKT phosphorylates CBY1 (Reaction) 5371 
9.17.7.2.7.8 YWHAZ binds p-CBY:CTNNB1 (Reaction) 5372 
9.17.7.2.7.9 XPO1 binds the beta-catenin:CBY complex (Reaction) 5374 
9.17.7.2.7.10 YWHAZ and XPO1 mediate the nuclear export of beta-catenin 5375 (BlackBoxEvent) 
9.17.7.2.7.11 CTNNBIP1 binds beta-catenin (Reaction) 5376 
9.17.7.2.7.12 CHD8 binds beta-catenin to negatively regulate WNT-dependent gene 5378 expression (Reaction) 
9.17.7.2.8 degradation of DVL (Pathway) 5379 
9.17.7.2.8.1 DVL is bound by the CUL3:KLHL12:RBX1 ubiquitin ligase complex 5380 (Reaction) 
9.17.7.2.8.2 DVL is ubiquitinated by CUL3:KLHL12:RBX1 (Reaction) 5382 
9.17.7.2.8.3 ubiquitinated DVL is degraded by the proteasome (BlackBoxEvent) 5383 
9.17.7.2.8.4 DVL1 is bound by the HECT ubiquitin ligase HECW1 (Reaction) 5384 
9.17.7.2.8.5 DVL1 is ubiquitinated by HECW1 (Reaction) 5385 
9.17.7.2.8.6 ubiquitinated DVL1 is degraded by the proteasome (BlackBoxEvent) 5387 
9.17.7.2.8.7 DACT1 binds DVL2 (Reaction) 5388 
9.17.7.2.9 degradation of AXIN (Pathway) 5389 
9.17.7.2.9.1 Tankyrase binds AXIN (Reaction) 5391 
9.17.7.2.9.2 Tankyrase ADP-ribosylates AXIN (Reaction) 5392 
9.17.7.2.9.3 RNF146 binds RibC-AXIN:TNKS complex (Reaction) 5394 
9.17.7.2.9.4 RNF146 ubiquitinates ADP-ribosylated AXIN (Reaction) 5396 
9.17.7.2.9.5 Ub-RibC-AXIN is degraded by the proteasome (BlackBoxEvent) 5397 
9.17.7.2.9.6 SMURF2 binds AXIN (Reaction) 5399 
9.17.7.2.9.7 AXIN is ubiquitinated by SMURF2 (Reaction) 5400 
9.17.7.2.9.8 ubiquitinated AXIN is degraded by the proteasome (BlackBoxEvent) 5401 
9.17.7.2.10 USP34 deubiquitinates AXIN (Reaction) 5402 
9.17.7.2.11 regulation of FZD by ubiquitination (Pathway) 5403 
9.17.7.2.11.1 ZNRF3/RNF43 binds the FZD:LRP5/6 receptor complex (Reaction) 5405 
9.17.7.2.11.2 ZNRF3 ubiquitinates FZD to promote its downregulation (Reaction) 5407 
9.17.7.2.11.3 USP8 deubiquitinates FZD to potentiate WNT signaling (Reaction) 5408 
9.17.7.2.11.4 RSPOs bind LGRs (Reaction) 5410 
9.17.7.2.11.5 RSPO:LGR binds ZNRF3 (Reaction) 5412 
9.17.7.2.11.6 ZNRF3 autoubiquitinates to promote its internalization (Reaction) 5413 
9.17.7.2.12 negative regulation of TCF-dependent signaling by WNT ligand antagonists5414 (Pathway) 
9.17.7.2.12.1 DKK and KRM bind LRP5/6 (Reaction) 5417 
9.17.7.2.12.2 DKK promotes clathrin-dependent internalization of LRP6 5419 (BlackBoxEvent) 
9.17.7.2.12.3 SOST binds LRP5/6 (Reaction) 5420 
9.17.7.2.12.4 WIF1 binds WNTs (Reaction) 5422 
9.17.7.2.12.5 sFRP binds WNT3A and inhibits WNT:FZD binding (Reaction) 5424 
9.17.7.2.13 negative regulation of TCF-dependent signaling by DVL-interacting proteins5426 (Pathway) 
9.17.7.2.13.1 CXXC4 binds DVL to prevent AXIN binding (Reaction) 5428 
9.17.7.2.13.2 DVL binds CCDC88C (Reaction) 5429 
9.17.7.2.14 canonical WNT signaling through the atypical receptor RYK (Reaction) 5431 
9.17.8 RNF mutants show enhanced WNT signaling and proliferation (Pathway) 5434 
9.17.8.1 RNF43 frameshift mutants show enhanced WNT siganling (FailedReaction) 5435 
9.17.8.2 TCF dependent signaling in response to WNT (Pathway) 5438 
9.17.8.2.1 WNT binds to FZD and LRP5/6 (Reaction) 5438 
9.17.8.2.2 WNT mediated activation of DVL (Pathway) 5438 
9.17.8.2.2.1 CSNK2-mediated phosphorylation of DVL (Reaction) 5438 
9.17.8.2.2.2 WNT signaling stimulates CSNK1-dependent phosphorylation of DVL 5439 (Reaction) 
9.17.8.2.2.3 Phosphorylated DVL recruits PIP5K1B to the plasma membrane (Reaction)5439 
9.17.8.2.2.4 DVL-associated PIP5K1B phosphorylates PI4P to PI(4,5)P2 (Reaction) 5439 
9.17.8.2.3 FZD recruits DVL to the receptor complex (Reaction) 5440 
9.17.8.2.4 disassembly of the destruction complex and recruitment of AXIN to the 5440 membrane (Pathway) 
9.17.8.2.4.1 FRAT proteins bind GSK3beta (Reaction) 5440 
9.17.8.2.4.2 PP2A dephosphorylates AXIN in the destruction complex (BlackBoxEvent)5440 
9.17.8.2.4.3 DVL recruits GSK3beta:AXIN1 to the receptor complex (Reaction) 5441 
9.17.8.2.4.4 phosphorylation of LRP5/6 cytoplasmic domain by membrane-associated5441 GSK3beta (Reaction) 
9.17.8.2.4.5 phosphorylation of LRP5/6 cytoplasmic domain by CSNKI (Reaction) 5441 
9.17.8.2.4.6 WNT3A stimulates the caveolin-dependent internalization of FZD5:p-LRP6
5442 (BlackBoxEvent) 
9.17.8.2.4.7 beta-catenin is released from the destruction complex (Reaction) 5442 
9.17.8.2.5 beta-catenin translocates to the nucleus (BlackBoxEvent) 5442 
9.17.8.2.6 formation of the beta-catenin:TCF transactivating complex (Pathway) 5442 
9.17.8.2.6.1 binding of TCF/LEF:CTNNB1 to target gene promoters (Pathway) 5443 
9.17.8.2.6.1.1 TCF7L1/TCF7L2/LEF1:CTNNB1 bind the MYC gene (Reaction) 5443 
9.17.8.2.6.1.2 TCF7L1/TCF7L2/LEF1:CTNNB1 promote transcription of the MYC gene5443 
(BlackBoxEvent) 
9.17.8.2.6.1.3 TCF/LEF:CTNNB1 bind the AXIN2 gene (Reaction) 5443 
9.17.8.2.6.1.4 TCF/LEF:CTNNB1 promote transcription of AXIN2 (BlackBoxEvent) 5444 
9.17.8.2.6.2 beta-catenin displaces TLE:HDAC1 from TCF/LEF (Reaction) 5444 
9.17.8.2.6.3 beta-catenin:TCF associates with BCL9 and PYGO (Reaction) 5444 
9.17.8.2.6.4 beta-catenin recruits CBP/p300 (Reaction) 5444 
9.17.8.2.6.5 beta-catenin recruits CDC73 and LEO1 (Reaction) 5445 
9.17.8.2.6.6 beta-catenin recruits SMARCA4 (Reaction) 5445 
9.17.8.2.6.7 Recruitment of SET1 methyltransferase complex (Reaction) 5445 
9.17.8.2.6.8 SET1 complex trimethylates H3K4 at the MYC gene (Reaction) 5445 
9.17.8.2.6.9 beta-catenin recruits TRRAP/KAT5 HAT components (Reaction) 5446 
9.17.8.2.6.10 KAT5 HAT complex acetylates TCF4 gene at histone H4 (Reaction) 5446 
9.17.8.2.7 deactivation of the beta-catenin transactivating complex (Pathway) 5446 
9.17.8.2.7.1 XIAP binds TLE (Reaction) 5446 
9.17.8.2.7.2 XIAP monoubiquinates TLE (Reaction) 5447 
9.17.8.2.7.3 XIAP dissociates from ub-TLE (Reaction) 5447 
9.17.8.2.7.4 APC promotes disassembly of beta-catenin transactivation complex 5447 (BlackBoxEvent) 
9.17.8.2.7.5 beta-catenin is replaced by repression complexes at the promoter 5447 (BlackBoxEvent) 
9.17.8.2.7.6 CBY1 binds beta-catenin (Reaction) 5448 
9.17.8.2.7.7 AKT phosphorylates CBY1 (Reaction) 5448 
9.17.8.2.7.8 YWHAZ binds p-CBY:CTNNB1 (Reaction) 5448 
9.17.8.2.7.9 XPO1 binds the beta-catenin:CBY complex (Reaction) 5448 
9.17.8.2.7.10 YWHAZ and XPO1 mediate the nuclear export of beta-catenin 5449 (BlackBoxEvent) 
9.17.8.2.7.11 CTNNBIP1 binds beta-catenin (Reaction) 5449 
9.17.8.2.7.12 CHD8 binds beta-catenin to negatively regulate WNT-dependent gene 5449 expression (Reaction) 
9.17.8.2.8 degradation of DVL (Pathway) 5449 
9.17.8.2.8.1 DVL is bound by the CUL3:KLHL12:RBX1 ubiquitin ligase complex 5450 (Reaction) 
9.17.8.2.8.2 DVL is ubiquitinated by CUL3:KLHL12:RBX1 (Reaction) 5450 
9.17.8.2.8.3 ubiquitinated DVL is degraded by the proteasome (BlackBoxEvent) 5450 
9.17.8.2.8.4 DVL1 is bound by the HECT ubiquitin ligase HECW1 (Reaction) 5451 
9.17.8.2.8.5 DVL1 is ubiquitinated by HECW1 (Reaction) 5451 
9.17.8.2.8.6 ubiquitinated DVL1 is degraded by the proteasome (BlackBoxEvent) 5451 
9.17.8.2.8.7 DACT1 binds DVL2 (Reaction) 5451 
9.17.8.2.9 degradation of AXIN (Pathway) 5452 
9.17.8.2.9.1 Tankyrase binds AXIN (Reaction) 5452 
9.17.8.2.9.2 Tankyrase ADP-ribosylates AXIN (Reaction) 5452 
9.17.8.2.9.3 RNF146 binds RibC-AXIN:TNKS complex (Reaction) 5452 
9.17.8.2.9.4 RNF146 ubiquitinates ADP-ribosylated AXIN (Reaction) 5453 
9.17.8.2.9.5 Ub-RibC-AXIN is degraded by the proteasome (BlackBoxEvent) 5453 
9.17.8.2.9.6 SMURF2 binds AXIN (Reaction) 5453 
9.17.8.2.9.7 AXIN is ubiquitinated by SMURF2 (Reaction) 5453 
9.17.8.2.9.8 ubiquitinated AXIN is degraded by the proteasome (BlackBoxEvent) 5454 
9.17.8.2.10 USP34 deubiquitinates AXIN (Reaction) 5454 
9.17.8.2.11 regulation of FZD by ubiquitination (Pathway) 5454 
9.17.8.2.11.1 ZNRF3/RNF43 binds the FZD:LRP5/6 receptor complex (Reaction) 5454 
9.17.8.2.11.2 ZNRF3 ubiquitinates FZD to promote its downregulation (Reaction) 5455 
9.17.8.2.11.3 USP8 deubiquitinates FZD to potentiate WNT signaling (Reaction) 5455 
9.17.8.2.11.4 RSPOs bind LGRs (Reaction) 5455 
9.17.8.2.11.5 RSPO:LGR binds ZNRF3 (Reaction) 5455 
9.17.8.2.11.6 ZNRF3 autoubiquitinates to promote its internalization (Reaction) 5456 
9.17.8.2.12 negative regulation of TCF-dependent signaling by WNT ligand antagonists5456 (Pathway) 
9.17.8.2.12.1 DKK and KRM bind LRP5/6 (Reaction) 5456 
9.17.8.2.12.2 DKK promotes clathrin-dependent internalization of LRP6 5456 (BlackBoxEvent) 
9.17.8.2.12.3 SOST binds LRP5/6 (Reaction) 5457 
9.17.8.2.12.4 WIF1 binds WNTs (Reaction) 5457 
9.17.8.2.12.5 sFRP binds WNT3A and inhibits WNT:FZD binding (Reaction) 5457 
9.17.8.2.13 negative regulation of TCF-dependent signaling by DVL-interacting proteins5457 (Pathway) 
9.17.8.2.13.1 CXXC4 binds DVL to prevent AXIN binding (Reaction) 5458 
9.17.8.2.13.2 DVL binds CCDC88C (Reaction) 5458 
9.17.8.2.14 canonical WNT signaling through the atypical receptor RYK (Reaction) 5458 
9.17.9 XAV939 inhibits tankyrase, stabilizing AXIN (Pathway) 5458 
9.17.9.1 XAV939 binds tankyrase to stabilize axin and inhibit WNT signaling (Reaction) 5460 
9.17.9.2 TCF dependent signaling in response to WNT (Pathway) 5461 
9.17.9.2.1 WNT binds to FZD and LRP5/6 (Reaction) 5461 
9.17.9.2.2 WNT mediated activation of DVL (Pathway) 5461 
9.17.9.2.2.1 CSNK2-mediated phosphorylation of DVL (Reaction) 5462 
9.17.9.2.2.2 WNT signaling stimulates CSNK1-dependent phosphorylation of DVL 5462 (Reaction) 
9.17.9.2.2.3 Phosphorylated DVL recruits PIP5K1B to the plasma membrane (Reaction)5462 
9.17.9.2.2.4 DVL-associated PIP5K1B phosphorylates PI4P to PI(4,5)P2 (Reaction) 5463 
9.17.9.2.3 FZD recruits DVL to the receptor complex (Reaction) 5463 
9.17.9.2.4 disassembly of the destruction complex and recruitment of AXIN to the 5463 membrane (Pathway) 
9.17.9.2.4.1 FRAT proteins bind GSK3beta (Reaction) 5463 
9.17.9.2.4.2 PP2A dephosphorylates AXIN in the destruction complex (BlackBoxEvent)5464 
9.17.9.2.4.3 DVL recruits GSK3beta:AXIN1 to the receptor complex (Reaction) 5464 
9.17.9.2.4.4 phosphorylation of LRP5/6 cytoplasmic domain by membrane-associated5464 GSK3beta (Reaction) 
9.17.9.2.4.5 phosphorylation of LRP5/6 cytoplasmic domain by CSNKI (Reaction) 5465 
9.17.9.2.4.6 WNT3A stimulates the caveolin-dependent internalization of FZD5:p-LRP6
5465 (BlackBoxEvent) 
9.17.9.2.4.7 beta-catenin is released from the destruction complex (Reaction) 5465 
9.17.9.2.5 beta-catenin translocates to the nucleus (BlackBoxEvent) 5466 
9.17.9.2.6 formation of the beta-catenin:TCF transactivating complex (Pathway) 5466 
9.17.9.2.6.1 binding of TCF/LEF:CTNNB1 to target gene promoters (Pathway) 5466 
9.17.9.2.6.1.1 TCF7L1/TCF7L2/LEF1:CTNNB1 bind the MYC gene (Reaction) 5466 
9.17.9.2.6.1.2 TCF7L1/TCF7L2/LEF1:CTNNB1 promote transcription of the MYC gene
5467 
(BlackBoxEvent) 
9.17.9.2.6.1.3 TCF/LEF:CTNNB1 bind the AXIN2 gene (Reaction) 5467 
9.17.9.2.6.1.4 TCF/LEF:CTNNB1 promote transcription of AXIN2 (BlackBoxEvent) 5467 
9.17.9.2.6.2 beta-catenin displaces TLE:HDAC1 from TCF/LEF (Reaction) 5467 
9.17.9.2.6.3 beta-catenin:TCF associates with BCL9 and PYGO (Reaction) 5468 
9.17.9.2.6.4 beta-catenin recruits CBP/p300 (Reaction) 5468 
9.17.9.2.6.5 beta-catenin recruits CDC73 and LEO1 (Reaction) 5468 
9.17.9.2.6.6 beta-catenin recruits SMARCA4 (Reaction) 5468 
9.17.9.2.6.7 Recruitment of SET1 methyltransferase complex (Reaction) 5469 
9.17.9.2.6.8 SET1 complex trimethylates H3K4 at the MYC gene (Reaction) 5469 
9.17.9.2.6.9 beta-catenin recruits TRRAP/KAT5 HAT components (Reaction) 5469 
9.17.9.2.6.10 KAT5 HAT complex acetylates TCF4 gene at histone H4 (Reaction) 5469 
9.17.9.2.7 deactivation of the beta-catenin transactivating complex (Pathway) 5470 
9.17.9.2.7.1 XIAP binds TLE (Reaction) 5470 
9.17.9.2.7.2 XIAP monoubiquinates TLE (Reaction) 5470 
9.17.9.2.7.3 XIAP dissociates from ub-TLE (Reaction) 5470 
9.17.9.2.7.4 APC promotes disassembly of beta-catenin transactivation complex 5471 (BlackBoxEvent) 
9.17.9.2.7.5 beta-catenin is replaced by repression complexes at the promoter 5471 (BlackBoxEvent) 
9.17.9.2.7.6 CBY1 binds beta-catenin (Reaction) 5471 
9.17.9.2.7.7 AKT phosphorylates CBY1 (Reaction) 5471 
9.17.9.2.7.8 YWHAZ binds p-CBY:CTNNB1 (Reaction) 5472 
9.17.9.2.7.9 XPO1 binds the beta-catenin:CBY complex (Reaction) 5472 
9.17.9.2.7.10 YWHAZ and XPO1 mediate the nuclear export of beta-catenin 5472 (BlackBoxEvent) 
9.17.9.2.7.11 CTNNBIP1 binds beta-catenin (Reaction) 5472 
9.17.9.2.7.12 CHD8 binds beta-catenin to negatively regulate WNT-dependent gene 5473 expression (Reaction) 
9.17.9.2.8 degradation of DVL (Pathway) 5473 
9.17.9.2.8.1 DVL is bound by the CUL3:KLHL12:RBX1 ubiquitin ligase complex 5473 (Reaction) 
9.17.9.2.8.2 DVL is ubiquitinated by CUL3:KLHL12:RBX1 (Reaction) 5473 
9.17.9.2.8.3 ubiquitinated DVL is degraded by the proteasome (BlackBoxEvent) 5474 
9.17.9.2.8.4 DVL1 is bound by the HECT ubiquitin ligase HECW1 (Reaction) 5474 
9.17.9.2.8.5 DVL1 is ubiquitinated by HECW1 (Reaction) 5474 
9.17.9.2.8.6 ubiquitinated DVL1 is degraded by the proteasome (BlackBoxEvent) 5474 
9.17.9.2.8.7 DACT1 binds DVL2 (Reaction) 5475 
9.17.9.2.9 degradation of AXIN (Pathway) 5475 
9.17.9.2.9.1 Tankyrase binds AXIN (Reaction) 5475 
9.17.9.2.9.2 Tankyrase ADP-ribosylates AXIN (Reaction) 5475 
9.17.9.2.9.3 RNF146 binds RibC-AXIN:TNKS complex (Reaction) 5476 
9.17.9.2.9.4 RNF146 ubiquitinates ADP-ribosylated AXIN (Reaction) 5476 
9.17.9.2.9.5 Ub-RibC-AXIN is degraded by the proteasome (BlackBoxEvent) 5476 
9.17.9.2.9.6 SMURF2 binds AXIN (Reaction) 5476 
9.17.9.2.9.7 AXIN is ubiquitinated by SMURF2 (Reaction) 5477 
9.17.9.2.9.8 ubiquitinated AXIN is degraded by the proteasome (BlackBoxEvent) 5477 
9.17.9.2.10 USP34 deubiquitinates AXIN (Reaction) 5477 
9.17.9.2.11 regulation of FZD by ubiquitination (Pathway) 5477 
9.17.9.2.11.1 ZNRF3/RNF43 binds the FZD:LRP5/6 receptor complex (Reaction) 5478 
9.17.9.2.11.2 ZNRF3 ubiquitinates FZD to promote its downregulation (Reaction) 5478 
9.17.9.2.11.3 USP8 deubiquitinates FZD to potentiate WNT signaling (Reaction) 5478 
9.17.9.2.11.4 RSPOs bind LGRs (Reaction) 5479 
9.17.9.2.11.5 RSPO:LGR binds ZNRF3 (Reaction) 5479 
9.17.9.2.11.6 ZNRF3 autoubiquitinates to promote its internalization (Reaction) 5479 
9.17.9.2.12 negative regulation of TCF-dependent signaling by WNT ligand antagonists5479 (Pathway) 
9.17.9.2.12.1 DKK and KRM bind LRP5/6 (Reaction) 5480 
9.17.9.2.12.2 DKK promotes clathrin-dependent internalization of LRP6 5480 (BlackBoxEvent) 
9.17.9.2.12.3 SOST binds LRP5/6 (Reaction) 5480 
9.17.9.2.12.4 WIF1 binds WNTs (Reaction) 5480 
9.17.9.2.12.5 sFRP binds WNT3A and inhibits WNT:FZD binding (Reaction) 5481 
9.17.9.2.13 negative regulation of TCF-dependent signaling by DVL-interacting proteins5481 (Pathway) 
9.17.9.2.13.1 CXXC4 binds DVL to prevent AXIN binding (Reaction) 5481 
9.17.9.2.13.2 DVL binds CCDC88C (Reaction) 5481 
9.17.9.2.14 canonical WNT signaling through the atypical receptor RYK (Reaction) 5482 
9.17.10 WNT ligand secretion is abrogated by the PORCN inhibitor LGK974 (Pathway) 5482 
9.17.10.1 PORCN-inhibitor LGK974 prevents WNT ligand palmitoyltation and secretion 5483 (Reaction) 
9.17.10.2 WNT ligand biogenesis and trafficking (Pathway) 5486 
9.17.10.2.1 N-linked glycosylation of WNTs (BlackBoxEvent) 5488 
9.17.10.2.2 PORCN palmitoleoylates N-glycosyl WNTs (Reaction) 5490 
9.17.10.2.3 WNT ligands traffic to the Golgi (BlackBoxEvent) 5494 
9.17.10.2.4 WLS binds WNT ligands in the Golgi (Reaction) 5496 
9.17.10.2.5 WNT ligands traffic to the plasma membrane (BlackBoxEvent) 5497 
9.17.10.2.6 secretion of WNT ligands (Reaction) 5499 
9.17.10.2.7 WLS is endocytosed to the early endosome (BlackBoxEvent) 5500 
9.17.10.2.8 Retromer associates with WLS (Reaction) 5502 
9.17.10.2.9 Retromer recycles WLS to the Golgi (BlackBoxEvent) 5504 
9.17.10.2.10 WLS dissociates from retromer (BlackBoxEvent) 5505 
9.18 Processing-defective Hh variants abrogate ligand secretion (Pathway) 5506 
9.18.1 Hh ligand biogenesis disease (Pathway) 5508 
9.18.1.1 HPE SHH variants don't undergo autoproteolytic cleavage (FailedReaction) 5509 
9.18.1.2 Hh processing variants bind lectins (Reaction) 5513 
9.18.1.3 Hh processing variants are recruited to SEL1:SYVN at the ER membrane 5515 (Reaction) 
9.18.1.4 Hh processing variants are ubiquitinated (Reaction) 5516 
9.18.1.5 Hh processing variants are translocated to the cytosol in a VCP-dependent 5517 manner (Reaction) 
9.18.1.6 processing defective Hh variants are degraded by the proteasome 5519 (BlackBoxEvent) 
9.18.1.7 G287V HHAT variants doesn't palmitoylate Hh-Np (FailedReaction) 5520 10 DNA Repair (Pathway) 5523 
10.1 Base Excision Repair (Pathway) 5524 
10.1.1 Base-Excision Repair, AP Site Formation (Pathway) 5525 
10.1.1.1 Depurination (Pathway) 5525 
10.1.1.1.1 Recognition and association of DNA glycosylase with site containing an 5526 affected purine (Pathway) 
10.1.1.1.1.1 MPG glycosylase mediated recognition and binding of 3-methyladenine 5527 (Reaction) 
10.1.1.1.1.2 MPG glycosylase mediated recognition and binding of ethenoadenine 5527 (Reaction) 
10.1.1.1.1.3 MPG glycosylase mediated recognition and binding of hypoxanthine 5528 (Reaction) 
10.1.1.1.1.4 MYH glycosylase mediated recognition and binding of an adenine opposite
5528 to an 8-oxo guanine (Reaction) 
10.1.1.1.1.5 hOGG1 glycosylase mediated recognition and binding of an 8-oxo guanine
5529 opposite to a cytosine (Reaction) 
10.1.1.1.1.6 hOGG1 glycosylase mediated recognition and binding of a 5529 formamidopyrimidine (Reaction) 
10.1.1.1.2 Cleavage of the damaged purine (Pathway) 5530 
10.1.1.1.2.1 Cleavage 8-oxo guanine by MYH glycosylase (Reaction) 5530 
10.1.1.1.2.2 Cleavage of 3-methyladenine by MPG glycosylase (Reaction) 5531 
10.1.1.1.2.3 Cleavage of ethenoadenine by MPG glycosylase (Reaction) 5532 
10.1.1.1.2.4 Cleavage of hypoxanthine by MPG glycosylase (Reaction) 5532 
10.1.1.1.2.5 Cleavage of 8-oxo guanine by hOGG1 glycosylase (Reaction) 5533 
10.1.1.1.2.6 Cleavage of formamidopyrimidine by hOGG1 glycosylase (Reaction) 5534 
10.1.1.2 Depyrimidination (Pathway) 5534 
10.1.1.2.1 Recognition and association of DNA glycosylase with site containing an 5535 affected pyrimidine (Pathway) 
10.1.1.2.1.1 UNG glycosylase mediated recognition and binding of a 5-hydroxyuracil 5535 opposite to a guanine (Reaction) 
10.1.1.2.1.2 UNG glycosylase mediated recognition and binding of an uracil opposite to
5536 a guanine (Reaction) 
10.1.1.2.1.3 TDG glycosylase mediated recognition and binding of an ethenocytosine5536 (Reaction) 
10.1.1.2.1.4 TDG glycosylase mediated recognition and binding of an thymine opposite
5537 to a guanine (Reaction) 
10.1.1.2.1.5 TDG glycosylase mediated recognition and binding of an uracil opposite to 
a guanine (Reaction) 
10.1.1.2.1.6 hSMUG1 glycosylase mediated recognition and binding of uracil within 5538 single-stranded DNA (Reaction) 
10.1.1.2.1.7 MBD4 glycosylase mediated recognition and binding of a thymine opposite
5538 to a guanine at CpG sequences (Reaction) 
10.1.1.2.1.8 MBD4 glycosylase mediated recognition and binding of an uracil opposite to
5539 a guanine at CpG sequences (Reaction) 
10.1.1.2.1.9 hNTH1 glycosylase mediated recognition and binding of cytosine glycol 5539 (Reaction) 
10.1.1.2.1.10 hNTH1 glycosylase mediated recognition and binding of dihydrouracil 5540 (Reaction) 
10.1.1.2.1.11 hNTH1 glycosylase mediated recognition and binding of 5540 formamidopyrimidine (Reaction) 
10.1.1.2.1.12 hNTH1 glycosylase mediated recognition and binding of thymine glycol 5541 (Reaction) 
10.1.1.2.2 Cleavage of the damaged pyrimidine (Pathway) 5541 
10.1.1.2.2.1 Cleavage of uracil by UNG2 glycosylase (Reaction) 5542 
10.1.1.2.2.2 Cleavage of 5-hydroxyluracil by UNG2 glycosylase (Reaction) 5542 
10.1.1.2.2.3 Cleavage of uracil by TDG glycosylase (Reaction) 5543 
10.1.1.2.2.4 Cleavage of thymine by TDG glycosylase (Reaction) 5543 
10.1.1.2.2.5 Cleavage of uracil by hSMUG1 glycosylase (Reaction) 5544 
10.1.1.2.2.6 Cleavage of thymine glycol by hNTH1 glycosylase (Reaction) 5545 
10.1.1.2.2.7 Cleavage of cytosine glycol by hNTH1 glycosylase (Reaction) 5545 
10.1.1.2.2.8 Cleavage of dihydrouracil by hNTH1 glycosylase (Reaction) 5546 
10.1.1.2.2.9 Cleavage of formamidopyrimidine by hNTH1 glycosylase (Reaction) 5546 
10.1.1.2.2.10 Cleavage of uracil by MBD4 glycosylase (Reaction) 5547 
10.1.1.2.2.11 Cleavage of thymine by MBD4 glycosylase (Reaction) 5547 
10.1.1.2.2.12 Cleavage of ethenocytosine by TDG glycosylase (Reaction) 5548 
10.1.2 Resolution of Abasic Sites (AP sites) (Pathway) 5548 
10.1.2.1 Resolution of AP sites via the single-nucleotide replacement pathway (Pathway)5548 
10.1.2.1.1 Base-free sugar-phosphate removal via the single-nucleotide replacement 5551 pathway (Pathway) 
10.1.2.1.1.1 Displacement of DNA glycosylase by APE1 (Pathway) 5551 
10.1.2.1.1.1.1 Displacement of UNG2 glycosylase by APE1 at the AP site (Reaction)5552 
10.1.2.1.1.1.2 Displacement of TDG glycosylase by APE1 at the AP site (Reaction) 5552 
10.1.2.1.1.1.3 Displacement of hSMUG1 glycosylase by APE1 at the AP site 5553 (Reaction) 
10.1.2.1.1.1.4 Displacement of hNTH1 glycosylase by APE1 at the AP site (Reaction)5553 
10.1.2.1.1.1.5 Displacement of MBD4 glycosylase by APE1 at the AP site (Reaction)5554 
10.1.2.1.1.1.6 Displacement of hOGG1 glycosylase by APE1 at the AP site (Reaction)5554 
10.1.2.1.1.1.7 Displacement of MYH glycosylase by APE1 at the AP site (Reaction) 5555 
10.1.2.1.1.1.8 Displacement of MPG glycosylase by APE1 at the AP site (Reaction) 5555 
10.1.2.1.1.2 APE1 mediated endonucleolytic cleavage at the 5' side of the base-free 5556 deoxyribose residue (Reaction) 
10.1.2.1.1.3 Recruitment of POL Beta to the AP site (Reaction) 5537
5557 
10.1.2.1.1.4 Excision of the abasic sugar phosphate (dRP) residue at the strand break5557 (Reaction) 
10.1.2.1.2 Recruitment of LIG3:XRRC1 complex to the site of repair by POL Beta 5558 (Reaction) 
10.1.2.1.3 Resynthesis of excised residue (Reaction) 5559 
10.1.2.1.4 DNA ligation via the single-nucleotide replacement pathway (Reaction) 5559 
10.1.2.1.5 Dissociation of LIG3:XRCC1 complex from site of BER (Reaction) 5560 
10.1.2.2 Resolution of AP sites via the multiple-nucleotide patch replacement pathway 5561 (Pathway) 
10.1.2.2.1 Removal of DNA patch containing abasic residue (Pathway) 5563 
10.1.2.2.1.1 Displacement of DNA glycosylase by APE1 (Pathway) 5563 
10.1.2.2.1.1.1 Displacement of UNG2 glycosylase by APE1 at the AP site (Reaction)5564 
10.1.2.2.1.1.2 Displacement of TDG glycosylase by APE1 at the AP site (Reaction) 5564 
10.1.2.2.1.1.3 Displacement of hSMUG1 glycosylase by APE1 at the AP site 5564 (Reaction) 
10.1.2.2.1.1.4 Displacement of hNTH1 glycosylase by APE1 at the AP site (Reaction)5565 
10.1.2.2.1.1.5 Displacement of MBD4 glycosylase by APE1 at the AP site (Reaction)5565 
10.1.2.2.1.1.6 Displacement of hOGG1 glycosylase by APE1 at the AP site (Reaction)5565 
10.1.2.2.1.1.7 Displacement of MYH glycosylase by APE1 at the AP site (Reaction) 5566 
10.1.2.2.1.1.8 Displacement of MPG glycosylase by APE1 at the AP site (Reaction) 5566 
10.1.2.2.1.2 APE1 mediated endonucleolytic cleavage at the 5' side of the base-free 5566 deoxyribose residue (Reaction) 
10.1.2.2.1.3 Recruitment of POL Beta to the AP site (Reaction) 5567 
10.1.2.2.1.4 POL Beta mediated incorporation of the first replacement nucleotide 5567 (Reaction) 
10.1.2.2.1.5 POL delta associates with AP site displacing POL Beta (Reaction) 5568 
10.1.2.2.1.6 DNA strand displacement synthesis (Reaction) 5568 
10.1.2.2.1.7 Interaction of APE1 with DNA ligase I (Reaction) 5569 
10.1.2.2.1.8 Interaction of APE1 with FEN1 (Reaction) 5570 
10.1.2.2.1.9 Interaction between FEN1 and PCNA (Reaction) 5570 
10.1.2.2.1.10 Cleavage of flap structures (Reaction) 5571 
10.1.2.2.2 Ligation of DNA at sites of patch replacement (Reaction) 5572 
10.2 DNA Damage Bypass (Pathway) 5573 
10.2.1 Translesion synthesis by DNA polymerases bypassing lesion on DNA template 5574 (Pathway) 
10.2.1.1 Translesion synthesis by HREV1 (Pathway) 5575 
10.2.1.1.1 Binding of REV1 to lesioned DNA template (Reaction) 5575 
10.2.1.1.2 Misinsertion of bases opposite to the lesion by HREV1 (Reaction) 5576 
10.2.1.1.3 Elongation by REV1 protein (Reaction) 5576 
10.2.1.2 Translesion synthesis by Pol eta (Pathway) 5577 
10.2.1.2.1 Binding of Pol eta to lesioned DNA template (Reaction) 5577 
10.2.1.2.2 Insertion of correct bases opposite to the lesion by Pol eta (Reaction) 5578 
10.2.1.2.3 Elongation by Pol eta (Reaction) 5578 
10.2.1.3 Translesion synthesis by Pol zeta (Pathway) 5579 
10.2.1.3.1 Binding of Pol zeta to lesioned DNA template (Reaction) 5579 10.2.1.3.2 Formation of Pol zeta complex (Reaction) 5580 
10.2.1.3.3 Elongation by Pol zeta complex (Reaction) 5580 
10.3 DNA Damage Reversal (Pathway) 5581 
10.3.1 MGMT/hAGT mediated DNA Damage Reversal (Reaction) 5581 
10.3.2 Reversal of Alkylation Damage By DNA Dioxygenases (Pathway) 5583 
10.3.2.1 ABH2 mediated Reversal of Alkylation Damage (Pathway) 5584 
10.3.2.1.1 Oxidative demethylation of 1-MeA damaged DNA By ABH2 (Reaction) 5585 
10.3.2.1.2 Oxidative demethylation of 3-MeC damaged DNA By ABH2 (Reaction) 5586 
10.3.2.1.3 Oxidative demethylation of 1-EtA damaged DNA By ABH2 (Reaction) 5586 
10.3.2.2 ABH3 mediated Reversal of Alkylation Damage (Pathway) 5587 
10.3.2.2.1 Oxidative demethylation of 1-MeA damaged DNA By ABH3 (Reaction) 5588 
10.3.2.2.2 Oxidative demethylation of 3-MeC damaged DNA By ABH3 (Reaction) 5589 
10.3.2.2.3 Oxidative demethylation of 1-EtA damaged DNA By ABH3 (Reaction) 5590 
10.4 Double-Strand Break Repair (Pathway) 5591 
10.4.1 Homologous Recombination Repair (Pathway) 5593 
10.4.1.1 Homologous recombination repair of replication-independent double-strand 5595 breaks (Pathway) 
10.4.1.1.1 ATM mediated response to DNA double-strand break (Pathway) 5596 
10.4.1.1.1.1 Intermolecular autophosphorylation of ATM within dimeric ATM complexes
5596 (Reaction) 
10.4.1.1.1.2 Dissociation of dimeric phospho-ATM complexes (Reaction) 5597 
10.4.1.1.1.3 ATM mediated phosphorylation of repair proteins (Pathway) 5598 
10.4.1.1.1.3.1 Phosphorylation of histone H2AX at Serine-139 by ATM at the site of 5599 DSB (Reaction) 
10.4.1.1.1.3.2 Phosphorylation of BRCA1 at multiple sites by ATM (Reaction) 5600 
10.4.1.1.1.3.3 Phosphorylation of NBS1 by ATM (Reaction) 5601 
10.4.1.1.1.3.4 Phosphorylation of MDC1/NFBD1 by ATM (within 2 c-term BRCT 5602 domains) (Reaction) 
10.4.1.1.2 Recruitment of repair and signaling proteins to double-strand breaks (Pathway)
5604 
10.4.1.1.2.1 MDC1/NFBD1 associates with gamma H2AX at nuclear foci (Reaction) 5606 
10.4.1.1.2.2 phospho-ATM (Serine 1981) associates with DNA at the site of 5607 double-strand breaks (Reaction) 
10.4.1.1.2.3 53BP1 associates with gamma H2AX at nuclear foci (Reaction) 5608 
10.4.1.1.2.4 MRN complex relocalizes to nuclear foci (Pathway) 5608 
10.4.1.1.2.4.1 Association of gamma-H2AX with NBS1 (Reaction) 5609 
10.4.1.1.2.4.2 Assembly of the RAD50-MRE11-NBS1 complex at DNA double-strand5610 breaks (Pathway) 
10.4.1.1.2.4.2.1 Formation of RAD50:MRE11 complex (Reaction) 5610 
10.4.1.1.2.4.2.2 Association of RAD50:MRE11 complex with NBS1 via MRE11 5611 interaction (Reaction) 
10.4.1.1.2.4.2.3 Association of MRN with sites of DSB (Reaction) 5611 
10.4.1.1.2.5 BRCA1 associates with 53BP1at the site of DNA double-strand break 5612 (Reaction) 
10.4.1.1.3 Processing of DNA double-strand break ends (Pathway) 5613 
10.4.1.1.3.1 Resection of double-strand break ends (Reaction) 5613 10.4.1.1.3.2 Association of RPA complexes with ssDNA (Reaction) 5616 
10.4.1.1.4 Homologous DNA pairing and strand exchange (Pathway) 5617 
10.4.1.1.4.1 Presynaptic phase of homologous DNA pairing and strand exchange 5618 (Pathway) 
10.4.1.1.4.1.1 Association of RAD51 with BRCA2 (Reaction) 5619 
10.4.1.1.4.1.2 Formation of RAD52 heptameric ring structure complexes on ssDNA 5619 (Reaction) 
10.4.1.1.4.1.3 Association of RAD52 with the RPA complex (Reaction) 5621 
10.4.1.1.4.1.4 Association of RAD52 with ssDNA at resected ends of double-strand 5621 break (Reaction) 
10.4.1.1.4.1.5 Assembly of the RAD51-ssDNA nucleoprotein complex (Pathway) 5622 
10.4.1.1.4.1.5.1 Association of RAD51 with RAD52:DNA double-strand break ends5624 (Reaction) 
10.4.1.1.4.1.5.2 Association of RAD51 with the RPA complex (Reaction) 5625 
10.4.1.1.4.1.5.3 Association of RAD51 with the resected ends of the DNA 5626 double-strand break (Reaction) 
10.4.1.1.4.2 Strand exchange/Branch migration (Reaction) 5627 
10.4.1.1.5 DNA repair synthesis (Reaction) 5629 
10.4.1.1.6 Resolution of D-loop structures (Pathway) 5631 
10.4.1.1.6.1 Resolution of D-loop structures through Holliday junction intermediates 5633 (Pathway) 
10.4.1.1.6.1.1 Ligation of DNA and formation of Holliday structures following repair 5635 synthesis (Reaction) 
10.4.1.1.6.1.2 Cleavage of Holliday junctions (Reaction) 5637 
10.4.1.1.6.2 Resolution of D-loop structures through synthesis-dependent 5639 strand-annealing (Pathway) 
10.4.1.1.6.2.1 Dissociation of the extended strands (Reaction) 5641 
10.4.1.1.6.2.2 Fill-in DNA synthesis (Reaction) 5643 
10.4.2 Nonhomologous End-joining (NHEJ) (Pathway) 5645 
10.4.2.1 Association of Ku heterodimer with ends of DNA double-strand break (Reaction)5647 
10.4.2.2 Association of DNA-PKcs with Ku-bound ends of DNA double-strand breaks 5649 (Reaction) 
10.4.2.3 Autophosphorylation of DNA-PKcs (Reaction) 5650 
10.4.2.4 Synapsis, or interaction between two DNA-PK:DNA complexes at opposing ends
5651 of DNA DSB (Reaction) 
10.4.2.5 Processing of DNA ends prior to end rejoining (Pathway) 5651 
10.4.2.5.1 Removal of 3'-phosphoglycolate (PG) moiety from DSB ends (Reaction) 5653 
10.4.2.5.2 Removal of 3'-phosphate moiety from DSB ends (Reaction) 5654 
10.4.2.6 Association of the XRCC4:DNA ligase IV complex with the DNA-PK:DNA synaptic
5655 complex (Reaction) 
10.4.2.7 Removal of repair proteins and ligation of the processed ends of the DNA 5656 double-strand break (Reaction) 
10.5 Nucleotide Excision Repair (Pathway) 5657 
10.5.1 Global Genomic NER (GG-NER) (Pathway) 5659 
10.5.1.1 DNA Damage Recognition in GG-NER (Pathway) 5660 10.5.1.1.1 XPC binds to HR23B forming a heterodimeric complex (Reaction) 5661 
10.5.1.1.2 XPC:HR23B complex binds to damaged DNA site with lesion (Reaction) 5661 
10.5.1.2 Formation of incision complex in GG-NER (Pathway) 5662 
10.5.1.2.1 Recruitment of repair factors to form preincision complex (Reaction) 5663 
10.5.1.2.2 Formation of open bubble structure in DNA by helicases (Reaction) 5664 
10.5.1.2.3 Formation of ERCC1-XPF heterodimeric complex (Reaction) 5665 
10.5.1.2.4 Binding of ERCC1-XPF to preincision complex (Reaction) 5665 
10.5.1.3 Dual incision reaction in GG-NER (Pathway) 5666 
10.5.1.3.1 3'- incision of DNA by XPG in GG-NER (Reaction) 5667 
10.5.1.3.2 5'-incision of DNA by ERCC1-XPF in GG-NER (Reaction) 5668 
10.5.1.4 Gap-filling DNA repair synthesis and ligation in GG-NER (Pathway) 5669 
10.5.1.4.1 Repair synthesis of patch ~27-30 bases long by DNA polymerase (Pathway)5670 
10.5.1.4.1.1 Repair synthesis of ~27-30 bases long patch by DNA Pol Epsilon 5670 (Reaction) 
10.5.1.4.1.2 Repair synthesis of patch ~27-30 bases long by DNA Pol Delta (Reaction)5671 
10.5.1.4.2 Ligation of newly synthesized repair patch to incised DNA in GG-NER 5672 (Reaction) 

10.5.2 Transcription-coupled NER (TC-NER) (Pathway) 5673 
10.5.2.1 Formation of transcription-coupled NER (TC-NER) repair complex (Pathway) 5674 
10.5.2.1.1 Formation of active Pol II complex with lesioned DNA template (Reaction) 5675 
10.5.2.1.2 RNA Pol II is blocked by the lesion leading to reduced transcription (Reaction)5675 
10.5.2.1.3 Assembly of repair proteins at the site of Pol II blockage (Reaction) 5676 
10.5.2.2 Dual incision reaction in TC-NER (Pathway) 5677 
10.5.2.2.1 Displacement of stalled Pol II from the lesion site (Reaction) 5678 
10.5.2.2.2 3' incision of the lesioned strand of DNA in TC-NER (Reaction) 5679 
10.5.2.2.3 5' incision leading to excision of DNA fragment with lesion in TC-NER 5679 (Reaction) 
10.5.2.3 Gap-filling DNA repair synthesis and ligation in TC-NER (Pathway) 5680 
10.5.2.3.1 Repair synthesis for gap-filling by DNA polymerase in TC-NER (Pathway) 5680 
10.5.2.3.1.1 Repair synthesis for gap-filling by DNA pol delta in TC-NER (Reaction) 5681 
10.5.2.3.1.2 Repair synthesis for gap-filling by DNA pol epsilon in TC-NER (Reaction)5681 
10.5.2.3.2 Ligation of newly synthesized repair patch to incised DNA in TC-NER 5682 (Reaction) 
10.5.2.4 Resumption of transcription after TC-NER (Reaction) 5683 
10.6 Fanconi Anemia pathway (Pathway) 5684 
10.6.1 Monoubiquitination of FANCD2 by the FA ubiquitin ligase complex (Reaction) 5685 
10.6.2 Monoubiquitination of FANCI by the FA ubiquitin ligase complex (Reaction) 5687 
10.6.3 Translocation of ub-FANCD2 and ub-FANCI to chromatin (Reaction) 5688 
10.6.4 Formation of the BRCA1-PALB2-BRCA2 complex (Reaction) 5690 
10.6.5 Regulation of the Fanconi anemia pathway (Pathway) 5691 
10.6.5.1 FANCD2 deubiquitination by USP1/UAF1 (Reaction) 5692 
10.6.5.2 Phosphorylation of FANCD2 by ATR/ATM (Reaction) 5694 
10.6.5.3 Phosphorylation of FANCI by ATM/ATR (Reaction) 5695 
10.7 Mismatch Repair (Pathway) 5697 
10.7.1 Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) (Pathway) 5699 
10.7.1.1 MSH2:MSH6 binds 1 base mismatch or 1-2 base insertion/deletion loop 5700 (Reaction) 
10.7.1.2 MSH2:MSH6 exchanges ADP for ATP (Reaction) 5702 
10.7.1.3 MSH2:MSH6 recruits MLH1:PMS2 to mismatch and interacts with PCNA 5704 (Reaction) 
10.7.1.4 MLH1:PMS2 makes single strand incision near 1-2 base mismatch (Reaction) 5706 
10.7.1.5 EXO1 interacts with MSH2:MSH6 (MutSalpha) and MLH1:PMS2 (MutLalpha) 5708 (Reaction) 
10.7.1.6 EXO1 interacting with MSH2:MSH6 excises single strand DNA containing a 5709 mismatch (BlackBoxEvent) 
10.7.1.7 DNA polymerase delta polymerizes DNA across single stranded gap (Reaction)5711 
10.7.1.8 DNA ligase I ligates single stranded nick in double stranded DNA (Reaction) 5713 
10.7.2 Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) (Pathway) 5714 
10.7.2.1 MSH2:MSH3 binds insertion/deletion loop of 2 bases or more (Reaction) 5716 
10.7.2.2 MSH2:MSH3 exchanges ADP for ATP (Reaction) 5718 
10.7.2.3 MSH2:MSH3 recruits MLH1:PMS2 to mismatch and interacts with PCNA 5720 (Reaction) 
10.7.2.4 MLH1:PMS2 makes single strand incision near insertion/deletion loop of 2 bases5723 or more (Reaction) 
10.7.2.5 EXO1 interacts with MSH2:MSH3 (MutSbeta) and MLH1:PMS2 (MutLalpha) 5725 (Reaction) 
10.7.2.6 EXO1 interacting with MSH2:MSH3 excises DNA strand containing an 5728 insertion/deletion loop (IDL) (BlackBoxEvent) 
10.7.2.7 DNA polymerase delta polymerizes DNA across single stranded gap (Reaction)5731 
10.7.2.8 DNA ligase I ligates single stranded nick in double stranded DNA (Reaction) 5731 11 DNA Replication (Pathway) 5732 
11.1 M/G1 Transition (Pathway) 5733 
11.1.1 DNA Replication Pre-Initiation (Pathway) 5733 
11.1.1.1 Assembly of the pre-replicative complex (Pathway) 5734 
11.1.1.1.1 Assembly of the ORC complex at the origin of replication (Pathway) 5734 
11.1.1.1.1.1 Orc3 associates with Orc2 constitutively bound at origins of replication 5734 (Reaction) 
11.1.1.1.1.2 Orc5 associates with Orc3:Orc2:origin complexes (Reaction) 5734 
11.1.1.1.1.3 Orc4 associates with Orc5:Orc3:Orc2:origin complexes (Reaction) 5735 
11.1.1.1.1.4 Orc1 associates with Orc4:Orc5:Orc3:Orc2:origin complexes (Reaction) 5735 
11.1.1.1.1.5 Orc6 associates with Orc1:Orc4:Orc5:Orc3:Orc2:origin complexes, forming
5735 ORC:origin complexes (Reaction) 
11.1.1.1.2 Association of MCM8 with ORC:origin complex (Reaction) 5736 
11.1.1.1.3 CDC6 association with the ORC:origin complex (Pathway) 5736 
11.1.1.1.3.1 CDC6 protein is synthesized under the control of E2F transcription factors5736 (BlackBoxEvent) 
11.1.1.1.3.2 CDC6 association with ORC:origin complexes mediated by MCM8 5737 (Reaction) 
11.1.1.1.4 CDT1 association with the CDC6:ORC:origin complex (Pathway) 5737 
11.1.1.1.4.1 The geminin component of geminin:Cdt1 complexes is ubiquitinated, 
releasing Cdt1 (Reaction) 
11.1.1.1.4.2 Ubiquitinated geminin is degraded by the proteasome (BlackBoxEvent) 5738 
11.1.1.1.4.3 Free CDT1 associates with CDC6:ORC:origin complexes (Reaction) 5738 
11.1.1.1.5 Mcm2-7 associates with the Cdt1:CDC6:ORC:origin complex, forming the 5739 pre-replicative complex (preRC) (Reaction) 
11.1.1.2 Activation of the pre-replicative complex (Pathway) 5739 
11.1.1.2.1 Mcm10 associates with the pre-replicative complex, stabilizing Mcm2-7 5739 (Reaction) 
11.1.1.2.2 Cdt1 is displaced from the pre-replicative complex. (Reaction) 5740 
11.1.1.2.3 CDK and DDK associate with the Mcm10:pre-replicative complex (Reaction)5740 
11.1.1.2.4 Mcm2-7 is phosphorylated by DDK (Reaction) 5740 
11.1.1.2.5 Cdc45 associates with the pre-replicative complex at the origin (Reaction) 5741 
11.1.1.2.6 DNA Replication Factor A (RPA) associates with the pre-replicative complex at
5741 the origin (Reaction) 
11.1.1.2.7 DNA polymerase alpha:primase binds at the origin (Reaction) 5741 
11.1.1.2.8 DNA polymerase epsilon binds at the origin (Reaction) 5742 
11.2 Synthesis of DNA (Pathway) 5742 
11.2.1 DNA replication initiation (Pathway) 5742 
11.2.1.1 The primase component of DNA polymerase:primase synthesizes a 6-10 5742 nucleotide RNA primer at the origin (Reaction) 
11.2.1.2 The polymerase component of DNA polymerase alpha:primase synthesizes a 5743 20-nucleotide primer at the origin (Reaction) 
11.2.2 Switching of origins to a post-replicative state (Pathway) 5743 
11.2.2.1 Orc1 removal from chromatin (Pathway) 5743 
11.2.2.1.1 Orc1 is phosphorylated by cyclin A/CDK2 (Reaction) 5744 
11.2.2.1.2 Phosphorylated Orc1 is ubiquitinated while still associated with chromatin 5744 (Reaction) 
11.2.2.1.3 Ubiquitinated Orc1 enters the cytosol (Reaction) 5744 
11.2.2.1.4 Ubiquitinated Orc1 is degraded by the proteasome (BlackBoxEvent) 5745 
11.2.2.2 CDK-mediated phosphorylation and removal of Cdc6 (Pathway) 5745 
11.2.2.2.1 Cdc6 protein is phosphorylated by CDK (Reaction) 5745 
11.2.2.2.2 Phosphorylated Cdc6 is exported from the nucleus (Reaction) 5746 
11.2.2.2.3 Cytoplasmic phosphorylated Cdc6 is ubiquitinated by the anaphase-promoting
5746 complex (Reaction) 
11.2.2.2.4 Ubiquitinated Cdc6 is degraded by the proteasome (BlackBoxEvent) 5747 
11.2.2.3 Mcm4,6,7 trimer forms and associates with the replication fork (Reaction) 5747 
11.2.3 DNA strand elongation (Pathway) 5748 
11.2.3.1 Unwinding of DNA (Pathway) 5748 
11.2.3.1.1 MCM2-7 mediated fork unwinding (Reaction) 5748 
11.2.3.1.2 MCM8 mediated fork unwinding (Reaction) 5748 
11.2.3.1.3 Formation of GINS complex (Reaction) 5749 
11.2.3.1.4 Multiple proteins are localized at replication fork (Reaction) 5749 
11.2.3.2 Leading Strand Synthesis (Pathway) 5750 
11.2.3.2.1 Polymerase switching (Pathway) 5750 
11.2.3.2.1.1 RFC binding displaces Pol Alpha (Reaction) 5737
5750 
11.2.3.2.1.2 Loading of PCNA - Sliding Clamp Formation (Reaction) 5750 
11.2.3.2.1.3 RFC dissociates after sliding clamp formation (Reaction) 5751 
11.2.3.2.1.4 Formation of Processive Complex (Reaction) 5751 
11.2.3.2.2 Processive synthesis on the leading strand (BlackBoxEvent) 5751 
11.2.3.3 Lagging Strand Synthesis (Pathway) 5752 
11.2.3.3.1 Polymerase switching (Pathway) 5752 
11.2.3.3.1.1 RFC binding displaces Pol Alpha (Reaction) 5752 
11.2.3.3.1.2 Loading of PCNA - Sliding Clamp Formation (Reaction) 5752 
11.2.3.3.1.3 RFC dissociates after sliding clamp formation (Reaction) 5753 
11.2.3.3.1.4 Formation of Processive Complex (Reaction) 5753 
11.2.3.3.2 Processive synthesis on the lagging strand (Pathway) 5753 
11.2.3.3.2.1 Formation of Okazaki fragments (Reaction) 5753 
11.2.3.3.2.2 Formation of the Flap Intermediate (Reaction) 5754 
11.2.3.3.2.3 Removal of the Flap Intermediate (Pathway) 5754 
11.2.3.3.2.3.1 RPA binds to the Flap (Reaction) 5754 
11.2.3.3.2.3.2 Recruitment of Dna2 endonuclease (Reaction) 5755 
11.2.3.3.2.3.3 Removal of RNA primer and dissociation of RPA and Dna2 (Reaction)5755 
11.2.3.3.2.3.4 Removal of remaining Flap (Reaction) 5755 
11.2.3.3.2.4 Joining of adjacent Okazaki fragments (Reaction) 5756 
11.3 Regulation of DNA replication (Pathway) 5756 
11.3.1 Association of licensing factors with the pre-replicative complex (Pathway) 5756 
11.3.1.1 Orc1 associates with Orc4:Orc5:Orc3:Orc2:origin complexes (Reaction) 5757 
11.3.1.2 CDC6 protein is synthesized under the control of E2F transcription factors 5757 (BlackBoxEvent) 
11.3.1.3 The geminin component of geminin:Cdt1 complexes is ubiquitinated, releasing 5757 Cdt1 (Reaction) 
11.3.2 Removal of licensing factors from origins (Pathway) 5758 
11.3.2.1 Orc1 removal from chromatin (Pathway) 5758 
11.3.2.1.1 Orc1 is phosphorylated by cyclin A/CDK2 (Reaction) 5758 
11.3.2.1.2 Phosphorylated Orc1 is ubiquitinated while still associated with chromatin 5758 (Reaction) 
11.3.2.1.3 Ubiquitinated Orc1 enters the cytosol (Reaction) 5759 
11.3.2.1.4 Ubiquitinated Orc1 is degraded by the proteasome (BlackBoxEvent) 5759 
11.3.2.2 Cdt1 is displaced from the pre-replicative complex. (Reaction) 5759 
11.3.2.3 Cdt1 associates with geminin (Reaction) 5759 
11.3.2.4 CDK-mediated phosphorylation and removal of Cdc6 (Pathway) 5760 
11.3.2.4.1 Cdc6 protein is phosphorylated by CDK (Reaction) 5760 
11.3.2.4.2 Phosphorylated Cdc6 is exported from the nucleus (Reaction) 5760 
11.3.2.4.3 Cytoplasmic phosphorylated Cdc6 is ubiquitinated by the anaphase-promoting
5760 complex (Reaction) 
11.3.2.4.4 Ubiquitinated Cdc6 is degraded by the proteasome (BlackBoxEvent) 5761 
11.3.2.5 Mcm4,6,7 trimer forms and associates with the replication fork (Reaction) 5761 12 Extracellular matrix organization (Pathway) 5762 
12.1 Collagen formation (Pathway) 5765 
12.1.1 Collagen biosynthesis and modifying enzymes (Pathway) 5769 12.1.1.1 PDI is a chaperone for collagen peptides (Reaction) 5773 
12.1.1.2 Collagen prolyl 4-hydroxylase converts proline to 4-hydroxyproline (Reaction) 5774 
12.1.1.3 Collagen prolyl 3-hydroxylase converts proline to 3-hydroxyproline (Reaction) 5778 
12.1.1.4 Procollagen lysyl hydrolases convert lysine to 5-hydroxylysine (Reaction) 5781 
12.1.1.5 Galactosylation of collagen propeptide hydroxylysines by procollagen 5784 galactosyltransferases 1, 2. (Reaction) 
12.1.1.6 Galactosylation of collagen propeptide hydroxylysines by PLOD3 (Reaction) 5786 
12.1.1.7 Glucosylation of collagen propeptide hydroxylysines (Reaction) 5787 
12.1.1.8 Association of procollagen chains (Reaction) 5789 
12.1.1.9 Procollagen triple helix formation (Reaction) 5790 
12.1.1.10 Dimerization of procollagen type VI (Reaction) 5793 
12.1.1.11 Tetramerization of procollagen VI (Reaction) 5794 
12.1.1.12 Secretion of collagens (BlackBoxEvent) 5796 
12.1.1.13 Secretion of transmembrane collagens (BlackBoxEvent) 5798 
12.1.1.14 Removal of fibrillar collagen N-propeptides (Reaction) 5799 
12.1.1.15 Removal of fibrillar collagen C-propeptides (Reaction) 5802 
12.1.2 Assembly of collagen fibrils and other multimeric structures (Pathway) 5805 
12.1.2.1 Formation of collagen fibrils (Polymerisation) 5811 
12.1.2.2 Formation of collagen networks (Reaction) 5814 
12.1.2.3 Anchoring fibril formation (Pathway) 5817 
12.1.2.3.1 Collagen type VII dimerization (Reaction) 5818 
12.1.2.3.2 Cleavage of collagen VII NC2 region by BMP1 (Reaction) 5820 
12.1.2.3.3 Formation of anchoring fibrils (Polymerisation) 5821 
12.1.2.3.4 Collagen type VII binds laminin-322 and collagen IV (Reaction) 5822 
12.1.2.4 Crosslinking of collagen fibrils (Pathway) 5824 
12.1.2.4.1 Prolysyl oxidase activation (Reaction) 5828 
12.1.2.4.2 Formation of allysine by LOX (Reaction) 5830 
12.1.2.4.3 Formation of hydroxyallysine by LOX (Reaction) 5831 
12.1.2.4.4 Formation of dehydro-lysinonorleucine cross-links (Reaction) 5832 
12.1.2.4.5 Formation of dehydro-hydroxylysino-norleucine cross-links (Reaction) 5834 
12.1.2.4.6 Formation of lysino-5-ketonorleucine cross-links (Reaction) 5835 
12.1.2.4.7 Formation of hydroxylysino-5-ketonorleucine cross-links (Reaction) 5836 
12.1.2.4.8 Formation of lysyl-pyridinoline cross-links (Reaction) 5837 
12.1.2.4.9 Formation of hydroxylysyl-pyridinoline cross-links (Reaction) 5839 
12.1.2.4.10 Formation of lysyl-pyrrole cross-links (Reaction) 5840 
12.1.2.4.11 Formation of hydroxylysyl-pyrrole cross-links (Reaction) 5842 
12.1.2.4.12 Formation of histidino-hydroxylysinonorleucine cross-links (Reaction) 5843 
12.1.2.5 Formation of collagen fibres (Polymerisation) 5845 
12.1.2.6 Collagen XI cross-links with collagen II (Reaction) 5846 
12.1.2.7 Collagen IX is cross-linked to the surface of collagen type II fibrils (Reaction) 5848 
12.1.2.8 Type XII and XIV collagens associate with type I and type II fibrils. 5849 (BlackBoxEvent) 
12.1.2.9 Type X collagen associates with collagen type II fibrils (Reaction) 5850 
12.1.2.10 Hemidesmosome formation (Reaction) 5852 
12.1.2.11 Release of endostatin-like peptides (Reaction) 5854 
12.2 Fibronectin matrix formation (Pathway) 5856 
12.2.1 FN1 dimerizes (Reaction) 5858 
12.2.2 Integrin alpha5beta1 binds FN1 dimer (Reaction) 5859 
12.2.3 FN1 aggregation (BlackBoxEvent) 5862 
12.3 FN1 binds Collagen types I-V, VII (Reaction) 5864 
12.4 Elastic fibre formation (Pathway) 5866 
12.4.1 Fibrillin C-terminal processing (Reaction) 5872 
12.4.2 Fibrillin-1 binds integrins (Reaction) 5873 
12.4.3 Fibrillin microfibril assembly (Polymerisation) 5875 
12.4.4 MFAP2, MFAP5 bind microfibrils (Reaction) 5877 
12.4.5 Tropoelastin forms aggregate globules (BlackBoxEvent) 5878 
12.4.6 Tropoelastin associates with microfibrils (BlackBoxEvent) 5880 
12.4.7 Elastin cross-linking by lysyl oxidase (Polymerisation) 5883 
12.4.8 Molecules associated with elastic fibres (Pathway) 5885 
12.4.8.1 Fibulin-1 and -2 bind fibronectin (Reaction) 5887 
12.4.8.2 Fibulin binds elastic fibres (Reaction) 5889 
12.4.8.3 Emilin is found in elastic fibres (Reaction) 5891 
12.4.8.4 LTBP1, LTBP3 bind TGF-Beta (Reaction) 5893 
12.4.8.5 LTBP4 binds TGF-Beta-1 (Reaction) 5895 
12.4.8.6 Latent TGF-beta-1 binds integrins (Reaction) 5897 
12.4.8.7 Latent TGF-beta-3 binds integrins (Reaction) 5898 
12.4.8.8 Fibrillins bind BMPs (Reaction) 5900 
12.4.8.9 Fibrillin-1 binds latent TGF-beta (Reaction) 5901 
12.4.8.10 Elastic fibres bind associated proteins (Reaction) 5903 
12.5 Laminin interactions (Pathway) 5905 
12.5.1 Formation of laminin networks (Polymerisation) 5907 
12.5.2 Integrins alpha3beta1, alpha6beta4 bind laminin-332, 511, 521, (211, 221) (Reaction)
5909 
12.5.3 Integrin alpha6beta1 binds laminin-322, 512, 521, 211, 221, 411 (Reaction) 5912 
12.5.4 Integrin alpha7beta1 binds Laminin-211, 221, 411, 512, 521 (Reaction) 5915 
12.5.5 Integrin alpha6beta1, alpha7beta1, alpha1beta1, alpha2beta1 bind laminin-111 5918 (Reaction) 
12.5.6 Integrin alpha2beta1 binds laminin-332 (Reaction) 5923 
12.5.7 Laminins bind Nidogens 1, 2 (Reaction) 5924 
12.5.8 Laminins bind HSPG2 (Reaction) 5927 
12.5.9 Laminins:Nidogens binds HSPG2 (Reaction) 5929 
12.5.10 Laminins bind galactosyl sulfatide and related sulfated glycolipids (Reaction) 5932 
12.5.11 Laminins:Nidogens binds collagen type IV networks (Reaction) 5934 
12.5.12 Laminin-111 binds collagen type IV (Reaction) 5936 
12.5.13 Laminin-332 binds collagen type VII (Reaction) 5941 
12.5.14 Collagen type VII binds collagen type IV (Reaction) 5942 
12.5.15 Laminin-111 binds endostatin dimer (Reaction) 5944 
12.6 Non-integrin membrane-ECM interactions (Pathway) 5945 
12.6.1 HSPG2 binds FGF2(10-155), Fibronectn matrix, Transthyretin tetramer, PDGFA 5946 homodimer, PDGFB homodimer (Reaction) 
12.6.2 Dystroglycan binds Laminins and Dystrophin (Reaction) 
12.6.3 Dystroglycan binds AGRN and HSPG2 (Reaction) 5951 
12.6.4 Dystroglycan binds NRXN1 (Reaction) 5954 
12.6.5 NTN4 binds laminins with gamma-1, gamma-3 (Reaction) 5956 
12.6.6 DDR1 binds collagen type I, II, III, IV, V, XI fibrils (Reaction) 5958 
12.6.7 DDR2 binds collagen type I, II, III, V, X fibrils (Reaction) 5959 
12.6.8 Syndecan interactions (Pathway) 5961 
12.6.8.1 Syndecan-1 binds Integrin alphaVbeta3 (Reaction) 5963 
12.6.8.2 Syndecan-1 binds Integrin alphaVBeta5 (Reaction) 5965 
12.6.8.3 Syndecan-1 binds Integrins alpha2beta1, (alpha6beta4) (Reaction) 5968 
12.6.8.4 Syndecan-1 binds THBS1 (Reaction) 5971 
12.6.8.5 Syndecan-1 binds collagen types I, III, V (Reaction) 5975 
12.6.8.6 Syndecan-1 binds fibronectin (Reaction) 5979 
12.6.8.7 Syndecan-2 binds CASK (Reaction) 5981 
12.6.8.8 Syndecan-2 binds TRAPPC4 (Reaction) 5984 
12.6.8.9 Syndecan-4 binds ACTN1 (Reaction) 5987 
12.6.8.10 Syndecan-4 binds PI(4,5)P2 (Reaction) 5990 
12.6.8.11 Syndecan-4:PI(4,5)P2 binds PKC alpha:DAG (Reaction) 5993 
12.6.8.12 Syndecans 1, 2 & 4 bind VTN (Reaction) 5994 
12.6.8.13 Syndecans 1, 2, 4, (3) bind FGF2 (Reaction) 5996 
12.6.8.14 Syndecans 2, (4) bind TGFB1 (Reaction) 5998 
12.6.8.15 TNC binds Syndecan-3 (Reaction) 6000 
12.7 ECM proteoglycans (Pathway) 6004 
12.7.1 SLRPs bind TGF Beta (Reaction) 6005 
12.7.2 DCN binds collagen I, II, III, VI fibrils (Reaction) 6010 
12.7.3 BGN binds Collagen types I, VI, (IX) (Reaction) 6013 
12.7.4 BGN binds Collagen types II, III (Reaction) 6014 
12.7.5 VTN binds collagens I, IV and VI (Reaction) 6017 
12.7.6 VTN binds collagens II, III and V (Reaction) 6019 
12.7.7 VTN binds integrins alphaVbeta1, alphaVbeta3, alpha3beta5, alphaIIBbeta3 6020 (Reaction) 
12.7.8 VTN binds Plasminogen activator inhibitor- 1 (Reaction) 6023 
12.7.9 AGRN binds Alpha-dystroglycan (Reaction) 6024 
12.7.10 AGRN binds LRP4:MUSK (Reaction) 6029 
12.7.11 AGRN binds Laminins with gamma-1 subunit (Reaction) 6032 
12.7.12 AGRN binds NCAM1, PTPRS (Reaction) 6035 
12.7.13 AGRN binds Beta amyloid fibril via GAG chains (Reaction) 6037 
12.7.14 SPARC binds Collagen type I fibril, hydroxylapatite and Ca2+ (Reaction) 6038 
12.7.15 TNC binds Integrin alphaVbeta3, alphaVbeta6, alpha2beta1, alpha7beta1, 6040 alpha8beta1, alpha9beta1, alphaXbeta1 (Reaction) 
12.7.16 Tenascins C, R, (X, N) bind lecticans (Reaction) 6042 
12.7.17 Tenascins C, R, (X, N) bind fibronectin matrix (Reaction) 6045 
12.7.18 COMP binds collagen, fibronectin, aggrecan and matrilins (Reaction) 6049 
12.7.19 Aggrecan binds Hyaluronan and HAPLN1 (Reaction) 6051 
12.7.20 IBSP binds collagen type I (Reaction) 6053 
12.7.21 Dentin matrix protein 1 binds integrin alphaVbeta3 (Reaction) 6055 
12.7.22 Dentin phosphoprotein binds integrin alphaVbeta1 (Reaction) 6056 
12.8 Degradation of the extracellular matrix (Pathway) 6057 
12.8.1 Activation of Matrix Metalloproteinases (Pathway) 6059 
12.8.1.1 Initial activation of proMMP1 (Reaction) 6061 
12.8.1.2 Autocatalytic activation of MMP1 (Reaction) 6063 
12.8.1.3 Full activation of MMP1 (Reaction) 6065 
12.8.1.4 proMMP9 binds TIMP1 (Reaction) 6066 
12.8.1.5 MMP14 (MT1-MMP) binds TIMP2 (Reaction) 6068 
12.8.1.6 MMP14:TIMP2 binds proMMP2 (Reaction) 6069 
12.8.1.7 Initial activation of proMMP2 by MMP1, 7 (Reaction) 6072 
12.8.1.8 Initial activation of proMMP2 by MMP14 (Reaction) 6074 
12.8.1.9 Autocatalytic activation of proMMP2 (Reaction) 6076 
12.8.1.10 Autocatalytic activation of bound proMMP2 (Reaction) 6078 
12.8.1.11 Initial activation of proMMP3 (Reaction) 6080 
12.8.1.12 Autocatalytic activation of MMP3 (Reaction) 6081 
12.8.1.13 Activation of proMMP7 by MMP3 (Reaction) 6083 
12.8.1.14 Initial activation of proMMP7 by trypsin (Reaction) 6084 
12.8.1.15 Autocatalytic activation of MMP7 (Reaction) 6086 
12.8.1.16 Activation of proMMP8 (BlackBoxEvent) 6087 
12.8.1.17 Initial activation of proMMP9 by MMPs (Reaction) 6089 
12.8.1.18 Activation of MMP9 intermediate form by MMPs (Reaction) 6091 
12.8.1.19 Activation of proMMP9 by proteases (Reaction) 6092 
12.8.1.20 Activation of proMMP10 (BlackBoxEvent) 6094 
12.8.1.21 Activation of proMMP11 by FURIN (Reaction) 6095 
12.8.1.22 Initial activation of proMMP13 by plasmin and trypsin (Reaction) 6097 
12.8.1.23 Initial activation of proMMP13 by MMP3 (Reaction) 6098 
12.8.1.24 Initial activation of proMMP13 by MMP14 (MT1-MMP) (Reaction) 6099 
12.8.1.25 Autocatalytic activation of proMMP13 (Reaction) 6101 
12.8.1.26 Activation of MT-MMPs by FURIN (Reaction) 6102 
12.8.1.27 MT-MMPs are sorted to the plasma membrane (BlackBoxEvent) 6104 
12.8.2 Collagen degradation (Pathway) 6106 
12.8.2.1 Collagen type I degradation by MMP1,2,8,13, PRSS2 (Reaction) 6109 
12.8.2.2 Collagen type I degradation by MMP14 (Reaction) 6111 
12.8.2.3 Collagen type I degradation by MMP15 (Reaction) 6112 
12.8.2.4 Collagen type II degradation by MMP1,3,8,13,PRSS2 (Reaction) 6114 
12.8.2.5 Collagen type II degradation by MMP14 (Reaction) 6115 
12.8.2.6 Collagen type II degradation by MMP15 (BlackBoxEvent) 6117 
12.8.2.7 Collagen type III degradation by MMP1,8,9,13 (Reaction) 6118 
12.8.2.8 Collagen type III degradation by MMP10 (Reaction) 6120 
12.8.2.9 Collagen type III degradation by MMP14 (Reaction) 6122 
12.8.2.10 Collagen type III degradation by MMP15 (BlackBoxEvent) 6123 
12.8.2.11 Collagen type IV degradation by MMP2,3,4,9,10,12 (Reaction) 6124 
12.8.2.12 Collagen type V degradation by MMP2,9,10 (Reaction) 6127 
12.8.2.13 Collagen type VI degradation by MMP2,9,11 (Reaction) 6130 
12.8.2.14 Collagen type VII degradation by MMP1,2,3 (Reaction) 6132 12.8.2.15 Collagen type VIII degradation by MMP1 (Reaction) 6133 
12.8.2.16 Collagen type VIII degradation by ELANE (Reaction) 6135 
12.8.2.17 Collagen type IX degradation by MMP3,13 (Reaction) 6138 
12.8.2.18 Collagen type X degradation by MMP1,2 (Reaction) 6140 
12.8.2.19 Collagen type X degradation by MMP3, 13 (Reaction) 6145 
12.8.2.20 Collagen type XI degradation by MMP1,2,3,9 (Reaction) 6149 
12.8.2.21 Collagen type XII degradation by MMP12 (Reaction) 6154 
12.8.2.22 Collagen type XIV degradation by MMP9,13 (Reaction) 6156 
12.8.2.23 Collagen type XV restin release (BlackBoxEvent) 6159 
12.8.2.24 Collagen type XVI degradation by MMP9 (Reaction) 6161 
12.8.2.25 Collagen type XVIII endostatin release (Reaction) 6164 
12.8.2.26 Endostatin degradation by cathepsins (BlackBoxEvent) 6166 
12.8.2.27 Collagen type XIX degradation (BlackBoxEvent) 6167 
12.8.2.28 Collagen type XIII ectodomain shedding (BlackBoxEvent) 6168 
12.8.2.29 Collagen type XVII ectodomain shedding (Reaction) 6170 
12.8.2.30 Collagen type XXIII ectodomain shedding (Reaction) 6174 
12.8.2.31 Collagen type XXV ectomain shedding (Reaction) 6176 
12.8.2.32 Gelatin degradation by MMP1, 2, 3, 7, 8, 9, 12, 13 (BlackBoxEvent) 6177 
12.8.2.33 Gelatin degradation by MMP19 (BlackBoxEvent) 6181 
12.8.3 Elastin degradation by elastin-degrading extracellular proteinases (Reaction) 6187 
12.8.4 Elastin degradation by MMP14 (BlackBoxEvent) 6189 
12.8.5 Fibrillin 1, 2,(3) degradation by MMP2, 9, 12 and 13 (Reaction) 6190 
12.8.6 Fibrillin-1 degradation by MMP3, CTSK, CTSL2 (Reaction) 6192 
12.8.7 Fibrillin-1 degradation by MMP14 (Reaction) 6193 
12.8.8 Fibrillin-1 degradation by ELANE (Reaction) 6195 
12.8.9 Fibronectin degradation by MMP1, 3, 7, 12, 13, 19, CTSS (Reaction) 6197 
12.8.10 Fibronectin degradation by MMP10 (Reaction) 6199 
12.8.11 Fibronectin degradation by MMP14 (Reaction) 6201 
12.8.12 Fibronectin degradation by CTSG (Reaction) 6202 
12.8.13 Fibronectin degradation by ADAM8 (Reaction) 6204 
12.8.14 Laminin-332 degradation by laminin-322 degrading extracellular proteinases 6205 (Reaction) 
12.8.15 Laminin-322 degradation by MMP14 (Reaction) 6210 
12.8.16 Laminin-511 degradation by MMP14 (Reaction) 6213 
12.8.17 NID1 degradation by MMP1, 9, 12, ELANE (Reaction) 6215 
12.8.18 NID1 degradation by MMP3, 7 (Reaction) 6218 
12.8.19 NID1 degradation by MMP14, MMP15 (Reaction) 6220 
12.8.20 NID1 degradation by MMP19 (Reaction) 6223 
12.8.21 Aggrecan degradation by ADAMTSs (Reaction) 6224 
12.8.22 Aggrecan degradation by MMP1,2,3,7,9,12,13 (Reaction) 6229 
12.8.23 Brevican degradation by ADAMTS4, ADAMTS5 (Reaction) 6233 
12.8.24 Brevican degradation by MMP1, 2, 3, 7,8,10,13,19 (Reaction) 6235 
12.8.25 HSPG2 (perlecan) degradation by MMP3, plasmin, (MMP12) (Reaction) 6237 
12.8.26 HSPG2 (perlecan) degradation by MMP13, CTSS (Reaction) 6239 
12.8.27 HSPG2 (perlecan) degradation by MMP14, MMP15 (Reaction) 6242 
12.8.28 HSPG2 (perlecan) is cleaved by BMP1, TLL1, TLL2, Cathepsin L1 (Reaction) 6243 
12.8.29 DCN (decorin) degradation by MMP2, MMP3, MMP7 (Reaction) 6245 
12.8.30 DCN (decorin) degradation by MMP14 (Reaction) 6247 
12.8.31 E-cadherin degradation by MMP3, MMP7 and plasmin. (Reaction) 6248 
12.8.32 E-cadherin degradation by MMP9, KLK7 (Reaction) 6253 
12.8.33 E-cadherin degradation by ADAM10, ADAM15 (Reaction) 6256 
12.8.34 E-cadherin degradation by PS1:NCSTN (Gamma-secretase) (Reaction) 6260 
12.8.35 E-cadherin degradation by caspase-3 and calpain-1 (Reaction) 6264 
12.8.36 MMP1,3,13 (2, 7-12, 19) binding by Alpha-2 macroglubulin (Reaction) 6268 
12.8.37 MMP2, MMP7, MMP9 bind CD44 (Reaction) 6271 
12.8.38 MMPs bind BSG (CD147) (Reaction) 6272 
12.8.39 OPN (osteopontin) degradation by MMP3, MMP7 (Reaction) 6274 
12.9 Integrin cell surface interactions (Pathway) 6275 
12.9.1 Collagen types III, IV, V, VI, VIII, IX, XVI bind integrins alpha1beta1 and alpha2beta1
6277 (Reaction) 
12.9.2 Collagen type I binds integrin alpha1beta1, alpha2beta1, alpha10beta1 (Reaction)6281 
12.9.3 Collagen type I binds integrin alpha11beta1 (Reaction) 6283 
12.9.4 Collagen type II binds integrin alpha2beta1, alpha1beta1, alpha11beta1 (Reaction)6285 
12.9.5 Collagen type II binds integrin alpha10beta1 (Reaction) 6286 
12.9.6 Collagen type IV networks bind integrins alpha1beta1, alpha2beta1 (Reaction) 6288 
12.9.7 Collagen type VII binds integrin alpha2beta1 (Reaction) 6289 
12.9.8 Collagen type X binds Integrin alpha2beta1 (Reaction) 6291 
12.9.9 Collagen type XIII binds Integrin alpha1beta1 (Reaction) 6293 
12.9.10 Collagen type XXIII binds Integrin alpha2beta1 (Reaction) 6294 
12.9.11 Collagen types VI, IX bind integrin alpha10beta1 (Reaction) 6296 
12.9.12 Collagen type IV binds integrin alpha10beta1 (Reaction) 6297 
12.9.13 Collagen type IX binds integrin alpha11beta1 (Reaction) 6299 
12.9.14 Arresten binds integrin alpha1beta1 (Reaction) 6300 
12.9.15 Endostatin binds integrin alphaVbeta3, alphaVbeta5, alpha3beta1, alpha5beta1 6301 (Reaction) 
12.9.16 Tumstatin binds integrin alphaVbeta 3, alpha3beta1 (Reaction) 6303 
12.9.17 Canstatin binds integrins alphaVbeta3, alphaVbeta5 (Reaction) 6304 
12.9.18 Tetrastatin binds integrin alphaVbeta3 (Reaction) 6305 
12.9.19 THBS1 (Thrombospondin-1) binds Integrin alpha3beta1, alpha4beta1 (Reaction) 6307 
12.9.20 Integrins alpha4beta1, alpha8beta1, alphaVbeta1, alphaVbeta3, alphaVbeta6 bind6308 Fibronectin matrix (Reaction) 
12.9.21 SPP1 (osteopontin) binds integrin alpha5beta1, alpha9beta1 (Reaction) 6310 
12.9.22 SPP1 (osteopontin) binds Integrin alpha4beta1 (Reaction) 6312 
12.9.23 SPP1 (osteopontin) binds integrin alpha8beta1 (Reaction) 6315 
12.9.24 SPP1 (osteopontin) binds integrins alphaVbeta1, alphaVbeta3, alphaVbeta5 6317 (Reaction) 
12.9.25 SPP1 (osteopontin) binds CD44 (Reaction) 6320 
12.9.26 VCAM1 binds Integrin alpha4beta1 (Reaction) 6322 
12.9.27 Integrin alpha4beta1 binds JAM2 (Reaction) 6323 
12.9.28 MADCAM1-1 binds Integrin alpha4beta7 (Reaction) 6324 
12.9.29 Interaction of integrin alpha8beta1 with Tenascin-C (Reaction) 6325 
12.9.30 Interaction of integrin alpha9beta1 with VCAM1 (Reaction) 6327 
12.9.31 Interaction of integrin alpha9beta1 with Tenascin-C (Reaction) 6328 
12.9.32 Interaction of integrin alphaDbeta2 with fibrin (Reaction) 6329 
12.9.33 Interaction of integrin alphaXbeta2 with fibrin (Reaction) 6331 
12.9.34 VTN (vitronectin) binds Integrin alphaVbeta3, alphaVbeta5, alphaVbeta8 (Reaction)
6332 
12.9.35 Integrin alphaXbeta2 binds JAM3 (Reaction) 6334 
12.9.36 ICAM1-4 bind Integrin alphaLbeta2 (LFA-1) (Reaction) 6335 
12.9.37 Integrin alphaLbeta2 (LFA-1) binds F11R (JAM-A) (Reaction) 6336 
12.9.38 Integrin alphaMbeta2 (MAC1) binds JAM3 (Reaction) 6337 
12.9.39 BSG (basigin) binds Integrin alpha3beta1, alpha6beta1 (Reaction) 6338 
12.9.40 Interaction of integrin alphaVbeta3 with IPSP (Bone sialoprotein 2) (Reaction) 6339 
12.9.41 Interaction of integrin alphaVbeta3 with Tenascin (Reaction) 6341 
12.9.42 Interaction of integrin alphaVbeta3 with Fibrillin (Reaction) 6342 
12.9.43 Interaction of integrin alphaVbeta3 with von Willbrand Factor (Reaction) 6343 
12.9.44 Interaction of integrin alphaVbeta3 with PECAM1 (Reaction) 6345 
12.9.45 Interaction of integrin alphaEbeta7 with Cadherin-1 (Reaction) 6346 
12.9.46 Interaction of integrin alphaIIbbeta3 with Fibronectin (Reaction) 6347 
12.9.47 Adhesion of integrin alphaIIbbeta3 to fibrin network (Reaction) 6348 
12.9.48 Interaction of integrin alphaIIbbeta3 with von Willebrand factor (Reaction) 6349 
12.9.49 Interaction of integrin alphaIIb beta 3 with THBS1 (Thrombospondin-1) (Reaction)6351 
12.9.50 LUM (lumican) binds integrin alpha2beta1 (Reaction) 6352 
12.9.51 HSPG2 (perlecan) binds alpha-dystroglycan (Reaction) 6354 
12.9.52 AGRN binds Integrins alphaVbeta1 (Other beta1-containing integrins) (Reaction) 6355 
12.9.53 COMP binds Integrin alpha5beta1, Integrin alphaVbeta3, CD47 (Reaction) 6358 
12.9.54 Endorepellin binds KDR (VEGFR2) (Reaction) 6359 
12.9.55 Endorepellin binds alpha2beta1 integrin (Reaction) 6361 13 Gene Expression (Pathway) 6363 
13.1 Generic Transcription Pathway (Pathway) 6364 
13.1.1 Formation of ARC coactivator complex (Reaction) 6370 
13.1.2 Formation of DRIP coactivator complex (Reaction) 6372 
13.1.3 Formation of TRAP coactivator complex (Reaction) 6375 
13.1.4 Notch-HLH transcription pathway (Pathway) 6377 
13.1.4.1 Formation of CSL-NICD coactivator complex (Reaction) 6380 
13.1.5 Nuclear Receptor transcription pathway (Pathway) 6381 
13.1.5.1 Formation of NR-MED1 Coactivator Complex (Reaction) 6383 
13.1.6 KRAB-ZNF / KAP Interaction (Reaction) 6385 
13.1.7 YAP1- and WWTR1 (TAZ)-stimulated gene expression (Pathway) 6389 
13.1.7.1 WWTR1 (TAZ) binds TEAD (Reaction) 6390 
13.1.7.2 YAP1 binds TEAD (Reaction) 6391 
13.1.7.3 WWTR1 (TAZ), TBX5, and PCAF form a complex (Reaction) 6392 
13.1.7.4 WWTR1 (TAZ) binds RUNX2 (Reaction) 6394 
13.1.7.5 Expression of CTGF (BlackBoxEvent) 6395 
13.1.7.6 Expression of NPPA (ANF) (BlackBoxEvent) 6397 
13.1.8 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway) 6399 
13.1.8.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway) 6399 
13.1.8.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 (Reaction)6399 
13.1.8.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction) 6400 
13.1.8.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or CDK9 6401 (Reaction) 
13.1.8.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 6401 
13.1.8.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 6401 
13.1.8.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent) 6402 
13.1.8.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while TGIF:SMAD and6402 SMAD7 inhibit it (BlackBoxEvent) 
13.1.8.1.8 RNF111 binds SMAD7 (Reaction) 6403 
13.1.8.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 6403 
13.1.8.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 6403 
13.1.8.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5 and 6404 DP1/2 (Reaction) 
13.1.8.1.12 MYC trancscription is negatively regulated by 6404 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
13.1.8.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 6404 
13.1.8.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B 6405 (BlackBoxEvent) 
13.1.8.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 6405 
13.1.8.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription 6405 (BlackBoxEvent) 
13.1.8.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway) 6406 
13.1.8.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling (Reaction)6406 
13.1.8.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to SKI/SKIL 6406 (Reaction) 
13.1.8.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 6407 
13.1.8.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 6407 
13.1.8.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus (Reaction) 6407 
13.1.8.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 6408 
13.1.8.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol (Reaction)6408 
13.1.8.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 6408 
13.1.8.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 6409 
13.1.8.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction) 6409 
13.1.8.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 6409 
13.1.8.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 6410 
13.1.8.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region (Reaction) 6410 
13.1.8.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 6410 
13.1.8.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction) 6411 
13.1.8.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 6411 
13.1.8.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 6411 
13.1.8.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 (Reaction) 6412 
13.1.8.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 6412 
13.1.8.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction) 6412 13.1.8.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates TGF-beta
6413 signaling (BlackBoxEvent) 
13.2 RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription (Pathway) 6413 
13.2.1 RNA Polymerase I Transcription (Pathway) 6414 
13.2.1.1 RNA Polymerase I Promoter Clearance (Pathway) 6415 
13.2.1.1.1 RNA Polymerase I Promoter Opening (Pathway) 6416 
13.2.1.1.1.1 UBF-1 Binds rDNA Promoter (Reaction) 6416 
13.2.1.1.1.2 Phosphorylation of UBF-1:rDNA Promoter (Reaction) 6418 
13.2.1.1.2 RNA Polymerase I Transcription Initiation (Pathway) 6419 
13.2.1.1.2.1 Formation of SL1 (Reaction) 6421 
13.2.1.1.2.2 Acetylation of SL1 (Reaction) 6422 
13.2.1.1.2.3 Recruitment of Acetylated SL1 to phosUBF-1:rDNA Promoter (Reaction) 6423 
13.2.1.1.2.4 Assembly of RNA Polymerase I Holoenzyme (human) (Reaction) 6425 
13.2.1.1.2.5 Binding of RRN3 to RNA Polymerase I (Reaction) 6427 
13.2.1.1.2.6 Recruitment of Active RNA Polymerase I to SL1:phos.UBF-1:rDNA 6428 Promoter (Reaction) 
13.2.1.1.3 RNA Polymerase I Promoter Escape (Pathway) 6430 
13.2.1.1.3.1 Loss of Rrn3 from RNA Polymerase I promoter escape complex (Reaction)
6430 
13.2.1.2 RNA Polymerase I Chain Elongation (Pathway) 6431 
13.2.1.2.1 Elongation of pre-rRNA transcript (Reaction) 6431 
13.2.1.3 RNA Polymerase I Transcription Termination (Pathway) 6432 
13.2.1.3.1 TTF-I binds to the Sal Box (Reaction) 6433 
13.2.1.3.2 Polymerase I Transcription Complex/Nascent Pre rRNA Complex pauses at6436 the TTF-I:Sal Box (Reaction) 
13.2.1.3.3 PTRF Binds the Polymerase I Transcription Complex/Nascent Pre rRNA 6436 Complex paused at the TTF-I:Sal Box (Reaction) 
13.2.1.3.4 Dissociation of PTRF:Polymerase I/Nascent Pre rRNA Complex:TTF-I:Sal Box
6438 (Reaction) 
13.2.2 RNA Polymerase III Transcription (Pathway) 6439 
13.2.2.1 RNA Polymerase III Abortive And Retractive Initiation (Pathway) 6440 
13.2.2.1.1 RNA Polymerase III Abortive Initiation At Type 1 Open Promoters (Reaction)6441 
13.2.2.1.2 RNA Polymerase III Abortive Initiation At Type 2 Open Promoters (Reaction)6442 
13.2.2.1.3 RNA Polymerase III Abortive Initiation At Type 3 Open Promoters (Reaction)6443 
13.2.2.1.4 RNA Polymerase III Productive Transcription (Reaction) 6444 
13.2.2.1.5 RNA Polymerase III Promoter Opening at Type 1 Promoters (Reaction) 6445 
13.2.2.1.6 RNA Polymerase III Promoter Opening at Type 2 Promoters (Reaction) 6447 
13.2.2.1.7 RNA Polymerase III Promoter Opening at Type 3 Promoters (Reaction) 6449 
13.2.2.1.8 RNA Polymerase III Retractive RNase Activity at U-tract Pause Sites 6451 (Reaction) 
13.2.2.1.9 RNA Polymerase III Simple Start Sequence Initiation At Type 1 Promoters 6453 (Reaction) 
13.2.2.1.10 RNA Polymerase III Simple Start Sequence Initiation At Type 2 Promoters 6454 (Reaction) 
13.2.2.1.11 RNA Polymerase III Simple Start Sequence Initiation At Type 3 Promoters 6456 (Reaction) 
13.2.2.1.12 RNA Polymerase III Termination and release of transcribed mRNA (Reaction)
6457 
13.2.2.1.13 RNA Polymerase III Transcriptional Pause at Terminator Sequence 6462 (Reaction) 
13.2.2.2 RNA Polymerase III Transcription Initiation (Pathway) 6464 
13.2.2.2.1 RNA Polymerase III Transcription Initiation From Type 1 Promoter (Pathway)6466 
13.2.2.2.1.1 Binding of TFIIIA To type 1 Promoter (Reaction) 6468 
13.2.2.2.1.2 Binding of TFIIIC to TFIIIA:Type I Promoter complex (Reaction) 6469 
13.2.2.2.1.3 Binding of TFIIIB to TFIIIC:TFIIIA:Type I Promoter complex (Reaction) 6472 
13.2.2.2.1.4 Recruitment of RNA polymerase III to TFIIIB:TFIIIC:TFIIIA:Type 1 Promoter
6473 Complex (Reaction) 
13.2.2.2.1.5 RNA Polymerase III Promoter Opening at Type 1 Promoters (Reaction) 6475 
13.2.2.2.2 RNA Polymerase III Transcription Initiation From Type 2 Promoter (Pathway)6476 
13.2.2.2.2.1 Binding of TFIIIC to Type 2 promoter (Reaction) 6477 
13.2.2.2.2.2 Binding of TFIIIB to TFIIC: Type 2 Promoter Complex (Reaction) 6479 
13.2.2.2.2.3 Recruitment of RNA Polymerase III to the TFIIIB:TFIIIC: Type 2 Promoter6480 Complex (Reaction) 
13.2.2.2.2.4 RNA Polymerase III Promoter Opening at Type 2 Promoters (Reaction) 6481 
13.2.2.2.3 RNA Polymerase III Transcription Initiation From Type 3 Promoter (Pathway)6481 
13.2.2.2.3.1 Binding of SNAPc, Oct-1, and Staf to Type 3 Promoter (Reaction) 6483 
13.2.2.2.3.2 Binding of TFIIIB to SNAPc:Oct-1:Staf:Type 3 Promoter Complex 6485 (Reaction) 
13.2.2.2.3.3 Recruitment of RNA Polymerase III to TFIIIB:SNAPc:Type 3 Promoter 6486 Complex (Reaction) 
13.2.2.2.3.4 RNA Polymerase III Promoter Opening at Type 3 Promoters (Reaction) 6487 
13.2.2.3 RNA Polymerase III Chain Elongation (Pathway) 6487 
13.2.2.3.1 Initiation of RNA Polymerase III Productive Transcription (Reaction) 6488 
13.2.2.3.2 RNA Polymerase III Productive Transcription (Reaction) 6490 
13.2.2.3.3 Resumption of RNA Polymerase III Productive Transcription (Reaction) 6490 
13.2.2.4 RNA Polymerase III Transcription Termination (Pathway) 6492 
13.2.2.4.1 RNA Polymerase III Transcriptional Pause at Terminator Sequence (Reaction)
6492 
13.2.2.4.2 RNA Polymerase III Termination and release of transcribed mRNA (Reaction)
6492 
13.2.3 Transcription from mitochondrial promoters (Pathway) 6493 
13.2.3.1 Mitochondrial transcription initiation (Pathway) 6495 
13.2.3.1.1 TFAM binds to mitochondrial promoters (Reaction) 6497 
13.2.3.1.2 Association of TFAM:mt promoter complex with POLRMT:TFB2M (Reaction)6498 
13.2.3.2 Mitochondrial transcription termination (Pathway) 6499 
13.2.3.2.1 Association of mTERF with the termination sequence (Reaction) 6501 
13.3 RNA Polymerase II Transcription (Pathway) 6502 
13.3.1 RNA Polymerase II Pre-transcription Events (Pathway) 6502 
13.3.1.1 Abortive initiation after formation of the first phosphodiester bond (Reaction) 6503 
13.3.1.2 Abortive Initiation After Second Transition (Reaction) 6504 
13.3.1.3 Abortive Initiation Before Second Transition (Reaction) 6504 
13.3.1.4 Formation of DSIF complex (Reaction) 6505 
13.3.1.5 Formation of Elongin BC complex (Reaction) 6506 
13.3.1.6 Formation of FACT complex (Reaction) 6506 
13.3.1.7 Formation of NELF complex (Reaction) 6507 
13.3.1.8 Formation of P-TEFb complex (Reaction) 6507 
13.3.1.9 Formation of elongin complex (Reaction) 6508 
13.3.1.10 Resumption of elongation after recovery from pausing (Reaction) 6508 
13.3.1.11 2-4 nt.backtracking of Pol II complex on the template leading to elongation 6509 pausing (Reaction) 
13.3.1.12 7-14 nt. Backtracking of Pol II complex on the template leading to elongation 6510 arrest (Reaction) 
13.3.1.13 TFIIS-mediated recovery of elongation from arrest (Reaction) 6511 
13.3.1.14 Abortive termination of early transcription elongation by DSIF:NELF (Reaction)6512 
13.3.1.15 Abortive termination of elongation after arrest (Reaction) 6513 
13.3.1.16 Elongating transcript encounters a lesion in the template (Reaction) 6513 
13.3.1.17 Fall Back to Closed Pre-initiation Complex (Reaction) 6514 
13.3.2 RNA Polymerase II Transcription Pre-Initiation And Promoter Opening (Pathway) 6515 
13.3.2.1 Recognition and Binding of Core Promoter Elements by TFIID (Reaction) 6516 
13.3.2.2 Binding of TFIIA and TFIIB to the pol II promoter:TFIID complex (Reaction) 6517 
13.3.2.3 Recruitment of RNA Polymerase II Holoenzyme by TFIIF to the pol II 6518 promoter:TFIID:TFIIA:TFIIB complex (Reaction) 
13.3.2.4 Binding of TFIIE to the growing preinitiation complex (Reaction) 6519 
13.3.2.5 Formation of the closed pre-initiation complex (Reaction) 6520 
13.3.3 RNA Polymerase II Transcription Initiation And Promoter Clearance (Pathway) 6521 
13.3.3.1 RNA Polymerase II Promoter Opening: First Transition (Reaction) 6521 
13.3.3.2 RNA Polymerase II Transcription Initiation (Pathway) 6523 
13.3.3.2.1 NTP Binds Active Site of RNA Polymerase II (Reaction) 6524 
13.3.3.2.2 Nucleophillic Attack by 3'-hydroxyl Oxygen of nascent transcript on the Alpha6525 Phosphate of NTP (Reaction) 
13.3.3.2.3 Newly Formed Phosphodiester Bond Stabilized and PPi Released (Reaction)6525 
13.3.3.3 RNA Polymerase II Promoter Escape (Pathway) 6526 
13.3.3.3.1 Addition of the third nucleotide on the nascent transcript (BlackBoxEvent) 6526 
13.3.3.3.2 Addition of the fourth nucleotide on the Nascent Transcript: Second Transition
6528 (BlackBoxEvent) 
13.3.3.3.3 Addition of Nucleotides 5 through 9 on the growing Transcript (Reaction) 6529 
13.3.3.3.4 Addition of nucleotides 10 and 11 on the growing transcript: Third Transition6530 (Reaction) 
13.3.3.3.5 Addition of nucleotides between position +11 and +30 (Reaction) 6531 
13.3.4 RNA Pol II CTD phosphorylation and interaction with CE (Pathway) 6533 
13.3.4.1 Extrusion of 5'-end of 30 nt long transcript through the pore in Pol II complex 6533 (Reaction) 
13.3.4.2 Phosphorylation (Ser5) of RNA pol II CTD (Reaction) 6534 
13.3.4.3 RNA Polymerase II CTD (phosphorylated) binds to CE (Reaction) 6534 
13.3.4.4 Activation of GT (Reaction) 6535 
13.3.4.5 SPT5 subunit of Pol II binds the RNA triphosphatase (RTP) (Reaction) 6535 
13.3.5 RNA Polymerase II Transcription Elongation (Pathway) 6536 
13.3.5.1 Formation of the Early Elongation Complex (Pathway) 6538 
13.3.5.1.1 Hypophosphorylation of RNA Pol II CTD by FCP1P protein (Reaction) 6539 13.3.5.1.2 DSIF complex binds to RNA Pol II (hypophosphorylated) (Reaction) 6540 
13.3.5.1.3 Formation of DSIF:NELF:early elongation complex (Reaction) 6541 
13.3.5.2 Formation of RNA Pol II elongation complex (Pathway) 6542 
13.3.5.2.1 Hyperphosphorylation (Ser2) of RNA Pol II CTD by P-TEFb complex 6543 (Reaction) 
13.3.5.2.2 Recruitment of elongation factors to form elongation complex (Reaction) 6544 
13.3.5.3 Addition of nucleotides leads to transcript elongation (Reaction) 6545 
13.3.5.4 Pol II elongation complex moves on the template as transcript elongates 6546 (Reaction) 
13.3.5.5 Separation of elongating transcript from template (Reaction) 6547 
13.3.6 RNA Polymerase II Transcription Termination (Pathway) 6547 
13.3.6.1 Cleavage of Growing Transcript in the Termination Region (Pathway) 6548 
13.3.6.1.1 Cleavage of mRNA at the 3'-end (Reaction) 6549 
13.3.6.1.2 Cleavage of the 3'-end of Replication Dependent Histone Pre-mRNA 6550 (Reaction) 
13.3.6.1.3 Cleavage of the 3'-end of the Histone Pre-mRNA (Reaction) 6551 
13.3.6.1.4 Cleavage of Intronless Pre-mRNA at 3'-end (Reaction) 6552 
13.4 mRNA Capping (Pathway) 6553 
13.4.1 Capping complex formation (Reaction) 6555 
13.4.2 Hydrolysis of the 5'-end of the nascent transcript by the capping enzyme (Reaction)6556 
13.4.3 Formation of the CE:GMP intermediate complex (Reaction) 6557 
13.4.4 Transfer of GMP from the capping enzyme GT site to 5'-end of mRNA (Reaction) 6558 
13.4.5 Dissociation of transcript with 5'-GMP from GT (Reaction) 6559 
13.4.6 Methylation of GMP-cap by RNA Methyltransferase (Reaction) 6560 
13.4.7 Recognition and binding of the mRNA cap by the cap-binding complex (Reaction) 6561 
13.4.8 Formation of cap binding complex (CBC) (Reaction) 6562 
13.4.9 SPT5 subunit of Pol II binds the RNA triphosphatase (RTP) (Reaction) 6563 
13.4.10 Activation of GT (Reaction) 6563 
13.4.11 RNA Polymerase II CTD (phosphorylated) binds to CE (Reaction) 6563 
13.5 Processing of Capped Intron-Containing Pre-mRNA (Pathway) 6564 
13.5.1 Internal Methylation of mRNA (Reaction) 6565 
13.5.2 Formation of pre-mRNPs (Reaction) 6566 
13.5.3 mRNA Splicing (Pathway) 6567 
13.5.3.1 mRNA Splicing - Major Pathway (Pathway) 6567 
13.5.3.1.1 Formation of the Spliceosomal E complex (Reaction) 6568 
13.5.3.1.2 Formation of the Spliceosomal A Complex (Reaction) 6569 
13.5.3.1.3 Formation of the Spliceosomal B Complex (Reaction) 6571 
13.5.3.1.4 Formation of the Cleavage and Polyadenylation Complex (Reaction) 6572 
13.5.3.1.5 Formation of an intermediate Spliceosomal C complex (Reaction) 6573 
13.5.3.1.6 Formation of the active Spliceosomal C complex (Reaction) 6574 
13.5.3.1.7 Lariat Formation and 5'-Splice Site Cleavage (Reaction) 6575 
13.5.3.1.8 Formation of Exon Junction Complex (Reaction) 6577 
13.5.3.1.9 Cleavage at the 3'-Splice Site and Exon Ligation (Reaction) 6578 
13.5.3.2 mRNA Splicing - Minor Pathway (Pathway) 6579 
13.5.3.2.1 Formation of AT-AC A complex (Reaction) 6581 13.5.3.2.2 Formation of AT-AC B Complex (Reaction) 6583 
13.5.3.2.3 Formation of AT-AC C complex (Reaction) 6585 
13.5.3.2.4 ATAC spliceosome mediated Lariat formation,5' splice site cleavage (Reaction)6587 
13.5.3.2.5 ATAC spliceosome mediated 3' splice site cleavage, exon ligation (Reaction)6589 
13.5.4 mRNA 3'-end processing (Pathway) 6591 
13.5.4.1 Cleavage of mRNA at the 3'-end (Reaction) 6592 
13.5.4.2 mRNA polyadenylation (Reaction) 6592 
13.5.5 Transport of Mature Transcript to Cytoplasm (Pathway) 6593 
13.5.5.1 Transport of Mature mRNA derived from an Intron-Containing Transcript 6594 (Pathway) 
13.5.5.1.1 Recruitment of TAP to the EJC (Reaction) 6594 
13.5.5.1.2 Docking of the TAP:EJC Complex with the NPC (Reaction) 6595 
13.5.5.1.3 Transport of the export-competent complex through the NPC (Reaction) 6596 
13.5.5.1.4 Release from the NPC and Disassembly of the mRNP (Reaction) 6597 
13.5.5.2 Transport of Mature mRNAs Derived from Intronless Transcripts (Pathway) 6597 
13.5.5.2.1 Transport of the SLBP Dependant Mature mRNA (Pathway) 6598 
13.5.5.2.1.1 Docking of Mature Replication Dependent Histone mRNA with the NPC 6598 (Reaction) 
13.5.5.2.1.2 Transport of the Mature IntronlessTranscript Derived Histone 6600 mRNA:SLBP:TAP:Aly/Ref complex through the NPC (Reaction) 
13.5.5.2.1.3 Release of the Mature intronless transcript derived Histone 6601 mRNA:SLBP:eIF4E Complex (Reaction) 
13.5.5.2.2 Transport of the SLBP independent Mature mRNA (Pathway) 6602 
13.5.5.2.2.1 Docking of Mature Histone mRNA complex:TAP at the NPC (Reaction) 6602 
13.5.5.2.2.2 Transport of the Mature Intronless Transcript Derived Histone 6603 mRNA:TAP:Aly/Ref Complex through the NPC (Reaction) 
13.5.5.2.2.3 Release of the SLBP independent Histone mRNA from the NPC (Reaction)6604 
13.5.5.2.3 Transport of Mature mRNA Derived from an Intronless Transcript (Pathway)6605 
13.5.5.2.3.1 Docking of the Mature intronless derived transcript derived mRNA, TAP and
6605 Aly/Ref at the NPC (Reaction) 
13.5.5.2.3.2 Transport of the Mature intronless transcript derived mRNA:TAP:Aly/Ref 6606 Complex through the NPC (Reaction) 
13.5.5.2.3.3 Release of the Mature intronless derived mRNA, TAP, and Aly/Ref from the
6607 NPC (Reaction) 
13.6 Processing of Capped Intronless Pre-mRNA (Pathway) 6608 
13.6.1 SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs 6609 (Pathway) 
13.6.1.1 Binding of SLBP to Replication-Dependent Histone Pre-mRNA (Reaction) 6611 
13.6.1.2 Recruitment of U7 snRNP:ZFP100 complex to the SLBP Bound Pre-mRNA 6612 (Reaction) 
13.6.1.3 Cleavage of the 3'-end of Replication Dependent Histone Pre-mRNA (Reaction)6614 
13.6.2 SLBP independent Processing of Histone Pre-mRNAs (Pathway) 6614 
13.6.2.1 Recruitment of U7 snRNP:ZFP100 complex to the Histone Pre-mRNA (Reaction)
6615 
13.6.2.2 Cleavage of the 3'-end of the Histone Pre-mRNA (Reaction) 6616 
13.6.3 Processing of Intronless Pre-mRNAs (Pathway) 6616 
13.6.3.1 Recognition of AAUAAA sequence by CPSF (Reaction) 6617 
13.6.3.2 Recruitment of CstF to the CPSF Bound Pre-mRNA (Reaction) 6618 
13.6.3.3 Binding of Cleavage factors and Poly(A)Polymerase to the CstF:CPSF:Pre-mRNA
6619 
Complex (Reaction) 
13.6.3.4 Cleavage and polyadenylation of Intronless Pre-mRNA (Reaction) 6620 
13.6.3.5 Cleavage of Intronless Pre-mRNA at 3'-end (Reaction) 6621 
13.7 mRNA Editing (Pathway) 6621 
13.7.1 mRNA Editing: C to U Conversion (Pathway) 6623 
13.7.1.1 Formation of the Editosome (Pathway) 6624 
13.7.1.1.1 Formation of stem-loop structure in ApoB mRNA (Reaction) 6624 
13.7.1.1.2 Binding of A1CF to stem-looped RNA (Reaction) 6625 
13.7.1.1.3 Binding of APOBEC-1 to form editosome (Reaction) 6626 
13.7.1.2 C4 deamination of cytidine (Reaction) 6626 
13.7.2 mRNA Editing: A to I Conversion (Pathway) 6627 
13.7.2.1 Formation of dsRNA structure by looping (Reaction) 6629 
13.7.2.2 Formation of editosomes by ADAR proteins (Pathway) 6629 
13.7.2.2.1 Formation of ADAR1 homodimer (Reaction) 6630 
13.7.2.2.2 Binding of ADAR1 homodimer to dsRNA duplex (Reaction) 6630 
13.7.2.2.3 Formation of ADAR2 homodimer (Reaction) 6631 
13.7.2.2.4 Binding of ADAR2 homodimer to dsRNA duplex (Reaction) 6631 
13.7.2.3 C6 deamination of adenosine (Pathway) 6632 
13.7.2.3.1 Deamination at C6 position of adenosine in Editosome (ADAR1) (Reaction) 6632 
13.7.2.3.2 Deamination at C6 position of adenosine in Editosome (ADAR2) (Reaction) 6633 
13.8 tRNA Aminoacylation (Pathway) 6633 
13.8.1 Cytosolic tRNA aminoacylation (Pathway) 6635 
13.8.1.1 alanine + tRNA(Ala) + ATP => Ala-tRNA(Ala) + AMP + pyrophosphate (Reaction)
6637 
13.8.1.2 arginine + tRNA(Arg) + ATP => Arg-tRNA(Arg) + AMP + pyrophosphate 6638 (Reaction) 
13.8.1.3 asparagine + tRNA(Asn) + ATP => Asn-tRNA(Asn) + AMP + pyrophosphate 6639 (Reaction) 
13.8.1.4 aspartate + tRNA(Asp) + ATP => Asp-tRNA(Asp) + AMP + pyrophosphate 6641 (Reaction) 
13.8.1.5 cysteine + tRNA(Cys) + ATP => Cys-tRNA(Cys) + AMP + pyrophosphate 6642 (Reaction) 
13.8.1.6 glutamate + tRNA(Glu) + ATP => Glu-tRNA(Glu) + AMP + pyrophosphate 6643 (Reaction) 
13.8.1.7 glutamine + tRNA(Gln) + ATP => Gln-tRNA(Gln) + AMP + pyrophosphate 6645 (Reaction) 
13.8.1.8 glycine + tRNA(Gly) + ATP => Gly-tRNA(Gly) + AMP + pyrophosphate (Reaction)6646 
13.8.1.9 histidine + tRNA(His) + ATP => His-tRNA(His) + AMP + pyrophosphate (Reaction)
6647 
13.8.1.10 isoleucine + tRNA(Ile) + ATP => Ile-tRNA(Ile) + AMP + pyrophosphate 6649 (Reaction) 
13.8.1.11 leucine + tRNA(Leu) + ATP => Leu-tRNA(Leu) + AMP + pyrophosphate 6650 (Reaction) 
13.8.1.12 lysine + tRNA(Lys) + ATP => Lys-tRNA(Lys) + AMP + pyrophosphate (Reaction)
13.8.1.13 methionine + tRNA(Met) + ATP => Met-tRNA(Met) + AMP + pyrophosphate 6653 (Reaction) 
13.8.1.14 phenylalanine + tRNA(Phe) + ATP => Phe-tRNA(Phe) + AMP + pyrophosphate6655 (Reaction) 
13.8.1.15 proline + tRNA(Pro) + ATP => Pro-tRNA(Pro) + AMP + pyrophosphate 6656 (Reaction) 
13.8.1.16 serine + tRNA(Ser) + ATP => Ser-tRNA(Ser) + AMP + pyrophosphate (Reaction)6658 
13.8.1.17 threonine + tRNA(Thr) + ATP => Thr-tRNA(Thr) + AMP + pyrophosphate 6659 (Reaction) 
13.8.1.18 tryptophan + tRNA(Trp) + ATP => Trp-tRNA(Trp) + AMP + pyrophosphate 6660 (Reaction) 
13.8.1.19 tyrosine + tRNA(Tyr) + ATP =>Tyr-tRNA(Tyr) + AMP + pyrophosphate 6662 (Reaction) 
13.8.1.20 valine + tRNA(Val) + ATP => Val-tRNA(Val) + AMP + pyrophosphate (Reaction)6663 
13.8.1.21 pyrophosphate + H2O => 2 orthophosphate [cytosolic] (Reaction) 6664 
13.8.2 Mitochondrial tRNA aminoacylation (Pathway) 6666 
13.8.2.1 alanine + tRNA(Ala) + ATP => Ala-tRNA(Ala) + AMP + pyrophosphate (Reaction)
6667 
13.8.2.2 arginine + tRNA(Arg) + ATP => Arg-tRNA(Arg) + AMP + pyrophosphate 6669 (Reaction) 
13.8.2.3 asparagine + tRNA(Asn) + ATP => Asn-tRNA(Asn) + AMP + pyrophosphate 6671 (Reaction) 
13.8.2.4 aspartate + tRNA(Asp) + ATP => Asp-tRNA(Asp) + AMP + pyrophosphate 6673 (Reaction) 
13.8.2.5 cysteine + tRNA(Cys) + ATP => Cys-tRNA(Cys) + AMP + pyrophosphate 6674 (Reaction) 
13.8.2.6 glutamate + tRNA(Glu) + ATP => Glu-tRNA(Glu) + AMP + pyrophosphate 6677 (Reaction) 
13.8.2.7 glutamine + tRNA(Glu) + ATP => Glu-tRNA(Glu) + AMP + pyrophosphate 6679 (Reaction) 
13.8.2.8 glycine + tRNA(Gly) + ATP => Gly-tRNA(Gly) + AMP + pyrophosphate (Reaction)6680 
13.8.2.9 histidine + tRNA(His) + ATP => His-tRNA(His) + AMP + pyrophosphate (Reaction)
6682 
13.8.2.10 isoleucine + tRNA(Ile) + ATP => Ile-tRNA(Ile) + AMP + pyrophosphate 6683 (Reaction) 
13.8.2.11 leucine + tRNA(Leu) + ATP => Leu-tRNA(Leu) + AMP + pyrophosphate 6684 (Reaction) 
13.8.2.12 lysine + tRNA(Lys) + ATP => Lys-tRNA(Lys) + AMP + pyrophosphate (Reaction)6686 
13.8.2.13 methionine + tRNA(Met) + ATP => Met-tRNA(Met) + AMP + pyrophosphate 6687 (Reaction) 
13.8.2.14 phenylalanine + tRNA(Phe) + ATP => Phe-tRNA(Phe) + AMP + pyrophosphate6688 (Reaction) 
13.8.2.15 proline + tRNA(Pro) + ATP => Pro-tRNA(Pro) + AMP + pyrophosphate 6690 (Reaction) 
13.8.2.16 serine + tRNA(Ser) + ATP => Ser-tRNA(Ser) + AMP + pyrophosphate (Reaction)6692 
13.8.2.17 threonine + tRNA(Thr) + ATP => Thr-tRNA(Thr) + AMP + pyrophosphate 6693 (Reaction) 
13.8.2.18 tryptophan + tRNA(Trp) + ATP => Trp-tRNA(Trp) + AMP + pyrophosphate 6696 (Reaction) 
13.8.2.19 tyrosine + tRNA(Tyr) + ATP => Tyr-tRNA(Tyr) + AMP + pyrophosphate 6697 (Reaction) 
13.8.2.20 valine + tRNA(Val) + ATP => Val-tRNA(Val) + AMP + pyrophosphate (Reaction)6698 
13.8.2.21 pyrophosphate + H2O => 2 orthophosphate [mitochondrial] (Reaction) 6701 
13.9 Deadenylation-dependent mRNA decay (Pathway) 6702 
13.9.1 Deadenylation of mRNA (Pathway) 6704 
13.9.1.1 PAN2-PAN3 complex partially deadenylates mRNA (Reaction) 6705 
13.9.1.2 PARN deadenylates mRNA (Reaction) 6707 
13.9.1.3 CCR4-NOT complex deadenylates mRNA (Reaction) 6709 
13.9.2 mRNA decay by 3' to 5' exoribonuclease (Pathway) 6711 
13.9.2.1 Exosome Complex hydrolyzes mRNA by 3' to 5' exoribonuclease digestion 6712 (Reaction) 
13.9.2.2 DCPS scavenges the 7-methylguanosine cap of mRNA (Reaction) 6714 
13.9.3 mRNA decay by 5' to 3' exoribonuclease (Pathway) 6716 
13.9.3.1 Lsm1-7 Complex binds deadenylated mRNA (Reaction) 6717 
13.9.3.2 DCP1-DCP2 complex decaps mRNA (Reaction) 6719 
13.9.3.3 5' to 3' exoribonuclease hydrolyzes decapped mRNA (Reaction) 6721 
13.10 Nonsense-Mediated Decay (NMD) (Pathway) 6724 
13.10.1 Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
6726 (Pathway) 
13.10.1.1 UPF1 binds an mRNP with a termination codon preceding an Exon Junction 6728 Complex (Reaction) 
13.10.1.2 SMG1 phosphorylates UPF1 (enhanced by Exon Junction Complex) (Reaction)6732 
13.10.1.3 p-4S-UPF1 recruits SMG5, SMG7, SMG6, and PP2A (BlackBoxEvent) 6734 
13.10.1.4 SMG6 hydrolyzes mRNA with premature termination codon (BlackBoxEvent) 6736 
13.10.1.5 Decay of mRNA in SMG6:SMG5:SMG7:mRNA complex (BlackBoxEvent) 6737 
13.10.2 Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex 6740 (EJC) (Pathway) 
13.10.2.1 Formation of UPF1:eRF3 complex on mRNA with a premature termination codon
6742 and no Exon Junction Complex (Reaction) 
13.11 Regulatory RNA pathways (Pathway) 6744 
13.11.1 MicroRNA (miRNA) biogenesis (Pathway) 6745 
13.11.1.1 Pol II mediated transcription of microRNA genes (BlackBoxEvent) 6748 
13.11.1.2 Microprocessor complex cleaves pri-miRNA to pre-miRNA (Reaction) 6750 
13.11.1.3 Exportin-5 recognizes 3' overhang of pre-miRNA (Reaction) 6752 
13.11.1.4 Exportin complex translocates pre-miRNA to cytosol (Reaction) 6754 
13.11.1.5 Dicer cleaves pre-miRNA to yield duplex miRNA (Reaction) 6755 
13.11.1.6 Duplex miRNA is loaded into Argonaute (BlackBoxEvent) 6757 
13.11.1.7 Removal of miRNA passenger strand (BlackBoxEvent) 6759 
13.11.2 Small interfering RNA (siRNA) biogenesis (Pathway) 6761 
13.11.2.1 Dicer cleaves double-stranded RNA to yield double-stranded siRNA (Reaction)6762 
13.11.2.2 Duplex siRNA is loaded into Argonaute (BlackBoxEvent) 6764 
13.11.2.3 Cleavage-based removal of the siRNA passenger strand by AGO2 (BlackBoxEvent) 
13.11.2.4 Removal of siRNA passenger strand (BlackBoxEvent) 6767 
13.11.3 Post-transcriptional silencing by small RNAs (Pathway) 6769 
13.11.3.1 Endonucleolytic RISC hydrolyzes target RNAs (Reaction) 6772 
13.11.3.2 RISC binds inexactly matching target RNAs (Reaction) 6773 
13.11.3.3 Nonendonucleolytic RISC binds exactly matching target RNAs (Reaction) 6775 
13.12 Regulation of mRNA stability by proteins that bind AU-rich elements (Pathway) 6777 
13.12.1 AUF1 (hnRNP D0) destabilizes mRNA (Pathway) 6778 
13.12.1.1 AUF1(hnRNP D0) dimers bind AU-rich element in 3' UTR of mRNA (Reaction)6780 
13.12.1.2 AUF1 binds translation and heat shock proteins (Reaction) 6782 
13.12.1.3 AUF1 (hnRNP D0) is ubiquitinylated (BlackBoxEvent) 6783 
13.12.1.4 AUF1:mRNA complex is destroyed (BlackBoxEvent) 6785 
13.12.2 Butyrate Response Factor 1 (BRF1) destabilizes mRNA (Pathway) 6786 
13.12.2.1 Butyrate Response Factor1 (BRF1) binds AU-rich element in 3' UTR of mRNA6788 (Reaction) 
13.12.2.2 BRF1 Complex recruits RNA degradation activities (Reaction) 6789 
13.12.2.3 Protein Kinase B/Akt phosphorylates BRF1 (Reaction) 6791 
13.12.2.4 MK2 phosphorylates BRF1 (Reaction) 6792 
13.12.2.5 p-S92,203-BRF1 binds 14-3-3 (Reaction) 6793 
13.12.2.6 p-S54,92,203-BRF1 binds 14-3-3 (Reaction) 6795 
13.12.3 Tristetraprolin (TTP) destabilizes mRNA (Pathway) 6796 
13.12.3.1 ZFP36 (Tristetraproline, TTP) binds AU-rich elements in 3' UTR of target mRNAs
6797 (Reaction) 
13.12.3.2 ZFP36 (TTP) recruits RNA degradation activities (Reaction) 6799 
13.12.3.3 MK2 phosphorylates ZFP36 (Tristetraproline, TTP) (Reaction) 6800 
13.12.3.4 p-S60,S186-ZFP36 (Tristetraproline, TTP) binds 14-3-3beta (Reaction) 6802 
13.12.4 KSRP destabilizes mRNA (Pathway) 6803 
13.12.4.1 KSRP binds AU-rich element in 3' UTR of mRNA (Reaction) 6804 
13.12.4.2 KSRP recruits RNA degradation activities (Reaction) 6806 
13.12.4.3 Protein Kinase B/Akt phosphorylates KSRP (Reaction) 6807 
13.12.4.4 p-S193-KSRP binds 14-3-3zeta in the nucleus (BlackBoxEvent) 6808 
13.12.4.5 MAP kinase p38 phosphorylates KSRP (Reaction) 6810 
13.12.5 HuR stabilizes mRNA (Pathway) 6811 
13.12.5.1 PKCalpha phosphorylates HuR (Reaction) 6813 
13.12.5.2 PKCdelta phosphorylates HuR (Reaction) 6814 
13.12.5.3 p-S158,221-HuR binds mRNA (Reaction) 6815 
13.12.5.4 p-S318,221-HuR binds mRNA (Reaction) 6817 
13.12.5.5 HuR binds mRNAs in the nucleus (Reaction) 6818 
13.12.5.6 HuR binds the CRM1 nuclear export machinery (Reaction) 6819 
13.12.5.7 HuR:mRNA complex translocates from the nucleus to the cytosol 6821 (BlackBoxEvent) 
13.13 Translation (Pathway) 6822 
13.13.1 Eukaryotic Translation Initiation (Pathway) 6823 
13.13.1.1 Cap-dependent Translation Initiation (Pathway) 6824 
13.13.1.1.1 Formation of a pool of free 40S subunits (Pathway) 6765
6826 
13.13.1.1.1.1 Release of 40S and 60S subunits from the 80S ribosome (Reaction) 6826 
13.13.1.1.1.2 eIF3 and eIF1A bind to the 40S subunit (Reaction) 6827 
13.13.1.1.2 Formation of the ternary complex, and subsequently, the 43S complex 6828 (Pathway) 
13.13.1.1.2.1 De novo formation of eIF2:GTP (Reaction) 6828 
13.13.1.1.2.2 Met-tRNAi binds to eIF2:GTP to form the ternary complex (Reaction) 6829 
13.13.1.1.2.3 Formation of the 43S pre-initiation complex (Reaction) 6830 
13.13.1.1.3 Activation of the mRNA upon binding of the cap-binding complex and eIFs,6831 and subsequent binding to 43S (Pathway) 
13.13.1.1.3.1 Release of eIF4E from the inactive eIF4E:4E-BP complex (Reaction) 6831 
13.13.1.1.3.2 Formation of the cap-binding eIF4F complex (Reaction) 6832 
13.13.1.1.3.3 eIF4F binds to mRNP (Reaction) 6832 
13.13.1.1.3.4 Cap-bound mRNA is activated by helicases (BlackBoxEvent) 6833 
13.13.1.1.3.5 Translation initiation complex formation (Pathway) 6834 
13.13.1.1.3.5.1 Formation of translation initiation complexes containing mRNA that 6835 does not circularize (Reaction) 
13.13.1.1.3.5.2 Formation of translation initiation complexes yielding circularized 6836 Ceruloplasmin mRNA in a 'closed-loop' conformation (Reaction) 
13.13.1.1.4 Ribosomal scanning and start codon recognition (Pathway) 6838 
13.13.1.1.4.1 Ribosomal scanning (Reaction) 6838 
13.13.1.1.4.2 Start codon recognition (Reaction) 6840 
13.13.1.1.5 GTP hydrolysis and joining of the 60S ribosomal subunit (Pathway) 6840 
13.13.1.1.5.1 eIF2:GTP is hydrolyzed, eIFs are released (Reaction) 6841 
13.13.1.1.5.2 eIF5B:GTP is hydrolyzed and released (Reaction) 6843 
13.13.1.1.5.3 The 60S subunit joins the translation initiation complex (Reaction) 6844 
13.13.1.1.6 Recycling of eIF2:GDP (Pathway) 6844 
13.13.1.1.6.1 Formation of eIF2:GDP:eIF2B intermediate (Reaction) 6845 
13.13.1.1.6.2 eIF2 activation (Reaction) 6846 
13.13.1.2 L13a-mediated translational silencing of Ceruloplasmin expression (Pathway) 6846 
13.13.1.2.1 Dissociation of L13a from the 60s ribosomal subunit (Reaction) 6849 
13.13.1.2.2 INF-gamma induced phosphorylation of L13a (Reaction) 6850 
13.13.1.2.3 Association of phospho-L13a with GAIT element of Ceruloplasmin mRNA 6851 (Reaction) 
13.13.2 SRP-dependent cotranslational protein targeting to membrane (Pathway) 6852 
13.13.2.1 Synthesis of nascent polypeptide containing signal sequence (BlackBoxEvent)6853 
13.13.2.2 Nascent polypeptide:mRNA:ribosome complex binds signal recognition particle6854 (SRP) (Reaction) 
13.13.2.3 The SRP receptor binds the SRP:nascent peptide:ribosome complex (Reaction)6855 
13.13.2.4 Signal-containing nascent peptide translocates to endoplasmic reticulum 6857 (Reaction) 
13.13.2.5 Signal peptidase hydrolyzes signal peptide from ribosome-associated nascent6859 protein (Reaction) 
13.13.3 Eukaryotic Translation Elongation (Pathway) 6861 
13.13.3.1 eEF1A complexes with GTP (Reaction) 6863 
13.13.3.2 eEF1A:GTP:aminoacyl tRNA ternary complex formation. (Reaction) 6864 
13.13.3.3 Peptide chain elongation (Pathway) 6866 
13.13.3.3.1 Aminoacyl-tRNA binds to the ribosome at the A-site (Reaction) 6866 
13.13.3.3.2 Hydrolysis of eEF1A:GTP (Reaction) 6868 
13.13.3.3.3 Peptide transfer from P-site tRNA to the A-site tRNA (Reaction) 6870 
13.13.3.3.4 Translocation of ribosome by 3 bases in the 3' direction (Reaction) 6872 
13.13.3.3.5 GTP-binding activates eEF2 (Reaction) 6875 
13.13.3.4 Regeneration of eEF1A:GTP by eEF1B activity (Reaction) 6875 
13.13.3.5 Formation of eEF1B complex (Reaction) 6877 
13.13.4 Eukaryotic Translation Termination (Pathway) 6877 
13.13.4.1 GTP bound eRF3:eRF1 complex binds the peptidyl tRNA:mRNA:80S Ribosome
6878 complex (Reaction) 
13.13.4.2 GTP Hydrolysis by eRF3 bound to the eRF1:mRNA:polypeptide:80S Ribosome6880 complex (Reaction) 
13.13.4.3 Polypeptide release from the eRF3-GDP:eRF1:mRNA:80S Ribosome complex6882 (Reaction) 
13.14 Metabolism of non-coding RNA (Pathway) 6884 
13.14.1 snRNP Assembly (Pathway) 6885 
13.14.1.1 Nuclear export of snRNA transcripts (Reaction) 6887 
13.14.1.2 Loading and methylation of Sm proteins onto SMN Complexes (Reaction) 6889 
13.14.1.3 snRNP complex assembly (Reaction) 6892 
13.14.1.4 snRNA Cap hypermethylation (Reaction) 6894 
13.14.1.5 snRNP:Snurportin complex formation (Reaction) 6896 
13.14.1.6 snRNP nuclear import and release (Reaction) 6898 
13.15 Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind 6900 RNA (Pathway) 
13.15.1 IGF2BP1 binds specific RNAs (Reaction) 6902 
13.15.2 IGF2BP2 binds specific RNAs (Reaction) 6904 
13.15.3 IGF2BP3 binds specific RNAs (Reaction) 6906 
13.16 Epigenetic regulation of gene expression (Pathway) 6907 
13.16.1 PRC2 methylates histones and DNA (Pathway) 6909 
13.16.1.1 Polycomb Repressive Complex 2 (PRC2) Is recruited to chromatin 6910 (BlackBoxEvent) 
13.16.1.2 PRC2 trimethylates histone H3 at lysine-27 (Reaction) 6912 
13.16.1.3 PRC2 recruits DNA methyltransferases (Reaction) 6914 
13.16.1.4 DNMT1,3A,3B:PRC2 methylates cytosine and histone H3 (BlackBoxEvent) 6915 
13.16.2 TET1,2,3 and TDG demethylate DNA (Pathway) 6917 
13.16.2.1 TET1,2,3 oxidizes 5-methylcytosine to 5-hydroxymethylcytosine (Reaction) 6920 
13.16.2.2 TET1,2,3 oxidizes 5-hydroxymethylcytosine to 5-formylcytosine (Reaction) 6925 
13.16.2.3 TET1,2,3 oxidizes 5-formylcytosine to 5-carboxylcytosine (Reaction) 6927 
13.16.2.4 TDG excises 5-formylcytosine (Reaction) 6929 
13.16.2.5 TDG excises 5-carboxylcytosine (Reaction) 6930 
13.16.3 Negative epigenetic regulation of rRNA expression (Pathway) 6932 
13.16.3.1 SIRT1 negatively regulates rRNA Expression (Pathway) 6933 
13.16.3.1.1 RRP8 binds RNA (Reaction) 6934 
13.16.3.1.2 Formation of energy-dependent Nucleolar Silencing Complex (eNoSC) (Reaction) 
13.16.3.1.3 eNoSC deacetylates histone H3 (Reaction) 6937 
13.16.3.1.4 eNoSC dimethylates histone H3 at lysine-9 (Reaction) 6938 
13.16.3.1.5 SIRT1 deacetylates TAF1B in SL1 complex (Reaction) 6940 
13.16.3.2 NoRC negatively regulates rRNA expression (Pathway) 6941 
13.16.3.2.1 Transcription of intergenic spacer of the rRNA gene (Reaction) 6944 
13.16.3.2.2 Cleavage of intergenic spacer RNA to yield fragments of 150-300 nucleotides
6946 (BlackBoxEvent) 
13.16.3.2.3 TTF-I binds to the Sal Box (Reaction) 6947 
13.16.3.2.4 Nucleolar Remodelling Complex (NoRC) binds intergenic region of rDNA 6947 (Reaction) 
13.16.3.2.5 NoRC:HDAC:DNMT deacetylates histone H4 and methylates histone H3 6950 (BlackBoxEvent) 
13.16.3.2.6 NoRC:HDAC:DNMT methylates cytosine of the rRNA genes (Reaction) 6952 
13.16.3.2.7 MBD2 binds methylcytosine in chromatin (Reaction) 6955 14 Hemostasis (Pathway) 6957 
14.1 Platelet homeostasis (Pathway) 6959 
14.1.1 Prostacyclin signalling through prostacyclin receptor (Pathway) 6960 
14.1.1.1 Prostacyclin binds the Prostacyclin receptor PTGIR (Reaction) 6961 
14.1.1.2 Activated prostacyclin receptor binds G-protein Gs (Reaction) 6963 
14.1.1.3 Gs activation by prostacyclin receptor (Reaction) 6964 
14.1.1.4 Dissociation of the Prostacyclin receptor:Gs complex (Reaction) 6965 
14.1.2 Nitric oxide stimulates guanylate cyclase (Pathway) 6967 
14.1.2.1 Nitric Oxide Synthase (NOS) produces Nitric Oxide (NO) (Reaction) 6968 
14.1.2.2 NO binds to Guanylate Cyclase (Reaction) 6969 
14.1.2.3 Soluble guanylate cyclase converts GTP to cGMP (Reaction) 6970 
14.1.2.4 cGMP effects (Pathway) 6973 
14.1.2.4.1 cGMP stimulates Protein Kinase G (Reaction) 6975 
14.1.2.4.2 cGMP is degraded by PDEs (Reaction) 6977 
14.1.2.4.3 PKG1 phosphorylates IRAG:IP3R1 inhibiting IP3-stimulated Ca2+ release 6978 (Reaction) 
14.1.2.4.4 PKG1 phosphorylates BK channels (Reaction) 6979 
14.1.3 Binding of ATP to P2X1 (Reaction) 6981 
14.1.4 Platelet calcium homeostasis (Pathway) 6982 
14.1.4.1 Elevation of cytosolic Ca2+ levels (Pathway) 6983 
14.1.4.1.1 Transport of Ca++ from platelet dense tubular system to cytoplasm (Reaction)
6984 
14.1.4.1.2 P2X1-mediated entry of Ca++ from plasma (Reaction) 6985 
14.1.4.1.3 Cation influx mediated by TRPC3/6/7 (Reaction) 6987 
14.1.4.1.4 STIM1 activation of CRAC (Reaction) 6988 
14.1.4.1.5 CRAC translocates calcium from the extracellular region to the cytosol 6991 (Reaction) 
14.1.4.2 Reduction of cytosolic Ca++ levels (Pathway) 6992 
14.1.4.2.1 ATP2A1-3 transport cytosolic Ca2+ to dense tubular network lumen (Reaction)
6994 
14.1.4.2.2 ATP2B1-4 transport cytosolic Ca2+ to extracellular region (Reaction) 6995 
14.1.4.2.3 Na+/Ca2+ exchanger transport (Reaction) 6935
6997 
14.1.5 Platelet sensitization by LDL (Pathway) 6998 
14.1.5.1 LDL binds to LRP8 (Reaction) 6999 
14.1.5.2 FGR binds and phosphorylates LRP8 (Reaction) 7000 
14.1.5.3 Fgr may phosphorylate p38 MAPK (BlackBoxEvent) 7002 
14.1.5.4 Phosphorylation of cPLA2 by MAPK p38 alpha (Reaction) 7003 
14.1.5.5 LDL leads to activation of PECAM1 (BlackBoxEvent) 7005 
14.1.5.6 PECAM-1 binds PP2A (Reaction) 7006 
14.1.5.7 Interaction of PECAM-1 and SHP-1 (Reaction) 7007 
14.1.5.8 Interaction of PECAM-1 and SHP-2 (Reaction) 7008 
14.2 Platelet Adhesion to exposed collagen (Pathway) 7010 
14.2.1 Collagen type I binds integrin alpha1beta1, alpha2beta1, alpha10beta1 (Reaction)7012 
14.2.2 Interaction of GPVI and FceRI gamma (Reaction) 7012 
14.2.3 GPVI binds Fyn and Lyn (Reaction) 7014 
14.2.4 Binding of GPVI:Fc Epsilon R1 gamma receptor complex with collagen (Reaction) 7015 
14.2.5 vWF binds to collagen (Reaction) 7016 
14.2.6 GPIb-IX-V binds to vWF:Collagen complex (Reaction) 7017 
14.3 Platelet activation, signaling and aggregation (Pathway) 7018 
14.3.1 GP1b-IX-V activation signalling (Pathway) 7020 
14.3.1.1 GP1b-IX-V binds 14-3-3-zeta (Reaction) 7022 
14.3.1.2 GPIb-IX-V binding to 14-3-3 zeta is reduced by shear stress (Reaction) 7023 
14.3.1.3 GP1b-IX-V binds filamin (Reaction) 7025 
14.3.1.4 GP1b-IX-V:13-3-3-zeta complexes with p85 PI3K (Reaction) 7026 
14.3.1.5 GP1b signaling involves c-Src (BlackBoxEvent) 7027 
14.3.1.6 c-Src binds Raf1 (Reaction) 7030 
14.3.1.7 14-3-3-zeta binds Raf1 (Reaction) 7031 
14.3.2 Signal amplification (Pathway) 7032 
14.3.2.1 ADP signalling through P2Y purinoceptor 12 (Pathway) 7034 
14.3.2.1.1 ADP binds to P2Y purinoceptor 12 (Reaction) 7035 
14.3.2.1.2 Activated P2Y purinoceptor 12 binds G-protein Gi (Reaction) 7036 
14.3.2.1.3 Gi activation by P2Y purinoceptor 12 (Reaction) 7037 
14.3.2.1.4 Dissociation of the P2Y purinoceptor 12:Gi complex (Reaction) 7039 
14.3.2.2 ADP signalling through P2Y purinoceptor 1 (Pathway) 7040 
14.3.2.2.1 ADP binds to P2Y purinoceptor 1 (Reaction) 7041 
14.3.2.2.2 Activated P2Y purinoceptor 1 binds G-protein Gq (Reaction) 7042 
14.3.2.2.3 Gq activation by P2Y purinoceptor 1 (Reaction) 7044 
14.3.2.2.4 Dissociation of the P2Y purinoceptor 1:Gq complex (Reaction) 7045 
14.3.2.2.5 Src activation following P2Y purinoceptor activation (BlackBoxEvent) 7047 

14.3.2.2.6 P2Y purinoceptor 1 activates MAP kinase p38 alpha (BlackBoxEvent) 7048 
14.3.2.2.7 Phosphorylation of cPLA2 by MAPK p38 alpha (Reaction) 7049 
14.3.2.3 Thromboxane signalling through TP receptor (Pathway) 7050 
14.3.2.3.1 TP receptor can bind thromboxane (Reaction) 7051 
14.3.2.3.2 Activated TP receptor binds G-proten Gq (Reaction) 7052 
14.3.2.3.3 Activated TP receptor binds G-protein G13 (Reaction) 7053 
14.3.2.3.4 Gq activation by TP receptor (Reaction) 7055 
14.3.2.3.5 G13 activation by TP receptor (Reaction) 7056 
14.3.2.3.6 Dissociation of the TP:Gq complex (Reaction) 7057 
14.3.2.3.7 Dissociation of the TP:G13 complex (Reaction) 7058 
14.3.3 Thrombin signalling through proteinase activated receptors (PARs) (Pathway) 7059 
14.3.3.1 Thrombin-mediated activation of Proteinase-activated receptors (Reaction) 7061 
14.3.3.2 Thrombin-activated PAR binds G-protein Gq (Reaction) 7062 
14.3.3.3 Gq activation by PAR (Reaction) 7063 
14.3.3.4 Dissociation of the PAR:Gq complex (Reaction) 7064 
14.3.3.5 Thrombin-activated PAR binds G-protein G12/13 (Reaction) 7065 
14.3.3.6 G12/13 activation by PAR (Reaction) 7067 
14.3.3.7 Dissociation of the PAR:G12/13 complex (Reaction) 7068 
14.3.3.8 Activated PAR1 binds Beta-arrestin-1 (Reaction) 7070 
14.3.3.9 Activated PAR1 binds beta-arrestin-2 (Reaction) 7071 
14.3.3.10 Beta-arrestin-1 acts as scaffold for a PAR1 signalling complex (Reaction) 7073 
14.3.3.11 Beta-arrestin-2 acts as scaffold for a PAR1 signalling complex (Reaction) 7074 
14.3.3.12 Activation of beta-arrestin-1-bound Src kinase (BlackBoxEvent) 7075 
14.3.3.13 Src bound to beta-arrestin-2 is not activated (BlackBoxEvent) 7077 
14.3.3.14 Activated Src activates ERK (BlackBoxEvent) 7078 
14.3.4 GPVI-mediated activation cascade (Pathway) 7079 
14.3.4.1 Fyn/Lyn-mediated phosphorylation of FcR1 gamma (Reaction) 7080 
14.3.4.2 Binding of Syk tyrosine kinase (Reaction) 7081 
14.3.4.3 Syk autophosphorylates (Reaction) 7082 
14.3.4.4 Syk is released (Reaction) 7083 
14.3.4.5 Syk binds Vav (Reaction) 7085 
14.3.4.6 Syk phosphorylates Vav (Reaction) 7087 
14.3.4.7 VAV1 is a GEF for Rho/Rac family kinases (Reaction) 7089 
14.3.4.8 VAV2 is a GEF for Rho/Rac family kinases (Reaction) 7091 
14.3.4.9 VAV3 is a GEF for Rho/Rac family kinases (Reaction) 7092 
14.3.4.10 Syk/Lck phosphorylate LAT (Reaction) 7094 
14.3.4.11 Syk activation leads to SLP-76 activation (BlackBoxEvent) 7095 
14.3.4.12 SLP-76 stimulates PLC gamma 2 (BlackBoxEvent) 7097 
14.3.4.13 p-SLP-76 binds VAV (Reaction) 7099 
14.3.4.14 PLC gamma 2-mediated PIP2 hydrolysis (Reaction) 7100 
14.3.4.15 PIP3 stimulates Vav (Reaction) 7101 
14.3.4.16 PIP2 inhibits Vav (Reaction) 7103 
14.3.4.17 GPVI stimulates PI3K beta, gamma (BlackBoxEvent) 7104 
14.3.4.18 PI3K alpha, beta, gamma convert PIP2 to PIP3 (Reaction) 7106 
14.3.4.19 PIP3 recruits PDK1 and AKT to the membrane (Reaction) 7107 
14.3.4.20 PDK1 binds PKC zeta (Reaction) 7109 
14.3.4.21 PDK1 activates PKC zeta (Reaction) 7111 
14.3.5 Platelet Aggregation (Plug Formation) (Pathway) 7112 
14.3.5.1 Integrin alphaIIb beta3 signaling (Pathway) 7113 
14.3.5.1.1 Activation of Rap1 by cytosolic GEFs (Reaction) 7116 
14.3.5.1.2 Activation of Rap1 by membrane-associated GEFs (Reaction) 7117 
14.3.5.1.3 Translocation of RIAM to plasma membrane (Reaction) 7119 
14.3.5.1.4 Activation of Talin (Reaction) 7120 14.3.5.1.5 Integrin alphaIIb beta3 activation (Reaction) 7122 
14.3.5.1.6 Interaction of integrin alphaIIb beta3 with Fibrinogen (Reaction) 7123 
14.3.5.1.7 Clustering of Integrin alphaIIb beta3 complexes (Reaction) 7125 
14.3.5.1.8 Release of CSK from SRC (Reaction) 7126 
14.3.5.1.9 Dephosphorylation of inactive SRC by PTPB1 (Reaction) 7127 
14.3.5.1.10 Autophosphorylation of SRC (Reaction) 7129 
14.3.5.1.11 Translocation of FADK1 to Focal complexes (Reaction) 7130 
14.3.5.1.12 Autophosphorylation of FADK1 at Y397 (Reaction) 7131 
14.3.5.1.13 Phosphorylation of pFADK1 by SRC (Reaction) 7132 
14.3.5.1.14 GRB2:SOS provides linkage to MAPK signaling for Integrins (Pathway) 7134 
14.3.5.1.14.1 Recruitment of GRB2 to p-FADK1 (Reaction) 7136 
14.3.5.1.14.2 Interaction of SOS with GRB2 bound to FADK1 (Reaction) 7137 
14.3.5.1.15 p130Cas linkage to MAPK signaling for integrins (Pathway) 7138 
14.3.5.1.15.1 Recruitment of p130Cas to FADK1 (Reaction) 7141 
14.3.5.1.15.2 Phosphorylation of p130Cas by SRC-FADK1 complex (Reaction) 7142 
14.3.5.1.15.3 Crk binding to p130cas (Reaction) 7143 
14.3.5.1.16 Integrin alpha IIb beta3 T779 phosphorylation blocks SHC binding (Reaction)
7145 
14.3.5.1.17 Activated integrin alphaIIb beta3 binds SHC1 (Reaction) 7146 
14.3.5.1.18 SHC1 bound to integrin alphaIIb beta3 is phosphorylated somehow 7147 (BlackBoxEvent) 
14.3.5.1.19 SHC1 dissociates from integrin alphaIIb beta3 (BlackBoxEvent) 7148 
14.3.5.1.20 SYK binds to integrin alphaIIb beta3 (Reaction) 7150 
14.3.5.1.21 SYK activation by SRC (Reaction) 7151 
14.3.5.2 Adrenaline signalling through Alpha-2 adrenergic receptor (Pathway) 7153 
14.3.5.2.1 Alpha-2 adrenoceptors bind catecholamines (Reaction) 7154 
14.3.5.3 Thrombin binding to GP1b:IX:V (Reaction) 7155 
14.3.5.4 Thrombopoietin binds the thrombopoietin receptor (Reaction) 7156 
14.3.6 Effects of PIP2 hydrolysis (Pathway) 7159 
14.3.6.1 Binding of IP3 to IP3 receptor (Reaction) 7160 
14.3.6.2 Transport of Ca++ from platelet dense tubular system to cytoplasm (Reaction) 7161 
14.3.6.3 Calcium and Diacylglycerol activate CalDAG-GEFs (RasGRPs) (Reaction) 7161 
14.3.6.4 Activation of Protein Kinase C novel isoforms (Reaction) 7164 
14.3.6.5 DAG activation of TRPC channels (Reaction) 7166 
14.3.6.6 Arachidonate production from DAG (Pathway) 7167 
14.3.6.6.1 DAG is metabolized by DAGL to 2-AG (Reaction) 7169 
14.3.6.6.2 2-AG hydrolysis to arachidonate by MAGL (Reaction) 7170 
14.3.6.7 DAG kinase produces phosphatidic acid from DAG (Reaction) 7172 
14.3.7 Response to elevated platelet cytosolic Ca2+ (Pathway) 7173 
14.3.7.1 Activation of conventional Protein Kinase C (Reaction) 7174 
14.3.7.2 Disinhibition of SNARE formation (Pathway) 7176 
14.3.7.2.1 Phosphorylation of Platelet Sec-1 (Reaction) 7176 
14.3.7.2.2 Phosphorylation of Syntaxin-4 (Reaction) 7177 
14.3.7.3 Platelet degranulation (Pathway) 7178 
14.3.7.3.1 ABCC4 accumulation of dense granule contents (Reaction) 7178 
14.3.7.3.2 Exocytosis of platelet dense granule content (Reaction) 7180 
14.3.7.3.3 Surface deployment of platelet dense granule membrane components 7181 (Reaction) 
14.3.7.3.4 Exocytosis of platelet alpha granule contents (Reaction) 7182 
14.3.7.3.5 Surface deployment of platelet alpha granule membrane components 7184 (Reaction) 
14.3.7.3.6 Release of platelet cytosolic components (Reaction) 7185 
14.3.7.3.7 Release of (inferred) platelet cytosolic components (Reaction) 7186 
14.3.7.3.8 Release of platelet secretory granule components (Reaction) 7188 
14.3.7.3.9 Release of Calumenin (Reaction) 7189 
14.3.7.3.10 Release of 78 kDa glucose-regulated protein (Reaction) 7191 
14.3.7.3.11 Exocytosis of Proactivator polypeptide (Reaction) 7193 
14.4 Formation of Fibrin Clot (Clotting Cascade) (Pathway) 7194 
14.4.1 Extrinsic Pathway (Pathway) 7195 
14.4.1.1 sequestered tissue factor -> tissue factor (Reaction) 7197 
14.4.1.2 tissue factor (TF) + factor VII (F7) -> TF:F7 complex (Reaction) 7197 
14.4.1.3 factor X -> factor Xa + factor X activation peptide (TF:F7 catalyst) (Reaction) 7198 
14.4.1.4 factor VII -> factor VIIa (Reaction) 7199 
14.4.1.5 tissue factor (TF) + activated factor VII (F7a) -> TF:F7a complex (Reaction) 7200 
14.4.1.6 factor X -> factor Xa + factor X activation peptide (TF:F7a catalyst) (Reaction) 7201 
14.4.1.7 factor IX -> factor IXa + factor IX activation peptide (TF:F7a catalyst) (Reaction)7202 
14.4.1.8 TFPI + TF:F7a + factor Xa -> TFPI:TF:F7a:factor Xa (Reaction) 7203 
14.4.2 Intrinsic Pathway (Pathway) 7203 
14.4.2.1 kininogen + C1q binding protein tetramer -> kininogen:C1q binding protein 7206 tetramer (Reaction) 
14.4.2.2 prekallikrein + kininogen:C1q binding protein tetramer -> 7208 prekallikrein:kininogen:C1q binding protein tetramer (Reaction) 
14.4.2.3 prekallikrein:kininogen:C1q binding protein tetramer -> kallikrein:kininogen:C1q7209 binding protein tetramer (Reaction) 
14.4.2.4 kallikrein:kininogen:C1q binding protein tetramer -> kallikrein + activated 7210 kininogen:C1q binding protein tetramer + bradykinin (Reaction) 
14.4.2.5 factor XII -> factor XIIa (Reaction) 7212 
14.4.2.6 factor XI + platelet glycoprotein (GP) Ib:IX:V complex -> factor XI:platelet 7214 glycoprotein (GP) Ib:IX:V complex (Reaction) 
14.4.2.7 factor XI:platelet glycoprotein (GP) Ib:IX:V complex -> factor XIa:platelet 7215 glycoprotein (GP) Ib:IX:V complex (XIIa catalyst) (Reaction) 
14.4.2.8 factor XI:platelet glycoprotein (GP) Ib:IX:V complex -> factor XIa:platelet 7217 glycoprotein (GP) Ib:IX:V complex (thrombin catalyst) (Reaction) 
14.4.2.9 factor IX -> factor IXa + factor IX activation peptide (factor XIa catalyst) (Reaction)7218 
14.4.2.10 factor VIII + von Willebrand factor multimer -> factor VIII:von Willibrand factor 7220 multimer (Reaction) 
14.4.2.11 factor VIII:von Willibrand factor multimer -> factor VIIIa + factor VIIIa B A3 acidic
7221 polypeptide + von Willibrand factor multimer (Reaction) 
14.4.2.12 factor VIIIa + factor IXa -> factor VIIIa:factor IXa (Reaction) 7223 
14.4.2.13 factor X -> factor Xa + factor X activation peptide (VIIIa:IXa catalyst) (Reaction)7224 
14.4.2.14 kallikrein + C1Inh -> kallikrein:C1Inh (Reaction) 
14.4.2.15 kallikrein + alpha2-macroglobulin -> kallikrein:alpha2-macrogloulin (Reaction) 7226 
14.4.2.16 factor XIIa + C1Inh -> factor XIIa:C1Inh (Reaction) 7227 
14.4.3 Common Pathway (Pathway) 7228 
14.4.3.1 prothrombin -> activated thrombin (factor IIa) + thrombin activation peptide (Xa 7229 catalyst) (Reaction) 
14.4.3.2 factor V -> factor Va + factor V activation peptide (Reaction) 7230 
14.4.3.3 factor Va + factor Xa -> Va:Xa complex (prothrombinase) (Reaction) 7231 
14.4.3.4 prothrombin -> activated thrombin (factor IIa) + thrombin activation peptide 7232 (prothrombinase catalyst) (Reaction) 
14.4.3.5 fibrinogen -> fibrin monomer + 2 fibrinopeptide A + 2 fibrinopeptide B (Reaction)7233 
14.4.3.6 n fibrin monomers -> fibrin multimer (Reaction) 7234 
14.4.3.7 factor XIII -> factor XIII cleaved tetramer + 2 factor XIII A activation peptides 7235 (Reaction) 
14.4.3.8 factor XIII cleaved tetramer + 2 Ca++ -> factor XIIIa + 2 factor XIII B chain 7236 (Reaction) 
14.4.3.9 fibrin multimer -> fibrin multimer, crosslinked + NH4+ (BlackBoxEvent) 7237 
14.4.3.10 antithrombin III + heparin -> antithrombin III:heparin (Reaction) 7238 
14.4.3.11 activated thrombin (factor IIa) + antithrombin III:heparin -> thrombin:antithrombin
7238 III:heparin (Reaction) 
14.4.3.12 thrombin:antithrombin III:heparin -> thrombin:cleaved antithrombin III:heparin 7239 (Reaction) 
14.4.3.13 thrombin:cleaved antithrombin III:heparin -> thrombin:cleaved antithrombin III +7240 heparin (Reaction) 
14.4.3.14 activated thrombin (factor IIa) + thrombomodulin -> activated 7241 thrombin:thrombomodulin (Reaction) 
14.4.3.15 protein C -> activated protein C + protein C heavy chain activation peptide 7242 (Reaction) 
14.4.3.16 factor Va -> factor Vi (Reaction) 7243 
14.5 Dissolution of Fibrin Clot (Pathway) 7244 
14.5.1 histidine-rich glycoprotein + plasminogen histidine-rich glycoprotein:plasminogen 7246 (Reaction) 
14.5.2 histidine-rich glycoprotein:plasminogen histidine-rich glycoprotein + plasminogen 7247 (Reaction) 
14.5.3 crosslinked fibrin multimer + tissue plasminogen activator (one-chain) -> crosslinked
7248 fibrin multimer:tissue plasminogen activator (one-chain) (Reaction) 
14.5.4 crosslinked fibrin multimer:tissue plasminogen activator (one-chain) + plasminogen7250 -> crosslinked fibrin multimer:tissue plasminogen activator (one-chain):plasminogen (Reaction) 
14.5.5 crosslinked fibrin multimer:tissue plasminogen activator (one-chain):plasminogen ->7251 crosslinked fibrin multimer:tissue plasminogen activator (one-chain) + plasmin (Reaction) 
14.5.6 fibrin multimer, crosslinked -> fibrin digestion products (plasmin) (Reaction) 7253 
14.5.7 crosslinked fibrin multimer:tissue plasminogen activator (one-chain) -> crosslinked7254 fibrin multimer:tissue plasminogen activator (two-chain) (Reaction) 
14.5.8 crosslinked fibrin multimer:tissue plasminogen activator (two-chain) + plasminogen ->
7255 crosslinked fibrin multimer:tissue plasminogen activator (two-chain):plasminogen (Reaction) 
14.5.9 crosslinked fibrin multimer:tissue plasminogen activator (two-chain):plasminogen ->7256 crosslinked fibrin multimer:tissue plasminogen activator (two-chain) + plasmin (Reaction) 
14.5.10 fibrin multimer, crosslinked:tissue plasminogen activator (two-chain) + plasminogen7257 
activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator 
(two-chain):plasminogen activator inhibitor 1 (Reaction) 
14.5.11 fibrin multimer, crosslinked:tissue plasminogen activator (one-chain) + plasminogen7258 
activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator 
(one-chain):plasminogen activator inhibitor 1 (Reaction) 
14.5.12 alpha-2-antiplasmin + plasmin -> alpha-2-antiplasmin:plasmin (Reaction) 7259 
14.5.13 urokinase plasminogen activator + urokinase plasminogen activator receptor 7261 (uPAR) -> urokinase plasminogen activator:uPAR (Reaction) 
14.5.14 plasminogen + histidine-rich glycoprotein -> plasminogen:histidine-rich glycoprotein
7262 (Reaction) 
14.5.15 plasminogen:histidine-rich glycoprotein -> plasmin + histidine-rich glycoprotein (uPA
7263 [one-chain] catalyst) (Reaction) 
14.5.16 urokinase plasminogen activator (one-chain):uPAR -> urokinase plasminogen 7264 activator (two-chain):uPAR (Reaction) 
14.5.17 plasminogen:histidine-rich glycoprotein -> plasmin + histidine-rich glycoprotein (uPA
7265 [two-chain] catalyst) (Reaction) 
14.5.18 urokinase plasminogen activator (two-chain):uPAR + plasminogen activator inhibitor
7267 1 (PAI-1) -> PAI-1:urokinase plasminogen activator (two-chain):uPAR (Reaction) 
14.5.19 urokinase plasminogen activator (two-chain):uPAR + plasminogen activator inhibitor
7268 2 (PAI-2) -> PAI-2:urokinase plasminogen activator (two-chain):uPAR (Reaction) 
14.6 Cell surface interactions at the vascular wall (Pathway) 7269 
14.6.1 Binding of GPVI:Fc Epsilon R1 gamma receptor complex with collagen (Reaction) 7271 
14.6.2 Integrin alphaMbeta2 (MAC1) binds JAM3 (Reaction) 7271 
14.6.3 JAM-B binds JAM-C (Reaction) 7272 
14.6.4 Integrin alpha4beta1 binds JAM2 (Reaction) 7273 
14.6.5 JAM-A homodimerises (Reaction) 7273 
14.6.6 Integrin alphaLbeta2 (LFA-1) binds F11R (JAM-A) (Reaction) 7274 
14.6.7 Integrin alphaXbeta2 binds JAM3 (Reaction) 7275 
14.6.8 MERTK receptor binds ligands (Gas6 or Protein S) (Reaction) 7275 
14.6.9 CD84 homodimerises (Reaction) 7277 
14.6.10 E-selectin binds E-selectin ligand (Reaction) 7278 
14.6.11 P-selectin binds P-selectin ligand (Reaction) 7279 
14.6.12 JAM-B homodimerises (Reaction) 7281 
14.6.13 JAM-C homodimerises (Reaction) 7282 
14.6.14 CD177 binds PECAM-1 (Reaction) 7283 
14.6.15 CD47 binds SIRP (Reaction) 7284 
14.6.16 CD48 binds CD244 (Reaction) 7285 
14.6.17 CD58 binds CD2 (Reaction) 7286 
14.6.18 Integrin alpha5beta1 binds FN1 dimer (Reaction) 7287 
14.6.19 CXADR binds to AMICA1 (Reaction) 7287 
14.6.20 protein C -> activated protein C + protein C heavy chain activation peptide 7288 (Reaction) 
14.6.21 OLR1 binds to oxidized LDL (Reaction) 7289 
14.6.22 Platelet-derived TREM-1 ligand binds to TREM-1 (Reaction) 7290 
14.6.23 Tie2 Signaling (Pathway) 7291 
14.6.23.1 Interaction of Tie2 with Ang1 (Reaction) 7292 
14.6.23.2 Dimerization of Tie2/Ang1 complex (Reaction) 7294 
14.6.23.3 Trans-phosphorylation of Tie2 (Reaction) 7295 
14.6.23.4 Interaction of Tie2 and p85 of PI3K (Reaction) 7297 
14.6.23.5 Interaction of Tie2 and Grb2 (Reaction) 7298 
14.6.23.6 Interaction of SOS-1 to Tie2 bound Grb2 (Reaction) 7300 
14.6.23.7 Sos-mediated nucleotide exchange of Ras (Tie2 receptor:Grb2:Sos) (Reaction)7301 
14.6.23.8 Interaction of Tie2 and Shc1 (Reaction) 7302 
14.6.23.9 Interaction of Tie2 and Dok-2 (Reaction) 7303 
14.6.23.10 Interaction of Tie2 with Ang2 (Reaction) 7304 
14.6.23.11 Interaction of Tie2 and Ang4 (Reaction) 7305 
14.6.23.12 Interaction of Tie2 and Shp2 (Reaction) 7307 
14.6.23.13 Interaction of Tie2 and Grb7 (Reaction) 7308 
14.6.23.14 Interaction of Tie2 and Grb14 (Reaction) 7309 
14.6.24 PECAM1 interactions (Pathway) 7311 
14.6.24.1 Trans-homophilic interaction of PECAM-1 (Reaction) 7312 
14.6.24.2 Interaction of integrin alphaVbeta3 with PECAM1 (Reaction) 7313 
14.6.24.3 Phoshorylation of PECAM-1 by Fyn or Lyn or c-Src (Reaction) 7313 
14.6.24.4 Interaction of PECAM-1 and SHIP (Reaction) 7314 
14.6.24.5 Interaction of PECAM-1 and SHP-2 (Reaction) 7316 
14.6.24.6 Interaction of PECAM-1 and PLC gamma1 (Reaction) 7316 
14.6.24.7 Interaction of PECAM-1 and SHP-1 (Reaction) 7317 
14.6.25 Basigin interactions (Pathway) 7317 
14.6.25.1 CyP60 chaperones Basigin (Reaction) 7318 
14.6.25.2 Basigin homodimerises (Reaction) 7319 
14.6.25.3 Caveolin-1 binds Basigin (Reaction) 7320 
14.6.25.4 Basigin binds CyPA (Reaction) 7321 
14.6.25.5 Basigin interacts with CD43 (Reaction) 7323 
14.6.25.6 Basigin binds Matrix metalloproteinase-1 (Reaction) 7324 
14.6.25.7 Basigin binds Mannose-carrying cell recognition molecules (Reaction) 7325 
14.6.25.8 BSG (basigin) binds Integrin alpha3beta1, alpha6beta1 (Reaction) 7327 
14.6.25.9 Basigin binds MCT1, MCT3 and MCT4 (Reaction) 7327 
14.6.25.10 Basigin binds CD98 complex (Reaction) 7329 
14.7 Factors involved in megakaryocyte development and platelet production (Pathway) 7330 
14.7.1 RAD51B binds RAD51C (Reaction) 7332 
14.7.2 RAD51B:RAD51C binds single-stranded DNA (Reaction) 7333 
14.7.3 Dual-specific AKAPs bind type I and II PKA regulatory subunits (Reaction) 7335 
14.7.4 Mitofusins trans-interact linking mitochondria prior to fusion (Reaction) 7336 
14.7.5 p53, SIN3A and MYB form a complex (Reaction) 7338 
14.7.6 IRF1 binds the promoters of Interferon alpha and beta (Reaction) 7341 
14.7.7 Expression of Interferon-alpha and beta (BlackBoxEvent) 7343 
14.7.8 IRF2 binds the promoters of Interferon alpha and beta (Reaction) 7344 14.7.9 HP1 alpha binds Histone H3K9(me)3 (Reaction) 7346 
14.7.10 ITPK1 converts Ins-3,4,5,6-P4 to Ins-1,3,4,5,6-P5 (Reaction) 7347 
14.7.11 ITPK1 converts Ins-1,3,4-P3 to Ins-1,3,4,5-P4 (Reaction) 7349 
14.7.12 ITPK1 converts Ins-1,3,4-P3 to Ins-1,3,4,6-P4 (Reaction) 7350 
14.7.13 LRRC16A binds F-actin capping protein (Reaction) 7351 
14.7.14 F-actin capping protein is a heterodimer (Reaction) 7353 
14.7.15 F-actin capping protein binds to the barbed end of elongating F-actin (Reaction) 7354 
14.7.16 REST recruits the BHC complex (Reaction) 7356 
14.7.17 ZFPM proteins bind GATA proteins (Reaction) 7357 
14.7.18 JMJD1C demethylates H3K9 mono- and di-methylation (Reaction) 7359 
14.7.19 SH2B proteins bind JAK2 (Reaction) 7360 
14.7.20 Adenylate Kinase 3 is a GTP-AMP phosphotransferase (Reaction) 7362 
14.7.21 NFE2 is a heterodimer (Reaction) 7363 
14.7.22 NFE2 binds the beta globin locus control region (Reaction) 7366 
14.7.23 Expression of globin genes under control of the beta globin control region 7367 (BlackBoxEvent) 
14.7.24 EHD proteins interact with Rabenosyn-5 (Reaction) 7368 
14.7.25 Rabenosyn-5 connects Rab5 to VPS-45 (Reaction) 7370 
14.7.26 DOCKs bind to RhoGEFs (Reaction) 7371 
14.7.27 Cables link CDK5 and ABL1 (Reaction) 7373 
14.7.28 Cables1 links CDK2 and WEE1 (Reaction) 7376 
14.7.29 Kinesins (Pathway) 7378 
14.7.29.1 Kinesin-1 is a heterotetramer (Reaction) 7379 
14.7.29.2 Kinesin-2 is a heterotrimer (Reaction) 7381 
14.7.29.3 Kinesin-3 is a dimer (Reaction) 7383 
14.7.29.4 Chromokinesins form dimers (Reaction) 7385 
14.7.29.5 Kinesin-5 is a homotetramer (Reaction) 7386 
14.7.29.6 Kinesin-6 and RACGAP1 form the heterotetrameric complex centralspindlin 7388 (Reaction) 
14.7.29.7 Kinesin-7 is a dimer (Reaction) 7389 
14.7.29.8 Kinesin-8 is a dimer (Reaction) 7391 
14.7.29.9 Kinesin-9 is a dimer (Reaction) 7393 
14.7.29.10 Kinesin-12 is a dimer (Reaction) 7394 
14.7.29.11 Kinesin-13 is a dimer (Reaction) 7396 
14.7.29.12 Kinesin-14 is a dimer (Reaction) 7397 
14.7.29.13 Kinesins bind microtubules (Reaction) 7399 
14.7.29.14 Kinesins move along microtubules consuming ATP (BlackBoxEvent) 7402 15 Immune System (Pathway) 7404 
15.1 Adaptive Immune System (Pathway) 7404 
15.1.1 TCR signaling (Pathway) 7406 
15.1.1.1 Phosphorylation of CD3 and TCR zeta chains (Pathway) 7408 
15.1.1.1.1 Interaction of Csk with PAG (Reaction) 7410 
15.1.1.1.2 Inactivation of Lck by Csk (Reaction) 7411 
15.1.1.1.3 Dephosphorylation of Lck-pY505 by CD45 (Reaction) 7413 
15.1.1.1.4 Activation of Lck (Reaction) 7414 
15.1.1.1.5 Phosphorylation of ITAM motifs in CD3 complexes (Reaction) 7415 
15.1.1.2 Translocation of ZAP-70 to Immunological synapse (Pathway) 7416 
15.1.1.2.1 Recruitment of ZAP-70 to phosphorylated ITAMs (Reaction) 7418 
15.1.1.2.2 Phosphorylation of ZAP-70 by Lck (Reaction) 7419 
15.1.1.2.3 Activation of ZAP-70 (Reaction) 7420 
15.1.1.3 Generation of second messenger molecules (Pathway) 7421 
15.1.1.3.1 Phosphorylation of TBSMs in LAT (Reaction) 7423 
15.1.1.3.2 Recruitment of Gads to LAT (Reaction) 7425 
15.1.1.3.3 Recruitment of SLP-76 to Gads (Reaction) 7426 
15.1.1.3.4 Phosphorylation of SLP-76 (Reaction) 7427 
15.1.1.3.5 Recruitment of ITK to SLP-76 (Reaction) 7428 
15.1.1.3.6 Recruitment of PLC-gamma1 to SLP-76 (Reaction) 7429 
15.1.1.3.7 Recruitment of PLC-gamma1 to LAT (Reaction) 7430 
15.1.1.3.8 Phosphorylation of PLC-gamma1 (Reaction) 7431 
15.1.1.3.9 Disassociation of PLC-gamma1 from LAT (Reaction) 7432 
15.1.1.3.10 Disassociation of PLC-gamma1 from SLP-76 (Reaction) 7433 
15.1.1.3.11 Translocation of PLC-gamma1 to PIP2 (Reaction) 7434 
15.1.1.3.12 PLC-gamma1 hydrolyses PIP2 (Reaction) 7435 
15.1.1.3.13 p-SLP-76 binds ADAP (Reaction) 7436 
15.1.1.3.14 p-SLP-76:ADAP binds Ena/VASP (Reaction) 7437 
15.1.1.3.15 p-SLP-76 binds NCK (Reaction) 7439 
15.1.1.3.16 NCK binds PAK (Reaction) 7441 
15.1.1.3.17 NCK recruits WASP (Reaction) 7442 
15.1.1.4 Downstream TCR signaling (Pathway) 7443 
15.1.1.4.1 Recruitment of PI3K to plasmamembrane (Reaction) 7446 
15.1.1.4.2 PI3K phosphorylates PIP2 to PIP3 (Reaction) 7447 
15.1.1.4.3 Hydrolysis of PIP3 to PI(3,4)P2 (Reaction) 7449 
15.1.1.4.4 Hydrolysis of PIP3 to PIP2 (Reaction) 7450 
15.1.1.4.5 Translocation of PDK1 to Plasma membrane (Reaction) 7451 
15.1.1.4.6 Translocation of PKC theta to plasma membrane (Reaction) 7452 
15.1.1.4.7 Change of PKC theta conformation (Reaction) 7453 
15.1.1.4.8 Phosphorylation of PKC theta (Reaction) 7454 
15.1.1.4.9 Translocation of CARMA1 to Plasma membrane (Reaction) 7455 
15.1.1.4.10 Phosphorylation of CARMA1 (Reaction) 7457 
15.1.1.4.11 Oligomerization of CARMA1 (Reaction) 7458 
15.1.1.4.12 Interaction of Bcl10 to CARMA1 (Reaction) 7459 
15.1.1.4.13 Phosphorylation of Bcl10 (Reaction) 7460 
15.1.1.4.14 Oligomerization of Bcl10 (Reaction) 7461 
15.1.1.4.15 Interaction and oligomerization of MALT1 to Bcl10 (Reaction) 7462 
15.1.1.4.16 Translocation of TRAF6 to CBM complex (Reaction) 7463 
15.1.1.4.17 Auto-ubiquitination of TRAF6 (Reaction) 7464 
15.1.1.4.18 Activation of TAK1-TAB2 complex (Reaction) 7465 
15.1.1.4.19 Activation of IKK complex (Reaction) 7466 
15.1.1.4.20 Ubiquitination of NEMO by TRAF6 (BlackBoxEvent) 7467 
15.1.1.4.21 Activation of NF-kB complex (Reaction) 7469 15.1.2 Costimulation by the CD28 family (Pathway) 7470 
15.1.2.1 CD28 co-stimulation (Pathway) 7473 
15.1.2.1.1 CD28 homodimer binds B7-1 homodimer (Reaction) 7475 
15.1.2.1.2 CD28 homodimer binds B7-2 monomer (Reaction) 7476 
15.1.2.1.3 Phosphorylation of CD28 (Reaction) 7477 
15.1.2.1.4 Gads binds CD28 (Reaction) 7479 
15.1.2.1.5 CD28 dependent PI3K/Akt signaling (Pathway) 7480 
15.1.2.1.5.1 PI3K binds CD28 (Reaction) 7482 
15.1.2.1.5.2 CD28 bound PI3K phosphorylates PIP2 to PIP3 (Reaction) 7483 
15.1.2.1.5.3 PIP3 recruits PDPK1 to the membrane (Reaction) 7484 
15.1.2.1.5.4 PIP3 recruits AKT to the membrane (Reaction) 7486 
15.1.2.1.5.5 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 7487 
15.1.2.1.5.6 AKT binds PDPK1 (Reaction) 7490 
15.1.2.1.5.7 PDPK1 phosphorylates AKT at T308 (Reaction) 7491 
15.1.2.1.5.8 AKT interacts and phosphorylates Cot (Reaction) 7493 
15.1.2.1.5.9 p-S400-Cot phosphorylates NIK (Reaction) 7494 
15.1.2.1.6 CD28 dependent Vav1 pathway (Pathway) 7495 
15.1.2.1.6.1 Grb2 binds CD28 (Reaction) 7497 
15.1.2.1.6.2 Translocation of Vav1 to CD28 (Reaction) 7498 
15.1.2.1.6.3 Activation of Vav1 (Reaction) 7499 
15.1.2.1.6.4 Activation of Rac1 by pVav1 (Reaction) 7501 
15.1.2.1.6.5 Activation of Cdc42 by pVav1 (Reaction) 7502 
15.1.2.1.6.6 Activation of PAK by Rac1 and Cdc42 (Reaction) 7503 
15.1.2.2 CTLA4 inhibitory signaling (Pathway) 7505 
15.1.2.2.1 PP2A binds CTLA4 homodimer (Reaction) 7506 
15.1.2.2.2 CTLA-4 binds B7-1/B7-2 (Reaction) 7507 
15.1.2.2.3 Phosphorylation of CTLA-4 (Reaction) 7509 
15.1.2.2.4 SHP2 phosphatase binds CTLA-4 (Reaction) 7510 
15.1.2.2.5 Dephosphorylation of AKT by PP2A (Reaction) 7511 
15.1.2.3 ICOS binds ICOSL/B7-H2 (Reaction) 7513 
15.1.2.4 PI3K binds ICOS (Reaction) 7514 
15.1.2.5 PD-1 signaling (Pathway) 7515 
15.1.2.5.1 PD-1 binds B7DC and B7H1 (Reaction) 7516 
15.1.2.5.2 Phosphorylation of PD-1 (Reaction) 7518 
15.1.2.5.3 Interaction of SHP-1 or SHP-2 with phospho PD-1 (Reaction) 7519 
15.1.2.5.4 Dephosphorylation of CD3-zeta by PD-1 bound phosphatases (Reaction) 7520 
15.1.2.6 BTLA interacts with HVEM (Reaction) 7522 
15.1.2.7 SHP-1 and SHP-2 bind pBTLA (Reaction) 7523 
15.1.2.8 Grb2 binds pBTLA (Reaction) 7524 
15.1.3 Signaling by the B Cell Receptor (BCR) (Pathway) 7525 
15.1.3.1 Antigen activates B Cell Receptor (BCR) leading to generation of second 7529 messengers (Pathway) 
15.1.3.1.1 The Immunoglobulin of the BCR binds antigen (Reaction) 7534 
15.1.3.1.2 FYN, LYN, BLK-like proteins phosphorylate ITAMs of Ig-alpha (CD79A) and7536 Ig-beta (CD79B) (BlackBoxEvent) 
15.1.3.1.3 SYK binds the activated BCR (Reaction) 7540 
15.1.3.1.4 SYK autophosphorylates at the activated BCR (Reaction) 7541 
15.1.3.1.5 p-6Y-SYK phosphorylates BLNK (SLP65) (Reaction) 7543 
15.1.3.1.6 Signalosomes assemble at the activated BCR (BlackBoxEvent) 7545 
15.1.3.1.7 BCAP Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3 (Reaction)7549 
15.1.3.1.8 CD19 Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3 (Reaction)7550 
15.1.3.1.9 BLNK (SLP-65) Signalosome hydrolyzes phosphatidyinositol bisphosphate 7552 forming diacylglycerol and inositol-1,4,5-trisphosphate (Reaction) 
15.1.3.1.10 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 7554 channel (Reaction) 
15.1.3.1.11 Release of calcium from intracellular stores by IP3 receptor activation 7556 (Reaction) 
15.1.3.1.12 STIM1 oligomerizes (Reaction) 7557 
15.1.3.1.13 STIM1 activation of CRAC (Reaction) 7559 
15.1.3.1.14 STIM1 binds TRPC1 forming STIM1:TRPC1 complex (Reaction) 7559 
15.1.3.1.15 CRAC translocates calcium from the extracellular region to the cytosol 7561 (Reaction) 
15.1.3.1.16 TRPC1 translocates calcium from the extracellular region to the cytosol 7561 (Reaction) 
15.1.3.1.17 Calcium binds calmodulin (Reaction) 7563 
15.1.3.2 Downstream signaling events of B Cell Receptor (BCR) (Pathway) 7564 
15.1.3.2.1 Activation of NF-kappaB in B cells (Pathway) 7565 
15.1.3.2.1.1 PRKCB (Protein kinase C beta, PKC-beta) binds diacylglycerol and 7568 phosphatidylserine (Reaction) 
15.1.3.2.1.2 PRKCB (PKC-beta) phosphorylates of CARMA1 (BlackBoxEvent) 7570 
15.1.3.2.1.3 CARMA1 recruits MALT1 and BCL10 forming CBM Complex (Reaction) 7571 
15.1.3.2.1.4 CARMA1:BCL10:MALT1 complex recruits TAK1 and IKK (BlackBoxEvent)7572 
15.1.3.2.1.5 TAK1 associated with the CBM complex phosphorylates IKKbeta (Reaction)7574 
15.1.3.2.1.6 Activated IKK phosphorylates I-kappaB (Reaction) 7578 
15.1.3.2.1.7 SCF with beta-TrCP1 or beta-TrCP2 binds NF-kappaB:phospho-IkB 7579 (Reaction) 
15.1.3.2.1.8 SCF-beta-TrCP ubiquitinylates IkB (BlackBoxEvent) 7581 
15.1.3.2.1.9 Ubiquitinated IkB is degraded (BlackBoxEvent) 7582 
15.1.3.2.1.10 NF-kappaB translocates from the cytosol to the nucleus (BlackBoxEvent)7584 
15.1.3.2.2 Activation of RAS in B cells (Pathway) 7586 
15.1.3.2.2.1 RasGRP1 and RasGRP3 binds diacylglycerol and is phosphorylated 7587 (BlackBoxEvent) 
15.1.3.2.2.2 p-RasGRP1,3:DAG cause RAS to exchange GDP for GTP (Reaction) 7589 
15.1.3.2.3 PIP3 activates AKT signaling (Pathway) 7591 
15.1.3.2.3.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 7593 
15.1.3.2.3.2 PIP3 recruits AKT to the membrane (Reaction) 7596 
15.1.3.2.3.3 PIP3 recruits PDPK1 to the membrane (Reaction) 7596 
15.1.3.2.3.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 7596 
15.1.3.2.3.5 AKT binds PDPK1 (Reaction) 7596 
15.1.3.2.3.6 PDPK1 phosphorylates AKT at T308 (Reaction) 7597 15.1.3.2.3.7 AKT phosphorylates targets in the cytosol (Pathway) 7597 
15.1.3.2.3.7.1 AKT phosphorylates BAD (Reaction) 7598 
15.1.3.2.3.7.2 AKT phosphorylates GSK3 (Reaction) 7598 
15.1.3.2.3.7.3 AKT phosphorylates caspase-9 (Reaction) 7600 
15.1.3.2.3.7.4 AKT phosphorylates MDM2 (Reaction) 7601 
15.1.3.2.3.7.5 AKT phosphorylates IKKalpha (Reaction) 7602 
15.1.3.2.3.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 7603 
15.1.3.2.3.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 7604 
15.1.3.2.3.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 7606 
15.1.3.2.3.8 AKT translocates to the nucleus (Reaction) 7607 
15.1.3.2.3.9 AKT phosphorylates targets in the nucleus (Pathway) 7609 
15.1.3.2.3.9.1 AKT phosphorylates CREB1 (Reaction) 7609 
15.1.3.2.3.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 7610 
15.1.3.2.3.9.3 AKT can phosphorylate RSK (Reaction) 7612 
15.1.3.2.3.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 7613 
15.1.3.2.3.10 Negative regulation of the PI3K/AKT network (Pathway) 7614 
15.1.3.2.3.10.1 PTEN dephosphorylates PIP3 (Reaction) 7614 
15.1.3.2.3.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction)7615 
15.1.3.2.3.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 7617 
15.1.3.2.3.11 PDPK1 binds PIP2 (Reaction) 7618 
15.1.3.2.3.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 7619 
15.1.3.2.3.13 PTEN mRNA translation negatively regulated by microRNAs 7621 (BlackBoxEvent) 
15.1.4 Class I MHC mediated antigen processing & presentation (Pathway) 7622 
15.1.4.1 Antigen processing: Ubiquitination & Proteasome degradation (Pathway) 7624 
15.1.4.1.1 E1 mediated ubiquitin activation (Reaction) 7625 
15.1.4.1.2 Transfer of ubiquitin from E1 to E2 (Reaction) 7627 
15.1.4.1.3 Interaction of E3 with substrate and E2-Ub complex (Reaction) 7628 
15.1.4.1.4 Transfer of Ub from E2 to substrate and release of E2 (Reaction) 7630 
15.1.4.1.5 Polyubiquitination of substrate (BlackBoxEvent) 7631 
15.1.4.1.6 Release of E3 from polyubiquitinated substrate (Reaction) 7632 
15.1.4.1.7 Proteasomal cleavage of substrate (BlackBoxEvent) 7634 
15.1.4.1.8 Trimming of N-ter extended precursor fragments by cytosolic aminopeptidases
7635 (BlackBoxEvent) 
15.1.4.2 Antigen Presentation: Folding, assembly and peptide loading of class I MHC 7637 (Pathway) 
15.1.4.2.1 Binding of newly synthesized MHC class I heavy chain (HC) with calnexin 7638 (Reaction) 
15.1.4.2.2 Interaction of Erp57 with MHC class I HC (Reaction) 7640 
15.1.4.2.3 Interaction of beta-2-microglobulin (B2M) chain with class I HC (Reaction) 7642 
15.1.4.2.4 Formation of peptide loading complex (PLC) (Reaction) 7643 
15.1.4.2.5 Transport of Antigen peptide in to ER (Reaction) 7645 
15.1.4.2.6 Trimming of peptides in ER (BlackBoxEvent) 7646 
15.1.4.2.7 Loading of antigenic peptides on to class I MHC (Reaction) 7648 
15.1.4.2.8 Transport of MHC heterotrimer to ER exit site (Reaction) 7649 15.1.4.2.9 Capturing cargo and formation of prebudding complex (Reaction) 7651 
15.1.4.2.10 Recruitment of Sec31p:Sec13p to prebudding complex and formation of 7652 COPII vesicle (Reaction) 
15.1.4.2.11 Budding of COPII coated vesicle (Reaction) 7653 
15.1.4.2.12 Disassembly of COPII coated vesicle (Reaction) 7655 
15.1.4.2.13 Journey of cargo through Golgi complex (BlackBoxEvent) 7656 
15.1.4.2.14 Expression of peptide bound class I MHC on cell surface (BlackBoxEvent) 7657 
15.1.4.3 Antigen processing-Cross presentation (Pathway) 7659 
15.1.4.3.1 Cross-presentation of particulate exogenous antigens (phagosomes) 7660 (Pathway) 
15.1.4.3.1.1 Interaction of particulate antigens with dendritic cell receptors (Reaction) 7662 
15.1.4.3.1.2 Engulfment of particulate antigen into phagocytic vesicle (Reaction) 7664 
15.1.4.3.1.3 Maturation of phagosome into phagolysosome (BlackBoxEvent) 7665 
15.1.4.3.1.4 Alkalization of the phagosomal lumen by NOX2 (Reaction) 7666 
15.1.4.3.1.5 Partial proteolysis of antigen in phagolysosomes (BlackBoxEvent) 7668 
15.1.4.3.1.6 Escape of antigens from phagosome to cytosol (BlackBoxEvent) 7669 
15.1.4.3.2 ER-Phagosome pathway (Pathway) 7670 
15.1.4.3.2.1 Egress of internalized antigen to the cytosol via sec61 (Reaction) 7673 
15.1.4.3.2.2 Proteasomal cleavage of substrate (BlackBoxEvent) 7675 
15.1.4.3.2.3 Translocation of antigenic peptides back to phagosomes via TAP 7677 (Reaction) 
15.1.4.3.2.4 Peptide loading on MHC class I in phagosome (BlackBoxEvent) 7680 
15.1.4.3.2.5 Export of peptide loaded MHC class I complex to PM (BlackBoxEvent) 7682 
15.1.4.3.3 Endosomal/Vacuolar pathway (Pathway) 7683 
15.1.4.3.3.1 Antigen processing by cathepsin S in endosoytic vesicle (Reaction) 7684 
15.1.4.3.3.2 Trimming of peptides by IRAP in endocytic vesicles (Reaction) 7686 
15.1.4.3.3.3 Loading of antigen peptide onto MHC class I molecule (Reaction) 7688 
15.1.4.3.3.4 Translocation of peptide bound MHC class I complex to cell surface 7689 (BlackBoxEvent) 
15.1.4.3.4 Cross-presentation of soluble exogenous antigens (endosomes) (Pathway) 7691 
15.1.4.3.4.1 Interaction of exogenous soluble antigen with its corresponding receptor 7692 (Reaction) 
15.1.4.3.4.2 Internalization of receptor bound antigen into clathrin coted vesicles 7694 (Reaction) 
15.1.4.3.4.3 Movement of clathrin coated vesicles into early endosome (Reaction) 7695 
15.1.4.3.4.4 Exogenous soluble antigen targeted to more stable early endosome 7697 (Reaction) 
15.1.4.3.4.5 Egress of internalized antigen into cytosol from early endosome 7698 (BlackBoxEvent) 
15.1.4.3.4.6 Proteasomal clevage of exogenous antigen (BlackBoxEvent) 7701 
15.1.5 MHC class II antigen presentation (Pathway) 7702 
15.1.5.1 Formation of MHC II alpha beta heterodimer (Reaction) 7704 
15.1.5.2 Interaction of invariant chain trimer and MHC II alpha beta dimer (Reaction) 7705 
15.1.5.3 Formation of nonameric complex (Reaction) 7707 
15.1.5.4 Formation of COPII vesicle (Reaction) 
15.1.5.5 Fusion of COPII vesicle with Golgi complex (Reaction) 7710 
15.1.5.6 Transport of MHC II:Ii complex along Golgi to TGN (BlackBoxEvent) 7712 
15.1.5.7 TGN-lysosomal vesicle coat assembly (Reaction) 7713 
15.1.5.8 Translocation of TGN-lysosome vesicle to lysosome (Reaction) 7716 
15.1.5.9 TGN-lysosome vesicle uncoating and release of nonameric complex to lysosome
7717 (Reaction) 
15.1.5.10 Transport of MHC II:Ii complex to plasma membrane (BlackBoxEvent) 7719 
15.1.5.11 Insertion of MHC II:Ii complex in to the plasma membrane (BlackBoxEvent) 7720 
15.1.5.12 Recruitment of clathrin coated vesicle by Ii (Reaction) 7722 
15.1.5.13 Internalization of MHC II:Ii clathrin coated vesicle (BlackBoxEvent) 7723 
15.1.5.14 Uncoating of clathrin-coated vesicles and fusion with endosomes (Reaction) 7725 
15.1.5.15 Trafficking of nonameric complex in the endocytic pathway (BlackBoxEvent) 7726 
15.1.5.16 Initial proteolyis of Ii by aspartic proteases to lip22 (Reaction) 7727 
15.1.5.17 Cleavage of lip22 to lip10 (Reaction) 7729 
15.1.5.18 Generation of CLIP from lip10 (Reaction) 7731 
15.1.5.19 Disassociation of CLIP from MHC II (Reaction) 7733 
15.1.5.20 MHC class II antigen internalization (BlackBoxEvent) 7735 
15.1.5.21 Reduction of disulphide bonds in MHC II antigens (Reaction) 7736 
15.1.5.22 MHC class II antigen processing (Reaction) 7738 
15.1.5.23 Loading of antigenic peptides (Reaction) 7740 
15.1.5.24 Transport of antigen loaded MHC II molecules to surface (BlackBoxEvent) 7741 
15.1.6 Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell 7744 (Pathway) 
15.1.6.1 VCAM1 binds Integrin alpha4beta1 (Reaction) 7745 
15.1.6.2 TCR complex interacts with peptide antigen-presenting MHC Class I (Reaction)7746 
15.1.6.3 KIR2DL2/3 interacting with HLA-C group 1 (Cw4) (Reaction) 7747 
15.1.6.4 NKG2D homodimer interacting with ligands (Reaction) 7749 
15.1.6.5 CD96 binds PVR (Reaction) 7750 
15.1.6.6 MADCAM1-1 binds Integrin alpha4beta7 (Reaction) 7752 
15.1.6.7 LILRs interact with MHC Class I (Reaction) 7752 
15.1.6.8 Ligands bind L-selectin (Reaction) 7753 
15.1.6.9 ICAM1-4 bind Integrin alphaLbeta2 (LFA-1) (Reaction) 7754 
15.1.6.10 KLRC1:KLRD1 heterodimer interacts with HLA-E (Reaction) 7755 
15.1.6.11 Epithelial cadherin binds to KLRG1 (Reaction) 7756 
15.1.6.12 CRTAM binds to NECL2 (Reaction) 7757 
15.1.6.13 PVR binds CD226 (Reaction) 7759 
15.1.6.14 Nectin 2 binds CD226 (Reaction) 7761 
15.1.6.15 CD200 binds to CD200R (Reaction) 7762 
15.1.6.16 MHC Class I interacts with CD160 (Reaction) 7763 
15.1.6.17 Fc gamma receptors interact with antigen-bound IgG (Reaction) 7764 
15.1.6.18 CD40 interacting with CD40L (Reaction) 7765 
15.1.6.19 CXADR binds to AMICA1 (Reaction) 7766 
15.1.6.20 C3d-complexed antigen binds to complement receptor (Reaction) 7766 
15.1.6.21 KIR2DL1 interacting with HLA-C group 2 (Cw3) (Reaction) 7768 
15.1.6.22 KIR3DL1 interacting with HLA Bw4 (Reaction) 7769 
15.1.6.23 KIR3DL2 interacting with HLA-A3 (Reaction) 7770 
15.1.6.24 KIR2DL4 interacting with HLA-G (Reaction) 7772 
15.1.6.25 KIR2DS1 interacting with HLA-C group 2 (Cw4) (Reaction) 7773 
15.1.6.26 KIR2DS2 interacting with HLA-C group 1 (Cw3) (Reaction) 7774 
15.1.7 Rap1 signalling (Pathway) 7776 
15.1.7.1 PKA/PKG phosphorylate Rap1GAP2 (Reaction) 7777 
15.1.7.2 14-3-3 proteins beta and zeta bind and inhibit Rap1Gap2 (Reaction) 7778 
15.1.7.3 Activation of EPACs by cAMP (Reaction) 7779 
15.1.7.4 Activation of Rap1 by membrane-associated GEFs (Reaction) 7781 
15.1.7.5 Activation of Rap1 by cytosolic GEFs (Reaction) 7781 
15.1.7.6 Rap1 signal termination by Rap1GAPs (Reaction) 7782 
15.1.7.7 Rap1 sequesters Raf1 to inhibit ERK cascade (Reaction) 7783 
15.2 Innate Immune System (Pathway) 7784 
15.2.1 Toll-Like Receptors Cascades (Pathway) 7785 
15.2.1.1 Trafficking and processing of endosomal TLR (Pathway) 7787 
15.2.1.1.1 TLR folding by chaperones GP96 and CNPY3 (Reaction) 7789 
15.2.1.1.2 Folded full-length TLR7/8/9 dissociates from the GP96:CNPY3 complex 7791 (Reaction) 
15.2.1.1.3 Full-length TLR3/7/8/9 binds to UNC93B1 (Reaction) 7792 
15.2.1.1.4 Endosomal TLRs pass through the Golgi (BlackBoxEvent) 7795 
15.2.1.1.5 UNC93B1 delivers endosomal full-length TLRs to endolysosome 7796 (BlackBoxEvent) 
15.2.1.1.6 TLR processing at low pH (Reaction) 7798 
15.2.1.1.7 TLR9 processing at neutral pH (Reaction) 7800 
15.2.1.2 Toll Like Receptor 10 (TLR10) Cascade (Pathway) 7801 
15.2.1.2.1 Ligand binds to TLR10 (BlackBoxEvent) 7802 
15.2.1.2.2 MyD88 cascade initiated on plasma membrane (Pathway) 7804 
15.2.1.2.2.1 MyD88 forms a complex with the activated TLR receptor (Reaction) 7805 
15.2.1.2.2.2 MyD88 oligomerization within the complex of activated TLR:MyD88 7806 (Reaction) 
15.2.1.2.2.3 IRAK4 binds to MyD88 bound to the activated TLR5 or 10 receptor 7808 (Reaction) 
15.2.1.2.2.4 IRAK4 autophosphorylation within the complex activated TLR:MyD88 7809 (Reaction) 
15.2.1.2.2.5 IRAK1/or IRAK2 binds to the activated IRAK4 :oligo MyD88:activated TLR5
7810 or 10 complex (Reaction) 
15.2.1.2.2.6 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 7812 oligomerl:activated TLR5 or 10 complex (Reaction) 
15.2.1.2.2.7 First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR7813 (Reaction) 
15.2.1.2.2.8 Second phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR
7814 complex (Reaction) 
15.2.1.2.2.9 Multiple IRAK1 autophosphorylation within the complex p-IRAK4:oligo 7816 MyD88:activated TLR (Reaction) 
15.2.1.2.2.10 TRAF6 binds to hp- IRAK1 or p-IRAK2 (Reaction) 
15.2.1.2.2.11 Dissociation of hp-IRAK1:TRAF6 or IRAK2:TRAF6-oligomer from the 7819 activated TLR5 or 10:oligo-Myd88:p-IRAK4 complex (Reaction) 
15.2.1.2.2.12 IRAK1 recruits IKK complex (Pathway) 7820 
15.2.1.2.2.12.1 Pellino binds hp-IRAK1:TRAF6 (Reaction) 7822 
15.2.1.2.2.12.2 IRAK1 phosphorylates Pellino (Reaction) 7824 
15.2.1.2.2.12.3 Pellino ubiquitinates hp-IRAK1 (Reaction) 7825 
15.2.1.2.2.12.4 NEMO subunit of IKK complex binds to activated IRAK1 (Reaction) 7828 
15.2.1.2.2.13 IRAK2 mediated activation of TAK1 complex (Pathway) 7829 
15.2.1.2.2.13.1 IRAK2 induces TRAF6 oligomerization (Reaction) 7831 
15.2.1.2.2.13.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 (BlackBoxEvent)7832 
15.2.1.2.2.13.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 7833 (Polymerisation) 
15.2.1.2.2.13.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex (Reaction) 7835 
15.2.1.2.2.13.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: 7836 free K63 pUb:TAB1:TAB2/TAB3 (Reaction) 
15.2.1.2.2.14 TRAF6 binds MEKK1 (Reaction) 7839 
15.2.1.2.2.15 TAK1 activates NFkB by phosphorylation and activation of IKKs complex7840 (Pathway) 
15.2.1.2.2.15.1 Activated TAK1 mediates phosphorylation of the IKK Complex 7842 (Reaction) 
15.2.1.2.2.15.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 7843 Complex (Reaction) 
15.2.1.2.2.15.3 Released NFkB complex is transported to nucleus (Reaction) 7845 
15.2.1.2.2.16 MAP kinase activation in TLR cascade (Pathway) 7846 
15.2.1.2.2.16.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 7848 activated human TAK1 (Pathway) 
15.2.1.2.2.16.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 7850 
15.2.1.2.2.16.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 7851 (Reaction) 
15.2.1.2.2.16.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 7852 
15.2.1.2.2.16.2 activated TAK1 mediates p38 MAPK activation (Pathway) 7852 
15.2.1.2.2.16.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction) 7854 
15.2.1.2.2.16.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 7855 
15.2.1.2.2.16.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 7856 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.2.2.16.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 7856 
15.2.1.2.2.16.2.5 Nuclear export of human p38 MAPK mediated by its substrate 7857 MAPKAPK2 or 3 (Reaction) 
15.2.1.2.2.16.3 ERK activation (Pathway) 7858 
15.2.1.2.2.16.3.1 ERK1 activation (Pathway) 7858 
15.2.1.2.2.16.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 7858 
15.2.1.2.2.16.3.1.2 MEK1 binds ERK-1 (Reaction) 7859 
15.2.1.2.2.16.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 7859 
15.2.1.2.2.16.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 7859 
15.2.1.2.2.16.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 7860 15.2.1.2.2.16.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 7860 
15.2.1.2.2.16.3.2 ERK2 activation (Pathway) 7860 
15.2.1.2.2.16.3.2.1 MEK2 binds ERK-2 (Reaction) 7861 
15.2.1.2.2.16.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 7861 
15.2.1.2.2.16.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 7861 
15.2.1.2.2.16.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 7862 
15.2.1.2.2.16.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 7862 
15.2.1.2.2.16.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway) 7862 
15.2.1.2.2.16.4.1 ERK/MAPK targets (Pathway) 7864 
15.2.1.2.2.16.4.1.1 ERK1/2 activates ELK1 (Reaction) 7865 
15.2.1.2.2.16.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 7866 
15.2.1.2.2.16.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 7867 
15.2.1.2.2.16.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 7868 
15.2.1.2.2.16.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 7868 
15.2.1.2.2.16.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction) 7870 
15.2.1.2.2.16.4.1.7 ERKs are inactivated (Pathway) 7871 
15.2.1.2.2.16.4.1.7.1 ERKs are inactivated by protein phosphatase 2A (Reaction)7872 
15.2.1.2.2.16.4.1.7.2 ERKs are inactivated by dual-specific phosphatases (DUSPs)
7872 (Reaction) 
15.2.1.2.2.16.4.2 CREB phosphorylation (Pathway) 7873 
15.2.1.2.2.16.4.2.1 MSK1 activates CREB (Reaction) 7874 
15.2.1.2.2.16.4.2.2 MSK1 activates ATF1 (Reaction) 7875 
15.2.1.2.2.16.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 7875 
15.2.1.2.2.16.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction) 7877 
15.2.1.2.2.16.4.3 Activation of the AP-1 family of transcription factors (Pathway) 7878 
15.2.1.2.2.16.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 7879 
15.2.1.2.2.16.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 7881 
15.2.1.2.2.16.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 7881 
15.2.1.2.2.16.4.3.4 Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN7882 heterodimer. (Reaction) 
15.2.1.2.2.16.4.3.5 Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN7883 heterodimer. (Reaction) 
15.2.1.3 Toll Like Receptor 3 (TLR3) Cascade (Pathway) 7883 
15.2.1.3.1 Viral dsRNA binds the Toll-Like Receptor 3 (TLR3) (Reaction) 7885 
15.2.1.3.2 MyD88-independent cascade (Pathway) 7886 
15.2.1.3.2.1 TRAM:TLR4:MD2:LPS:CD14 recruits TRIF (TICAM1) (Reaction) 7887 
15.2.1.3.2.2 Viral dsRNA:TLR3 recruits TRIF (TICAM1) (Reaction) 7889 
15.2.1.3.2.3 Negative regulator SARM binds to TRIF (Reaction) 7890 
15.2.1.3.2.4 TRIF-mediated TLR3/TLR4 signaling (Pathway) 7892 
15.2.1.3.2.4.1 Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon (Pathway) 7893 
15.2.1.3.2.4.1.1 TRAF3 binds to TRIF:activated TLR3/4 complex (Reaction) 7895 
15.2.1.3.2.4.1.2 Auto-ubiquitination of TRAF3 (BlackBoxEvent) 7896 
15.2.1.3.2.4.1.3 TANK binds K63-poly-Ub-TRAF3:TRIF:activated TLR3/TLR4 7898 (Reaction) 
15.2.1.3.2.4.1.4 TANK is ubiquitinated within 
TANK:K63polyUb-TRAF3:TRIF:activated TLR3/4 (BlackBoxEvent) 
15.2.1.3.2.4.1.5 Recruitment of TBK1/IKK epsilon to 7902 K63-pUb-TANK:K63-pUb-TRAF3:TRIF:activated TLR3/TLR4 followed by their phosphorylation (Reaction) 
15.2.1.3.2.4.1.6 IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the 7904 activated TLR (Reaction) 
15.2.1.3.2.4.1.7 Phosphorylation of IRF-3/IRF7 and their release from the activated7906 TLR complex (Reaction) 
15.2.1.3.2.4.1.8 Dimerization of phosphorylated IRF3/IRF7 (Reaction) 7907 
15.2.1.3.2.4.1.9 Dimerized phospho-IRF3/IRF7 is transported to the nucleus 7909 (Reaction) 
15.2.1.3.2.4.2 IKK complex recruitment mediated by RIP1 (Pathway) 7910 
15.2.1.3.2.4.2.1 TRIF:activated TLR3/TLR4 complex recruits RIP1 (Reaction) 7911 
15.2.1.3.2.4.2.2 K63-linked ubiquitination of RIP1 bound to the activated TLR complex
7913 (Reaction) 
15.2.1.3.2.4.2.3 Nemo subunit of IKK complex binds polyubiquinated RIP1 (Reaction)7915 
15.2.1.3.2.4.3 TRIF-mediated programmed cell death (Pathway) 7916 
15.2.1.3.2.4.3.1 TLR3/4-induced ripoptosome assembly (Reaction) 7918 
15.2.1.3.2.4.3.2 Caspase-8 processing within TLR3/4 complex (Reaction) 7920 
15.2.1.3.2.4.3.3 RIP3 binds TRIF to mediate necroptosis (Reaction) 7922 
15.2.1.3.2.4.4 TRAF6 mediated induction of TAK1 complex (Pathway) 7923 
15.2.1.3.2.4.4.1 Activated TLR3/4:TRIF recruits TRAF6 (Reaction) 7925 
15.2.1.3.2.4.4.2 Auto ubiquitination of TRAF6 bound to the activated TLR complex 7927 (BlackBoxEvent) 
15.2.1.3.2.4.4.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 7928 (Polymerisation) 
15.2.1.3.2.4.4.4 Activated TLR:TRIF:K63-pUb-TRAF6 recruits TAK1complex 7928 (Reaction) 
15.2.1.3.2.4.4.5 Activation of TAK1 complex bound to activated TLR (Reaction) 7930 
15.2.1.3.2.4.4.6 Phosphorylated TAK1 leaves activated TLR receptor complex 7932 (Reaction) 
15.2.1.3.2.4.5 TAK1 activates NFkB by phosphorylation and activation of IKKs complex
7933 (Pathway) 
15.2.1.3.2.4.5.1 Activated TAK1 mediates phosphorylation of the IKK Complex 7933 (Reaction) 
15.2.1.3.2.4.5.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 7934 Complex (Reaction) 
15.2.1.3.2.4.5.3 Released NFkB complex is transported to nucleus (Reaction) 7934 
15.2.1.3.2.4.6 MAP kinase activation in TLR cascade (Pathway) 7934 
15.2.1.3.2.4.6.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 7934 activated human TAK1 (Pathway) 
15.2.1.3.2.4.6.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 7935 
15.2.1.3.2.4.6.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 7935 (Reaction) 
15.2.1.3.2.4.6.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 79007935 
15.2.1.3.2.4.6.2 activated TAK1 mediates p38 MAPK activation (Pathway) 7935 
15.2.1.3.2.4.6.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction)7936 
15.2.1.3.2.4.6.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 7936 
15.2.1.3.2.4.6.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 7936 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.3.2.4.6.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 7937 
15.2.1.3.2.4.6.2.5 Nuclear export of human p38 MAPK mediated by its substrate 7937 MAPKAPK2 or 3 (Reaction) 
15.2.1.3.2.4.6.3 ERK activation (Pathway) 7937 
15.2.1.3.2.4.6.3.1 ERK1 activation (Pathway) 7937 
15.2.1.3.2.4.6.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 7938 
15.2.1.3.2.4.6.3.1.2 MEK1 binds ERK-1 (Reaction) 7938 
15.2.1.3.2.4.6.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 7938 
15.2.1.3.2.4.6.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 7938 
15.2.1.3.2.4.6.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 7939 
15.2.1.3.2.4.6.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 7939 
15.2.1.3.2.4.6.3.2 ERK2 activation (Pathway) 7939 
15.2.1.3.2.4.6.3.2.1 MEK2 binds ERK-2 (Reaction) 7939 
15.2.1.3.2.4.6.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 7940 
15.2.1.3.2.4.6.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 7940 
15.2.1.3.2.4.6.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 7940 
15.2.1.3.2.4.6.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 7940 
15.2.1.3.2.4.6.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway)7941 
15.2.1.3.2.4.6.4.1 ERK/MAPK targets (Pathway) 7941 
15.2.1.3.2.4.6.4.1.1 ERK1/2 activates ELK1 (Reaction) 7941 
15.2.1.3.2.4.6.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 7941 
15.2.1.3.2.4.6.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 7942 
15.2.1.3.2.4.6.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 7942 
15.2.1.3.2.4.6.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 7942 
15.2.1.3.2.4.6.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction) 7942 
15.2.1.3.2.4.6.4.1.7 ERKs are inactivated (Pathway) 7943 
15.2.1.3.2.4.6.4.1.7.1 ERKs are inactivated by protein phosphatase 2A (Reaction)
7943 
15.2.1.3.2.4.6.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 7943 (DUSPs) (Reaction) 
15.2.1.3.2.4.6.4.2 CREB phosphorylation (Pathway) 7943 
15.2.1.3.2.4.6.4.2.1 MSK1 activates CREB (Reaction) 7944 
15.2.1.3.2.4.6.4.2.2 MSK1 activates ATF1 (Reaction) 7944 
15.2.1.3.2.4.6.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 7944 
15.2.1.3.2.4.6.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)7944 
15.2.1.3.2.4.6.4.3 Activation of the AP-1 family of transcription factors (Pathway) 7945 
15.2.1.3.2.4.6.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 7945 
15.2.1.3.2.4.6.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 7945 
15.2.1.3.2.4.6.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 7945 
15.2.1.3.2.4.6.4.3.4 Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN
7946 
heterodimer. (Reaction) 
15.2.1.3.2.4.6.4.3.5 Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN 
heterodimer. (Reaction) 
15.2.1.4 Toll Like Receptor 5 (TLR5) Cascade (Pathway) 7946 
15.2.1.4.1 Flagellin binds to TLR5 (Reaction) 7948 
15.2.1.4.2 MyD88 cascade initiated on plasma membrane (Pathway) 7949 
15.2.1.4.2.1 MyD88 forms a complex with the activated TLR receptor (Reaction) 7949 
15.2.1.4.2.2 MyD88 oligomerization within the complex of activated TLR:MyD88 7949 (Reaction) 
15.2.1.4.2.3 IRAK4 binds to MyD88 bound to the activated TLR5 or 10 receptor 7949 (Reaction) 
15.2.1.4.2.4 IRAK4 autophosphorylation within the complex activated TLR:MyD88 7950 (Reaction) 
15.2.1.4.2.5 IRAK1/or IRAK2 binds to the activated IRAK4 :oligo MyD88:activated TLR5
7950 or 10 complex (Reaction) 
15.2.1.4.2.6 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 7950 oligomerl:activated TLR5 or 10 complex (Reaction) 
15.2.1.4.2.7 First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR7951 (Reaction) 
15.2.1.4.2.8 Second phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR
7951 complex (Reaction) 
15.2.1.4.2.9 Multiple IRAK1 autophosphorylation within the complex p-IRAK4:oligo 7951 MyD88:activated TLR (Reaction) 
15.2.1.4.2.10 TRAF6 binds to hp- IRAK1 or p-IRAK2 (Reaction) 7952 
15.2.1.4.2.11 Dissociation of hp-IRAK1:TRAF6 or IRAK2:TRAF6-oligomer from the 7952 activated TLR5 or 10:oligo-Myd88:p-IRAK4 complex (Reaction) 
15.2.1.4.2.12 IRAK1 recruits IKK complex (Pathway) 7952 
15.2.1.4.2.12.1 Pellino binds hp-IRAK1:TRAF6 (Reaction) 7952 
15.2.1.4.2.12.2 IRAK1 phosphorylates Pellino (Reaction) 7953 
15.2.1.4.2.12.3 Pellino ubiquitinates hp-IRAK1 (Reaction) 7953 
15.2.1.4.2.12.4 NEMO subunit of IKK complex binds to activated IRAK1 (Reaction) 7953 
15.2.1.4.2.13 IRAK2 mediated activation of TAK1 complex (Pathway) 7953 
15.2.1.4.2.13.1 IRAK2 induces TRAF6 oligomerization (Reaction) 7954 
15.2.1.4.2.13.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 (BlackBoxEvent)7954 
15.2.1.4.2.13.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 7954 (Polymerisation) 
15.2.1.4.2.13.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex (Reaction) 7955 
15.2.1.4.2.13.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: 7955 free K63 pUb:TAB1:TAB2/TAB3 (Reaction) 
15.2.1.4.2.14 TRAF6 binds MEKK1 (Reaction) 7955 
15.2.1.4.2.15 TAK1 activates NFkB by phosphorylation and activation of IKKs complex7955 (Pathway) 
15.2.1.4.2.15.1 Activated TAK1 mediates phosphorylation of the IKK Complex 7956 (Reaction) 
15.2.1.4.2.15.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 7956 Complex (Reaction) 
15.2.1.4.2.15.3 Released NFkB complex is transported to nucleus (Reaction) 7956 
15.2.1.4.2.16 MAP kinase activation in TLR cascade (Pathway) 7957 
15.2.1.4.2.16.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 7957 activated human TAK1 (Pathway) 
15.2.1.4.2.16.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 7957 
15.2.1.4.2.16.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 7957 (Reaction) 
15.2.1.4.2.16.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 7958 
15.2.1.4.2.16.2 activated TAK1 mediates p38 MAPK activation (Pathway) 7958 
15.2.1.4.2.16.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction) 7958 
15.2.1.4.2.16.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 7958 
15.2.1.4.2.16.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 7959 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.4.2.16.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 7959 
15.2.1.4.2.16.2.5 Nuclear export of human p38 MAPK mediated by its substrate 7959 MAPKAPK2 or 3 (Reaction) 
15.2.1.4.2.16.3 ERK activation (Pathway) 7960 
15.2.1.4.2.16.3.1 ERK1 activation (Pathway) 7960 
15.2.1.4.2.16.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 7960 
15.2.1.4.2.16.3.1.2 MEK1 binds ERK-1 (Reaction) 7960 
15.2.1.4.2.16.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 7961 
15.2.1.4.2.16.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 7961 
15.2.1.4.2.16.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 7961 
15.2.1.4.2.16.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 7961 
15.2.1.4.2.16.3.2 ERK2 activation (Pathway) 7962 
15.2.1.4.2.16.3.2.1 MEK2 binds ERK-2 (Reaction) 7962 
15.2.1.4.2.16.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 7962 
15.2.1.4.2.16.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 7962 
15.2.1.4.2.16.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 7963 
15.2.1.4.2.16.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 7963 
15.2.1.4.2.16.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway) 7963 
15.2.1.4.2.16.4.1 ERK/MAPK targets (Pathway) 7963 
15.2.1.4.2.16.4.1.1 ERK1/2 activates ELK1 (Reaction) 7964 
15.2.1.4.2.16.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 7964 
15.2.1.4.2.16.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 7964 
15.2.1.4.2.16.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 7964 
15.2.1.4.2.16.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 7965 
15.2.1.4.2.16.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction) 7965 
15.2.1.4.2.16.4.1.7 ERKs are inactivated (Pathway) 7965 
15.2.1.4.2.16.4.1.7.1 ERKs are inactivated by protein phosphatase 2A (Reaction)7965 
15.2.1.4.2.16.4.1.7.2 ERKs are inactivated by dual-specific phosphatases (DUSPs)
7966 (Reaction) 
15.2.1.4.2.16.4.2 CREB phosphorylation (Pathway) 7966 
15.2.1.4.2.16.4.2.1 MSK1 activates CREB (Reaction) 7966 
15.2.1.4.2.16.4.2.2 MSK1 activates ATF1 (Reaction) 7966 15.2.1.4.2.16.4.3.4 Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN 7968 heterodimer. (Reaction) 
15.2.1.4.2.16.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction)  7967  
15.2.1.4.2.16.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)  7967  
15.2.1.4.2.16.4.3 Activation of the AP-1 family of transcription factors (Pathway)  7967  
15.2.1.4.2.16.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction)  7967  
15.2.1.4.2.16.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction)  7968  
15.2.1.4.2.16.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction)  7968  

15.2.1.4.2.16.4.3.5 Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN 7968 heterodimer. (Reaction) 
15.2.1.5 Toll Like Receptor 7/8 (TLR7/8) Cascade (Pathway) 7969 
15.2.1.5.1 Ligand binds to TLR7 or TLR8 (Reaction) 7970 
15.2.1.5.2 MyD88 dependent cascade initiated on endosome (Pathway) 7971 
15.2.1.5.2.1 MyD88 interacts with the activated TLR receptor 7, 8 or 9 (Reaction) 7973 
15.2.1.5.2.2 MyD88 oligomerization within the complex of activated TLR 7/8 or 9 : 7974 MyD88 (Reaction) 
15.2.1.5.2.3 IRAK4 binds to the activated TLR7/8 or 9 receptor:MyD88 complex 7976 (Reaction) 
15.2.1.5.2.4 IRAK4 autophosphorylation in the complex with MyD88:activated TLR 7/8 7977 or 9 (Reaction) 
15.2.1.5.2.5 IRAK1/or IRAK2 binds to the activated IRAK4 :MyD88:activated TLR 7/8 or 7979 
9. (Reaction) 
15.2.1.5.2.6 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 7981 oligomer:activated TLR 7/8 or 9 (Reaction) 
15.2.1.5.2.7 First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR 7982 7/8 or 9 (Reaction) 
15.2.1.5.2.8 Second phosphorylation of IRAK1 by IRAK4 bound to MyD88: activated 7983 TLR 7/8 or 9 (Reaction) 
15.2.1.5.2.9 Multiple IRAK1 autophosphorylation steps within the complex 7985 pIRAK4:MyD88:activated TLR7/8 or 9 (Reaction) 
15.2.1.5.2.10 TRAF6 binds to hp- IRAK1/or p-IRAK2:p-IRAK4:MyD88:activated TLR7/8 
7986 or 9 (Reaction) 
15.2.1.5.2.11 TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 7988 activation (Pathway) 
15.2.1.5.2.11.1 Dissociation of hp-IRAK1/or IRAK2:TRAF6-oligomer from the p-IRAK4 
7989 :oligo-Myd88:activated TLR7/8 or 9 complex (Reaction) 
15.2.1.5.2.11.2 IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation (Pathway)7991 
15.2.1.5.2.11.2.1 Pellino binds hp-IRAK1:TRAF6 upon TLR7/8 or 9 activation 7993 (Reaction) 
15.2.1.5.2.11.2.2 IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation 7995 (Reaction) 
15.2.1.5.2.11.2.3 Pellino ubiquitinates hp-IRAK1 upon TLR7/8 or 9 activation 7996 (Reaction) 
15.2.1.5.2.11.2.4 NEMO subunit of IKK complex binds to activated IRAK1 upon 7998 stimulation of TLR7/8 or 9. (Reaction) 
15.2.1.5.2.11.3 IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 8000 stimulation (Pathway) 
15.2.1.5.2.11.3.1 IRAK2 induces TRAF6 oligomerization initiated from endosomal 8001 compartments (Reaction) 
15.2.1.5.2.11.3.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 at endosome
8002 membrane (BlackBoxEvent) 
15.2.1.5.2.11.3.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains upon
8004 TLR stimulation (Polymerisation) 
15.2.1.5.2.11.3.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex upon 8005 TLR7/8 or 9 stimulation (Reaction) 
15.2.1.5.2.11.3.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6:
8006 free K63 pUb:TAB1:TAB2/TAB3 upon TLR7/8 or 9 activation (Reaction) 
15.2.1.5.2.11.4 TAK1 activates NFkB by phosphorylation and activation of IKKs 8008 complex (Pathway) 
15.2.1.5.2.11.4.1 Activated TAK1 mediates phosphorylation of the IKK Complex 8009 (Reaction) 
15.2.1.5.2.11.4.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 8009 Complex (Reaction) 
15.2.1.5.2.11.4.3 Released NFkB complex is transported to nucleus (Reaction) 8009 
15.2.1.5.2.11.5 TRAF6 binds MEKK1 (Reaction) 8010 
15.2.1.5.2.11.6 MAP kinase activation in TLR cascade (Pathway) 8010 
15.2.1.5.2.11.6.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 8010 activated human TAK1 (Pathway) 
15.2.1.5.2.11.6.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 8010 
15.2.1.5.2.11.6.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 8011 (Reaction) 
15.2.1.5.2.11.6.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 8011 
15.2.1.5.2.11.6.2 activated TAK1 mediates p38 MAPK activation (Pathway) 8011 
15.2.1.5.2.11.6.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction)8011 
15.2.1.5.2.11.6.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 8012 
15.2.1.5.2.11.6.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 8012 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.5.2.11.6.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction)8012 
15.2.1.5.2.11.6.2.5 Nuclear export of human p38 MAPK mediated by its substrate8013 MAPKAPK2 or 3 (Reaction) 
15.2.1.5.2.11.6.3 ERK activation (Pathway) 8013 
15.2.1.5.2.11.6.3.1 ERK1 activation (Pathway) 8013 
15.2.1.5.2.11.6.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8013 
15.2.1.5.2.11.6.3.1.2 MEK1 binds ERK-1 (Reaction) 8014 
15.2.1.5.2.11.6.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8014 
15.2.1.5.2.11.6.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8014 
15.2.1.5.2.11.6.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8014 
15.2.1.5.2.11.6.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8015 
15.2.1.5.2.11.6.3.2 ERK2 activation (Pathway) 8015 
15.2.1.5.2.11.6.3.2.1 MEK2 binds ERK-2 (Reaction) 
15.2.1.5.2.11.6.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8015 
15.2.1.5.2.11.6.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8016 
15.2.1.5.2.11.6.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8016 
15.2.1.5.2.11.6.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8016 
15.2.1.5.2.11.6.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway)
8016 
15.2.1.5.2.11.6.4.1 ERK/MAPK targets (Pathway) 8017 
15.2.1.5.2.11.6.4.1.1 ERK1/2 activates ELK1 (Reaction) 8017 
15.2.1.5.2.11.6.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 8017 
15.2.1.5.2.11.6.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 8017 
15.2.1.5.2.11.6.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 8018 
15.2.1.5.2.11.6.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 8018 
15.2.1.5.2.11.6.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction)8018 
15.2.1.5.2.11.6.4.1.7 ERKs are inactivated (Pathway) 8018 
15.2.1.5.2.11.6.4.1.7.1 ERKs are inactivated by protein phosphatase 2A 8019 (Reaction) 
15.2.1.5.2.11.6.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 8019 (DUSPs) (Reaction) 
15.2.1.5.2.11.6.4.2 CREB phosphorylation (Pathway) 8019 
15.2.1.5.2.11.6.4.2.1 MSK1 activates CREB (Reaction) 8019 
15.2.1.5.2.11.6.4.2.2 MSK1 activates ATF1 (Reaction) 8020 
15.2.1.5.2.11.6.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 8020 
15.2.1.5.2.11.6.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)8020 
15.2.1.5.2.11.6.4.3 Activation of the AP-1 family of transcription factors (Pathway)8020 
15.2.1.5.2.11.6.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 8021 
15.2.1.5.2.11.6.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 8021 
15.2.1.5.2.11.6.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 8021 
15.2.1.5.2.11.6.4.3.4 Formation of Activated Protein 1 (AP-1) complex. 8021 ATF2/c-JUN heterodimer. (Reaction) 
15.2.1.5.2.11.6.4.3.5 Formation of Activated Protein 1 (AP-1) complex. 8022 cFOS/c-JUN heterodimer. (Reaction) 
15.2.1.5.2.12 TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling (Pathway) 8022 
15.2.1.5.2.12.1 TRAF6 interacts with IRF7 upon TLR7/8 or 9 activation (Reaction) 8023 
15.2.1.5.2.12.2 TRAF6 ubiquitinqtes IRF7 in a K63-dependent manner following 8025 TLR7/8 or 9 stimulation (Reaction) 
15.2.1.5.2.12.3 Phosphorylation and release of IRF7 upon TLR7/8 or 9 activation 8026 (Reaction) 
15.2.1.5.2.12.4 Dimerization of p-IRF7 (Reaction) 8028 
15.2.1.5.2.12.5 Translocation of p-IRF7:p-IRF7 to nucleus (Reaction) 8029 
15.2.1.6 Toll Like Receptor 9 (TLR9) Cascade (Pathway) 8030 
15.2.1.6.1 Engulfed CpG DNA binds to endosomal full-length TLR9 (Reaction) 8032 
15.2.1.6.2 Engulfed CpG DNA binds to endosomal N-ter TLR9 dimer (Reaction) 8033 
15.2.1.6.3 Engulfed CpG DNA binds to endosomal C-ter TLR9 (Reaction) 8035 
15.2.1.6.4 Rab5-mediated recruitment of class III PI3K to TLR9 (Reaction) 8036 
15.2.1.6.5 MyD88 dependent cascade initiated on endosome (Pathway) 8037 
15.2.1.6.5.1 MyD88 interacts with the activated TLR receptor 7, 8 or 9 (Reaction) 8037 15.2.1.6.5.4 IRAK4 autophosphorylation in the complex with MyD88:activated TLR 7/8 8038 or 9 (Reaction) 
15.2.1.6.5.2 MyD88 oligomerization within the complex of activated TLR 7/8 or 9 :  8037  
MyD88 (Reaction)  
15.2.1.6.5.3 IRAK4 binds to the activated TLR7/8 or 9 receptor:MyD88 complex  8038  
(Reaction)  

15.2.1.6.5.5 IRAK1/or IRAK2 binds to the activated IRAK4 :MyD88:activated TLR 7/8 or 8038 
9. (Reaction) 
15.2.1.6.5.6 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 8039 oligomer:activated TLR 7/8 or 9 (Reaction) 
15.2.1.6.5.7 First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR 8039 7/8 or 9 (Reaction) 
15.2.1.6.5.8 Second phosphorylation of IRAK1 by IRAK4 bound to MyD88: activated 8039 TLR 7/8 or 9 (Reaction) 
15.2.1.6.5.9 Multiple IRAK1 autophosphorylation steps within the complex 8040 pIRAK4:MyD88:activated TLR7/8 or 9 (Reaction) 
15.2.1.6.5.10 TRAF6 binds to hp- IRAK1/or p-IRAK2:p-IRAK4:MyD88:activated TLR7/8 
8040 or 9 (Reaction) 
15.2.1.6.5.11 TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 8040 activation (Pathway) 
15.2.1.6.5.11.1 Dissociation of hp-IRAK1/or IRAK2:TRAF6-oligomer from the p-IRAK4 
8041 :oligo-Myd88:activated TLR7/8 or 9 complex (Reaction) 
15.2.1.6.5.11.2 IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation (Pathway)8041 
15.2.1.6.5.11.2.1 Pellino binds hp-IRAK1:TRAF6 upon TLR7/8 or 9 activation 8041 (Reaction) 
15.2.1.6.5.11.2.2 IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation 8041 (Reaction) 
15.2.1.6.5.11.2.3 Pellino ubiquitinates hp-IRAK1 upon TLR7/8 or 9 activation 8042 (Reaction) 
15.2.1.6.5.11.2.4 NEMO subunit of IKK complex binds to activated IRAK1 upon 8042 stimulation of TLR7/8 or 9. (Reaction) 
15.2.1.6.5.11.3 IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 8042 stimulation (Pathway) 
15.2.1.6.5.11.3.1 IRAK2 induces TRAF6 oligomerization initiated from endosomal 8043 compartments (Reaction) 
15.2.1.6.5.11.3.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 at endosome 
8043 membrane (BlackBoxEvent) 
15.2.1.6.5.11.3.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains upon 
8043 TLR stimulation (Polymerisation) 
15.2.1.6.5.11.3.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex upon 8044 TLR7/8 or 9 stimulation (Reaction) 
15.2.1.6.5.11.3.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: 
8044 free K63 pUb:TAB1:TAB2/TAB3 upon TLR7/8 or 9 activation (Reaction) 
15.2.1.6.5.11.4 TAK1 activates NFkB by phosphorylation and activation of IKKs 8044 complex (Pathway) 
15.2.1.6.5.11.4.1 Activated TAK1 mediates phosphorylation of the IKK Complex 8045 (Reaction) 
15.2.1.6.5.11.4.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 8045 Complex (Reaction) 
15.2.1.6.5.11.4.3 Released NFkB complex is transported to nucleus (Reaction) 8045 
15.2.1.6.5.11.5 TRAF6 binds MEKK1 (Reaction) 8046 
15.2.1.6.5.11.6 MAP kinase activation in TLR cascade (Pathway) 8046 
15.2.1.6.5.11.6.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 8046 activated human TAK1 (Pathway) 
15.2.1.6.5.11.6.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 8046 
15.2.1.6.5.11.6.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 8047 (Reaction) 
15.2.1.6.5.11.6.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 8047 
15.2.1.6.5.11.6.2 activated TAK1 mediates p38 MAPK activation (Pathway) 8047 
15.2.1.6.5.11.6.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction)8047 
15.2.1.6.5.11.6.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 8048 
15.2.1.6.5.11.6.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 8048 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.6.5.11.6.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction)8048 
15.2.1.6.5.11.6.2.5 Nuclear export of human p38 MAPK mediated by its substrate8049 MAPKAPK2 or 3 (Reaction) 
15.2.1.6.5.11.6.3 ERK activation (Pathway) 8049 
15.2.1.6.5.11.6.3.1 ERK1 activation (Pathway) 8049 
15.2.1.6.5.11.6.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8049 
15.2.1.6.5.11.6.3.1.2 MEK1 binds ERK-1 (Reaction) 8050 
15.2.1.6.5.11.6.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8050 
15.2.1.6.5.11.6.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8050 
15.2.1.6.5.11.6.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8050 
15.2.1.6.5.11.6.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8051 
15.2.1.6.5.11.6.3.2 ERK2 activation (Pathway) 8051 
15.2.1.6.5.11.6.3.2.1 MEK2 binds ERK-2 (Reaction) 8051 
15.2.1.6.5.11.6.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8051 
15.2.1.6.5.11.6.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8052 
15.2.1.6.5.11.6.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8052 
15.2.1.6.5.11.6.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8052 
15.2.1.6.5.11.6.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway)
8052 
15.2.1.6.5.11.6.4.1 ERK/MAPK targets (Pathway) 8053 
15.2.1.6.5.11.6.4.1.1 ERK1/2 activates ELK1 (Reaction) 8053 
15.2.1.6.5.11.6.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 8053 
15.2.1.6.5.11.6.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 8053 
15.2.1.6.5.11.6.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 8054 
15.2.1.6.5.11.6.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 8054 
15.2.1.6.5.11.6.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction)8054 
15.2.1.6.5.11.6.4.1.7 ERKs are inactivated (Pathway) 8054 
15.2.1.6.5.11.6.4.1.7.1 ERKs are inactivated by protein phosphatase 2A (Reaction) 
15.2.1.6.5.11.6.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 8055 (DUSPs) (Reaction) 
15.2.1.6.5.11.6.4.2 CREB phosphorylation (Pathway) 8055 
15.2.1.6.5.11.6.4.2.1 MSK1 activates CREB (Reaction) 8055 
15.2.1.6.5.11.6.4.2.2 MSK1 activates ATF1 (Reaction) 8056 
15.2.1.6.5.11.6.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 8056 
15.2.1.6.5.11.6.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)8056 
15.2.1.6.5.11.6.4.3 Activation of the AP-1 family of transcription factors (Pathway)8056 
15.2.1.6.5.11.6.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 8057 
15.2.1.6.5.11.6.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 8057 
15.2.1.6.5.11.6.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 8057 
15.2.1.6.5.11.6.4.3.4 Formation of Activated Protein 1 (AP-1) complex. 8057 ATF2/c-JUN heterodimer. (Reaction) 
15.2.1.6.5.11.6.4.3.5 Formation of Activated Protein 1 (AP-1) complex. 8058 cFOS/c-JUN heterodimer. (Reaction) 
15.2.1.6.5.12 TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling (Pathway) 8058 
15.2.1.6.5.12.1 TRAF6 interacts with IRF7 upon TLR7/8 or 9 activation (Reaction) 8058 
15.2.1.6.5.12.2 TRAF6 ubiquitinqtes IRF7 in a K63-dependent manner following 8059 TLR7/8 or 9 stimulation (Reaction) 
15.2.1.6.5.12.3 Phosphorylation and release of IRF7 upon TLR7/8 or 9 activation 8059 (Reaction) 
15.2.1.6.5.12.4 Dimerization of p-IRF7 (Reaction) 8059 
15.2.1.6.5.12.5 Translocation of p-IRF7:p-IRF7 to nucleus (Reaction) 8059 
15.2.1.7 Toll Like Receptor 4 (TLR4) Cascade (Pathway) 8060 
15.2.1.7.1 Association of LBP with LPS (Reaction) 8061 
15.2.1.7.2 Transfer of LPS from LBP carrier to CD14 (Pathway) 8063 
15.2.1.7.2.1 GPI-bound CD14 binds LPS (Reaction) 8064 
15.2.1.7.2.2 Secreted CD14 binds LPS (Reaction) 8065 
15.2.1.7.3 Transfer of LPS onto TLR4 (Reaction) 8066 

15.2.1.7.4 CD14:LPS binds CR3 (Reaction) 8068 
15.2.1.7.5 MAL(TIRAP) binds PIP2-rich regions in the plasma membrane (Reaction) 8070 
15.2.1.7.6 Endocytosis of TLR4:MD2:LPS:CD14 (Reaction) 8071 
15.2.1.7.7 Endocytosis of TRAM (TICAM2) (Reaction) 8073 
15.2.1.7.8 TLR4:MD2:LPS:CD14 recruits TRAM (TICAM2) (Reaction) 8075 
15.2.1.7.9 Activated TLR4 signalling (Pathway) 8076 
15.2.1.7.9.1 MyD88:Mal cascade initiated on plasma membrane (Pathway) 8078 
15.2.1.7.9.1.1 Activated TLR2/4 interacts with MAL(TIRAP) (Reaction) 8079 
15.2.1.7.9.1.2 Activated TLR2/4:MAL interacts with BTK (Reaction) 8080 
15.2.1.7.9.1.3 MAL is phosphorylated by BTK (Reaction) 8082 
15.2.1.7.9.1.4 MyD88 forms a complex with MAL:activated TLR2/4 (Reaction) 8084 
15.2.1.7.9.1.5 MyD88 oligomerization within the complex of activated TLR:Mal:MyD88
8086 (Reaction) 
15.2.1.7.9.1.6 IRAK4 binds to the activated TLR receptor:Mal:MyD88 complex 8088 (Reaction) 8055 15.2.1.7.9.1.7 IRAK4 autophosphorylation in the complex with activated 8089 TLR:MyD88:Mal (Reaction) 
15.2.1.7.9.1.8 IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:Mal
8091 complex (Reaction) 
15.2.1.7.9.1.9 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 8093 oligomer:Mal:activated TLR complex (Reaction) 
15.2.1.7.9.1.10 First phosphorylation of IRAK1 by IRAK4 bound to activated 8094 TLR:MyD88:Mal (Reaction) 
15.2.1.7.9.1.11 Second phosphorylation of IRAK1 by IRAK4 bound to activated 8095 TLR:MyD88:Mal (Reaction) 
15.2.1.7.9.1.12 Multiple IRAK1 autophosphorylation steps (Reaction) 8096 
15.2.1.7.9.1.13 TRAF6 binds to hp- IRAK1 (Reaction) 8098 
15.2.1.7.9.1.14 TRAF6 binds to p-IRAK2 (Reaction) 8099 
15.2.1.7.9.1.15 Dissociation of hp-IRAK1:TRAF6 from the activated 8101 TLR:oligo-Myd88:Mal:p-IRAK4 complex (Reaction) 
15.2.1.7.9.1.16 Dissociation of p-IRAK2:TRAF6 from the activated 8102 TLR:oligo-Myd88:Mal:p-IRAK4 complex (Reaction) 
15.2.1.7.9.1.17 IRAK2 mediated activation of TAK1 complex (Pathway) 8104 
15.2.1.7.9.1.17.1 IRAK2 induces TRAF6 oligomerization (Reaction) 8104 
15.2.1.7.9.1.17.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 8104 (BlackBoxEvent) 
15.2.1.7.9.1.17.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 8104 (Polymerisation) 
15.2.1.7.9.1.17.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex (Reaction)8105 
15.2.1.7.9.1.17.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6:
8105 free K63 pUb:TAB1:TAB2/TAB3 (Reaction) 
15.2.1.7.9.1.18 IRAK1 recruits IKK complex (Pathway) 8105 
15.2.1.7.9.1.18.1 Pellino binds hp-IRAK1:TRAF6 (Reaction) 8105 
15.2.1.7.9.1.18.2 IRAK1 phosphorylates Pellino (Reaction) 8106 
15.2.1.7.9.1.18.3 Pellino ubiquitinates hp-IRAK1 (Reaction) 8106 
15.2.1.7.9.1.18.4 NEMO subunit of IKK complex binds to activated IRAK1 (Reaction)8106 
15.2.1.7.9.1.19 TRAF6 binds MEKK1 (Reaction) 8106 
15.2.1.7.9.1.20 TAK1 activates NFkB by phosphorylation and activation of IKKs 8107 complex (Pathway) 
15.2.1.7.9.1.20.1 Activated TAK1 mediates phosphorylation of the IKK Complex 8107 (Reaction) 
15.2.1.7.9.1.20.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 8107 Complex (Reaction) 
15.2.1.7.9.1.20.3 Released NFkB complex is transported to nucleus (Reaction) 8108 
15.2.1.7.9.1.21 MAP kinase activation in TLR cascade (Pathway) 8108 
15.2.1.7.9.1.21.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 8108 activated human TAK1 (Pathway) 
15.2.1.7.9.1.21.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 8108 
15.2.1.7.9.1.21.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 8109 (Reaction) 
15.2.1.7.9.1.21.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 8109 
15.2.1.7.9.1.21.2 activated TAK1 mediates p38 MAPK activation (Pathway) 8109 
15.2.1.7.9.1.21.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction)8109 
15.2.1.7.9.1.21.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 8110 
15.2.1.7.9.1.21.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 8110 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.7.9.1.21.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction)8110 
15.2.1.7.9.1.21.2.5 Nuclear export of human p38 MAPK mediated by its substrate8111 MAPKAPK2 or 3 (Reaction) 
15.2.1.7.9.1.21.3 ERK activation (Pathway) 8111 
15.2.1.7.9.1.21.3.1 ERK1 activation (Pathway) 8111 
15.2.1.7.9.1.21.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8111 
15.2.1.7.9.1.21.3.1.2 MEK1 binds ERK-1 (Reaction) 8112 
15.2.1.7.9.1.21.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8112 
15.2.1.7.9.1.21.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8112 
15.2.1.7.9.1.21.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8112 
15.2.1.7.9.1.21.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8113 
15.2.1.7.9.1.21.3.2 ERK2 activation (Pathway) 8113 
15.2.1.7.9.1.21.3.2.1 MEK2 binds ERK-2 (Reaction) 8113 
15.2.1.7.9.1.21.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8113 
15.2.1.7.9.1.21.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8114 
15.2.1.7.9.1.21.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8114 
15.2.1.7.9.1.21.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8114 
15.2.1.7.9.1.21.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway)8114 
15.2.1.7.9.1.21.4.1 ERK/MAPK targets (Pathway) 8115 
15.2.1.7.9.1.21.4.1.1 ERK1/2 activates ELK1 (Reaction) 8115 
15.2.1.7.9.1.21.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 8115 
15.2.1.7.9.1.21.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 8115 
15.2.1.7.9.1.21.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 8116 
15.2.1.7.9.1.21.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 8116 
15.2.1.7.9.1.21.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction)8116 
15.2.1.7.9.1.21.4.1.7 ERKs are inactivated (Pathway) 8116 
15.2.1.7.9.1.21.4.1.7.1 ERKs are inactivated by protein phosphatase 2A 8117 (Reaction) 
15.2.1.7.9.1.21.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 8117 (DUSPs) (Reaction) 
15.2.1.7.9.1.21.4.2 CREB phosphorylation (Pathway) 8117 
15.2.1.7.9.1.21.4.2.1 MSK1 activates CREB (Reaction) 8117 
15.2.1.7.9.1.21.4.2.2 MSK1 activates ATF1 (Reaction) 8118 
15.2.1.7.9.1.21.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 8118 
15.2.1.7.9.1.21.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)8118 
15.2.1.7.9.1.21.4.3 Activation of the AP-1 family of transcription factors (Pathway)8118 
15.2.1.7.9.1.21.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 8119 
15.2.1.7.9.1.21.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 8119 
15.2.1.7.9.1.21.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 8119 
15.2.1.7.9.1.21.4.3.4 Formation of Activated Protein 1 (AP-1) complex. 8119 ATF2/c-JUN heterodimer. (Reaction) 
15.2.1.7.9.1.21.4.3.5 Formation of Activated Protein 1 (AP-1) complex. 8120 cFOS/c-JUN heterodimer. (Reaction) 
15.2.1.7.9.2 MyD88-independent cascade (Pathway) 8120 
15.2.1.7.9.2.1 TRAM:TLR4:MD2:LPS:CD14 recruits TRIF (TICAM1) (Reaction) 8120 
15.2.1.7.9.2.2 Viral dsRNA:TLR3 recruits TRIF (TICAM1) (Reaction) 8120 
15.2.1.7.9.2.3 Negative regulator SARM binds to TRIF (Reaction) 8121 
15.2.1.7.9.2.4 TRIF-mediated TLR3/TLR4 signaling (Pathway) 8121 
15.2.1.7.9.2.4.1 Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon (Pathway) 8121 
15.2.1.7.9.2.4.1.1 TRAF3 binds to TRIF:activated TLR3/4 complex (Reaction) 8121 
15.2.1.7.9.2.4.1.2 Auto-ubiquitination of TRAF3 (BlackBoxEvent) 8122 
15.2.1.7.9.2.4.1.3 TANK binds K63-poly-Ub-TRAF3:TRIF:activated TLR3/TLR4 8122 (Reaction) 
15.2.1.7.9.2.4.1.4 TANK is ubiquitinated within 8122 TANK:K63polyUb-TRAF3:TRIF:activated TLR3/4 (BlackBoxEvent) 
15.2.1.7.9.2.4.1.5 Recruitment of TBK1/IKK epsilon to 8123 K63-pUb-TANK:K63-pUb-TRAF3:TRIF:activated TLR3/TLR4 followed by their phosphorylation (Reaction) 
15.2.1.7.9.2.4.1.6 IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the 8123 activated TLR (Reaction) 
15.2.1.7.9.2.4.1.7 Phosphorylation of IRF-3/IRF7 and their release from the 8123 activated TLR complex (Reaction) 
15.2.1.7.9.2.4.1.8 Dimerization of phosphorylated IRF3/IRF7 (Reaction) 8124 
15.2.1.7.9.2.4.1.9 Dimerized phospho-IRF3/IRF7 is transported to the nucleus 8124 (Reaction) 
15.2.1.7.9.2.4.2 IKK complex recruitment mediated by RIP1 (Pathway) 8124 
15.2.1.7.9.2.4.2.1 TRIF:activated TLR3/TLR4 complex recruits RIP1 (Reaction) 8124 
15.2.1.7.9.2.4.2.2 K63-linked ubiquitination of RIP1 bound to the activated TLR 8125 complex (Reaction) 
15.2.1.7.9.2.4.2.3 Nemo subunit of IKK complex binds polyubiquinated RIP1 8125 (Reaction) 
15.2.1.7.9.2.4.3 TRIF-mediated programmed cell death (Pathway) 8125 
15.2.1.7.9.2.4.3.1 TLR3/4-induced ripoptosome assembly (Reaction) 8125 
15.2.1.7.9.2.4.3.2 Caspase-8 processing within TLR3/4 complex (Reaction) 8126 
15.2.1.7.9.2.4.3.3 RIP3 binds TRIF to mediate necroptosis (Reaction) 8126 
15.2.1.7.9.2.4.4 TRAF6 mediated induction of TAK1 complex (Pathway) 8126 
15.2.1.7.9.2.4.4.1 Activated TLR3/4:TRIF recruits TRAF6 (Reaction) 8126 
15.2.1.7.9.2.4.4.2 Auto ubiquitination of TRAF6 bound to the activated TLR complex
8127 (BlackBoxEvent) 
15.2.1.7.9.2.4.4.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 8127 (Polymerisation) 
15.2.1.7.9.2.4.4.4 Activated TLR:TRIF:K63-pUb-TRAF6 recruits TAK1complex 8127 (Reaction) 
15.2.1.7.9.2.4.4.5 Activation of TAK1 complex bound to activated TLR (Reaction) 8128 
15.2.1.7.9.2.4.4.6 Phosphorylated TAK1 leaves activated TLR receptor complex 8128 (Reaction) 
15.2.1.7.9.2.4.5 TAK1 activates NFkB by phosphorylation and activation of IKKs 8128 complex (Pathway) 
15.2.1.7.9.2.4.5.1 Activated TAK1 mediates phosphorylation of the IKK Complex 8129 (Reaction) 
15.2.1.7.9.2.4.5.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB8129 Complex (Reaction) 
15.2.1.7.9.2.4.5.3 Released NFkB complex is transported to nucleus (Reaction) 8129 
15.2.1.7.9.2.4.6 MAP kinase activation in TLR cascade (Pathway) 8130 
15.2.1.7.9.2.4.6.1 JNK (c-Jun kinases) phosphorylation and activation mediated by8130 activated human TAK1 (Pathway) 
15.2.1.7.9.2.4.6.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 8130 
15.2.1.7.9.2.4.6.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 8130 (Reaction) 
15.2.1.7.9.2.4.6.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 8131 
15.2.1.7.9.2.4.6.2 activated TAK1 mediates p38 MAPK activation (Pathway) 8131 
15.2.1.7.9.2.4.6.2.1 activated human TAK1 phosphorylates MKK3/MKK6 8131 (Reaction) 
15.2.1.7.9.2.4.6.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction)8131 
15.2.1.7.9.2.4.6.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 8132 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.7.9.2.4.6.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction)8132 
15.2.1.7.9.2.4.6.2.5 Nuclear export of human p38 MAPK mediated by its substrate
8132 MAPKAPK2 or 3 (Reaction) 
15.2.1.7.9.2.4.6.3 ERK activation (Pathway) 8133 
15.2.1.7.9.2.4.6.3.1 ERK1 activation (Pathway) 8133 
15.2.1.7.9.2.4.6.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8133 
15.2.1.7.9.2.4.6.3.1.2 MEK1 binds ERK-1 (Reaction) 8133 
15.2.1.7.9.2.4.6.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8134 
15.2.1.7.9.2.4.6.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8134 
15.2.1.7.9.2.4.6.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8134 
15.2.1.7.9.2.4.6.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction)8134 
15.2.1.7.9.2.4.6.3.2 ERK2 activation (Pathway) 8135 
15.2.1.7.9.2.4.6.3.2.1 MEK2 binds ERK-2 (Reaction) 8135 
15.2.1.7.9.2.4.6.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8135 
15.2.1.7.9.2.4.6.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8135 
15.2.1.7.9.2.4.6.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8136 
15.2.1.7.9.2.4.6.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction)8136 
15.2.1.7.9.2.4.6.4 MAPK targets/ Nuclear events mediated by MAP kinases 8136 (Pathway) 
15.2.1.7.9.2.4.6.4.1 ERK/MAPK targets (Pathway) 8136 
15.2.1.7.9.2.4.6.4.1.1 ERK1/2 activates ELK1 (Reaction) 8137 
15.2.1.7.9.2.4.6.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 8137 
15.2.1.7.9.2.4.6.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 8137 15.2.1.7.9.2.4.6.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 8137 
15.2.1.7.9.2.4.6.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 8138 
15.2.1.7.9.2.4.6.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction)8138 
15.2.1.7.9.2.4.6.4.1.7 ERKs are inactivated (Pathway) 8138 
15.2.1.7.9.2.4.6.4.1.7.1 ERKs are inactivated by protein phosphatase 2A 8138 (Reaction) 
15.2.1.7.9.2.4.6.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 8139 (DUSPs) (Reaction) 
15.2.1.7.9.2.4.6.4.2 CREB phosphorylation (Pathway) 8139 
15.2.1.7.9.2.4.6.4.2.1 MSK1 activates CREB (Reaction) 8139 
15.2.1.7.9.2.4.6.4.2.2 MSK1 activates ATF1 (Reaction) 8139 
15.2.1.7.9.2.4.6.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction)8140 
15.2.1.7.9.2.4.6.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)8140 
15.2.1.7.9.2.4.6.4.3 Activation of the AP-1 family of transcription factors (Pathway)8140 
15.2.1.7.9.2.4.6.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 8140 
15.2.1.7.9.2.4.6.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 8141 
15.2.1.7.9.2.4.6.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 8141 
15.2.1.7.9.2.4.6.4.3.4 Formation of Activated Protein 1 (AP-1) complex. 8141 ATF2/c-JUN heterodimer. (Reaction) 
15.2.1.7.9.2.4.6.4.3.5 Formation of Activated Protein 1 (AP-1) complex. 8141 cFOS/c-JUN heterodimer. (Reaction) 
15.2.1.8 Toll Like Receptor 2 (TLR2) Cascade (Pathway) 8142 
15.2.1.8.1 Toll Like Receptor TLR1:TLR2 Cascade (Pathway) 8143 
15.2.1.8.1.1 TLR1/2 ligand binds to CD14 (Reaction) 8144 
15.2.1.8.1.2 TLR1:TLR2 is recruited to ligand:CD14 (Reaction) 8145 
15.2.1.8.1.3 MyD88:Mal cascade initiated on plasma membrane (Pathway) 8147 
15.2.1.8.1.3.1 Activated TLR2/4 interacts with MAL(TIRAP) (Reaction) 8147 
15.2.1.8.1.3.2 Activated TLR2/4:MAL interacts with BTK (Reaction) 8147 
15.2.1.8.1.3.3 MAL is phosphorylated by BTK (Reaction) 8148 
15.2.1.8.1.3.4 MyD88 forms a complex with MAL:activated TLR2/4 (Reaction) 8148 
15.2.1.8.1.3.5 MyD88 oligomerization within the complex of activated TLR:Mal:MyD88
8148 (Reaction) 
15.2.1.8.1.3.6 IRAK4 binds to the activated TLR receptor:Mal:MyD88 complex 8148 (Reaction) 
15.2.1.8.1.3.7 IRAK4 autophosphorylation in the complex with activated 8149 TLR:MyD88:Mal (Reaction) 
15.2.1.8.1.3.8 IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:Mal
8149 complex (Reaction) 
15.2.1.8.1.3.9 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 8149 oligomer:Mal:activated TLR complex (Reaction) 
15.2.1.8.1.3.10 First phosphorylation of IRAK1 by IRAK4 bound to activated 8150 TLR:MyD88:Mal (Reaction) 
15.2.1.8.1.3.11 Second phosphorylation of IRAK1 by IRAK4 bound to activated 8150 TLR:MyD88:Mal (Reaction) 
15.2.1.8.1.3.12 Multiple IRAK1 autophosphorylation steps (Reaction) 
15.2.1.8.1.3.13 TRAF6 binds to hp- IRAK1 (Reaction) 8151 
15.2.1.8.1.3.14 TRAF6 binds to p-IRAK2 (Reaction) 8151 
15.2.1.8.1.3.15 Dissociation of hp-IRAK1:TRAF6 from the activated 8151 TLR:oligo-Myd88:Mal:p-IRAK4 complex (Reaction) 
15.2.1.8.1.3.16 Dissociation of p-IRAK2:TRAF6 from the activated 8151 TLR:oligo-Myd88:Mal:p-IRAK4 complex (Reaction) 
15.2.1.8.1.3.17 IRAK2 mediated activation of TAK1 complex (Pathway) 8152 
15.2.1.8.1.3.17.1 IRAK2 induces TRAF6 oligomerization (Reaction) 8152 
15.2.1.8.1.3.17.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 8152 (BlackBoxEvent) 
15.2.1.8.1.3.17.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 8152 (Polymerisation) 
15.2.1.8.1.3.17.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex (Reaction)8153 
15.2.1.8.1.3.17.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6:
8153 free K63 pUb:TAB1:TAB2/TAB3 (Reaction) 
15.2.1.8.1.3.18 IRAK1 recruits IKK complex (Pathway) 8153 
15.2.1.8.1.3.18.1 Pellino binds hp-IRAK1:TRAF6 (Reaction) 8153 
15.2.1.8.1.3.18.2 IRAK1 phosphorylates Pellino (Reaction) 8154 
15.2.1.8.1.3.18.3 Pellino ubiquitinates hp-IRAK1 (Reaction) 8154 
15.2.1.8.1.3.18.4 NEMO subunit of IKK complex binds to activated IRAK1 (Reaction)8154 
15.2.1.8.1.3.19 TRAF6 binds MEKK1 (Reaction) 8154 
15.2.1.8.1.3.20 TAK1 activates NFkB by phosphorylation and activation of IKKs 8155 complex (Pathway) 
15.2.1.8.1.3.20.1 Activated TAK1 mediates phosphorylation of the IKK Complex 8155 (Reaction) 
15.2.1.8.1.3.20.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 8155 Complex (Reaction) 
15.2.1.8.1.3.20.3 Released NFkB complex is transported to nucleus (Reaction) 8156 
15.2.1.8.1.3.21 MAP kinase activation in TLR cascade (Pathway) 8156 
15.2.1.8.1.3.21.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 8156 activated human TAK1 (Pathway) 
15.2.1.8.1.3.21.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 8156 
15.2.1.8.1.3.21.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 8157 (Reaction) 
15.2.1.8.1.3.21.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 8157 
15.2.1.8.1.3.21.2 activated TAK1 mediates p38 MAPK activation (Pathway) 8157 
15.2.1.8.1.3.21.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction)8157 
15.2.1.8.1.3.21.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 8158 
15.2.1.8.1.3.21.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 8158 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.8.1.3.21.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction)8158 
15.2.1.8.1.3.21.2.5 Nuclear export of human p38 MAPK mediated by its substrate8159 MAPKAPK2 or 3 (Reaction) 
15.2.1.8.1.3.21.3 ERK activation (Pathway) 8159 
15.2.1.8.1.3.21.3.1 ERK1 activation (Pathway) 8159 15.2.1.8.1.3.21.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8159 
15.2.1.8.1.3.21.3.1.2 MEK1 binds ERK-1 (Reaction) 8160 
15.2.1.8.1.3.21.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8160 
15.2.1.8.1.3.21.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8160 
15.2.1.8.1.3.21.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8160 
15.2.1.8.1.3.21.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8161 
15.2.1.8.1.3.21.3.2 ERK2 activation (Pathway) 8161 
15.2.1.8.1.3.21.3.2.1 MEK2 binds ERK-2 (Reaction) 8161 
15.2.1.8.1.3.21.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8161 
15.2.1.8.1.3.21.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8162 
15.2.1.8.1.3.21.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8162 
15.2.1.8.1.3.21.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8162 
15.2.1.8.1.3.21.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway)
8162 
15.2.1.8.1.3.21.4.1 ERK/MAPK targets (Pathway) 8163 
15.2.1.8.1.3.21.4.1.1 ERK1/2 activates ELK1 (Reaction) 8163 
15.2.1.8.1.3.21.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 8163 
15.2.1.8.1.3.21.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 8163 
15.2.1.8.1.3.21.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 8164 
15.2.1.8.1.3.21.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 8164 
15.2.1.8.1.3.21.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction)8164 
15.2.1.8.1.3.21.4.1.7 ERKs are inactivated (Pathway) 8164 
15.2.1.8.1.3.21.4.1.7.1 ERKs are inactivated by protein phosphatase 2A 8165 (Reaction) 
15.2.1.8.1.3.21.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 8165 (DUSPs) (Reaction) 
15.2.1.8.1.3.21.4.2 CREB phosphorylation (Pathway) 8165 
15.2.1.8.1.3.21.4.2.1 MSK1 activates CREB (Reaction) 8165 
15.2.1.8.1.3.21.4.2.2 MSK1 activates ATF1 (Reaction) 8166 
15.2.1.8.1.3.21.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 8166 
15.2.1.8.1.3.21.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)8166 
15.2.1.8.1.3.21.4.3 Activation of the AP-1 family of transcription factors (Pathway)8166 
15.2.1.8.1.3.21.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 8167 
15.2.1.8.1.3.21.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 8167 
15.2.1.8.1.3.21.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 8167 
15.2.1.8.1.3.21.4.3.4 Formation of Activated Protein 1 (AP-1) complex. 8167 ATF2/c-JUN heterodimer. (Reaction) 
15.2.1.8.1.3.21.4.3.5 Formation of Activated Protein 1 (AP-1) complex. 8168 cFOS/c-JUN heterodimer. (Reaction) 
15.2.1.8.2 Toll Like Receptor TLR6:TLR2 Cascade (Pathway) 8168 
15.2.1.8.2.1 TLR6/2 ligand associates with CD14 and CD36 within lipid rafts (Reaction)
8169 
15.2.1.8.2.2 TLR6:TLR2 is recruited to ligand:CD14:CD36 (Reaction) 8170 
15.2.1.8.2.3 MyD88:Mal cascade initiated on plasma membrane (Pathway) 8172 
15.2.1.8.2.3.1 Activated TLR2/4 interacts with MAL(TIRAP) (Reaction) 8172 
15.2.1.8.2.3.2 Activated TLR2/4:MAL interacts with BTK (Reaction) 8172 
15.2.1.8.2.3.3 MAL is phosphorylated by BTK (Reaction) 8173 
15.2.1.8.2.3.4 MyD88 forms a complex with MAL:activated TLR2/4 (Reaction) 8173 
15.2.1.8.2.3.5 MyD88 oligomerization within the complex of activated TLR:Mal:MyD88
8173 (Reaction) 
15.2.1.8.2.3.6 IRAK4 binds to the activated TLR receptor:Mal:MyD88 complex 8173 (Reaction) 
15.2.1.8.2.3.7 IRAK4 autophosphorylation in the complex with activated 8174 TLR:MyD88:Mal (Reaction) 
15.2.1.8.2.3.8 IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:Mal
8174 complex (Reaction) 
15.2.1.8.2.3.9 Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 8174 oligomer:Mal:activated TLR complex (Reaction) 
15.2.1.8.2.3.10 First phosphorylation of IRAK1 by IRAK4 bound to activated 8175 TLR:MyD88:Mal (Reaction) 
15.2.1.8.2.3.11 Second phosphorylation of IRAK1 by IRAK4 bound to activated 8175 TLR:MyD88:Mal (Reaction) 
15.2.1.8.2.3.12 Multiple IRAK1 autophosphorylation steps (Reaction) 8175 
15.2.1.8.2.3.13 TRAF6 binds to hp- IRAK1 (Reaction) 8176 
15.2.1.8.2.3.14 TRAF6 binds to p-IRAK2 (Reaction) 8176 
15.2.1.8.2.3.15 Dissociation of hp-IRAK1:TRAF6 from the activated 8176 TLR:oligo-Myd88:Mal:p-IRAK4 complex (Reaction) 
15.2.1.8.2.3.16 Dissociation of p-IRAK2:TRAF6 from the activated 8176 TLR:oligo-Myd88:Mal:p-IRAK4 complex (Reaction) 
15.2.1.8.2.3.17 IRAK2 mediated activation of TAK1 complex (Pathway) 8177 
15.2.1.8.2.3.17.1 IRAK2 induces TRAF6 oligomerization (Reaction) 8177 
15.2.1.8.2.3.17.2 Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 8177 (BlackBoxEvent) 
15.2.1.8.2.3.17.3 Activated TRAF6 synthesizes unanchored polyubiquitin chains 8177 (Polymerisation) 
15.2.1.8.2.3.17.4 Activated TRAF6:p-IRAK2 interacts with TAK1 complex (Reaction)8178 
15.2.1.8.2.3.17.5 Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6:
8178 free K63 pUb:TAB1:TAB2/TAB3 (Reaction) 
15.2.1.8.2.3.18 IRAK1 recruits IKK complex (Pathway) 8178 
15.2.1.8.2.3.18.1 Pellino binds hp-IRAK1:TRAF6 (Reaction) 8178 
15.2.1.8.2.3.18.2 IRAK1 phosphorylates Pellino (Reaction) 8179 
15.2.1.8.2.3.18.3 Pellino ubiquitinates hp-IRAK1 (Reaction) 8179 
15.2.1.8.2.3.18.4 NEMO subunit of IKK complex binds to activated IRAK1 (Reaction)8179 
15.2.1.8.2.3.19 TRAF6 binds MEKK1 (Reaction) 8179 
15.2.1.8.2.3.20 TAK1 activates NFkB by phosphorylation and activation of IKKs 8180 complex (Pathway) 
15.2.1.8.2.3.20.1 Activated TAK1 mediates phosphorylation of the IKK Complex 8180 (Reaction) 
15.2.1.8.2.3.20.2 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB 8180 Complex (Reaction) 
15.2.1.8.2.3.20.3 Released NFkB complex is transported to nucleus (Reaction) 8181 
15.2.1.8.2.3.21 MAP kinase activation in TLR cascade (Pathway) 8181 15.2.1.8.2.3.21.1 JNK (c-Jun kinases) phosphorylation and activation mediated by 8181 activated human TAK1 (Pathway) 
15.2.1.8.2.3.21.1.1 Activated TAK1 phosphorylates MKK4/MKK7 (Reaction) 8181 
15.2.1.8.2.3.21.1.2 Phosphorylation of human JNKs by activated MKK4/MKK7 8182 (Reaction) 
15.2.1.8.2.3.21.1.3 Activated human JNKs migrate to nucleoplasm (Reaction) 8182 
15.2.1.8.2.3.21.2 activated TAK1 mediates p38 MAPK activation (Pathway) 8182 
15.2.1.8.2.3.21.2.1 activated human TAK1 phosphorylates MKK3/MKK6 (Reaction)8182 
15.2.1.8.2.3.21.2.2 Phosphorylated MKK3/MKK6 migrates to nucleus (Reaction) 8183 
15.2.1.8.2.3.21.2.3 Activated human MKK3/MKK6 phosphorylates p38 MAPK 8183 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
15.2.1.8.2.3.21.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction)8183 
15.2.1.8.2.3.21.2.5 Nuclear export of human p38 MAPK mediated by its substrate8184 MAPKAPK2 or 3 (Reaction) 
15.2.1.8.2.3.21.3 ERK activation (Pathway) 8184 
15.2.1.8.2.3.21.3.1 ERK1 activation (Pathway) 8184 
15.2.1.8.2.3.21.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8184 
15.2.1.8.2.3.21.3.1.2 MEK1 binds ERK-1 (Reaction) 8185 
15.2.1.8.2.3.21.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8185 
15.2.1.8.2.3.21.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8185 
15.2.1.8.2.3.21.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8185 
15.2.1.8.2.3.21.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8186 
15.2.1.8.2.3.21.3.2 ERK2 activation (Pathway) 8186 
15.2.1.8.2.3.21.3.2.1 MEK2 binds ERK-2 (Reaction) 8186 
15.2.1.8.2.3.21.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8186 
15.2.1.8.2.3.21.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8187 
15.2.1.8.2.3.21.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8187 
15.2.1.8.2.3.21.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8187 
15.2.1.8.2.3.21.4 MAPK targets/ Nuclear events mediated by MAP kinases (Pathway)8187 
15.2.1.8.2.3.21.4.1 ERK/MAPK targets (Pathway) 8188 
15.2.1.8.2.3.21.4.1.1 ERK1/2 activates ELK1 (Reaction) 8188 
15.2.1.8.2.3.21.4.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 8188 
15.2.1.8.2.3.21.4.1.3 p38MAPK phosphorylates MSK1 (Reaction) 8188 
15.2.1.8.2.3.21.4.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 8189 
15.2.1.8.2.3.21.4.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 8189 
15.2.1.8.2.3.21.4.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction)8189 
15.2.1.8.2.3.21.4.1.7 ERKs are inactivated (Pathway) 8189 
15.2.1.8.2.3.21.4.1.7.1 ERKs are inactivated by protein phosphatase 2A 8190 (Reaction) 
15.2.1.8.2.3.21.4.1.7.2 ERKs are inactivated by dual-specific phosphatases 8190 (DUSPs) (Reaction) 
15.2.1.8.2.3.21.4.2 CREB phosphorylation (Pathway) 8190 
15.2.1.8.2.3.21.4.2.1 MSK1 activates CREB (Reaction) 8190 
15.2.1.8.2.3.21.4.2.2 MSK1 activates ATF1 (Reaction) 8191 
15.2.1.8.2.3.21.4.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 8191 15.2.1.8.2.3.21.4.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction)8191 
15.2.1.8.2.3.21.4.3 Activation of the AP-1 family of transcription factors (Pathway)8191 
15.2.1.8.2.3.21.4.3.1 Phosphorylated MAPKs phosphorylate ATF-2 (Reaction) 8192 
15.2.1.8.2.3.21.4.3.2 Activated JNKs phosphorylate c-JUN (Reaction) 8192 
15.2.1.8.2.3.21.4.3.3 c-FOS activation by phospho ERK1/2 (Reaction) 8192 
15.2.1.8.2.3.21.4.3.4 Formation of Activated Protein 1 (AP-1) complex. 8192 ATF2/c-JUN heterodimer. (Reaction) 
15.2.1.8.2.3.21.4.3.5 Formation of Activated Protein 1 (AP-1) complex. 8193 cFOS/c-JUN heterodimer. (Reaction) 
15.2.2 Complement cascade (Pathway) 8193 
15.2.2.1 Initial triggering of complement (Pathway) 8201 
15.2.2.1.1 Creation of C4 and C2 activators (Pathway) 8202 
15.2.2.1.1.1 Lectin pathway of complement activation (Pathway) 8203 
15.2.2.1.1.1.1 Ficolins bind to repetitive carbohydrate structures on the target cell 8206 surface (Pathway) 
15.2.2.1.1.1.1.1 Ficolin-1 binds to molecular patterns on the target cell surface 8208 (Reaction) 
15.2.2.1.1.1.1.2 Ficolin-2 binds to molecular patterns on the target cell surface 8210 (Reaction) 
15.2.2.1.1.1.1.3 Ficolin-3 binds to molecular patterns on the target cell surface 8212 (Reaction) 
15.2.2.1.1.1.2 MBL binds to repetitive carbohydrate structures on the surfaces of 8213 viruses, bacteria, fungi, and protozoa (Reaction) 
15.2.2.1.1.1.3 Activation of MASPs (Reaction) 8215 
15.2.2.1.1.2 Classical antibody-mediated complement activation (Pathway) 8216 
15.2.2.1.1.2.1 Activation of C1R (Reaction) 8217 
15.2.2.1.1.2.2 Activation of C1S (Reaction) 8219 
15.2.2.1.2 Conversion of C4 into C4a and C4b (Reaction) 8220 
15.2.2.1.3 C4b binds to cell surface (Reaction) 8222 
15.2.2.1.4 Conversion of C2 into C2a and C2b (Reaction) 8223 
15.2.2.1.5 Formation of Classical C3 convertase (C4b:C2a complex) (Reaction) 8225 
15.2.2.1.6 Alternative complement activation (Pathway) 8226 
15.2.2.1.6.1 Spontaneous hydrolysis of C3 thioester (Reaction) 8227 
15.2.2.1.6.2 Factor B binds to C3(H2O) (Reaction) 8228 
15.2.2.1.6.3 Factor D cleaves C3(H2O)-bound Factor B (Reaction) 8229 
15.2.2.1.6.4 C3(H2O):Factor Bb cleaves C3 to C3b and C3a (Reaction) 8231 
15.2.2.1.6.5 C3b binds to cell surface (Reaction) 8232 
15.2.2.1.6.6 Factor B binds to surface-associated C3b (Reaction) 8233 
15.2.2.1.6.7 Factor D cleaves C3b-bound Factor B (Reaction) 8234 
15.2.2.1.6.8 Properdin stabilizes C3b:Bb bound to cell surfaces (Reaction) 8236 
15.2.2.1.6.9 Formation of alternative pathway C5 convertase (Reaction) 8237 
15.2.2.2 Activation of C3 and C5 (Pathway) 8239 
15.2.2.2.1 Cleavage of C3 by C3 convertases (Reaction) 8240 
15.2.2.2.2 Formation of classic pathway C5 convertase (Reaction) 8243 
15.2.2.2.3 Activation of C5 (Reaction) 8244 
15.2.2.3 Terminal pathway of complement (Pathway) 8246 
15.2.2.3.1 Formation of C5b:C6 complex (Reaction) 8247 
15.2.2.3.2 Formation of C5b:C6:C7 complex (Reaction) 8247 
15.2.2.3.3 C7 allows complex to insert into membrane under attack (Reaction) 8248 
15.2.2.3.4 Formation of C5b:C6:C7:C8 complex (Reaction) 8249 
15.2.2.3.5 Creation of the Membrane Attack Complex (MAC) (Reaction) 8250 
15.2.2.4 Regulation of Complement cascade (Pathway) 8251 
15.2.2.4.1 C3 convertases spontaneously dissociate (Reaction) 8253 
15.2.2.4.2 Factor H binds to C3b (Reaction) 8254 
15.2.2.4.3 Factor H binds host cell surface markers (Reaction) 8255 
15.2.2.4.4 Factor H binds to membrane-associated C3b (Reaction) 8257 
15.2.2.4.5 Factor H binds to C3bBb (Reaction) 8258 
15.2.2.4.6 Factor H displaces Bb (Reaction) 8260 
15.2.2.4.7 Complement factor I complex formation (Reaction) 8261 
15.2.2.4.8 Complement factor I binds to extracellular Factor H:C3b (Reaction) 8262 
15.2.2.4.9 Factor I inactivates plasma Factor H-bound C3b (Reaction) 8263 
15.2.2.4.10 Complement factor I binds to membrane-associated Factor H:C3b (Reaction)
8264 
15.2.2.4.11 Factor I inactivates Factor H-boundC3b (Reaction) 8265 
15.2.2.4.12 iC3b proteolysis (Reaction) 8267 
15.2.2.4.13 CR1 binds C3bBb/C4bC2a (Reaction) 8268 
15.2.2.4.14 Displacement of C2a/Bb by CR1 (Reaction) 8270 
15.2.2.4.15 MCP binds C3b, C4b (Reaction) 8271 
15.2.2.4.16 Complement factor I binds to MCP, CR1:C4b, C3b (Reaction) 8272 
15.2.2.4.17 Factor I inactivates MCP/CR1-bound C4b/C3b (Reaction) 8274 
15.2.2.4.18 CD55 (DAF) binds C3bBb, C4bC2a (Reaction) 8275 
15.2.2.4.19 DAF accelerates C3bBb/C4bC2a dissociation (Reaction) 8277 
15.2.2.4.20 C4b-binding protein binds C4b (Reaction) 8278 
15.2.2.4.21 Complement factor I binds C4BP (Reaction) 8280 
15.2.2.4.22 Complement factor I inactivates C4BP-bound C4b (Reaction) 8281 
15.2.2.4.23 C4b binding protein binds C4bC2a (BlackBoxEvent) 8282 
15.2.2.4.24 C4b binding protein displaces C2a (BlackBoxEvent) 8283 
15.2.2.4.25 C4b binding protein binds Protein S (Reaction) 8285 
15.2.2.4.26 CD59 inhibits MAC formation (Reaction) 8286 
15.2.2.4.27 Formation of soluble VTN:C5b-C9 (Reaction) 8288 
15.2.2.4.28 Vitronectin(VTN) binds to C5b:C6:C7 (Reaction) 8289 
15.2.2.4.29 Hydrolysis of internal thioester in C4b (Reaction) 8290 
15.2.3 Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling8292 pathways (Pathway) 
15.2.3.1 NOD1/2 Signaling Pathway (Pathway) 8294 
15.2.3.1.1 iE-DAP elicits a NOD1 response (Reaction) 8296 
15.2.3.1.2 MDP elicits a NOD2 response (Reaction) 8297 
15.2.3.1.3 Activated NOD1 oligomerizes (Reaction) 8299 
15.2.3.1.4 Activated NOD2 oligomerizes (Reaction) 8300 
15.2.3.1.5 Activated NOD oligomer recruites RIP2 (RICK) (Reaction) 8302 
15.2.3.1.6 RIP2 binds NEMO (Reaction) 8303 15.2.3.1.7 RIP2 induces K63-linked ubiquitination of NEMO (Reaction) 8305 
15.2.3.1.8 CYLD deubiquitinates NEMO (Reaction) 8306 
15.2.3.1.9 RIP2 is K63 polyubiquitinated (Reaction) 8307 
15.2.3.1.10 A20 deubiquitinates RIP2 (Reaction) 8309 
15.2.3.1.11 K63 polyubiquitinated RIP2 associates with the TAK1 complex (Reaction) 8311 
15.2.3.1.12 TAK1 is activated (BlackBoxEvent) 8312 
15.2.3.1.13 Activated TAK1 mediates phosphorylation of the IKK Complex (Reaction) 8313 
15.2.3.1.14 TAK1 phosphorylates MKK6 (Reaction) 8314 
15.2.3.1.15 NOD1 induced apoptosis is mediated by RIP2 and CARD8 (Reaction) 8315 
15.2.3.1.16 CARD9 binds RIP2 (and NOD2) (Reaction) 8316 
15.2.3.1.17 Activation of p38 MAPK (Reaction) 8318 
15.2.3.2 Inflammasomes (Pathway) 8320 
15.2.3.2.1 The NLRP3 inflammasome (Pathway) 8322 
15.2.3.2.1.1 ATP binds to P2X7 (Reaction) 8323 
15.2.3.2.1.2 P2X7 forms oligomeric non-selective cation channels (Reaction) 8325 
15.2.3.2.1.3 P2X7 mediates loss of intracellular K+ (Reaction) 8326 
15.2.3.2.1.4 P2X7 mediates membrane pores that include pannexin-1 (BlackBoxEvent)
8328 
15.2.3.2.1.5 SGT1 binds HSP90 (Reaction) 8330 
15.2.3.2.1.6 SGT1:HSP90 binds inactive NLRP3 (Reaction) 8331 
15.2.3.2.1.7 TXNIP binds reduced thioredoxin (Reaction) 8332 
15.2.3.2.1.8 ROS oxidize thioredoxin (BlackBoxEvent) 8333 
15.2.3.2.1.9 TXNIP is released from oxidized thioredoxin (Reaction) 8335 
15.2.3.2.1.10 TXNIP binds NLRP3 (Reaction) 8336 
15.2.3.2.1.11 NLRP3 activation by small molecules (BlackBoxEvent) 8338 
15.2.3.2.1.12 NLRP3 activation by elicitor proteins (BlackBoxEvent) 8340 
15.2.3.2.1.13 NLRP3 oligomerizes via NACHT domains (Polymerisation) 8343 
15.2.3.2.1.14 ASC is recruited via a PYD-PYD interaction (Reaction) 8344 
15.2.3.2.1.15 The CARD domain of ASC recruits Procaspase-1 (Reaction) 8346 
15.2.3.2.1.16 PSTPIP1 binds Pyrin (Reaction) 8347 
15.2.3.2.1.17 Pyrin binds ASC (Reaction) 8349 
15.2.3.2.2 The NLRP1 inflammasome (Pathway) 8350 
15.2.3.2.2.1 Bcl-2 and Bcl-XL bind NLRP1 (Reaction) 8352 
15.2.3.2.2.2 NLRP1 senses MDP (BlackBoxEvent) 8353 
15.2.3.2.2.3 MDP:NLRP1 binds ATP (Reaction) 8354 
15.2.3.2.2.4 NLRP1 oligomerizes (Polymerisation) 8355 
15.2.3.2.3 The IPAF inflammasome (Pathway) 8357 
15.2.3.2.3.1 IPAF is activated (BlackBoxEvent) 8359 
15.2.3.2.3.2 IPAF binds procaspase-1 (Reaction) 8362 
15.2.3.2.4 The AIM2 inflammasome (Pathway) 8363 
15.2.3.2.4.1 AIM2 binds dsDNA (Reaction) 8364 
15.2.3.2.4.2 AIM2 oligomerizes (Polymerisation) 8365 
15.2.3.2.4.3 dsDNA:AIM2 clusters bind ASC (Reaction) 8367 
15.2.3.2.4.4 dsDNA:AIM2:ASC cluster binds procaspase-1 (Reaction) 8369 
15.2.4 Advanced glycosylation endproduct receptor signaling (Pathway) 8370 
15.2.4.1 The TRTK-12 fragment of F-actin capping protein alpha binds the AGER ligand 
S100B (Reaction) 
15.2.4.2 Advanced glycosylation end product-specific receptor (AGER/RAGE) is a 8373 multiligand receptor (Reaction) 
15.2.4.3 AGER binds ERK1/2 (Reaction) 8376 
15.2.4.4 AGER-1,2,3 bind AGEs (Reaction) 8378 
15.2.5 RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways (Pathway) 8380 
15.2.5.1 dsRNA binds to RIG-I (Reaction) 8382 
15.2.5.2 K-63-linked polyubiquitination of RIG-I (Reaction) 8383 
15.2.5.3 dsRNA binds to MDA5 (Reaction) 8385 
15.2.5.4 RIG-I/MDA5 interacts with IPS-1 (Reaction) 8387 
15.2.5.5 TRAF3-dependent IRF activation pathway (Pathway) 8389 
15.2.5.5.1 Recruitment of TRAF3 to IPS-1 (Reaction) 8390 
15.2.5.5.2 TBK1/IKK epsilon complex interacts with IPS-1 bound TRAF3 (Reaction) 8391 
15.2.5.5.3 Recruitment of IRF3/7Â (Reaction) 8393 
15.2.5.5.4 Phosphorylation and release of IRF3/IRF7 (Reaction) 8394 
15.2.5.5.5 Dimerization of Phospho IRF3 or phospho IRF7 (Reaction) 8396 
15.2.5.5.6 Translocation of phosphorylated IRF3/7 dimers into nucleus (Reaction) 8397 
15.2.5.5.7 Interaction of CBP/p300 with p-IRF3 dimer (Reaction) 8398 
15.2.5.5.8 IRF3:CBP/p300 complex binds the promoters of IFN-beta (Reaction) 8400 
15.2.5.5.9 Expression of IFN-beta (BlackBoxEvent) 8401 
15.2.5.6 NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -108402 (Pathway) 
15.2.5.6.1 IPS-1 interacts with RIP-1 and FADD (Reaction) 8404 
15.2.5.6.2 Recruitment of caspase-8 and -10 to FADD complex (Reaction) 8405 
15.2.5.6.3 Dimerzation of procaspase-8/10 (Reaction) 8406 
15.2.5.6.4 Processing of caspases (Reaction) 8408 
15.2.5.6.5 Recruitment of IKK complex (Reaction) 8409 
15.2.5.7 TRAF6 mediated IRF7 activation (Pathway) 8410 
15.2.5.7.1 Recruitment of TRAF6/TRAF2 to IPS-1 (Reaction) 8412 
15.2.5.7.2 Recruitment of TANK to TRAF6 (Reaction) 8413 
15.2.5.7.3 Recruitment of TBK1/IKK epsilon complex to TANK:TRAF6 (Reaction) 8414 
15.2.5.7.4 Recruitment of IRF7 to TRAF6 (Reaction) 8416 
15.2.5.7.5 Phosphorylation and release of IRF7 (Reaction) 8417 
15.2.5.7.6 Dimerization of p-IRF7 (Reaction) 8418 
15.2.5.7.7 Translocation of p-IRF7:p-IRF7 to nucleus (Reaction) 8418 
15.2.5.7.8 p-IRF7 dimer interacts with coactivator CBP/p300 (Reaction) 8418 
15.2.5.7.9 Formation of VAF (virus-activated factor) complex (Reaction) 8419 
15.2.5.7.10 VAF/pIRF7:CBP/p300 binds the promoters of type-I IFN genes (Reaction) 8421 
15.2.5.7.11 Expression of Interferon-alpha and beta (BlackBoxEvent) 8422 
15.2.5.8 TRAF6 mediated NF-kB activation (Pathway) 8422 
15.2.5.8.1 Interaction of MEKK1 with TRAF6 (Reaction) 8423 
15.2.5.8.2 Activation of IKK by MEKK1 (Reaction) 8425 
15.2.5.8.3 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB Complex 8426 (Reaction) 
15.2.5.8.4 Released NFkB complex is transported to nucleus (Reaction) 8372
8427 
15.2.5.9 Negative regulators of RIG-I/MDA5 signaling (Pathway) 8427 
15.2.5.9.1 RNF125 mediated ubiquitination of RIG-I, MDA5 and IPS-1 (BlackBoxEvent)8428 
15.2.5.9.2 Interaction of PIN1 with p-IRF3 (Reaction) 8430 
15.2.5.9.3 PIN1 mediated IRF3 degradation (BlackBoxEvent) 8432 
15.2.5.9.4 Inhibition of RIG-I/MDA5 signaling by ATG5-ATG12 conjugate (Reaction) 8434 
15.2.5.9.5 CYLD mediated deubiquitination of RIG-I (BlackBoxEvent) 8436 
15.2.5.9.6 Negative regulation of RIG-I/MDA5 signaling by DUBA (BlackBoxEvent) 8437 
15.2.5.9.7 Negative regulation of RIG-I/MDA5 signaling by TRIAD3A (BlackBoxEvent) 8438 
15.2.5.9.8 NLRX1 inhibits IPS-1-RIG-I interaction. (Reaction) 8440 
15.2.5.9.9 ISGylation of RIG-I (Reaction) 8441 
15.2.5.9.10 TAX1BP1:A20 inhibit TBK1/IKKi K63-polyubiquitination (Reaction) 8442 
15.2.5.9.11 NLRC5 interacts with RIG-I/MDA5 and inhibit IPS-1 binding (Reaction) 8443 
15.2.5.9.12 Interaction of PCBP2 with MAVS/IPS-1 (Reaction) 8445 
15.2.5.9.13 Recruitment of AIP4 and K-48 ubiquitination of MAVS/IPS-1 (Reaction) 8446 
15.2.6 Defensins (Pathway) 8447 
15.2.6.1 Pre-pro-defensins are cleaved to remove the signal peptide (BlackBoxEvent) 8450 
15.2.6.2 Alpha-defensins (Pathway) 8451 
15.2.6.2.1 Pro-HNP1-4 are cleaved to biologically active defensin (Reaction) 8453 
15.2.6.2.2 HNP1-4 are stored in primary neutrophil granules (Reaction) 8454 
15.2.6.2.3 HNP1-4 are released into phagocytic vacuoles (Reaction) 8456 
15.2.6.2.4 pro-defensin alpha 5 is stored in Paneth cell granules (Reaction) 8457 
15.2.6.2.5 pro-defensin alpha 5 is secreted (Reaction) 8458 
15.2.6.2.6 pro-HD5 is cleaved by trypsin (Reaction) 8459 
15.2.6.2.7 Alpha-defensins form biologically active dimers (Reaction) 8461 
15.2.6.2.8 Alpha-defensin dimers adsorb onto microbial membrane anionic phospholipids
8463 (Reaction) 
15.2.6.2.9 Alpha-defensin dimers multimerize to form a pore complex (BlackBoxEvent)8464 
15.2.6.2.10 HNP1-3 bind gp120 (Reaction) 8466 
15.2.6.2.11 HNP1-3 bind CD4 (Reaction) 8467 
15.2.6.2.12 ADP-Ribosylation of HNP-1 (Reaction) 8469 
15.2.6.3 Beta defensins (Pathway) 8470 
15.2.6.3.1 Beta-defensins are secreted (Reaction) 8473 
15.2.6.3.2 Beta-defensins bind microbial membranes causing disruption (BlackBoxEvent)
8475 
15.2.6.3.3 Beta-defensins 1, 4A and 103 bind CCR6 (Reaction) 8477 
15.2.6.3.4 Beta-defensins 4A and 103 bind CCR2 (Reaction) 8478 
15.2.6.3.5 Beta defensin 103 activates TLR1:TLR2 (Reaction) 8479 
15.2.6.4 Binding of defensins to lipid II (Reaction) 8481 
15.2.7 Cytosolic sensors of pathogen-associated DNA (Pathway) 8482 
15.2.7.1 ZBP1(DAI) mediated induction of type I IFNs (Pathway) 8484 
15.2.7.1.1 ZBP1 binds cytosolic DNA (Reaction) 8485 
15.2.7.1.2 IRF3 mediated activation of type 1 IFN (Pathway) 8487 
15.2.7.1.2.1 Recruitment TBK1 to dsDNA:ZBP1 followed by its activation (Reaction) 8488 
15.2.7.1.2.2 Recruitment of IRF3 to activated ZBP1:TBK1 (Reaction) 8490 
15.2.7.1.2.3 Phosphorylation and release of IRF3 (Reaction) 8491 
15.2.7.1.2.4 p-T,4S-IRF3 is dimerized (Reaction) 8493 
15.2.7.1.2.5 Dimerized phospho-IRF3 migrates to the nucleus (Reaction) 8494 
15.2.7.1.3 RIP-mediated NFkB activation via ZBP1 (Pathway) 8495 
15.2.7.1.3.1 ZBP1(DAI) recruits RIP1 and RIP3 (Reaction) 8497 
15.2.7.1.3.2 RIP1 facilitates IKK complex phosphorylation (Reaction) 8498 
15.2.7.1.3.3 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB Complex8500 (Reaction) 
15.2.7.1.3.4 Released NFkB complex is transported to nucleus (Reaction) 8501 
15.2.7.2 STING mediated induction of host immune responses (Pathway) 8501 
15.2.7.2.1 cGAS binds cytosolic DNA (Reaction) 8504 
15.2.7.2.2 cGAS produces cyclic GMP-AMP (Reaction) 8505 
15.2.7.2.3 IFI16 binds cytosolic dsDNA (Reaction) 8507 
15.2.7.2.4 DDX41 binds dsDNA or c-di-NMP (Reaction) 8508 
15.2.7.2.5 STING dimerization (Reaction) 8510 
15.2.7.2.6 STING binds c-di-GMP (BlackBoxEvent) 8512 
15.2.7.2.7 STING binds cyclic GMP-AMP (BlackBoxEvent) 8515 
15.2.7.2.8 IRF3-mediated induction of type I IFN (Pathway) 8516 
15.2.7.2.8.1 STING recruits TBK1 and IRF3 (Reaction) 8518 
15.2.7.2.8.2 TBK1 is phosphorylated within STING:TBK1:IRF3 complex (Reaction) 8520 
15.2.7.2.8.3 IRF3 is phosphorylated by TBK1 (Reaction) 8522 
15.2.7.2.8.4 p-T,4S-IRF3 is dimerized (Reaction) 8524 
15.2.7.2.8.5 Dimerized phospho-IRF3 migrates to the nucleus (Reaction) 8524 
15.2.7.2.9 STAT6-mediated induction of chemokines (Pathway) 8524 
15.2.7.2.9.1 STING recruits TBK1 and STAT6 (Reaction) 8526 
15.2.7.2.9.2 TBK1 is phosphorylated within STING:TBK1:STAT6 complex (Reaction) 8527 
15.2.7.2.9.3 TBK1 phosphorylates STAT6 at Ser407 (Reaction) 8529 
15.2.7.2.9.4 p-S407-STAT6 is phosphorylated at Tyr641 (Reaction) 8530 
15.2.7.2.9.5 p-S407,Y641-STAT6 is dimerized (Reaction) 8531 
15.2.7.2.9.6 p-S407,Y641-STAT6 dimer migrates to the nucleus (Reaction) 8532 
15.2.7.3 RNA polymerase III transcribes microbial dsDNA to dsRNA (BlackBoxEvent) 8534 
15.2.7.4 LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production 8535 (Pathway) 
15.2.7.4.1 LRR FLII-interacting protein 1 binds dsDNA (Reaction) 8536 
15.2.7.4.2 LRR FLII-interacting protein 1 associates with beta-catenin (Reaction) 8538 
15.2.7.4.3 Phosphorylation of beta-catenin at Ser552 (Reaction) 8539 
15.2.7.4.4 Beta-catenin migrates to the nucleus (BlackBoxEvent) 8540 
15.2.7.4.5 Beta-catenin enhances association of IRF3 with CBP/p300 (Reaction) 8542 
15.2.7.5 DEx/H-box helicases activate type I IFN and inflammatory cytokines production8543 (Pathway) 
15.2.7.5.1 DHX36 binds DNA (Reaction) 8544 
15.2.7.5.2 DHX9 binds DNA (Reaction) 8545 
15.2.7.5.3 DHX36 or DHX9 binds MyD88 (Reaction) 8546 
15.2.7.5.4 Translocation of p-IRF7:p-IRF7 to nucleus (Reaction) 8548 
15.2.7.5.5 Released NFkB complex is transported to nucleus (Reaction) 8548 
15.2.7.6 DNA-PK binds microbial dsDNA (Reaction) 8548 
15.2.7.7 MRE11 binds cytosolic DNA (Reaction) 8551 15.2.7.8 Regulation of innate immune responses to cytosolic DNA (Pathway) 8552 
15.2.7.8.1 DDX41 ubiquitination by TRIM21 (Reaction) 8553 
15.2.7.8.2 STING binds TRIM32 or TRIM56 (Reaction) 8554 
15.2.7.8.3 STING ubiquitination by TRIM32 or TRIM56 (Reaction) 8556 
15.2.7.8.4 NLRP4 and DTX4 associate with p-S172-TBK1 (Reaction) 8557 
15.2.7.8.5 p-S172-TBK1 is ubiquitinated by DTX4 (Reaction) 8558 
15.2.7.8.6 Regulation by TREX1 (Pathway) 8560 
15.2.7.8.6.1 TREX1 binds retroviral-derived DNA (Reaction) 8562 
15.2.7.8.6.2 Viral DNA cleavage by TREX1 (BlackBoxEvent) 8565 
15.2.8 Fcgamma receptor (FCGR) dependent phagocytosis (Pathway) 8566 
15.2.8.1 FCGR activation (Pathway) 8568 
15.2.8.1.1 Cross-linking of FCGRIA with IgG-coated Ag (Reaction) 8569 
15.2.8.1.2 Cross-linking of FCGRIIA with IgG-coated Ag (Reaction) 8571 
15.2.8.1.3 Cross-linking of FCGRIIIA with IgG-coated Ag (Reaction) 8573 
15.2.8.1.4 Sequestering and phosphorylation Fc gamma receptors in the lipid rafts 8575 (BlackBoxEvent) 
15.2.8.1.5 Recruitment of SYK to phosphorylated ITAMs (Reaction) 8577 
15.2.8.1.6 Phosphorylation of SYK by Src kinases (Reaction) 8580 
15.2.8.2 Regulation of actin dynamics for phagocytic cup formation (Pathway) 8582 
15.2.8.2.1 Recruitment of VAV1 to p-6Y-SYK (Reaction) 8584 
15.2.8.2.2 Phosphorylation of VAV (Reaction) 8585 
15.2.8.2.3 Activation of RAC1 by VAV (Reaction) 8587 
15.2.8.2.4 Recruitment of CRKII:DOCK180:ELMO complex to FCGR (Reaction) 8588 
15.2.8.2.5 Activation of RAC1 by CRKII:DOCK180:ELMO (Reaction) 8590 
15.2.8.2.6 WAVE Regulatory Complex (WRC) interacts with RAC1 and PIP3 and gets 8591 activated (Reaction) 
15.2.8.2.7 ERK2 phosphorylates WAVE2 and ABI (Reaction) 8593 
15.2.8.2.8 ABL phosphorylates WAVE2 (Reaction) 8595 
15.2.8.2.9 Activation of CDC42 by unknown mechanism (BlackBoxEvent) 8596 
15.2.8.2.10 Activation of WASP and N-WASP by CDC42 (Reaction) 8598 
15.2.8.2.11 Activation of WASP/N-WASP by WIP family and SH3 domain proteins 8601 (Reaction) 
15.2.8.2.12 Phosphorylation of WASP/N-WASP (Reaction) 8603 
15.2.8.2.13 WAVE2 or WASP/N-WASP activate the ARP2/3 complex (Reaction) 8604 
15.2.8.2.14 Attachment of preexisting mother filament and initiation of branching 8607 (Reaction) 
15.2.8.2.15 Detachment of WASP/WAVE (Reaction) 8609 
15.2.8.2.16 Branching and elongation of mother and daughter filaments (Polymerisation)8610 
15.2.8.2.17 RAC and CDC42 activate PAK (Reaction) 8611 
15.2.8.2.18 Autophosphorylation of PAK1 (Reaction) 8613 
15.2.8.2.19 Phosphorylation of LIMK1 by PAK (Reaction) 8614 
15.2.8.2.20 Dimerization of LIMK1 by Hsp90 (Reaction) 8616 
15.2.8.2.21 Transphosphorylation of pLIMK1 (BlackBoxEvent) 8616 
15.2.8.2.22 Phosphorylation of cofilin by LIMK-1 (Reaction) 8616 
15.2.8.2.23 Extension of pseudopodia by myosin-X in a PI3K dependent manner (Reaction) 
15.2.8.2.24 Role of myosins in phagosome formation (BlackBoxEvent) 8618 
15.2.8.3 Role of phospholipids in phagocytosis (Pathway) 8620 
15.2.8.3.1 PI3K binds to p-6Y-SYK (Reaction) 8622 
15.2.8.3.2 PI3K phosphorylates PIP2 to PIP3 (Reaction) 8623 
15.2.8.3.3 Recruitment of PLCgamma to membrane (Reaction) 8625 
15.2.8.3.4 Phosphorylation and activation of PLCG (Reaction) 8626 
15.2.8.3.5 Release of PLCG from FCGR (Reaction) 8628 
15.2.8.3.6 Active PLCG1 hydrolyses PIP2 (Reaction) 8629 
15.2.8.3.7 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 8631 channel (Reaction) 
15.2.8.3.8 Release of calcium from intracellular stores by IP3 receptor activation 8631 (Reaction) 
15.2.8.3.9 DAG stimulates protein kinase C-delta (Reaction) 8631 
15.2.8.3.10 Hydrolysis of PC to PA by PLD (Reaction) 8632 
15.2.8.3.11 Conversion of PA into DAG by PAP-1 (Reaction) 8634 
15.2.8.3.12 Production of AA by iPLA2 upon FCGR activation (BlackBoxEvent) 8636 
15.2.9 DAP12 interactions (Pathway) 8637 
15.2.9.1 Dimerization of DAP12 (Reaction) 8639 
15.2.9.2 Interaction of DAP12 and KIR2DS1 (Reaction) 8641 
15.2.9.3 Interaction of DAP12 and KIR2DS2 (Reaction) 8642 
15.2.9.4 Interaction of DAP12 and KIR2DS4 (Reaction) 8643 
15.2.9.5 Interaction of DAP12 and KIR2DS5 (Reaction) 8645 
15.2.9.6 Interaction of DAP12 and KIR3DS1 (Reaction) 8646 
15.2.9.7 Interaction of DAP12 and MDL-1 (Reaction) 8648 
15.2.9.8 DAP12 interacts with NKG2C (Reaction) 8650 
15.2.9.9 Interaction of DAP12 and NKG2D (Reaction) 8651 
15.2.9.10 Interaction of DAP12 and NKp44 (Reaction) 8654 
15.2.9.11 Interaction of DAP12 and SIRP beta (Reaction) 8655 
15.2.9.12 Interaction of DAP12 and TREM1 (Reaction) 8656 
15.2.9.13 Interaction of DAP12 and TREM2 (Reaction) 8657 
15.2.9.14 Interaction of SIGLEC14/15/16 and DAP12 (Reaction) 8659 
15.2.9.15 Interaction of DAP12 and IREM2 (Reaction) 8661 
15.2.9.16 Interaction of DAP12 and CLM7 (Reaction) 8662 
15.2.9.17 DAP12 signaling (Pathway) 8663 
15.2.9.17.1 Phosphorylation of DAP12 (Reaction) 8665 
15.2.9.17.2 Recruitment of SYK to p-DAP12 (Reaction) 8667 
15.2.9.17.3 Phosphorylation of SYK (Reaction) 8668 
15.2.9.17.4 p85 regulatory unit of PI3K binds p-6Y-SYK (Reaction) 8670 
15.2.9.17.5 PI3K phosphorylates PIP2 to PIP3 (Reaction) 8671 
15.2.9.17.6 PIP3 activates AKT signaling (Pathway) 8673 
15.2.9.17.6.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 8673 
15.2.9.17.6.2 PIP3 recruits AKT to the membrane (Reaction) 8673 
15.2.9.17.6.3 PIP3 recruits PDPK1 to the membrane (Reaction) 8673 
15.2.9.17.6.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 8617
8674 
15.2.9.17.6.5 AKT binds PDPK1 (Reaction) 8674 
15.2.9.17.6.6 PDPK1 phosphorylates AKT at T308 (Reaction) 8674 
15.2.9.17.6.7 AKT phosphorylates targets in the cytosol (Pathway) 8674 
15.2.9.17.6.7.1 AKT phosphorylates BAD (Reaction) 8675 
15.2.9.17.6.7.2 AKT phosphorylates GSK3 (Reaction) 8675 
15.2.9.17.6.7.3 AKT phosphorylates caspase-9 (Reaction) 8675 
15.2.9.17.6.7.4 AKT phosphorylates MDM2 (Reaction) 8675 
15.2.9.17.6.7.5 AKT phosphorylates IKKalpha (Reaction) 8676 
15.2.9.17.6.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 8676 
15.2.9.17.6.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 8676 
15.2.9.17.6.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 8676 
15.2.9.17.6.8 AKT translocates to the nucleus (Reaction) 8677 
15.2.9.17.6.9 AKT phosphorylates targets in the nucleus (Pathway) 8677 
15.2.9.17.6.9.1 AKT phosphorylates CREB1 (Reaction) 8677 
15.2.9.17.6.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction)8677 
15.2.9.17.6.9.3 AKT can phosphorylate RSK (Reaction) 8678 
15.2.9.17.6.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 8678 
15.2.9.17.6.10 Negative regulation of the PI3K/AKT network (Pathway) 8678 
15.2.9.17.6.10.1 PTEN dephosphorylates PIP3 (Reaction) 8678 
15.2.9.17.6.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction)
8679 
15.2.9.17.6.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 8679 
15.2.9.17.6.11 PDPK1 binds PIP2 (Reaction) 8679 
15.2.9.17.6.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 8679 
15.2.9.17.6.13 PTEN mRNA translation negatively regulated by microRNAs 8680 (BlackBoxEvent) 
15.2.9.17.7 Phosphorylation of LAT by p-SYK (Reaction) 8680 
15.2.9.17.8 Recruitment of GRB2:SOS to p-5Y-LAT (Reaction) 8682 
15.2.9.17.9 Recruitment of GADS:SLP-76 to p-5Y-LAT (Reaction) 8683 
15.2.9.17.10 Recruitment of PLC-gamma to SLP-76 and p-5Y-LAT (Reaction) 8685 
15.2.9.17.11 SOS mediated nucleotide exchange of RAS (SHC) (Reaction) 8688 
15.2.9.17.12 RAF/MAP kinase cascade (Pathway) 8689 
15.2.9.17.12.1 RAF activation (Pathway) 8689 
15.2.9.17.12.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 8689 
15.2.9.17.12.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 8690 
15.2.9.17.12.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 8690 
15.2.9.17.12.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 8691 
15.2.9.17.12.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)
8691 
15.2.9.17.12.2 MEK activation (Pathway) 8692 
15.2.9.17.12.2.1 Activated RAF1 complex binds MEK (Reaction) 8692 
15.2.9.17.12.2.2 RAF phosphorylates MEK (Pathway) 8692 
15.2.9.17.12.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 8692 
15.2.9.17.12.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 8693 
15.2.9.17.12.3 ERK activation (Pathway) 8693 
15.2.9.17.12.3.1 ERK1 activation (Pathway) 8693 
15.2.9.17.12.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8693 15.2.9.17.12.3.1.2 MEK1 binds ERK-1 (Reaction) 8694 
15.2.9.17.12.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8694 
15.2.9.17.12.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8694 
15.2.9.17.12.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8694 
15.2.9.17.12.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8695 
15.2.9.17.12.3.2 ERK2 activation (Pathway) 8695 
15.2.9.17.12.3.2.1 MEK2 binds ERK-2 (Reaction) 8695 
15.2.9.17.12.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8695 
15.2.9.17.12.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8696 
15.2.9.17.12.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8696 
15.2.9.17.12.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8696 
15.2.9.17.13 Phosphorylation of SLP-76 by p-SYK (Reaction) 8696 
15.2.9.17.14 Recruitment of VAV and BTK to p-SLP-76 (Reaction) 8698 
15.2.9.17.15 Phosphorylation of BTK by p-SYK (Reaction) 8699 
15.2.9.17.16 Phosphorylation of PLC-gamma by p-BTK/p-SYK (Reaction) 8701 
15.2.9.17.17 Release of p-PLCG1 (Reaction) 8702 
15.2.9.17.18 DAG and IP3 signaling (Pathway) 8704 
15.2.9.17.18.1 Active PLCG1 hydrolyses PIP2 (Reaction) 8704 
15.2.9.17.18.2 DAG stimulates protein kinase C-delta (Reaction) 8705 
15.2.9.17.18.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+8705 channel (Reaction) 
15.2.9.17.18.4 Release of calcium from intracellular stores by IP3 receptor activation 8705 (Reaction) 
15.2.9.17.18.5 CaM pathway (Pathway) 8705 
15.2.9.17.18.5.1 Calcium binds calmodulin (Reaction) 8707 
15.2.9.17.18.5.2 Calmodulin induced events (Pathway) 8707 
15.2.9.17.18.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 8708 
15.2.9.17.18.5.2.1.1 PKA activation (Pathway) 8709 
15.2.9.17.18.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 8710 
15.2.9.17.18.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers 8711 (Reaction) 
15.2.9.17.18.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 8713 
15.2.9.17.18.5.2.1.3 PKA phosphorylates CREB (Reaction) 8714 
15.2.9.17.18.5.2.1.4 Dimerisation of CREB (Reaction) 8716 
15.2.9.17.18.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 8717 
15.2.9.17.18.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 8718 
15.2.9.17.18.5.2.2.2 CamKIV enters the nucleus (Reaction) 8719 
15.2.9.17.18.5.2.2.3 CaMK IV autophosphorylation (Reaction) 8720 
15.2.9.17.18.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 8722 
15.2.9.17.18.5.2.2.5 Dimerisation of CREB (Reaction) 8723 
15.2.9.17.18.5.2.3 Cam-PDE 1 activation (Pathway) 8724 
15.2.9.17.18.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 8725 
15.2.9.17.18.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 8726 
15.2.9.17.18.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 8727 
15.2.9.17.18.5.2.5 PKC phosphorylates GRK2 (Reaction) 8729 
15.2.9.17.19 Phosphorylation and activation of VAV2/VAV3 by SYK (Reaction) 8730 
15.2.9.17.20 Activation of RAC1 by VAV2/3 (Reaction) 8731 
15.2.10 Fc epsilon receptor (FCERI) signaling (Pathway) 8733 
15.2.10.1 Allergen dependent IgE bound FCERI aggregation (BlackBoxEvent) 8735 
15.2.10.2 Autophosphorylation of LYN kinase (Reaction) 8736 
15.2.10.3 Phosphorylation of beta and gamma subunits by LYN (Reaction) 8737 
15.2.10.4 Recruitment of SYK to p-FCERI gamma subunit (Reaction) 8739 
15.2.10.5 Phosphorylation of SYK (Reaction) 8741 
15.2.10.6 Phosphorylation of LAT by p-SYK (Reaction) 8743 
15.2.10.7 FCERI mediated MAPK activation (Pathway) 8745 
15.2.10.7.1 Phosphorylation of SHC by SYK kinase (Reaction) 8746 
15.2.10.7.2 Interaction of GRB2:SOS complex with p-SHC1 (Reaction) 8748 
15.2.10.7.3 Recruitment of GRB2:SOS to p-5Y-LAT (Reaction) 8749 
15.2.10.7.4 SOS mediated nucleotide exchange of RAS (SHC) (Reaction) 8749 
15.2.10.7.5 RAF/MAP kinase cascade (Pathway) 8750 
15.2.10.7.5.1 RAF activation (Pathway) 8750 
15.2.10.7.5.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 8750 
15.2.10.7.5.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 8750 
15.2.10.7.5.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 8751 
15.2.10.7.5.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 8751 
15.2.10.7.5.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)8751 
15.2.10.7.5.2 MEK activation (Pathway) 8751 
15.2.10.7.5.2.1 Activated RAF1 complex binds MEK (Reaction) 8752 
15.2.10.7.5.2.2 RAF phosphorylates MEK (Pathway) 8752 
15.2.10.7.5.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 8752 
15.2.10.7.5.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 8752 
15.2.10.7.5.3 ERK activation (Pathway) 8753 
15.2.10.7.5.3.1 ERK1 activation (Pathway) 8753 
15.2.10.7.5.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 8753 
15.2.10.7.5.3.1.2 MEK1 binds ERK-1 (Reaction) 8753 
15.2.10.7.5.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 8754 
15.2.10.7.5.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 8754 
15.2.10.7.5.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 8754 
15.2.10.7.5.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 8754 
15.2.10.7.5.3.2 ERK2 activation (Pathway) 8755 
15.2.10.7.5.3.2.1 MEK2 binds ERK-2 (Reaction) 8755 
15.2.10.7.5.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 8755 
15.2.10.7.5.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 8755 
15.2.10.7.5.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 8756 
15.2.10.7.5.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 8756 
15.2.10.7.6 Recruitment of GADS:SLP-76 to p-5Y-LAT (Reaction) 8756 
15.2.10.7.7 Recruitment of PLC-gamma to SLP-76 and p-5Y-LAT (Reaction) 8756 
15.2.10.7.8 Phosphorylation of SLP-76 by p-SYK (Reaction) 8757 
15.2.10.7.9 Recruitment of VAV to p-SLP-76 (Reaction) 8758 
15.2.10.7.10 Phosphorylation and activation of VAV (Reaction) 8760 15.2.10.7.11 Activation of RAC1 by VAV (Reaction) 8762 
15.2.10.7.12 Recruitment of PAK to the membrane by binding active RAC1 (Reaction) 8763 
15.2.10.7.13 Autophosphorylation of PAK (Reaction) 8765 
15.2.10.7.14 Autophosphorylation and activation of MEKK1 (Reaction) 8766 
15.2.10.7.15 Phosphorylation of MEK4 by MEKK1 (Reaction) 8768 
15.2.10.7.16 Phosphorylation of MEK7 by MEKK1 (Reaction) 8769 
15.2.10.7.17 Phosphorylation of human JNKs by activated MKK4/MKK7 (Reaction) 8771 
15.2.10.7.18 Activated human JNKs migrate to nucleoplasm (Reaction) 8771 
15.2.10.7.19 Activated JNKs phosphorylate c-JUN (Reaction) 8771 
15.2.10.7.20 c-FOS activation by phospho ERK1/2 (Reaction) 8771 
15.2.10.7.21 Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer.
8772 (Reaction) 
15.2.10.8 FCERI mediated Ca+2 mobilization (Pathway) 8772 
15.2.10.8.1 Recruitment of TEC kinases to p-SLP-76 (Reaction) 8773 
15.2.10.8.2 Phosphorylation of TEC kinases by p-SYK (Reaction) 8776 
15.2.10.8.3 Autophosphorylation of BTK/ITK (Reaction) 8778 
15.2.10.8.4 Phosphorylation of PLC-gamma (Reaction) 8779 
15.2.10.8.5 Hydrolysis of PIP2 by PLCG (Reaction) 8781 
15.2.10.8.6 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 8782 channel (Reaction) 
15.2.10.8.7 Release of calcium from intracellular stores by IP3 receptor activation 8783 (Reaction) 
15.2.10.8.8 Calcium binds calmodulin (Reaction) 8783 
15.2.10.8.9 Activation of Calcineurin (Reaction) 8783 
15.2.10.8.10 Calcineurin binds and dephosphorylates NFAT (BlackBoxEvent) 8785 
15.2.10.8.11 Translocation of CaN:CaM:NFAT to nucleus (Reaction) 8786 
15.2.10.9 FCERI mediated NF-kB activation (Pathway) 8788 
15.2.10.9.1 RasGRP interacts with DAG and Ca2+ (Reaction) 8789 
15.2.10.9.2 DAG recruits PKC-theta to plasma membrane (Reaction) 8792 
15.2.10.9.3 Phosphorylation of PKC-theta (Reaction) 8793 
15.2.10.9.4 Autophosphorylation of PKC-theta (Reaction) 8795 
15.2.10.9.5 Phosphorylation of CARMA1 by PKC-theta (Reaction) 8796 
15.2.10.9.6 Oligomerization of p-CARMA1 (BlackBoxEvent) 8798 
15.2.10.9.7 Interaction of BCL10:MALT1 with CARMA1 to form CBM complex (Reaction)
8799 
15.2.10.9.8 Oligomerization of BCL10 and MALT1 (BlackBoxEvent) 8802 
15.2.10.9.9 Recruitment of TRAF6 to CBM complex by binding to MALT1 (Reaction) 8803 
15.2.10.9.10 Oligomerization of TRAF6 (BlackBoxEvent) 8804 
15.2.10.9.11 Auto-ubiquitination of TRAF6 (BlackBoxEvent) 8805 
15.2.10.9.12 Recruitment of TAK1 kinase complex to oligo-K63-pUb-TRAF6 (Reaction)8807 
15.2.10.9.13 Activation of TAK1 complex bound to pUb-TRAF6 (BlackBoxEvent) 8808 
15.2.10.9.14 Phosphorylation of IKK-beta by TAK1 (Reaction) 8810 
15.2.10.9.15 Ubiquitination of NEMO by TRAF6 (BlackBoxEvent) 8812 
15.2.10.9.16 Activation of NF-kB complex (Reaction) 8812 
15.2.10.9.17 Released NF-kB complex is transported to the nucleus (Reaction) 8812 
15.2.10.10 Role of LAT2/NTAL/LAB on calcium mobilization (Pathway) 8813 
15.2.10.10.1 Phosphorylation of NTAL by p-SYK/Lyn (Reaction) 8815 
15.2.10.10.2 Recruitment of GRB2:SOS to p-10Y-NTAL (Reaction) 8816 
15.2.10.10.3 Recruitment of GAB2 to PM and FCERI by binding to GRB2 (Reaction) 8818 
15.2.10.10.4 Phoshorylation of GAB2 by SYK/FYN (Reaction) 8820 
15.2.10.10.5 PI3K associates with phosphorylated GAB2 (Reaction) 8822 
15.2.10.10.6 Phosphorylation of PIP2 to PIP3 by PI3K (Reaction) 8823 
15.2.10.10.7 Translocation of PDK1 to Plasma membrane (Reaction) 8824 
15.2.10.10.8 PIP3 activates AKT signaling (Pathway) 8825 
15.2.10.10.8.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 8825 
15.2.10.10.8.2 PIP3 recruits AKT to the membrane (Reaction) 8825 
15.2.10.10.8.3 PIP3 recruits PDPK1 to the membrane (Reaction) 8825 
15.2.10.10.8.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 8826 
15.2.10.10.8.5 AKT binds PDPK1 (Reaction) 8826 
15.2.10.10.8.6 PDPK1 phosphorylates AKT at T308 (Reaction) 8826 
15.2.10.10.8.7 AKT phosphorylates targets in the cytosol (Pathway) 8826 
15.2.10.10.8.7.1 AKT phosphorylates BAD (Reaction) 8827 
15.2.10.10.8.7.2 AKT phosphorylates GSK3 (Reaction) 8827 
15.2.10.10.8.7.3 AKT phosphorylates caspase-9 (Reaction) 8827 
15.2.10.10.8.7.4 AKT phosphorylates MDM2 (Reaction) 8827 
15.2.10.10.8.7.5 AKT phosphorylates IKKalpha (Reaction) 8828 
15.2.10.10.8.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 8828 
15.2.10.10.8.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 8828 
15.2.10.10.8.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 8828 
15.2.10.10.8.8 AKT translocates to the nucleus (Reaction) 8829 
15.2.10.10.8.9 AKT phosphorylates targets in the nucleus (Pathway) 8829 
15.2.10.10.8.9.1 AKT phosphorylates CREB1 (Reaction) 8829 
15.2.10.10.8.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction)8829 
15.2.10.10.8.9.3 AKT can phosphorylate RSK (Reaction) 8830 
15.2.10.10.8.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 8830 
15.2.10.10.8.10 Negative regulation of the PI3K/AKT network (Pathway) 8830 
15.2.10.10.8.10.1 PTEN dephosphorylates PIP3 (Reaction) 8830 
15.2.10.10.8.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation 8831 (Reaction) 
15.2.10.10.8.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 8831 
15.2.10.10.8.11 PDPK1 binds PIP2 (Reaction) 8831 
15.2.10.10.8.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 8831 
15.2.10.10.8.13 PTEN mRNA translation negatively regulated by microRNAs 8832 (BlackBoxEvent) 
15.3 Cytokine Signaling in Immune system (Pathway) 8832 
15.3.1 Interferon Signaling (Pathway) 8833 
15.3.1.1 Interferon alpha/beta signaling (Pathway) 8835 
15.3.1.1.1 IFN alpha/beta binds to IFNAR2 (Reaction) 8836 
15.3.1.1.2 Recruitment of IFNAR1 (Reaction) 8839 
15.3.1.1.3 Activation of JAK kinases (Reaction) 8840 
15.3.1.1.4 Phosphorylation of INFAR1 by TYK2 (Reaction) 8842 
15.3.1.1.5 Recruitment of STAT2 to p-IFNAR1 (Reaction) 8843 
15.3.1.1.6 Phosphorylation of STAT2 (Reaction) 8844 
15.3.1.1.7 Phosphorylation of STAT1 (Reaction) 8846 
15.3.1.1.8 Release of p-STAT2:p-STAT1 dimer (Reaction) 8848 
15.3.1.1.9 Interaction of IRF9 with p-STAT2:p-STAT1 (Reaction) 8849 
15.3.1.1.10 Translocation of ISGF3 complex to nucleus (Reaction) 8850 
15.3.1.1.11 Formation of p-STAT1 homodimer (Reaction) 8852 
15.3.1.1.12 Translocation of p-STAT1:p-STAT1 dimer to nucleus (Reaction) 8853 
15.3.1.1.13 ISGF3 binds the ISRE promoter elements in IFN-stimulated genes (Reaction)
8854 
15.3.1.1.14 Expression of IFN-induced genes (BlackBoxEvent) 8856 
15.3.1.1.15 Regulation of IFNA signaling (Pathway) 8859 
15.3.1.1.15.1 Inhibition of JAK kinase activity by SOCS1/3 (Reaction) 8860 
15.3.1.1.15.2 UBP43 binds IFNAR2 and prevents JAK1 interaction (Reaction) 8862 
15.3.1.1.15.3 Dephosphorylation of TYK2 by PTP1B (Reaction) 8863 
15.3.1.1.15.4 Dephosphorylation of JAK1 by SHP1 (Reaction) 8864 
15.3.1.1.15.5 Dephosphorylation of STAT1 by SHP2 (Reaction) 8865 
15.3.1.2 Interferon gamma signaling (Pathway) 8867 
15.3.1.2.1 Interaction of IFNG with IFNGR (Reaction) 8868 
15.3.1.2.2 Phosphorylation of JAK2 (Reaction) 8870 
15.3.1.2.3 Transphosphorylation of JAK1 (Reaction) 8872 
15.3.1.2.4 Phosphorylation of IFNGR1 by JAK kinases (Reaction) 8873 
15.3.1.2.5 Binding of STAT1 to p-IFNGR1 (Reaction) 8875 
15.3.1.2.6 Phoshorylation of STAT1 by JAK kinases (Reaction) 8876 
15.3.1.2.7 Phosphorylation of STAT1 at Ser727 (Reaction) 8878 
15.3.1.2.8 Release of STAT1 dimer from active receptor unit (Reaction) 8879 
15.3.1.2.9 Translocation of STAT1 dimer to nucleus (Reaction) 8880 
15.3.1.2.10 GAF binds the GAS promoter elements in the IFNG-regulated genes 8882 (Reaction) 
15.3.1.2.11 Expression of IFNG-stimulated genes (BlackBoxEvent) 8883 
15.3.1.2.12 Regulation of IFNG signaling (Pathway) 8886 
15.3.1.2.12.1 SOCS-1 and SOCS-3 binds to p-JAK2 (Reaction) 8887 
15.3.1.2.12.2 Dephosphorylation of JAKs by PTPs (Reaction) 8888 
15.3.1.2.12.3 PIAS1 binds p-STAT1 dimer (Reaction) 8890 
15.3.1.2.12.4 Dephosphorylation of p-STAT1 dimer by nuclear isoform of TCPTP 8891 (Reaction) 
15.3.1.3 Antiviral mechanism by IFN-stimulated genes (Pathway) 8892 
15.3.1.3.1 ISG15 antiviral mechanism (Pathway) 8893 
15.3.1.3.1.1 Activation of ISG15 by UBE1L E1 ligase (Reaction) 8895 
15.3.1.3.1.2 Transfer of ISG15 from E1 to E2 (UBCH8) (Reaction) 8896 
15.3.1.3.1.3 Interaction of E3 ligase with ISG15:E2 complex (Reaction) 8897 
15.3.1.3.1.4 ISGylation of host proteins (Reaction) 8899 
15.3.1.3.1.5 ISGylation of host protein filamin B (Reaction) 8900 
15.3.1.3.1.6 ISGylation of protein phosphatase 1 beta (PP2CB) (Reaction) 8902 
15.3.1.3.1.7 ISGylation of E2 conjugating enzymes (Reaction) 8903 
15.3.1.3.1.8 Interaction of ISG15 with NEDD4 and inhibition of Ebola virus budding (Reaction) 
15.3.1.3.1.9 ISGylation of viral protein NS1 (Reaction) 8906 
15.3.1.3.1.10 Translocation of Influenza A virus nonstructural protein 1 (NS1A) into the8908 nucleus (BlackBoxEvent) 
15.3.1.3.1.11 ISGylation of IRF3 (Reaction) 8909 
15.3.1.3.1.12 ISGylation of protein translation regulator 4EHP (Reaction) 8911 
15.3.1.3.1.13 Competitive inhibition of translation initiation by ISGylated 4EHP 8912 (Reaction) 
15.3.1.3.1.14 PIN1 mediated IRF3 degradation (BlackBoxEvent) 8913 
15.3.1.3.1.15 Monoubiquitination of N-myristoyl GAG (P12493) protein (BlackBoxEvent)8914 
15.3.1.3.1.16 Regulation of protein ISGylation by ISG15 deconjugating enzyme USP18
8915 (BlackBoxEvent) 
15.3.2 Signaling by Interleukins (Pathway) 8917 
15.3.2.1 Interleukin-1 processing (Pathway) 8918 
15.3.2.1.1 Caspase-1 precursor is cleaved releasing p10 and p20 subunits (Reaction) 8920 
15.3.2.1.2 Formation of caspase-1 p10/p20 dimer (Reaction) 8921 
15.3.2.1.3 Caspase-1 active tetramer formation (Reaction) 8922 
15.3.2.1.4 Interleukin-1 family precursors are cleaved by caspase-1 (Reaction) 8923 
15.3.2.1.5 Interleukin-1 family are secreted (BlackBoxEvent) 8926 
15.3.2.2 Interleukin-1 signaling (Pathway) 8927 
15.3.2.2.1 Interleukin-1 receptor type 1 binds Interleukin 1 (Reaction) 8930 
15.3.2.2.2 Interleukin-1 receptor type 2 binds Interleukin 1 (Reaction) 8931 
15.3.2.2.3 IL1 receptor antagonist protein binds Interleukin 1 receptors (Reaction) 8932 
15.3.2.2.4 Interleukin-1 receptor type 1: Interleukin 1 binds Interleukin-1 receptor 8934 accessory protein, membrane associated isoform (Reaction) 
15.3.2.2.5 IL1R1:IL1:IL1RAP binds MYD88 homodimer (Reaction) 8935 
15.3.2.2.6 IL1R1:IL1:IL1RAP:MYD88 homodimer binds IRAK4 (Reaction) 8936 
15.3.2.2.7 The Interleukin 1 receptor complex binds Tollip (Reaction) 8938 
15.3.2.2.8 IRAK4 is activated by autophosphorylation (Reaction) 8939 
15.3.2.2.9 IRAK1 binds to MYD88 within the IL1R complex (Reaction) 8940 
15.3.2.2.10 IRAK4 phosphorylates IRAK1 (Reaction) 8941 
15.3.2.2.11 IRAK4-activated IRAK1 autophosphorylates (Reaction) 8943 
15.3.2.2.12 IRAK2 is phosphorylated downstream of IRAK4 following IL1 receptor 8944 activation (BlackBoxEvent) 
15.3.2.2.13 Hyperphosphorylated IRAK1 associates with TRAF6 (Reaction) 8946 
15.3.2.2.14 p62:MEKK3 binds to TRAF6 (Reaction) 8947 
15.3.2.2.15 TRAF6 binding leads to IRAK1:TRAF6 release (Reaction) 8949 
15.3.2.2.16 IRAK1 induces oligomerisation of TRAF6 (Reaction) 8950 
15.3.2.2.17 TRAF6 auto-ubiquitinates with Lys63-linked polyubiquitin chains (Reaction)8952 
15.3.2.2.18 Polyubiquitinated TRAF6 interacts with TAK1 complex (Reaction) 8953 
15.3.2.2.19 TAK1 is activated within the TAK1 complex (BlackBoxEvent) 8954 
15.3.2.2.20 IRAK1 and 4 interact with Pellino1,2 and 3 (Reaction) 8956 
15.3.2.2.21 IRAK1 and 4 can phosphorylate Pellino-1 and 2. (Reaction) 8958 
15.3.2.2.22 Pellino ubiquitinates IRAK1 (Reaction) 8959 
15.3.2.2.23 NEMO binds polyubiquitinated IRAK1 (Reaction) 8905
8961 
15.3.2.2.24 Activated TAK1 mediates phosphorylation of the IKK Complex (Reaction) 8962 
15.3.2.2.25 TAK1 phosphorylates MKK6 (Reaction) 8962 
15.3.2.2.26 The IKKB complex phosphorylates NFkB p105 (Reaction) 8963 
15.3.2.2.27 The SCF betaTrCP complex binds p-NFkB p105 (Reaction) 8964 
15.3.2.2.28 Beta-TrCP ubiquitinates then dissociates from p-NFKB p105 (Reaction) 8965 
15.3.2.2.29 NFKB p105, TPL2 (COT) and ABIN2 form a stable complex (Reaction) 8966 
15.3.2.2.30 TPL2 phosphorylates MEK1, SEK1 (Reaction) 8968 
15.3.2.3 Interleukin-2 signaling (Pathway) 8970 
15.3.2.3.1 IL2RB associates with JAK1 (Reaction) 8973 
15.3.2.3.2 IL2RG associates with JAK3 (BlackBoxEvent) 8974 

15.3.2.3.3 Interleukin-2 receptor alpha binds interleukin-2 (Reaction) 8975 
15.3.2.3.4 Interleukin-2 receptor alpha:IL2 binds Interleukin-2 receptor beta (Reaction) 8977 
15.3.2.3.5 Interleukin-2: IL2 receptor alpha:beta binds IL2 receptor gamma subunit 8979 (Reaction) 
15.3.2.3.6 Within the IL-2R complex JAK3 phosphorylates JAK1 (Reaction) 8980 
15.3.2.3.7 JAK1 phosphorylates Y338, Y392 and Y510 of IL2RB (Reaction) 8982 
15.3.2.3.8 Phosphorylation of IL2RB Y338 enables SHC recruitment (Reaction) 8984 
15.3.2.3.9 Phosphorylation of IL2RB Y338, Y392 or Y510 enables STAT recruitment 8985 (Reaction) 
15.3.2.3.10 SHC1 bound to IL2 receptor is phosphorylated (Reaction) 8987 
15.3.2.3.11 Interleukin receptor SHC signaling (Pathway) 8988 
15.3.2.3.11.1 Phosphorylated SHC1 recruits GRB2:GAB2 (BlackBoxEvent) 8991 
15.3.2.3.11.2 SHC1 mediates cytokine-induced phosphorylation of GAB2 8992 (BlackBoxEvent) 
15.3.2.3.11.3 Gab2 binds the p85 subunit of Class 1A PI3 kinases (Reaction) 8994 
15.3.2.3.11.4 Phosphorylated SHC recruits GRB2:SOS1 (Reaction) 8995 
15.3.2.3.11.5 SOS1 activates H-Ras (Reaction) 8997 
15.3.2.3.11.6 Phosphorylated SHC1 recruits SHIP (Reaction) 8998 
15.3.2.3.11.7 The SHC1:SHIP1 complex is stabilized by GRB2 (Reaction) 9000 
15.3.2.3.12 RAF/MAP kinase cascade (Pathway) 9002 
15.3.2.3.12.1 RAF activation (Pathway) 9002 
15.3.2.3.12.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 9002 
15.3.2.3.12.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 9002 
15.3.2.3.12.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 9003 
15.3.2.3.12.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 9003 
15.3.2.3.12.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)9003 
15.3.2.3.12.2 MEK activation (Pathway) 9003 
15.3.2.3.12.2.1 Activated RAF1 complex binds MEK (Reaction) 9004 
15.3.2.3.12.2.2 RAF phosphorylates MEK (Pathway) 9004 
15.3.2.3.12.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 9004 
15.3.2.3.12.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 9004 
15.3.2.3.12.3 ERK activation (Pathway) 9005 
15.3.2.3.12.3.1 ERK1 activation (Pathway) 9005 
15.3.2.3.12.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 9005 
15.3.2.3.12.3.1.2 MEK1 binds ERK-1 (Reaction) 9005 15.3.2.3.12.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 9006 
15.3.2.3.12.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 9006 
15.3.2.3.12.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 9006 
15.3.2.3.12.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 9006 
15.3.2.3.12.3.2 ERK2 activation (Pathway) 9007 
15.3.2.3.12.3.2.1 MEK2 binds ERK-2 (Reaction) 9007 
15.3.2.3.12.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 9007 
15.3.2.3.12.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 9007 
15.3.2.3.12.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 9008 
15.3.2.3.12.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 9008 
15.3.2.3.13 Recruited STAT5 is phosphorylated (Reaction) 9008 
15.3.2.3.14 Phosphorylated STAT5 is released (Reaction) 9010 
15.3.2.3.15 Phosphorylated STAT5 forms dimers (Reaction) 9011 
15.3.2.3.16 STAT5 dimers translocate to the nucleus and bind to specific DNA sequences
9013 (BlackBoxEvent) 
15.3.2.3.17 Syk binds IL2RB (Reaction) 9015 
15.3.2.3.18 SYK is a substrate for JAK1 (Reaction) 9016 
15.3.2.3.19 Pyk2 associates with Jak3 (Reaction) 9017 
15.3.2.3.20 Pyk2 is activated following IL2 stimulation (BlackBoxEvent) 9019 
15.3.2.4 Interleukin-3, 5 and GM-CSF signaling (Pathway) 9020 
15.3.2.4.1 The common beta chain IL3RB binds JAK2 (Reaction) 9023 
15.3.2.4.2 GM-CSF receptor alpha subunit binds GM-CSF (Reaction) 9026 
15.3.2.4.3 GM-CSF receptor alpha:GM-CSF binds Bc (Reaction) 9027 
15.3.2.4.4 Interleukin-5 is a homodimer (Reaction) 9029 
15.3.2.4.5 Interleukin-5 receptor alpha subunit binds Interleukin-5 (Reaction) 9030 
15.3.2.4.6 Interleukin-5:Interleukin-5 receptor alpha binds IL3RB:JAK2 (Reaction) 9031 
15.3.2.4.7 Interleukin-3 receptor alpha subunit binds Interleukin-3 (Reaction) 9033 
15.3.2.4.8 Interleukin-3 receptor alpha: Interleukin-3 binds IL3RB:JAK2 (Reaction) 9034 
15.3.2.4.9 The receptor is activated (BlackBoxEvent) 9036 
15.3.2.4.10 JAK2 is phosphorylated, activated (Reaction) 9038 
15.3.2.4.11 STAT5 is recruited by JAK2 (Reaction) 9041 
15.3.2.4.12 Activation of STAT5a/b by JAK2 (Reaction) 9044 
15.3.2.4.13 p-STAT5 is released from the receptor complex (Reaction) 9045 
15.3.2.4.14 Phosphorylated STAT5 forms dimers (Reaction) 9046 
15.3.2.4.15 STAT5 dimers translocate to the nucleus and bind to specific DNA sequences
9047 (BlackBoxEvent) 
15.3.2.4.16 Tyrosine kinases phosphorylate the receptor (Reaction) 9047 
15.3.2.4.17 Recruitment of SHC1 is mediated by Y593 of the common beta chain 9049 (Reaction) 
15.3.2.4.18 SHC1 bound to the common beta chain becomes tyrosine phosphorylated 9050 (Reaction) 
15.3.2.4.19 Interleukin receptor SHC signaling (Pathway) 9052 
15.3.2.4.19.1 Phosphorylated SHC1 recruits GRB2:GAB2 (BlackBoxEvent) 9052 
15.3.2.4.19.2 SHC1 mediates cytokine-induced phosphorylation of GAB2 9052 (BlackBoxEvent) 
15.3.2.4.19.3 Gab2 binds the p85 subunit of Class 1A PI3 kinases (Reaction) 9052 
15.3.2.4.19.4 Phosphorylated SHC recruits GRB2:SOS1 (Reaction) 9053 
15.3.2.4.19.5 SOS1 activates H-Ras (Reaction) 9053 
15.3.2.4.19.6 Phosphorylated SHC1 recruits SHIP (Reaction) 9053 
15.3.2.4.19.7 The SHC1:SHIP1 complex is stabilized by GRB2 (Reaction) 9053 
15.3.2.4.20 Regulation of signaling by CBL (Pathway) 9054 
15.3.2.4.20.1 CBL, GRB2, FYN and PI3K p85 subunit are constitutively associated 9056 (Reaction) 
15.3.2.4.20.2 CBL is tyrosine phosphorylated (Reaction) 9058 
15.3.2.4.20.3 CBL ubiquitinates PI3K (BlackBoxEvent) 9062 
15.3.2.4.20.4 CBL binds CRK (Reaction) 9064 
15.3.2.4.20.5 CBL:CRKL binds RAPGEF1 (Reaction) 9065 
15.3.2.4.20.6 CBL binds B-cell linker protein (Reaction) 9066 
15.3.2.4.20.7 CBL binds VAV (Reaction) 9068 
15.3.2.4.21 IL3 stimulation induces Vav binding to Tec kinase (Reaction) 9070 
15.3.2.4.22 SHP1 and SHP2 bind the common beta chain (Reaction) 9071 
15.3.2.4.23 SHP1 and SHP2 dephosphorylate Y628 of IL3RB (Reaction) 9073 
15.3.2.4.24 SHP2 can recruit GRB2 (Reaction) 9074 
15.3.2.4.25 IL3RB is phosphorylated on Ser-585 (Reaction) 9076 
15.3.2.4.26 p-S585-IL3RB binds 14-3-3 proteins (Reaction) 9078 
15.3.2.4.27 14-3-3 zeta binding allows recruitment of PI3K (Reaction) 9079 
15.3.2.5 Interleukin-6 signaling (Pathway) 9080 
15.3.2.5.1 JAKs associate with IL6RB (gp130) (Reaction) 9082 
15.3.2.5.2 Interleukin-6 binds to soluble IL-6 receptor (Reaction) 9085 
15.3.2.5.3 IL6:sIL6R binds sgp130 (Reaction) 9086 
15.3.2.5.4 Interleukin-6 binds to IL-6 receptor alpha subunit (Reaction) 9087 
15.3.2.5.5 IL6:sIL6R binds to JAKs:IL6RB (gp130) (Reaction) 9088 
15.3.2.5.6 IL6:IL6RA binds JAKs:IL6RB (gp130) (Reaction) 9090 
15.3.2.5.7 Assembly of a hexameric IL-6 receptor (Reaction) 9091 
15.3.2.5.8 JAK activation (BlackBoxEvent) 9092 
15.3.2.5.9 Phosphorylation of gp130 (BlackBoxEvent) 9094 
15.3.2.5.10 STATs bind gp130 phosphotyrosines (Reaction) 9095 
15.3.2.5.11 Tyrosine phosphorylation of STATs by IL6 receptor (Reaction) 9097 
15.3.2.5.12 Serine phosphorylation of STATs (BlackBoxEvent) 9099 
15.3.2.5.13 Phosphorylated STATs are released (Reaction) 9100 
15.3.2.5.14 Phosphorylated STAT1, STAT3 form dimers (Reaction) 9101 
15.3.2.5.15 STAT1/3 dimers translocate to the nucleus (BlackBoxEvent) 9103 
15.3.2.5.16 SHP2 binds gp130 phosphotyrosine-759 (Reaction) 9104 
15.3.2.5.17 SHP2 is phosphorylated (Reaction) 9107 
15.3.2.5.18 SOCS3 binds gp130 (Reaction) 9108 
15.3.2.5.19 SHP2 binds c-Cbl upon IL-6 stimulation (Reaction) 9110 
15.3.2.6 Interleukin-7 signaling (Pathway) 9112 
15.3.2.6.1 PPBSF is a complex of IL7 and HGFbeta (Reaction) 9116 
15.3.2.6.2 IL7RA associates with JAK1 (Reaction) 9118 
15.3.2.6.3 IL2RG associates with JAK3 (BlackBoxEvent) 9121 15.3.2.6.4 Interleukin-7 binds IL7RA:JAK1 (Reaction) 9121 
15.3.2.6.5 Interleukin-7:IL7RA:JAK1 binds Gc:JAK3 (Reaction) 9122 
15.3.2.6.6 IL7RA is phosphorylated on Y449 (Reaction) 9124 
15.3.2.6.7 p(Y449)-IL7RA mediates STAT5 activation (BlackBoxEvent) 9126 
15.3.2.6.8 p85 binds p(Y449)-IL7RA (Reaction) 9130 
15.3.3 Growth hormone receptor signaling (Pathway) 9134 
15.3.3.1 Growth hormone forms dimers and oligomers (Polymerisation) 9135 
15.3.3.2 Growth hormone receptor binds JAK2 (Reaction) 9136 
15.3.3.3 Growth hormone receptor dimerizes (Reaction) 9138 
15.3.3.4 Growth hormone binds the growth hormone receptor (Reaction) 9139 
15.3.3.5 GH:GHR:JAK2 complex undergoes a conformational change (BlackBoxEvent) 9141 
15.3.3.6 JAK2 phosphorylation (BlackBoxEvent) 9142 
15.3.3.7 JAK2 phosphorylation of IRS-1/2 (Reaction) 9145 
15.3.3.8 JAK2 phosphorylation of GHR (Reaction) 9149 
15.3.3.9 STAT5 association with GHR (Reaction) 9152 
15.3.3.10 STAT5 tyrosine phosphorylation (Reaction) 9154 
15.3.3.11 Phosphorylated STAT5 is released (Reaction) 9156 
15.3.3.12 Phosphorylated STAT5 forms dimers (Reaction) 9157 
15.3.3.13 STAT5 dimers translocate to the nucleus and bind to specific DNA sequences9158 (BlackBoxEvent) 
15.3.3.14 Growth hormone receptor binds Lyn (Reaction) 9158 
15.3.3.15 Lyn activates ERK (BlackBoxEvent) 9161 
15.3.3.16 JAK2 binds STAT1/3 (Reaction) 9162 
15.3.3.17 JAK2 phosphorylates STAT1/STAT3 (Reaction) 9164 
15.3.3.18 SOCS binding to GHR (Reaction) 9166 
15.3.3.19 SOCS binding to JAK2 (Reaction) 9168 
15.3.3.20 PTP1B binds the GH receptor complex (Reaction) 9170 
15.3.3.21 PTP1B dephosphorylates GHR (Reaction) 9172 
15.3.3.22 PTP1B dephosphorylates JAK2 (Reaction) 9173 
15.3.3.23 SHP1 (PTPN6) binds JAK2 in the receptor complex (Reaction) 9174 
15.3.3.24 SHP1 (PTPN6) dephosphorylates JAK2 (Reaction) 9176 
15.3.3.25 Metalloprotease cleavage of GHR (Reaction) 9177 
15.3.3.26 GHBP binds GH (Reaction) 9180 
15.3.3.27 GHBP binds GHR (Reaction) 9181 
15.3.3.28 GHR internalization (BlackBoxEvent) 9183 
15.3.4 Prolactin receptor signaling (Pathway) 9184 
15.3.4.1 PRLR associates with JAK2 (Reaction) 9188 
15.3.4.2 PRLR:JAK2 dimerizes (Reaction) 9192 
15.3.4.3 Prolactin receptor ligands bind the prolactin receptor (Reaction) 9193 
15.3.4.4 PRLR activation (BlackBoxEvent) 9195 
15.3.4.5 SH2B binds JAK2 (Reaction) 9196 
15.3.4.6 JAK2 phosphorylation (BlackBoxEvent) 9197 
15.3.4.7 Tyrosine phosphorylation of PRLR (BlackBoxEvent) 9198 
15.3.4.8 PRLR binds STAT5 (Reaction) 9200 
15.3.4.9 PRLR-bound STAT5 is phosphorylated (Reaction) 9202 
15.3.4.10 PRLR binds SHP2 (PTPN11) (Reaction) 9204 
15.3.4.11 SHP2 is phosphorylated (Reaction) 9205 
15.3.4.12 PRLR is phosphorylated at Ser-349 (BlackBoxEvent) 9208 
15.3.4.13 PRLR binds SCF beta-TrCP complex (Reaction) 9209 
15.3.4.14 Prolactin receptor is internalized (BlackBoxEvent) 9211 16 Membrane Trafficking (Pathway) 9213 
16.1 ER to Golgi Transport (Pathway) 9214 
16.1.1 COPII (Coat Protein 2) Mediated Vesicle Transport (Pathway) 9215 
16.1.1.1 Sar1p Activation And Membrane Binding (Reaction) 9217 
16.1.1.2 Coat Assembly (Reaction) 9218 
16.1.1.3 Loss of Sar1b GTPase (Reaction) 9219 
16.1.1.4 Cargo, Sec31p:Sec13p, and v-SNARE recruitment (Reaction) 9220 
16.1.1.5 Vesicle Budding (Reaction) 9222 
16.1.1.6 Vesicle Uncoating (Reaction) 9223 
16.2 Golgi to ER Retrograde Transport (Pathway) 9224 
16.2.1 COPI Mediated Transport (Pathway) 9225 
16.2.1.1 Arf1 Activation by GBF1 (Reaction) 9226 
16.2.1.2 Coat Complex Formation (Reaction) 9228 
16.2.1.3 GAP Recruitment to the Coatomer:Arf1-GTP Complex (Reaction) 9229 
16.2.1.4 Coatomer:Arf1-GTP:GAP lattice formation on golgi membrane (Polymerisation)9230 
16.2.1.5 Sculpting and pinching-off of Golgi vessicle (Reaction) 9231 
16.2.1.6 Hydrolysis of Arf1-GTP to Arf1-GDP (BlackBoxEvent) 9232 
16.2.1.7 Diffusion of inactive Arf1-GDP from membrane (BlackBoxEvent) 9233 
16.2.1.8 Golgi vesicle lattice disassociation (BlackBoxEvent) 9234 
16.3 trans-Golgi Network Vesicle Budding (Pathway) 9235 
16.3.1 Clathrin derived vesicle budding (Pathway) 9236 
16.3.1.1 trans-Golgi Network Coat Activation (Reaction) 9237 
16.3.1.2 Golgi Associated Vesicle Biogenesis (Pathway) 9239 
16.3.1.2.1 Formation Of Bloc-1 Complex (Reaction) 9239 
16.3.1.2.2 Recruitment Of Cytoplasmic Proteins To Vesicles (Reaction) 9241 
16.3.1.2.3 Vamp And trans-Golgi Network AP-1 Binding Coupled With Cargo Capture 9242 (Reaction) 
16.3.1.2.4 trans-Golgi Network Coat Assembly (Reaction) 9243 
16.3.1.2.5 trans-Golgi Network Derived Vesicle Uncoating (Reaction) 9245 
16.3.1.2.6 trans-Golgi Network Vesicle Scission (Reaction) 9246 
16.3.1.3 Lysosome Vesicle Biogenesis (Pathway) 9248 
16.3.1.3.1 Vamp And trans-Golgi Network AP-1 Binding Coupled With Cargo Capture On
9248 Lysosome Vesicle Destined Golgi Membrane (Reaction) 
16.3.1.3.2 trans-Golgi Network Lysosome Vesicle Destined Membrane Coat Assembly9250 (Reaction) 
16.3.1.3.3 trans-Golgi Network Lysosomal Vesicle Scission (Reaction) 9251 
16.3.1.3.4 trans-Golgi Network Derived Lysosomal Vesicle Uncoating (Reaction) 9253 
16.3.1.4 Vamp2 associated secretory vesicle to plasma membrane transport (Reaction) 9254 
16.3.1.5 Vamp7 associated Lysosome to Plasma membrane transport (Reaction) 9255 
16.3.1.6 Vamp8 associated secretory vesicle to plasma membrane transport (Reaction) 9256 16.4 Gap junction trafficking and regulation (Pathway) 9257 
16.4.1 Gap junction trafficking (Pathway) 9259 
16.4.1.1 Gap junction assembly (Pathway) 9261 
16.4.1.1.1 Connexin synthesis (generic) (BlackBoxEvent) 9263 
16.4.1.1.2 Synthesis of Cx26 (BlackBoxEvent) 9265 
16.4.1.1.3 Synthesis of Cx32 (BlackBoxEvent) 9266 
16.4.1.1.4 Synthesis of Cx43 (BlackBoxEvent) 9267 
16.4.1.1.5 Transport of connexins along the secretory pathway (Pathway) 9268 
16.4.1.1.5.1 Transport of connexins to the ER-Golgi intermediate compartment 9270 (Reaction) 
16.4.1.1.5.2 Transport of connexins to the Trans-Golgi Network (TGN) (Reaction) 9271 
16.4.1.1.6 Oligomerization of connexins into connexons (Pathway) 9272 
16.4.1.1.6.1 Connexin oligomerization in endoplasmic reticulum membrane (Reaction)9274 
16.4.1.1.6.2 Connexin oligomerization in ER-Golgi-Intermediate Compartment 9275 (Reaction) 
16.4.1.1.6.3 Connexin oligomerization in Trans-Golgi Network (TGN) (Reaction) 9277 
16.4.1.1.7 Transport of connexons to the plasma membrane (Pathway) 9278 
16.4.1.1.7.1 Microtubule-independent trafficking of connexons to the plasma membrane
9279 (Reaction) 
16.4.1.1.7.2 Microtubule-dependent trafficking of connexons from Golgi to the plasma9281 membrane (Pathway) 
16.4.1.1.7.2.1 Budding of connexon-containing transport vesicles from the Golgi 9282 (Reaction) 
16.4.1.1.7.2.2 Association of Golgi transport vesicles with microtubules (Reaction) 9283 
16.4.1.1.8 Docking of connexons into junctional, double-membrane spanning channels9284 (Reaction) 
16.4.1.1.9 Insertion of connexons into the plasma membrane resulting in the formation of
9286 hemi-channels (Reaction) 
16.4.1.1.10 Formation of junctional channels (Reaction) 9289 
16.4.1.1.11 Assembly of gap junction plaques (Reaction) 9291 
16.4.1.2 Gap junction degradation (Pathway) 9294 
16.4.1.2.1 Formation of annular gap junctions (Pathway) 9295 
16.4.1.2.1.1 Dab2 is recruited to the junctional plaques (Reaction) 9296 
16.4.1.2.1.2 Dynamin is recruited to the gap junction plaque (Reaction) 9297 
16.4.1.2.2 Internalization of gap junction plaques (Reaction) 9298 
16.4.1.2.3 Lysosomal degradation of gap junction plaques (BlackBoxEvent) 9300 
16.4.2 Regulation of gap junction activity (Pathway) 9301 
16.4.2.1 c-src mediated regulation of Cx43 function and closure of gap junctions (Pathway)
9302 
16.4.2.1.1 Association of Cx43 with TJP1 (Reaction) 9303 
16.4.2.1.2 c-src associates with Cx43 in gap junctions (Reaction) 9304 
16.4.2.1.3 Phosphorylation of Cx43 by c-src (Reaction) 9305 
16.4.2.1.4 Closure of gap junction (Reaction) 9306 
16.5 Endosomal Sorting Complex Required For Transport (ESCRT) (Pathway) 9307 
16.5.1 Cargo Recognition And Sorting (Reaction) 9309 
16.5.2 Cargo Sequestration (Reaction) 9310 
16.5.3 MVB Vesicle Formation (Reaction) 9311 
16.5.4 ESCRT Disassembly (Reaction) 9313 
16.6 Translocation of GLUT4 to the plasma membrane (Pathway) 9314 
16.6.1 RAB4A:GTP binds KIF3 and activates KIF3 (Reaction) 9316 
16.6.2 AKT1,AKT2 phosphorylates AS160 (TBC1D4) (BlackBoxEvent) 9317 
16.6.3 14-3-3 binds p-5S,T642-AS160 (TBC1D4) (Reaction) 9320 
16.6.4 AMPK-alpha2 phosphorylates TBC1D1 (Reaction) 9321 
16.6.5 14-3-3 Binds p-S237-TBC1D1 (Reaction) 9324 
16.6.6 RAB8A,10,13,14 exchange GDP for GTP (Reaction) 9325 
16.6.7 RAB8A,10,13,14 hydrolyze GTP (Reaction) 9327 
16.6.8 AKT2 phosphorylates RGC2 (Reaction) 9328 
16.6.9 RALA exchanges GDP for GTP (Reaction) 9330 
16.6.10 RALA:GTP binds MYO1C:CALM1 and activates MYO1C (Reaction) 9331 
16.6.11 RALA hydrolyzes GTP (Reaction) 9333 
16.6.12 AKT2 phosphorylates Myosin 5A (Reaction) 9335 
16.6.13 Translocation of GLUT4 Vesicle translocates and docks at the plasma membrane9336 (BlackBoxEvent) 
16.6.14 GLUT4 vesicle fuses with the plasma membrane (BlackBoxEvent) 9339 17 Metabolism (Pathway) 9342 
17.1 Metabolism of carbohydrates (Pathway) 9342 
17.1.1 Digestion of dietary carbohydrate (Pathway) 9343 
17.1.1.1 Digestion of linear starch (amylose) by extracellular amylase (Reaction) 9343 
17.1.1.2 Digestion of branched starch (amylopectin) by extracellular amylase (Reaction)9343 
17.1.1.3 Digestion of 1-6 linkages of limit dextrins to yield maltose, maltotriose, longer 9344 maltosides, and glucose (Reaction) 
17.1.1.4 maltotriose + H2O => maltose + D-glucose (maltase-glucoamylase) (Reaction) 9345 
17.1.1.5 maltotriose + H2O => maltose + D-glucose (sucrase-isomaltase) (Reaction) 9345 
17.1.1.6 maltose + H2O => 2 D-glucose (maltase-glucoamylase) (Reaction) 9346 
17.1.1.7 maltose + H2O => 2 D-glucose (sucrase-isomaltase) (Reaction) 9346 
17.1.1.8 lactose + H2O => D-glucose + D-galactose (Reaction) 9347 
17.1.1.9 sucrose + H2O => glucose + fructose (Reaction) 9347 
17.1.1.10 trehalose + H2O => 2 D-glucose (Reaction) 9348 
17.1.2 Hexose transport (Pathway) 9348 
17.1.2.1 Transport (influx) of fructose by GLUT5 (Reaction) 9348 
17.1.2.2 Transport (influx) of glucose, galactose, and sodium ions by SGLT1 (Reaction) 9349 
17.1.2.3 Transport (efflux) of fructose, galactose, and glucose by GLUT2 (Reaction) 9349 
17.1.2.4 Glucose transport (Pathway) 9350 
17.1.2.4.1 GLUT tetramers transport Glc from extracellular region to cytosol (Reaction)9350 
17.1.2.4.2 alpha-D-glucose (cytosol) alpha-D-glucose (extracellular) (Reaction) 9350 
17.1.2.4.3 GLUT1 + ATP GLUT1:ATP (Reaction) 9351 
17.1.2.4.4 GLUT1:ATP GLUT1 + ATP (Reaction) 9351 
17.1.2.4.5 alpha-D-Glucose + ATP => alpha-D-glucose 6-phosphate + ADP (Reaction)9351 
17.1.2.4.6 Regulation of Glucokinase by Glucokinase Regulatory Protein (Pathway) 9352 
17.1.2.4.6.1 glucokinase (GCK1) + glucokinase regulatory protein (GKRP) GCK1:GKRP9352 
complex (Reaction) 
17.1.2.4.6.2 cytosolic GCK1:GKRP complex glucokinase (GCK1) + glucokinase 9352 regulatory protein (GKRP) (Reaction) 
17.1.2.4.6.3 GCK1:GKRP [cytosol] => GCK1:GKRP [nucleoplasm] (Reaction) 9353 
17.1.2.4.6.4 nucleoplasmic GCK1:GKRP complex => glucokinase (GCK1) + glucokinase
9353 regulatory protein (GKRP) (Reaction) 
17.1.2.4.6.5 glucokinase [nucleoplasm] => glucokinase [cytosol] (Reaction) 9354 
17.1.2.4.7 Cytosolic glucose 6-phosphate is exchanged for orthophosphate from the 9354 endoplasmic reticulum lumen by SLC37A4 (Reaction) 
17.1.2.4.8 G6PC hydrolyzes glucose 6-phosphate to form glucose and orthophosphate9355 (liver) (Reaction) 
17.1.2.4.9 G6PC2 hydrolyzes glucose 6-phosphate to form glucose and orthophosphate9355 (islet) (Reaction) 
17.1.2.4.10 G6PC3 hydrolyzes glucose 6-phosphate to form glucose and orthophosphate
9356 (ubiquitous) (Reaction) 
17.1.2.4.11 Efflux of glucose from the endoplasmic reticulum (BlackBoxEvent) 9356 
17.1.3 Glucose metabolism (Pathway) 9357 
17.1.3.1 Glycolysis (Pathway) 9357 
17.1.3.1.1 alpha-D-glucose 6-phosphate D-fructose 6-phosphate (Reaction) 9357 
17.1.3.1.2 Dephosphorylation of phosphoPFKFB1 by PP2A complex (Reaction) 9358 
17.1.3.1.3 D-fructose 6-phosphate + ATP => D-fructose 2,6-bisphosphate + ADP 9358 (Reaction) 
17.1.3.1.4 D-fructose 6-phosphate + ATP => D-fructose 1,6-bisphosphate + ADP 9359 (Reaction) 
17.1.3.1.5 D-fructose 1,6-bisphosphate dihydroxyacetone phosphate + D-glyceraldehyde
9359 3-phosphate (Reaction) 
17.1.3.1.6 dihydroxyacetone phosphate D-glyceraldehyde 3-phosphate (Reaction) 9360 
17.1.3.1.7 D-glyceraldehyde 3-phosphate + orthophosphate + NAD+ 9360 1,3-bisphospho-D-glycerate + NADH + H+ (Reaction) 
17.1.3.1.8 1,3-bisphospho-D-glycerate + ADP 3-phospho-D-glycerate + ADP (Reaction)9361 
17.1.3.1.9 3-Phospho-D-glycerate 2-Phospho-D-glycerate (Reaction) 9361 
17.1.3.1.10 2-Phospho-D-glycerate Phosphoenolpyruvate + H2O (Reaction) 9362 
17.1.3.1.11 phosphoenolpyruvate + ADP => pyruvate + ATP (Reaction) 9362 
17.1.3.2 Gluconeogenesis (Pathway) 9363 
17.1.3.2.1 Pyruvate + CO2 + ATP => ADP + Orthophosphate + Oxaloacetate (Reaction)
9363 
17.1.3.2.2 Oxaloacetate + NADH + H+ (S)-Malate + NAD+ (Reaction) 9363 
17.1.3.2.3 malate [mitochondrial matrix] + orthophosphate [cytosol] malate [cytosol] + 9364 orthophosphate [mitochondrial matrix] (Reaction) 
17.1.3.2.4 malate + NAD+ oxaloacetate + NADH + H+ (Reaction) 9364 
17.1.3.2.5 oxaloacetate + glutamate aspartate + alpha-ketoglutarate [GOT2] (Reaction)9365 
17.1.3.2.6 malate [mitochondrial matrix] + alpha-ketoglutarate [cytosol] malate [cytosol] +
9365 alpha-ketoglutarate [mitochondrial matrix] (Reaction) 
17.1.3.2.7 aspartate [mitochondrial matrix] + glutamate [cytosol] => aspartate [cytosol] +9366 glutamate [mitochondrial matrix] (Reaction) 
17.1.3.2.8 aspartate + alpha-ketoglutarate oxaloacetate + glutamate [GOT1] (Reaction)9366 
17.1.3.2.9 oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [cytosol] (Reaction) 
17.1.3.2.10 oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [mitochondrial9367 matrix] (Reaction) 
17.1.3.2.11 phosphoenolpyruvate [mitochondrial matrix] + citrate [cytosol] => 9368 phosphoenolpyruvate [cytosol] + citrate [mitochondrial matrix] (Reaction) 
17.1.3.2.12 Phosphoenolpyruvate + H2O 2-Phospho-D-glycerate (Reaction) 9368 
17.1.3.2.13 2-Phospho-D-glycerate 3-Phospho-D-glycerate (Reaction) 9369 
17.1.3.2.14 ATP + 3-Phospho-D-glycerate ADP + 1,3-bisphospho-D-glycerate (Reaction)9369 
17.1.3.2.15 1,3-bisphospho-D-glycerate + NADH + H+ D-glyceraldehyde 3-phosphate +9370 Orthophosphate + NAD+ (Reaction) 
17.1.3.2.16 D-glyceraldehyde 3-phosphate dihydroxyacetone phosphate (Reaction) 9370 
17.1.3.2.17 dihydroxyacetone phosphate + D-glyceraldehyde 3-phosphate D-fructose 9371 1,6-bisphosphate (Reaction) 
17.1.3.2.18 D-fructose 1,6-bisphosphate + H2O => D-fructose 6-phosphate + 9371 orthophosphate (Reaction) 
17.1.3.2.19 Phosphorylation of PF2K-Pase by PKA catalytic subunit (Reaction) 9372 
17.1.3.2.20 Fructose 2,6-bisphosphate is hydrolyzed to form fructose-6-phosphate and9372 orthophosphate (Reaction) 
17.1.3.2.21 D-fructose 6-phosphate alpha-D-Glucose 6-phosphate (Reaction) 9373 
17.1.3.3 Glycogen synthesis (Pathway) 9373 
17.1.3.3.1 alpha-D-Glucose 6-phosphate D-Glucose 1-phosphate (Reaction) 9373 
17.1.3.3.2 UTP + D-glucose 1-phosphate pyrophosphate + UDP-glucose (Reaction) 9374 
17.1.3.3.3 Autoglucosylation of GYG1 complexed with GYS1-a (Reaction) 9374 
17.1.3.3.4 Autoglucosylation of GYG1 complexed with GYS1-b (Reaction) 9375 
17.1.3.3.5 Autoglucosylation of GYG2 complexed with GYS2-a (Reaction) 9375 
17.1.3.3.6 Autoglucosylation of GYG2 complexed with GYS2-b (Reaction) 9375 
17.1.3.3.7 GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1 (Reaction) 9376 
17.1.3.3.8 Phosphorylated GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1 9376 (Reaction) 
17.1.3.3.9 GYS2 catalyzes the polyglucosylation of oligoGlc-GYG2 (Reaction) 9376 
17.1.3.3.10 GBE1 catalyzes branch formation in polyGlc-GYG1 complexed with GYS1-a9377 (Reaction) 
17.1.3.3.11 GBE1 catalyzes branch formation in polyGlc-GYG1 complexed with GYS1-b9377 (Reaction) 
17.1.3.3.12 GBE1 catalyzes branch formation in polyGlc-GYG2 complexed with GYS2-a9378 (Reaction) 
17.1.3.3.13 PPP1R3C binds to glycogen:GYG1:GYS1 (Reaction) 9378 
17.1.3.3.14 PPP1R3C binds to glycogen:GYG2:GYS2 (Reaction) 9378 
17.1.3.3.15 GYS1 catalyzes the incorporation of phosphoglucose into glycogen-GYG1 9379 (Reaction) 
17.1.3.3.16 GYS2 catalyzes the incorporation of phosphoglucose into glycogen-GYG2 9379 (Reaction) 
17.1.3.3.17 EPM2A binds PPP1R3C:phosphoglycogen-GYG1 complex (Reaction) 9379 
17.1.3.3.18 EPM2A binds PPP1R3C:phosphoglycogen-GYG2 complex (Reaction) 9380 
17.1.3.3.19 EPM2A dephosphorylates phosphoglycogen-GYG1 (Reaction) 93679380 17.1.3.3.20 EPM2A dephosphorylates phosphoglycogen-GYG2 (Reaction) 9380 
17.1.3.3.21 NHLRC1 mediated ubiquitination of EPM2A and PPP1RC3 associated with9381 glycogen-GYG1 (BlackBoxEvent) 
17.1.3.3.22 NHLRC1 mediated ubiquitination of EPM2A (laforin) and PPP1RC3 (PTG) 9381 associated with glycogen-GYG2 (BlackBoxEvent) 
17.1.3.4 Glycogen breakdown (glycogenolysis) (Pathway) 9382 
17.1.3.4.1 glycogen phosphorylase (PYGB) dimer b + 2 ATP => glycogen phosphorylase
9382 (PYGB) dimer a + 2 ADP (Reaction) 
17.1.3.4.2 glycogen phosphorylase (PYGM) dimer b + 2 ATP => glycogen phosphorylase
9382 (PYGM) dimer a + 2 ADP (Reaction) 
17.1.3.4.3 glycogen phosphorylase (PYGL) dimer b + 2 ATP => glycogen phosphorylase
9383 (PYGL) dimer a + 2 ADP (Reaction) 
17.1.3.4.4 PGYB dimer, b form + 2 AMP PGYB b dimer:AMP complex (Reaction) 9383 
17.1.3.4.5 PGYB b dimer:AMP complex PGYB dimer, b form + 2 AMP (Reaction) 9384 
17.1.3.4.6 PGYM dimer, b form + 2 AMP PGYM b dimer:AMP complex (Reaction) 9384 
17.1.3.4.7 PGYM b dimer:AMP complex PGYM dimer, b form + 2 AMP (Reaction) 9385 
17.1.3.4.8 glycogen-glycogenin-1 + n orthophosphate => limit dextrin-glycogenin-1 + n9385 D-glucose 1-phosphate [PYGM,PYGB] (Reaction) 
17.1.3.4.9 glycogen-glycogenin-2 + n orthophosphate => limit dextrin-glycogenin-2 + n9386 D-glucose 1-phosphate [PYGL] (Reaction) 
17.1.3.4.10 limit dextrin-glycogenin => ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl) 9386 glycogenin (Reaction) 
17.1.3.4.11 ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => 9387 poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose (Reaction) 
17.1.3.4.12 poly((1,4)-alpha-glycosyl) glycogenin-1 + n orthophosphate => glycogenin-1 +
9387 n D-glucose 1-phosphate [PYGM,PYGB] (Reaction) 
17.1.3.4.13 poly((1,4)-alpha-glucosyl) glycogenin-2 + n orthophosphate => glycogenin-2 +
9388 n D-glucose 1-phosphate [PYGL] (Reaction) 
17.1.3.4.14 D-Glucose 1-phosphate alpha-D-Glucose 6-phosphate (Reaction) 9388 
17.1.4 Fructose catabolism (Pathway) 9389 
17.1.4.1 ATP + beta-D-fructose => ADP + D-fructose 1-phosphate (Reaction) 9389 
17.1.4.2 D-fructose 1-phosphate D-glyceraldehyde + dihydroxyacetone phosphate 9389 (Reaction) 
17.1.4.3 ATP + D-glyceraldehyde => ADP + D-glyceraldehyde 3-phosphate (Reaction) 9390 
17.1.5 Galactose catabolism (Pathway) 9390 
17.1.5.1 ATP + D-galactose => ADP + D-galactose 1-phosphate (Reaction) 9390 
17.1.5.2 D-galactose 1-phosphate + UDP-glucose D-glucose 1-phosphate + 9391 UDP-galactose (Reaction) 
17.1.5.3 D-Glucose 1-phosphate alpha-D-Glucose 6-phosphate (Reaction) 9391 
17.1.5.4 UDP-galactose UDP-glucose (Reaction) 9391 
17.1.6 Pentose phosphate pathway (hexose monophosphate shunt) (Pathway) 9392 
17.1.6.1 alpha-D-glucose 6-phosphate + NADP+ => D-glucono-1,5-lactone 6-phosphate +
9392 NADPH + H+ (Reaction) 
17.1.6.2 D-glucono-1,5-lactone 6-phosphate + H2O => 6-phospho-D-gluconate (Reaction)9392 
17.1.6.3 6-phospho-D-gluconate + NADP+ => D-ribulose 5-phosphate + CO2 + NADPH + 
H+ (Reaction) 
17.1.6.4 D-ribulose 5-phosphate xylulose 5-phosphate (Reaction) 9393 
17.1.6.5 xylulose 5-phosphate D-ribulose 5-phosphate (Reaction) 9394 
17.1.6.6 ribose 5-phosphate + xylulose 5-phosphate sedoheptulose 7-phosphate + 9394 D-glyceraldehyde 3-phosphate (Reaction) 
17.1.6.7 D-glyceraldehyde 3-phosphate + sedoheptulose 7-phosphate xylulose 9395 5-phosphate+ribose 5-phosphate (Reaction) 
17.1.6.8 sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate D-erythrose 9395 4-phosphate + D-fructose 6-phosphate (Reaction) 
17.1.6.9 D-fructose 6-phosphate + D-erythrose 4-phosphate sedoheptulose 7-phosphate +
9396 D-glyceraldehyde 3-phosphate (Reaction) 
17.1.6.10 xylulose 5-phosphate + D-erythrose 4-phosphate D-glyceraldehyde 3-phosphate9396 
+ D-fructose 6-phosphate (Reaction) 
17.1.6.11 D-glyceraldehyde 3-phosphate + D-fructose 6-phosphate xylulose 5-phosphate +
9397 D-erythrose 4-phosphate (Reaction) 
17.1.6.12 D-ribulose 5-phosphate ribose 5-phosphate (Reaction) 9397 
17.1.6.13 ribose 5-phosphate D-ribulose 5-phosphate (Reaction) 9398 
17.1.7 5-Phosphoribose 1-diphosphate biosynthesis (Pathway) 9398 
17.1.7.1 D-ribose 5-phosphate + 2'-deoxyadenosine 5'-triphosphate (dATP) => 9398 5-Phospho-alpha-D-ribose 1-diphosphate (PRPP) + 2'-deoxyadenosine 5'-monophosphate (Reaction) 
17.1.7.2 D-ribose 5-phosphate + ATP => 5-phospho-alpha-D-ribose 1-diphosphate (PRPP)9399 
+ adenosine 5'-monophosphate (Reaction) 
17.1.8 Glycosaminoglycan metabolism (Pathway) 9399 
17.1.8.1 Hyaluronan metabolism (Pathway) 9399 
17.1.8.1.1 Hyaluronan biosynthesis and export (Pathway) 9400 
17.1.8.1.1.1 HAS1,2,3 mediate the polymerisation of HA (Polymerisation) 9400 
17.1.8.1.1.2 Growing HA is extruded from the cell by ABCC5 (Reaction) 9400 
17.1.8.1.2 Hyaluronan uptake and degradation (Pathway) 9401 
17.1.8.1.2.1 Receptor-mediated uptake of HA (Reaction) 9401 
17.1.8.1.2.2 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+ (Reaction) 9401 
17.1.8.1.2.3 Hyaluronidase 2 (HYAL2) hydrolyses HA into 20kDa fragments 9402 (BlackBoxEvent) 
17.1.8.1.2.4 20kDa HA fragments are translocated to lysosomes (BlackBoxEvent) 9402 
17.1.8.1.2.5 Hyaluronidase 1 (HYAL1) hydrolyses HA from 20kDa to 800Da fragments9402 (BlackBoxEvent) 
17.1.8.1.2.6 Beta-glucuronidase (GUSB) hydrolyses glucuronate from HA 9403 tetrasaccharides (Reaction) 
17.1.8.1.2.7 HEXA,B cleave the terminal GalNAc from small HA fragments (Reaction)9403 
17.1.8.1.2.8 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the HA 9404 disaccharides (Reaction) 
17.1.8.1.2.9 The single sugars GlcA and GlcNAc translocate from the lysosome to the9404 cytosol (BlackBoxEvent) 
17.1.8.2 Transport and synthesis of PAPS (Pathway) 9405 
17.1.8.2.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 93939405 17.1.8.2.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 9405 
17.1.8.2.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS (Reaction)9406 
17.1.8.2.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 9407 
17.1.8.3 Keratan sulfate/keratin metabolism (Pathway) 9408 
17.1.8.3.1 Keratan sulfate biosynthesis (Pathway) 9408 
17.1.8.3.1.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 9408 
17.1.8.3.1.2 B4GALTs add galactose to the N-glycan precursor (Reaction) 9409 
17.1.8.3.1.3 B3GNT1,2,3,4,7 add GlcNAc to form Keratan-PG (Reaction) 9409 
17.1.8.3.1.4 B4GALTs add another galactose to the chain (Reaction) 9410 
17.1.8.3.1.5 B4GALTs can add galactose to a branch of keratan (Reaction) 9410 
17.1.8.3.1.6 The keratan chain can be capped by N-acetylneuraminic acid (Reaction) 9411 
17.1.8.3.1.7 Sulfation of GlcNAc residues on Keratan-PG forms KSPG (Reaction) 9411 
17.1.8.3.1.8 Further sulfation on galactose residues produces KSPG (Reaction) 9412 
17.1.8.3.1.9 KSPG is secreted from the cell (BlackBoxEvent) 9412 
17.1.8.3.2 Keratan sulfate degradation (Pathway) 9413 
17.1.8.3.2.1 Extracellular KSPG translocates to the lysosome for degradation 9413 (BlackBoxEvent) 
17.1.8.3.2.2 Keratan sulfate is cleaved from its proteoglycan by an unknown 9413 galactosidase (BlackBoxEvent) 
17.1.8.3.2.3 N-acetylgalactosamine-6-sulfatase (GALNS) hydrolyses the sulfate groups
9414 of galactose 6-sulfate units of keratan sulfate (Reaction) 
17.1.8.3.2.4 Beta-galactosidase (GLB1) can cleave galactose from a glycosaminoglycan
9414 (Reaction) 
17.1.8.3.2.5 N-acetylglucosamine 6-sulfatase (GNS) hydrolyses 6-sulfate groups of the9415 N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate (Reaction) 
17.1.8.3.2.6 HEXA,B cleave the terminal GalNAc from keratan sulfate (Reaction) 9415 
17.1.8.4 Heparan sulfate/heparin (HS-GAG) metabolism (Pathway) 9416 
17.1.8.4.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway) 9416 
17.1.8.4.1.1 GXYLTs transfer Xyl to core protein (Reaction) 9416 
17.1.8.4.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 9417 
17.1.8.4.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 9417 
17.1.8.4.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 9418 
17.1.8.4.2 HS-GAG biosynthesis (Pathway) 9418 
17.1.8.4.2.1 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 9418 
17.1.8.4.2.2 The addition of GlcNAc to the terminal glucuronate residue creates heparan
9419 (Reaction) 
17.1.8.4.2.3 Glucuronate is added to the heparan chain (Reaction) 9419 
17.1.8.4.2.4 Another GlcNAc addition extends the heparan chain (Reaction) 9420 
17.1.8.4.2.5 Another GlcA addition extends the heparan chain (Reaction) 9420 
17.1.8.4.2.6 NDST1-4 N-deacetylates GlcNAc residues in heparan (Reaction) 9421 
17.1.8.4.2.7 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan 9421 sulfate (HS) (Reaction) 
17.1.8.4.2.8 GLCE epimerises GlcA to IdoA (Reaction) 9422 
17.1.8.4.2.9 HS2ST1 sulfates IdoA at C2 in heparan sulfate (Reaction) 9422 
17.1.8.4.2.10 HS3STs sulfate GlcN at C3 in heparan sulfate (Reaction) 9423 17.1.8.4.2.11 HS3ST1 sulfates GlcN at C3 in heparan sulfate (Reaction) 9423 
17.1.8.4.2.12 GLCE epimerises more GlcA to IdoA as sulfate content rises (Reaction)9424 
17.1.8.4.2.13 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin (Reaction) 9424 
17.1.8.4.2.14 Some HSPGs are secreted to the plasma membrane (BlackBoxEvent) 9425 
17.1.8.4.3 HS-GAG degradation (Pathway) 9425 
17.1.8.4.3.1 HS-GAGs translocate to the lysosome for degradation (BlackBoxEvent) 9426 
17.1.8.4.3.2 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan 9426 (lysosome) (Reaction) 
17.1.8.4.3.3 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan 9427 (plasma membrane) (Reaction) 
17.1.8.4.3.4 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated alpha-L-iduronosidic 
9427 linkage in heparan sulfate (Reaction) 
17.1.8.4.3.5 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses sulfate from the 9428 
N-sulphoglucosamine residue of heparan sulfate (Reaction)  
17.1.8.4.3.6 HGSNAT acetylates the terminal N-glucosamine in heparan sulfate  9428  
(Reaction)  
17.1.8.4.3.7 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses  9429  
N-acetyl-D-glucosamine residues from heparan sulfate (Reaction)  

17.1.8.4.3.8 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate 9429 units of heparan sulfate (Reaction) 
17.1.8.4.3.9 Alpha-L-iduronidase (IDUA) hydrolyses another unsulfated 9430 alpha-L-iduronosidic linkage in heparan sulfate (Reaction) 
17.1.8.4.3.10 N-sulphoglucosamine sulphohydrolase (SGSH) hydrolyses another sulfate 
9430 from the N-sulphoglucosamine residue of heparan sulfate (Reaction) 
17.1.8.4.3.11 HGSNAT acetylates another terminal N-glucosamine in heparan 9431 (Reaction) 
17.1.8.4.3.12 Alpha-N-acetylglucosaminidase (NAGLU) hydrolyses another 9431 N-acetyl-D-glucosamine residue from heparan (Reaction) 
17.1.8.4.3.13 Beta-glucuronidase (GUSB) hydrolyses glucuronate from the linker chain 9432 (Reaction) 
17.1.8.4.3.14 Beta-galactosidase (GLB1) can cleave galactose from the linker chain 9432 (Reaction) 
17.1.8.5 Chondroitin sulfate/dermatan sulfate metabolism (Pathway) 9433 
17.1.8.5.1 A tetrasaccharide linker sequence is required for GAG synthesis (Pathway) 9433 
17.1.8.5.1.1 GXYLTs transfer Xyl to core protein (Reaction) 9433 
17.1.8.5.1.2 B4GALT7 transfers Gal group to tetrasaccharide linker (Reaction) 9433 
17.1.8.5.1.3 B3GALT6 transfers Gal to the tetrasaccharide linker (Reaction) 9434 
17.1.8.5.1.4 B3GATs transfer GlcA to tetrasaccharide linker (Reaction) 9434 
17.1.8.5.2 Chondroitin sulfate biosynthesis (Pathway) 9434 
17.1.8.5.2.1 The addition of GalNAc to the terminal glucuronate residue forms 9434 chondroitin (Reaction) 
17.1.8.5.2.2 A glucuronate moiety is added to chondroitin (Reaction) 9435 
17.1.8.5.2.3 GalNAc is added to chondroitin (Reaction) 9435 
17.1.8.5.2.4 Chondroitin can be sulfated on position 4 of GalNAc by CHST9, 11, 12 and 
9436 13 (Reaction) 
17.1.8.5.2.5 Chondroitin 4-sulfate (C4S) can be further sulfated on position 6 by 9436 CHST15 (Reaction) 
17.1.8.5.2.6 Chondroitin can be sulfated on position 6 of GalNAc by CHST3,7 (Reaction)9437 
17.1.8.5.2.7 CSPG is secreted (BlackBoxEvent) 9437 
17.1.8.5.3 Dermatan sulfate biosynthesis (Pathway) 9438 
17.1.8.5.3.1 Dermatan-sulfate epimerase (DSE) converts chondroitin sulfate (CS) to 9438 dermatan sulfate (DS) (Reaction) 
17.1.8.5.3.2 Dermatan sulfate can be further sulfated on position 2 of iduronate 9438 (Reaction) 
17.1.8.5.3.3 CHST14 transfers SO4(2-) to DS (Reaction) 9439 
17.1.8.5.3.4 DSPGs are secreted (BlackBoxEvent) 9439 
17.1.8.5.4 CS/DS degradation (Pathway) 9440 
17.1.8.5.4.1 DSPG and CSPG translocate to the lysosome for degradation 9440 (BlackBoxEvent) 
17.1.8.5.4.2 DS is cleaved from its proteoglycan (BlackBoxEvent) 9440 
17.1.8.5.4.3 CS is cleaved from its proteoglycan (BlackBoxEvent) 9441 
17.1.8.5.4.4 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate9441 units of DS (Reaction) 
17.1.8.5.4.5 Iduronate 2-sulfatase (IDS) hydrolyses sulfates from L-iduronate 2-sulfate9442 units of dermatan sulfate (Reaction) 
17.1.8.5.4.6 HEXA,B cleaves the terminal GalNAc from DS (Reaction) 9442 
17.1.8.5.4.7 Alpha-L-iduronidase (IDUA) hydrolyses the unsulfated alpha-L-iduronosidic
9443 linkage in DS (Reaction) 
17.1.8.5.4.8 Arylsulfatase B (ARSB) hydrolyses sulfate groups from GalNAc 4-sulfate9443 units of CS (Reaction) 
17.1.8.5.4.9 Hyaluronidase 1 (HYAL1) hydrolyses 1-4 linkages between GalNAc and 9444 D-glucuronate residues in CS. (Reaction) 
17.2 Inositol phosphate metabolism (Pathway) 9444 
17.2.1 Synthesis of IP3 and IP4 in the cytosol (Pathway) 9446 
17.2.1.1 PI(4,5)P2 is hydrolysed to I(1,4,5)P3 and DAG by cytosolic PLC[2] at the plasma9447 membrane (Reaction) 
17.2.1.2 PI(4,5)P2 is hydrolysed to I(1,4,5)P3 and DAG by tethered PLC[1] at the plasma9449 membrane (Reaction) 
17.2.1.3 PI(4,5)P2 is hydrolysed to I(1,4,5)P3 and DAG by PLCD4 at the ER membrane9451 (Reaction) 
17.2.1.4 I(1,4,5)P3 is phosphorylated to I(1,3,4,5)P4 by ITPKA/B/C in the cytosol 9452 (Reaction) 
17.2.1.5 I(1,3,4,5)P4 is dephosphorylated to I(1,4,5)P3 by PTEN in the cytosol (Reaction)9453 
17.2.1.6 I(1,3,4,5)P4 is dephosphorylated to I(1,3,4)P3 by INPP5[3]/ITPK1 in the cytosol9454 (Reaction) 
17.2.1.7 I(1,3,4,5)P4 is dephosphorylated to I(1,3,4)P3 by INPP5B at the plasma 9456 membrane (Reaction) 
17.2.1.8 I(1,3,4)P3 is phosphorylated to I(1,3,4,5)P4 by ITPK1 in the cytosol (Reaction) 9458 
17.2.1.9 I(1,3,4)P3 is phosphorylated to I(1,3,4,6)P4 by ITPK1 in the cytosol (Reaction) 9459 
17.2.1.10 I(1,3,4,6)P4 is dephosphorylated to I(1,3,4)P3 by ITPK1 in the cytosol (Reaction)17.2.1.11 I(1,3,4,6)P4 is dephosphorylated to I(3,4,6)P3 by ITPK1 in the cytosol (Reaction)
9461 
17.2.1.12 I(3,4,6)P3 is phosphorylated to I(1,3,4,6)P4 by ITPK1 in the cytosol (Reaction)9462 
17.2.2 IP3 and IP4 transport between cytosol and nucleus (Pathway) 9463 
17.2.2.1 I(1,4,5)P3 transports from the cytosol to the nucleus (Reaction) 9464 
17.2.2.2 I(1,3,4,5)P4 transports from the cytosol to the nucleus (Reaction) 9465 
17.2.2.3 I(1,3,4,6)P4 transports from the cytosol to the nucleus (Reaction) 9466 
17.2.3 Synthesis of IPs in the nucleus (Pathway) 9467 
17.2.3.1 I(1,4,5)P3 is phosphorylated to I(1,3,4,5)P4 by IPMK in the nucleus (Reaction) 9469 
17.2.3.2 I(1,3,4,5)P4 is phosphorylated to I(1,3,4,5,6)P5 by IPMK in the nucleus (Reaction)
9470 
17.2.3.3 I(1,3,4,6)P4 is phosphorylated to I(1,3,4,5,6)P5 by IPMK in the nucleus (Reaction)
9471 
17.2.3.4 I(1,4,5,6)P4 is phosphorylated to I(1,3,4,5,6)P5 by IPMK in the nucleus (Reaction)
9473 
17.2.3.5 I(1,3,4,5,6)P5 is phosphorylated to IP6 by IPPK (IP5-2K) in the nucleus (Reaction)
9474 
17.2.3.6 I(1,3,4,5,6)P5 is phosphorylated to 5-PP-IP4 by IP6K1/2 in the nucleus (Reaction)
9476 
17.2.3.7 5-PP-IP4 is phosphorylated to 1,5-(PP)2-IP3 by IP6K1/2 in the nucleus (Reaction)
9477 
17.2.3.8 IP6 is phosphorylated to 5-PP-IP5 by IP6K1/2 in the nucleus (Reaction) 9479 
17.2.3.9 5-PP-IP5 is phosphorylated to 5-PPP-IP5 by IP6K1/2 in the nucleus (Reaction) 9480 
17.2.3.10 1-PP-IP5 is phosphorylated to 1,5-(PP)2-IP4 by IP6K1/2 in the nucleus 9481 (Reaction) 
17.2.4 IPs transport between nucleus and cytosol (Pathway) 9483 
17.2.4.1 I(1,3,4,5,6)P5 transports from the nucleus to the cytosol (Reaction) 9484 
17.2.4.2 5-PP-IP4 transports from the nucleus to the cytosol (Reaction) 9486 
17.2.4.3 5-PP-IP5 transports from the nucleus to the cytosol (Reaction) 9487 
17.2.4.4 (PP)2-IP4 transports from the nucleus to the cytosol (Reaction) 9488 
17.2.5 Synthesis of pyrophosphates in the cytosol (Pathway) 9489 
17.2.5.1 I(1,3,4,5,6)P5 is dephosphorylated to I(3,4,5,6)P4 by ITPK1 in the cytosol 9491 (Reaction) 
17.2.5.2 I(3,4,5,6)P4 is phosphorylated to I(1,3,4,5,6)P5 by ITPK1 in the cytosol (Reaction)9492 
17.2.5.3 I(1,3,4,5,6)P5 is phosphorylated to IP6 by IPPK in the cytosol (Reaction) 9493 
17.2.5.4 I(1,3,4,5,6)P5 is phosphorylated to 5-PP-IP4 by IP6K1/3 in the cytosol (Reaction)
9495 
17.2.5.5 PP-IP4 is dephosphorylated to I(1,3,4,5,6)P5 by NUDT4 in the cytosol (Reaction)
9497 
17.2.5.6 1-PP-IP4 is phosphorylated to 1,5-(PP)2-IP3 by IP6K1/3 in the cytosol (Reaction)
9498 
17.2.5.7 IP6 is phosphorylated to 5-PP-IP5 by IP6K1/3 in the cytosol (Reaction) 9500 
17.2.5.8 5-PP-IP5 is dephosphorylated to IP6 by NUDT(1) in the cytosol (Reaction) 9501 
17.2.5.9 IP6 is phosphorylated to 1-PP-IP5 by PPIP5K1/2 in the cytosol (Reaction) 9503 
17.2.5.10 1/3 PP-IP5 is dephosphorylated to IP6 by NUDT(1) in the cytosol (Reaction) 9505 
17.2.5.11 5-PP-IP5 is phosphorylated to 5-PPP-IP5 by IP6K1/3 in the cytosol (Reaction)9507 
17.2.5.12 5-PP-IP5 is phosphorylated to 1,5-(PP)2-IP4 by PPIP5K1/2 in the cytosol 9508 (Reaction) 
17.2.5.13 (PP)2-IP4 is dephosphorylated to 5-PP-IP5 by NUDT(1) in the cytosol (Reaction)9510 
17.2.5.14 1-PP-IP5 is phosphorylated to 1,5-(PP)2-IP4 by IP6K1/3 in the cytosol 9511 (Reaction) 
17.2.5.15 (PP)2-IP4 is dephosphorylated to 1/3-PP-IP5 by NUDT(1) in the cytosol 9513 (Reaction) 
17.2.6 IP6 and IP7 transport between cytosol and nucleus (Pathway) 9515 
17.2.6.1 IP6 transports from the cytosol to the nucleus (Reaction) 
17.2.6.2 1/3-PP-IP5 transports from the cytosol to the nucleus (Reaction) 9517 
17.2.7 IPs transport between cytosol and ER lumen (Pathway) 9518 
17.2.7.1 I(1,3,4,5)P4 transports from the cytosol to the ER lumen (Reaction) 9519 
17.2.7.2 I(1,3,4,5,6)P5 transports from the cytosol to the ER lumen (Reaction) 9520 
17.2.7.3 IP6 transports from the cytosol to the ER lumen (Reaction) 9522 
17.2.8 Synthesis of IPs in the ER lumen (Pathway) 9523 
17.2.8.1 I(1,3,4,5)P4 is dephosphorylated to I(1,4,5)P3 by MINPP1 in the ER lumen 9524 (Reaction) 
17.2.8.2 I(1,3,4,5,6)P5 is dephosphorylated to I(1,4,5,6)P4 by MINPP1 in the ER lumen 9526 (Reaction) 
17.2.8.3 IP6 is dephosphorylated to I(1,2,4,5,6)P5 by MINPP1 in the ER lumen (Reaction)9527 
17.2.9 IPs transport between ER lumen and cytosol (Pathway) 9529 
17.2.9.1 I(1,4,5)P3 transports from the ER lumen to the cytosol (Reaction) 9530 
17.2.9.2 I(1,3,4,5,6)P5 transports from the ER lumen to the cytosol (Reaction) 9531 
17.2.10 IPs transport between ER lumen and nucleus (Pathway) 9533 
17.2.10.1 I(1,4,5,6)P4 transports from the ER lumen to the nucleus (Reaction) 9534 
17.2.10.2 I(1,3,4,5,6)P5 transports from the ER lumen to the nucleus (Reaction) 9535 
17.2.11 IPs transport between nucleus and ER lumen (Pathway) 9537 
17.2.11.1 IP6 transports from the nucleus to the ER lumen (Reaction) 9538 
17.2.12 Synthesis of IP2, IP, and Ins in the cytosol (Pathway) 9539 
17.2.12.1 I(1,4,5)P3 is dephosphorylated to I(1,4)P2 by INPP5(4) in the cytosol (Reaction)
9540 
17.2.12.2 I(1,4,5)P3 is dephosphorylated to I(1,4)P2 by INPP5A/B at the plasma 9542 membrane (Reaction) 
17.2.12.3 I(1,4)P2 is dephosphorylated to I4P by INPP1 in the cytosol (Reaction) 9544 
17.2.12.4 I4P is dephosphorylated to Ins by IMPA1/2 in the cytosol (Reaction) 9545 
17.2.12.5 I1P is dephosphorylated to Ins by IMPA1/2 in the cytosol (Reaction) 9546 
17.2.12.6 I(1,3,4)P3 is dephosphorylated to I(1,3)P2 by INPP4A/B in the cytosol (Reaction)9548 
17.2.12.7 I(1,3,4)P3 is dephosphorylated to I(3,4)P2 by INPP1 in the cytosol (Reaction) 9549 
17.2.12.8 I(3,4)P2 is dephosphorylated to I3P by INPP4A/B in the cytosol (Reaction) 9550 
17.2.12.9 Glc6P is isomerised to I3P by ISYNA1 in the cytosol (Reaction) 9552 
17.2.12.10 I3P is dephosphorylated to Ins by IMPA1/2 in the cytosol (Reaction) 9553 
17.3 Metabolism of lipids and lipoproteins (Pathway) 9554 
17.3.1 Lipid digestion, mobilization, and transport (Pathway) 9555 
17.3.1.1 Digestion of dietary lipid (Pathway) 9556 
17.3.1.1.1 Digestion of cholesterol esters by extracellular CEL (bile salt-dependent lipase)
9557 (Reaction) 
17.3.1.1.2 Digestion of monoacylglycerols by extracellular CEL (bile salt-dependent 9558 lipase) (Reaction) 
17.3.1.1.3 Digestion of diacylglycerols by extracellular PTL:colipase (Reaction) 9560 
17.3.1.1.4 Digestion of triacylglycerols by extracellular CEL (bile salt-dependent lipase)9561 (Reaction) 
17.3.1.1.5 Digestion of triacylglycerols by extracellular PTL:colipase (Reaction) 9562 
17.3.1.1.6 Digestion of triacylglycerols by extracellular pancreatic lipase-related protein 2
9563 (Reaction) 
17.3.1.1.7 PNLIP:CLPS hydrolyses RPALM to atROL and PALM (Reaction) 
17.3.1.2 Trafficking of dietary sterols (Pathway) 9566 
17.3.1.2.1 NPC1L1-mediated cholesterol uptake (Reaction) 9567 
17.3.1.2.2 NPC1L1-mediated phytosterol uptake (Reaction) 9569 
17.3.1.2.3 NPC1L1 inactivation by ezetimibe (Reaction) 9572 
17.3.1.2.4 ABCG5:ABCG8-mediated export of cholesterol and phytosterols (Reaction) 9573 
17.3.1.3 Lipoprotein metabolism (Pathway) 9575 
17.3.1.3.1 Chylomicron-mediated lipid transport (Pathway) 9575 
17.3.1.3.1.1 ApoB-48 + 40 triacylglycerol + 60 phospholipid => ApoB-48:TG:PL complex 
9577 (Reaction) 
17.3.1.3.1.2 Degradation of newly synthesized ApoB-48 (BlackBoxEvent) 9578 
17.3.1.3.1.3 ApoB-48:TG:PL complex + 100 triacylglycerols + ApoA-I + ApoA-IV => 9579 nascent chylomicron (Reaction) 
17.3.1.3.1.4 nascent chylomicron [endoplasmic reticulum lumen] => nascent 9581 chylomicron [extracellular] (Reaction) 
17.3.1.3.1.5 nascent chylomicron + spherical HDL:apoC-II:apoC-III:apoE =>spherical 9582 HDL + chylomicron (Reaction) 
17.3.1.3.1.6 chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 9584 diacylglycerols (Reaction) 
17.3.1.3.1.7 TG-depleted chylomicron + spherical HDL => chylomicron remnant + 9586 spherical HDL:apoA-I:apoA-II:apoA-IV:apoC-II:apoC-III (Reaction) 
17.3.1.3.1.8 chylomicron remnant + apoE => chylomicron remnant:apoE complex 9587 (Reaction) 
17.3.1.3.1.9 chylomicron remnant:apoE complex + LDLR => chylomicron 9588 remnant:apoE:LDLR complex (Reaction) 
17.3.1.3.1.10 chylomicron remnant:apoE:LDLR complex [plasma membrane] => 9590 chylomicron remnant:apoE:LDLR complex [clathrin-coated vesicle] (LDLRAP1-dependent) (Reaction) 
17.3.1.3.1.11 chylomicron remnant:apoE:LDLR complex [coated vesicle membrane] => 
9592 chylomicron remnant:apoE:LDLR complex [endosome membrane] (Reaction) 
17.3.1.3.1.12 chylomicron remnant:apoE:LDLR complex => chylomicron remnant:apoE 9593 
+ LDLR (Reaction) 
17.3.1.3.2 HDL-mediated lipid transport (Pathway) 9594 
17.3.1.3.2.1 Conversion of pro-apoA-I to apoA-I (Reaction) 9595 
17.3.1.3.2.2 ABCA1 tetramer binds apoA-I (Reaction) 9597 
17.3.1.3.2.3 ABCA1-mediated transport of intracellular cholesterol to the cell surface 9598 (Reaction) 
17.3.1.3.2.4 ABCA1-mediated transport of intracellular phospholipid to the cell surface 9600 (Reaction) 
17.3.1.3.2.5 Apolipoprotein A-I binds membrane-associated cholesterol and 9601 phospholipid to form a discoidal HDL particle (Reaction) 
17.3.1.3.2.6 pre-beta HDL binds membrane-associated cholesterol and phospholipid to 
9602 form a discoidal HDL particle (Reaction) 
17.3.1.3.2.7 ABCG1-mediated transport of intracellular cholesterol to the cell surface 9604 (Reaction) 
17.3.1.3.2.8 Discoidal HDL binds membrane-associated free cholesterol (Reaction) 9605 
17.3.1.3.2.9 LCAT + discoidal HDL LCAT:discoidal HDL complex (Reaction) 9606 
17.3.1.3.2.10 LCAT:discoidal HDL complex LCAT + discoidal HDL (Reaction) 9608 
17.3.1.3.2.11 Spherical HDL binds C and E apolipoproteins (Reaction) 9609 
17.3.1.3.2.12 Spherical HDL binds membrane-associated free cholesterol and 9610 phospholipids (Reaction) 
17.3.1.3.2.13 cholesterol + phosphatidylcholine (lecithin) => cholesterol ester + 9612 2-lysophosphatidylcholine (lysolecithin) (Reaction) 
17.3.1.3.2.14 Serum albumin binds 2-lysophosphatidylcholine (Reaction) 9614 
17.3.1.3.2.15 LCAT + spherical HDL LCAT:spherical HDL complex (Reaction) 9615 
17.3.1.3.2.16 LCAT:spherical HDL complex LCAT + spherical HDL (Reaction) 9616 
17.3.1.3.2.17 CETP-mediated lipid exchange: spherical HDL gains triacylglycerol 9617 (Reaction) 
17.3.1.3.2.18 CETP + spherical HDL + torcetrapib => CETP:spherical HDL:torcetrapib9619 complex (Reaction) 
17.3.1.3.2.19 spherical HDL and SR-BI receptor form a complex at the cell surface 9620 (Reaction) 
17.3.1.3.2.20 Disassembly of SR-BI-bound spherical HDL (Reaction) 9621 
17.3.1.3.2.21 apoA-I binds to CUBN:AMN (Reaction) 9623 
17.3.1.3.2.22 Endocytosis and degradation of apoA-I (BlackBoxEvent) 9624 
17.3.1.3.3 LDL-mediated lipid transport (Pathway) 9625 
17.3.1.3.3.1 CETP-mediated lipid exchange: LDL gains cholesterol ester (Reaction) 9627 
17.3.1.3.3.2 apolipoprotein(a) + LDL => Lp(a) (Reaction) 9629 
17.3.1.3.3.3 LDL + LDLR => LDL:LDLR complex (Reaction) 9630 
17.3.1.3.3.4 LDL:LDLR complex [plasma membrane] => LDL:LDLR complex 9631 [clathrin-coated vesicle] (LDLRAP1-dependent) (Reaction) 
17.3.1.3.3.5 LDL:LDLR complex [plasma membrane] => LDL:LDLR complex 9633 [clathrin-coated vesicle] (LDLRAP1-independent) (Reaction) 
17.3.1.3.3.6 LDLR:LDL complex [coated vesicle membrane] => LDLR:LDL complex 9634 [endosome membrane] (Reaction) 
17.3.1.3.3.7 LDLR:LDL complex => LDLR + LDL (Reaction) 9635 
17.3.1.3.3.8 LDLR [endosome membrane] => LDLR [plasma membrane] (Reaction) 9636 
17.3.1.4 Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis (Pathway) 9637 
17.3.1.4.1 hormone-sensitive lipase (HSL) + 2 ATP -> phosphorylated HSL + 2 ADP 9640 (Reaction) 
17.3.1.4.2 2 phosphorylated HSL monomers -> phosphorylated HSL dimer (Reaction) 9642 
17.3.1.4.3 perilipin:CGI-58 complex -> perilipin + CGI-58 (Reaction) 9643 
17.3.1.4.4 perilipin + 2 ATP -> phosphorylated perilipin + 2 ADP (Reaction) 9646 
17.3.1.4.5 Phosphorylated HSL dimer translocates from the cytosol to the lipid particle 9650 (Reaction) 
17.3.1.4.6 phosphorylated HSL dimer + FABP4 -> phosphorylated HSL dimer:FABP4 9652 complex (Reaction) 
17.3.1.4.7 cholesterol ester + H2O -> cholesterol + fatty acid (Reaction) 9654 
17.3.1.4.8 triacylglycerol + H2O -> diacylglycerol + fatty acid (Reaction) 9655 
17.3.1.4.9 diacylglycerol + H2O -> 2-acylglycerol + fatty acid (Reaction) 9657 
17.3.1.4.10 2-acylglycerol + H2O -> glycerol + fatty acid (Reaction) 9659 17.3.1.4.11 phosphorylated HSL + H2O -> HSL + orthophosphate (Reaction) 9661 
17.3.1.4.12 phosphorylated perilipin + H2O -> perilipin + orthophosphate (Reaction) 9663 
17.3.2 Fatty acid, triacylglycerol, and ketone body metabolism (Pathway) 9664 
17.3.2.1 Triglyceride Biosynthesis (Pathway) 9665 
17.3.2.1.1 Fatty Acyl-CoA Biosynthesis (Pathway) 9665 
17.3.2.1.1.1 Transport of Citrate from Mitochondrial Matrix to cytosol (Reaction) 9666 
17.3.2.1.1.2 Generation of Cytoplasmic Acetyl CoA from Citrate (Reaction) 9667 
17.3.2.1.1.3 acetyl-CoA + bicarbonate + ATP => malonyl-CoA + H2O + ADP + 9668 orthophosphate (Reaction) 
17.3.2.1.1.4 Formation of fatty acid synthase (FAS) dimer (Reaction) 9669 
17.3.2.1.1.5 acetyl-CoA + 7 malonyl-CoA + 14 NADHP + 14 H+ => palmitate + 7 CO2 + 
9670 14 NADP+ + 8 CoASH + 6 H2O (Reaction) 
17.3.2.1.1.6 Synthesis of very long-chain fatty acyl-CoAs (Pathway) 9671 
17.3.2.1.1.6.1 palmitate + CoASH + ATP => palmitoyl-CoA + AMP + pyrophosphate + 
9673 H2O [ACSL1] (Reaction) 
17.3.2.1.1.6.2 palmitate + CoASH + ATP => palmitoyl-CoA + AMP + pyrophosphate + 
9674 H2O [ACSL3] (Reaction) 
17.3.2.1.1.6.3 arachidonate + CoASH + ATP => arachidonoyl-CoA + AMP + 9675 pyrophosphate + H2O [ACSL4] (Reaction) 
17.3.2.1.1.6.4 palmitate + CoASH + ATP => palmitoyl-CoA + AMP + pyrophosphate + 
9676 H2O [ACSL5] (Reaction) 
17.3.2.1.1.6.5 palmitate + CoASH + ATP => palmitoyl-CoA + AMP + pyrophosphate + 
9677 H2O [ACSL6] (Reaction) 
17.3.2.1.1.6.6 palmitoyl-CoA + malonyl-CoA => 3-oxooctadecanoyl-CoA 9679 (3-oxostearoyl-CoA) + CO2 + CoASH [ELOVL1] (Reaction) 
17.3.2.1.1.6.7 palmitoyl-CoA + malonyl-CoA => 3-oxooctadecanoyl-CoA 9680 (3-oxostearoyl-CoA) + CO2 + CoASH [ELOVL2] (Reaction) 
17.3.2.1.1.6.8 palmitoyl-CoA + malonyl-CoA => 3-oxooctadecanoyl-CoA 9681 (3-oxostearoyl-CoA) + CO2 + CoASH [ELOVL3] (Reaction) 
17.3.2.1.1.6.9 lignoceroyl-CoA + malonyl-CoA => 3-oxocerotoyl-CoA + CO2 + CoASH 
9682 [ELOVL4] (Reaction) 
17.3.2.1.1.6.10 arachidonoyl-CoA + malonyl-CoA => 9684 3-oxo-(7,10,13,16)-docosatetraenoyl-CoA + CO2 + CoASH [ELOVL5] (Reaction) 
17.3.2.1.1.6.11 palmitoyl-CoA + malonyl-CoA => 3-oxooctadecanoyl-CoA 9685 (3-oxostearoyl-CoA) + CO2 + CoASH [ELOVL6] (Reaction) 
17.3.2.1.1.6.12 arachidoyl-CoA + malonyl-CoA => 3-oxobehenoyl-CoA + CO2 + 9687 CoASH [ELOVL7] (Reaction) 
17.3.2.1.1.6.13 3-oxooctadecanoyl-CoA (3-oxostearoyl-CoA) + NADPH + H+ => 9688 3-hydroxyoctadecanoyl-CoA + NADP+ (Reaction) 
17.3.2.1.1.6.14 3-hydroxyoctadecanoyl-CoA => trans-octadec-2-enoyl-CoA + H2O 9689 (Reaction) 
17.3.2.1.1.6.15 trans-octadec-2-enoyl-CoA + NADPH + H+ => stearoyl-CoA + NADP+ 
9690 (Reaction) 
17.3.2.1.2 DHAP is converted to G3P by GPD1/GPD1L (Reaction) 9692 
17.3.2.1.3 Conversion of Glycerol to Glycerol-3-phosphate (Reaction) 9693 17.3.2.1.4 G3P is acylated to 1-acyl LPA by AGPAT6 (Reaction) 9694 
17.3.2.1.5 glycerol 3-phosphate + acyl-CoA => 1-acylglycerol 3-phosphate + CoASH 9695 [mitochondrial membrane-associated] (Reaction) 
17.3.2.1.6 1-acyl LPA is acylated to PA by AGPAT (LPAAT) (Reaction) 9696 
17.3.2.1.7 1,2-diacyl-glycerol 3-phosphate + H2O => 1,2-diacyl-glycerol + orthophosphate
9698 (Reaction) 
17.3.2.1.8 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT1] (Reaction)9699 
17.3.2.1.9 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2] (Reaction)
9700 
17.3.2.2 Import of palmitoyl-CoA into the mitochondrial matrix (Pathway) 9701 
17.3.2.2.1 palmitoyl-CoA + carnitine => palmitoylcarnitine + CoASH (Reaction) 9702 
17.3.2.2.2 Exchange of palmitoylcarnitine and carnitine across the inner mitochondrial 9704 membrane (Reaction) 
17.3.2.2.3 palmitoylcarnitine + CoASH => palmitoyl-CoA + carnitine (Reaction) 9705 
17.3.2.2.4 Formation of Malonyl-CoA from Acetyl-CoA (muscle) (Reaction) 9706 
17.3.2.2.5 pAMPK inactivates ACC2 inhibiting malonyl-CoA synthesis (Reaction) 9708 
17.3.2.3 Mitochondrial Fatty Acid Beta-Oxidation (Pathway) 9709 
17.3.2.3.1 mitochondrial fatty acid beta-oxidation of saturated fatty acids (Pathway) 9710 
17.3.2.3.1.1 Beta oxidation of palmitoyl-CoA to myristoyl-CoA (Pathway) 9711 
17.3.2.3.1.1.1 palmitoyl-CoA+FADtrans-Hexadec-2-enoyl-CoA+FADH2 (Reaction) 9712 
17.3.2.3.1.1.2 trans-Hexadec-2-enoyl-CoA+H2O(S)-3-Hydroxyhexadecanoyl-CoA 9713 (Reaction) 
17.3.2.3.1.1.3 (S)-3-Hydroxyhexadecanoyl-CoA+NAD3-Oxopalmitoyl-CoA+NADH+H9714 (Reaction) 
17.3.2.3.1.1.4 3-Oxopalmitoyl-CoA+CoA-SHmyristoyl-CoA (Reaction) 9715 
17.3.2.3.1.2 Beta oxidation of myristoyl-CoA to lauroyl-CoA (Pathway) 9716 
17.3.2.3.1.2.1 myristoyl-CoA+FADtrans-Tetradec-2-enoyl-CoA+FADH2 (Reaction) 9717 
17.3.2.3.1.2.2 trans-Tetradec-2-enoyl-CoA+H2O(S)-3-Hydroxytetradecanoyl-CoA 9718 (Reaction) 
17.3.2.3.1.2.3 9719 (S)-3-Hydroxytetradecanoyl-CoA+NAD3-Oxotetradecanoyl-CoA+NADH+H (Reaction) 
17.3.2.3.1.2.4 3-Oxotetradecanoyl-CoA+CoA-SHLauroyl-CoA (Reaction) 9719 
17.3.2.3.1.3 Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA (Pathway) 9720 
17.3.2.3.1.3.1 lauroyl-CoA+FAD2-trans-Dodecenoyl-CoA+FADH2 (Reaction) 9721 
17.3.2.3.1.3.2 2-trans-Dodecenoyl-CoA+H2O(S)-3-Hydroxydodecanoyl-CoA (Reaction)9722 
17.3.2.3.1.3.3 (S)-3-Hydroxydodecanoyl-CoA+NAD3-Oxododecanoyl-CoA+NADH+H9723 (Reaction) 
17.3.2.3.1.3.4 3-Oxododecanoyl-CoA+CoA-SHDecanoyl-CoA (Reaction) 9723 
17.3.2.3.1.4 Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA (Pathway) 9724 
17.3.2.3.1.4.1 Decanoyl-CoA+FADtrans-Dec-2-enoyl-CoA+FADH2 (Reaction) 9725 
17.3.2.3.1.4.2 trans-Dec-2-enoyl-CoA+H2O(S)-Hydroxydecanoyl-CoA (Reaction) 9726 
17.3.2.3.1.4.3 (S)-Hydroxydecanoyl-CoA+NAD3-Oxodecanoyl-CoA+NADH+H 9726 (Reaction) 
17.3.2.3.1.4.4 3-Oxodecanoyl-CoA+CoA-SHOctanoyl-CoA (Reaction) 9727 
17.3.2.3.1.5 Beta oxidation of octanoyl-CoA to hexanoyl-CoA (Pathway) 9728 
17.3.2.3.1.5.1 Octanoyl-CoA+FADtrans-Oct-2-enoyl-CoA+FADH2 (Reaction) 9729 17.3.2.3.1.5.2 trans-Oct-2-enoyl-CoA+H2O(S)-Hydroxyoctanoyl-CoA (Reaction) 9730 
17.3.2.3.1.5.3 (S)-Hydroxyoctanoyl-CoA+NAD3-Oxooctanoyl-CoA+NADH+H 9730 (Reaction) 
17.3.2.3.1.5.4 3-Oxooctanoyl-CoA+CoA-SHHexanoyl-CoA (Reaction) 9731 
17.3.2.3.1.6 Beta oxidation of hexanoyl-CoA to butanoyl-CoA (Pathway) 9732 
17.3.2.3.1.6.1 Hexanoyl-CoA+FADtrans-Hex-2-enoyl-CoA+FADH2 (Reaction) 9733 
17.3.2.3.1.6.2 trans-Hex-2-enoyl-CoA+H2O(S)-Hydroxyhexanoyl-CoA (Reaction) 9734 
17.3.2.3.1.6.3 (S)-Hydroxyhexanoyl-CoA+NAD3-Oxohexanoyl-CoA+NADH+H 9734 (Reaction) 
17.3.2.3.1.6.4 3-Oxohexanoyl-CoA+CoA-SHButanoyl-CoA (Reaction) 9735 
17.3.2.3.1.7 Beta oxidation of butanoyl-CoA to acetyl-CoA (Pathway) 9736 
17.3.2.3.1.7.1 Butanoyl-CoA+FADCrotonoyl-CoA+FADH2 (Reaction) 9737 
17.3.2.3.1.7.2 Crotonoyl-CoA+H2O(S)-3-Hydroxybutanoyl-CoA (Reaction) 9738 
17.3.2.3.1.7.3 (S)-Hydroxybutanoyl-CoA+NADAcetoacetyl-CoA+NADH+H (Reaction)9738 
17.3.2.3.2 mitochondrial fatty acid beta-oxidation of unsaturated fatty acids (Pathway) 9739 
17.3.2.3.2.1 Linoleoyl-CoA is converted to cis,cis-3,6- dodecadienoyl-CoA by three 9741 cycles of beta-oxidation (BlackBoxEvent) 
17.3.2.3.2.2 Isomerization of cis,cis-3,6-Dodecadienoyl-CoA to form 9743 trans,cis-Lauro-2,6-dienoyl-CoA (Reaction) 
17.3.2.3.2.3 Trans,cis-lauro-2,6-dienoyl-CoA is converted to cis,cis-3,6-9745 4-cis-decenoyl-CoA by one cycle of beta-oxidation (BlackBoxEvent) 
17.3.2.3.2.4 dehydrogenation of 4-cis-decenoyl-CoA to form 9747 2-trans-4-cis-decadienoyl-CoA (Reaction) 
17.3.2.3.2.5 Reduction of 2-trans-4-cis-decadienoyl-CoA to form 3-trans-decenoyl-CoA9749 (Reaction) 
17.3.2.3.2.6 Isomerization of 3-trans-decenoyl-CoA to form trans-dec-2-enoyl-CoA 9751 (Reaction) 
17.3.2.3.3 Propionyl-CoA catabolism (Pathway) 9753 
17.3.2.3.3.1 propionyl-CoA + CO2 + ATP D-methylmalonyl-CoA + ADP + 9754 orthophosphate (Reaction) 
17.3.2.3.3.2 D-methylmalonyl-CoA L-methylmalonyl-CoA (Reaction) 9755 
17.3.2.3.3.3 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 9756 
17.3.2.4 Ketone body metabolism (Pathway) 9756 
17.3.2.4.1 Synthesis of Ketone Bodies (Pathway) 9757 
17.3.2.4.1.1 2 acetyl-CoA acetoacetyl-CoA + CoA (Reaction) 9758 
17.3.2.4.1.2 acetoacetyl-CoA+acetyl-CoA => HMG-CoA + CoASH (Reaction) 9759 
17.3.2.4.1.3 HMG CoA => acetoacetic acid + acetyl CoA (Reaction) 9759 
17.3.2.4.1.4 acetoacetic acid + NADH + H+ beta-hydroxybutyrate + NAD+ (Reaction) 9760 
17.3.2.4.2 Utilization of Ketone Bodies (Pathway) 9761 
17.3.2.4.2.1 D-beta hydroxybutyrate+NAD+ acetoacetate+NADH+H+ (Reaction) 9761 
17.3.2.4.2.2 acetoacetate + succinyl-CoA acetoacetyl-CoA + succinate (Reaction) 9762 
17.3.2.4.2.3 acetoacetyl-CoA + CoA 2 acetyl-CoA (Reaction) 9763 
17.3.2.5 Gly-3-P+FAD->DHAP+FADH2 (catalyzed by mitochondrial Gly-Phos 9763 dehydrogenase) (Reaction) 
17.3.2.6 Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha 
(PPARalpha) (Pathway) 
17.3.2.6.1 PPARA binds RXRA forming PPARA:RXRA heterodimer at promoter of target 
gene (Reaction) 
17.3.2.6.2 PPARA:RXRA heterodimer recruits corepressors (Reaction) 9768 
17.3.2.6.3 Fatty acid ligands activate PPARA (Reaction) 9769 
17.3.2.6.4 PPARA activates gene expression (Pathway) 9773 
17.3.2.6.4.1 Expression of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase 9774 (HMGCR) (BlackBoxEvent) 
17.3.2.6.4.2 Expression of ABCA1 (BlackBoxEvent) 9776 
17.3.2.6.4.3 Expression of ABCB4 (BlackBoxEvent) 9777 
17.3.2.6.4.4 Expression of ACADM (BlackBoxEvent) 9779 
17.3.2.6.4.5 Expression of ACOX1 (BlackBoxEvent) 9780 
17.3.2.6.4.6 Expression of ACSL1 (BlackBoxEvent) 9782 
17.3.2.6.4.7 Expression of AGT (BlackBoxEvent) 9783 
17.3.2.6.4.8 Expression of ALAS1 (BlackBoxEvent) 9785 
17.3.2.6.4.9 Expression of ANGPTL4 (BlackBoxEvent) 9787 
17.3.2.6.4.10 Expression of ANKRD1 (BlackBoxEvent) 9787 
17.3.2.6.4.11 Expression of APOA1 (BlackBoxEvent) 9789 
17.3.2.6.4.12 Expression of APOA2 (BlackBoxEvent) 9790 
17.3.2.6.4.13 Expression of APOA5 (BlackBoxEvent) 9792 
17.3.2.6.4.14 Expression of CD36 (platelet glycoprotein IV, FAT) (BlackBoxEvent) 9793 
17.3.2.6.4.15 Expression of CPT1A (BlackBoxEvent) 9794 
17.3.2.6.4.16 Expression of CPT2 (BlackBoxEvent) 9794 
17.3.2.6.4.17 Expression of CTGF (BlackBoxEvent) 9796 
17.3.2.6.4.18 Expression of CYP1A1 (BlackBoxEvent) 9796 
17.3.2.6.4.19 Expression of CYP4A11 (BlackBoxEvent) 9798 
17.3.2.6.4.20 Expression of CYP7A1 (BlackBoxEvent) 9799 
17.3.2.6.4.21 Expression of FABP1 (BlackBoxEvent) 9801 
17.3.2.6.4.22 Expression of FADS1 (BlackBoxEvent) 9802 
17.3.2.6.4.23 Expression of FATP1 (SLC27A1) (BlackBoxEvent) 9804 
17.3.2.6.4.24 Expression of FHL2 (BlackBoxEvent) 9805 
17.3.2.6.4.25 Expression of Farnesyldiphosphate Farnesyltransferase (FDFT1, 9807 Squalene Synthase) (BlackBoxEvent) 
17.3.2.6.4.26 Expression of G0S2 (BlackBoxEvent) 9808 
17.3.2.6.4.27 Expression of GLIPR1 (BlackBoxEvent) 9810 
17.3.2.6.4.28 Expression of GRHL1 (BlackBoxEvent) 9811 
17.3.2.6.4.29 Expression of Hydroxymethylglutaryl coenzyme A synthase (HMGCS1)9813 (BlackBoxEvent) 
17.3.2.6.4.30 Expression of HMGCS2 (BlackBoxEvent) 9814 
17.3.2.6.4.31 Expression of ME1 (BlackBoxEvent) 9816 
17.3.2.6.4.32 Expression of NPAS2 (BlackBoxEvent) 9817 
17.3.2.6.4.33 Expression of PEX11A (BlackBoxEvent) 9817 
17.3.2.6.4.34 Expression of PLIN2 (BlackBoxEvent) 9819 
17.3.2.6.4.35 Expression of PPARA (BlackBoxEvent) 9820 
17.3.2.6.4.36 Expression of RGL1 (BlackBoxEvent) 9765
9820 
17.3.2.6.4.37 Expression of SULT2A1 (BlackBoxEvent) 9822 
17.3.2.6.4.38 Expression of TIAM2 (BlackBoxEvent) 9823 
17.3.2.6.4.39 Expression of TNFRSF21 (BlackBoxEvent) 9825 
17.3.2.6.4.40 Expression of TRIB3 (BlackBoxEvent) 9826 
17.3.2.6.4.41 Expression of TXNRD1 (BlackBoxEvent) 9828 
17.3.2.6.4.42 Expression of UGT1A9 (BlackBoxEvent) 9829 
17.3.3 Peroxisomal lipid metabolism (Pathway) 9831 
17.3.3.1 Alpha-oxidation of phytanate (Pathway) 9832 
17.3.3.1.1 PMP34-mediated exchange of cytosolic ATP for peroxisomal AMP (Reaction)9833 
17.3.3.1.2 phytanate + CoA-SH + ATP => phytanoyl-CoA + AMP + pyrophosphate 9834 (Reaction) 
17.3.3.1.3 phytanoyl-CoA + 2-oxoglutarate + O2 => 2-hydroxyphytanoyl-CoA + succinate9835 
+ CO2 (Reaction) 
17.3.3.1.4 2-hydroxyphytanoyl-CoA => pristanal + formyl-CoA (Reaction) 9837 
17.3.3.1.5 formyl-CoA + H2O => formate + CoASH (Reaction) 9838 
17.3.3.1.6 pristanal + NAD+ => pristanate + NADH + H+ (Reaction) 9839 
17.3.3.1.7 pristanate + CoA-SH + ATP => pristanoyl-CoA + AMP + pyrophosphate 9840 (Reaction) 
17.3.3.2 Beta-oxidation of pristanoyl-CoA (Pathway) 9842 
17.3.3.2.1 Isomerization of (2R)-pristanoyl-CoA to (2S)-pristanoyl-CoA (Reaction) 9843 
17.3.3.2.2 (2S)-pristanoyl-CoA + O2 => trans-2,3-dehydropristanoyl-CoA + H2O2 9844 (ACOX2) (Reaction) 
17.3.3.2.3 (2S)-pristanoyl-CoA + O2 => trans-2,3-dehydropristanoyl-CoA + H2O2 9846 (ACOX3) (Reaction) 
17.3.3.2.4 trans-2,3-dehydropristanoyl-CoA + H2O => 3-hydroxypristanoyl-CoA 9847 (Reaction) 
17.3.3.2.5 3-hydroxypristanoyl-CoA + NAD+ => 3-ketoxypristanoyl-CoA + NADH + H+ 9849 (Reaction) 
17.3.3.2.6 3-ketopristanoyl-CoA + CoASH => 4,8,12-trimethyltridecanoyl-CoA + 9850 propionyl-CoA (Reaction) 
17.3.3.2.7 4,8,12-trimethyltridecanoyl-CoA + 2 O2 + 2 H2O + 2 NAD+ + 2 CoASH => 9852 4,8-dimethylnonanoyl-CoA + 2 H2O2 + 2 NADH + 2 H+ + acetyl-CoA + propionyl-CoA (BlackBoxEvent) 
17.3.3.2.8 4,8-dimethylnonanoyl-CoA + carnitine => 4,8-dimethylnonanoylcarnitine + 9853 CoASH (Reaction) 
17.3.3.2.9 acetyl-CoA + carnitine => acetylcarnitine + CoASH (Reaction) 9854 
17.3.3.2.10 acetyl-CoA + H2O => acetate + CoASH (Reaction) 9856 
17.3.3.2.11 propionyl-CoA + carnitine => propionylcarnitine + CoASH (Reaction) 9857 
17.3.3.3 Beta-oxidation of very long chain fatty acids (Pathway) 9858 
17.3.3.3.1 Peroxisomal uptake of very long-chain fatty acyl CoA (Reaction) 9859 
17.3.3.3.2 hexacosanoyl-CoA + O2 => trans-2,3-dehydrohexacosanoyl-CoA + H2O2 9861 (Reaction) 
17.3.3.3.3 trans-2,3-dehydrohexacosanoyl-CoA + H2O => 3-hydroxyhexacosanoyl-CoA9862 (Reaction) 
17.3.3.3.4 3-hydroxyhexacosanoyl-CoA + NAD+ => 3-ketohexacosanoyl-CoA + NADH + 
H+ (Reaction) 
17.3.3.3.5 3-ketohexacosanoyl-CoA + CoASH => tetracosanoyl-CoA + acetyl-CoA 9865 (Reaction) 
17.3.3.3.6 tetracosenoyl-CoA + 8 O2 + 8 H2O + 8 NAD+ + 8 CoASH => octanoyl-CoA + 8
9866 H2O2 + 8 NADH + 8 H+ + 8 acetyl-CoA (BlackBoxEvent) 
17.3.3.3.7 acetyl-CoA + carnitine => acetylcarnitine + CoASH (Reaction) 9867 
17.3.3.3.8 acetyl-CoA + H2O => acetate + CoASH (Reaction) 9868 
17.3.3.4 Plasmalogen biosynthesis (Pathway) 9868 
17.3.3.4.1 palmitoyl-CoA + 2 NADPH + 2 H+ => hexadecanol + 2 NADP+ [FAR1] 9869 (Reaction) 
17.3.3.4.2 palmitoyl-CoA + 2 NADPH + 2 H+ => hexadecanol + 2 NADP+ [FAR2] 9870 (Reaction) 
17.3.3.4.3 palmitoyl-CoA + DHAP => 1-palmitoylglycerone phosphate + CoASH 9872 (Reaction) 
17.3.3.4.4 1-palmitoylglycerone phosphate + hexadecanol => O-hexadecylglycerone 9873 phosphate + palmitate (Reaction) 
17.3.3.4.5 Movement of O-hexadecylglycerone phosphate from the peroxisomal matrix to
9875 the cytosol (Reaction) 
17.3.3.4.6 O-hexadecylglycerone phosphate + NADPH + H+ => 1-hexadecyl 9876 glycerol-3-phosphate + NADP+ (Reaction) 
17.3.3.5 NADPH regeneration (Pathway) 9877 
17.3.3.5.1 isocitrate + NADP+ => 2-oxoglutarate + CO2 + NADPH + H+ (Reaction) 9878 
17.3.3.5.2 isocitrate + NADP+ => 2-oxoglutarate + CO2 + NADPH + H+ (Reaction) 9879 
17.3.3.5.3 Exchange of isocitrate and 2-oxoglutarate across the peroxisomal membrane9881 (Reaction) 
17.3.3.6 malonyl-CoA is decarboxylated to acetyl-CoA in peroxisome (Reaction) 9882 
17.3.4 Cholesterol biosynthesis (Pathway) 9883 
17.3.4.1 Condensation of acetyl CoA with acetoacetyl CoA to form HMG-CoA (Reaction)9885 
17.3.4.2 Reduction of HMG-CoA produces mevalonate (Reaction) 9886 
17.3.4.3 Mevalonate is phosphorylated to mevalonate-5-phosphate (Reaction) 9887 
17.3.4.4 Mevalonate-5-phosphate is further phosphorylated. (Reaction) 9888 
17.3.4.5 MVD decarboxylates MVA5PP to IPPP (Reaction) 9889 
17.3.4.6 Isopentenyl pyrophosphate rearranges to dimethylallyl pyrophosphate (Reaction)9891 
17.3.4.7 Addition of isopentenyl pyrophosphate to DMAPP (Reaction) 9892 
17.3.4.8 Another isopentenyl pyrophosphate is added to geranyl pyrophosphate (Reaction)9893 
17.3.4.9 Two FPP molecules dimerize to form presqualene diphosphate (Reaction) 9894 
17.3.4.10 Reduction of presqualene diphosphate to form squalene (Reaction) 9895 
17.3.4.11 Squalene is oxidized to its epoxide (Reaction) 9896 
17.3.4.12 Squalene 2,3-epoxide cyclizes, forming lanosterol (Reaction) 9897 
17.3.4.13 Lanosterol is oxidatively demethylated to 9898 4,4-dimethylcholesta-8(9),14,24-trien-3beta-ol (Reaction) 
17.3.4.14 4,4-dimethylcholesta-8(9),14,24-trien-3beta-ol is reduced to 9899 4,4-dimethylcholesta-8(9),24-dien-3beta-ol [LBR] (Reaction) 
17.3.4.15 4,4-dimethylcholesta-8(9),14,24-trien-3beta-ol is reduced to 9901 4,4-dimethylcholesta-8(9),24-dien-3beta-ol [TM7SF2] (Reaction) 9864 17.3.4.16 4,4-dimethylcholesta-8(9),24-dien-3beta-ol is oxidized to 9903 4-methyl,4-carboxycholesta-8(9),24-dien-3beta-ol (Reaction) 
17.3.4.17 4-methyl,4-carboxycholesta-8(9),24-dien-3beta-ol is decarboxylated and 9904 oxidized to form 4-methylcholesta-8(9),24-dien-3-one (Reaction) 
17.3.4.18 4-methylcholesta-8(9),24-dien-3-one is reduced to 9906 4-methylcholesta-8(9),24-dien-3beta-ol (Reaction) 
17.3.4.19 4-methylcholesta-8(9),24-dien-3beta-ol is oxidized to 9907 4-carboxycholesta-8(9),24-dien-3beta-ol (Reaction) 
17.3.4.20 4-carboxycholesta-8(9),24-dien-3beta-ol is decarboxylated and oxidized to form
9908 cholesta-8(9),24-dien-3-one (zymosterone) (Reaction) 
17.3.4.21 Zymosterone (cholesta-8(9),24-dien-3-one) is reduced to zymosterol 9910 (cholesta-8(9),24-dien-3beta-ol) (Reaction) 
17.3.4.22 Zymosterol is isomerized to cholesta-7,24-dien-3beta-ol (Reaction) 9911 
17.3.4.23 Cholesta-7,24-dien-3beta-ol is desaturated to form cholesta-5,7,24-trien-3beta-ol
9912 (Reaction) 
17.3.4.24 Cholesta-5,7,24-trien-3beta-ol is reduced to desmosterol (Reaction) 9914 
17.3.4.25 Reduction of desmosterol to cholesterol (Reaction) 9915 
17.3.5 Regulation of cholesterol biosynthesis by SREBP (SREBF) (Pathway) 9916 
17.3.5.1 SREBP1A,1C,2 binds SCAP:cholesterol:INSIG and is retained in the endoplasmic
9918 reticulum (BlackBoxEvent) 
17.3.5.2 SREBP1A,1C,2 binds SCAP:INSIG:oxysterol and is retained in the endoplasmic9920 reticulum (BlackBoxEvent) 
17.3.5.3 SREBP1A,1C,2:SCAP binds CopII Coat Complex (BlackBoxEvent) 9922 
17.3.5.4 SREBP1A,1C,2:SCAP translocates to the Golgi (BlackBoxEvent) 9924 
17.3.5.5 S1P hydrolyzes SREBP1A,1C,2 (Reaction) 9926 
17.3.5.6 S2P hydrolyzes SREBP1A,1C,2 (Reaction) 9927 
17.3.5.7 SREBP1A,1C,2 binds SREBP1A,1C,2 forming dimers (Reaction) 9929 
17.3.5.8 SREBP1A,1C,2 binds Importin beta-1 (Reaction) 9930 
17.3.5.9 SREBP1A,1C,2 translocates to the nucleus (BlackBoxEvent) 9931 
17.3.5.10 SREBP1A,1C,2:Importin beta-1 dissociates (Reaction) 9933 
17.3.5.11 Activation of gene expression by SREBF (SREBP) (Pathway) 9934 
17.3.5.11.1 SREBP1A,1C,2 binds the ACACA promoter (Reaction) 9936 
17.3.5.11.2 SREBP1A,1C binds the ACACB promoter (Reaction) 9937 
17.3.5.11.3 SREBP1A,1C,2 binds the TM7SF2 promoter (Reaction) 9938 
17.3.5.11.4 SREBP1A,1C binds the GPAM promoter (Reaction) 9940 
17.3.5.11.5 SREBP1A,1C binds the FASN promoter (Reaction) 9941 
17.3.5.11.6 SREBP1A,2 binds the LSS promoter (Reaction) 9943 
17.3.5.11.7 SREBP1A,2 binds the MVD promoter (Reaction) 9944 
17.3.5.11.8 SREBP1A,2 binds the HMGCR promoter (Reaction) 9945 
17.3.5.11.9 SREBP1A,2 binds the SC5DL promoter (Reaction) 9947 
17.3.5.11.10 SREBP1A,2 binds the CYP51A1 promoter (Reaction) 9948 
17.3.5.11.11 SREBP1A,2 binds the DHCR7 promoter (Reaction) 9949 
17.3.5.11.12 SREBP1A,2 binds the GGPS1 promoter (Reaction) 9950 
17.3.5.11.13 SREBP1A,2 binds the IDI1 promoter (Reaction) 9951 
17.3.5.11.14 SREBP1A,2 binds the MVK promoter (Reaction) 9952 17.3.5.11.15 SREBP1A,2 binds the PMVK promoter (Reaction) 9953 
17.3.5.11.16 SREBP1A,2 binds the SQLE promoter (Reaction) 9954 
17.3.5.11.17 SREBP1A,1C,2 binds the ELOVL6 promoter (Reaction) 9956 
17.3.5.11.18 SREBP1A,1C,2 binds the FDPS promoter (Reaction) 9957 
17.3.5.11.19 SREBP1A,1C,2 binds the HMGCS1 promoter (Reaction) 9959 
17.3.5.11.20 SREBP1A,1C,2 binds the FDFT1 promoter (Reaction) 9961 
17.3.5.11.21 Expression of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase (HMGCR)
9962 (BlackBoxEvent) 
17.3.5.11.22 Expression of 7-Dehydrocholesterol Reductase (DHCR7) (BlackBoxEvent)9963 
17.3.5.11.23 Expression of Acetyl CoA Carboxylase 1 (ACACA, ACC1) (BlackBoxEvent)9964 
17.3.5.11.24 Expression of Acetyl CoA Carboxylase 2 (ACACB, ACC2) (BlackBoxEvent)
9966 
17.3.5.11.25 Expression of Diphosphomevalonate Decarboxylase (MVD) 9967 (BlackBoxEvent) 
17.3.5.11.26 Expression of ELOVL6 (BlackBoxEvent) 9969 
17.3.5.11.27 Expression of Farnesyl Diphosphate Synthase (FDPS) (BlackBoxEvent) 9970 
17.3.5.11.28 Expression of Farnesyldiphosphate Farnesyltransferase (FDFT1, Squalene
9972 Synthase) (BlackBoxEvent) 
17.3.5.11.29 Expression of Fatty Acid Synthase (FASN) (BlackBoxEvent) 9973 
17.3.5.11.30 Expression of Geranylgeranyl Pyrophosphate Synthase (GGPS1) 9975 (BlackBoxEvent) 
17.3.5.11.31 Expression of Glycerol-3-phosphate Acyltransferase (GPAM, GPAT) 9976 (BlackBoxEvent) 
17.3.5.11.32 Expression of Hydroxymethylglutaryl coenzyme A synthase (HMGCS1) 9978 (BlackBoxEvent) 
17.3.5.11.33 Expression of Isopentenyl-diphosphate Delta-isomerase 1 (IDI1) 9978 (BlackBoxEvent) 
17.3.5.11.34 Expression of Lanosterol Demethylase (CYP51A1) (BlackBoxEvent) 9980 
17.3.5.11.35 Expression of Lanosterol Synthase (LSS) (BlackBoxEvent) 9981 
17.3.5.11.36 Expression of Lathosterol Oxidase (SC5D, SC5DL) (BlackBoxEvent) 9983 
17.3.5.11.37 Expression of Mevalonate Kinase (MVK) (BlackBoxEvent) 9984 
17.3.5.11.38 Expression of Phosphomevalonate Kinase (PMVK) (BlackBoxEvent) 9986 
17.3.5.11.39 Expression of Squalene Monooxygenase (SQLE) (BlackBoxEvent) 9987 
17.3.5.11.40 Expression of TM7SF2 (BlackBoxEvent) 9989 
17.3.6 Bile acid and bile salt metabolism (Pathway) 9990 
17.3.6.1 Synthesis of bile acids and bile salts (Pathway) 9992 
17.3.6.1.1 Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol (Pathway)
9993 
17.3.6.1.1.1 Cholesterol is hydroxylated to 7alpha-hydroxycholesterol by CYP7A1 9995 (Reaction) 
17.3.6.1.1.2 7alpha-hydroxycholesterol is oxidized and isomerized to 9997 4-cholesten-7alpha-ol-3-one (Reaction) 
17.3.6.1.1.3 4-Cholesten-7alpha-ol-3-one is 12alpha-hydroxylated to 9998 7-alpha,12-alpha-dihydroxycholest-4-en-3-one (Reaction) 
17.3.6.1.1.4 4-cholesten-7alpha, 12alpha-diol-3-one is reduced to 10000 5beta-cholesten-7alpha, 12alpha-diol-3-one (Reaction) 
17.3.6.1.1.5 4-cholesten-7alpha-ol-3-one is reduced to 5beta-cholestan-7alpha-ol-3-one 
(Reaction) 
17.3.6.1.1.6 5Beta-cholesten-7alpha, 12alpha-diol-3-one is reduced to 
10002 5beta-cholestan-3alpha, 7alpha, 12alpha-triol (Reaction) 
17.3.6.1.1.7 5beta-cholestan-7alpha-ol-3-one is reduced to 5beta-cholestan-3alpha,10004 7alpha-diol (Reaction) 
17.3.6.1.1.8 5beta-cholestan-3alpha, 7alpha, 12alpha-triol is translocated from the 10005 cytosol to the mitochondrial matrix (Reaction) 
17.3.6.1.1.9 5beta-cholestan-3alpha, 7alpha-diol is translocated from the cytosol to the
10006 mitochondrial matrix (Reaction) 
17.3.6.1.1.10 5beta-cholestan-3alpha, 7alpha, 12alpha-triol is hydroxylated to 10008 5beta-cholestan-3alpha, 7alpha, 12alpha, 27-tetrol (Reaction) 
17.3.6.1.1.11 5beta-cholestan-3alpha, 7alpha-diol is hydroxylated to 10009 5beta-cholestan-3alpha, 7alpha, 26-triol (Reaction) 
17.3.6.1.1.12 5beta-cholestan-3alpha,7alpha,12alpha,27-tetrol is oxidized to 10011 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-27-al (Reaction) 
17.3.6.1.1.13 5beta-cholestan-3alpha, 7alpha, 26-triol is oxidized to 3alpha, 10012 7alpha-dihydroxy-5beta-cholestan-26-al (Reaction) 
17.3.6.1.1.14 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-27-al is oxidized to 10013 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoate (THCA) (Reaction) 
17.3.6.1.1.15 3alpha, 7alpha-dihydroxy-5beta-cholestan-26-al is oxidized to 3alpha, 10015 7alpha-dihydroxy-5beta-cholestanoate (DHCA) (Reaction) 
17.3.6.1.1.16 THCA is translocated from the mitochondrial matrix to the cytosol 10016 (Reaction) 
17.3.6.1.1.17 DHCA is translocated from the mitochondrial matrix to the cytosol 10017 (Reaction) 
17.3.6.1.1.18 THCA is conjugated with Coenzyme A (SLC27A2 VLCS) (Reaction) 10019 

17.3.6.1.1.19 DHCA is conjugated with Coenzyme A (SLC27A2 VLCS) (Reaction) 10020 
17.3.6.1.1.20 THCA is conjugated with Coenzyme A (SLC27A5 BACS) (Reaction) 10022 
17.3.6.1.1.21 DHCA is conjugated with Coenzyme A (SLC27A5 BACS) (Reaction) 10023 
17.3.6.1.1.22 25(R) THCA-CoA is translocated from the cytosol to the peroxisome 10025 (Reaction) 
17.3.6.1.1.23 25(R) DHCA-CoA is translocated from the cytosol to the peroxisome 10026 (Reaction) 
17.3.6.1.1.24 Isomerization of 25(R) THCA-CoA to 25(S) THCA-CoA (Reaction) 10027 
17.3.6.1.1.25 Isomerization of 25(R) DHCA-CoA to 25(S) DHCA-CoA (Reaction) 10029 
17.3.6.1.1.26 25(S) THCA-CoA is dehydrogenated to 10030 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA (THCA-CoA) (Reaction) 
17.3.6.1.1.27 25(S) DHCA-CoA is dehydrogenated to 25(S) 10032 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA (Reaction) 
17.3.6.1.1.28 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA 10033 (THCA-CoA) is hydrated to (24R, 25R) 3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestanoyl-CoA (Reaction) 
17.3.6.1.1.29 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA is hydrated to
10035 (24R, 25R) 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA (Reaction) 
17.3.6.1.1.30 (24R, 25R) 10001 

3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestanoyl-CoA is oxidized to 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA (Reaction) 
17.3.6.1.1.31 (24R, 25R) 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA is 10037 oxidized to 3alpha,7alpha-dihydroxy-5beta-cholest-24-one-CoA (Reaction) 
17.3.6.1.1.32 Thiolysis of 3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-one-CoA 
10039 yields choloyl-CoA (3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-one-CoA) and propionyl CoA (Reaction) 
17.3.6.1.1.33 Thiolysis of 3alpha,7alpha-dihydroxy-5beta-cholan-24-one-CoA yields 10040 chenodeoxycholoyl-CoA (3alpha,7alpha-dihydroxy-5beta-cholan-24-one-CoA) and 
propionyl CoA (Reaction)  
17.3.6.1.1.34 Hydrolysis of choloyl-CoA to cholate and CoASH (Reaction)  10042  
17.3.6.1.1.35 Cholate is translocated from the peroxisomal matrix to the cytosol  10043  
(Reaction)  
17.3.6.1.1.36 Choloyl CoA reacts with glycine or taurine to form glycocholate or  10044  
taurocholate (Reaction)  
17.3.6.1.1.37 Chenodeoxycholoyl CoA reacts with glycine or taurine to form  10046  
glycochenodeoxycholate or taurochenodeoxycholate (Reaction)  
17.3.6.1.1.38 Bile salts are translocated from the peroxisomal matrix to the cytosol  10047  
(Reaction)  
17.3.6.1.1.39 Transport (efflux) of bile salts by ABCB11 (bile salt export pump)  10049  
(Reaction)  

17.3.6.1.2 Synthesis of bile acids and bile salts via 24-hydroxycholesterol (Pathway) 10051 
17.3.6.1.2.1 Cholesterol is hydroxylated to 24-hydroxycholesterol by CYP46A1 10053 (Reaction) 
17.3.6.1.2.2 Efflux of 24-hydroxycholesterol (Reaction) 10054 
17.3.6.1.2.3 Influx of 24-hydroxycholesterol (Reaction) 10055 
17.3.6.1.2.4 24-hydroxycholesterol is 7alpha-hydroxylated to yield 10057 cholest-5-ene-3beta,7alpha,24-triol (Reaction) 
17.3.6.1.2.5 Cholest-5-ene-3beta,7alpha,24(S)-triol is oxidized and isomerized to 10058 4-cholesten-7alpha,24(S)-diol-3-one (Reaction) 
17.3.6.1.2.6 4-Cholesten-7alpha,24(S)-diol-3-one is 12alpha-hydroxylated to 10059 4-cholesten-7-alpha,12-alpha,24(S)-triol-3-one (Reaction) 
17.3.6.1.2.7 4-cholesten-7alpha,12alpha,24(S)-triol-3-one is reduced to 10061 5beta-cholestan-7alpha,12alpha,24(S)-triol-3-one (Reaction) 
17.3.6.1.2.8 4-cholesten-7alpha,24(S)-diol-3-one is reduced to 10062 5beta-cholestan-7alpha,24(S)-diol-3-one (Reaction) 
17.3.6.1.2.9 5Beta-cholestan-7alpha,12alpha,24(S)-triol-3-one is reduced to 10063 5beta-cholestan-3alpha,7alpha,12alpha,24(S)-tetrol (Reaction) 
17.3.6.1.2.10 5beta-cholestan-7alpha,24(S)-diol-3-one is reduced to 
10065 5beta-cholestan-3alpha,7alpha,24(S)-triol (Reaction) 
17.3.6.1.2.11 5beta-cholestan-3alpha,7alpha,12alpha,24(S)-tetrol is translocated from 
10066 the cytosol to the mitochondrial matrix (Reaction) 
17.3.6.1.2.12 5beta-cholestan-3alpha,7alpha,24(S)-triol is translocated from the cytosol 
10067 to the mitochondrial matrix (Reaction) 
17.3.6.1.2.13 5beta-cholestan-3alpha,7alpha,12alpha,24(S)-tetrol is hydroxylated to 10036 5beta-cholestan-3alpha,7alpha,12alpha,24(S), 27-pentol (Reaction) 
17.3.6.1.2.14 5beta-cholestan-3alpha,7alpha,24(S)-triol is hydroxylated to 10070 5beta-cholestan-3alpha,7alpha,24(S), 27-tetrol (Reaction) 
17.3.6.1.2.15 5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol is oxidized to 10071 3alpha,7alpha,12alpha,24(S)-tetrahydroxy-5beta-cholestan-27-al (Reaction) 
17.3.6.1.2.16 5beta-cholestan-3alpha,7alpha,24(S),27-tetrol is oxidized to 10072 3alpha,7alpha,24(S)-trihydroxy-5beta-cholestan-27-al (Reaction) 
17.3.6.1.2.17 3alpha,7alpha,12alpha,24(S)-tetrahydroxy-5beta-cholestan-27-al is 10074 oxidized to 3alpha,7alpha,12alpha,24(S)-tetrahydroxy-5beta-cholestanoate (TetraHCA) (Reaction) 
17.3.6.1.2.18 3alpha,7alpha,24(S)-trihydroxy-5beta-cholestan-27-al is oxidized to 10075 3alpha,7alpha,24(S)-trihydroxy-5beta-cholestanoate (3,7,24THCA) (Reaction) 
17.3.6.1.2.19 TetraHCA is translocated from the mitochondrial matrix to the cytosol 10076 (Reaction) 
17.3.6.1.2.20 3,7,24THCA is translocated from the mitochondrial matrix to the cytosol10078 (Reaction) 
17.3.6.1.2.21 TetraHCA is conjugated with Coenzyme A (SLC27A5 BACS) (Reaction)10079 
17.3.6.1.2.22 3,7,24THCA is conjugated with Coenzyme A (SLC27A5 BACS) (Reaction)
10081 
17.3.6.1.2.23 TetraHCA is conjugated with Coenzyme A (SLC27A2 VLCS) (Reaction)10082 
17.3.6.1.2.24 3,7,24THCA is conjugated with Coenzyme A (SLC27A2 VLCS) (Reaction)10084 
17.3.6.1.2.25 25(R) TetraHCA-CoA is translocated from the cytosol to the peroxisome
10085 (Reaction) 
17.3.6.1.2.26 3,7,24THCA-CoA is translocated from the cytosol to the peroxisome 10086 (Reaction) 
17.3.6.1.2.27 Isomerization of 25(R) TetraHCA-CoA to (24R, 25R) 10088 3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestanoyl-CoA (Reaction) 
17.3.6.1.2.28 Isomerization of 3,7,24THCA-CoA to (24R, 25R) 10089 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA (Reaction) 
17.3.6.1.3 Synthesis of bile acids and bile salts via 27-hydroxycholesterol (Pathway) 10091 
17.3.6.1.3.1 Cholesterol is hydroxylated to 27-hydroxycholesterol by CYP27 (Reaction)
10093 
17.3.6.1.3.2 Efflux of 27-hydroxycholesterol (Reaction) 10094 
17.3.6.1.3.3 Influx of 27-hydroxycholesterol (Reaction) 10095 
17.3.6.1.3.4 27-hydroxycholesterol is 7alpha-hydroxylated (Reaction) 10097 
17.3.6.1.3.5 Cholest-5-ene-3beta,7alpha,27-triol is oxidized and isomerized to 10098 4-cholesten-7alpha,27-diol-3-one (Reaction) 
17.3.6.1.3.6 4-Cholesten-7alpha,27-diol-3-one is 12alpha-hydroxylated to 10100 4-Cholesten-7alpha,12alpha,27-triol-3-one (Reaction) 
17.3.6.1.3.7 4-cholesten-7alpha,12alpha,27-triol-3-one is reduced to 10101 5beta-cholestan-7alpha,12alpha,27-triol-3-one (Reaction) 
17.3.6.1.3.8 4-cholesten-7alpha,27-diol-3-one is reduced to 
10102 5beta-cholestan-7alpha,27-diol-3-one (Reaction) 
17.3.6.1.3.9 5Beta-cholestan-7alpha,12alpha,27-triol-3-one is reduced to 10104 5beta-cholestan-3alpha,7alpha,12alpha,27-tetrol (Reaction) 
17.3.6.1.3.10 5beta-cholestan-7alpha,27-diol-3-one is reduced to 10105 
5beta-cholestan-3alpha,7alpha,27-triol (Reaction) 10068 
17.3.6.1.3.11 5beta-cholestan-3alpha,7alpha,12alpha,27-tetrol is translocated from the
10106 cytosol to the mitochondrial matrix (Reaction) 
17.3.6.1.3.12 5beta-cholestan-3alpha,7alpha,27-triol is translocated from the cytosol to
10108 the mitochondrial matrix (Reaction) 
17.3.6.1.4 Cholesterol is hydroxylated to 25-hydroxycholesterol (Reaction) 10109 
17.3.6.1.5 25-hydroxycholesterol is 7alpha-hydroxylated by CYP7B1 (Reaction) 10110 
17.3.6.2 Recycling of bile acids and salts (Pathway) 10112 
17.3.6.2.1 SLC10A2,6 transport bile salts and acids and Na+ from extracellular region to
10113 cytosol (Reaction) 
17.3.6.2.2 Transport (efflux) of bile salts by ABCC3 (MRP3) (Reaction) 10115 
17.3.6.2.3 Co-transport (influx) of bile salts and sodium ions by NTCP (Reaction) 10117 
17.3.6.2.4 Transport (influx) of bile salts and acids by OATP-A (Reaction) 10118 
17.3.6.2.5 Transport (influx) of glycocholate and taurocholate by OATP-C (Reaction) 10120 
17.3.6.2.6 Transport (influx) of glycocholate and taurocholate by OATP-8 (Reaction) 10121 
17.3.6.2.7 Cytosolic cholate and chenodeoxycholate are conjugated with Coenzyme A10123 (SLC27A5 BACS) (Reaction) 
17.3.6.2.8 Cytosolic chenodeoxycholoyl-CoA or choloyl-CoA are conjugated with glycine
10124 or taurine (Reaction) 
17.3.6.2.9 Transport (efflux) of bile salts by ABCB11 (bile salt export pump) (Reaction)10126 
17.3.7 Metabolism of steroid hormones and vitamin D (Pathway) 10126 
17.3.7.1 Pregnenolone biosynthesis (Pathway) 10128 
17.3.7.1.1 Cholesterol translocates to the inner mitochondrial membrane (Reaction) 10129 
17.3.7.1.2 Cholesterol is released into the inner mitochondrial membrane (Reaction) 10131 
17.3.7.1.3 Oxidation of cholesterol to 22beta-hydroxycholesterol (Reaction) 10132 
17.3.7.1.4 Oxidation of 22beta-hydroxycholesterol to 20alpha,22beta-hydroxycholesterol
10133 (Reaction) 
17.3.7.1.5 20alpha,22beta-hydroxycholesterol is cleaved by CYP11A1 to yield 10134 pregnenolone and isocaproaldehyde (Reaction) 
17.3.7.1.6 Translocation of isocaproaldehyde from the mitochondrial matrix to the cytosol
10136 (Reaction) 
17.3.7.1.7 Reduction of isocaproaldehyde to 4-methylpentan-1-ol (Reaction) 10136 
17.3.7.1.8 Pregnenolone translocates from the mitochondrial matrix to the cytosol 10137 (Reaction) 
17.3.7.2 Glucocorticoid biosynthesis (Pathway) 10138 
17.3.7.2.1 Hydroxylation of pregnenolone to form 17alpha-hydroxypregnenolone 10139 (Reaction) 
17.3.7.2.2 17-Hydroxypregnenolone is dehydrogenated to form 10141 pregn-5-ene-3,20-dione-17-ol (Reaction) 
17.3.7.2.3 Pregn-5-ene-3,20-dione-17-ol isomerizes to 17-hydroxyprogesterone 10142 (Reaction) 
17.3.7.2.4 Hydroxylation of 17-hydroxyprogesterone to form 11-deoxycortisol (Reaction)10144 
17.3.7.2.5 11-deoxycortisol translocates to the mitochondrion (Reaction) 10145 
17.3.7.2.6 11-deoxycortisol is oxidised to cortisol by CYP11B1 (Reaction) 10146 
17.3.7.2.7 Cortisol translocates from the mitochondrial matrix to the cytosol (Reaction)10148 
17.3.7.2.8 Oxidation of cortisol to yield cortisone (Reaction) 10149 17.3.7.3 Mineralocorticoid biosynthesis (Pathway) 10150 
17.3.7.3.1 Pregnenolone is dehydrogenated to form pregn-5-ene-3,20-dione (Reaction)
10152 
17.3.7.3.2 Pregn-5-ene-3,20-dione isomerizes to progesterone (Reaction) 10153 
17.3.7.3.3 21-hydroxylation of progesterone to form 11-deoxycorticosterone (Reaction)10155 
17.3.7.3.4 11-deoxycorticosterone translocates from the cytosol to the mitochondrial 10156 matrix (Reaction) 
17.3.7.3.5 Hydroxylation of 11-deoxycorticosterone to form corticosterone (Reaction) 10158 
17.3.7.3.6 Hydroxylation of corticosterone to form 18-hydroxycorticosterone (Reaction)10159 
17.3.7.3.7 Conversion of 18-hydroxycorticosterone to aldosterone (Reaction) 10160 
17.3.7.4 Androgen biosynthesis (Pathway) 10162 
17.3.7.4.1 Hydroxylation of pregnenolone to form 17alpha-hydroxypregnenolone 10163 (Reaction) 
17.3.7.4.2 Side chain cleavage of 17alpha-hydroxypregnenolone to yield DHA (Reaction)10163 
17.3.7.4.3 DHA isomerizes to 4-Androstene3,17-dione (Reaction) 10165 
17.3.7.4.4 Hydroxylation of progesterone to form 17alpha-hydroxyprogesterone 10166 (Reaction) 
17.3.7.4.5 Side chain cleavage of 17alpha-hydroxyprogesterone to form 4-Androstene-3,
10168 17-dione (Reaction) 
17.3.7.4.6 Reduction of androstenedione to testosterone (Reaction) 10169 
17.3.7.4.7 Testosterone is converted to 5-alpha-dihydroxytestosterone (Reaction) 10171 
17.3.7.5 Estrogen biosynthesis (Pathway) 10173 
17.3.7.5.1 Testosterone is converted to estradiol (Reaction) 10174 
17.3.7.5.2 Androstenedione is converted to estrone by Aromatase (CYP19A1) (Reaction)10175 
17.3.7.5.3 Estrone is hydrogenated to estradiol (Reaction) 10177 
17.3.7.6 Vitamin D (calciferol) metabolism (Pathway) 10178 
17.3.7.6.1 Photolytic cleavage and thermal isomerization of 7-dehydrocholesterol 10179 (BlackBoxEvent) 
17.3.7.6.2 Vitamin D3 translocates to the blood serum and is transported to the liver 10180 (Reaction) 
17.3.7.6.3 Vitamin D3 translocates into the cytosol (Reaction) 10182 
17.3.7.6.4 25-Hydroxylation of vitamin D3 in liver (Reaction) 10183 
17.3.7.6.5 Calcidiol binds to DBP in the bloodstream and is delivered to the kidney 10184 (Reaction) 
17.3.7.6.6 CUBN binds GC:CDL (Reaction) 10185 
17.3.7.6.7 Megalin internalizes the cubilin-DBP:Calcidiol complex (Reaction) 10186 
17.3.7.6.8 DBP:Calcidiol translocates into lysosomes (Reaction) 10188 
17.3.7.6.9 Legumain degrades DBP (BlackBoxEvent) 10189 
17.3.7.6.10 Vitamin D3 translocates to the cytosol and binds to IDBP (Reaction) 10190 
17.3.7.6.11 Further hydroxylation of calcidiol in kidney to form calcitriol (Reaction) 10192 
17.3.7.6.12 1,25-dihydroxyvitamin D3 is deactivated (Reaction) 10193 
17.3.8 Phospholipid metabolism (Pathway) 10194 
17.3.8.1 Glycerophospholipid biosynthesis (Pathway) 10196 
17.3.8.1.1 Synthesis of PA (Pathway) 10198 
17.3.8.1.1.1 DHAP is converted to G3P by GPD1/GPD1L (Reaction) 10199 
17.3.8.1.1.2 DHAP is converted to 1-acyl GO3P by GNPAT (Reaction) 10199 
17.3.8.1.1.3 G3P is acylated to 1-acyl LPA by AGPAT6 (Reaction) 10200 
17.3.8.1.1.4 1-acyl LPA is acylated to PA by AGPAT (LPAAT) (Reaction) 10201 
17.3.8.1.1.5 PA is hydrolysed to 1-acyl LPA by PLA2[1] (Reaction) 10201 
17.3.8.1.1.6 PA is hydrolysed to 1-acyl LPA by PLA2G2A (Reaction) 10202 
17.3.8.1.1.7 G3P is acylated to 1-acyl LPA by GPAM/GPAT2 (OM) (Reaction) 10203 
17.3.8.1.1.8 1-acyl LPA is acylated to PA by AGPAT5 (OM) (Reaction) 10204 
17.3.8.1.1.9 PA is hydrolyzed to 1-acyl LPA by PLA2[1] (OM) (Reaction) 10205 
17.3.8.1.1.10 PC is hydrolyzed to PA and choline by PLD1/2 (Reaction) 10206 
17.3.8.1.1.11 PA is hydrolyzed to 1-acyl LPA by PLA2[15] (Reaction) 10207 
17.3.8.1.2 Acyl chain remodeling of DAG and TAG (Pathway) 10209 
17.3.8.1.2.1 TAG is hydrolyzed to DAG by PNPLA2/3 (Reaction) 10210 
17.3.8.1.2.2 DAG is acylated to TAG by DGAT1/2 (Reaction) 10212 
17.3.8.1.2.3 DAG is hydrolyzed to 2-MAG by PNPLA2/3 (Reaction) 10213 
17.3.8.1.2.4 2-MAG is transacylated to DAG by PNPLA2/3 (Reaction) 10214 
17.3.8.1.2.5 2-MAG and DAG are transacylated to TAG by PNPLA2/3 (Reaction) 10215 
17.3.8.1.2.6 2-MAG is hydrolyzed to fatty acid and glycerol by MGLL (Reaction) 10216 
17.3.8.1.3 Synthesis of PE (Pathway) 10218 
17.3.8.1.3.1 ETA is phosphorylated to PETA by CHK/ETNK (Reaction) 10219 
17.3.8.1.3.2 PETA is dephosphorylated to ETA by PHOSPHO1 (Reaction) 10220 
17.3.8.1.3.3 PETA and CTP are condensed to CDP-ETA by PCY2 (Reaction) 10221 
17.3.8.1.3.4 PA is dephosphorylated to DAG by LPIN (Reaction) 10222 
17.3.8.1.3.5 CDP-ETA and DAG are converted to PE by CEPT1/EPT1 (Reaction) 10223 
17.3.8.1.3.6 PS transports from the ER membrane to the IM membrane (Reaction) 10224 
17.3.8.1.3.7 PS is decarboxylated to PE by PISD (Reaction) 10226 
17.3.8.1.3.8 PE transports from the mitochondrial membrane to the ER (Reaction) 10227 
17.3.8.1.4 Acyl chain remodelling of PE (Pathway) 10229 
17.3.8.1.4.1 PE is hydrolyzed to 1-acyl LPE by PLA2[2] (Reaction) 10231 
17.3.8.1.4.2 PE is hydrolyzed to 1-acyl LPE by PLA2[3] (Reaction) 10233 
17.3.8.1.4.3 1-acyl LPE is acylated to PE by LPEAT (Reaction) 10234 
17.3.8.1.4.4 PE is hydrolyzed to 2-acyl LPE by PLA2[4] (Reaction) 10236 
17.3.8.1.4.5 PE is hydrolyzed to 2-acyl LPE by PLA2G4C (Reaction) 10237 
17.3.8.1.4.6 2-acyl LPE is acylated to PE by LPEAT (Reaction) 10238 
17.3.8.1.4.7 PE is hydrolyzed to 1-acyl LPE by PLA2[16] (Reaction) 10240 
17.3.8.1.5 Hydrolysis of LPE (Pathway) 10242 
17.3.8.1.5.1 1-acyl LPE is hydrolyzed to GPETA by PLA2G4C (Reaction) 10243 
17.3.8.1.5.2 2-acyl LPE is hydrolyzed to GPETA by PLA2G4C (Reaction) 10244 
17.3.8.1.5.3 GPETA is hydrolyzed to ETA and G3P by GPCPD1 (Reaction) 10245 
17.3.8.1.6 Synthesis of PC (Pathway) 10247 
17.3.8.1.6.1 PE is methylated to PC by PEMT (Reaction) 10248 
17.3.8.1.6.2 AcCho is hydrolyzed to Cho and acetate by ACHE (Reaction) 10249 
17.3.8.1.6.3 Cho transports from the extracellular space to the cytosol (Reaction) 10251 
17.3.8.1.6.4 Cho is phosphorylated to PCho by CHK dimer (Reaction) 10252 
17.3.8.1.6.5 PCho is dephosphorylated to Cho by PHOSPHO1 (Reaction) 10253 
17.3.8.1.6.6 Cho is acetylated to AcCho by CHAT (Reaction) 10254 
17.3.8.1.6.7 PCho and CTP are condensed to CDP-Cho by PCYT1 dimer (Reaction)10255 
17.3.8.1.6.8 PA is dephosphorylated to DAG by LPIN (Reaction) 10256 
17.3.8.1.6.9 CDP-Cho and DAG are converted to PC by CEPT1 at the ER membrane10257 (Reaction) 
17.3.8.1.6.10 CDP-Cho and DAG are converted to PC by CHPT1 at the Golgi 10258 membrane (Reaction) 
17.3.8.1.7 PI and PC transport between ER and Golgi membranes (Pathway) 10260 
17.3.8.1.7.1 PI:PITPNB is transported from the ER membrane to the Golgi membrane
10261 (Reaction) 
17.3.8.1.7.2 PI is exchanged with PC by PITPNB (Reaction) 10262 
17.3.8.1.7.3 PC:PITPNB is transported from the Golgi membrane to the ER membrane
10264 (Reaction) 
17.3.8.1.7.4 PC is exchanged with PI by PITPNB (Reaction) 10265 
17.3.8.1.8 Acyl chain remodelling of PC (Pathway) 10267 
17.3.8.1.8.1 PC is hydrolyzed to 1-acyl LPC by PLA2[5] (Reaction) 10268 
17.3.8.1.8.2 PC is hydrolyzed to 1-acyl LPC by PLA2[6] (Reaction) 10270 
17.3.8.1.8.3 1-acyl LPC is acylated to PC by LPCAT (Reaction) 10272 
17.3.8.1.8.4 PC is hydrolysed to 2-acyl LPC by PLA2[7] (Reaction) 10274 
17.3.8.1.8.5 PC is hydrolyzed to 2-acyl LPC by PLA2G4C (Reaction) 10275 
17.3.8.1.8.6 2-acyl LPC is acylated to PC by LPCAT (Reaction) 10276 
17.3.8.1.8.7 PC is hydrolyzed to 1-acyl LPC by PLA2[16] (Reaction) 10278 
17.3.8.1.8.8 PC is hydrolyzed to 1-acyl LPC by PLB1 (Reaction) 10280 
17.3.8.1.9 Hydrolysis of LPC (Pathway) 10281 
17.3.8.1.9.1 1-acyl LPC is hydrolyzed to GPCho by PLA2[8] (Reaction) 10283 
17.3.8.1.9.2 1-acyl LPC is hydrolyzed to GPCho by PLA2G4C (Reaction) 10284 
17.3.8.1.9.3 2-acyl LPC is hydrolyzed to GPCho by PLA2[8] (Reaction) 10285 
17.3.8.1.9.4 2-acyl LPC is hydrolyzed to GPCho by PLA2G4C (Reaction) 10287 
17.3.8.1.9.5 GPCho is hydrolyzed to Cho and G3P by GPCPD1 (Reaction) 10288 
17.3.8.1.10 Synthesis of PS (Pathway) 10290 
17.3.8.1.10.1 PC is converted to PS by PTDSS1 (Reaction) 10291 
17.3.8.1.10.2 PE is converted to PS by PTDSS2 (Reaction) 10292 
17.3.8.1.11 Acyl chain remodelling of PS (Pathway) 10293 
17.3.8.1.11.1 PS is hydrolyzed to 1-acyl LPS by PLA2[9] (Reaction) 10294 
17.3.8.1.11.2 PS is hydrolyzed to 1-acyl LPS by PLA2G2A (Reaction) 10295 
17.3.8.1.11.3 1-acyl LPS is acylated to PS by LPSAT (Reaction) 10296 
17.3.8.1.11.4 PS is hydrolyzed to 2-acyl LPS by PLA2[10] (Reaction) 10297 
17.3.8.1.11.5 2-acyl LPS is acylated to PS by LPSAT (Reaction) 10298 
17.3.8.1.11.6 PS is hydrolyzed to 1-acyl LPS by PLA2[15] (Reaction) 10300 
17.3.8.1.12 Synthesis of PI (Pathway) 10302 
17.3.8.1.12.1 PA is converted to CDP-DAG by CDS1 (Reaction) 10303 
17.3.8.1.12.2 CDP-DAG is converted to PI by CDIPT (Reaction) 10304 
17.3.8.1.13 Acyl chain remodelling of PI (Pathway) 10305 
17.3.8.1.13.1 PI is hydrolyzed to 1-acyl LPI by PLA2[11] (Reaction) 10307 
17.3.8.1.13.2 PI is hydrolyzed to 1-acyl LPI by PLA2[12] (Reaction) 10308 
17.3.8.1.13.3 1-acyl LPI is acylated to PI by MBOAT7 (Reaction) 10309 
17.3.8.1.13.4 PI is hydrolyzed to 2-acyl LPI by PLA2[13] (Reaction) 10310 
17.3.8.1.13.5 2-acyl LPI is acylated to PI by MBOAT7 (Reaction) 10311 
17.3.8.1.13.6 PI is hydrolyzed to 1-acyl LPI by PLA2[15] (Reaction) 10312 
17.3.8.1.14 Synthesis of PG (Pathway) 10314 
17.3.8.1.14.1 PC is transphosphatidylated to PG by PLD1-4/6 (Reaction) 10316 
17.3.8.1.14.2 PA transports from the outer to the inner mitochondrial membrane 10317 (Reaction) 
17.3.8.1.14.3 PA is converted to CDP-DAG by CDS2 (Reaction) 10319 
17.3.8.1.14.4 CDP-DAG is converted to PGP by PGS1 (Reaction) 10320 
17.3.8.1.14.5 PTPMT1 dephosphorylates PGP to PG (Reaction) 10322 
17.3.8.1.15 Acyl chain remodelling of PG (Pathway) 10324 
17.3.8.1.15.1 PG is hydrolyzed to 1-acyl LPG by PLA2[1] (Reaction) 10325 
17.3.8.1.15.2 PG is hydrolyzed to 1-acyl LPG by PLA2G2A (Reaction) 10326 
17.3.8.1.15.3 1-acyl LPG is acylated to PG by LPGAT (Reaction) 10327 
17.3.8.1.15.4 PG is hydrolyzed to 2-acyl LPG by PLA2[14] (Reaction) 10329 
17.3.8.1.15.5 2-acyl LPG is acylated to PG by LPGAT (Reaction) 10330 
17.3.8.1.15.6 PG is hydrolyzed to 1-acyl LPG by PLA2G4B (IM) (Reaction) 10331 
17.3.8.1.15.7 1-acyl LPG is acylated to PG by CRLS1 (IM) (Reaction) 10332 
17.3.8.1.15.8 PG is hydrolysed to 2-acyl LPG by PLA2G4B (IM) (Reaction) 10333 
17.3.8.1.15.9 2-acyl LPG is acylated to PG by CRLS1 (IM) (Reaction) 10334 
17.3.8.1.15.10 PG is hydrolyzed to 1-acyl LPG by PLA2[16] (Reaction) 10335 
17.3.8.1.16 Synthesis of CL (Pathway) 10337 
17.3.8.1.16.1 PG and CDP-DAG are converted to CL by CRLS1 (Reaction) 10338 
17.3.8.1.17 Acyl chain remodeling of CL (Pathway) 10339 
17.3.8.1.17.1 CL is hydrolyzed to MLCL by PLA2G6 (IM) (Reaction) 10341 
17.3.8.1.17.2 MLCL and PC are converted to CL and 1-acyl LPC by TAZ (IM) 10343 (Reversible) (Reaction) 
17.3.8.1.17.3 CL and 1-acyl LPC are converted to MLCL and PC by TAZ (IM) 10344 (Reversible) (Reaction) 
17.3.8.1.17.4 MLCL and PE are converted to CL and 1-acyl LPE by TAZ (IM) 10346 (Reversible) (Reaction) 
17.3.8.1.17.5 CL and 1-acyl LPE are converted to MLCL and PE by TAZ (IM) 10347 (Reversible) (Reaction) 
17.3.8.1.17.6 MLCL is acylated to CL by HADH (IM) (Reaction) 10348 
17.3.8.1.17.7 MLCL transports from the IM to the ER (Reaction) 10349 
17.3.8.1.17.8 MLCL is acylated to CL by LCLAT1 (ER) (Reaction) 10351 
17.3.8.1.17.9 CL transports from the ER to the IM (Reaction) 10352 
17.3.8.1.17.10 MLCL is hydrolyzed to DLCL by PLA2G4A (IM) (Reaction) 10353 
17.3.8.1.17.11 DLCL transports from the IM to the ER (Reaction) 10354 
17.3.8.1.17.12 DLCL is acylated to MLCL by LCLAT1 (ER) (Reaction) 10355 
17.3.8.1.18 Synthesis of BMP (Pathway) 10356 
17.3.8.1.18.1 PG transports from the ER membrane to the late endosome membrane10358 (Reaction) 
17.3.8.1.18.2 PG is converted to BMP (BlackBoxEvent) 10359 
17.3.8.2 PI Metabolism (Pathway) 10361 
17.3.8.2.1 Synthesis of PIPs at the ER membrane (Pathway) 10363 
17.3.8.2.1.1 PI is phosphorylated to PI4P by PI4KA/2B at the ER membrane (Reaction)
10365 
17.3.8.2.1.2 PI4P is dephosphorylated to PI by SACM1L at the ER membrane 10366 (Reaction) 
17.3.8.2.2 PI and PC transport between ER and Golgi membranes (Pathway) 10368 
17.3.8.2.2.1 PI:PITPNB is transported from the ER membrane to the Golgi membrane
10368 (Reaction) 
17.3.8.2.2.2 PI is exchanged with PC by PITPNB (Reaction) 10368 
17.3.8.2.2.3 PC:PITPNB is transported from the Golgi membrane to the ER membrane
10368 (Reaction) 
17.3.8.2.2.4 PC is exchanged with PI by PITPNB (Reaction) 10369 
17.3.8.2.3 Synthesis of PIPs at the Golgi membrane (Pathway) 10369 
17.3.8.2.3.1 PI is phosphorylated to PI4P by PI4KA/2A/2B at the Golgi membrane 10371 (Reaction) 
17.3.8.2.3.2 PI4KB binds to ARF1/3:GTP at the Golgi membrane (Reaction) 10372 
17.3.8.2.3.3 PI is phosphorylated to PI4P by PI4KB at the Golgi membrane (Reaction)10374 
17.3.8.2.3.4 PI4P is dephosphorylated to PI by SACM1L at the Golgi membrane 10375 (Reaction) 
17.3.8.2.3.5 PI is phosphorylated to PI3P by PIK3C2A/3 at the Golgi membrane 10376 (Reaction) 
17.3.8.2.3.6 PI3P is dephosphorylated to PI by SACM1L at the Golgi membrane 10378 (Reaction) 
17.3.8.2.3.7 PI3P is phosphorylated to PI(3,5)P2 by PIKFYVE at the Golgi membrane10379 (Reaction) 
17.3.8.2.3.8 PI(3,5)P2 is dephosphorylated to PI3P by FIG4 at the Golgi membrane 10382 (Reaction) 
17.3.8.2.3.9 PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A/G at the Golgi membrane
10383 (Reaction) 
17.3.8.2.3.10 PI(3,4)P2 is dephosphorylated to PI4P by TPTE2 at the Golgi membrane
10385 (Reaction) 
17.3.8.2.3.11 PI(4,5)P2 is dephosphorylated to PI4P by OCRL/INPP5E at the Golgi 10386 membrane (Reaction) 
17.3.8.2.4 PIPs transport between Golgi and plasma membranes (Pathway) 10388 
17.3.8.2.4.1 PI4P transports from the Golgi membrane to the plasma membrane 10389 (Reaction) 
17.3.8.2.5 Synthesis of PIPs at the plasma membrane (Pathway) 10391 
17.3.8.2.5.1 PI4P is phosphorylated to PI(4,5)P2 by PIP5K1A-C at the plasma 10392 membrane (Reaction) 
17.3.8.2.5.2 PI(4,5)P2 is dephosphorylated to PI4P by SYNJ/INPP5[1] at the plasma10394 membrane (Reaction) 
17.3.8.2.5.3 PI(4,5)P2 is phosphorylated to PI(3,4,5)P3 by PIK3C[1] at the plasma 10396 membrane (Reaction) 
17.3.8.2.5.4 PI(3,4,5)P3 is dephosphorylated to PI (4,5)P2 by PTEN at the plasma 10398 membrane (Reaction) 
17.3.8.2.5.5 PI(3,4)P2 is phosphorylated to PI(3,4,5)P3 by PIP5K1A-C at the plasma10399 membrane (Reaction) 
17.3.8.2.5.6 PI(3,4,5)P3 is dephosphorylated to PI(3,4)P2 by INPP5[2] at the plasma 10401 membrane (Reaction) 
17.3.8.2.5.7 PI4P is phosphorylated to PI(3,4)P2 by PI3K3C[2] at the plasma membrane 
10403 (Reaction) 
17.3.8.2.5.8 PI(3,4)P2 is dephosphorylated to PI4P by PTEN at the plasma membrane 10405 
(Reaction)  
17.3.8.2.5.9 PI3P is phosphorylated to PI(3,4)P2 by PIP4K2/5K1 at the plasma  10407  
membrane (Reaction)  
17.3.8.2.5.10 PI(3,4)P2 is dephosphorylated to PI3P by INPP4A/B at the plasma  10409  
membrane (Reaction)  

17.3.8.2.5.11 PI3P is dephosphorylated to PI by SYNJ/MTM[1] at the plasma membrane 
10410 (Reaction) 
17.3.8.2.5.12 PI is phosphorylated to PI5P by PIP5K1A/B at the plasma membrane 10412 (Reaction) 
17.3.8.2.5.13 PI3P is phosphorylated to PI(3,5)P2 by PIP5K1A/B at the plasma 10414 membrane (Reaction) 
17.3.8.2.5.14 PI(3,5)P2 is dephosphorylated to PI3P by SYNJ at the plasma membrane 
10415 (Reaction) 
17.3.8.2.5.15 PI(3,5)P2 is dephosphorylated to PI5P by SYNJ/MTM[1] at the plasma 10416 membrane (Reaction) 
17.3.8.2.5.16 PI5P is phosphorylated to PI(4,5)P2 by PIP4K2A/B at the plasma 10418 membrane (Reaction) 
17.3.8.2.5.17 PI is phosphorylated to PI4P by PI4K2A/B at the plasma membrane 10420 (Reaction) 
17.3.8.2.5.18 PI4P is dephosphorylated to PI by SYNJ at the plasma membrane 10421 (Reaction) 
17.3.8.2.6 PIPs transport between plasma and early endosome membranes (Pathway)10423 
17.3.8.2.6.1 PI(3,4)P2 is transported from the plasma membrane to the early endosome 
10424 membrane (Reaction) 
17.3.8.2.7 Synthesis of PIPs at the early endosome membrane (Pathway) 10426 
17.3.8.2.7.1 PI(3,4)P2 is dephosphorylated to PI3P by INPP4A/B at the early endosome 
10427 membrane (Reaction) 
17.3.8.2.7.2 PI3P is phosphorylated to PI(3,5)P2 by PIKFYVE at the early endosome 10429 membrane (Reaction) 
17.3.8.2.7.3 PI(3,5)P2 is dephosphorylated to PI3P by FIG4 at the early endosome 10431 membrane (Reaction) 
17.3.8.2.7.4 PI(3,5)P2 is dephosphorylated to PI5P by MTM[2] at the early endosome 10432 membrane (Reaction) 
17.3.8.2.7.5 PI is phosphorylated to PI3P by PIK3C2A/3 at the early endosome 10434 membrane (Reaction) 
17.3.8.2.7.6 PI3P is dephosphorylated to PI by MTM[2] at the early endosome 10435 membrane (Reaction) 
17.3.8.2.7.7 PI is phosphorylated to PI4P by PI4K2A/B at the early endosome 10437 membrane (Reaction) 
17.3.8.2.7.8 PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A at the early endosome 
membrane (Reaction) 
17.3.8.2.8 PIPs transport between early endosome and Golgi membranes (Pathway) 10439 
17.3.8.2.8.1 PI(3,5)P2 transports from the early endosome membrane to the Golgi 10440 membrane (Reaction) 
17.3.8.2.9 PIPs transport between early and late endosome membranes (Pathway) 10442 
17.3.8.2.9.1 Presence of PI(3,5)P2 stimulates the maturation of the early endosome into
10443 the late endosome (Reaction) 
17.3.8.2.10 Synthesis of PIPs at the late endosome membrane (Pathway) 10444 
17.3.8.2.10.1 PI3P is phosphorylated to PI(3,5)P2 by PIKFYVE at the late endosome10445 membrane (Reaction) 
17.3.8.2.10.2 PI(3,5)P2 is dephosphorylated to PI3P by FIG4 at the late endosome 10448 membrane (Reaction) 
17.3.8.2.10.3 PI(3,5)P2 is dephosphorylated to PI5P by MTM[3] at the late endosome10449 membrane (Reaction) 
17.3.8.2.10.4 PI is phosphorylated to PI5P by PIKFYVE at the late endosome 10451 membrane (Reaction) 
17.3.8.2.10.5 PI is phosphorylated to PI3P by PIK3C2A/3 at the late endosome 10453 membrane (Reaction) 
17.3.8.2.10.6 PI3P is dephosphorylated to PI by MTM[3] at the late endosome 10454 membrane (Reaction) 
17.3.8.2.11 PIPs transport between late endosome and Golgi membranes (Pathway) 10456 
17.3.8.2.11.1 PI(3,5)P2 transports from the late endosome membrane to the Golgi 10457 membrane (Reaction) 
17.3.9 alpha-linolenic (omega3) and linoleic (omega6) acid metabolism (Pathway) 10458 
17.3.9.1 alpha-linolenic acid (ALA) metabolism (Pathway) 10459 
17.3.9.1.1 Activation of alpha-linolenic acid to alpha-linolenoyl-CoA (Reaction) 10461 
17.3.9.1.2 Desaturation of alpha-linoleoyl-CoA to Stearidonoyl-CoA (Reaction) 10462 
17.3.9.1.3 Elongation of stearidonoyl-CoA to eicosatetraenoyl-CoA (Reaction) 10463 
17.3.9.1.4 Desaturation of eicosatetraenoyl-CoA to eicosapentaenoyl-CoA (Reaction)10464 
17.3.9.1.5 Elongation of eicosapentaenoyl-CoA to docosapentaenoyl-CoA (Reaction) 10466 
17.3.9.1.6 Elongation of docosapentaenoyl-CoA to tetracosapentaenoyl-CoA (Reaction)10467 
17.3.9.1.7 Desaturation of tetracosapentaenoyl-CoA to tetracosahexaenoyl-CoA 10468 (Reaction) 
17.3.9.1.8 Translocation of tetracosahexaenoyl-CoA to peroxisomes (Reaction) 10470 
17.3.9.1.9 Oxidation of tetracosapentaenoyl-CoA to delta2-tetracosaheptaenoyl-CoA 10471 (Reaction) 
17.3.9.1.10 Hydration of delta2-tetracosaheptaenoyl-CoA to 3-hydroxy 10472 tetracosahexaenoyl-CoA (Reaction) 
17.3.9.1.11 Dehydrogenation of 3-hydroxy tetracosahexaenoyl-CoA (Reaction) 10474 
17.3.9.1.12 Formation of DHA-CoA catalysed by sterol carrier protein X (SCPx) 10475 (Reaction) 
17.3.9.1.13 Formation of DHA-CoA catalysed by 3-ketoacyl-CoA thiolase (Reaction) 10476 
17.3.9.1.14 Conversion of DHA-CoA to docosahexaenoic acid (DHA) (Reaction) 10477 
17.3.9.1.15 Retranslocation of DHA back to ER (Reaction) 10478 
17.3.9.2 Linoleic acid (LA) metabolism (Pathway) 1043810479 17.3.9.2.1 Activation of linoleic acid to linoleoyl-CoA (Reaction) 10481 
17.3.9.2.2 Desaturation of Linoleoyl-CoA to gamma-linolenoyl-CoA (Reaction) 10482 
17.3.9.2.3 Elongation of gamma-lenolenoyl-CoA to dihomo-gamma-lenolenoyl-CoA 10484 (Reaction) 
17.3.9.2.4 Desaturation of dihomo-gamma-lenolenoyl-CoA to arachidonoyl-CoA 10485 (Reaction) 
17.3.9.2.5 Elongation of arachidonyl-CoA to docosatetraenoyl-CoA (Reaction) 10487 
17.3.9.2.6 Elongation of docosatetraenoyl-CoA to tetracosatetraenoyl-CoA (Reaction)10488 
17.3.9.2.7 Desaturation of tetracosatetraenoyl-CoA to tetracosapentaenoyl-CoA 10489 (Reaction) 
17.3.9.2.8 Translocation of tetracosapentaenoyl-CoA to peroxisomes (Reaction) 10490 
17.3.9.2.9 Peroxisomal beta-oxidation of tetracosapentaenoyl-CoA to 10492 Docosapentaenoyl-CoA (BlackBoxEvent) 
17.3.9.2.10 Translocation of DPA to the ER (Reaction) 10493 
17.3.10 Arachidonic acid metabolism (Pathway) 10494 
17.3.10.1 Hydrolysis of phosphatidylcholine (Reaction) 10495 
17.3.10.2 Arachidonate diffuses across the ER membrane (Reaction) 10497 
17.3.10.3 Synthesis of Prostaglandins (PG) and Thromboxanes (TX) (Pathway) 10498 
17.3.10.3.1 PTGS2 dimer binds celecoxib (Reaction) 10499 
17.3.10.3.2 Aspirin acetylates PTGS1 (Reaction) 10500 
17.3.10.3.3 Aspirin acetylates PTGS2 (Reaction) 10502 
17.3.10.3.4 Arachidonic acid is oxidised to PGG2 by PTGS1 (Reaction) 10503 
17.3.10.3.5 Arachidonic acid is oxidised to PGG2 by PTGS2 (Reaction) 10504 
17.3.10.3.6 PGG2 is reduced to PGH2 by PTGS1 (Reaction) 10506 
17.3.10.3.7 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 10507 
17.3.10.3.8 PGH2 diffuses from the endoplasmic reticulum lumen to the cytosol 10508 (BlackBoxEvent) 
17.3.10.3.9 PGH2 is reduced to PGF2a by AKR1C3 (Reaction) 10509 
17.3.10.3.10 PGH2 is reduced to PGF2a by FAM213B (Reaction) 10510 
17.3.10.3.11 PGH2 is isomerised to PGE2 by PTGES (Reaction) 10512 
17.3.10.3.12 Prostaglandin E synthase isomerizes PGH2 to PGE2 (Reaction) 10513 
17.3.10.3.13 PGE2 is converted to PGF2a by CBR1 (Reaction) 10514 
17.3.10.3.14 PGE2 is dehydrated to PGA2 (Reaction) 10516 
17.3.10.3.15 PGA2 is isomerised to PGC2 (Reaction) 10517 
17.3.10.3.16 PGC2 is isomerised to PGB2 (Reaction) 10518 
17.3.10.3.17 PGA2 is dehydrated to 15d-PGA2 (Reaction) 10519 
17.3.10.3.18 PGH2 is isomerised to PGD2 by PTGDS (Reaction) 10521 
17.3.10.3.19 PGH2 is isomerised to PGD2 by HPGDS (Reaction) 10522 
17.3.10.3.20 PGD2 is dehydrated to PGJ2 (Reaction) 10523 
17.3.10.3.21 PGJ2 is isomerised to delta12-PGJ2 (Reaction) 10524 
17.3.10.3.22 Delta12-PGJ2 is dehydrated to 15d-PGJ2 (Reaction) 10525 
17.3.10.3.23 PGD2 is dehydrated to 15d-PGD2 (Reaction) 10526 
17.3.10.3.24 PGD2 is reduced to 11-epi-PGF2a by AKRIC3 (Reaction) 10527 
17.3.10.3.25 PGD2/E2/F2a is oxidised to 15k-PGD2/E2/F2a by HPGD (Reaction) 10529 
17.3.10.3.26 15k-PGE2/F2a is reduced to dhk-PGE2/F2a by PTGR1 (Reaction) 10530 
17.3.10.3.27 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 10532 
17.3.10.3.28 PGI2 is hydrolysed to 6k-PGF1a (Reaction) 10533 
17.3.10.3.29 PGH2 is isomerised to TXA2 by TBXAS1 (Reaction) 10534 
17.3.10.3.30 TXA2 is hydrolysed to TXB2 (Reaction) 10535 
17.3.10.3.31 TXB2 is converted to 11dh-TXB2 by TXDH (Reaction) 10537 
17.3.10.3.32 PGH2 is degraded to 12S-HHT and MDA by TBXAS1 (Reaction) 10538 
17.3.10.4 Synthesis of Leukotrienes (LT) and Eoxins (EX) (Pathway) 10539 
17.3.10.4.1 ALOX5 is phosphorylated by MAPKAP2 (Reaction) 10541 
17.3.10.4.2 Arachidonic acid is oxidised to 5S-HpETE by ALOX5 (Reaction) 10542 
17.3.10.4.3 5S-HpETE is dehydrated to LTA4 by ALOX5 (Reaction) 10543 
17.3.10.4.4 LTA4 is hydolysed to LTB4 by LTA4H (Reaction) 10545 
17.3.10.4.5 LTB4 is oxidised to 12-oxoLTB4 by PTGR1 (Reaction) 10546 
17.3.10.4.6 LTB4 is hydroxylated to 20oh-LTB4 by CYP4F2/4F3 (Reaction) 10548 
17.3.10.4.7 20oh-LTB4 is oxidised to 20cho-LTB4 by CYP4F2/4F3 (Reaction) 10549 
17.3.10.4.8 20cho-LTB4 is oxidised to 20cooh-LTB4 by CYP4F2/4F3 (Reaction) 10551 
17.3.10.4.9 20cho-LTB4 is oxidised to 20cooh-LTB4 by ALDH (Reaction) 10552 
17.3.10.4.10 20cooh-LTB4 is converted to 18cooh-LTB4 (BlackBoxEvent) 10553 
17.3.10.4.11 LTA4 is converted to LTC4 by LTC4S (Reaction) 10554 
17.3.10.4.12 LTC4 is exported from the cytosol by ABCC1 (Reaction) 10556 
17.3.10.4.13 LTC4 is converted to LTD4 by GGT1/5 (Reaction) 10557 
17.3.10.4.14 LTD4 is converted to LTE4 by DPEP1/2 (Reaction) 10558 
17.3.10.4.15 LTA4 is hydrolysed to 6t-/6t,12epi-LTB4 (Reaction) 10560 
17.3.10.4.16 LTA4 is converted to EXA4 by ALOX15 (Reaction) 10561 
17.3.10.4.17 EXA4 is converted to EXC4 by LTC4S (Reaction) 10563 
17.3.10.4.18 EXC4 is converted to EXD4 by GGT (Reaction) 10564 
17.3.10.4.19 EXD4 is converted to EXE4 by DPEP (Reaction) 10565 
17.3.10.5 Synthesis of 5-eicosatetraenoic acids (Pathway) 10567 
17.3.10.5.1 Arachidonic acid is oxidised to 5S-HpETE by ALOX5 (Reaction) 10568 
17.3.10.5.2 5S-HpETE is reduced to 5S-HETE by GPX1/2/4 (Reaction) 10568 
17.3.10.5.3 5S-HETE is oxidised to 5-oxoETE by 5-HEDH (Reaction) 10570 
17.3.10.6 Synthesis of 15-eicosatetraenoic acid derivatives (Pathway) 10572 
17.3.10.6.1 Arachidonic acid is oxidised to 15S-HpETE by ALOX15/15B (Reaction) 10573 
17.3.10.6.2 15S-HpETE is reduced to 15S-HETE by GPX1/2/4 (Reaction) 10574 
17.3.10.6.3 15S-HETE is oxidised to 15-oxoETE by 15-HEDH (Reaction) 10575 
17.3.10.6.4 Arachidonic acid is oxidised to 15R-HETE by Acetyl-PTGS2 (Reaction) 10577 
17.3.10.7 Synthesis of 12-eicosatetraenoic acid derivatives (Pathway) 10578 
17.3.10.7.1 Arachidonic acid is oxidised to 12R-HpETE by ALOX12B (Reaction) 10579 
17.3.10.7.2 12R-HpETE is reduced to 12R-HETE by GPX1/2/4 (Reaction) 10580 
17.3.10.7.3 Arachidonic acid is oxidised to 12S-HpETE by ALOX12/15 (Reaction) 10582 
17.3.10.7.4 12S-HpETE is reduced to 12S-HETE by GPX1/2/4 (Reaction) 10583 
17.3.10.7.5 Arachidonic acid is converted to 12-oxoETE by ALOX12 (Reaction) 10585 
17.3.10.8 Synthesis of Lipoxins (LX) (Pathway) 10586 
17.3.10.8.1 LTA4 is converted to LXA4/B4 by ALOX12 (Reaction) 10587 
17.3.10.8.2 15S-HpETE is oxidised to LXA4/B4 by ALOX5 (Reaction) 10589 
17.3.10.8.3 15R-HETE is converted to 15epi-LXA4/B4 by ALOX5 (Reaction) 10590 
17.3.10.8.4 LXA4 is oxidised to 15k-LXA4 by HPGD (Reaction) 10592 
17.3.10.8.5 15k-LXA4 is reduced to dhk-LXA4 by PTGR1 (Reaction) 10593 
17.3.10.9 Synthesis of Hepoxilins (HX) and Trioxilins (TrX) (Pathway) 10595 
17.3.10.9.1 Arachidonic acid is converted to HXA3/B3 by ALOX12 (Reaction) 10596 
17.3.10.9.2 HXA3/B3 is hydrolysed to TrXA3/B3 by HXEH (Reaction) 10597 
17.3.10.10 Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) (Pathway) 10599 
17.3.10.10.1 Arachidonic acid is hydroxylated to 16/17/18-HETE by CYP(1) (Reaction)10600 
17.3.10.10.2 Arachidonic acid is hydroxylated to 19-HETE by CYP(2) (Reaction) 10601 
17.3.10.10.3 Arachidonic acid is hydroxylated to 20-HETE by CYP(3) (Reaction) 10603 
17.3.10.11 Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) (Pathway)
10604 
17.3.10.11.1 Arachidonic acid is epoxidated to 5,6-EET by CYP(4) (Reaction) 10606 
17.3.10.11.2 Arachidonic acid is epoxidated to 8,9/11,12/14,15-EET by CYP(5) 10607 (Reaction) 
17.3.10.11.3 EET(1) is hydrolysed to DHET(1) by EPHX2 (Reaction) 10609 
17.3.11 Sphingolipid metabolism (Pathway) 10610 
17.3.11.1 Sphingolipid de novo biosynthesis (Pathway) 10612 
17.3.11.1.1 3-ketosphinganine + NADPH + H+ => sphinganine + NADP+ (Reaction) 10613 
17.3.11.1.2 CERT + ATP => monophospho-CERT + ADP (Reaction) 10614 
17.3.11.1.3 CERT [ER] + ceramide [ER] => CERT:ceramide [ER] (Reaction) 10615 
17.3.11.1.4 CERT:PPM1L:VAPA/B [ER] => CERT [cytosol] + PPM1L:VAPA/B [ER] 10617 (Reaction) 
17.3.11.1.5 CERT:ceramide [ER] => ceramide [Golgi] + CERT [ER] (Reaction) 10618 
17.3.11.1.6 ceramide + H2O stearate + sphingosine [endoplasmic reticulum] (Reaction)10619 
17.3.11.1.7 ceramide + H2O => stearate + sphingosine [Golgi] (Reaction) 10621 
17.3.11.1.8 dihydroceramide + NAD(P)H + H+ + O2 => ceramide + NAD(P)+ + H2O 10622 (Reaction) 
17.3.11.1.9 dihydroceramide + NADPH + H+ + O2 => phytoceramide + NADP+ + H2O10624 (Reaction) 
17.3.11.1.10 monophospho-CERT + 2 ATP => multiphospho-CERT + 2 ADP (Reaction)10625 
17.3.11.1.11 multiphospho-CERT + PPM1L:VAPA/B => 10626 multiphospho-CERT:PPM1L:VAPA/B (Reaction) 
17.3.11.1.12 multiphospho-CERT:PPM1L:VAPA/B + 3 H2O => CERT:PPM1L:VAPA/B +
10628 3 orthophosphate (Reaction) 
17.3.11.1.13 palmitoyl-CoA + serine => 3-ketosphinganine + CoASH + CO2 (Reaction)10629 
17.3.11.1.14 phosphatidylcholine + ceramide sphingomyelin + diacylglycerol [SGMS1]10631 (Reaction) 
17.3.11.1.15 phosphatidylcholine + ceramide sphingomyelin + diacylglycerol [SGMS2]10633 (Reaction) 
17.3.11.1.16 phytoceramide + H2O => stearate + phytosphingosine (Reaction) 10635 
17.3.11.1.17 sphinganine (dihydrosphingosine) +ATP => sphinganine 1-phosphate + 10636 ADP (Reaction) 
17.3.11.1.18 sphinganine + stearyl-CoA => dihydroceramide + CoASH (Reaction) 10637 
17.3.11.1.19 sphinganine 1-phosphate + H2O => sphinganine + orthophosphate 10639 (Reaction) 
17.3.11.1.20 sphinganine 1-phosphate => phosphoethanolamine + hexadecanal 
(Reaction) 
17.3.11.1.21 sphingosine +ATP => sphingosine 1-phosphate + ADP (Reaction) 10641 
17.3.11.1.22 sphingosine 1-phosphate + H2O => sphingosine + orthophosphate 10643 [cytosolic - PPAP] (Reaction) 
17.3.11.1.23 sphingosine 1-phosphate + H2O => sphingosine + orthophosphate 10644 [cytosolic - SGPP] (Reaction) 
17.3.11.1.24 sphingosine 1-phosphate + H2O => sphingosine + orthophosphate 10645 [extracellular] (Reaction) 
17.3.11.1.25 sphingosine 1-phosphate => phosphoethanolamine + hexadec-2-enal 10647 (Reaction) 
17.3.11.2 Glycosphingolipid metabolism (Pathway) 10648 
17.3.11.2.1 Beta-galactosidase hydrolyses GM1 to GM2 (Reaction) 10649 
17.3.11.2.2 Ganglioside GM2 activator presents GM2 to hexosaminidase for cleavage10650 (Reaction) 
17.3.11.2.3 Hexosaminidase A cleaves GalNAc from GM2 to form GM3 (Reaction) 10652 
17.3.11.2.4 Neu5Ac is cleaved from GM3 by NEU1 and 4 to form a globoside (lysosomal
10653 lumen) (Reaction) 
17.3.11.2.5 Beta-galactosidase can also hydrolyse globosides to form cerebrosides 10655 (Reaction) 
17.3.11.2.6 Both hexosaminidase A and B can cleave GalNAc from globoside (Reaction)10656 
17.3.11.2.7 Alpha-galactosidase A removes a terminal galactose from 10658 alpha-D-galactoside oligomers (Reaction) 
17.3.11.2.8 SUMF1 mediates the oxidation of cysteine to formylglycine, producing active
10659 arylsulfatases (Reaction) 
17.3.11.2.9 Active ARSA translocates to the lysosome (BlackBoxEvent) 10661 
17.3.11.2.10 Arylsulfatase A hydrolyses sulfate from sulfatide to form cerebroside 10662 (Reaction) 
17.3.11.2.11 Galactocerebrosidase cleaves the galactosyl bond of galactocerebroside to
10664 form ceramide (Reaction) 
17.3.11.2.12 Sphingomyelin phosphodiesterase (SMPD1) hydrolyses sphingomyelin to10665 ceramide (lysosome) (Reaction) 
17.3.11.2.13 Sphingomyelin phosphodiesterase 2 and 3 (SMPD2 and 3) hydrolyse 10667 sphingomyelin to ceramide (plasma membrane) (Reaction) 
17.3.11.2.14 Sphingomyelin phosphodiesterase 4 (SMPD4) hydrolyses sphingomyelin to
10668 ceramide (ER membrane) (Reaction) 
17.3.11.2.15 Glucosylceramidase cleaves the glucosidic bond of glucocerebroside to 10669 form ceramide (Reaction) 
17.3.11.2.16 Glucosylceramidase 2 cleaves the glucosidic bond of glucocerebroside to10671 form ceramide (plasma membrane) (Reaction) 
17.3.11.2.17 Glucosylceramidase 3 cleaves the glucosidic bond of glucocerebroside to10672 form ceramide (cytosol) (Reaction) 
17.3.11.2.18 Acid ceramidase hydrolyses ceramide into sphingosine and free fatty acid
10673 (lysosome) (Reaction) 
17.3.11.2.19 Ectonucleotide pyrophosphatase/phosphodiesterase 7 (ENPP7) hydrolyses10675 
sphingomyelin (Reaction) 10640 
17.3.11.2.20 Neu5Ac is cleaved from GM3 by NEU2 to form a globoside (cytosol) 10677 (Reaction) 
17.3.11.2.21 Neu5Ac is cleaved from GM3 by NEU3 to form globoside (plasma 10678 membrane) (Reaction) 
17.3.11.2.22 Neutral ceramidase hydrolyses ceramide into sphingosine and free fatty acid
10679 (plasma membrane) (Reaction) 
17.3.11.2.23 Steryl sulfatase hydrolyses sulfate from steroid sulfates (Reaction) 10681 
17.3.11.2.24 Ceramide glucosyltransferase (UGCG) catalyses the transfer of glucose to
10683 ceramide (Reaction) 
17.3.11.2.25 CERK phosphorylates CERA to form C1P (Reaction) 10684 
17.3.12 Ubiquinol biosynthesis (Pathway) 10685 
17.3.12.1 FPP and IPPP are combined into all-E-10PrP2 by PDSS1/2 tetramer (Reaction)
10687 
17.3.12.2 PHB and all-E-10PrP2 are combined into DHB by COQ2 (Reaction) 10688 
17.3.12.3 DHB is hydroxylated to DHDB by COQ6 (Reaction) 10689 
17.3.12.4 DHDB is methylated to MHDB by COQ3 (Reaction) 10691 
17.3.12.5 MHDB is decarboxylated to DMPhOH by MHDB decarboxylase (BlackBoxEvent)10693 
17.3.12.6 DMPhOH is hydroxylated to MDMQ10H2 by DMPhOH monooxygenase 10695 (BlackBoxEvent) 
17.3.12.7 MDMQ10H2 is methylated to DMQ10H2 by COQ5 (Reaction) 10697 
17.3.12.8 DMQ10H2 is hydroxylated to DeMQ10H2 by COQ7 (Reaction) 10698 
17.3.12.9 DeMQ10H2 is methylated to Q10H2 by COQ3 (Reaction) 10700 
17.4 Integration of energy metabolism (Pathway) 10702 
17.4.1 Regulation of insulin secretion (Pathway) 10705 
17.4.1.1 Adrenaline,noradrenaline inhibits insulin secretion (Pathway) 10708 
17.4.1.1.1 Alpha-2A,alpha-2C Adrenergic Receptors bind adrenaline or noradrenaline10710 (Reaction) 
17.4.1.1.2 Alpha-2A,alpha-2C Adrenergic Receptors activate Gi.Go heterotrimeric G 10712 proteins (Reaction) 
17.4.1.1.3 Gi,Go Heterotrimeric G-protein complex dissociates (Reaction) 10714 
17.4.1.1.4 L-type Calcium Channels close in pancreatic beta cells (BlackBoxEvent) 10716 
17.4.1.1.5 Low conductance potassium channels in pancreatic beta cells open in 10718 response to epinephrine (BlackBoxEvent) 
17.4.1.1.6 G-beta:G-gamma inhibits Adenylate cyclase (Reaction) 10721 
17.4.1.2 Acetylcholine regulates insulin secretion (Pathway) 10723 
17.4.1.2.1 Acetylcholine binds Muscarinic Acetylcholine Receptor M3 (Reaction) 10724 
17.4.1.2.2 Muscarinic Acetylcholine Receptor M3 activates Gq (Reaction) 10726 
17.4.1.2.3 Gq alpha:G beta:G gamma dissociates to Gq alpha:GTP and G beta:G gamma
10728 (Reaction) 
17.4.1.2.4 Gq alpha activates Phospholipase C beta (Reaction) 10730 
17.4.1.2.5 Activated Phospholipase C beta-1 hydrolyzes 1-Phosphatidyl-D-myo-inositol
10732 4,5-bisphosphate (Reaction) 
17.4.1.2.6 Diacylgycerol activates Protein kinase C, alpha type (Reaction) 10733 
17.4.1.2.7 Protein kinase C, alpha type phosphorylates MARCKS (Reaction) 10734 
17.4.1.3 Free fatty acids regulate insulin secretion (Pathway) 10736 
17.4.1.3.1 Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion (Pathway)10737 
17.4.1.3.1.1 GPR40 (Free fatty acid receptor 1, FFAR1) binds fatty acids (Reaction) 10738 
17.4.1.3.1.2 GPR40:fatty acid activates Gq (Reaction) 10740 
17.4.1.3.1.3 Gq alpha:G beta:G gamma dissociates to Gq alpha:GTP and G beta:G 10742 gamma (Reaction) 
17.4.1.3.1.4 Gq alpha activates Phospholipase C beta (Reaction) 10742 
17.4.1.3.1.5 Activated Phospholipase C beta-1 hydrolyzes 10743 1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate (Reaction) 
17.4.1.4 Glucagon-like Peptide-1 (GLP1) regulates insulin secretion (Pathway) 10743 
17.4.1.4.1 Glucagon-like Peptide-1 Receptor (GLP1R) binds Glucagon-like peptide-1 10745 (Reaction) 
17.4.1.4.2 GLP-1R:GLP-1 activates G(s) (Reaction) 10747 
17.4.1.4.3 Heterotrimeric G(s) complex rearranges (Reaction) 10749 
17.4.1.4.4 G(s):GTP activates Adenylyl cyclase (Reaction) 10750 
17.4.1.4.5 Activated Adenylyl cyclase synthesizes cyclic AMP (Reaction) 10752 
17.4.1.4.6 PKA:AKAP79:IQGAP1 complex dissociates to active PKA subunits in 10754 response to cAMP (Reaction) 
17.4.1.4.7 Potassium voltage-gated channels close in reponse to PKA (BlackBoxEvent)10756 
17.4.1.4.8 ER calcium channels open in response to activated PKA (BlackBoxEvent) 10758 
17.4.1.4.9 cAMP activates EPAC1 (Reaction) 10760 
17.4.1.4.10 cAMP activates EPAC2 (Reaction) 10762 
17.4.1.4.11 RAP1A exchanges GDP for GTP (Reaction) 10764 
17.4.1.5 Transport of Extracellular Glucose to the Cytosol by GLUT1 and GLUT2 10766 (Reaction) 
17.4.1.6 ADP-ATP translocase maintains a high ADP:ATP ratio in the matrix (Reaction)10768 
17.4.1.7 Closing of Inward Rectifying, ATP-sensitive Potassium Channels (KATP 10769 channels) (Reaction) 
17.4.1.8 Calcium Influx through Voltage-gated Calcium Channels (Reaction) 10772 
17.4.1.9 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel
10775 (Reaction) 
17.4.1.10 Release of calcium from intracellular stores by IP3 receptor activation (Reaction)10776 
17.4.1.11 Exocytosis of Insulin (BlackBoxEvent) 10776 
17.4.2 Glucagon signaling in metabolic regulation (Pathway) 10783 
17.4.2.1 Glucagon binds to Glucagon receptor (Reaction) 10785 
17.4.2.2 Glucagon:GCGR mediates GTP-GDP exchange (Reaction) 10787 
17.4.2.3 G(s):GTP activates Adenylyl cyclase (Reaction) 10788 
17.4.2.4 G alpha (s) activates adenylate cyclase (Reaction) 10788 
17.4.2.5 PKA activation in glucagon signalling (Pathway) 10789 
17.4.2.5.1 Activated Adenylate cyclase catalyses cAMP synthesis (Reaction) 10790 
17.4.2.5.2 cAMP induces dissociation of inactive PKA tetramers (Reaction) 10790 
17.4.3 PKA-mediated phosphorylation of key metabolic factors (Pathway) 10791 
17.4.3.1 Phosphorylation of ChREBP at Thr(666) by PKA (Reaction) 10791 
17.4.3.2 PhosphoChREBP (Thr 666) is exported to cytosol (Reaction) 10793 
17.4.3.3 Phosphorylation of pChREBP (Thr 666) at Ser(196) by PKA (Reaction) 10793 
17.4.3.4 Nuclear transport of pChREBP (Thr 666) protein (Reaction) 10795 
17.4.3.5 Phosphorylation of PF2K-Pase by PKA catalytic subunit (Reaction) 10795 17.4.4 Insulin effects increased synthesis of Xylulose-5-Phosphate (Pathway) 10795 
17.4.4.1 D-fructose 6-phosphate + D-erythrose 4-phosphate sedoheptulose 7-phosphate +
10796 D-glyceraldehyde 3-phosphate (Reaction) 
17.4.4.2 D-glyceraldehyde 3-phosphate + D-fructose 6-phosphate xylulose 5-phosphate +10797 
D-erythrose 4-phosphate (Reaction) 
17.4.4.3 D-glyceraldehyde 3-phosphate + sedoheptulose 7-phosphate xylulose 10797 5-phosphate+ribose 5-phosphate (Reaction) 
17.4.5 Activation of PP2A by Xylulose-5-phosphate (Reaction) 10797 
17.4.6 AMPK inhibits chREBP transcriptional activation activity (Pathway) 10800 
17.4.6.1 AMP binds to gamma subunit of AMP kinase heterotrimer (Reaction) 10801 
17.4.6.2 LKB1 phosphorylates the alpha subunit of AMPK heterotrimer (Reaction) 10802 
17.4.6.3 Phosphorylation of ChREBP at Serine 568 by AMPK (Reaction) 10803 
17.4.7 PP2A-mediated dephosphorylation of key metabolic factors (Pathway) 10805 
17.4.7.1 Dephosphorylation of pChREBP (Ser 196) by PP2A (Reaction) 10806 
17.4.7.2 Dephosphorylation of pChREBP (Ser 568) by PP2A (Reaction) 10807 
17.4.7.3 Dephosphorylation of pChREBP (Thr 666) by PP2A (Reaction) 10808 
17.4.7.4 Dephosphorylation of phosphoPFKFB1 by PP2A complex (Reaction) 10809 
17.4.8 ChREBP activates metabolic gene expression (Pathway) 10809 
17.4.8.1 Formation of ChREBP:MLX heterodimer (Reaction) 10810 
17.4.8.2 Transcriptional activation of pyruvate kinase gene by ChREBP:MLX 10811 (BlackBoxEvent) 
17.4.8.3 Transcriptional activation of Citrate lyase monomer gene by ChREBP:MLX 10813 (BlackBoxEvent) 
17.4.8.4 Transcriptional activation of FAS monomer gene by ChREBP:MLX 10813 (BlackBoxEvent) 
17.4.8.5 Transcriptional activation of Acetyl-CoA carboxylase by ChREBP:MLX 10814 (BlackBoxEvent) 
17.4.8.6 Transcriptional activation of GP-acyl transferase gene by ChREBP:MLX 10815 (BlackBoxEvent) 
17.5 Metabolism of nitric oxide (Pathway) 10815 
17.5.1 eNOS activation and regulation (Pathway) 10817 
17.5.1.1 eNOS activation (Pathway) 10818 
17.5.1.1.1 N-myristoylation of eNOS (Reaction) 10820 
17.5.1.1.2 palmitoylation of eNOS (Reaction) 10821 
17.5.1.1.3 eNOS translocation from Golgi to Caveolae (BlackBoxEvent) 10822 
17.5.1.1.4 eNOS associates with Caveolin-1 (Reaction) 10823 
17.5.1.1.5 eNOS:Caveolin-1 complex binds to CaM (Reaction) 10824 
17.5.1.1.6 HSP90 binds eNOS:Caveolin-1:CaM complex (Reaction) 10825 
17.5.1.1.7 Caveolin-1 dissociates from eNOS:CaM:HSP90 complex (Reaction) 10826 
17.5.1.1.8 AKT1 binds eNOS complex via HSP90 (Reaction) 10827 
17.5.1.1.9 AKT1 phosphorylates eNOS (Reaction) 10828 
17.5.1.1.10 The cofactor BH4 is required for electron transfer in the eNOS catalytic cycle
10830 (Reaction) 
17.5.1.1.11 NO biosynthesis (Reaction) 10831 
17.5.1.1.12 Uncoupled eNOS favours the formation of superoxide (Reaction) 10832 
17.5.1.1.13 Superoxide reacts rapidly with NO to form peroxynitrite (ONOO-) (Reaction)
10834 
17.5.1.1.14 depalmitoylation of eNOS (Reaction) 10835 
17.5.1.1.15 depalmitoylated eNOS translocates from plasma membrane (Reaction) 10836 
17.5.1.2 NOSIP mediated eNOS trafficking (Pathway) 10837 
17.5.1.2.1 eNOS binds NOSIP (Reaction) 10838 
17.5.1.2.2 eNOS:NOSIP translocation from caveolae to intracellular compartments 10838 (BlackBoxEvent) 
17.5.1.3 NOSTRIN mediated eNOS trafficking (Pathway) 10839 
17.5.1.3.1 eNOS:Caveolin-1 complex binds to Nostrin (Reaction) 10840 
17.5.1.3.2 eNOS:Caveolin-1:NOSTRIN complex binds dynamin-2 (Reaction) 10841 
17.5.1.3.3 eNOS:Caveolin-1:NOSTRIN:dynamin-2 complex binds N-WASP (Reaction)10842 
17.5.1.3.4 NOSTRIN mediated translocation of eNOS from plasma membrane 10843 (BlackBoxEvent) 
17.5.1.4 Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation (Pathway)
10844 
17.5.1.4.1 GCH1 reduces GTP to dihydroneopterin triphosphate (Reaction) 10845 
17.5.1.4.2 PTPS is phosphorylated by cGMP-dependant protein kinase II (Reaction) 10847 
17.5.1.4.3 DHNTP is dephosphorylated by PTPS to PTHP (Reaction) 10848 
17.5.1.4.4 Sepiapterin reductase (SPR) is phosphorylated by Ca2+/calmodulin-dependent
10850 protein kinase II (Reaction) 
17.5.1.4.5 PTHP is reduced to BH4 by sepiapterin reductase (SPR) (Reaction) 10851 
17.5.1.4.6 BH4 is oxidised to the BH3 radical during the eNOS catalytic cycle (Reaction)10853 
17.5.1.4.7 Peroxynitrite can oxidise BH4 to the BH3 radical (Reaction) 10854 
17.5.1.4.8 Ferrous iron reduces the BH3 radical back to BH4 (Reaction) 10855 
17.5.1.4.9 Ascorbate can reduce the BH3 radical back to BH4 (Reaction) 10856 
17.5.1.4.10 The BH3 radical can decay to dihydrobiopterin (BH2) (BlackBoxEvent) 10858 
17.5.1.4.11 BH2 binding can lead to eNOS uncoupling (Reaction) 10859 
17.5.1.4.12 GCHFR binds to GCH1 and negatively regulates its activity (Reaction) 10860 
17.5.1.4.13 Salvage - Sepiapterin is reduced to BH2 (Reaction) 10861 
17.5.1.4.14 Salvage - BH2 is reduced to BH4 by DHFR (Reaction) 10862 
17.6 The citric acid (TCA) cycle and respiratory electron transport (Pathway) 10865 
17.6.1 Pyruvate metabolism and Citric Acid (TCA) cycle (Pathway) 10865 
17.6.1.1 Pyruvate metabolism (Pathway) 10867 
17.6.1.1.1 Pyruvate + NADH + H+ (S)-Lactate + NAD+ (Reaction) 10867 
17.6.1.1.2 lactate + H+ [cytosol] lactate + H+ [extracellular] (Reaction) 10868 
17.6.1.1.3 lactate + H+ [extracellular] lactate + H+ [cytosol] (Reaction) 10869 
17.6.1.1.4 (S)-Lactate + NAD+ Pyruvate + NADH + H+ (Reaction) 10870 
17.6.1.1.5 Cytosolic PYR is transported to the mitochondrial matrix by MPC1:MPC2 10871 (Reaction) 
17.6.1.1.6 pyruvate + CoASH + NAD+ => acetylCoA + CO2 + NADH + H+ (Reaction)10873 
17.6.1.1.7 Regulation of pyruvate dehydrogenase (PDH) complex (Pathway) 10876 
17.6.1.1.7.1 PDK-catalyzed phosphorylation (inactivation) of PDC E1 alpha subunit 10877 (Reaction) 
17.6.1.1.7.2 PDP-catalyzed dephosphorylation (activation) of phospho E1 alpha subunit
10879 (Reaction) 
17.6.1.2 Citric acid cycle (TCA cycle) (Pathway) 
17.6.1.2.1 Acetyl-CoA + H2O + Oxaloacetate => Citrate + CoA (Reaction) 10882 
17.6.1.2.2 citrate isocitrate (Reaction) 10883 
17.6.1.2.3 isocitrate citrate (Reaction) 10884 
17.6.1.2.4 isocitrate + NAD+ => alpha-ketoglutarate + CO2 + NADH + H+ [IDH3] 10885 (Reaction) 
17.6.1.2.5 isocitrate + NADP+ => alpha-ketoglutarate + CO2 + NADPH + H+ [IDH2] 10886 (Reaction) 
17.6.1.2.6 NADPH + NAD+ + H+ [cytosol] => NADP+ + NADH + H+ [mitochondrial 10888 matrix] (Reaction) 
17.6.1.2.7 alpha-ketoglutarate + CoASH + NAD+ => succinyl-CoA + CO2 + NADH + H+
10889 (Reaction) 
17.6.1.2.8 GDP + Orthophosphate + Succinyl-CoA GTP + Succinate + CoA (Reaction)10891 
17.6.1.2.9 ADP + Orthophosphate + Succinyl-CoA ATP + Succinate + CoA (Reaction)10892 
17.6.1.2.10 Succinate Fumarate (with FAD redox reaction on enzyme) (Reaction) 10894 
17.6.1.2.11 Fumarate + H2O (S)-Malate (Reaction) 10895 
17.6.1.2.12 (S)-Malate Fumarate + H2O (Reaction) 10896 
17.6.1.2.13 (S)-Malate + NAD+ Oxaloacetate + NADH + H+ (Reaction) 10897 
17.6.1.2.14 Oxaloacetate + NADH + H+ (S)-Malate + NAD+ (Reaction) 10897 
17.6.1.3 Interconversion of 2-oxoglutarate and 2-hydroxyglutarate (Pathway) 10898 
17.6.1.3.1 (S)-2-hydroxyglutarate + FAD => 2-oxoglutarate + FADH2 (Reaction) 10899 
17.6.1.3.2 (R)-2-hydroxyglutarate + FAD => 2-oxoglutarate + FADH2 (Reaction) 10901 
17.6.1.3.3 (R)-2-hydroxyglutarate + succinate semialdehyde 2-oxoglutarate + 10903 4-hydroxybutyrate (Reaction) 
17.6.1.3.4 2-oxoglutarate + 4-hydroxybutyrate (R)-2-hydroxyglutarate + succinate 10904 semialdehyde (Reaction) 
17.6.2 Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat10906 production by uncoupling proteins. (Pathway) 
17.6.2.1 Respiratory electron transport (Pathway) 10907 
17.6.2.1.1 NADH enters the respiratory chain at Complex I (Reaction) 10910 
17.6.2.1.2 Transfer of electrons through the succinate dehydrogenase complex 10912 (Reaction) 
17.6.2.1.3 Reducing equivalents from beta-oxidation of fatty acids transfer to ETF 10914 (Reaction) 
17.6.2.1.4 Transfer of electrons from ETF to ubiquinone by ETF-QO (Reaction) 10914 
17.6.2.1.5 Electron transfer from ubiquinol to cytochrome c of complex III (Reaction) 10915 
17.6.2.1.6 Electron transfer from reduced cytochrome c to molecular oxygen (Reaction)10916 
17.6.2.2 Formation of ATP by chemiosmotic coupling (Pathway) 10918 
17.6.2.2.1 ADP and Pi bind to ATPase (Reaction) 10919 
17.6.2.2.2 ATP is synthesized from ADP and Pi by ATPase (Reaction) 10920 
17.6.2.2.3 Enzyme-bound ATP is released (Reaction) 10921 
17.6.2.3 Mitochondrial Uncoupling Proteins (Pathway) 10922 
17.6.2.3.1 The fatty acid cycling model (Pathway) 10924 
17.6.2.3.1.1 FA anion diffuses laterally to UCP (Reaction) 10925 
17.6.2.3.1.2 FA anion flip-flops to the opposite surface (Reaction) 10925 
17.6.2.3.1.3 The FA anion diffuses away laterally from UCP (Reaction) 10926 17.6.2.3.1.4 FA anion picks up a proton (Reaction) 10926 
17.6.2.3.1.5 FA spontaneously flip-flops back to the matrix side (Reaction) 10927 
17.6.2.3.1.6 The proton is delivered to the matrix side (Reaction) 10928 
17.6.2.3.2 The proton buffering model (Pathway) 10929 
17.6.2.3.2.1 Protons are translocated from the intermembrane space to the matrix 10930 (Reaction) 
17.7 Metabolism of nucleotides (Pathway) 10931 
17.7.1 Purine metabolism (Pathway) 10933 
17.7.1.1 Purine ribonucleoside monophosphate biosynthesis (Pathway) 10934 
17.7.1.1.1 Formation of phosphoribosyl pyrophosphate amidotransferase tetramer 10936 (Reaction) 
17.7.1.1.2 Dissociation of phosphoribosyl pyrophosphate amidotransferase tetramer 10937 (Reaction) 
17.7.1.1.3 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) + H2O + L-glutamine 10938 5-phosphoribosylamine + L-glutamate +pyrophosphate (Reaction) 
17.7.1.1.4 5-Phosphoribosylamine + Glycine + ATP => GAR + ADP + Pi (Reaction) 10940 
17.7.1.1.5 GAR + 10-Formyl-THF => FGAR + THF (Reaction) 10941 
17.7.1.1.6 FGAR + L-Glutamine + ATP + H2O => FGAM + L-Glutamate + ADP + Pi 10943 (Reaction) 
17.7.1.1.7 FGAM + ATP => AIR + ADP + Pi (Reaction) 10944 
17.7.1.1.8 AIR + CO2 => CAIR (Reaction) 10945 
17.7.1.1.9 CAIR + Aspartate + ATP => SAICAR + ADP + Pi (Reaction) 10947 
17.7.1.1.10 SAICAR => AICAR + Fumarate (Reaction) 10948 
17.7.1.1.11 AICAR + 10-Formyl-THF => FAICAR + THF (Reaction) 10949 
17.7.1.1.12 FAICAR => IMP + H2O (Reaction) 10951 
17.7.1.1.13 IMP + H2O + NAD+ => XMP + NADH + H+ [IMPDH1,2] (Reaction) 10952 
17.7.1.1.14 XMP + L-Glutamine + ATP + H2O => GMP + L-Glutamate + AMP + 10953 pyrophosphate (Reaction) 
17.7.1.1.15 IMP + L-Aspartate + GTP => Adenylosuccinate + GDP + Pi [ADSS] 10954 (Reaction) 
17.7.1.1.16 adenylosuccinate => adenosine 5'-monophosphate + fumarate (Reaction)10956 
17.7.1.2 Purine salvage (Pathway) 10957 
17.7.1.2.1 (2'-deoxy)adenosine + H2O => (2'-deoxy)inosine + NH3 [ADA] (Reaction) 10959 
17.7.1.2.2 (2'-deoxy)adenosine + ATP => (d)AMP + ADP [ADK] (Reaction) 10960 
17.7.1.2.3 deoxyadenosine or deoxyguanosine + ATP => dAMP or dGMP + ADP [DCK]
10961 (Reaction) 
17.7.1.2.4 dA, dG, or dI + ATP => dAMP, dGMP, or dIMP + ADP [DGUOK] (Reaction)10962 
17.7.1.2.5 AMP + H2O => IMP + NH3 [AMPD] (Reaction) 10963 
17.7.1.2.6 N6-methyl-AMP + H2O => IMP + methylamine (Reaction) 10963 
17.7.1.2.7 guanine + (deoxy)ribose 1-phosphate (deoxy)guanosine + orthophosphate10965 [NP] (Reaction) 
17.7.1.2.8 hypoxanthine + (deoxy)ribose 1-phosphate (deoxy)inosine + orthophosphate
10966 [NP] (Reaction) 
17.7.1.2.9 Adenine + PRPP => AMP + PPi (Reaction) 10967 
17.7.1.2.10 guanine or hypoxanthine + PRPP => GMP or IMP + PPi [HPRT1] (Reaction)
17.7.1.2.11 GMP + NADPH + H+ => IMP + NADP+ + NH4+ [GMPR,GMPR2] (Reaction)
10969 
17.7.1.3 Purine catabolism (Pathway) 10970 
17.7.1.3.1 AMP, dAMP, GMP, or IMP + H2O => adenosine, deoxyadenosine, guanosine,
10971 or inosine + orthophosphate [NT5E] (Reaction) 
17.7.1.3.2 (d)GMP or (d)IMP + H2O => (2'-deoxy)guanosine or (2'-deoxy)inosine + 10972 orthophosphate [NT5C2] (Reaction) 
17.7.1.3.3 AMP + H2O => adenosine + orthophosphate [NT5C1B] (Reaction) 10973 
17.7.1.3.4 (d)AMP, (d)GMP, or (d)IMP + H2O => (deoxy)adenosine, (deoxy)guanosine, or
10974 (deoxy)inosine + orthophosphate [NT5C1A] (Reaction) 
17.7.1.3.5 (d)GMP or (d)IMP + H2O => (d)G or (d)I + orthophosphate [NT5C] (Reaction)10975 
17.7.1.3.6 (deoxy)guanosine + orthophosphate guanine + (deoxy)ribose 1-phosphate10976 [NP] (Reaction) 
17.7.1.3.7 (deoxy)inosine + orthophosphate hypoxanthine + (deoxy)ribose 1-phosphate
10977 [NP] (Reaction) 
17.7.1.3.8 Guanine + H2O => Xanthine + NH3 (Reaction) 10978 
17.7.1.3.9 Hypoxanthine + H2O + O2 => Xanthine + H2O2 (Reaction) 10979 
17.7.1.3.10 Xanthine + H2O + O2 => Urate + H2O2 (Reaction) 10980 
17.7.1.3.11 2 glutathione, reduced + H2O2 => glutathione, oxidized + 2 H2O (Reaction)10981 
17.7.1.3.12 2 H2O2 => O2 + 2 H2O (Reaction) 10981 
17.7.2 Pyrimidine metabolism (Pathway) 10982 
17.7.2.1 Pyrimidine biosynthesis (Pathway) 10983 
17.7.2.1.1 L-glutamine + 2 ATP + HCO3- + H2O => carbamoyl phosphate + L-glutamate
10984 
+ 2 ADP + orthophosphate (Reaction) 
17.7.2.1.2 carbamoyl phosphate + L-aspartate N-carbamoyl L-aspartate + 10985 orthophosphate (Reaction) 
17.7.2.1.3 N-carbamoyl L-aspartate + H+ (S)-dihydroorotate + H2O (Reaction) 10987 
17.7.2.1.4 (S)-dihydroorotate + ubiquinone => orotate + ubiquinol (Reaction) 10988 
17.7.2.1.5 orotate + 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) orotidine 10990 5'-monophosphate (OMP) + pyrophosphate (Reaction) 
17.7.2.1.6 orotidine 5'-monophosphate => uridine 5'-monophosphate + CO2 (Reaction)10991 
17.7.2.1.7 dCMP + H2O => dUMP + NH4+ (Reaction) 10993 
17.7.2.1.8 dUTP + H2O => dUMP + pyrophosphate (Reaction) 10993 
17.7.2.1.9 dUMP + N5,N10-methylene tetrahydrofolate => TMP + dihydrofolate 10994 (Reaction) 
17.7.2.2 Pyrimidine salvage reactions (Pathway) 10995 
17.7.2.2.1 uracil + (deoxy)ribose 1-phosphate (deoxy)uridine + orthophosphate [UPP]10996 (Reaction) 
17.7.2.2.2 thymine or uracil + 2-deoxy-D-ribose 1-phosphate thymidine or deoxyuridine +
10997 orthophosphate [TYMP] (Reaction) 
17.7.2.2.3 cytidine or uridine + ATP => CMP or UMP + ADP [UCK1] (Reaction) 10998 
17.7.2.2.4 cytidine or uridine + ATP => CMP or UMP + ADP [UCK2] (Reaction) 10999 
17.7.2.2.5 thymidine + ATP => TMP (deoxythymidine 5'-monophosphate) + ADP [TK1]11000 (Reaction) 
17.7.2.2.6 deoxycytidine, thymidine, or deoxyuridine + ATP => dCMP, TMP, or dUMP +
11001 ADP [TK2] (Reaction) 
17.7.2.2.7 (2'-deoxy)cytidine + ATP => (d)CMP + ADP [DCK] (Reaction) 11002 
17.7.2.2.8 (deoxy)cytidine + H2O => (deoxy)uridine + NH4+ [CDA] (Reaction) 11004 
17.7.2.3 Pyrimidine catabolism (Pathway) 11004 
17.7.2.3.1 TMP, (d)UMP, uridine 2' monophosphate, or uridine 3'-monophosphate + H2O
11006 => thymidine, deoxyuridine, or uridine + orthophosphate [NT5M] (Reaction) 
17.7.2.3.2 CMP or TMP or UMP + H2O => cytidine, thymidine, or uridine + 11007 orthophosphate [NT5E] (Reaction) 
17.7.2.3.3 (d)CMP, TMP, or (d)UMP + H2O => (deoxy)cytidine, thymidine, or 11008 (deoxy)uridine + orthophosphate [NT5C3] (Reaction) 
17.7.2.3.4 (d)CMP, TMP, or (d)UMP + H2O => (deoxy)cytidine, thymidine, or 11009 (deoxy)uridine + orthophosphate [NT5C1A] (Reaction) 
17.7.2.3.5 TMP, uridine 2', 3', or 5' monophosphates, or deoxyuridine 3' or 5' 11010 monophosphates + H2O => thymidine or (deoxy)uridine + orthophosphate [NT5C] (Reaction) 
17.7.2.3.6 (deoxy)uridine + orthophosphate uracil + (deoxy)ribose 1-phosphate [UPP]11011 (Reaction) 
17.7.2.3.7 thymidine or deoxyuridine + orthophosphate thymine or uracil + 11012 2-deoxy-D-ribose 1-phosphate [TYMP] (Reaction) 
17.7.2.3.8 uracil + NADPH + H+ => 5,6-dihydrouracil + NADP+ (Reaction) 11013 
17.7.2.3.9 5,6-dihydrouracil + H2O => beta-ureidopropionate (Reaction) 11013 
17.7.2.3.10 beta-ureidopropionate + H2O => beta-alanine + NH4+ + CO2 (Reaction) 11014 
17.7.2.3.11 Mitochondrial uptake of beta-alanine (BlackBoxEvent) 11015 
17.7.2.3.12 beta-alanine + pyruvate => 3-oxopropanoate + alanine (Reaction) 11017 
17.7.2.3.13 thymine + NADPH + H+ => 5,6-dihydrothymine + NADP+ (Reaction) 11018 
17.7.2.3.14 5,6-dihydrothymine + H2O => beta-ureidoisobutyrate (Reaction) 11019 
17.7.2.3.15 beta-ureidoisobutyrate + H2O => 3-aminoisobutyrate + NH4+ + CO2 11020 (Reaction) 
17.7.2.3.16 Mitochondrial uptake of (R)-3-aminoisobutyric acid (BlackBoxEvent) 11021 
17.7.2.3.17 (R)-3-aminoisobutyric acid + pyruvate => 2-methyl-3-oxopropanoate + 11022 alanine (Reaction) 
17.7.3 Synthesis and interconversion of nucleotide di- and triphosphates (Pathway) 11024 
17.7.3.1 (d)AMP + ATP (d)ADP + ADP [AK1] (Reaction) 11026 
17.7.3.2 (d)ADP + ADP (d)AMP + ATP [AK1] (Reaction) 11027 
17.7.3.3 AMP + ATP ADP + ADP [AK2] (Reaction) 11028 
17.7.3.4 ADP + ADP AMP + ATP [AK2] (Reaction) 11029 
17.7.3.5 (d)AMP or (d)CMP + ATP (d)ADP or (d)CDP + ADP [AK5] (Reaction) 11030 
17.7.3.6 (d)ADP or (d)CDP + ADP (d)AMP or (d)CMP + ATP [AK5] (Reaction) 11031 
17.7.3.7 (d)GMP + ATP (d)GDP + ADP [GUK1] (Reaction) 11032 
17.7.3.8 (d)GDP + ADP (d)GMP + ATP [GUK1] (Reaction) 11033 
17.7.3.9 (d)CMP or UMP + ATP (d)CDP or UDP + ADP [CMPK1] (Reaction) 11034 
17.7.3.10 (d)CDP or UDP + ADP (d)CMP or UMP + ATP [CMPK1] (Reaction) 11034 
17.7.3.11 dUMP or TMP + ATP dUDP or TDP + ADP [DTYMK] (Reaction) 11035 
17.7.3.12 dUDP or TDP + ADP dUMP or TMP + ATP [DTYMK] (Reaction) 11036 
17.7.3.13 UTP + glutamine + ATP + H2O => CTP + glutamate + ADP + orthophosphate11037 
[CTPS] (Reaction) 17.7.3.14 UTP + glutamine + ATP + H2O => CTP + glutamate + ADP + orthophosphate11038 [CTPS2] (Reaction) 
17.7.3.15 NDP + reduced glutaredoxin => dNDP + oxidized glutaredoxin + H2O (Reaction)11039 
17.7.3.16 NDP + reduced thioredoxin => dNDP + oxidized thioredoxin + H2O (Reaction)11040 
17.7.3.17 NDP + reduced thioredoxin => dNDP + oxidized thioredoxin + H2O (Reaction)11042 
17.7.3.18 glutaredoxin (oxidized) + glutathione (reduced) => glutaredoxin (reduced) + 11042 glutathione (oxidized) (Reaction) 
17.7.3.19 glutathione (oxidized) + NADPH + H+ => 2 glutathione (reduced) + NADP+ 11043 (Reaction) 
17.7.3.20 thioredoxin, oxidized (nucleus) thioredoxin, oxidized (cytosol) (Reaction) 11043 
17.7.3.21 thioredoxin, oxidized + NADPH + H+ => thioredoxin, reduced + NADP+ 11044 (Reaction) 
17.7.3.22 thioredoxin, reduced (cytosol) thioredoxin, reduced (nucleus) (Reaction) 11044 
17.7.3.23 (d)NDP + ATP (d)NTP + ADP [NME1,2,3] (Reaction) 11045 
17.7.3.24 (d)NTP + ADP (d)NDP + ATP [NME1,2,3] (Reaction) 11047 
17.7.3.25 (d)NDP + ATP (d)NTP + ADP [NME4] (Reaction) 11048 
17.7.3.26 (d)NTP + ADP (d)NDP + ATP [NME4] (Reaction) 11050 
17.7.4 adenosine 5'-diphosphate (cytosolic) adenosine 5'-diphosphate (nuclear) (Reaction)
11052 
17.7.5 cytidine 5'-diphosphate (cytosolic) cytidine 5'-diphosphate (nuclear) (Reaction) 11052 
17.7.6 guanosine 5'-diphosphate (cytosolic) guanosine 5'-diphosphate (nuclear) (Reaction)
11053 
17.7.7 uridine 5'-diphosphate (cytosolic) uridine 5'-diphosphate (nuclear) (Reaction) 11053 
17.7.8 ITPA hydrolyses ITP to IMP (Reaction) 11054 
17.7.9 ITPA hydrolyses dITP to dIMP (Reaction) 11055 
17.7.10 ITPA hydrolyses XTP to XMP (Reaction) 11057 
17.7.11 Phosphate bond hydrolysis by NUDT proteins (Pathway) 11059 
17.7.11.1 NUDT1 hydrolyses 8-oxo-dGTP to 8-oxo-dGMP (Reaction) 11061 
17.7.11.2 NUDT15 hydrolyses 8-oxo-dGTP to 8-oxo-dGMP (Reaction) 11063 
17.7.11.3 NUDT15 hydrolyses 8-oxo-dGDP to 8-oxo-dGMP (Reaction) 11064 
17.7.11.4 NUDT18 hydrolyses 8-oxo-dGDP to 8-oxo-dGMP (Reaction) 11066 
17.7.11.5 NUDT18 hydrolyses 8-oxo-GDP to 8-oxo-GMP (Reaction) 11067 
17.7.11.6 NUDT1 hydrolyses 2-OH-dATP to 2-OH-dAMP (Reaction) 11068 
17.7.11.7 NUDT1 hydrolyses 2-OH-ATP to 2-OH-AMP (Reaction) 11071 
17.7.11.8 NUDT18 hydrolyses 8-OH-dADP to 8-OH-dAMP (Reaction) 11072 
17.7.11.9 NUDT16 hydrolyses dIDP to dIMP (Reaction) 11074 
17.7.11.10 NUDT16 hydrolyses IDP to IMP (Reaction) 11075 
17.7.11.11 Cytosolic NUDT5 hydrolyses ADP-ribose to R5P and AMP (Reaction) 11077 
17.7.11.12 Mitochondrial NUDT9 hydrolyses ADP-ribose to R5P and AMP (Reaction) 11079 
17.8 Metabolism of vitamins and cofactors (Pathway) 11080 
17.8.1 Metabolism of water-soluble vitamins and cofactors (Pathway) 11081 
17.8.1.1 Vitamin C (ascorbate) metabolism (Pathway) 11081 
17.8.1.1.1 GLUT1/3 transports extracellular DHvitC to cytosol (Reaction) 11081 
17.8.1.1.2 SVCT1/2 cotransports extracellular VitC and 2Na+ to cytosol (Reaction) 11082 
17.8.1.1.3 CYB5A:heme reduces SDA to VitC (Reaction) 11082 
17.8.1.1.4 CYB5R3:FAD reduces CYB5A:ferriheme to CYB5A:heme (Reaction) 11083 
17.8.1.1.5 2xGSTOs reduce DHvitC to VitC (Reaction) 11083 
17.8.1.2 Vitamin B1 (thiamin) metabolism (Pathway) 11084 
17.8.1.2.1 SLC19A2/3 transport extracellular THMN to cytosol (Reaction) 11084 
17.8.1.2.2 2xTPK1:Mg2+ phosphorylates THMN (Reaction) 11084 
17.8.1.2.3 TDPK phosphorylates ThDP to ThTP (Reaction) 11085 
17.8.1.2.4 THTPA:Mg2+ hydrolyzes ThTP to TDP (Reaction) 11085 
17.8.1.3 Vitamin B2 (riboflavin) metabolism (Pathway) 11086 
17.8.1.3.1 SLC52A3 transports extracellular RIB to cytosol (Reaction) 11086 
17.8.1.3.2 RFK:Mg2+ phosphorylates RIB (Reaction) 11086 
17.8.1.3.3 FLAD1 phosphorylates FMN (Reaction) 11087 
17.8.1.3.4 2xENPP1 hydrolyzes FAD to FMN (Reaction) 11087 
17.8.1.3.5 2xTRAP hydrolyzes FMN to RIB (Reaction) 11087 
17.8.1.4 Vitamin B5 (pantothenate) metabolism (Pathway) 11088 
17.8.1.4.1 SLC5A6 cotransports extracellular PanK and 2Na+ to cytosol (Reaction) 11088 
17.8.1.4.2 Coenzyme A biosynthesis (Pathway) 11088 
17.8.1.4.2.1 PANK2 phosphorylates PanK (Reaction) 11089 
17.8.1.4.2.2 PANK1/3/4 phosphorylate PanK (Reaction) 11089 
17.8.1.4.2.3 2xPPCS ligates PPanK with Cys (Reaction) 11090 
17.8.1.4.2.4 3xPPCDC:3FMN decarboxylates PPC (Reaction) 11090 
17.8.1.4.2.5 COASY transfers an adenylyl group from ATP to PPANT (Reaction) 11091 
17.8.1.4.2.6 COASY phosphorylates DP-CoA (Reaction) 11091 
17.8.1.4.2.7 SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix (Reaction)
11092 
17.8.1.4.3 Phosphopantetheine conjugation of the ACP domain of FAS (Reaction) 11092 
17.8.1.5 Vitamins B6 activation to pyridoxal phosphate (Pathway) 11093 
17.8.1.5.1 2xPDXK:2xZn2+ phosphorylates PXL (Reaction) 11093 
17.8.1.5.2 2xPDXK:2xZn2+ phosphorylates PXA (Reaction) 11093 
17.8.1.5.3 2xPDKX:2xZn2+ phosphorylates PDX (Reaction) 11094 
17.8.1.5.4 2xPNPO:2xFMN oxidizes PXAP to PXLP (Reaction) 11094 
17.8.1.5.5 2xPNPO:2xFMN oxidizes PDXP to PXLP (Reaction) 11095 
17.8.1.5.6 AOX1 oxidises PXL to PDXate (Reaction) 11095 
17.8.1.6 Cobalamin (Cbl, vitamin B12) transport and metabolism (Pathway) 11096 
17.8.1.6.1 TCN1 binds Cbl (Reaction) 11096 
17.8.1.6.2 Pancreatic proteases degrade TCN1:Cbl (BlackBoxEvent) 11096 
17.8.1.6.3 GIF binds Cbl (Reaction) 11097 
17.8.1.6.4 CUBN:AMN binds GIF:Cbl (Reaction) 11097 
17.8.1.6.5 CUBN:AMN transports extracellular GIF:Cbl to endosome (Reaction) 11097 
17.8.1.6.6 Endosomal GIF:Cbl translocates to lysosome (BlackBoxEvent) 11098 
17.8.1.6.7 GIF:Cbl is degraded to release Cbl (BlackBoxEvent) 11098 
17.8.1.6.8 LMBRD1 transports lysosomal Cbl to cytosol (Reaction) 11098 
17.8.1.6.9 MMACHC reduces Cbl (Reaction) 11099 
17.8.1.6.10 MMACHC decyanates CNCbl (Reaction) 11099 
17.8.1.6.11 MMACHC:cob(II)alamin binds MMADHC (Reaction) 11099 
17.8.1.6.12 cob(II)alamin dissociates from MMACHC:MMADHC (BlackBoxEvent) 11100 
17.8.1.6.13 cob(II)alamin binds to MTRR:MTR (Reaction) 11100 
17.8.1.6.14 MTRR reduces cob(II)alamin to meCbl (Reaction) 11100 
17.8.1.6.15 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 11101 
17.8.1.6.16 MTR transfers CH3 group from MTHF to cob(I)alamin (Reaction) 11101 
17.8.1.6.17 MMADHC targets transport of cytosolic cob(II)alamin to mitochondria 11102 (BlackBoxEvent) 
17.8.1.6.18 Unknown reductase reduces cob(II)alamin to cob(I)alamin (Reaction) 11102 
17.8.1.6.19 MMAB transfers adenosyl group from ATP to cob(I)alamin (Reaction) 11103 
17.8.1.6.20 MMAA:MUT binds AdoCbl (Reaction) 11103 
17.8.1.6.21 MUT isomerises L-MM-CoA to SUCC-CoA (Reaction) 11103 
17.8.1.6.22 ABCC1 transports cytosolic Cbl to extracellular region (Reaction) 11104 
17.8.1.6.23 TCII binds Cbl in the circulation (Reaction) 11104 
17.8.1.6.24 TCN1 binds Cbl in the circulation (Reaction) 11104 
17.8.1.6.25 CD320 transports extracellular TCII:Cbl to endosome (Reaction) 11105 
17.8.1.6.26 CD320:TCII:Cbl dissociates into CD320 and TCII:Cbl (Reaction) 11105 
17.8.1.6.27 Endosomal TCII:Cbl translocates to lysosome (BlackBoxEvent) 11105 
17.8.1.6.28 TCII:Cbl is degraded to release Cbl (BlackBoxEvent) 11106 
17.8.1.7 Biotin transport and metabolism (Pathway) 11106 
17.8.1.7.1 SLC5A6 cotransports extracellular Btn and 2xNa+ to cytosol (Reaction) 11106 
17.8.1.7.2 HLCS biotinylates PCCA:PCCB (Reaction) 11107 
17.8.1.7.3 HLCS biotinylates PC:Mn2+ (Reaction) 11107 
17.8.1.7.4 HLCS biotinylates MCCC1:MCCC2 (Reaction) 11107 
17.8.1.7.5 Cytoslic carboxylases translocate to mitochondrial matrix (BlackBoxEvent) 11108 
17.8.1.7.6 HLCS biotinylates ACACA (Reaction) 11108 
17.8.1.7.7 HLCS biotinylates ACACB (Reaction) 11108 
17.8.1.7.8 An unknown protease degrades hCBXs (BlackBoxEvent) 11109 
17.8.1.7.9 An unknown protease degrades ACACA (BlackBoxEvent) 11109 
17.8.1.7.10 An unknown protease degrades ACACB (BlackBoxEvent) 11110 
17.8.1.7.11 Mitochondrial BTD hydrolyses BCTN (Reaction) 11110 
17.8.1.7.12 BCTN translocates to extracellular region (BlackBoxEvent) 11111 
17.8.1.7.13 Extracellular BTD hydrolyses BCTN (Reaction) 11111 
17.8.1.8 Nicotinate metabolism (Pathway) 11111 
17.8.1.8.1 2-amino 3-carboxymuconate semialdehyde transforms non-enzymatically to11112 quinolinate (Reaction) 
17.8.1.8.2 A phospho-ribosyl group is added to quinolinate (Reaction) 11112 
17.8.1.8.3 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate 11113 [NMNAT1] (Reaction) 
17.8.1.8.4 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate 11113 [NMNAT2] (Reaction) 
17.8.1.8.5 Nicotinate D-ribonucleotide + ATP => deamino-NAD+ + pyrophosphate 11114 [NMNAT3] (Reaction) 
17.8.1.8.6 Amidation of deamino-NAD+ to NAD+ (Reaction) 11114 
17.8.1.8.7 NAD+ is phosphorylated to NADP+ (Reaction) 11115 
17.8.1.8.8 Nicotinamide salvaging (Pathway) 11115 
17.8.1.8.8.1 Deamination of nicotinamide to nicotinate (Reaction) 11115 
17.8.1.8.8.2 Condensation of nicotinamide to nicotinamide D-ribonucleotide (NMN) 11116 (Reaction) 
17.8.1.8.8.3 A phosphoribosyl group is added to nicotinate to form nicotinate 
mononucleotide (NaMN) (Reaction) 
17.8.1.8.8.4 PGG2 is reduced to PGH2 by PTGS2 (Reaction) 11117 
17.8.1.8.8.5 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 11117 
17.8.1.9 Metabolism of folate and pterines (Pathway) 11117 
17.8.1.9.1 Extracellular folate import across the plasma membrane (Reaction) 11117 
17.8.1.9.2 Cytosolic folate export across the plasma membrane (Reaction) 11118 
17.8.1.9.3 Extracellular 5-methyltetrahydrofolate import across the plasma membrane11118 (Reaction) 
17.8.1.9.4 Folate is reduced to dihydrofolate (DHF) (Reaction) 11119 
17.8.1.9.5 DHF is reduced to tetrahydrofolate (THF) (Reaction) 11119 
17.8.1.9.6 Conversion of cytosolic THF to THF-polyglutamate (Reaction) 11119 
17.8.1.9.7 Conversion of cytosolic 5-methyltetrahydrofolate (5-methylTHF) to 11120 5-methylTHF-polyglutamate (Reaction) 
17.8.1.9.8 Cytosolic tetrahydrofolate import across the inner mitochondrial membrane11120 (Reaction) 
17.8.1.9.9 Mitochondrial tetrahydrofolate export across the inner mitochondrial membrane
11121 (Reaction) 
17.8.1.9.10 Conversion of mitochondrial THF to THF-polyglutamate (Reaction) 11121 
17.8.1.9.11 THF polyglutamate + formate + ATP => 10-formylTHF polyglutamate + ADP
11122 + orthophosphate (Reaction) 
17.8.1.9.12 10-formylTHF polyglutamate 5,10-methenylTHF polyglutamate + H2O 11122 (Reaction) 
17.8.1.9.13 5,10-methenylTHF polyglutamate + NADPH + H+ 5,10-methyleneTHF 11123 polyglutamate + NADP+ (Reaction) 
17.8.1.9.14 Tetrahydrofolate polyglutamate (THF polyglutamate) + serine 11123 5,10-methyleneTHF polyglutamate + glycine (Reaction) 
17.8.1.9.15 5,10-methyleneTHF polyglutamate + NADPH + H+ => 5-methylTHF 11124 polyglutamate + NADP+ (Reaction) 
17.8.1.9.16 5,10-methyleneTHF polyglutamate + glycine tetrahydrofolate polyglutamate
11124 (THF polyglutamate) + serine (Reaction) 
17.8.1.9.17 5,10-methyleneTHF polyglutamate + NADP+ 5,10-methenylTHF 11125 polyglutamate + NADPH + H+ (Reaction) 
17.8.1.9.18 5,10-methenylTHF polyglutamate + H2O 10-formylTHF polyglutamate 11125 (Reaction) 
17.8.1.10 Molybdenum cofactor biosynthesis (Pathway) 11126 
17.8.1.10.1 Cyclisation of GTP to precursor Z (Reaction) 11126 
17.8.1.10.2 NFS1 transfers sulfur from cysteine onto MOCS3 (Reaction) 11126 
17.8.1.10.3 Transfer of sulfur from MOCS3-S-S onto MOCS2A (Reaction) 11127 
17.8.1.10.4 Sulfhydrylation and ring cleavage of precursor Z (Reaction) 11127 
17.8.1.10.5 Molybdenum ion transfer onto molybdopterin (Reaction) 11127 
17.8.1.10.6 Exchange of oxygen with sulfur in MoCo (Reaction) 11128 
17.9 Metabolism of amino acids and derivatives (Pathway) 11128 
17.9.1 Amino acid synthesis and interconversion (transamination) (Pathway) 11129 
17.9.1.1 alanine + alpha-ketoglutarate pyruvate + glutamate [GPT] (Reaction) 11130 

17.9.1.2 pyruvate + glutamate alanine + alpha-ketoglutarate [GPT] (Reaction) 1111611131 17.9.1.3 alanine + alpha-ketoglutarate pyruvate + glutamate [GPT2] (Reaction) 11132 
17.9.1.4 pyruvate + glutamate alanine + alpha-ketoglutarate [GPT2] (Reaction) 11133 
17.9.1.5 aspartate + alpha-ketoglutarate oxaloacetate + glutamate [GOT1] (Reaction) 11135 
17.9.1.6 oxaloacetate + glutamate aspartate + alpha-ketoglutarate [GOT1] (Reaction) 11135 
17.9.1.7 aspartate + alpha-ketoglutarate oxaloacetate + glutamate [GOT2] (Reaction) 11136 
17.9.1.8 oxaloacetate + glutamate aspartate + alpha-ketoglutarate [GOT2] (Reaction) 11137 
17.9.1.9 ornithine + alpha-ketoglutarate glutamate + L-glutamate gamma-semialdehyde11137 [OAT] (Reaction) 
17.9.1.10 glutamate + L-glutamate gamma-semialdehyde ornithine + alpha-ketoglutarate
11138 [OAT] (Reaction) 
17.9.1.11 glutamate + ATP + NADPH + H+ => L-glutamate gamma-semialdehyde + 11139 NADP+ + ADP + orthophosphate [P5CS] (Reaction) 
17.9.1.12 L-glutamate gamma-semialdehyde L-1-pyrroline-5-carboxylate (Reaction) 11140 
17.9.1.13 L-1-pyrroline-5-carboxylate + NADPH + H+ => proline + NADP+ (Reaction) 11141 
17.9.1.14 aspartate + glutamine + ATP asparagine + glutamate + AMP + pyrophosphate
11142 [ASNS] (Reaction) 
17.9.1.15 alpha-ketoglutarate + NH4+ + NAD(P)H + H+ glutamate + NAD(P)+ [GLUD1]11142 (Reaction) 
17.9.1.16 glutamate + NAD(P)+ => alpha-ketoglutarate + NH4+ + NAD(P)H + H+ [GLUD1]
11144 (Reaction) 
17.9.1.17 glutamate + NH4+ + ATP => glutamine + ADP + orthophosphate [GLUL] 11145 (Reaction) 
17.9.1.18 glutamine + H2O => glutamate + NH4+ [GLS] (Reaction) 11146 
17.9.1.19 glutamine + pyruvate => 2-oxoglutaramate + alanine (Reaction) 11147 
17.9.1.20 Serine biosynthesis (Pathway) 11149 
17.9.1.20.1 3-phosphoglycerate is dehydrogenated (Reaction) 11150 
17.9.1.20.2 3-phosphonooxypyruvic acid + L-glutamate = O-phospho-L-serine + 11151 2-oxoglutarate (Reaction) 
17.9.1.20.3 phosphoserine is dephosphorylated (Reaction) 11152 
17.9.2 Branched-chain amino acid catabolism (Pathway) 11154 
17.9.2.1 leu, ile, or val + alpha-ketoglutarate a-ketoisocaproate, a-keto-b-methylvalerate, or
11155 a-ketoisovalerate + glutamate [BCAT1] (Reaction) 
17.9.2.2 a-ketoisocaproate, a-keto-b-methylvalerate, or a-ketoisovalerate + glutamate leu,
11156 ile, or val + alpha-ketoglutarate [BCAT1] (Reaction) 
17.9.2.3 leu, ile, or val + alpha-ketoglutarate a-ketoisocaproate, a-keto-b-methylvalerate, or
11157 a-ketoisovalerate + glutamate [BCAT2] (Reaction) 
17.9.2.4 a-ketoisocaproate, a-keto-b-methylvalerate, or a-ketoisovalerate + glutamate leu,
11158 ile, or val + alpha-ketoglutarate [BCAT2] (Reaction) 
17.9.2.5 a-ketoisocaproate, a-keto b-methylvalerate, or a-ketoisovalerate + CoA + NAD+
11160 => isovaleryl-CoA, a-methylbutyryl-CoA, or isobuyryl-CoA + CO2 + NADH + H+ (Reaction) 
17.9.2.6 isovaleryl-CoA + FAD => beta-methylcrotonyl-CoA + FADH2 (Reaction) 11162 
17.9.2.7 beta-methylcrotonyl-CoA + ATP + CO2 beta-methylglutaconyl-CoA + ADP + 11163 orthophosphate + H2O [MCCA] (Reaction) 
17.9.2.8 beta-methylglutaconyl-CoA + ADP + orthophosphate + H2O 
11164 beta-methylcrotonyl-CoA + ATP + CO2 [MCCA] (Reaction) 
17.9.2.9 beta-methylglutaconyl-CoA + H2O beta-hydroxy-beta-methylglutaryl-CoA 11165 (Reaction) 
17.9.2.10 alpha-methylbutyryl-CoA + FAD => tiglyl-CoA + FADH2 (Reaction) 11166 
17.9.2.11 tiglyl-CoA + H2O alpha-methyl-beta-hydroxybutyryl-CoA (Reaction) 11167 
17.9.2.12 alpha-methyl-beta-hydroxybutyryl-CoA + NAD+ alpha-methylacetoacetyl-CoA +
11168 NADH + H+ (Reaction) 
17.9.2.13 alpha-methylacetoacetyl-CoA + NADH + H+ 
11169 alpha-methyl-beta-hydroxybutyryl-CoA + NAD+ (Reaction) 
17.9.2.14 alpha-methyl-acetoacetyl-CoA + CoA => propionyl-CoA + acetyl-CoA (Reaction)11170 
17.9.2.15 isobutyryl-CoA + FAD => methacrylyl-CoA + FADH2 (Reaction) 11170 
17.9.2.16 methacrylyl-CoA + H2O beta-hydroxyisobutyryl-CoA (Reaction) 11171 
17.9.2.17 beta-hydroxyisobutyryl-CoA + H2O => beta-hydroxyisobutyrate + CoA 11172 (Reaction) 
17.9.2.18 beta-hydroxyisobutyrate + NAD+ methylmalonyl semialdehyde + NADH + H+11173 (Reaction) 
17.9.2.19 methylmalonyl semialdehyde + NADH + H+ beta-hydroxyisobutyrate + NAD+11174 (Reaction) 
17.9.2.20 methylmalonate semialdehyde + NAD+ + CoA => propionyl-CoA + CO2 + NADH11175 
+ H+ (Reaction) 
17.9.3 Histidine catabolism (Pathway) 11176 
17.9.3.1 histidine => urocanate + NH4+ (Reaction) 11176 
17.9.3.2 urocanate + H2O => 4-imidazolone-5-propionate (Reaction) 11177 
17.9.3.3 4-imidazolone-5-propionate + H2O => N-formiminoglutamate + 2H+ (Reaction)11179 
17.9.3.4 N-formiminoglutamate + tetrahydrofolate => glutamate + 11180 5-formiminotetrahydrofolate (Reaction) 
17.9.3.5 Histidine is decarboxylated to histamine (Reaction) 11181 
17.9.4 Lysine catabolism (Pathway) 11182 
17.9.4.1 lysine + alpha-ketoglutarate +NADPH + H+ => saccharopine + NADP+ + H2O11184 (Reaction) 
17.9.4.2 saccharopine + NAD+ + H2O => alpha-aminoadipic semialdehyde + glutamate +
11185 NADH + H+ (Reaction) 
17.9.4.3 alpha-aminoadipic semialdehyde + NAD+ => alpha-aminoadipate + NADH + H+
11186 (Reaction) 
17.9.4.4 alpha-aminoadipate + alpha-ketoglutarate alpha-ketoadipate + glutamate 11188 (Reaction) 
17.9.4.5 alpha-ketoadipate + glutamate alpha-aminoadipate + alpha-ketoglutarate 11189 (Reaction) 
17.9.4.6 2-oxoglutarate [mitochondrial matrix] + 2-oxoadipate [cytosol] 2-oxoglutarate 11190 [cytosol] + 2-oxoadipate [mitochondrial matrix] (Reaction) 
17.9.4.7 alpha-ketoadipate + CoASH + NAD+ => glutaryl-CoA + CO2 + NADH + H+ 11191 (Reaction) 
17.9.4.8 glutaryl-CoA + FAD => crotonyl-CoA + FADH2 + CO2 (Reaction) 11193 
17.9.5 Phenylalanine and tyrosine catabolism (Pathway) 11195 
17.9.5.1 phenylalanine + pyruvate => 3-(indol-3-yl)pyruvate + alanine (Reaction) 11196 
17.9.5.2 phenylalanine + tetrahydrobiopterin + O2 => tyrosine + 4a-hydroxytetrahydrobiopterin + H2O (Reaction) 
17.9.5.3 4a-hydroxytetrahydrobiopterin => q-dihydrobiopterin + H2O (Reaction) 11198 
17.9.5.4 q-dihydrobiopterin + NADH + H+ => tetrahydrobiopterin + NAD+ (Reaction) 11199 
17.9.5.5 tyrosine + alpha-ketoglutarate p-hydroxyphenylpyruvate + glutamate (Reaction)11200 
17.9.5.6 p-hydroxyphenylpyruvate + glutamate tyrosine + alpha-ketoglutarate (Reaction)11201 
17.9.5.7 p-hydroxyphenylpyruvate + O2 => homogentisate + CO2 (Reaction) 11202 
17.9.5.8 homogentisate + O2 => maleylacetoacetate (Reaction) 11203 
17.9.5.9 maleylacetoacetate => fumarylacetoacetate (Reaction) 11204 
17.9.5.10 fumarylacetoacetate => fumarate + acetoacetate (Reaction) 11205 
17.9.6 Proline catabolism (Pathway) 11206 
17.9.6.1 proline => L-1-pyrroline-5-carboxylate (Reaction) 11207 
17.9.6.2 L-1-pyrroline-5-carboxylate L-glutamate gamma-semialdehyde (Reaction) 11208 
17.9.6.3 L-glutamate gamma-semialdehyde + NAD+ => glutamate + NADH + H+ 11209 (Reaction) 
17.9.7 Tryptophan catabolism (Pathway) 11210 
17.9.7.1 tryptophan + O2 => N-formylkynurenine [TDO] (Reaction) 11211 
17.9.7.2 tryptophan + O2 => N-formylkynurenine [IDO] (Reaction) 11212 
17.9.7.3 tryptophan + O2 => N-formylkynurenine [IDO2] (Reaction) 11213 
17.9.7.4 N-formylkynurenine + H2O => kynurenine + formate (Reaction) 11215 
17.9.7.5 kynurenine + pyruvate => 4-(2-aminophenyl)-2,4-dioxobutanoic acid + alanine11216 [CCBL1] (Reaction) 
17.9.7.6 kynurenine + pyruvate => 4-(2-aminophenyl)-2,4-dioxobutanoic acid + alanine11217 [CCBL2] (Reaction) 
17.9.7.7 4-(2-aminophenyl)-2,4-dioxobutanoate => kynurenic acid + H2O [cytosolic] 11219 (Reaction) 
17.9.7.8 kynurenine + O2 + NADPH + H+ => 3-hydroxykynurenine + NADP+ + H2O 11220 (Reaction) 
17.9.7.9 3-hydroxykynurenine + H2O => 3-hydroxyanthranilate + alanine (Reaction) 11221 
17.9.7.10 3-hydroxyanthranilate + O2 => 2-amino-3-carboxymuconate semialdehyde 11222 (Reaction) 
17.9.7.11 2-amino-3-carboxymuconate semialdehyde => 2-aminomuconate semialdehyde11223 
+ CO2 (Reaction) 
17.9.7.12 2-aminomuconate semialdehyde + NAD+ + H2O => aminomuconate + NADH +
11225 H+ (Reaction) 
17.9.7.13 kynurenine + 2-oxoglutarate => 4-(2-aminophenyl)-2,4-dioxobutanoic acid + 11226 glutamate (Reaction) 
17.9.7.14 4-(2-aminophenyl)-2,4-dioxobutanoate => kynurenic acid + H2O [mitochondrial]
11228 (Reaction) 
17.9.8 Urea cycle (Pathway) 11229 
17.9.8.1 glutamate + acetyl CoA => N-acetyl glutamate + CoA (Reaction) 11230 
17.9.8.2 2 ATP + NH4+ + HCO3- => 2 ADP + orthophosphate + carbamoyl phosphate 11231 [mitochondrial] (Reaction) 
17.9.8.3 carbamoyl phosphate + ornithine => citrulline + orthophosphate (Reaction) 11233 
17.9.8.4 ATP + aspartate + citrulline argininosuccinate + AMP + pyrophosphate (Reaction)11234 
17.9.8.5 argininosuccinate fumarate + arginine (Reaction) 1119711235 17.9.8.6 arginine + H2O => ornithine + urea [ARG1] (Reaction) 11236 
17.9.8.7 arginine + H2O => ornithine + urea [ARG2] (Reaction) 11237 
17.9.8.8 ornithine (cytosolic) + citrulline (mitochondrial) => ornithine (mitochondrial) + 11239 citrulline (cytosolic) (Reaction) 
17.9.9 Carnitine synthesis (Pathway) 11240 
17.9.9.1 trimethyllysine + alpha-ketoglutarate + O2 => beta-hydroxy-trimethyllysine + 11241 succinate + CO2 (Reaction) 
17.9.9.2 beta-hydroxy-trimethyllysine => gamma-butyrobetaine aldehyde + glycine 11242 (Reaction) 
17.9.9.3 gamma-butyrobetaine semialdehyde + NAD+ => gamma-butyrobetaine + NADH +
11242 H+ (Reaction) 
17.9.9.4 gamma-butyrobetaine + alpha-ketoglutarate + O2 => carnitine + succinate + CO2
11243 (Reaction) 
17.9.10 Creatine metabolism (Pathway) 11244 
17.9.10.1 arginine + glycine => ornithine + guanidoacetate (Reaction) 11245 
17.9.10.2 guanidinoacetate + S-adenosylmethionine => creatine + 11246 S-adenosylhomocysteine (Reaction) 
17.9.10.3 creatine + ATP => phosphocreatine + ADP [CKB,CKM] (Reaction) 11246 
17.9.10.4 creatine + ATP => phosphocreatine + ADP [CK octamer] (Reaction) 11247 
17.9.10.5 phosphocreatine + H2O => creatinine + orthophosphate (Reaction) 11249 
17.9.10.6 Creatine transport across the plasma membrane (Reaction) 11250 
17.9.11 Metabolism of polyamines (Pathway) 11251 
17.9.11.1 Agmatine biosynthesis (Pathway) 11253 
17.9.11.1.1 ArginineAgmatine+CO2 (Reaction) 11254 
17.9.11.1.2 Agmatine + H2O putrescine + urea (BlackBoxEvent) 11255 
17.9.11.2 ornithine => putrescine + CO2 (Reaction) 11256 
17.9.11.3 S-Adenosyl methionine Decarboxylated-Adenosyl methionine + CO2 (Reaction)11257 
17.9.11.4 Putrescine + dc-Adenosyl methionine => Spermidine + 5'-methylthioadenosine
11259 (Reaction) 
17.9.11.5 dc-Adenosyl methionine + Spermidine => Spermine + 5'-methylthioadenosine11260 (Reaction) 
17.9.11.6 Interconversion of polyamines (Pathway) 11261 
17.9.11.6.1 Spermidine => N-acetylated spermidine (Reaction) 11263 
17.9.11.6.2 N-acetylated spermidine (cytosol)=>N-acetylated spermidine (peroxisomal)11264 (Reaction) 
17.9.11.6.3 N-acetylspermidine is oxidized to putrescine (Reaction) 11265 
17.9.11.6.4 Spermine => N-acetylated spermine (Reaction) 11266 
17.9.11.6.5 N-acetylated spermine (cytosol)=>N-acetylated spermine (peroxisomal) 11268 (BlackBoxEvent) 
17.9.11.6.6 N-acetylspermine is oxidised to spermidine (Reaction) 11269 
17.9.11.6.7 Spermine is oxidized to spermidine (Reaction) 11270 
17.9.11.7 Methionine salvage pathway (Pathway) 11271 
17.9.11.7.1 MTA is cleaved and phosphorylated (Reaction) 11273 
17.9.11.7.2 Methylthio-ribose-P = Methylthio-ribulose-P (Reaction) 11274 
17.9.11.7.3 Methylthio-ribulose-P = Methylthio-ribose-P (Reaction) 11275 
17.9.11.7.4 Dehydration of methylthio-ribulose-P (Reaction) 11277 
17.9.11.7.5 Acireductone is created (Reaction) 11278 
17.9.11.7.6 Acireductone is oxidized to MOB (Reaction) 11279 
17.9.11.7.7 Transamination of MOB to methionine (Reaction) 11281 
17.9.12 Regulation of ornithine decarboxylase (ODC) (Pathway) 11282 
17.9.12.1 Antizyme OAZ binds to Ornithine decarboxylase (Reaction) 11284 
17.9.12.2 26S proteosome degrades ODC holoenzyme complex (BlackBoxEvent) 11286 
17.9.12.3 Antizyme inhibitor binds to OAZ and stablizes ODC complex (Reaction) 11287 
17.9.12.4 NQO1 interaction with ODC (Reaction) 11289 
17.9.13 Amine-derived hormones (Pathway) 11290 
17.9.13.1 Catecholamine biosynthesis (Pathway) 11291 
17.9.13.1.1 Tyrosine is hydroxylated to dopa (Reaction) 11292 
17.9.13.1.2 Dopa is decarboxylated to dopamine (Reaction) 11294 
17.9.13.1.3 Dopamine translocates to a secretory vesicle (BlackBoxEvent) 11295 
17.9.13.1.4 Dopamine is oxidised to noradrenaline (Reaction) 11296 
17.9.13.1.5 Noradrenaline translocates to the cytosol (BlackBoxEvent) 11297 
17.9.13.1.6 Noradrenaline is converted to adrenaline (Reaction) 11299 
17.9.13.2 Thyroxine biosynthesis (Pathway) 11300 
17.9.13.2.1 Iodide is taken up by thyroid epithelial cells (Reaction) 11301 
17.9.13.2.2 Iodide is organified (Reaction) 11302 
17.9.13.2.3 Tyrosine is monoiodinated (Reaction) 11304 
17.9.13.2.4 Monoiodinated tyrosine can be deiodinated (Reaction) 11305 
17.9.13.2.5 Tyrosine is diiodinated (Reaction) 11306 
17.9.13.2.6 Diiodinated tyrosine can be deiodinated (Reaction) 11307 
17.9.13.2.7 DIT and MIT combine to form triiodothyronine (Reaction) 11309 
17.9.13.2.8 Two DITs combine to form thyroxine (Reaction) 11310 
17.9.13.2.9 Regulation of thyroid hormone activity (Pathway) 11311 
17.9.13.2.9.1 Thyroxine is deiodinated to triiodothyronine (Reaction) 11313 
17.9.13.2.9.2 Thyroxine is deiodinated to reverse triiodothyronine (RT3) (Reaction) 11314 
17.9.13.3 Serotonin and melatonin biosynthesis (Pathway) 11315 
17.9.13.3.1 Tryptophan is hydroxylated (Reaction) 11316 
17.9.13.3.2 Decarboxylation of 5-hydroxytryptophan forms serotonin (Reaction) 11318 
17.9.13.3.3 N-acetylation of serotonin (Reaction) 11319 
17.9.13.3.4 Methylation of N-acetyl-5-HT to form melatonin (Reaction) 11320 
17.9.14 Glyoxylate metabolism (Pathway) 11321 
17.9.14.1 Synthesis of glyoxylate from hydroxyproline (BlackBoxEvent) 11323 
17.9.14.2 glycine + O2 => glyoxylate + H2O2 + NH4+ (Reaction) 11324 
17.9.14.3 glyoxylate + alanine => glycine + pyruvate [peroxisome] (Reaction) 11326 
17.9.14.4 glyoxylate + alanine => glycine + pyruvate [mitochondrial matrix] (Reaction) 11327 
17.9.14.5 glyoxylate + NADPH + H+ => glycolate + NADP+ (Reaction) 11329 
17.9.14.6 glycolate + O2 => glyoxylate + H2O2 (Reaction) 11330 
17.9.14.7 Conversion of glyoxylate to oxalate (Reaction) 11332 
17.9.15 Sulfur amino acid metabolism (Pathway) 11333 
17.9.15.1 Methionine salvage pathway (Pathway) 11334 
17.9.15.1.1 MTA is cleaved and phosphorylated (Reaction) 11334 
17.9.15.1.2 Methylthio-ribose-P = Methylthio-ribulose-P (Reaction) 11335 
17.9.15.1.3 Methylthio-ribulose-P = Methylthio-ribose-P (Reaction) 11335 
17.9.15.1.4 Dehydration of methylthio-ribulose-P (Reaction) 11335 
17.9.15.1.5 Acireductone is created (Reaction) 11335 
17.9.15.1.6 Acireductone is oxidized to MOB (Reaction) 11336 
17.9.15.1.7 Transamination of MOB to methionine (Reaction) 11336 
17.9.15.2 SAM is sythesized from methionine's reaction with ATP (Reaction) 11336 
17.9.15.3 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 11338 
17.9.15.4 S-adenoylhomocysteine is hydrolyzed (Reaction) 11338 
17.9.15.5 Remethylation of homocysteine via betaine degradation (Reaction) 11339 
17.9.15.6 Cysteine formation from homocysteine (Pathway) 11340 
17.9.15.6.1 Cystathionine is formed from homocysteine and serine (Reaction) 11341 
17.9.15.6.2 Cleavage of cystathionine into cysteine (Reaction) 11342 
17.9.15.7 Glutamate and cysteine combine (Reaction) 11344 
17.9.15.8 A dipeptidase cleaves cysteinylglycine (Reaction) 11345 
17.9.15.9 Degradation of cysteine and homocysteine (Pathway) 11346 
17.9.15.9.1 Homocysteine is degraded to oxobutanoate and H2S (Reaction) 11347 
17.9.15.9.2 Cysteine is degraded to serine and H2S (Reaction) 11349 
17.9.15.9.3 Cysteine is oxidized (Reaction) 11350 
17.9.15.9.4 CSAD decarboxylates 3-sulfinoalanine to hypotaurine (Reaction) 11351 
17.9.15.9.5 Oxidation of hypotaurine to taurine (Reaction) 11353 
17.9.15.9.6 Excess homocysteine yields homolanthionine and H2S (Reaction) 11354 
17.9.15.9.7 Excess cysteine yields lanthionine and H2S (Reaction) 11356 
17.9.15.9.8 Sulfide oxidation to sulfate (Pathway) 11357 
17.9.15.9.8.1 SQR oxidizes sulfide to bound persulfide (Reaction) 11359 
17.9.15.9.8.2 Persulfide sulfur is dioxygenated (Reaction) 11360 
17.9.15.9.8.3 Persulfide sulfur is transferred onto sulfite (Reaction) 11362 
17.9.15.9.8.4 Thiosulfate can transfer its sulfate to glutathione (BlackBoxEvent) 11363 
17.9.15.9.8.5 Sulfite is oxidized to sulfate (Reaction) 11364 
17.9.15.9.8.6 Sulfate is exported to the cytosol in exchange for dicarboxylate (Reaction)11365 
17.10 Metabolism of porphyrins (Pathway) 11367 
17.10.1 Heme biosynthesis (Pathway) 11368 
17.10.1.1 ALAS condenses SUCC-CoA and Gly to form dALA (Reaction) 11370 
17.10.1.2 Mitochondrial dALA translocates to cytosol (Reaction) 11371 
17.10.1.3 ALAD binds to Pb2+ (Reaction) 11372 
17.10.1.4 ALAD condenses 2 dALAs to form PBG (Reaction) 11373 
17.10.1.5 4 PBGs bind to form HMB (Reaction) 11375 
17.10.1.6 UROS transforms HMB to URO3 (Reaction) 11376 
17.10.1.7 HMBL spontaneously transforms to URO1 (Reaction) 11378 
17.10.1.8 UROD decarboxylates URO3 to COPRO3 (Reaction) 11379 
17.10.1.9 UROD decarboxylates URO1 to COPRO1 (Reaction) 11380 
17.10.1.10 Cytosolic COPRO3 translocates to mitochondrial intermembrane space 11382 (Reaction) 
17.10.1.11 CPO transforms COPRO3 to PPGEN9 (Reaction) 11383 
17.10.1.12 PPO oxidises PPGEN9 to PRIN9 (Reaction) 11384 17.10.1.13 Mitochondrial intermembrane PRIN9 translocates to mitochondrial matrix 11385 (Reaction) 
17.10.1.14 FECH binds Fe2+ to PRIN9 to form heme (Reaction) 11386 
17.10.1.15 COX10 transforms heme to heme O (Reaction) 11388 
17.10.1.16 COX15 transforms heme O to heme A (Reaction) 11389 
17.10.2 Heme degradation (Pathway) 11391 
17.10.2.1 The heme ring is cleaved by heme oxygenase (Reaction) 11391 
17.10.2.2 Biliverdin is reduced to bilirubin (Reaction) 11392 
17.10.2.3 Bilirubin translocates from the cytosol to the ER lumen (Reaction) 11393 
17.10.2.4 bilirubin + UDP-glucuronic acid => bilirubin monoglucuronide + UDP (Reaction)11394 
17.10.2.5 bilirubin monoglucuronide + UDP-glucuronic acid => bilirubin diglucuronide +11395 UDP (Reaction) 
17.11 Biological oxidations (Pathway) 11397 
17.11.1 Phase 1 - Functionalization of compounds (Pathway) 11399 
17.11.1.1 Cytochrome P450 - arranged by substrate type (Pathway) 11401 
17.11.1.1.1 Endogenous sterols (Pathway) 11404 
17.11.1.1.1.1 CYP1B1 4-hydroxylates estradiol-17beta (Reaction) 11405 
17.11.1.1.1.2 Cholesterol is hydroxylated to 7alpha-hydroxycholesterol by CYP7A1 11407 (Reaction) 
17.11.1.1.1.3 25-hydroxycholesterol is 7alpha-hydroxylated by CYP7B1 (Reaction) 11407 
17.11.1.1.1.4 Sterols are 12-hydroxylated by CYP8B1 (Pathway) 11407 
17.11.1.1.1.4.1 4-Cholesten-7alpha,24(S)-diol-3-one is 12alpha-hydroxylated to 11408 4-cholesten-7-alpha,12-alpha,24(S)-triol-3-one (Reaction) 
17.11.1.1.1.4.2 4-Cholesten-7alpha,27-diol-3-one is 12alpha-hydroxylated to 11409 4-Cholesten-7alpha,12alpha,27-triol-3-one (Reaction) 
17.11.1.1.1.4.3 4-Cholesten-7alpha-ol-3-one is 12alpha-hydroxylated to 11409 7-alpha,12-alpha-dihydroxycholest-4-en-3-one (Reaction) 
17.11.1.1.1.5 20alpha,22beta-hydroxycholesterol is cleaved by CYP11A1 to yield 11409 pregnenolone and isocaproaldehyde (Reaction) 
17.11.1.1.1.6 11-deoxycortisol is oxidised to cortisol by CYP11B1 (Reaction) 11410 
17.11.1.1.1.7 11-deoxycorticosterone is oxidised to corticosterone by CYP11B2 11410 (Reaction) 
17.11.1.1.1.8 Hydroxylation of pregnenolone to form 17alpha-hydroxypregnenolone 11411 (Reaction) 
17.11.1.1.1.9 Androstenedione is converted to estrone by Aromatase (CYP19A1) 11412 (Reaction) 
17.11.1.1.1.10 21-hydroxylation of progesterone to form 11-deoxycorticosterone 11412 (Reaction) 
17.11.1.1.1.11 Cholesterol is hydroxylated to 27-hydroxycholesterol by CYP27 11412 (Reaction) 
17.11.1.1.1.12 24-hydroxycholesterol is 7alpha-hydroxylated to yield 11413 cholest-5-ene-3beta,7alpha,24-triol (Reaction) 
17.11.1.1.1.13 Cholesterol is hydroxylated to 24-hydroxycholesterol by CYP46A1 11413 (Reaction) 
17.11.1.1.1.14 Lanosterol is oxidatively demethylated to 
4,4-dimethylcholesta-8(9),14,24-trien-3beta-ol (Reaction) 
17.11.1.1.2 Xenobiotics (Pathway) 11414 
17.11.1.1.2.1 Ethylene is oxidized to Ethylene oxide by CYP1A1 (Reaction) 11415 
17.11.1.1.2.2 Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 11416 (Pathway) 
17.11.1.1.2.2.1 N-atom dealkylation of caffeine (Reaction) 11417 
17.11.1.1.2.2.2 N-hydroxylation of 4-aminobiphenyl (Reaction) 11418 
17.11.1.1.2.3 Coumarin is 7-hydroxylated by CYP2A6 (Reaction) 11419 
17.11.1.1.2.4 Coumarin is 7-hydroxylated by CYP2A13 (Reaction) 11420 
17.11.1.1.2.5 Cyclophosphamide is 4-hydroxylated by CYP2B6 (Reaction) 11422 
17.11.1.1.2.6 CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation (Reaction) 11423 
17.11.1.1.2.7 CYP2C9 inactivates tolbutamide by 4methyl-hydroxylation (Reaction) 11424 
17.11.1.1.2.8 CYP2C18 initiates bioactivation of phenytoin by 4-hydroxylation (Reaction)
11426 
17.11.1.1.2.9 CYP2C19 5-hydroxylates omeprazole (Reaction) 11427 
17.11.1.1.2.10 CYP2E1 reactions (Pathway) 11428 
17.11.1.1.2.10.1 Acetaminophen oxidised to N-acetylbenzoquinoneimine (NAPQI) 11429 (Reaction) 
17.11.1.1.2.10.2 Benzene is hydroxylated to phenol (Reaction) 11430 
17.11.1.1.2.10.3 Dehalogenation of carbon tetrachloride to form a free radical 11432 (Reaction) 
17.11.1.1.2.10.4 Dehalogenation of the poly-halogenated hydrocarbon Halothane to11433 form the acylhalide Trifluoroacetlychloride and hydrogen bromide (Reaction) 
17.11.1.1.2.10.5 MEOS oxidizes ethanol to acetaldehyde (Reaction) 11434 
17.11.1.1.2.10.6 Vinyl chloride is oxidized to 2-Chloroethylene oxide (Reaction) 11436 
17.11.1.1.2.11 O-atom dealkylation of dextromethorphan (Reaction) 11438 
17.11.1.1.2.12 CYP2D6 4-hydroxylates debrisoquine (Reaction) 11438 
17.11.1.1.2.13 CYP2F1 dehydrogenates 3-methylindole (Reaction) 11440 
17.11.1.1.2.14 CYP3A4 can N-demethylate loperamide (Reaction) 11442 
17.11.1.1.2.15 CYP3A4,5 oxidise AFB1 to AFXBO (Reaction) 11443 
17.11.1.1.2.16 CYP3A7 can 6beta-hydroxylate testosterone (Reaction) 11444 
17.11.1.1.3 Fatty acids (Pathway) 11446 
17.11.1.1.3.1 CYP2J2 epoxygenates arachidonic acid (Reaction) 11447 
17.11.1.1.3.2 CYP4A11 omega-hydroxylates laurate (Reaction) 11449 
17.11.1.1.3.3 CYP4B1 can 12-hydroxylate arachidonic acid (Reaction) 11450 
17.11.1.1.3.4 CYP4F12 hydroxylates arachidonic acid (Reaction) 11451 
17.11.1.1.4 Eicosanoids (Pathway) 11452 
17.11.1.1.4.1 LTB4 is hydroxylated to 20oh-LTB4 by CYP4F2/4F3 (Reaction) 11454 
17.11.1.1.4.2 CYP4F8 hydroxylates prostaglandin H2 (Reaction) 11454 
17.11.1.1.4.3 PGH2 is isomerised to TXA2 by TBXAS1 (Reaction) 11455 
17.11.1.1.4.4 PTGIS, CYP8A1 isomerise PGH2 to PGI2 (Reaction) 11456 
17.11.1.1.5 Vitamins (Pathway) 11456 
17.11.1.1.5.1 25-Hydroxylation of vitamin D3 in liver (Reaction) 11457 
17.11.1.1.5.2 CYP24A1 catalyzes the initial step in the deactivation of the hormonally11457 active form of vitamin D3 (Reaction) 
17.11.1.1.5.3 CYP26A1,B1 4-hydroxylate atRA (Reaction) 
11413
11459 
17.11.1.1.5.4 CYP26C1 4-hydroxylates 9cRA (Reaction) 11460 
17.11.1.1.5.5 Further hydroxylation of calcidiol in kidney to form calcitriol (Reaction) 11461 
17.11.1.1.6 Miscellaneous substrates (Pathway) 11462 
17.11.1.1.6.1 CYP2S1 can deactivate all-trans-retinoic acid (Reaction) 11463 
17.11.1.1.6.2 CYP2U1 can omega-hydroxylate arachidonate (Reaction) 11464 
17.11.1.1.6.3 CYP2W1 can oxidize indole (Reaction) 11465 
17.11.1.1.6.4 CYP3A43 catalyzes the 6beta-hydroxylation of testosterone (Reaction)11467 
17.11.1.1.6.5 CYP4F11 omega-hydroxylates 3-hydroxypalmitate (Reaction) 11469 
17.11.1.2 FMO oxidizes nucleophiles (Pathway) 11470 
17.11.1.2.1 FMO1 N-oxidizes the anti-cancer drug tamoxifen (Reaction) 11472 
17.11.1.2.2 FMO2 S-oxidizes the antithyroid drug methimazole (Reaction) 11473 
17.11.1.2.3 FMO3 N-oxidizes the tertiary amine trimethylamine (Reaction) 11474 
17.11.1.3 COX reactions (Pathway) 11476 
17.11.1.3.1 Arachidonic acid is oxidised to PGG2 by PTGS1 (Reaction) 11478 
17.11.1.3.2 PGG2 is reduced to PGH2 by PTGS1 (Reaction) 11478 
17.11.1.4 Amine Oxidase reactions (Pathway) 11478 
17.11.1.4.1 Monoamines are oxidized to aldehydes by MAOA and MAOB, producing NH3
11480 and H2O2 (Pathway) 
17.11.1.4.1.1 Dietary tyramine is oxidatively deaminated to an aldehyde by MAOB 11481 (Reaction) 
17.11.1.4.1.2 Oxidative deamination of 5-Hydroxytryptamine by MAOA (Reaction) 11482 
17.11.1.4.1.3 Oxidative deamination of Phenyethylamine by MAOB (Reaction) 11484 
17.11.1.4.2 Polyamines are oxidized to amines, aldehydes and H2O2 by PAOs (Pathway)
11485 
17.11.1.4.2.1 Spermine is oxidized to spermidine (Reaction) 11487 
17.11.1.4.2.2 N-acetylspermidine is oxidized to putrescine (Reaction) 11487 
17.11.1.4.2.3 N-acetylspermine is oxidised to spermidine (Reaction) 11487 
17.11.1.5 Ethanol oxidation (Pathway) 11487 
17.11.1.5.1 ethanol + NAD+ => acetaldehyde + NADH + H+ (Reaction) 11490 
17.11.1.5.2 acetaldehyde [cytosolic] => acetaldehyde [mitochondrial] (Reaction) 11492 
17.11.1.5.3 acetaldehyde + NAD+ => acetate + NADH + H+ [mitochondrial] (Reaction)11493 
17.11.1.5.4 acetate + CoA + ATP => acetyl-CoA + AMP + pyrophosphate [mitochondrial]
11494 (Reaction) 
17.11.1.5.5 acetaldehyde + NAD+ => acetate + NADH + H+ [cytosolic] (Reaction) 11496 
17.11.1.5.6 acetate + CoA + ATP => acetyl-CoA + AMP + pyrophosphate [cytosolic] 11497 (Reaction) 
17.11.2 Phase II conjugation (Pathway) 11498 
17.11.2.1 Glucuronidation (Pathway) 11499 
17.11.2.1.1 Formation of the active cofactor, UDP-glucuronate (Pathway) 11501 
17.11.2.1.1.1 UTP + D-glucose 1-phosphate pyrophosphate + UDP-glucose (Reaction)
11502 
17.11.2.1.1.2 UDP-glucose is oxidised to UDP-glucuronate (Reaction) 11503 
17.11.2.1.1.3 UDP-glucuronate transport from the cytosol to ER lumen (Reaction) 11504 
17.11.2.1.2 Formation of O-glucuronides (Reaction) 11505 
17.11.2.1.3 Formation of N-glucuronides (Reaction) 11506 
17.11.2.2 Cytosolic sulfonation of small molecules (Pathway) 11507 
17.11.2.2.1 Transport and synthesis of PAPS (Pathway) 11509 
17.11.2.2.1.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 11510 
17.11.2.2.1.2 PAPSS1,2 transfer PO4(2-) group from ATP to form APS (Reaction) 11510 
17.11.2.2.1.3 PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS 11510 (Reaction) 
17.11.2.2.1.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 11511 
17.11.2.2.2 Acetaminophen can form an O- sulfate conjugate (Reaction) 11511 
17.11.2.2.3 N-hydroxy-4-aminobiphenyl can form a sulfate conjugate (Reaction) 11512 
17.11.2.2.4 Phenol can form a sulfate conjugate (Reaction) 11513 
17.11.2.2.5 Dopamine can form an O-sulfate conjugate (Reaction) 11514 
17.11.2.2.6 3,3'-diiodothyronine + PAPS => 3,3'-diiodothyronine 4-sulfate + PAP 11515 (Reaction) 
17.11.2.2.7 3,5,3'-triiodothyronine + PAPS => 3,5,3'-triiodothyronine 4-sulfate + PAP 11517 (Reaction) 
17.11.2.2.8 p-nitrophenol + PAPS => p-nitrophenol sulfate + PAP (Reaction) 11518 
17.11.2.2.9 N-hydroxy-2-acetylaminofluorene + PAPS => 2-acetylaminofluorene-N-sulfate11520 
+ PAP (Reaction) 
17.11.2.2.10 cholesterol + PAPS => cholesterol sulfate + PAP (Reaction) 11521 
17.11.2.2.11 SULTs transfer (SO4)2- group to 27HCHOL (Reaction) 11522 
17.11.2.2.12 SULTs transfer (SO4)2- group to PREG (Reaction) 11523 
17.11.2.2.13 estrone + PAPS => estrone 3-sulfate + PAP (Reaction) 11524 
17.11.2.2.14 dehydroepiandrosterone (DHEA) + PAPS => DHEA sulfate + PAP 11525 (Reaction) 
17.11.2.2.15 beta-estradiol + PAPS => beta-estradiol 3-sulfate + PAP (Reaction) 11526 
17.11.2.2.16 lithocholate + PAPS => lithocholate sulfate + PAP (Reaction) 11527 
17.11.2.2.17 taurolithocholate + PAPS => taurolithocholate sulfate + PAP (Reaction) 11528 
17.11.2.2.18 Adenosine 3',5'-bisphosphate (PAP) + H2O => AMP + orthophosphate 11529 (Reaction) 
17.11.2.3 Acetylation (Pathway) 11531 
17.11.2.3.1 The acetyl group from acetyl-CoA is transferred to the NAT1 (Reaction) 11532 
17.11.2.3.2 The acetyl group from acetyl-CoA is transferred to the NAT2 (Reaction) 11533 
17.11.2.3.3 NAT1 acetylation (Reaction) 11534 
17.11.2.3.4 NAT2 acetylation (Reaction) 11535 
17.11.2.4 Methylation (Pathway) 11535 
17.11.2.4.1 SAM is sythesized from methionine's reaction with ATP (Reaction) 11538 
17.11.2.4.2 S-atom dealkylation of 6-methylmercaptopurine (Reaction) 11538 
17.11.2.4.3 6-mercaptopurine can be S-methylated (Reaction) 11539 
17.11.2.4.4 2-mercaptoethanol can be S-methylated (Reaction) 11540 
17.11.2.4.5 Pyridine can be N-methylated (Reaction) 11541 
17.11.2.4.6 3,4-dihydroxybenzoate can be O-methylated (Reaction) 11541 
17.11.2.4.7 S-adenoylhomocysteine is hydrolyzed (Reaction) 11542 
17.11.2.4.8 MTR transfers CH3 group from MeCbl to HCYS (Reaction) 11542 
17.11.2.5 Glutathione conjugation (Pathway) 11543 
17.11.2.5.1 Glutathione synthesis and recycling (Pathway) 11544 
17.11.2.5.1.1 Cleavage of 5-oxoproline to form glutamate (Reaction) 11545 
17.11.2.5.1.2 Glutamate and cysteine combine (Reaction) 11546 
17.11.2.5.1.3 Formation of 5-oxoproline from gamma-glutamylcysteine (Reaction) 11547 
17.11.2.5.1.4 gamma-glutamylcysteine combines with glycine to form glutathione 11548 (Reaction) 
17.11.2.5.1.5 Export of glutathione to the extracellular space (BlackBoxEvent) 11549 
17.11.2.5.1.6 Glutathione is hydrolyzed (Reaction) 11550 
17.11.2.5.1.7 Cysteinylglycine and gamma-glutamate:AA are imported into the cell 11552 (BlackBoxEvent) 
17.11.2.5.1.8 5-oxoproline can be formed from gamma-glutamyl-AA products (Reaction)11553 
17.11.2.5.1.9 A dipeptidase cleaves cysteinylglycine (Reaction) 11554 
17.11.2.5.2 GST trimers transfer GS from GSH to luminal substrates (Reaction) 11555 
17.11.2.5.3 GST dimers conjugate GSH with cytosolic substrates (Reaction) 11556 
17.11.2.6 Amino Acid conjugation (Pathway) 11559 
17.11.2.6.1 Conjugation of carboxylic acids (Pathway) 11560 
17.11.2.6.1.1 Conjugation of benzoate with glycine (Pathway) 11561 
17.11.2.6.1.1.1 benzoate + Coenzyme A + ATP => benzoyl-CoA + AMP + 11562 pyrophosphate (Reaction) 
17.11.2.6.1.1.2 benzoyl-CoA + glycine => benzoyl glycine (hippuric acid) + Coenzyme
11563 A (Reaction) 
17.11.2.6.1.2 Conjugation of phenylacetate with glutamine (Pathway) 11564 
17.11.2.6.1.2.1 phenylacetate + Coenzyme A + ATP => phenylacetyl-CoA + AMP +11566 pyrophosphate (Reaction) 
17.11.2.6.1.2.2 phenylacetyl-CoA + glutamine => phenylacetyl glutamine + Coenzyme
11567 A (Reaction) 
17.11.2.6.1.3 Conjugation of salicylate with glycine (Pathway) 11568 
17.11.2.6.1.3.1 salicylic acid + Coenzyme A + ATP => salicylate-CoA + AMP + 11569 pyrophosphate (Reaction) 
17.11.2.6.1.3.2 salicylate-CoA + glycine => salicyluric acid + Coenzyme A (Reaction)11570 
17.11.3 Aflatoxin activation and detoxification (Pathway) 11571 
17.11.3.1 CYP3A4,5 hydroxylates AFB1 to AFQ1 (Reaction) 11573 
17.11.3.2 CYP1A2 hydroxylates AFB1 to AFM1 (Reaction) 11575 
17.11.3.3 CYP2A13 oxidises AFM1 to AFM1E (Reaction) 11576 
17.11.3.4 CYP1A2,3A4,3A5,2A13 oxidise AFB1 to AFXBO (Reaction) 11577 
17.11.3.5 CYP1A2, 3A4 oxidise AFB1 to AFNBO (Reaction) 11579 
17.11.3.6 AFXBO translocates from cytosol to nucleoplasm (BlackBoxEvent) 11580 
17.11.3.7 AFXBO binds DNA (Reaction) 11581 
17.11.3.8 MGST trimers transfer GS from GSH to AFXBO and AFNBO (Reaction) 11582 
17.11.3.9 AFXBO-SG, AFNBO-SG translocate from cytosol to extracellular region 11584 (Reaction) 
17.11.3.10 GGTs hydrolyse glutamate from AFXBO-SG, AFNBO-SG (Reaction) 11585 
17.11.3.11 DPEPs hydrolyse glycine from AFXBO-CG, AFNBO-CG (Reaction) 11587 
17.11.3.12 AFXBO-C, AFNBO-C translocate from extracellular region to cytosol 11588 (BlackBoxEvent) 
17.11.3.13 Unknown NAT transfers COCH3 to AFXBO-C, AFNBO-C (BlackBoxEvent) 11589 
17.11.3.14 ACY:Zn2+ dimers hydrolyse mercapturic acids (Reaction) 11591 
17.11.3.15 AFXBO hydrolyses non-enzymatically to AFBDHD (Reaction) 11592 
17.11.3.16 AFBDHD hydrolyses non-enzymatically to AFBDHO (Reaction) 11593 
17.11.3.17 AKR dimers reduce AFBDHO to AFBDOH (Reaction) 11594 
17.12 Mitochondrial iron-sulfur cluster biogenesis (Pathway) 11596 
17.12.1 Mitoferrin translocates iron from the mitochondrial intermembrane space to the 11598 mitochondrial matrix (Reaction) 
17.12.2 Frataxin binds iron (Reaction) 11600 
17.12.3 Electron transport from NADPH to Ferredoxin (Pathway) 11602 
17.12.3.1 NADPH transfers electrons to FDXR (Reaction) 11603 
17.12.3.2 FDXR transfers electrons to FDX1/1L (Reaction) 11604 
17.12.4 FXN:NFS1:ISD11:ISCU assembles iron-sulfur cluster (BlackBoxEvent) 11605 
17.13 O2/CO2 exchange in erythrocytes (Pathway) 11608 
17.13.1 Erythrocytes take up carbon dioxide and release oxygen (Pathway) 11610 
17.13.1.1 Carbonic anhydrase IV hydrates carbon dioxide to bicarbonate and a proton 11611 (Reaction) 
17.13.1.2 AQP1 passively tranlocates carbon dioxide from the extracellular region to the11613 cytosol (Reaction) 
17.13.1.3 RhAG passively translocates carbon dioxide from the extracellular region to the
11614 cytosol (Reaction) 
17.13.1.4 Carbonic anhydrase I/II hydrates carbon dioxide (Reaction) 11616 
17.13.1.5 Band 3 Anion Exchanger (AE1, SLC4A1) exchanges cytosolic bicarbonate for11618 extracellular chloride (Reaction) 
17.13.1.6 Hemoglobin A is protonated and carbamated causing release of oxygen 11619 (Reaction) 
17.13.2 Erythrocytes take up oxygen and release carbon dioxide (Pathway) 11622 
17.13.2.1 Hemoglobin A binds oxygen and releases protons and carbon dioxide (Reaction)
11623 
17.13.2.2 Band 3 Anion Exchanger (AE1, SLC4A1) exchanges cytosolic chloride for 11625 extracellular bicarbonate (Reaction) 
17.13.2.3 Carbonic anhydrase I/II dehydrates bicarbonate (Reaction) 11627 
17.13.2.4 AQP1 passively translocates carbon dioxide from the cytosol to the extracellular
11629 region (Reaction) 
17.13.2.5 RhAG passively translocates carbon dioxide from the cytosol to the extracellular
11630 region (Reaction) 
17.13.2.6 Carbonic anhydrase IV dehydrates bicarbonate to water and carbon dioxide 11632 (Reaction) 
17.14 Abacavir transport and metabolism (Pathway) 11633 
17.14.1 Abacavir transmembrane transport (Pathway) 11635 
17.14.1.1 abacavir [extracellular] => abacavir [cytosol] (Reaction) 11636 
17.14.1.2 abacavir [cytosol] + ATP + H2O => abacavir[extracellular] + ADP + phosphate11637 (Reaction) 
17.14.1.3 abacavir [cytosol] + ATP + H2O => abacavir[extracellular] + ADP + phosphate11639 (Reaction) 
17.14.2 Abacavir metabolism (Pathway) 11641 
17.14.2.1 abacavir + UDP-glucuronate => abacavir 5'-glucuronide + UDP (Reaction) 11642 
17.14.2.2 abacavir + 2 NAD+ => abacavir 5'-carboxylate + 2 NADH + 2 H+ (Reaction) 11643 
17.14.2.3 abacavir + AMP => abacavir monophosphate + adenosine (Reaction) 11645 17.14.2.4 abacavir monophosphate + H2O => carbovir monophosphate + 11646 cyclopropylamine (Reaction) 
17.14.2.5 carbovir + IMP => carbovir monophosphate + inosine (Reaction) 11647 
17.14.2.6 carbovir monophosphate + ATP => carbovir diphosphate + ADP (Reaction) 11649 
17.14.2.7 carbovir diphosphate + ATP => carbovir triphosphate + ADP (Reaction) 11650 
17.15 Reversible hydration of carbon dioxide (Pathway) 11652 
17.15.1 Carbonic anhydrase hydrates carbon dioxide (cytosol) (Reaction) 11654 
17.15.2 Carbonic anhydrase dehydrates bicarbonate (cytosol) (Reaction) 11657 
17.15.3 Carbonic anhydrase hydrates carbon dioxide (plasma membrane) (Reaction) 11660 
17.15.4 Carbonic anhydrase dehydrates bicarbonate (plasma membrane) (Reaction) 11662 
17.15.5 Carbonic anhydrase hydrates carbon dioxide (mitochondria) (Reaction) 11665 
17.15.6 Carbonic anhydrase dehydrates bicarbonate (mitochondria) (Reaction) 11666 
17.15.7 Carbonic Anhydrase VI hydrates carbon dioxide to bicarbonate and a proton 11668 (Reaction) 
17.15.8 Carbonic anhydrase VI dehydrates bicarbonate to water and carbon dioxide 11670 (Reaction) 
17.16 Cytosolic iron-sulfur cluster assembly (Pathway) 11671 
17.16.1 NADPH reduces NDOR1:CIAPIN1 (Reaction) 11674 
17.16.2 4Fe-4S cluster assembles on NUBP2:NUBP1 scaffold (BlackBoxEvent) 11675 
17.16.3 CIA Targeting Complex transfers 4Fe-4S cluster to apoproteins (BlackBoxEvent)11678 18 Metabolism of proteins (Pathway) 11681 
18.1 Translation (Pathway) 11681 
18.1.1 Eukaryotic Translation Initiation (Pathway) 11681 
18.1.1.1 Cap-dependent Translation Initiation (Pathway) 11682 
18.1.1.1.1 Formation of a pool of free 40S subunits (Pathway) 11682 
18.1.1.1.1.1 Release of 40S and 60S subunits from the 80S ribosome (Reaction) 11682 
18.1.1.1.1.2 eIF3 and eIF1A bind to the 40S subunit (Reaction) 11682 
18.1.1.1.2 Formation of the ternary complex, and subsequently, the 43S complex 11683 (Pathway) 
18.1.1.1.2.1 De novo formation of eIF2:GTP (Reaction) 11683 
18.1.1.1.2.2 Met-tRNAi binds to eIF2:GTP to form the ternary complex (Reaction) 11683 
18.1.1.1.2.3 Formation of the 43S pre-initiation complex (Reaction) 11684 
18.1.1.1.3 Activation of the mRNA upon binding of the cap-binding complex and eIFs, and
11684 subsequent binding to 43S (Pathway) 
18.1.1.1.3.1 Release of eIF4E from the inactive eIF4E:4E-BP complex (Reaction) 11684 
18.1.1.1.3.2 Formation of the cap-binding eIF4F complex (Reaction) 11685 
18.1.1.1.3.3 eIF4F binds to mRNP (Reaction) 11685 
18.1.1.1.3.4 Cap-bound mRNA is activated by helicases (BlackBoxEvent) 11686 
18.1.1.1.3.5 Translation initiation complex formation (Pathway) 11686 
18.1.1.1.3.5.1 Formation of translation initiation complexes containing mRNA that does
11686 not circularize (Reaction) 
18.1.1.1.3.5.2 Formation of translation initiation complexes yielding circularized 11687 Ceruloplasmin mRNA in a 'closed-loop' conformation (Reaction) 
18.1.1.1.4 Ribosomal scanning and start codon recognition (Pathway) 11687 
18.1.1.1.4.1 Ribosomal scanning (Reaction) 11687 18.1.1.1.4.2 Start codon recognition (Reaction) 11688 
18.1.1.1.5 GTP hydrolysis and joining of the 60S ribosomal subunit (Pathway) 11688 
18.1.1.1.5.1 eIF2:GTP is hydrolyzed, eIFs are released (Reaction) 11688 
18.1.1.1.5.2 eIF5B:GTP is hydrolyzed and released (Reaction) 11689 
18.1.1.1.5.3 The 60S subunit joins the translation initiation complex (Reaction) 11689 
18.1.1.1.6 Recycling of eIF2:GDP (Pathway) 11689 
18.1.1.1.6.1 Formation of eIF2:GDP:eIF2B intermediate (Reaction) 11690 
18.1.1.1.6.2 eIF2 activation (Reaction) 11690 
18.1.1.2 L13a-mediated translational silencing of Ceruloplasmin expression (Pathway) 11690 
18.1.1.2.1 Dissociation of L13a from the 60s ribosomal subunit (Reaction) 11691 
18.1.1.2.2 INF-gamma induced phosphorylation of L13a (Reaction) 11691 
18.1.1.2.3 Association of phospho-L13a with GAIT element of Ceruloplasmin mRNA 11692 (Reaction) 
18.1.2 SRP-dependent cotranslational protein targeting to membrane (Pathway) 11692 
18.1.2.1 Synthesis of nascent polypeptide containing signal sequence (BlackBoxEvent)11692 
18.1.2.2 Nascent polypeptide:mRNA:ribosome complex binds signal recognition particle11693 (SRP) (Reaction) 
18.1.2.3 The SRP receptor binds the SRP:nascent peptide:ribosome complex (Reaction)11693 
18.1.2.4 Signal-containing nascent peptide translocates to endoplasmic reticulum 11693 (Reaction) 
18.1.2.5 Signal peptidase hydrolyzes signal peptide from ribosome-associated nascent11694 protein (Reaction) 
18.1.3 Eukaryotic Translation Elongation (Pathway) 11694 
18.1.3.1 eEF1A complexes with GTP (Reaction) 11694 
18.1.3.2 eEF1A:GTP:aminoacyl tRNA ternary complex formation. (Reaction) 11695 
18.1.3.3 Peptide chain elongation (Pathway) 11695 
18.1.3.3.1 Aminoacyl-tRNA binds to the ribosome at the A-site (Reaction) 11695 
18.1.3.3.2 Hydrolysis of eEF1A:GTP (Reaction) 11696 
18.1.3.3.3 Peptide transfer from P-site tRNA to the A-site tRNA (Reaction) 11696 
18.1.3.3.4 Translocation of ribosome by 3 bases in the 3' direction (Reaction) 11696 
18.1.3.3.5 GTP-binding activates eEF2 (Reaction) 11697 
18.1.3.4 Regeneration of eEF1A:GTP by eEF1B activity (Reaction) 11697 
18.1.3.5 Formation of eEF1B complex (Reaction) 11697 
18.1.4 Eukaryotic Translation Termination (Pathway) 11698 
18.1.4.1 GTP bound eRF3:eRF1 complex binds the peptidyl tRNA:mRNA:80S Ribosome
11698 complex (Reaction) 
18.1.4.2 GTP Hydrolysis by eRF3 bound to the eRF1:mRNA:polypeptide:80S Ribosome11698 complex (Reaction) 
18.1.4.3 Polypeptide release from the eRF3-GDP:eRF1:mRNA:80S Ribosome complex11699 (Reaction) 
18.2 Protein folding (Pathway) 11699 
18.2.1 Chaperonin-mediated protein folding (Pathway) 11700 
18.2.1.1 Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding (Pathway) 11702 
18.2.1.1.1 Prefoldin mediated transfer of substrate to CCT/TriC (Pathway) 11703 
18.2.1.1.1.1 unfolded actin/tubulin associates with prefoldin (Reaction) 11705 18.2.1.1.1.2 Actin/tubulin:prefoldin complex associates with CCT/TriC (Reaction) 11706 
18.2.1.1.2 Formation of tubulin folding intermediates by CCT/TriC (Pathway) 11708 
18.2.1.1.2.1 ADP is exchanged for ATP in the (ADP:CCT/TriC):tubulin complex 11710 (Reaction) 
18.2.1.1.2.2 Hydrolysis of ATP and release of tubulin folding intermediate from CCT/TriC
11712 (Reaction) 
18.2.1.1.3 Folding of actin by CCT/TriC (Pathway) 11714 
18.2.1.1.3.1 Exchange of ADP for ATP in CCT/TriC:actin complex (Reaction) 11715 
18.2.1.1.3.2 Hydrolysis of ATP and release of folded actin from CCT/TriC (Reaction)11717 
18.2.1.2 Association of TriC/CCT with target proteins during biosynthesis (Pathway) 11719 
18.2.1.2.1 Association of CCT/TriC with sphingosine kinase 1 (Reaction) 11720 
18.2.1.2.2 Association of CCT/TriC with other substrates during biosynthesis (unknown11722 chaperone) (Reaction) 
18.2.2 Post-chaperonin tubulin folding pathway (Pathway) 11724 
18.2.2.1 Beta-tubulin:GTP + Cofactor A -> Beta-tubulin:GTP: Cofactor A (Reaction) 11726 
18.2.2.2 Beta-tubulin:GTP + Cofactor D -> Beta-tubulin:GTP: Cofactor D (Reaction) 11729 
18.2.2.3 Beta-tubulin:GTP: Cofactor A+ Cofactor D -> Beta-tubulin:GTP:Cofactor D + 11733 Cofactor A (Reaction) 
18.2.2.4 alpha-tubulin:GTP + Cofactor B -> alpha-tubulin:GTP: Cofactor B (Reaction) 11735 
18.2.2.5 alpha-tubulin:GTP + Cofactor E -> alpha-tubulin:GTP:Cofactor E (Reaction) 11739 
18.2.2.6 alpha-tubulin:GTP:Cofactor B +Cofactor E -> alpha-tubulin:GTP: Cofactor E 11741 +Cofactor B (Reaction) 
18.2.2.7 Beta-tubulin:GTP:Cofactor D+alpha-tubulin:GTP:Cofactor E-> 11745 Beta-tubulin:GTP:Cofactor D:alpha-tubulin:GTP:Cofactor E (Reaction) 
18.2.2.8 Beta-tubulin:GTP:Cofactor D:alpha-tubulin:GTP:Cofactor E+ Cofactor C-> 11747 Beta-tubulin:GTP:Cofactor D:alpha-tubulin:GTP:Cofactor E:Cofactor C (Reaction) 
18.2.2.9 Beta-tubulin:GTP:Cofactor D:alpha-tubulin:GTP:Cofactor E:Cofactor C-> 11749 
Beta-tubulin:GDP :alpha-tubulin:GTP heterodimer +Cofactor E+ Cofactor D+ Cofactor C+ 
Pi (Reaction) 

18.3 Post-translational protein modification (Pathway) 11752 
18.3.1 PTM: gamma carboxylation, hypusine formation and arylsulfatase activation 11753 (Pathway) 
18.3.1.1 Gamma-carboxylation, transport, and amino-terminal cleavage of proteins 11754 (Pathway) 
18.3.1.1.1 vitamin K epoxide -> vitamin K hydroquinone (BlackBoxEvent) 11755 
18.3.1.1.2 Gamma-carboxylation of protein precursors (Pathway) 11756 
18.3.1.1.2.1 pro-factor IX, uncarboxylated + 12 CO2 + 12 O2 + 12 vitamin K 11757 hydroquinone -> pro-factor IX + 12 H2O + 12 vitamin K epoxide (Reaction) 
18.3.1.1.2.2 pro-factor VII, uncarboxylated + 10 CO2 + 10 O2 + 10 vitamin K 11758 hydroquinone -> pro-factor VII + 10 H2O + 10 vitamin K epoxide (Reaction) 
18.3.1.1.2.3 pro-factor X, uncarboxylated + 11 CO2 + 11 O2 + 11 vitamin K 11759 hydroquinone -> pro-factor X + 11 H2O + 11 vitamin K epoxide (Reaction) 
18.3.1.1.2.4 pro-prothrombin, uncarboxylated + 10 CO2 + 10 O2 + 10 vitamin K 11760 hydroquinone -> pro-prothrombin + 10 H2O + 10 vitamin K epoxide (Reaction) 
18.3.1.1.2.5 pro-protein C, uncarboxylated + 8 CO2 + 8 O2 + 8 vitamin K hydroquinone 
-> pro-protein C + 8 H2O + 8 vitamin K epoxide (Reaction) 
18.3.1.1.2.6 pro-protein S, uncarboxylated + 11 CO2 + 11 O2 + 11 vitamin K 11762 hydroquinone -> pro-protein S + 11 H2O + 11 vitamin K epoxide (Reaction) 
18.3.1.1.2.7 pro-protein Z, uncarboxylated + 13 CO2 + 13 O2 + 13 vitamin K 11763 hydroquinone -> pro-protein Z + 13 H2O + 13 vitamin K epoxide (Reaction) 
18.3.1.1.2.8 pro-GAS6, uncarboxylated + 11 CO2 + 11 O2 + 11 vitamin K hydroquinone
11764 -> pro-GAS6 + 11 H2O + 11 vitamin K epoxide (Reaction) 
18.3.1.1.3 Transport of gamma-carboxylated protein precursors from the endoplasmic11766 reticulum to the Golgi apparatus (Pathway) 
18.3.1.1.3.1 Pro-factor IX is transported from the endoplasmic reticulum to the Golgi11766 apparatus (Reaction) 
18.3.1.1.3.2 Pro-factor VII is transported from the endoplasmic reticulum to the Golgi11767 apparatus (Reaction) 
18.3.1.1.3.3 Pro-factor X is transported from the endoplasmic reticulum to the Golgi 11767 apparatus (Reaction) 
18.3.1.1.3.4 Pro-prothrombin is transported from the endoplasmic reticulum to the Golgi
11768 apparatus (Reaction) 
18.3.1.1.3.5 Pro-protein C is transported from the endoplasmic reticulum to the Golgi11768 apparatus (Reaction) 
18.3.1.1.3.6 Pro-protein S is transported from the endoplasmic reticulum to the Golgi11769 apparatus (Reaction) 
18.3.1.1.3.7 Pro-protein Z is transported from the endoplasmic reticulum to the Golgi11769 apparatus (Reaction) 
18.3.1.1.3.8 Pro-GAS6 is transported from the endoplasmic reticulum to the Golgi 11770 apparatus (Reaction) 
18.3.1.1.4 Removal of aminoterminal propeptides from gamma-carboxylated proteins11770 (Pathway) 
18.3.1.1.4.1 pro-factor IX -> factor IX + factor IX propeptide (Reaction) 11771 
18.3.1.1.4.2 pro-factor VII -> factor VII + factor VII propeptide (Reaction) 11772 
18.3.1.1.4.3 pro-factor X -> factor X + factor X propeptide (Reaction) 11772 
18.3.1.1.4.4 pro-prothrombin -> prothrombin + prothrombin propeptide (Reaction) 11773 
18.3.1.1.4.5 pro-protein C -> protein C + protein C propeptide (Reaction) 11773 
18.3.1.1.4.6 pro-protein S -> protein S + protein S propeptide (Reaction) 11774 
18.3.1.1.4.7 pro-protein Z -> protein Z + protein Z propeptide (Reaction) 11774 
18.3.1.1.4.8 pro-GAS6 -> GAS6 + GAS6 propeptide (Reaction) 11775 
18.3.1.2 Hypusine synthesis from eIF5A-lysine (Pathway) 11776 
18.3.1.2.1 EIF5A + spermidine EIF5A(Dhp) + 1,3-diaminopropane (Reaction) 11777 
18.3.1.2.2 EIF5A(Dhp) + 1,3-diaminopropane EIF5A + spermidine (Reaction) 11778 
18.3.1.2.3 EIF5A(Dhp) + O2 => EIF5A(Hyp) (Reaction) 11780 
18.3.1.3 The activation of arylsulfatases (Pathway) 11781 
18.3.1.3.1 SUMF1 mediates the oxidation of cysteine to formylglycine, producing active
11783 arylsulfatases (Reaction) 
18.3.1.3.2 SUMF2 inhibits SUMF1-mediated activation of arylsulfatases (Reaction) 11783 
18.3.2 Post-translational modification: synthesis of GPI-anchored proteins (Pathway) 11785 
18.3.2.1 Synthesis of dolichyl-phosphate mannose (Pathway) 1176111785 18.3.2.1.1 dolichyl phosphate + GDP-alpha-D-mannose -> dolichyl phosphate 11787 D-mannose (Reaction) 
18.3.2.1.2 Reorientation of dolichyl phosphate D-mannose in the endoplasmic reticulum 
11788 membrane (Reaction) 
18.3.2.2 Synthesis of glycosylphosphatidylinositol (GPI) (Pathway) 11789 
18.3.2.2.1 phosphatidylinositol + UDP-N-acetyl-D-glucosamine -> 11791 N-acetylglucosaminyl-PI + UDP (Reaction) 
18.3.2.2.2 N-acetylglucosaminyl-PI + H2O -> glucosaminyl-PI + acetate (Reaction) 11792 
18.3.2.2.3 Reorientation of glucosaminyl-acyl-PI in the endoplasmic reticulum membrane 
11793 (Reaction) 
18.3.2.2.4 glucosaminyl-PI + fatty acyl-CoA -> glucosaminyl-acyl-PI + CoA-SH (Reaction)11795 
18.3.2.2.5 glucosaminyl-acyl-PI + dolichol phosphate D-mannose -> 11796 mannose(al1-4)glucosaminyl-acyl-PI + dolichol phosphate (Reaction) 
18.3.2.2.6 mannose(a1-4)glucosaminyl-acyl-PI + phosphatidylethanolamine -> 11797 (ethanolamineP) mannose(al1-4)glucosaminyl-acyl-PI + diacylglycerol (Reaction) 
18.3.2.2.7 (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI + dolichol phosphate 11798 D-mannose -> mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI + dolichol phosphate (Reaction) 
18.3.2.2.8 mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI + 11799 dolichol phosphate D-mannose -> mannose (a1-2) mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI + dolichol phosphate (Reaction) 
18.3.2.2.9 mannose (a1-2) mannose (a1-6) (ethanolamineP) mannose (a1-4) 11800 glucosaminyl-acyl-PI + phosphatidylethanolamine -> (ethanolamineP) mannose (a1-2) mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI (acyl-GPI) + diacylglycerol (Reaction) 
18.3.2.2.10 mannose (a1-2) mannose (a1-6) (ethanolamineP) mannose (a1-4) 11803 glucosaminyl-acyl-PI -> mannose (a1) mannose (a1-2) mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI (Reaction) 
18.3.2.2.11 (ethanolamineP) mannose (a1-2) mannose (a1-6) (ethanolamineP) mannose 
11804 (a1-4) glucosaminyl-acyl-PI -> (ethanolamineP) mannose (a1-2) (ethanolamineP) mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI (Reaction) 
18.3.2.3 Attachment of GPI anchor to uPAR (Pathway) 11805 
18.3.2.3.1 uPAR precursor + acyl-GPI -> uPAR-acyl-GPI + uPAR propeptide (Reaction)
11806 
18.3.2.3.2 uPAR-acyl-GPI + H2O -> uPAR + long-chain fatty acid (Reaction) 11807 
18.3.3 Asparagine N-linked glycosylation (Pathway) 11808 
18.3.3.1 Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) 
11810 and transfer to a nascent protein (Pathway) 
18.3.3.1.1 Synthesis of substrates in N-glycan biosythesis (Pathway) 11812 
18.3.3.1.1.1 Synthesis of Dolichyl-phosphate (Pathway) 11814 
18.3.3.1.1.1.1 MVD decarboxylates MVA5PP to IPPP (Reaction) 11815 
18.3.3.1.1.1.2 DHDDS elongates E,E-FPP with (n)IPPP to form pPPP (Reaction) 11815 
18.3.3.1.1.1.3 Unknown pPPP phosphatase dephosphorylates pPPP to pPNOL 11817 (Reaction) 
18.3.3.1.1.1.4 SRD5A3 reduces pPNOL to DCHOL (Reaction) 11818 
18.3.3.1.1.1.5 DOLK phosphorylates DCHOL to DOLP (Reaction) 11820 18.3.3.1.1.1.6 DOLPP1 dephosphorylates DOLDP to DOLP (Reaction) 11821 
18.3.3.1.1.2 Synthesis of UDP-N-acetyl-glucosamine (Pathway) 11822 
18.3.3.1.1.2.1 GFPT1,2 transfer an amino group from L-Gln to F6P to form GlcN6P11823 (Reaction) 
18.3.3.1.1.2.2 Acetylation of glucosamine 6-phosphate to GlcNAc6P (Reaction) 11825 
18.3.3.1.1.2.3 Isomerization of GlcNAc6P to GlcNAc1P (Reaction) 11826 
18.3.3.1.1.2.4 GlcNAc1P is dephosphorylated to UDP-N-acetyl-glucosamine (Reaction)11827 
18.3.3.1.1.3 Synthesis of GDP-mannose (Pathway) 11828 
18.3.3.1.1.3.1 MPI isomerizes Fru6P to Man6P (Reaction) 11829 
18.3.3.1.1.3.2 PMM1,2 isomerize Man6P to Man1P (Reaction) 11831 
18.3.3.1.1.3.3 Mannose-1-phosphate converted to GDP-Mannose (Reaction) 11832 
18.3.3.1.1.4 Synthesis of dolichyl-phosphate mannose (Pathway) 11834 
18.3.3.1.1.4.1 dolichyl phosphate + GDP-alpha-D-mannose -> dolichyl phosphate 11834 D-mannose (Reaction) 
18.3.3.1.1.4.2 Reorientation of dolichyl phosphate D-mannose in the endoplasmic 11834 reticulum membrane (Reaction) 
18.3.3.1.1.5 Synthesis of dolichyl-phosphate-glucose (Pathway) 11835 
18.3.3.1.1.5.1 Synthesis of dolichyl-phosphate-glucose (Reaction) 11835 
18.3.3.1.1.5.2 Flipping of dolichyl-phosphate-glucose into the ER lumen (Reaction)11837 
18.3.3.1.1.6 Sialic acid metabolism (Pathway) 11838 
18.3.3.1.1.6.1 GNE hydrolyzes/epimerises UDP-GlcNAc to ManNAc and UDP 11839 (Reaction) 
18.3.3.1.1.6.2 GNE phosphorylates ManNAc to ManNAc-6-P (Reaction) 11842 
18.3.3.1.1.6.3 NANS converts ManNAc-6-P to Neu5Ac-9-P (Reaction) 11844 
18.3.3.1.1.6.4 NANP dephosphorylates Neu5Ac-9-P to Neu5Ac (Reaction) 11845 
18.3.3.1.1.6.5 Cytosolic Neu5Ac translocates to nucleus (BlackBoxEvent) 11846 
18.3.3.1.1.6.6 CMAS transfers CMP from CTP to Neu5Ac, forming CMP-Neu5Ac 11847 (Reaction) 
18.3.3.1.1.6.7 Nuclear CMP-Neu5Ac translocates to cytosol (BlackBoxEvent) 11849 
18.3.3.1.1.6.8 SLC35A1 exchanges CMP-Neu5Ac for CMP (Reaction) 11850 
18.3.3.1.1.6.9 ST3GAL1-6 transfer Neu5Ac to terminal Gal (alpha-2,3 link) (Reaction)11851 
18.3.3.1.1.6.10 ST6GAL1,2 transfer Neu5Ac to terminal Gal (alpha-2,6 link) (Reaction)
11853 
18.3.3.1.1.6.11 ST6GALNAC1-6 transfer Neu5Ac to terminal GalNAc (alpha-2,6 link)
11855 (Reaction) 
18.3.3.1.1.6.12 ST8SIA1-6 transfer Neu5Ac to terminal Neu5Ac residues (Reaction)11856 
18.3.3.1.1.6.13 Golgi lumen glycoconjugates translocate to the plasma membrane 11858 (BlackBoxEvent) 
18.3.3.1.1.6.14 NEU3 hydrolyzes Neu5Ac from glycoconjugates (Reaction) 11859 
18.3.3.1.1.6.15 Cytosolic glycoconjugates translocate to the lysosome (BlackBoxEvent)11860 
18.3.3.1.1.6.16 NEU1,4 hydrolyzes Neu5Ac from glycoconjugates (Reaction) 11861 
18.3.3.1.1.6.17 Plasma membrane glycoconjugates translocate to the cytosol 11864 (BlackBoxEvent) 
18.3.3.1.1.6.18 NEU2 hydrolyzes Neu5Ac from glycoconjugates (Reaction) 11865 
18.3.3.1.1.6.19 SLC17A5 cotransports lysosomal Neu5Ac and H+ to cytosol (Reaction)11866 
18.3.3.1.1.6.20 NPL cleaves Neu5Ac,Neu5Gc to ManNAc,ManNGc and pyruvate (Reaction) 
18.3.3.1.2 Addition of N-acetyl-D-glucosamine to Dolichyl phosphate (Reaction) 11869 
18.3.3.1.3 Addition of the second N-acetyl-glucosamine to the N-glycan precursor 11871 (Reaction) 
18.3.3.1.4 Addition of the first mannose to the N-glycan precursor by ALG1 (Reaction)11872 
18.3.3.1.5 Addition of a second mannose to the N-glycan precursor by ALG2 (Reaction)11874 
18.3.3.1.6 Addition of a third mannose to the N-glycan precursor by ALG2 (Reaction) 11875 
18.3.3.1.7 ALG11 transfers the fourth and fifth Man to the N-glycan precursor (Reaction)11878 
18.3.3.1.8 Flipping of the N-glycan precursor to inside the ER (Reaction) 11879 
18.3.3.1.9 Addition of the sixth mannose to the N-glycan precursor by ALG3. (Reaction)11882 
18.3.3.1.10 Addition of the seventh mannose to the N-glycan precursor by ALG9 11883 (Reaction) 
18.3.3.1.11 Addition of the eighth mannose to the N-glycan precursor by ALG12 11885 (Reaction) 
18.3.3.1.12 Addition of the last mannose to the N-glycan precursor by ALG9 (Reaction)11887 
18.3.3.1.13 Addition of the first glucose to the N-glycan precursor by ALG6 (Reaction)11889 
18.3.3.1.14 Addition of a second glucose to the N-glycan precursor by ALG8 (Reaction)11890 
18.3.3.1.15 Addition of a third glucose to the N-glycan precursor by an ALG10 homologue
11892 (Reaction) 
18.3.3.2 Transfer of N-glycan to the protein (Reaction) 11894 
18.3.3.3 N-glycan trimming in the ER and Calnexin/Calreticulin cycle (Pathway) 11895 
18.3.3.3.1 Trimming of the first glucose by glucosidase I (Reaction) 11897 
18.3.3.3.2 Binding of Malectin (Reaction) 11898 
18.3.3.3.3 Removal of the second glucose by glucosidase II (Reaction) 11900 
18.3.3.3.4 Calnexin/calreticulin cycle (Pathway) 11901 
18.3.3.3.4.1 Binding of calnexin/calreticulin to the unfolded protein (Reaction) 11902 
18.3.3.3.4.2 Binding of ERp57 (Reaction) 11904 
18.3.3.3.4.3 Removal of the third glucose by glucosidase II and release from the 11905 chaperone (Reaction) 
18.3.3.3.4.4 Incorrectly folded glycoproteins translocate to the ERQC (Reaction) 11906 
18.3.3.3.4.5 ER Quality Control Compartment (ERQC) (Pathway) 11907 
18.3.3.3.4.5.1 Trimming of the terminal mannose on the B branch (Reaction) 11909 
18.3.3.3.4.5.2 Trimming of the terminal mannose on the C branch (Reaction) 11910 
18.3.3.3.4.5.3 Trimming of the first mannose on the A branch (Reaction) 11912 
18.3.3.3.4.5.4 Trimming of the second mannose on the A branch (Reaction) 11914 
18.3.3.3.4.5.5 Re-addition of a glucose on the alpha 1,3 branch (Reaction) 11915 
18.3.3.3.4.5.6 Glycoproteins with major folding defects are sent to degradation by 11917 EDEMs (Reaction) 
18.3.3.3.4.5.7 Glycoproteins with lesser folding defects get transported back to the ER
11918 and the CNX/CRT complex (Reaction) 
18.3.3.4 Transport to the Golgi and subsequent modification (Pathway) 11919 
18.3.3.4.1 Correctly folded glycoproteins translocate to the Golgi (BlackBoxEvent) 11920 
18.3.3.4.2 Transport of glycoproteins with Man8 (or Man9) N-glycans to the Golgi 11921 (Reaction) 
18.3.3.4.3 ER to Golgi Transport (Pathway) 
11868
11923 
18.3.3.4.3.1 COPII (Coat Protein 2) Mediated Vesicle Transport (Pathway) 11923 
18.3.3.4.3.1.1 Sar1p Activation And Membrane Binding (Reaction) 11923 
18.3.3.4.3.1.2 Coat Assembly (Reaction) 11924 
18.3.3.4.3.1.3 Loss of Sar1b GTPase (Reaction) 11924 
18.3.3.4.3.1.4 Cargo, Sec31p:Sec13p, and v-SNARE recruitment (Reaction) 11924 
18.3.3.4.3.1.5 Vesicle Budding (Reaction) 11925 
18.3.3.4.3.1.6 Vesicle Uncoating (Reaction) 11925 
18.3.3.4.4 N-glycan trimming and elongation in the cis-Golgi (Pathway) 11925 
18.3.3.4.4.1 Alternative endo-mannosidase I route (Reaction) 11927 
18.3.3.4.4.2 Progressive trimming of alpha-1,2-linked mannose residues from 11929 Man9/8/7GlcNAc2 to produce Man5GlcNAc2 (Pathway) 
18.3.3.4.4.2.1 Progressive trimming of alpha-1,2-linked mannose residues from 11930 Man9GlcNAc2 to produce Man5GlcNAc2 (Reaction) 
18.3.3.4.4.2.2 Progressive trimming of alpha-1,2-linked mannose residues from 11932 Man8GlcNAc2 to produce Man5GlcNAc2 (Reaction) 
18.3.3.4.4.2.3 Progressive trimming of alpha-1,2-linked mannose residues from 11933 Man7GlcNAc2 to produce Man5GlcNAc2 (Reaction) 
18.3.3.4.4.3 Addition of GlcNAc to the glycan on the A arm (Reaction) 11934 
18.3.3.4.5 N-glycan antennae elongation in the medial/trans-Golgi (Pathway) 11936 
18.3.3.4.5.1 Reactions specific to the hybrid N-glycan synthesis pathway (Pathway) 11937 
18.3.3.4.5.1.1 Addition of a bifurcating GlcNAc to the N-glycan by MGAT3 (Reaction)
11938 
18.3.3.4.5.2 Reactions specific to the complex N-glycan synthesis pathway (Pathway)
11940 
18.3.3.4.5.2.1 Trimming of mannoses on the alpha1,6 arm by MAN2A1 (Reaction) 11940 
18.3.3.4.5.2.2 Addition of a GlcNAc on the alpha 1,4 branch by MGAT2 (Reaction) 11942 
18.3.3.4.5.2.3 Addition of alpha 1,6 fucose to the first GlcNAc of the N-glycan 11943 (Reaction) 
18.3.3.4.5.3 N-Glycan antennae elongation (Pathway) 11945 
18.3.3.4.5.3.1 Addition of GlcNAc to position 4 by N-acetylglucosaminyltransferase11946 (GnT)-IV (Reaction) 
18.3.3.4.5.3.2 Addition of GlcNAc to position 5 by MGAT5 (Reaction) 11948 
18.3.3.4.5.3.3 Addition of galactose by beta 4-galactosyltransferases (Reaction) 11949 
18.3.3.4.5.3.4 ST6GAL1 transfers Neu5Ac to terminal Gal of N-glycans (Reaction) 11951 
18.3.3.4.5.3.5 ST8SIA2,3,6 transfer Neu5Ac to terminal Gal of N-glycans (Reaction)11953 
18.3.3.4.5.3.6 ST3GAL4 transfers Neu5Ac to terminal Gal of N-glycans (Reaction) 11956 
18.3.4 O-linked glycosylation (Pathway) 11958 
18.3.4.1 O-glycosylation of TSR domain-containing proteins (Pathway) 11959 
18.3.4.1.1 POFUT2 transfers fucose to TSR domain-containing proteins (Reaction) 11960 
18.3.4.1.2 B3GALTL transfers glucose to O-fucosyl-proteins (Reaction) 11962 
18.3.4.2 O-linked glycosylation of mucins (Pathway) 11963 
18.3.4.2.1 Addition of GalNAc to mucins to form the Tn antigen (Reaction) 11964 
18.3.4.2.2 C1GALT1 transfers galactose to the Tn antigen forming Core 1 glycoproteins
11966 (T antigens) (Reaction) 
18.3.4.2.3 Addition of GlcNAc to the T antigen forms a Core 2 glycoprotein (Reaction)11967 
18.3.4.2.4 Addition of GlcNAc to the Tn antigen forms a Core 3 glycoprotein (Reaction)11969 
18.3.4.2.5 Addition of GlcNAc to Core 3 forms a Core 4 glycoprotein (Reaction) 11971 18.3.4.2.6 Addition of GlcNAc to the Tn antigen via an alpha-1,3 linkage forms a Core 5
11972 glycoprotein (BlackBoxEvent) 
18.3.4.2.7 Addition of GlcNAc to the Tn antigen via a beta-1,6 linkage forms a Core 611973 glycoprotein (BlackBoxEvent) 
18.3.4.2.8 Addition of galactose to Core 6 glycoprotein (Reaction) 11974 
18.3.4.2.9 Addition of GalNAc to the Tn antigen via an alpha-1,6 linkage forms a Core 7
11975 glycoprotein (BlackBoxEvent) 
18.3.4.2.10 Addition of galactose to the Tn antigen via an alpha-1,3 linkage forms a Core
11976 8 glycoprotein (BlackBoxEvent) 
18.3.4.2.11 Termination of O-glycan biosynthesis (Pathway) 11977 
18.3.4.2.11.1 Sialyltransferase I can add sialic acid to the Tn antigen at the alpha 6 11978 position (Reaction) 
18.3.4.2.11.2 Sialyltransferase I can add sialic acid to the T antigen at the alpha 6 11980 position (Reaction) 
18.3.4.2.11.3 GalNAc alpha-2,6-sialyltransferase II can add a sialic acid to the T antigen
11981 at the alpha 6 position (Reaction) 
18.3.4.2.11.4 ST3GAL1-4 can add a sialic acid to the T antigen at the alpha 3 position
11983 (Reaction) 
18.3.4.2.11.5 ST6GALNAC3/4 can add a sialic acid to the sialyl T antigen to form the11984 disialyl T antigen (Reaction) 
18.3.5 SUMOylation (Pathway) 11986 
18.3.5.1 Processing and activation of SUMO (Pathway) 11987 
18.3.5.1.1 SUMO is proteolytically processed (Pathway) 11989 
18.3.5.1.1.1 SENP1,2,5 proteolytically process SUMO1 (Reaction) 11991 
18.3.5.1.1.2 SEN1,2,5 proteolytically process SUMO2 (Reaction) 11993 
18.3.5.1.1.3 SENP1,2,5 proteolytically process SUMO3 (Reaction) 11995 
18.3.5.1.2 SUMO is conjugated to E1 (UBA2:SAE1) (Pathway) 11997 
18.3.5.1.2.1 Conjugation of SUMO1 to UBA2:SAE1 (Reaction) 11998 
18.3.5.1.2.2 Conjugation of SUMO2 to UBA2:SAE1 (Reaction) 11999 
18.3.5.1.2.3 Conjugation of SUMO3 to UBA2:SAE1 (Reaction) 12001 
18.3.5.1.3 SUMO is transferred from E1 to E2 (UBE2I, UBC9) (Pathway) 12003 
18.3.5.1.3.1 Transfer of SUMO1 from E1 to UBE2I (UBC9) (Reaction) 12004 
18.3.5.1.3.2 Transfer of SUMO2 from E1 to UBE2I (UBC9) (Reaction) 12006 
18.3.5.1.3.3 Transfer of SUMO3 from E1 to UBE2I (UBC9) (Reaction) 12008 
18.4 Mitochondrial protein import (Pathway) 12010 
18.4.1 TOMM40 complex translocates proteins from the cytosol to the mitochondrial 12012 intermembrane space (Reaction) 
18.4.2 MIA40:ERV1 (CHCHD4:GFER) oxidizes cysteine residues to cystine disulfide bonds
12017 (Reaction) 
18.4.3 TIMM8:TIMM13 chaperones hydrophobic proteins (Reaction) 12021 
18.4.4 TIMM9:TIMM10 binds hydrophobic proteins (Reaction) 12023 
18.4.5 TIMM9:TIMM10 transfers proteins to TIMM22 (Reaction) 12026 
18.4.6 SAM50 complex inserts proteins into mitochondrial outer membrane (Reaction) 12027 
18.4.7 TIMM22 inserts proteins into inner membrane (Reaction) 12030 
18.4.8 Precursor proteins enter TIMM23 SORT (Reaction) 12033 18.4.9 MPP hydrolyzes presequence of inner membrane precursors (Reaction) 12036 
18.4.10 TIMM23 SORT inserts proteins into inner membrane (Reaction) 12038 
18.4.11 Precursor proteins enter TIMM23 PAM (Reaction) 12042 
18.4.12 MPP hydrolyzes presequence of matrix precursors (Reaction) 12044 
18.4.13 TIMM23 PAM translocates proteins from the mitochndrial intermebrane space to the
12047 mitochondrial matrix (Reaction) 
18.5 Peptide hormone metabolism (Pathway) 12051 
18.5.1 Insulin processing (Pathway) 12052 
18.5.1.1 Oxidation of cysteine to cystine in Proinsulin (Reaction) 12055 
18.5.1.2 Cystine-bonded Proinsulin translocates from the endoplasmic reticulum to the12057 Golgi (BlackBoxEvent) 
18.5.1.3 ZnT6 transports zinc into the golgi apparatus (Reaction) 12058 
18.5.1.4 ZnT7 transports zinc into the golgi apparatus (Reaction) 12059 
18.5.1.5 Proinsulin binds zinc and calcium forming Proinsulin:zinc:calcium (Reaction) 12061 
18.5.1.6 Proinsulin:Zinc:Calcium complex translocates to immature secretory granule 12062 (BlackBoxEvent) 
18.5.1.7 Processing of Proinsulin to Insulin (BlackBoxEvent) 12063 
18.5.1.8 ZnT5 transports zinc into secretory granules in pancreatic beta cells (Reaction)12066 
18.5.1.9 SLC30A8 transports Zn2+ from cytosol to secretory granule (Reaction) 12068 
18.5.1.10 Insulin secretory granule translocates to cell cortex (BlackBoxEvent) 12069 
18.5.1.11 Insulin secretory granules translocate across the cortical actin network to dock at
12071 plasma membrane (BlackBoxEvent) 
18.5.1.12 Exocyst complex formation (BlackBoxEvent) 12074 
18.5.2 Synthesis, secretion, and deacylation of Ghrelin (Pathway) 12075 
18.5.2.1 Synthesis of Preproghrelin (BlackBoxEvent) 12077 
18.5.2.2 Cleavage of the signal peptide of Preproghrelin (Reaction) 12079 
18.5.2.3 Ghrelin O-acyltransferase octanoylates Proghrelin (Reaction) 12080 
18.5.2.4 Ghrelin O-acyltransferase decanoylates Proghrelin (Reaction) 12082 
18.5.2.5 PCSK1 hydrolyzes acyl Proghrelin to acyl Ghrelin (Reaction) 12083 
18.5.2.6 Acyl Ghrelin and C-Ghrelin are secreted (BlackBoxEvent) 12085 
18.5.2.7 Butyrylcholinesterase and Platelet-activating factor acetylhydrolase hydrolyze acyl
12088 Ghrelin (BlackBoxEvent) 
18.5.3 Metabolism of Angiotensinogen to Angiotensins (Pathway) 12090 
18.5.3.1 Renin hydrolyzes Angiotensinogen to Angiotensin-(1-10) (Reaction) 12092 
18.5.3.2 Renin:Prorenin Receptor hydrolyzes Angiotensinogen to Angiotensin-(1-10) 12094 (Reaction) 
18.5.3.3 Prorenin:Prorenin Receptor hydrolyzes Angiotensinogen to Angiotensin-(1-10)12096 (Reaction) 
18.5.3.4 ACE hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) (Reaction) 12098 
18.5.3.5 Secreted ACE hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) (Reaction) 12101 
18.5.3.6 Chymase hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) (Reaction) 12104 
18.5.3.7 Cathepsin G hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) (Reaction) 12106 
18.5.3.8 Cathepsin Z (Cathepsin X) hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8)12107 (Reaction) 
18.5.3.9 ACE2 hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-9) (Reaction) 12108 
18.5.3.10 ACE hydrolyzes Angiotensin-(1-9) to Angiotensin-(1-7) (Reaction) 12110 
18.5.3.11 Neprilysin hydrolyzes Angiotensin-(1-9) to Angiotensin-(1-7) (Reaction) 12111 
18.5.3.12 Neprilysin hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-7) (Reaction) 12112 
18.5.3.13 ENPEP hydrolyzes Angiotensin-(1-8) to Angiotensin-(2-8) (Reaction) 12114 
18.5.3.14 ANPEP hydrolyzes Angiotensin-(2-8) to Angiotensin-(3-8) (Reaction) 12115 
18.5.3.15 ACE2 hydrolyzes Angiotensin-(1-8) to Angiotensin-(1-7) (Reaction) 12117 
18.5.3.16 Mast Cell Carboxypeptidase Hydrolyzes Angiotensin-(1-10) to Yield 12118 Angiotensin-(1-9) (Reaction) 
18.5.4 Incretin synthesis, secretion, and inactivation (Pathway) 12119 
18.5.4.1 Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) 12121 (Pathway) 
18.5.4.1.1 Synthesis of Preproglucagon in intestinal L cells (BlackBoxEvent) 12122 
18.5.4.1.2 Signal peptidase hydrolyzes preproGLP-1 to proGLP-1 (Reaction) 12125 
18.5.4.1.3 Proglucagon translocates from the ER Lumen to secretory granules 12126 (BlackBoxEvent) 
18.5.4.1.4 PCSK1 hydrolyzes Proglucagon to Glucagon-like Peptide-1 (BlackBoxEvent)12127 
18.5.4.1.5 Glucagon-like Peptide 1 is secreted from intestinal L cells (BlackBoxEvent)12130 
18.5.4.1.6 DPP4 hydrolyzes Glucagon-like Peptide-1 (GLP-1) (Reaction) 12133 
18.5.4.2 Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic 12134 Polypeptide (GIP) (Pathway) 
18.5.4.2.1 Synthesis of prepro-Glucose-dependent Insulinotropic Polypeptide (preproGIP)
12136 in intestinal K cells (BlackBoxEvent) 
18.5.4.2.2 Signal peptidase hydrolyzes preproGIP to proGIP (Reaction) 12138 
18.5.4.2.3 ProGIP translocates from the ER Lumen to secretory granules 12139 (BlackBoxEvent) 
18.5.4.2.4 PCSK1 hydrolyzes proGIP to GIP (Reaction) 12140 
18.5.4.2.5 Glucose-dependent Insulinotropic Polypeptide is secreted from intestinal K12142 cells (BlackBoxEvent) 
18.5.4.2.6 DPP4 hydrolyzes Glucose-dependent Insulinotropic Polypeptide (GIP) 12144 (Reaction) 
18.5.5 Peptide hormone biosynthesis (Pathway) 12145 
18.5.5.1 Corticotropin cleavage from POMC (Reaction) 12146 
18.5.5.2 Glycoprotein hormones (Pathway) 12147 
18.5.5.2.1 Human chorionic gonadotropin (hCG) is a heterodimer (Reaction) 12148 
18.5.5.2.2 Luteinizing hormone is a heterodimer (Reaction) 12150 
18.5.5.2.3 Thyrotropin is a heterodimer (Reaction) 12151 
18.5.5.2.4 Follitropin is a heterodimer (Reaction) 12152 
18.6 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like 12153 Growth Factor Binding Proteins (IGFBPs) (Pathway) 
18.6.1 IGFBP1 binds IGF forming IGF:IGFBP1 (Reaction) 12156 
18.6.2 IGFBP2 binds IGF forming IGF:IGFBP2 (Reaction) 12157 
18.6.3 Formation of the IGF:IGFBP3:ALS complex (Reaction) 12159 
18.6.4 IGFBP4 binds IGF forming IGF:IGFBP4 (Reaction) 12162 
18.6.5 Formation of the IGF:IGFBP5:ALS complex (Reaction) 12164 
18.6.6 IGFBP6 binds IGF forming IGF:IGFBP6 (Reaction) 12166 
18.6.7 Cathepsin G proteolyzes IGF:IGFBP3:ALS (Reaction) 12168 
18.6.8 Matrix metalloproteinase proteolyzes IGF:IGFBP3:ALS (Reaction) 12169 
18.6.9 Plasmin proteolyzes IGF:IGFBP-3:ALS (Reaction) 12170 
18.6.10 Prostate-specific Antigen proteolyzes IGF:IGFBP3:ALS (Reaction) 12172 
18.6.11 Thrombin proteolyzes IGF:IGFBP3:ALS (Reaction) 12174 
18.6.12 PAAP-A proteolyzes IGF:IGFBP4 (Reaction) 12175 
18.6.13 PAPP-A2 proteolyzes IGF:IGFBP5:ALS (Reaction) 12178 
18.7 Unfolded Protein Response (UPR) (Pathway) 12180 
18.7.1 ATF6-alpha activates chaperones (Pathway) 12182 
18.7.1.1 ATF6-alpha:BiP dissociates in response to unfolded protein (Reaction) 12183 
18.7.1.2 ATF6-alpha translocates from the endoplasmic reticulum to the Golgi 12184 (BlackBoxEvent) 
18.7.1.3 S1P hydrolyzes ATF6-alpha (Reaction) 12186 
18.7.1.4 S2P hydrolyzes ATF6-alpha (Reaction) 12187 
18.7.1.5 ATF6-alpha translocates from the Golgi to the Nucleus (BlackBoxEvent) 12189 
18.7.1.6 ATF6-alpha activates chaperone genes (Pathway) 12190 
18.7.1.6.1 Expression of BIP (78 kDa Glucose-regulated protein, GRP78, HSPA5) 12191 (BlackBoxEvent) 
18.7.1.6.2 Expression of CHOP (DDIT3, GADD153) (BlackBoxEvent) 12193 
18.7.1.6.3 Expression of Calreticulin (BlackBoxEvent) 12195 
18.7.1.6.4 Expression of HSP90B1 (Endoplasmin) (BlackBoxEvent) 12196 
18.7.1.6.5 Expression of Xbp1(S) (BlackBoxEvent) 12198 
18.7.2 IRE1alpha activates chaperones (Pathway) 12199 
18.7.2.1 IRE1:BiP dissociates in response to unfolded protein (Reaction) 12201 
18.7.2.2 IRE1 binds IRE1 forming dimer (Reaction) 12202 
18.7.2.3 IRE1 dimer autophosphorylates (Reaction) 12204 
18.7.2.4 Phosphorylated IRE1 dimer binds ADP (Reaction) 12206 
18.7.2.5 IRE1alpha hydrolyzes Xbp1 mRNA and Xbp1 mRNA is spliced (BlackBoxEvent)
12207 
18.7.2.6 XBP(S) mRNA is translated and XBP1(S) translocates to the nucleus 12209 (BlackBoxEvent) 
18.7.2.7 XBP1(S) activates chaperone genes (Pathway) 12212 
18.7.2.7.1 Expression of ACADVL (BlackBoxEvent) 12214 
18.7.2.7.2 Expression of ADD1 (Adducin alpha) (BlackBoxEvent) 12215 
18.7.2.7.3 Expression of ATP6VOD1 (BlackBoxEvent) 12217 
18.7.2.7.4 Expression of C19orf10 (BlackBoxEvent) 12218 
18.7.2.7.5 Expression of CTDSP2 (BlackBoxEvent) 12220 
18.7.2.7.6 Expression of CXXC1 (BlackBoxEvent) 12221 
18.7.2.7.7 Expression of Cullin-7 (BlackBoxEvent) 12223 
18.7.2.7.8 Expression of DCTN1 (BlackBoxEvent) 12224 
18.7.2.7.9 Expression of DDX11 (BlackBoxEvent) 12226 
18.7.2.7.10 Expression of DNAJB11 (BlackBoxEvent) 12227 
18.7.2.7.11 Expression of DNAJB9 (BlackBoxEvent) 12229 
18.7.2.7.12 Expression of EDEM (BlackBoxEvent) 12230 
18.7.2.7.13 Expression of EXTL3 (BlackBoxEvent) 12232 
18.7.2.7.14 Expression of FKBP14 (BlackBoxEvent) 12233 18.7.2.7.15 Expression of ARFGAP1 (GAP) (BlackBoxEvent) 12235 
18.7.2.7.16 Expression of GFPT1 (BlackBoxEvent) 12236 
18.7.2.7.17 Expression of GOSR2 (BlackBoxEvent) 12238 
18.7.2.7.18 Expression of GSK3A (BlackBoxEvent) 12239 
18.7.2.7.19 Expression of HDGF (BlackBoxEvent) 12241 
18.7.2.7.20 Expression of HYOU1 (BlackBoxEvent) 12242 
18.7.2.7.21 Expression of KDELR3 (BlackBoxEvent) 12244 
18.7.2.7.22 Expression of KLHDC3 (BlackBoxEvent) 12245 
18.7.2.7.23 Expression of LMNA (BlackBoxEvent) 12247 
18.7.2.7.24 Expression of PDIA5 (BlackBoxEvent) 12248 
18.7.2.7.25 Expression of PDIA6 (Protein disulfide-isomerase A6) (BlackBoxEvent) 12250 
18.7.2.7.26 Expression of PLA2G4B (BlackBoxEvent) 12251 
18.7.2.7.27 Expression of PPP2R5B (BlackBoxEvent) 12253 
18.7.2.7.28 Expression of SERP1 (RAMP4) (BlackBoxEvent) 12254 
18.7.2.7.29 Expression of SHC1 (BlackBoxEvent) 12256 
18.7.2.7.30 Expression of SRPR (SRP Receptor subunit alpha) (BlackBoxEvent) 12257 
18.7.2.7.31 Expression of SRPRB (SRP Receptor subunit beta) (BlackBoxEvent) 12259 
18.7.2.7.32 Expression of SSR1 (Trap alpha) (BlackBoxEvent) 12260 
18.7.2.7.33 Expression of SULT1A3 (BlackBoxEvent) 12262 
18.7.2.7.34 Expression of SYVN1 (HRD1) (BlackBoxEvent) 12263 
18.7.2.7.35 Expression of Sec12 (BlackBoxEvent) 12265 
18.7.2.7.36 Expression of Sec31A (BlackBoxEvent) 12266 
18.7.2.7.37 Expression of TATDN2 (BlackBoxEvent) 12268 
18.7.2.7.38 Expression of TPP1 (BlackBoxEvent) 12269 
18.7.2.7.39 Expression of TSPYL2 (BlackBoxEvent) 12271 
18.7.2.7.40 Expression of Talin-1 (BlackBoxEvent) 12272 
18.7.2.7.41 Expression of WFS1 (BlackBoxEvent) 12274 
18.7.2.7.42 Expression of WIPI1 (BlackBoxEvent) 12275 
18.7.2.7.43 Expression of YIF1A (BlackBoxEvent) 12277 
18.7.2.7.44 Expression of ZBTB17 (BlackBoxEvent) 12278 
18.7.2.7.45 Expression of DNAJC3 (p58IPK) (BlackBoxEvent) 12280 
18.7.3 PERK regulates gene expression (Pathway) 12281 
18.7.3.1 Dissociation of PERK:BiP Heterodimer (Reaction) 12283 
18.7.3.2 Dimerization of PERK (Reaction) 12284 
18.7.3.3 Phosphorylation of eIF2-alpha by PERK (Reaction) 12285 
18.7.3.4 Translation and translocation of ATF4 (BlackBoxEvent) 12287 
18.7.3.5 ATF4 activates genes (Pathway) 12289 
18.7.3.5.1 Expression of ATF3 (BlackBoxEvent) 12290 
18.7.3.5.2 Expression of Asparagine Synthetase (BlackBoxEvent) 12292 
18.7.3.5.3 Expression of CCL2 (BlackBoxEvent) 12293 
18.7.3.5.4 Expression of CHOP (DDIT3, GADD153) (BlackBoxEvent) 12295 
18.7.3.5.5 Expression of HERPUD (BlackBoxEvent) 12295 
18.7.3.5.6 Expression of IGFBP1 (BlackBoxEvent) 12296 
18.7.3.5.7 Expression of IL-8 (BlackBoxEvent) 12298 19 Muscle contraction (Pathway) 12300 
19.1 Striated Muscle Contraction (Pathway) 12300 
19.1.1 Calcium Binds Troponin-C (Reaction) 12302 
19.1.2 Myosin Binds ATP (Reaction) 12303 
19.1.3 ATP Hydrolysis By Myosin (Reaction) 12304 
19.1.4 Release Of ADP From Myosin (Reaction) 12306 
19.2 Smooth Muscle Contraction (Pathway) 12307 
19.2.1 Calcium binds calmodulin (Reaction) 12308 
19.2.2 MLCK Active Calmodulin Binding (Reaction) 12309 
19.2.3 Phosphorylation of Smooth Muscle Myosin Light Chains (Reaction) 12311 
19.2.4 Calcium Binds Caldesmon (Reaction) 12312 
19.2.5 Release Of ADP From Myosin (Reaction) 12313 
19.2.6 Myosin Binds ATP (Reaction) 12315 
19.2.7 ATP Hydrolysis By Myosin (Reaction) 12316 20 Mycobacterium tuberculosis biological processes (Pathway) 12318 
20.1 Mycothiol metabolism (Pathway) 12319 
20.1.1 Mycothiol biosynthesis (Pathway) 12320 
20.1.1.1 glucose-6-phosphate is converted to inositol-1-phosphate (Reaction) 12321 
20.1.1.2 acetylglucosamine is transferred from UDP-GlcNAc onto inositol-1-phosphate12323 (Reaction) 
20.1.1.3 acetylglucosamine-inositol-phosphate is dephosphorylated (Reaction) 12324 
20.1.1.4 glucosaminyl-inositol and cysteine are ligated to desacetylmycothiol (Reaction)12325 
20.1.1.5 desacetylmycothiol is acetylated to mycothiol using acetyl-CoA (Reaction) 12327 
20.1.1.6 acetylglucosamine-inositol is deacetylated by Mca (Reaction) 12328 
20.1.2 Mycothiol catabolism (Pathway) 12329 
20.1.2.1 mycothiol is cleaved to acetylcysteine and glucosaminylinositol (Reaction) 12331 
20.1.3 Mycothiol-dependent detoxification (Pathway) 12332 
20.1.3.1 mycothiol conjugates with electrophilic xenobiotic (Reaction) 12333 
20.1.3.2 mycothiol S-conjugate is cleaved into mercapturic acid and GlcN-Ins (Reaction)12334 
20.1.3.3 mycothiol binds formaldehyde and is dehydrogenated (Reaction) 12335 
20.1.3.4 formylmycothiol hydrolyzes into mycothiol and formate (Reaction) 12337 
20.1.4 mycothiol is oxidized to mycothione (Reaction) 12338 
20.1.5 mycothione is reduced to mycothiol (Reaction) 12339 

20.2 Trehalose biosynthesis (Pathway) 12341 
20.2.1 Glucose is transferred from UDP-glucose onto glucose-6-phosphate (Reaction) 12343 
20.2.2 Trehalose-6-phosphate is hydrolyzed to trehalose (Reaction) 12344 
20.2.3 Maltose is converted to trehalose (Reaction) 12345 
20.2.4 1,4-alpha-glucan is converted to glucanotrehalose (Reaction) 12347 
20.2.5 Glucanotrehalose is hydrolyzed to 1,4-alpha-glucan and trehalose (Reaction) 12348 
20.3 Sulfur compound metabolism (Pathway) 12349 
20.3.1 Sulfate assimilation (Pathway) 12350 
20.3.1.1 sulfate binds to SubI outside the membrane (Reaction) 12351 
20.3.1.2 sulfate uptake in the cytosol (Reaction) 12353 
20.3.1.3 sulfate is activated to APS (Reaction) 12354 
20.3.1.4 APS is phosphorylated to PAPS (Reaction) 12355 
20.3.1.5 PAPS is dephosphorylated to APS (Reaction) 12357 
20.3.2 Sulfur amino acid metabolism (Pathway) 12358 
20.3.2.1 Cysteine synthesis from O-acetylserine (Pathway) 12359 
20.3.2.1.1 sulfite results from reduction of APS (Reaction) 12360 
20.3.2.1.2 sulfite is reduced to sulfide (Reaction) 12362 
20.3.2.1.3 acetylation of serine (Reaction) 12363 
20.3.2.1.4 deacetylation of O-acetylserine and sulfhydrylation using CysK1 (Reaction)12364 
20.3.2.1.5 deacetylation of O-acetylserine and sulfhydrylation using CysK2 (Reaction)12366 
20.3.2.2 Cysteine synthesis from O-phosphoserine (Pathway) 12367 
20.3.2.2.1 sulfur transfer to carrier protein (Reaction) 12368 
20.3.2.2.2 OPS is added to the carrier sulfide (Reaction) 12369 
20.3.2.2.3 cleavage of L-cysteine from carrier protein (Reaction) 12371 
20.3.2.3 Cysteine from cystathionine and vice versa (Reaction) 12372 
20.4 Chorismate via Shikimate Pathway (Pathway) 12373 
20.4.1 DHAP from Ery4P and PEP (Reaction) 12374 
20.4.2 DHQ from DAHP dephosphorylation (Reaction) 12376 
20.4.3 Dehydratation of DHQ yields DHS (Reaction) 12377 
20.4.4 Shikimate results from hydration of DHS (Reaction) 12378 
20.4.5 Phosphorylation of shikimate (Reaction) 12380 
20.4.6 EPSP from shikimate 3-phosphate (Reaction) 12381 
20.4.7 Dephosphorylation of EPSP yields chorismate (Reaction) 12382 21 Neuronal System (Pathway) 12384 
21.1 Transmission across Electrical Synapses (Pathway) 12385 
21.1.1 Electric Transmission Across Gap Junctions (Pathway) 12386 
21.1.1.1 Connexin 36 mediated neuronal gap junction communication (Reaction) 12387 
21.1.1.2 Connexin 45/Connexin 36 mediated neuronal gap junction communication 12389 (Reaction) 
21.1.1.3 Connexin 62 mediated neuronal gap junction communication (Reaction) 12390 
21.1.1.4 Pannexin 1/Pannexin2 mediated neuronal gap junction communication (Reaction)12391 
21.2 Transmission across Chemical Synapses (Pathway) 12392 
21.2.1 Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium 12393 Channels (Pathway) 
21.2.1.1 Ca2+ influx through voltage gated Ca2+ channels (Reaction) 12394 
21.2.2 Neurotransmitter Release Cycle (Pathway) 12396 
21.2.2.1 Norepinephrine Neurotransmitter Release Cycle (Pathway) 12397 
21.2.2.1.1 Re-acidification of clathrin sculpted monoamine tranport vesicle lumen 12398 (BlackBoxEvent) 
21.2.2.1.2 Loading of dopamine into synaptic veiscles (Reaction) 12399 
21.2.2.1.3 Noradrenalin synaptic vesicle docking and priming (Reaction) 12401 
21.2.2.1.4 Release of noradrenaline at the synapse (Reaction) 12402 
21.2.2.1.5 Metabolism of Noradrenaline (Reaction) 12404 
21.2.2.1.6 Uptake of Noradrenaline (Reaction) 12405 
21.2.2.2 Serotonin Neurotransmitter Release Cycle (Pathway) 12406 
21.2.2.2.1 Re-acidification of clathrin sculpted monoamine tranport vesicle lumen 12407 (BlackBoxEvent) 
21.2.2.2.2 loading of Serotonin in synaptic vesicles (Reaction) 
21.2.2.2.3 Serotonin loaded synaptic vesicle docking and priming (Reaction) 12408 
21.2.2.2.4 Release of docked serotonin loaded synaptic vesicle (Reaction) 12410 
21.2.2.3 Glutamate Neurotransmitter Release Cycle (Pathway) 12411 
21.2.2.3.1 L-Glutamine transport into neurons (Reaction) 12414 
21.2.2.3.2 Transport of L-Glutamine (cytosol) to mitochondrial matrix (BlackBoxEvent)12415 
21.2.2.3.3 glutamine + H2O => glutamate + NH4+ [GLS] (Reaction) 12416 
21.2.2.3.4 Tranport of L-Glutamate (mitochondrial matrix) to cytosol (BlackBoxEvent) 12416 
21.2.2.3.5 L-Glutamate loading of synaptic vesicle (Reaction) 12417 
21.2.2.3.6 Glutamate synaptic vesicle docking and priming (Reaction) 12418 
21.2.2.3.7 release of L-Glutamate at the synapse (Reaction) 12420 
21.2.2.3.8 L-Glutamate uptake by neurons (Reaction) 12422 
21.2.2.4 Dopamine Neurotransmitter Release Cycle (Pathway) 12424 
21.2.2.4.1 Re-acidification of clathrin sculpted monoamine tranport vesicle lumen 12425 (BlackBoxEvent) 
21.2.2.4.2 Loading of dopamine into synaptic veiscles (Reaction) 12425 
21.2.2.4.3 Dopamine synaptic vesicle docking and priming (Reaction) 12425 
21.2.2.4.4 Release of docked dopamine loaded synaptic vesicle (Reaction) 12428 
21.2.2.5 Acetylcholine Neurotransmitter Release Cycle (Pathway) 12430 
21.2.2.5.1 Transport of Choline (Reaction) 12431 
21.2.2.5.2 Cho is acetylated to AcCho by CHAT (Reaction) 12432 
21.2.2.5.3 Re-acidification of the clathrin sculpted acetylcholine transport vesicle 12432 (BlackBoxEvent) 
21.2.2.5.4 Loading of acetylcholine in synaptic vesicle (Reaction) 12433 
21.2.2.5.5 Acetylcholine synaptic vesicle docking and priming (Reaction) 12434 
21.2.2.5.6 Release of acetylcholine at the synapse (Reaction) 12436 
21.2.2.6 GABA synthesis, release, reuptake and degradation (Pathway) 12437 
21.2.2.6.1 GABA synthesis (Pathway) 12439 
21.2.2.6.1.1 Synthesis of GABA by GAD1 (Reaction) 12440 
21.2.2.6.1.2 Synthesis of GABA by GAD2 (Reaction) 12441 
21.2.2.6.2 Loading of GABA into clathrin sculpted GABA transport vesicle lumen 12442 (Reaction) 
21.2.2.6.3 GABA loaded synaptic vesicle Docking and Priming (Reaction) 12443 
21.2.2.6.4 Release of GABA at the synapse (Reaction) 12445 
21.2.2.6.5 Reuptake of GABA (Pathway) 12446 
21.2.2.6.5.1 GAT1-3 mediate Na+/Cl- dependent GABA transport (Reaction) 12448 
21.2.2.6.5.2 SLC6A12 (BGT-1)-mediated uptake of GABA and betaine (Reaction) 12449 
21.2.2.6.6 Degradation of GABA (Pathway) 12451 
21.2.2.6.6.1 Conversion of GABA to Succinate Semialdehyde (Reaction) 12452 
21.2.2.6.6.2 Conversion of succinate semialdehyde to succinate (Reaction) 12453 
21.2.3 Neurotransmitter Clearance In The Synaptic Cleft (Pathway) 12454 
21.2.3.1 AcCho is hydrolyzed to Cho and acetate by ACHE (Reaction) 12455 
21.2.3.2 Noradrenaline clearance from the synaptic cleft (Reaction) 12456 
21.2.3.3 Dopamine clearance from the synaptic cleft (Pathway) 12457 
21.2.3.3.1 Reuptake of dopamine from the synaptic cleft into neurons (Reaction) 12458 
21.2.3.3.2 Enzymatic degradation of dopamine by COMT (Pathway) 12459 
21.2.3.3.2.1 methylation of Dopamine to form 3-Methoxytyramine (Reaction) 12460 
21.2.3.3.2.2 Oxidation of 3-Methoxytyramine to homovanillic acid (Reaction) 12461 
21.2.3.3.3 Enzymatic degradation of Dopamine by monoamine oxidase (Pathway) 12462 
21.2.3.3.3.1 oxidation of dopamine to 3,4dihydroxyphenylacetic acid (DOPAC) 12463 (Reaction) 
21.2.3.3.3.2 Methylation of 3,4-dihydroxyphenylacetic acid to homovanillic acid 12464 (Reaction) 
21.2.3.4 Serotonin clearance from the synaptic cleft (Pathway) 12465 
21.2.3.4.1 Reuptake of serotonin from the synapse (Reaction) 12465 
21.2.3.4.2 Metabolism of serotonin (Pathway) 12467 
21.2.3.4.2.1 Oxidative deamination of 5-Hydroxytryptamine by MAOA (Reaction) 12467 
21.2.3.4.2.2 5-hydroxyindole acetaldehyde to 5-hydroxyindole acetic acid (Reaction)12468 
21.2.4 Neurotransmitter uptake and Metabolism In Glial Cells (Pathway) 12470 
21.2.4.1 Astrocytic Glutamate-Glutamine Uptake And Metabolism (Pathway) 12470 
21.2.4.1.1 glutamate uptake by astrocytes (Reaction) 12471 
21.2.4.1.2 glutamate + NH4+ + ATP => glutamine + ADP + orthophosphate [GLUL] 12473 (Reaction) 
21.2.4.1.3 Glutamine transport from astrocytes (Reaction) 12473 
21.2.5 Neurotransmitter Receptor Binding And Downstream Transmission In The 12475 Postsynaptic Cell (Pathway) 
21.2.5.1 Acetylcholine Binding And Downstream Events (Pathway) 12475 
21.2.5.1.1 Activation of Nicotinic Acetylcholine Receptors (Pathway) 12476 
21.2.5.1.1.1 Presynaptic nicotinic acetylcholine receptors (Pathway) 12477 
21.2.5.1.1.1.1 Highly calcium permeable nicotinic acetylcholine receptors (Pathway)12478 
21.2.5.1.1.1.1.1 Binding of acetylcholine to highly calcium permeable acetylcholine12480 receptors (Reaction) 
21.2.5.1.1.1.1.2 Activation of highly calcium permeable nicotinic acetylcholine 12481 receptors (Reaction) 
21.2.5.1.1.1.2 Highly sodium permeable acetylcholine nicotinic receptors (Pathway)12482 
21.2.5.1.1.1.2.1 Binding of acetylcholine to highly sodium permeable acetylcholine12483 receptors (Reaction) 
21.2.5.1.1.1.2.2 Activation of highly sodium permeable nicotinic acetylcholine 12485 receptors (Reaction) 
21.2.5.1.1.2 Postsynaptic nicotinic acetylcholine receptors (Pathway) 12486 
21.2.5.1.1.2.1 Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
12487 (Pathway) 
21.2.5.1.1.2.1.1 Binding of acetylcholine to highly calcium permeable postsynaptic12488 nicotinic acetylcholine receptors (Reaction) 
21.2.5.1.1.2.1.2 Activation of highly calcium permeable postsynaptic nicotinic 12489 acetylcholine receptors (Reaction) 
21.2.5.1.1.2.2 Highly sodium permeable acetylcholine nicotinic receptors (Pathway)12490 
21.2.5.1.1.2.2.1 Binding of acetylcholine to highly sodium permeable acetylcholine12491 receptors (Reaction) 
21.2.5.1.1.2.2.2 Activation of highly sodium permeable nicotinic acetylcholine 12491 receptors (Reaction) 
21.2.5.2 Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity 12491 (Pathway) 
21.2.5.2.1 Trafficking of AMPA receptors (Pathway) 12493 
21.2.5.2.1.1 Trafficking of GluR1-containing AMPA receptors (Reaction) 12494 
21.2.5.2.1.2 Trafficking of GluR2-containing AMPA receptors (Pathway) 12496 
21.2.5.2.1.2.1 Trafficking of GluR2-containing AMPA receptors to extrasynaptic sites
12498 (Reaction) 
21.2.5.2.1.2.2 Trafficking of GluR2-containing AMPA receptors to synapse (Reaction)12499 
21.2.5.2.1.2.3 Endocytosis of Ca impermeable AMPA receptors (Reaction) 12500 
21.2.5.2.2 Activation of AMPA receptors (Pathway) 12502 
21.2.5.2.2.1 Ca permeable AMPA receptor ligand binding (Reaction) 12504 
21.2.5.2.2.2 Activation of Ca permeable AMPA receptors (Reaction) 12505 
21.2.5.2.2.3 Activation of Ca permeable AMPA receptors (Reaction) 12507 
21.2.5.2.2.4 Ca impermeable AMPA receptor ligand binding (Reaction) 12508 
21.2.5.2.2.5 Activation of Ca impermeable AMPA receptors (Reaction) 12509 
21.2.5.3 Activation of NMDA receptor upon glutamate binding and postsynaptic events12511 (Pathway) 
21.2.5.3.1 Unblocking of NMDA receptor, glutamate binding and activation (Pathway)12512 
21.2.5.3.1.1 Membrane depolarization upon activation of Ca impermeable AMPA 12513 receptors (Reaction) 
21.2.5.3.1.2 Unblocking of NMDA receptor (Reaction) 12514 
21.2.5.3.1.3 Glutamate binding to NMDA receptor (Reaction) 12516 
21.2.5.3.1.4 Activation of NMDA Receptor (Reaction) 12517 
21.2.5.3.2 Post NMDA receptor activation events (Pathway) 12519 
21.2.5.3.2.1 CREB phosphorylation through the activation of Ras (Pathway) 12520 
21.2.5.3.2.1.1 Ras activation uopn Ca2+ infux through NMDA receptor (Pathway) 12522 
21.2.5.3.2.1.1.1 Activation of RasGRF (Reaction) 12523 
21.2.5.3.2.1.1.2 Ras activation (Reaction) 12524 
21.2.5.3.2.1.2 Raf activation (Reaction) 12525 
21.2.5.3.2.1.3 Activation of MAPK (Reaction) 12527 
21.2.5.3.2.1.4 RSK activation (Pathway) 12528 
21.2.5.3.2.1.4.1 Phosphorylation by MAPK/ERK (Reaction) 12529 
21.2.5.3.2.1.4.2 Phophorylation by PDK1 (Reaction) 12530 
21.2.5.3.2.1.5 Phosphorylation of CREB by ribosomal protein S6 kinase (Reaction)12532 
21.2.5.3.2.2 CREB phosphorylation through the activation of Adenylate Cyclase 12533 (Pathway) 
21.2.5.3.2.2.1 Activation of Adenylate Cyclase (Reaction) 12534 
21.2.5.3.2.2.2 Phosphorylation of CREB by PKA (Reaction) 12535 
21.2.5.3.2.3 CREB phosphorylation through the activation of CaMKII (Pathway) 12537 
21.2.5.3.2.3.1 Activation of CaMKII (Reaction) 12538 
21.2.5.3.2.3.2 CaMKII enters cytoplasm (Reaction) 12539 
21.2.5.3.2.3.3 CaMKII enters nucleus (Reaction) 12540 
21.2.5.3.2.3.4 Phosphorylation of CREB by CaMKII (Reaction) 12541 
21.2.5.3.2.4 CREB phosphorylation through the activation of CaMKK (Pathway) 12543 
21.2.5.3.2.4.1 Activation of CaMKK (Reaction) 12544 21.2.5.3.2.4.2 Activation of CaMK IV (Pathway) 12545 
21.2.5.3.2.4.2.1 Calmodulin binds CaMK IV (Reaction) 12546 
21.2.5.3.2.4.2.2 CamKIV enters the nucleus (Reaction) 12546 
21.2.5.3.2.4.2.3 CaMK IV autophosphorylation (Reaction) 12547 
21.2.5.3.2.4.3 Phosphorylation of CREB by CaMKIV (Reaction) 12547 
21.2.5.4 Activation of Kainate Receptors upon glutamate binding (Pathway) 12548 
21.2.5.4.1 Ionotropic activity of Kainate Receptors (Pathway) 12550 
21.2.5.4.1.1 Activation of Na-permeable Kainate Receptors (Pathway) 12551 
21.2.5.4.1.1.1 Edited Kainate Receptor binds glutamate (Reaction) 12552 
21.2.5.4.1.1.2 Activation of Edited Kainate receptors (Reaction) 12553 
21.2.5.4.1.2 Activation of Ca-permeable Kainate Receptor (Pathway) 12554 
21.2.5.4.1.2.1 kainate receptor binds glutamate (Reaction) 12555 
21.2.5.4.1.2.2 Activation of Ca-permeable Kainate receptors (Reaction) 12556 
21.2.5.4.2 Presynaptic function of Kainate receptors (Pathway) 12558 
21.2.5.4.2.1 GRIK3 homomer binds glutamate (Reaction) 12559 
21.2.5.4.2.2 Activation of GRIK3 homomer (Reaction) 12560 
21.2.5.5 GABA receptor activation (Pathway) 12561 
21.2.5.5.1 GABA A receptor activation (Pathway) 12563 
21.2.5.5.1.1 GABR heteropentamers:GABA transport Cl- from extracellular region to12564 cytosol (Reaction) 
21.2.5.5.2 GABA B receptor activation (Pathway) 12566 
21.2.5.5.2.1 GABAB heterodimeric receptor binds GABA (Reaction) 12567 
21.2.5.5.2.2 Activation of GABAB receptors (Pathway) 12569 
21.2.5.5.2.2.1 Inhibition of adenylate cyclase pathway (Pathway) 12570 
21.2.5.5.2.2.1.1 Adenylate cyclase inhibitory pathway (Pathway) 12571 
21.2.5.5.2.2.1.1.1 G alpha (i) inhibits adenylate cyclase (Reaction) 12572 
21.2.5.5.2.2.1.1.2 G alpha-olf:GTP binds to Gi alpha1:GTP:adenylate cyclase 12574 complex (Reaction) 
21.2.5.5.2.2.1.1.3 Adenylate cyclase increases the GTPase activity of G alpha-olf12575 (Reaction) 
21.2.5.5.2.2.1.1.4 Adenylate cyclase increases the GTPase activity of Gi alpha 12576 (Reaction) 
21.2.5.5.2.2.1.1.5 Dissociation of the Gi alpha:G olf complex (Reaction) 12577 
21.2.5.5.2.2.2 Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits12578 (Pathway) 
21.2.5.5.2.2.2.1 Activation of GIRK/Kir3 Channels (Reaction) 12580 
21.2.5.5.3 GABA A (rho) receptor activation (Pathway) 12581 
21.2.5.5.3.1 GABRR pentamer:GABA transports extracellular Cl- to cytosol (Reaction)
12582 
21.3 Potassium Channels (Pathway) 12584 
21.3.1 Ca2+ activated K+ channels (Pathway) 12585 
21.3.1.1 Activation of Ca2+ activated Potassium channels with large conductance 12587 (Reaction) 
21.3.1.2 Activation of Ca2+ activated Potassium channels with Intermeidtance 12588 conductance (Reaction) 
21.3.1.3 Activation of Ca2+ activated Potassium channels with small conductance 
(Reaction) 
21.3.2 HCN channels (Pathway) 12591 
21.3.2.1 Binding of cAMP to HCN channels (Reaction) 12592 
21.3.2.2 Activation of HCN channels (Reaction) 12593 
21.3.3 Inwardly rectifying K+ channels (Pathway) 12595 
21.3.3.1 G protein gated Potassium channels (Pathway) 12596 
21.3.3.1.1 Activation of G protein gated Potassium channels (Pathway) 12597 
21.3.3.1.1.1 Activation of GIRK/Kir3 Channels (Reaction) 12598 
21.3.3.2 Potassium transport channels (Pathway) 12598 
21.3.3.2.1 Activation of Potassium transport channels (Reaction) 12599 
21.3.3.3 ATP sensitive Potassium channels (Pathway) 12600 
21.3.3.3.1 Activation of ATP sensitive Potassium channels in neuroendocrine cells 12602 (Reaction) 
21.3.3.3.2 Activation of ATP sensitive Potassium channels in muscle cells (Reaction) 12603 
21.3.3.4 Classical Kir channels (Pathway) 12604 
21.3.3.4.1 KCNJs transport K+ from cytosol to extracellular region (Reaction) 12605 
21.3.4 Voltage gated Potassium channels (Pathway) 12606 
21.3.4.1 Activation of voltage gated Potassium channels (Reaction) 12608 
21.3.5 Tandem pore domain potassium channels (Pathway) 12609 
21.3.5.1 Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) 12610 (Pathway) 
21.3.5.1.1 Activation of tandem pore domain in a weak inwardly rectifying K+ channels12611 (Reaction) 
21.3.5.2 TWIK related potassium channel (TREK) (Pathway) 12612 
21.3.5.2.1 Activation of TWIK-related K+ channel (TREK) (Reaction) 12613 
21.3.5.3 TWIK-releated acid-sensitive K+ channel (TASK) (Pathway) 12615 
21.3.5.3.1 Activation of TASK (Reaction) 12616 
21.3.5.4 TWIK-related alkaline pH activated K+ channel (TALK) (Pathway) 12617 
21.3.5.4.1 Activation of TALK (Reaction) 12618 
21.3.5.5 TWIK-related spinal cord K+ channel (TRESK) (Pathway) 12619 
21.3.5.5.1 Activation of TRESK (Reaction) 12620 
21.3.5.6 Tandem pore domain halothane-inhibited K+ channel (THIK) (Pathway) 12622 
21.3.5.6.1 Activation of THIK (Reaction) 12623 22 Organelle biogenesis and maintenance (Pathway) 12625 
22.1 Mitochondrial biogenesis (Pathway) 12626 
22.1.1 Activation of PPARGC1A (PGC-1alpha) by phosphorylation (Pathway) 12628 
22.1.1.1 AMPK phosphorylates PPARGC1A (Reaction) 12630 
22.1.1.2 p38 MAPK phosphorylates PPARGC1A (Reaction) 12632 
22.1.2 Transcriptional activation of mitochondrial biogenesis (Pathway) 12634 
22.1.2.1 Formation of NRF2 (Reaction) 12635 
22.1.2.2 Expression of NRF1 (BlackBoxEvent) 12636 
22.1.2.3 NRF1, PPRC1:HCFC1:NRF2 bind the TFB1M promoter (Reaction) 12638 
22.1.2.4 NRF1, PPRC1:HCFC1:NRF2 bind the TFB2M promoter (Reaction) 12639 
22.1.2.5 NRF1:p-PPARGC1A, NRF2 bind the TFB1M promoter (Reaction) 12641 
22.1.2.6 NRF1:p-PPARGC1A, NRF2 bind the TFB2M promoter (Reaction) 12589
12642 
22.1.2.7 NRF1, PPRC1, NRF2 bind the TFAM promoter (Reaction) 12643 
22.1.2.8 NRF1:p-PPARGC1A, NRF2 bind the TFAM promoter (Reaction) 12645 
22.1.2.9 NRF1:PPARGC1B binds the ALAS1 promoter (Reaction) 12646 
22.1.2.10 NRF1:PPARGC1B binds the ATP5B promoter (Reaction) 12647 
22.1.2.11 NRF1:PPARGC1B binds the CYCS promoter (Reaction) 12649 
22.1.2.12 Expression of GABPA (NRF2 alpha subunit) (BlackBoxEvent) 12650 
22.1.2.13 Expression of TFB1M (BlackBoxEvent) 12652 
22.1.2.14 Expression of TFB2M (BlackBoxEvent) 12654 
22.1.2.15 Expression of TFAM (BlackBoxEvent) 12655 
22.1.2.16 TFAM translocates from the cytosol to the mitochondrial matrix (BlackBoxEvent)12657 
22.1.2.17 Expression of CYCS (BlackBoxEvent) 12659 
22.1.2.18 Expression of ATP5B (BlackBoxEvent) 12660 
22.1.2.19 Expression of ALAS1 (BlackBoxEvent) 12662 
22.1.2.20 Expression of POLRMT (BlackBoxEvent) 12662 
22.1.2.21 Expression of SSBP1 (BlackBoxEvent) 12664 
22.1.2.22 Expression of mTERF (BlackBoxEvent) 12665 
22.1.2.23 Expression of POLG2 (BlackBoxEvent) 12667 
22.1.2.24 Expression of PEO1 (BlackBoxEvent) 12668 
22.1.2.25 CaMK IV phosphorylates CREB (Reaction) 12670 
22.1.2.26 Expression of PPARGC1A (PGC-1alpha) (BlackBoxEvent) 12670 
22.1.2.27 Expression of ESRRA (ERR1, ERRalpha) (BlackBoxEvent) 12670 
22.1.2.28 Expression of SIRT3 (BlackBoxEvent) 12672 23 Reproduction (Pathway) 12674 
23.1 Fertilization (Pathway) 12675 
23.1.1 Sperm Motility And Taxes (Pathway) 12676 
23.1.1.1 Progesterone Activation Of CatSper (Reaction) 12677 
23.1.1.2 CatSper Channel Mediated Calcium Transport (Reaction) 12678 
23.1.1.3 Slo3 Potassium Transport (Reaction) 12680 
23.1.1.4 Hv1 Mediated H+ Permeability (Reaction) 12682 
23.1.2 Interaction With Cumulus Cells (Pathway) 12683 
23.1.2.1 SPAM1 Binds Hyaluronic Acid (Reaction) 12684 
23.1.3 Interaction With The Zona Pellucida (Pathway) 12685 
23.1.3.1 Association of ADAM and B4GALT1 With ZP3 (Reaction) 12686 
23.1.4 Acrosome Reaction (Pathway) 12688 
23.1.4.1 Acrosin Cleavage (Reaction) 12689 
23.1.4.2 Association of Acrosin Heavy and Light Chain (Reaction) 12690 
23.1.5 Sperm:Oocyte Membrane Binding (Pathway) 12691 
23.1.5.1 CD9:Izumo Binding (Reaction) 12692 24 Signal Transduction (Pathway) 12694 
24.1 Signaling by EGFR (Pathway) 12697 
24.1.1 Pro-EGF is cleaved to form mature EGF (Reaction) 12700 
24.1.2 EGFR binds EGF ligand (Reaction) 12701 
24.1.3 EGFR dimerization (Reaction) 12703 
24.1.4 EGFR autophosphorylation (Reaction) 12704 
24.1.5 Phosphorylation of EGFR by SRC kinase (Reaction) 12706 24.1.6 EGFR interacts with phospholipase C-gamma (Pathway) 12707 
24.1.6.1 Phospholipase C-gamma1 binds to the activated EGF receptor (Reaction) 12708 
24.1.6.2 EGFR activates PLC-gamma1 by phosphorylation (Reaction) 12709 
24.1.6.3 Active PLC-gamma1 dissociates from EGFR (Reaction) 12710 
24.1.6.4 DAG and IP3 signaling (Pathway) 12711 
24.1.6.4.1 Active PLCG1 hydrolyses PIP2 (Reaction) 12711 
24.1.6.4.2 DAG stimulates protein kinase C-delta (Reaction) 12712 
24.1.6.4.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 12713 channel (Reaction) 
24.1.6.4.4 Release of calcium from intracellular stores by IP3 receptor activation 12713 (Reaction) 
24.1.6.4.5 CaM pathway (Pathway) 12714 
24.1.6.4.5.1 Calcium binds calmodulin (Reaction) 12714 
24.1.6.4.5.2 Calmodulin induced events (Pathway) 12715 
24.1.6.4.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 12715 
24.1.6.4.5.2.1.1 PKA activation (Pathway) 12715 
24.1.6.4.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 12715 
24.1.6.4.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers (Reaction)12716 
24.1.6.4.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 12716 
24.1.6.4.5.2.1.3 PKA phosphorylates CREB (Reaction) 12717 
24.1.6.4.5.2.1.4 Dimerisation of CREB (Reaction) 12717 
24.1.6.4.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 12717 
24.1.6.4.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 12718 
24.1.6.4.5.2.2.2 CamKIV enters the nucleus (Reaction) 12718 
24.1.6.4.5.2.2.3 CaMK IV autophosphorylation (Reaction) 12718 
24.1.6.4.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 12719 
24.1.6.4.5.2.2.5 Dimerisation of CREB (Reaction) 12719 
24.1.6.4.5.2.3 Cam-PDE 1 activation (Pathway) 12719 
24.1.6.4.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 12720 
24.1.6.4.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 12720 
24.1.6.4.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 12721 
24.1.6.4.5.2.5 PKC phosphorylates GRK2 (Reaction) 12721 
24.1.7 GRB2 events in EGFR signaling (Pathway) 12722 
24.1.7.1 GRB2 binds SOS1 (Reaction) 12723 
24.1.7.2 GRB2:SOS1 complex binds to EGF:EGFR complex (Reaction) 12724 
24.1.7.3 SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:GRB2:SOS1) 12726 (Reaction) 
24.1.7.4 RAF/MAP kinase cascade (Pathway) 12728 
24.1.7.4.1 RAF activation (Pathway) 12728 
24.1.7.4.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 12728 
24.1.7.4.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 12728 
24.1.7.4.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 12729 
24.1.7.4.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 12729 
24.1.7.4.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 12730 
24.1.7.4.2 MEK activation (Pathway) 12730 
24.1.7.4.2.1 Activated RAF1 complex binds MEK (Reaction) 12730 
24.1.7.4.2.2 RAF phosphorylates MEK (Pathway) 12731 
24.1.7.4.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 12731 
24.1.7.4.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 12731 
24.1.7.4.3 ERK activation (Pathway) 12732 
24.1.7.4.3.1 ERK1 activation (Pathway) 12732 
24.1.7.4.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 12732 
24.1.7.4.3.1.2 MEK1 binds ERK-1 (Reaction) 12733 
24.1.7.4.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 12733 
24.1.7.4.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 12733 
24.1.7.4.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 12734 
24.1.7.4.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 12734 
24.1.7.4.3.2 ERK2 activation (Pathway) 12734 
24.1.7.4.3.2.1 MEK2 binds ERK-2 (Reaction) 12735 
24.1.7.4.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 12735 
24.1.7.4.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 12735 
24.1.7.4.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 12736 
24.1.7.4.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 12736 
24.1.8 SHC1 events in EGFR signaling (Pathway) 12736 
24.1.8.1 SHC1 binds to the phosphorylated EGF receptor:ligand complex (Reaction) 12737 
24.1.8.2 SHC1 phosphorylation by phosphorylated EGFR (Reaction) 12739 
24.1.8.3 GRB2:SOS1 binds to phosphorylated SHC1 in complex with EGFR (Reaction)12741 
24.1.8.4 SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:SHC1:GRB2:SOS1)12743 (Reaction) 
24.1.8.5 RAF/MAP kinase cascade (Pathway) 12744 
24.1.8.5.1 RAF activation (Pathway) 12744 
24.1.8.5.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 12745 
24.1.8.5.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 12745 
24.1.8.5.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 12745 
24.1.8.5.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 12745 
24.1.8.5.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 12746 
24.1.8.5.2 MEK activation (Pathway) 12746 
24.1.8.5.2.1 Activated RAF1 complex binds MEK (Reaction) 12746 
24.1.8.5.2.2 RAF phosphorylates MEK (Pathway) 12746 
24.1.8.5.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 12747 
24.1.8.5.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 12747 
24.1.8.5.3 ERK activation (Pathway) 12747 
24.1.8.5.3.1 ERK1 activation (Pathway) 12747 
24.1.8.5.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 12748 
24.1.8.5.3.1.2 MEK1 binds ERK-1 (Reaction) 12748 
24.1.8.5.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 12748 
24.1.8.5.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 12748 
24.1.8.5.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 12749 
24.1.8.5.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 12749 
24.1.8.5.3.2 ERK2 activation (Pathway) 12749 24.1.8.5.3.2.1 MEK2 binds ERK-2 (Reaction) 12749 
24.1.8.5.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 12750 
24.1.8.5.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 12750 
24.1.8.5.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 12750 
24.1.8.5.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 12750 
24.1.9 GAB1 signalosome (Pathway) 12751 
24.1.9.1 Binding of GRB2 to GAB1 (Reaction) 12752 
24.1.9.2 Binding of PIK3 regulatory alpha subunit to GRB2:GAB1 (Reaction) 12754 
24.1.9.3 GRB2:GAB1:PIK3R1 binds to phosphorylated EGFR (Reaction) 12756 
24.1.9.4 PIK3 catalytic subunit binds to EGF:EGFR:GRB2:GAB1:PIK3R1 (Reaction) 12757 
24.1.9.5 PIK3 converts phosphatidylinositol-4,5-bisphosphate (PIP2) to 12758 phosphatidylinositol-3,4,5-trisphosphate (PIP3) (Reaction) 
24.1.9.6 PIP3 activates AKT signaling (Pathway) 12760 
24.1.9.6.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 12760 
24.1.9.6.2 PIP3 recruits AKT to the membrane (Reaction) 12761 
24.1.9.6.3 PIP3 recruits PDPK1 to the membrane (Reaction) 12761 
24.1.9.6.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 12762 
24.1.9.6.5 AKT binds PDPK1 (Reaction) 12762 
24.1.9.6.6 PDPK1 phosphorylates AKT at T308 (Reaction) 12763 
24.1.9.6.7 AKT phosphorylates targets in the cytosol (Pathway) 12763 
24.1.9.6.7.1 AKT phosphorylates BAD (Reaction) 12763 
24.1.9.6.7.2 AKT phosphorylates GSK3 (Reaction) 12764 
24.1.9.6.7.3 AKT phosphorylates caspase-9 (Reaction) 12764 
24.1.9.6.7.4 AKT phosphorylates MDM2 (Reaction) 12765 
24.1.9.6.7.5 AKT phosphorylates IKKalpha (Reaction) 12765 
24.1.9.6.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 12766 
24.1.9.6.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 12766 
24.1.9.6.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 12767 
24.1.9.6.8 AKT translocates to the nucleus (Reaction) 12767 
24.1.9.6.9 AKT phosphorylates targets in the nucleus (Pathway) 12768 
24.1.9.6.9.1 AKT phosphorylates CREB1 (Reaction) 12768 
24.1.9.6.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 12768 
24.1.9.6.9.3 AKT can phosphorylate RSK (Reaction) 12769 
24.1.9.6.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 12769 
24.1.9.6.10 Negative regulation of the PI3K/AKT network (Pathway) 12769 
24.1.9.6.10.1 PTEN dephosphorylates PIP3 (Reaction) 12770 
24.1.9.6.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction) 12770 
24.1.9.6.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 12771 
24.1.9.6.11 PDPK1 binds PIP2 (Reaction) 12771 
24.1.9.6.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 12772 
24.1.9.6.13 PTEN mRNA translation negatively regulated by microRNAs (BlackBoxEvent)
12772 
24.1.9.7 Gab1 binds phosphatidylinositol-3,4,5-trisphosphate (Reaction) 12773 
24.1.9.8 Gab1:Grb2 binds to EGF:Phospho-EGFR (Reaction) 12774 
24.1.9.9 Gab1 phosphorylation by EGFR kinase (Reaction) 12775 
24.1.9.10 Activation of SHP2 through the binding to phospho-Gab1 (Reaction) 12776 24.1.9.11 Dephosphorylation of Gab1 by SHP2 (Reaction) 12777 
24.1.9.12 SHP2 dephosphorylates Tyr 992 on EGFR (Reaction) 12779 
24.1.9.13 Dephosphorylation of PAG by SHP2 (Reaction) 12780 
24.1.9.14 Sustained activation of SRC kinase by SHP2 (Reaction) 12781 
24.1.10 EGFR downregulation (Pathway) 12782 
24.1.10.1 Binding of CBL to EGFR (Reaction) 12783 
24.1.10.2 Phosphorylation of CBL (EGFR:CBL) (Reaction) 12784 
24.1.10.3 CBL binds and ubiquitinates phosphorylated Sprouty (Reaction) 12786 
24.1.10.4 Ubiquitination of stimulated EGFR (CBL) (Reaction) 12787 
24.1.10.5 CBL binds to GRB2 (Reaction) 12788 
24.1.10.6 Localization of CBL:GRB2 to the membrane (Reaction) 12789 
24.1.10.7 Phosphorylation of CBL (EGFR:GRB2:CBL) (Reaction) 12790 
24.1.10.8 Ubiquitination of stimulated EGFR (CBL:GRB2) (Reaction) 12792 
24.1.10.9 Sprouty lures cytosolic CBL away from EGFR (BlackBoxEvent) 12793 
24.1.10.10 Sprouty lures membrane-bound CBL away from EGFR (BlackBoxEvent) 12794 
24.1.10.11 CDC42 lures CBL away from the receptor (Reaction) 12796 
24.1.10.12 Beta-Pix pushes CIN85 away from CBL (Reaction) 12797 
24.1.10.13 CBL escapes CDC42-mediated inhibition by down-regulating the adaptor 12798 molecule Beta-Pix (Reaction) 
24.1.10.14 Assembly of EGFR complex in clathrin-coated vesicles (Reaction) 12800 
24.1.10.15 Assembly in clathrin-coated vesicles (CCVs) (Reaction) 12801 
24.1.10.16 EGFR non-clathrin mediated endocytosis (Reaction) 12802 
24.1.10.17 CBL ubiquitinates Sprouty (Reaction) 12803 
24.1.10.18 CBL-mediated ubiquitination of CIN85 (Reaction) 12804 
24.1.10.19 Sprouty sequesters CBL away from active EGFR (Reaction) 12805 
24.2 Signaling by FGFR (Pathway) 12807 
24.2.1 FGFR ligand binding and activation (Pathway) 12809 
24.2.1.1 FGFR1 ligand binding and activation (Pathway) 12811 
24.2.1.1.1 FGFR1b ligand binding and activation (Pathway) 12812 
24.2.1.1.1.1 FGFR1b binds to FGF (Reaction) 12813 
24.2.1.1.1.2 Autocatalytic phosphorylation of FGFR1b (Reaction) 12814 
24.2.1.1.2 FGFR1c ligand binding and activation (Pathway) 12816 
24.2.1.1.2.1 FGFR1c binds to FGF (Reaction) 12816 
24.2.1.1.2.2 Autocatalytic phosphorylation of FGFR1c (Reaction) 12818 
24.2.1.2 FGFR2 ligand binding and activation (Pathway) 12819 
24.2.1.2.1 FGFR2b ligand binding and activation (Pathway) 12820 
24.2.1.2.1.1 FGFR2b binds to FGF (BlackBoxEvent) 12821 
24.2.1.2.1.2 Autocatalytic phosphorylation of FGFR2b (Reaction) 12822 
24.2.1.2.2 FGFR2c ligand binding and activation (Pathway) 12824 
24.2.1.2.2.1 FGFR2c binds to FGF (BlackBoxEvent) 12824 
24.2.1.2.2.2 Autocatalytic phosphorylation of FGFR2c (Reaction) 12826 
24.2.1.3 FGFR3 ligand binding and activation (Pathway) 12827 
24.2.1.3.1 FGFR3b ligand binding and activation (Pathway) 12828 
24.2.1.3.1.1 FGFR3b binds to FGF (Reaction) 12829 
24.2.1.3.1.2 Autocatalytic phosphorylation of FGFR3b (Reaction) 12830 
24.2.1.3.2 FGFR3c ligand binding and activation (Pathway) 12832 
24.2.1.3.2.1 FGFR3c binds to FGF (Reaction) 12832 
24.2.1.3.2.2 Autocatalytic phosphorylation of FGFR3c (Reaction) 12834 
24.2.1.4 FGFR4 ligand binding and activation (Pathway) 12835 
24.2.1.4.1 FGFR4 binds to FGF (Reaction) 12836 
24.2.1.4.2 Autocatalytic phosphorylation of FGFR4 (Reaction) 12838 
24.2.1.5 Klotho-mediated ligand binding (Pathway) 12839 
24.2.1.5.1 betaKlotho-mediated ligand binding (Pathway) 12840 
24.2.1.5.1.1 FGFR4 binds HS:KLB:FGF19 (Reaction) 12841 
24.2.1.5.1.2 Autocatalytic phosphorylation of BetaKlotho-bound FGFR4 (Reaction) 12843 
24.2.1.5.2 FGFR1c and Klotho ligand binding and activation (Pathway) 12844 
24.2.1.5.2.1 FGFR1c binds to Klotho-bound FGF23 (Reaction) 12845 
24.2.1.5.2.2 Autocatalytic phosphorylation of Klotho-bound FGFR1c (Reaction) 12846 
24.2.2 Downstream signaling of activated FGFR (Pathway) 12848 
24.2.2.1 FRS2-mediated cascade (Pathway) 12849 
24.2.2.1.1 Activated FGFR binds FRS2alpha (Reaction) 12851 
24.2.2.1.2 Activated FGFR binds FRS2beta (Reaction) 12852 
24.2.2.1.3 Phosphorylation of FRS2-alpha by activated FGFR (Reaction) 12853 
24.2.2.1.4 Phosphorylation of FRS2-beta by activated FGFR (Reaction) 12855 
24.2.2.1.5 Activated FGFR and FRS2 bind to SHP2 (Reaction) 12856 
24.2.2.1.6 SHP2 is phosphorylated by activated FGFR (Reaction) 12857 
24.2.2.1.7 GRB2:SOS1 binds to p-FRS2:activated FGFR (Reaction) 12859 
24.2.2.1.8 Ras nucleotide exchange by GRB2:SOS1 bound to p-FRS2:activated FGFR
12860 (Reaction) 
24.2.2.1.9 RAF/MAP kinase cascade (Pathway) 12861 
24.2.2.1.9.1 RAF activation (Pathway) 12862 
24.2.2.1.9.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 12862 
24.2.2.1.9.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 12862 
24.2.2.1.9.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 12862 
24.2.2.1.9.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 12863 
24.2.2.1.9.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)12863 
24.2.2.1.9.2 MEK activation (Pathway) 12863 
24.2.2.1.9.2.1 Activated RAF1 complex binds MEK (Reaction) 12863 
24.2.2.1.9.2.2 RAF phosphorylates MEK (Pathway) 12864 
24.2.2.1.9.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 12864 
24.2.2.1.9.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 12864 
24.2.2.1.9.3 ERK activation (Pathway) 12864 
24.2.2.1.9.3.1 ERK1 activation (Pathway) 12865 
24.2.2.1.9.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 12865 
24.2.2.1.9.3.1.2 MEK1 binds ERK-1 (Reaction) 12865 
24.2.2.1.9.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 12865 
24.2.2.1.9.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 12866 
24.2.2.1.9.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 12866 
24.2.2.1.9.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 12866 
24.2.2.1.9.3.2 ERK2 activation (Pathway) 12866 24.2.2.1.9.3.2.1 MEK2 binds ERK-2 (Reaction) 12867 
24.2.2.1.9.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 12867 
24.2.2.1.9.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 12867 
24.2.2.1.9.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 12867 
24.2.2.1.9.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 12868 
24.2.2.2 Phospholipase C-mediated cascade (Pathway) 12868 
24.2.2.2.1 Activated FGFR binds PLC-gamma (Reaction) 12869 
24.2.2.2.2 PLC-gamma phosphorylation by FGFR (Reaction) 12871 
24.2.2.2.3 Activated PLC gamma release by activated FGFR (Reaction) 12872 
24.2.2.2.4 DAG and IP3 signaling (Pathway) 12873 
24.2.2.2.4.1 Active PLCG1 hydrolyses PIP2 (Reaction) 12873 
24.2.2.2.4.2 DAG stimulates protein kinase C-delta (Reaction) 12873 
24.2.2.2.4.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 12874 channel (Reaction) 
24.2.2.2.4.4 Release of calcium from intracellular stores by IP3 receptor activation 12874 (Reaction) 
24.2.2.2.4.5 CaM pathway (Pathway) 12874 
24.2.2.2.4.5.1 Calcium binds calmodulin (Reaction) 12874 
24.2.2.2.4.5.2 Calmodulin induced events (Pathway) 12875 
24.2.2.2.4.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 12875 
24.2.2.2.4.5.2.1.1 PKA activation (Pathway) 12875 
24.2.2.2.4.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 12875 
24.2.2.2.4.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers 12876 (Reaction) 
24.2.2.2.4.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 12876 
24.2.2.2.4.5.2.1.3 PKA phosphorylates CREB (Reaction) 12876 
24.2.2.2.4.5.2.1.4 Dimerisation of CREB (Reaction) 12876 
24.2.2.2.4.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 12877 
24.2.2.2.4.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 12877 
24.2.2.2.4.5.2.2.2 CamKIV enters the nucleus (Reaction) 12877 
24.2.2.2.4.5.2.2.3 CaMK IV autophosphorylation (Reaction) 12877 
24.2.2.2.4.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 12878 
24.2.2.2.4.5.2.2.5 Dimerisation of CREB (Reaction) 12878 
24.2.2.2.4.5.2.3 Cam-PDE 1 activation (Pathway) 12878 
24.2.2.2.4.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 12878 
24.2.2.2.4.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 12879 
24.2.2.2.4.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 12879 
24.2.2.2.4.5.2.5 PKC phosphorylates GRK2 (Reaction) 12879 
24.2.2.3 SHC-mediated cascade (Pathway) 12879 
24.2.2.3.1 Activated FGFR recruits SHC1 (Reaction) 12881 
24.2.2.3.2 SHC1 is phosphorylated (Reaction) 12882 
24.2.2.3.3 GRB2:SOS1 is recruited to activated FGFR through p-SHC1 (Reaction) 12884 
24.2.2.3.4 Ras nucleotide exchange by GRB2:SOS1 through p-SHC (Reaction) 12885 
24.2.2.4 PI-3K cascade (Pathway) 12886 
24.2.2.4.1 Binding of PIK3 regulatory alpha subunit to GRB2:GAB1 (Reaction) 12887 24.2.2.4.2 GRB2:GAB1:PI3Kreg binds directly to p-FRS2:activated FGFR (Reaction) 12888 
24.2.2.4.3 GRB2:GAB1:PI3Kreg binds to p-SHP2 on p-FRS2:activated FGFR (Reaction)
12889 
24.2.2.4.4 PI3K catalytic subunit is recruited by FGFR-associated PI3KR1 (Reaction) 12890 
24.2.2.4.5 PI3K catalytic subunit binds to GRB2:GAB1:PI3Kreg (indirect) (Reaction) 12891 
24.2.2.4.6 FGFR-associated PI3K phosphorylates PIP2 to PIP3 (Reaction) 12892 
24.2.2.4.7 FGFR associated PI3K phosphorylates PIP2 to PIP3 (Reaction) 12893 
24.2.2.4.8 PIP3 activates AKT signaling (Pathway) 12894 
24.2.2.4.8.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 12895 
24.2.2.4.8.2 PIP3 recruits AKT to the membrane (Reaction) 12895 
24.2.2.4.8.3 PIP3 recruits PDPK1 to the membrane (Reaction) 12895 
24.2.2.4.8.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 12895 
24.2.2.4.8.5 AKT binds PDPK1 (Reaction) 12896 
24.2.2.4.8.6 PDPK1 phosphorylates AKT at T308 (Reaction) 12896 
24.2.2.4.8.7 AKT phosphorylates targets in the cytosol (Pathway) 12896 
24.2.2.4.8.7.1 AKT phosphorylates BAD (Reaction) 12896 
24.2.2.4.8.7.2 AKT phosphorylates GSK3 (Reaction) 12897 
24.2.2.4.8.7.3 AKT phosphorylates caspase-9 (Reaction) 12897 
24.2.2.4.8.7.4 AKT phosphorylates MDM2 (Reaction) 12897 
24.2.2.4.8.7.5 AKT phosphorylates IKKalpha (Reaction) 12897 
24.2.2.4.8.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 12898 
24.2.2.4.8.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 12898 
24.2.2.4.8.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 12898 
24.2.2.4.8.8 AKT translocates to the nucleus (Reaction) 12898 
24.2.2.4.8.9 AKT phosphorylates targets in the nucleus (Pathway) 12899 
24.2.2.4.8.9.1 AKT phosphorylates CREB1 (Reaction) 12899 
24.2.2.4.8.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction)12899 
24.2.2.4.8.9.3 AKT can phosphorylate RSK (Reaction) 12899 
24.2.2.4.8.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 12900 
24.2.2.4.8.10 Negative regulation of the PI3K/AKT network (Pathway) 12900 
24.2.2.4.8.10.1 PTEN dephosphorylates PIP3 (Reaction) 12900 
24.2.2.4.8.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction)12900 
24.2.2.4.8.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 12901 
24.2.2.4.8.11 PDPK1 binds PIP2 (Reaction) 12901 
24.2.2.4.8.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 12901 
24.2.2.4.8.13 PTEN mRNA translation negatively regulated by microRNAs 12901 (BlackBoxEvent) 
24.2.3 Negative regulation of FGFR signaling (Pathway) 12902 
24.2.3.1 Activated ERK1/2 threonine-phosphorylate FRS2alpha. (Reaction) 12903 
24.2.3.2 p-CBL:GRB2 binds p-FRS2alpha:activated FGFR (Reaction) 12904 
24.2.3.3 CBL ubiquitinates FRS2 and FGFR (Reaction) 12905 
24.2.3.4 Spry regulation of FGF signaling (Pathway) 12907 
24.2.3.4.1 PPA2A dephosphorylates SPRY2 (Reaction) 12908 
24.2.3.4.2 SPRY2 translocates to the plasma membrane (Reaction) 12909 
24.2.3.4.3 SRC phosphorylates SPRY2 on Y55 and Y227 (Reaction) 12910 
24.2.3.4.4 SPRY2 binds GRB2 (Reaction) 12912 
24.2.3.4.5 SPRY2 binds CBL (Reaction) 12913 
24.2.3.4.6 Phosphorylated SPRY2 is ubiquitinated by CBL (Reaction) 12914 
24.2.3.4.7 CBL dissociates from ubiquitinated p-SPRY2 (Reaction) 12915 
24.2.3.4.8 SPRY2 is phosphorylated by phosphorylated MNK1 (Reaction) 12916 
24.2.3.4.9 SPRY2 is serine phosphorylated in response to MAPK activation 12918 (BlackBoxEvent) 
24.2.3.4.10 B-RAF dissociates from S111/S120 p-SPRY2 (Reaction) 12919 
24.2.3.4.11 SHP2 dephosphorylates SPRY2 (Reaction) 12920 
24.2.4 p-MEK phosphorylates ERK (Reaction) 12921 
24.2.5 Dissociation of p-ERK from p-MEK (Reaction) 12923 
24.2.6 p-ERK dimerizes (Reaction) 12925 
24.3 Signaling by Insulin receptor (Pathway) 12925 
24.3.1 Insulin binding (Reaction) 12927 
24.3.2 Autophosphorylation of insulin receptor (Reaction) 12929 
24.3.3 Insulin receptor signalling cascade (Pathway) 12931 
24.3.3.1 SHC-related events (Pathway) 12932 
24.3.3.1.1 SHC activation (Pathway) 12932 
24.3.3.1.1.1 Binding of SHC to insulin receptor (Reaction) 12933 
24.3.3.1.1.2 Phosphorylation of SHC (Reaction) 12933 
24.3.3.1.1.3 Dissociation of SHC-P from insulin receptor (Reaction) 12934 
24.3.3.1.2 SHC-mediated signalling (Pathway) 12934 
24.3.3.1.2.1 GRB2:SOS binds to SHC-P (Reaction) 12935 
24.3.3.1.2.2 SOS mediated nucleotide exchange of RAS (SHC) (Reaction) 12936 
24.3.3.1.2.3 RAF/MAP kinase cascade (Pathway) 12939 
24.3.3.1.2.3.1 RAF activation (Pathway) 12939 
24.3.3.1.2.3.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 12939 
24.3.3.1.2.3.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 12939 
24.3.3.1.2.3.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 12940 
24.3.3.1.2.3.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 12940 
24.3.3.1.2.3.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)12940 
24.3.3.1.2.3.2 MEK activation (Pathway) 12940 
24.3.3.1.2.3.2.1 Activated RAF1 complex binds MEK (Reaction) 12941 
24.3.3.1.2.3.2.2 RAF phosphorylates MEK (Pathway) 12941 
24.3.3.1.2.3.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 12941 
24.3.3.1.2.3.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 12941 
24.3.3.1.2.3.3 ERK activation (Pathway) 12942 
24.3.3.1.2.3.3.1 ERK1 activation (Pathway) 12942 
24.3.3.1.2.3.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 12942 
24.3.3.1.2.3.3.1.2 MEK1 binds ERK-1 (Reaction) 12942 
24.3.3.1.2.3.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 12943 
24.3.3.1.2.3.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 12943 
24.3.3.1.2.3.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 12943 
24.3.3.1.2.3.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 12943 
24.3.3.1.2.3.3.2 ERK2 activation (Pathway) 12944 
24.3.3.1.2.3.3.2.1 MEK2 binds ERK-2 (Reaction) 12944 24.3.3.1.2.3.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 12944 
24.3.3.1.2.3.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 12944 
24.3.3.1.2.3.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 12945 
24.3.3.1.2.3.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 12945 
24.3.3.2 IRS-related events (Pathway) 12945 
24.3.3.2.1 IRS activation (Pathway) 12946 
24.3.3.2.1.1 Binding of IRS to insulin receptor (Reaction) 12946 
24.3.3.2.1.2 Phosphorylation of IRS (Reaction) 12947 
24.3.3.2.1.3 Dissociation of IRS-P from insulin receptor (Reaction) 12948 
24.3.3.2.2 IRS-mediated signalling (Pathway) 12948 
24.3.3.2.2.1 PI3K Cascade (Pathway) 12949 
24.3.3.2.2.1.1 PI3K activation (Reaction) 12949 
24.3.3.2.2.1.2 PIP2 conversion to PIP3 (Reaction) 12949 
24.3.3.2.2.1.3 PKB-mediated events (Pathway) 12951 
24.3.3.2.2.1.3.1 PDE3B signalling (Pathway) 12951 
24.3.3.2.2.1.3.1.1 Phosphorylation of PDE3B (Reaction) 12951 
24.3.3.2.2.1.3.1.2 Hydrolysis of cAMP to 5' AMP by Phosphorylated PDE3B 12952 (Reaction) 
24.3.3.2.2.1.3.2 mTOR signalling (Pathway) 12953 
24.3.3.2.2.1.3.2.1 Inhibition of TSC complex formation by PKB (Pathway) 12953 
24.3.3.2.2.1.3.2.1.1 Phosphorylation of TSC2 by PKB (Reaction) 12953 
24.3.3.2.2.1.3.2.1.2 Phosphorylation of complexed TSC2 by PKB (Reaction) 12954 
24.3.3.2.2.1.3.2.2 GTP loading by Rheb (Reaction) 12955 
24.3.3.2.2.1.3.2.3 Formation of active mTORC1 complex (Reaction) 12956 
24.3.3.2.2.1.3.2.4 mTORC1-mediated signalling (Pathway) 12956 
24.3.3.2.2.1.3.2.4.1 S6K1-mediated signalling (Pathway) 12957 
24.3.3.2.2.1.3.2.4.1.1 Activation of S6K1 (Reaction) 12957 
24.3.3.2.2.1.3.2.4.1.2 S6K1 signalling (Pathway) 12958 
24.3.3.2.2.1.3.2.4.1.2.1 Phosphorylation of Ribosomal protein S6 by activated12958 S6K1 (Reaction) 
24.3.3.2.2.1.3.2.4.1.2.2 Phosphorylation and inactivation of eEF2K by activated
12959 S6K1 (Reaction) 
24.3.3.2.2.1.3.2.4.1.2.3 Phosphorylation and activation of eIF4G by activated12959 S6K1 (Reaction) 
24.3.3.2.2.1.3.2.4.1.2.4 Phosphorylation and activation of eIF4B by activated12960 S6K1 (Reaction) 
24.3.3.2.2.1.3.2.4.2 Release of eIF4E (Pathway) 12961 
24.3.3.2.2.1.3.2.4.2.1 Phosphorylation of 4E-BP1 by activated mTORC1 12961 (Reaction) 
24.3.3.2.2.1.3.2.4.2.2 Dissociation of phosphorylated 4EBP1 from eIF4E 12962 (Reaction) 
24.3.3.2.2.1.3.2.5 Energy dependent regulation of mTOR by LKB1-AMPK (Pathway)12963 
24.3.3.2.2.1.3.2.5.1 Regulation of AMPK activity via LKB1 (Pathway) 12964 
24.3.3.2.2.1.3.2.5.1.1 LKB1 forms a trimeric complex with STRAD and MO25 12965 
(Reaction) 24.3.3.2.2.1.3.2.5.1.2 Activation of cytosolic AMPK by phosphorylation (Reaction)12966 
24.3.3.2.2.1.3.2.5.1.3 AMPK is dephosphorylated (Reaction) 12968 
24.3.3.2.2.1.3.2.5.1.4 Phosphorylated AMPK binds AMP (Reaction) 12970 
24.3.3.2.2.1.3.2.5.1.5 AMPK phosphorylates Raptor (Reaction) 12971 
24.3.3.2.2.1.3.2.5.2 Regulation of Rheb GTPase activity by AMPK (Pathway) 12972 
24.3.3.2.2.1.3.2.5.2.1 p-AMPK phosphorylates TSC2 (Reaction) 12973 
24.3.3.2.2.1.3.2.5.2.2 TSC2 activates intrinsic GTPase activity of Rheb (Reaction)12975 
24.3.3.2.2.1.4 Activation of PKB (Pathway) 12976 
24.3.3.2.2.1.4.1 PDK1 attachment to plasma membrane (Reaction) 12976 
24.3.3.2.2.1.4.2 PKB attachment to plasma membrane (Reaction) 12977 
24.3.3.2.2.1.4.3 Phosphorylation of AKT2 by PDK1 (Reaction) 12978 
24.3.3.2.2.2 SOS-mediated signalling (Pathway) 12979 
24.3.3.2.2.2.1 GRB2:SOS binds IRS-P (Reaction) 12979 
24.3.3.2.2.2.2 SOS mediated nucleotide exchange of RAS (IRS) (Reaction) 12981 
24.3.3.2.2.2.3 RAF/MAP kinase cascade (Pathway) 12983 
24.3.3.2.2.2.3.1 RAF activation (Pathway) 12984 
24.3.3.2.2.2.3.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 12984 
24.3.3.2.2.2.3.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 12984 
24.3.3.2.2.2.3.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 12984 
24.3.3.2.2.2.3.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 12985 
24.3.3.2.2.2.3.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex 12985 (Reaction) 
24.3.3.2.2.2.3.2 MEK activation (Pathway) 12985 
24.3.3.2.2.2.3.2.1 Activated RAF1 complex binds MEK (Reaction) 12985 
24.3.3.2.2.2.3.2.2 RAF phosphorylates MEK (Pathway) 12986 
24.3.3.2.2.2.3.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 12986 
24.3.3.2.2.2.3.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 12986 
24.3.3.2.2.2.3.3 ERK activation (Pathway) 12986 
24.3.3.2.2.2.3.3.1 ERK1 activation (Pathway) 12987 
24.3.3.2.2.2.3.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 12987 
24.3.3.2.2.2.3.3.1.2 MEK1 binds ERK-1 (Reaction) 12987 
24.3.3.2.2.2.3.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 12987 
24.3.3.2.2.2.3.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 12988 
24.3.3.2.2.2.3.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 12988 
24.3.3.2.2.2.3.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 12988 
24.3.3.2.2.2.3.3.2 ERK2 activation (Pathway) 12988 
24.3.3.2.2.2.3.3.2.1 MEK2 binds ERK-2 (Reaction) 12989 
24.3.3.2.2.2.3.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 12989 
24.3.3.2.2.2.3.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 12989 
24.3.3.2.2.2.3.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 12989 
24.3.3.2.2.2.3.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 12990 
24.3.3.3 Signal attenuation (Pathway) 12990 
24.3.3.3.1 De-phosphorylation of IRS (Reaction) 12990 
24.3.3.3.2 De-phosphorylation of SHC (Reaction) 12991 
24.3.3.3.3 SOS phosphorylation and dissociation (SHC) (Reaction) 12991 
24.3.3.3.4 SOS phosphorylation and dissociation (IRS) (Reaction) 12992 
24.3.3.3.5 SOS phosphorylation and dissociation (IRS, Crk) (Reaction) 12993 
24.3.3.3.6 Binding of Grb10 to the insulin receptor (Reaction) 12994 
24.3.4 Internalisation of the insulin receptor (BlackBoxEvent) 12995 
24.3.5 Insulin receptor recycling (Pathway) 12997 
24.3.5.1 Endosome acidification (Reaction) 12997 
24.3.5.2 Dissociation of insulin from insulin receptor (Reaction) 12999 
24.3.5.3 Insulin degradation (BlackBoxEvent) 13000 
24.3.5.4 Insulin receptor de-phosphorylation (Reaction) 13002 
24.3.5.5 Re-integration of insulin receptor into plasma membrane (BlackBoxEvent) 13004 
24.4 Signalling by NGF (Pathway) 13005 
24.4.1 NGF processing (Pathway) 13007 
24.4.1.1 The signal peptide is excised from beta-NGF pre-pro-precursor (Reaction) 13008 
24.4.1.2 pro-beta-NGF dimerizes (Reaction) 13010 
24.4.1.3 pro-beta-NGF homodimer transits to the golgi apparatus (Reaction) 13012 
24.4.1.4 Part of pro-beta-NGF is processed to mature beta-NGF (Reaction) 13013 
24.4.1.5 Pro-beta-NGF and mature beta-NGF are secreted (Reaction) 13015 
24.4.2 p75 NTR receptor-mediated signalling (Pathway) 13016 
24.4.2.1 NFG and proNGF binds to p75NTR (Pathway) 13017 
24.4.2.1.1 Binding of pro-NGF to p75NTR:sortilin (Reaction) 13018 
24.4.2.1.2 NGF homodimer binds to p75NTR (Reaction) 13020 
24.4.2.2 Cell death signalling via NRAGE, NRIF and NADE (Pathway) 13022 
24.4.2.2.1 NRAGE signals death through JNK (Pathway) 13023 
24.4.2.2.1.1 NGF:p75NTR complex binds to NRAGE (Reaction) 13024 
24.4.2.2.1.2 NRAGE sequesters CHE1 in the cytoplasm (Reaction) 13025 
24.4.2.2.1.3 NRAGE activates JNK (Reaction) 13027 
24.4.2.2.1.4 p75NTR indirectly activates RAC and Cdc42 via a guanyl-nucleotide 13028 exchange factor (Reaction) 
24.4.2.2.1.5 GTP-bound RAC contributes to JNK activation (Reaction) 13029 
24.4.2.2.1.6 JNK phosphorylates BIM, BAD and other targets (Reaction) 13031 
24.4.2.2.1.7 Active JNK moves to the nucleus and phosphorylates different transcription
13032 factors (Reaction) 
24.4.2.2.2 NRIF signals cell death from the nucleus (Pathway) 13033 
24.4.2.2.2.1 NRIF binds to p75NTR (Reaction) 13034 
24.4.2.2.2.2 TRAF6 binds to p75NTR:NRIF (Reaction) 13036 
24.4.2.2.2.3 NRIF and TRAF6 may activate JNK (Reaction) 13037 
24.4.2.2.2.4 gamma-secretase cleaves p75NTR, releasing NRIF and TRAF6 (Reaction)13039 
24.4.2.2.2.5 TRAF6 polyubiquitinates NRIF (Reaction) 13040 
24.4.2.2.2.6 Polyubiquitinated NRIF binds to p62 (Sequestosome) (Reaction) 13041 
24.4.2.2.2.7 Polyubiquitinated NRIF migrates to the nucleus (Reaction) 13042 
24.4.2.2.3 NADE modulates death signalling (Pathway) 13044 
24.4.2.2.3.1 p75NTR binds to NADE (Reaction) 13045 
24.4.2.2.3.2 p75NTR:NADE promotes caspase2/3 activation (Reaction) 13046 
24.4.2.2.3.3 14-3-3epsilon attentuates NADE-related apoptosis (Reaction) 13047 
24.4.2.3 p75NTR negatively regulates cell cycle via SC1 (Pathway) 13049 24.4.2.3.1 PRDM4 (SC1) binds to p75NTR (Reaction) 13050 
24.4.2.3.2 PRDM4 translocates to the nucleus (Reaction) 13051 
24.4.2.3.3 PRDM4 inhibits cyclin E transcription (Reaction) 13053 
24.4.2.4 p75NTR signals via NF-kB (Pathway) 13054 
24.4.2.4.1 p75NTR recruits signalling complexes (Pathway) 13055 
24.4.2.4.1.1 p75NTR interacts with RIP2 (Reaction) 13056 
24.4.2.4.1.2 p75NTR interacts with IRAK:MYD88 (Reaction) 13057 
24.4.2.4.1.3 IRAK is activated (Reaction) 13059 
24.4.2.4.1.4 IRAK interacts with TRAF6 (Reaction) 13060 
24.4.2.4.1.5 MYD88 dissociates (Reaction) 13061 
24.4.2.4.1.6 p62 is recruited and forms a complex with TRAF6 (Reaction) 13062 
24.4.2.4.1.7 TRAF6 is auto-ubiquitinated (BlackBoxEvent) 13064 
24.4.2.4.1.8 p62 recruits an atypical PKC (Reaction) 13065 
24.4.2.4.1.9 IKK-beta is recruited (Reaction) 13066 
24.4.2.4.2 NF-kB is activated and signals survival (Pathway) 13067 
24.4.2.4.2.1 IKKbeta is activated (Reaction) 13068 
24.4.2.4.2.2 IKKbeta phosphorylates IkB causing NF-kB to dissociate (Reaction) 13069 
24.4.2.4.2.3 IkB is ubiquitinated and degraded (Reaction) 13070 
24.4.2.4.2.4 NF-kB migrates to the nucleus and turns on transcription (Reaction) 13071 
24.4.2.5 Ceramide signalling (Pathway) 13072 
24.4.2.5.1 Sphingomyelinase is activated by the NGF:p75NTR complex (Reaction) 13074 
24.4.2.5.2 Production of ceramide which can activate JNK and other targets (Reaction)13075 
24.4.2.6 p75NTR regulates axonogenesis (Pathway) 13077 
24.4.2.6.1 Axonal growth stimulation (Pathway) 13078 
24.4.2.6.1.1 p75NTR and RHOA-GDI interact (Reaction) 13079 
24.4.2.6.1.2 NGF binding to p75NTR inactivates RHOA (Reaction) 13080 
24.4.2.6.2 Axonal growth inhibition (RHOA activation) (Pathway) 13081 
24.4.2.6.2.1 p75NTR interacts with the NOGO receptor (Reaction) 13082 
24.4.2.6.2.2 p75NTR:NgR complex interacts with the axonal inhibitor LINGO1 13083 (Reaction) 
24.4.2.6.2.3 Myelin components can interact with p75NTR:NgR:LINGO1 (Reaction) 13085 
24.4.2.6.2.4 The p75NTR:NgR:MDGI complex reduces RHOA-GDI activity, displacing
13086 RHOA (Reaction) 
24.4.2.6.2.5 RhoA is activated by nucleotide exchange and inhibits axonal growth 13087 (Reaction) 
24.4.2.7 Regulated proteolysis of p75NTR (Pathway) 13088 
24.4.2.7.1 alpha-secretase cleaves the p75NTR extracellular domain (Reaction) 13090 
24.4.2.7.2 The p75NTR C-terminal fragment enters endosomes (Reaction) 13091 
24.4.2.7.3 gamma-secretase cleaves the p75NTR transmembrane domain (Reaction)13092 
24.4.2.7.4 p75NTR ICD signals to NF-kB (Reaction) 13094 
24.4.2.7.5 Part of the ICD migrates to the nucleus (Reaction) 13095 
24.4.3 NGF signalling via TRKA from the plasma membrane (Pathway) 13096 
24.4.3.1 Activation of TRKA receptors (Pathway) 13097 
24.4.3.1.1 TRKA activation by NGF (Pathway) 13098 
24.4.3.1.1.1 beta-NGF dimer binds to TrkA receptor (Reaction) 13100 
24.4.3.1.1.2 The bound receptor dimerizes (Reaction) 13101 
24.4.3.1.1.3 TrkA receptor autophosphorylates (Reaction) 13102 
24.4.3.1.1.4 Activated TrkA receptor internalizes to endosomes (BlackBoxEvent) 13104 
24.4.3.1.2 NGF-independant TRKA activation (Pathway) 13104 
24.4.3.1.2.1 TRKA activation by adenosine A2a receptor (Reaction) 13105 
24.4.3.1.2.2 TRKA activation by PACAP type 1 receptor (Reaction) 13107 
24.4.3.2 Signalling to ERKs (Pathway) 13108 
24.4.3.2.1 Signalling to RAS (Pathway) 13109 
24.4.3.2.1.1 SHC binds to the activated TrkA receptor (Reaction) 13110 
24.4.3.2.1.2 SHC, complexed with TrkA, is tyrosine-phosphorylated (Reaction) 13111 
24.4.3.2.1.3 Phospho-Shc dissociates from the TrkA receptor (Reaction) 13113 
24.4.3.2.1.4 GRB2:SOS binds to SHC-P (Reaction) 13114 
24.4.3.2.1.5 SOS mediated nucleotide exchange of RAS (SHC) (Reaction) 13114 
24.4.3.2.1.6 RAF/MAP kinase cascade (Pathway) 13114 
24.4.3.2.1.6.1 RAF activation (Pathway) 13114 
24.4.3.2.1.6.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13115 
24.4.3.2.1.6.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13115 
24.4.3.2.1.6.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13115 
24.4.3.2.1.6.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13115 
24.4.3.2.1.6.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)
13116 
24.4.3.2.1.6.2 MEK activation (Pathway) 13116 
24.4.3.2.1.6.2.1 Activated RAF1 complex binds MEK (Reaction) 13116 
24.4.3.2.1.6.2.2 RAF phosphorylates MEK (Pathway) 13116 
24.4.3.2.1.6.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13117 
24.4.3.2.1.6.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13117 
24.4.3.2.1.6.3 ERK activation (Pathway) 13117 
24.4.3.2.1.6.3.1 ERK1 activation (Pathway) 13117 
24.4.3.2.1.6.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13118 
24.4.3.2.1.6.3.1.2 MEK1 binds ERK-1 (Reaction) 13118 
24.4.3.2.1.6.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13118 
24.4.3.2.1.6.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13118 
24.4.3.2.1.6.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13119 
24.4.3.2.1.6.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13119 
24.4.3.2.1.6.3.2 ERK2 activation (Pathway) 13119 
24.4.3.2.1.6.3.2.1 MEK2 binds ERK-2 (Reaction) 13119 
24.4.3.2.1.6.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13120 
24.4.3.2.1.6.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13120 
24.4.3.2.1.6.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13120 
24.4.3.2.1.6.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13120 
24.4.3.2.1.7 Feedback control in the MAPK signaling module (Pathway) 13121 
24.4.3.2.1.8 p38MAPK events (Pathway) 13121 
24.4.3.2.1.8.1 Ral-GDS binds to Ras-GTP (Reaction) 13123 
24.4.3.2.1.8.2 Guanine nucleotide exchange on RAL (Reaction) 13124 
24.4.3.2.1.8.3 Activation of SRC by RAL-GTP (Reaction) 13125 
24.4.3.2.1.8.4 Binding and activation of MAP Kinase (BlackBoxEvent) 13127 
24.4.3.2.1.8.5 MAP kinase activates MAPKAPK2, MAPKAPK3 and MSK1 (Reaction)
13128 
24.4.3.2.2 Signalling to p38 via RIT and RIN (Pathway) 13130 
24.4.3.2.2.1 TRKA recruits RIT and RIN (Reaction) 13131 
24.4.3.2.2.2 RIT/RIN are activated (Reaction) 13132 
24.4.3.2.2.3 RIT/RIN-GTP binds B-RAF (Reaction) 13134 
24.4.3.2.2.4 RAF/MAP kinase cascade (Pathway) 13135 
24.4.3.2.2.4.1 RAF activation (Pathway) 13135 
24.4.3.2.2.4.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13135 
24.4.3.2.2.4.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13136 
24.4.3.2.2.4.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13136 
24.4.3.2.2.4.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13136 
24.4.3.2.2.4.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)
13136 
24.4.3.2.2.4.2 MEK activation (Pathway) 13137 
24.4.3.2.2.4.2.1 Activated RAF1 complex binds MEK (Reaction) 13137 
24.4.3.2.2.4.2.2 RAF phosphorylates MEK (Pathway) 13137 
24.4.3.2.2.4.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13137 
24.4.3.2.2.4.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13138 
24.4.3.2.2.4.3 ERK activation (Pathway) 13138 
24.4.3.2.2.4.3.1 ERK1 activation (Pathway) 13138 
24.4.3.2.2.4.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13138 
24.4.3.2.2.4.3.1.2 MEK1 binds ERK-1 (Reaction) 13139 
24.4.3.2.2.4.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13139 
24.4.3.2.2.4.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13139 
24.4.3.2.2.4.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13139 
24.4.3.2.2.4.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13140 
24.4.3.2.2.4.3.2 ERK2 activation (Pathway) 13140 
24.4.3.2.2.4.3.2.1 MEK2 binds ERK-2 (Reaction) 13140 
24.4.3.2.2.4.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13140 
24.4.3.2.2.4.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13141 
24.4.3.2.2.4.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13141 
24.4.3.2.2.4.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13141 
24.4.3.2.3 Prolonged ERK activation events (Pathway) 13141 
24.4.3.2.3.1 Frs2-mediated activation (Pathway) 13143 
24.4.3.2.3.1.1 FRS2 binds to active TrkA receptor (Reaction) 13144 
24.4.3.2.3.1.2 FRS2 is phosphorylated by active TrkA receptor (Reaction) 13145 
24.4.3.2.3.1.3 p-FRS2 binds CRKL (Reaction) 13146 
24.4.3.2.3.1.4 Phospho-Frs2:CrkL engages C3G (Reaction) 13148 
24.4.3.2.3.1.5 (Frs2)C3G stimulates nucleotide exchange on Rap1 (Reaction) 13149 
24.4.3.2.3.1.6 (Frs2)Rap1-GTP binds to and activates B-Raf (Reaction) 13151 
24.4.3.2.3.1.7 RAF/MAP kinase cascade (Pathway) 13152 
24.4.3.2.3.1.7.1 RAF activation (Pathway) 13153 
24.4.3.2.3.1.7.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13153 
24.4.3.2.3.1.7.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13153 
24.4.3.2.3.1.7.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13153 
24.4.3.2.3.1.7.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13154 
24.4.3.2.3.1.7.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex 13154 (Reaction) 
24.4.3.2.3.1.7.2 MEK activation (Pathway) 13154 
24.4.3.2.3.1.7.2.1 Activated RAF1 complex binds MEK (Reaction) 13154 
24.4.3.2.3.1.7.2.2 RAF phosphorylates MEK (Pathway) 13155 
24.4.3.2.3.1.7.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13155 
24.4.3.2.3.1.7.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13155 
24.4.3.2.3.1.7.3 ERK activation (Pathway) 13155 
24.4.3.2.3.1.7.3.1 ERK1 activation (Pathway) 13156 
24.4.3.2.3.1.7.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13156 
24.4.3.2.3.1.7.3.1.2 MEK1 binds ERK-1 (Reaction) 13156 
24.4.3.2.3.1.7.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13156 
24.4.3.2.3.1.7.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13157 
24.4.3.2.3.1.7.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13157 
24.4.3.2.3.1.7.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13157 
24.4.3.2.3.1.7.3.2 ERK2 activation (Pathway) 13157 
24.4.3.2.3.1.7.3.2.1 MEK2 binds ERK-2 (Reaction) 13158 
24.4.3.2.3.1.7.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13158 
24.4.3.2.3.1.7.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13158 
24.4.3.2.3.1.7.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13158 
24.4.3.2.3.1.7.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13159 
24.4.3.2.3.2 ARMS-mediated activation (Pathway) 13159 
24.4.3.2.3.2.1 ARMS:Crk complex binds to active TrkA receptor (Reaction) 13160 
24.4.3.2.3.2.2 ARMS is phosphorylated by active TrkA receptor (Reaction) 13161 
24.4.3.2.3.2.3 Crk's SH3 domain engages C3G (Reaction) 13162 
24.4.3.2.3.2.4 C3G stimulates nucleotide exchange on Rap1 (Reaction) 13163 
24.4.3.2.3.2.5 (ARMS)Rap1-GTP binds and activates B-Raf (Reaction) 13165 
24.4.3.2.3.2.6 RAF/MAP kinase cascade (Pathway) 13166 
24.4.3.2.3.2.6.1 RAF activation (Pathway) 13167 
24.4.3.2.3.2.6.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13167 
24.4.3.2.3.2.6.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13167 
24.4.3.2.3.2.6.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13167 
24.4.3.2.3.2.6.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13168 
24.4.3.2.3.2.6.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex 13168 (Reaction) 
24.4.3.2.3.2.6.2 MEK activation (Pathway) 13168 
24.4.3.2.3.2.6.2.1 Activated RAF1 complex binds MEK (Reaction) 13168 
24.4.3.2.3.2.6.2.2 RAF phosphorylates MEK (Pathway) 13169 
24.4.3.2.3.2.6.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13169 
24.4.3.2.3.2.6.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13169 
24.4.3.2.3.2.6.3 ERK activation (Pathway) 13169 
24.4.3.2.3.2.6.3.1 ERK1 activation (Pathway) 13170 
24.4.3.2.3.2.6.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13170 
24.4.3.2.3.2.6.3.1.2 MEK1 binds ERK-1 (Reaction) 13170 
24.4.3.2.3.2.6.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13170 24.4.3.2.3.2.6.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13171 
24.4.3.2.3.2.6.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13171 
24.4.3.2.3.2.6.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13171 
24.4.3.2.3.2.6.3.2 ERK2 activation (Pathway) 13171 
24.4.3.2.3.2.6.3.2.1 MEK2 binds ERK-2 (Reaction) 13172 
24.4.3.2.3.2.6.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13172 
24.4.3.2.3.2.6.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13172 
24.4.3.2.3.2.6.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13172 
24.4.3.2.3.2.6.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13173 
24.4.3.3 PLC-gamma1 signalling (Pathway) 13173 
24.4.3.3.1 Binding of PLCG1 to active TrkA receptor (Reaction) 13174 
24.4.3.3.2 Active PLCG1 dissociates from TrkA receptor (Reaction) 13175 
24.4.3.3.3 DAG and IP3 signaling (Pathway) 13177 
24.4.3.3.3.1 Active PLCG1 hydrolyses PIP2 (Reaction) 13177 
24.4.3.3.3.2 DAG stimulates protein kinase C-delta (Reaction) 13177 
24.4.3.3.3.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 13177 channel (Reaction) 
24.4.3.3.3.4 Release of calcium from intracellular stores by IP3 receptor activation 13178 (Reaction) 
24.4.3.3.3.5 CaM pathway (Pathway) 13178 
24.4.3.3.3.5.1 Calcium binds calmodulin (Reaction) 13178 
24.4.3.3.3.5.2 Calmodulin induced events (Pathway) 13178 
24.4.3.3.3.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 13179 
24.4.3.3.3.5.2.1.1 PKA activation (Pathway) 13179 
24.4.3.3.3.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 13179 
24.4.3.3.3.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers 13179 (Reaction) 
24.4.3.3.3.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 13180 
24.4.3.3.3.5.2.1.3 PKA phosphorylates CREB (Reaction) 13180 
24.4.3.3.3.5.2.1.4 Dimerisation of CREB (Reaction) 13180 
24.4.3.3.3.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 13180 
24.4.3.3.3.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 13181 
24.4.3.3.3.5.2.2.2 CamKIV enters the nucleus (Reaction) 13181 
24.4.3.3.3.5.2.2.3 CaMK IV autophosphorylation (Reaction) 13181 
24.4.3.3.3.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 13181 
24.4.3.3.3.5.2.2.5 Dimerisation of CREB (Reaction) 13182 
24.4.3.3.3.5.2.3 Cam-PDE 1 activation (Pathway) 13182 
24.4.3.3.3.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 13182 
24.4.3.3.3.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 13182 
24.4.3.3.3.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 13183 
24.4.3.3.3.5.2.5 PKC phosphorylates GRK2 (Reaction) 13183 
24.4.3.4 PI3K/AKT activation (Pathway) 13183 
24.4.3.4.1 Active TRKA binds IRS1/2 (Reaction) 13184 
24.4.3.4.2 TRKA phosphorylates IRS (Reaction) 13185 
24.4.3.4.3 Active IRS recruits PI3K to the plasma membrane and activates it (Reaction)
13186 
24.4.3.4.4 PI3K produces PIP3 and other phosphatidyl inositides (Reaction) 13187 
24.4.3.4.5 PIP3 binds to RhoA and activates it (Reaction) 13188 
24.4.3.4.6 PIP3 activates AKT signaling (Pathway) 13189 
24.4.3.4.6.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 13189 
24.4.3.4.6.2 PIP3 recruits AKT to the membrane (Reaction) 13190 
24.4.3.4.6.3 PIP3 recruits PDPK1 to the membrane (Reaction) 13190 
24.4.3.4.6.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13190 
24.4.3.4.6.5 AKT binds PDPK1 (Reaction) 13190 

24.4.3.4.6.6 PDPK1 phosphorylates AKT at T308 (Reaction) 13191 
24.4.3.4.6.7 AKT phosphorylates targets in the cytosol (Pathway) 13191 
24.4.3.4.6.7.1 AKT phosphorylates BAD (Reaction) 13191 
24.4.3.4.6.7.2 AKT phosphorylates GSK3 (Reaction) 13191 
24.4.3.4.6.7.3 AKT phosphorylates caspase-9 (Reaction) 13192 
24.4.3.4.6.7.4 AKT phosphorylates MDM2 (Reaction) 13192 
24.4.3.4.6.7.5 AKT phosphorylates IKKalpha (Reaction) 13192 
24.4.3.4.6.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 13192 
24.4.3.4.6.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 13193 
24.4.3.4.6.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 13193 
24.4.3.4.6.8 AKT translocates to the nucleus (Reaction) 13193 
24.4.3.4.6.9 AKT phosphorylates targets in the nucleus (Pathway) 13193 
24.4.3.4.6.9.1 AKT phosphorylates CREB1 (Reaction) 13194 
24.4.3.4.6.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction)13194 
24.4.3.4.6.9.3 AKT can phosphorylate RSK (Reaction) 13194 
24.4.3.4.6.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 13194 
24.4.3.4.6.10 Negative regulation of the PI3K/AKT network (Pathway) 13195 
24.4.3.4.6.10.1 PTEN dephosphorylates PIP3 (Reaction) 13195 
24.4.3.4.6.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction)13195 
24.4.3.4.6.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 13195 
24.4.3.4.6.11 PDPK1 binds PIP2 (Reaction) 13196 
24.4.3.4.6.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 13196 
24.4.3.4.6.13 PTEN mRNA translation negatively regulated by microRNAs 13196 (BlackBoxEvent) 
24.4.3.5 Signalling to STAT3 (Pathway) 13196 
24.4.3.5.1 STAT3 activation (Reaction) 13197 
24.4.3.6 Signalling to ERK5 (Pathway) 13199 
24.4.3.6.1 ERK5 is activated (Reaction) 13200 
24.4.3.6.2 ERK5 translocates to the nucleus (Reaction) 13201 
24.4.3.7 Retrograde neurotrophin signalling (Pathway) 13202 
24.4.3.7.1 Formation of clathrin-coated vesicle (Reaction) 13203 
24.4.3.7.2 Endocytosis (internalization) of clathrin-coated vesicle (Reaction) 13205 
24.4.3.7.3 Axonal transport of NGF:Trk complexes (Reaction) 13207 
24.4.3.8 Nuclear Events (kinase and transcription factor activation) (Pathway) 13208 
24.4.3.8.1 ERK/MAPK targets (Pathway) 13209 
24.4.3.8.1.1 ERK1/2 activates ELK1 (Reaction) 13209 
24.4.3.8.1.2 ERK1/2 phosphorylates MSK1 (Reaction) 13209 
24.4.3.8.1.3 p38MAPK phosphorylates MSK1 (Reaction) 13210 
24.4.3.8.1.4 ERK1/2/5 activate RSK1/2/3 (Reaction) 13210 
24.4.3.8.1.5 ERK5 activates the transcription factor MEF2 (Reaction) 13210 
24.4.3.8.1.6 ERKs are inactivated by protein phosphatase 2A (Reaction) 13211 
24.4.3.8.1.7 ERKs are inactivated (Pathway) 13211 
24.4.3.8.1.7.1 ERKs are inactivated by protein phosphatase 2A (Reaction) 13211 
24.4.3.8.1.7.2 ERKs are inactivated by dual-specific phosphatases (DUSPs) (Reaction)
13212 
24.4.3.8.2 CREB phosphorylation (Pathway) 13212 
24.4.3.8.2.1 MSK1 activates CREB (Reaction) 13212 
24.4.3.8.2.2 MSK1 activates ATF1 (Reaction) 13213 
24.4.3.8.2.3 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 13213 
24.4.3.8.2.4 MAPKAPK2 phosphorylates CREB at Serine 133 (Reaction) 13214 
24.5 Signaling by PDGF (Pathway) 13214 
24.5.1 Translocation of PDGF from ER to Golgi (Reaction) 13216 
24.5.2 Processing of classical PDGFs (BlackBoxEvent) 13217 
24.5.3 Release of novel PDGFs as latent factors (BlackBoxEvent) 13219 
24.5.4 Extracellular processing of novel PDGFs (Reaction) 13220 
24.5.5 PDGF binds to extracellular matrix proteins (Reaction) 13221 
24.5.6 PDGF dimer binds two receptors simultaneously (BlackBoxEvent) 13223 
24.5.7 Autophosphorylation of PDGF beta receptors (Reaction) 13224 
24.5.8 Autophosphorylation of PDGF alpha receptors (Reaction) 13226 
24.5.9 Autophosphorylation of PDGF alpha/beta receptors (Reaction) 13227 
24.5.10 Downstream signal transduction (Pathway) 13229 
24.5.10.1 PI3-kinase binds to the active receptor (Reaction) 13231 
24.5.10.2 PI3K catalyses the phosphorylation of PIP2 to PIP3 (Reaction) 13232 
24.5.10.3 PIP3 activates AKT signaling (Pathway) 13233 
24.5.10.3.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 13234 
24.5.10.3.2 PIP3 recruits AKT to the membrane (Reaction) 13234 
24.5.10.3.3 PIP3 recruits PDPK1 to the membrane (Reaction) 13234 
24.5.10.3.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13234 
24.5.10.3.5 AKT binds PDPK1 (Reaction) 13235 
24.5.10.3.6 PDPK1 phosphorylates AKT at T308 (Reaction) 13235 
24.5.10.3.7 AKT phosphorylates targets in the cytosol (Pathway) 13235 
24.5.10.3.7.1 AKT phosphorylates BAD (Reaction) 13235 
24.5.10.3.7.2 AKT phosphorylates GSK3 (Reaction) 13236 
24.5.10.3.7.3 AKT phosphorylates caspase-9 (Reaction) 13236 
24.5.10.3.7.4 AKT phosphorylates MDM2 (Reaction) 13236 
24.5.10.3.7.5 AKT phosphorylates IKKalpha (Reaction) 13236 
24.5.10.3.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 13237 
24.5.10.3.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 13237 
24.5.10.3.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 13237 
24.5.10.3.8 AKT translocates to the nucleus (Reaction) 13237 
24.5.10.3.9 AKT phosphorylates targets in the nucleus (Pathway) 13238 
24.5.10.3.9.1 AKT phosphorylates CREB1 (Reaction) 13238 
24.5.10.3.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 13238 24.5.10.3.9.3 AKT can phosphorylate RSK (Reaction) 13238 
24.5.10.3.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 13239 
24.5.10.3.10 Negative regulation of the PI3K/AKT network (Pathway) 13239 
24.5.10.3.10.1 PTEN dephosphorylates PIP3 (Reaction) 13239 
24.5.10.3.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction)13239 
24.5.10.3.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 13240 
24.5.10.3.11 PDPK1 binds PIP2 (Reaction) 13240 
24.5.10.3.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 13240 
24.5.10.3.13 PTEN mRNA translation negatively regulated by microRNAs 13240 (BlackBoxEvent) 
24.5.10.4 PLC-gamma binds to the active receptor (Reaction) 13241 
24.5.10.5 Phosphorylation of PLCgamma by PDGFR (Reaction) 13242 
24.5.10.6 Activated PLC gamma dissociates from the PDGF receptor (Reaction) 13243 
24.5.10.7 DAG and IP3 signaling (Pathway) 13244 
24.5.10.7.1 Active PLCG1 hydrolyses PIP2 (Reaction) 13245 
24.5.10.7.2 DAG stimulates protein kinase C-delta (Reaction) 13245 
24.5.10.7.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 13245 channel (Reaction) 
24.5.10.7.4 Release of calcium from intracellular stores by IP3 receptor activation 13245 (Reaction) 
24.5.10.7.5 CaM pathway (Pathway) 13246 
24.5.10.7.5.1 Calcium binds calmodulin (Reaction) 13246 
24.5.10.7.5.2 Calmodulin induced events (Pathway) 13246 
24.5.10.7.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 13246 
24.5.10.7.5.2.1.1 PKA activation (Pathway) 13246 
24.5.10.7.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 13247 
24.5.10.7.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers (Reaction)13247 
24.5.10.7.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 13247 
24.5.10.7.5.2.1.3 PKA phosphorylates CREB (Reaction) 13247 
24.5.10.7.5.2.1.4 Dimerisation of CREB (Reaction) 13248 
24.5.10.7.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 13248 
24.5.10.7.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 13248 
24.5.10.7.5.2.2.2 CamKIV enters the nucleus (Reaction) 13248 
24.5.10.7.5.2.2.3 CaMK IV autophosphorylation (Reaction) 13249 
24.5.10.7.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 13249 
24.5.10.7.5.2.2.5 Dimerisation of CREB (Reaction) 13249 
24.5.10.7.5.2.3 Cam-PDE 1 activation (Pathway) 13249 
24.5.10.7.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 13250 
24.5.10.7.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 13250 
24.5.10.7.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 13250 
24.5.10.7.5.2.5 PKC phosphorylates GRK2 (Reaction) 13250 
24.5.10.8 SH2 domain of Src binds to the active receptor (Reaction) 13251 
24.5.10.9 Activation of Src (Reaction) 13252 
24.5.10.10 SHP2 binds to the active receptor (Reaction) 13254 
24.5.10.11 GAP binds to PDGF-beta receptors only (Reaction) 13255 24.5.10.12 Grb2/Sos1 complex binds to the active receptor (Reaction) 13256 
24.5.10.13 Sos-mediated nucleotide exchange of Ras (PDGF receptor:Grb2:Sos) 13258 (Reaction) 
24.5.10.14 RAF/MAP kinase cascade (Pathway) 13259 
24.5.10.14.1 RAF activation (Pathway) 13259 
24.5.10.14.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13259 
24.5.10.14.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13260 
24.5.10.14.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13260 
24.5.10.14.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13260 
24.5.10.14.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)13260 
24.5.10.14.2 MEK activation (Pathway) 13261 
24.5.10.14.2.1 Activated RAF1 complex binds MEK (Reaction) 13261 
24.5.10.14.2.2 RAF phosphorylates MEK (Pathway) 13261 
24.5.10.14.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13261 
24.5.10.14.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13262 
24.5.10.14.3 ERK activation (Pathway) 13262 
24.5.10.14.3.1 ERK1 activation (Pathway) 13262 
24.5.10.14.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13262 
24.5.10.14.3.1.2 MEK1 binds ERK-1 (Reaction) 13263 
24.5.10.14.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13263 
24.5.10.14.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13263 
24.5.10.14.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13263 
24.5.10.14.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13264 
24.5.10.14.3.2 ERK2 activation (Pathway) 13264 
24.5.10.14.3.2.1 MEK2 binds ERK-2 (Reaction) 13264 
24.5.10.14.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13264 
24.5.10.14.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13265 
24.5.10.14.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13265 
24.5.10.14.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13265 
24.5.10.15 STAT binds to the active receptor (Reaction) 13265 
24.5.10.16 Crk binds to the active PDGF receptor (Reaction) 13267 
24.5.10.17 p130Cas and C3G bind PDGFR bound Crk (Reaction) 13268 
24.5.10.18 Nck binds to the active PDGF receptor (Reaction) 13269 
24.5.10.19 Grb7 binds to the active PDGF receptor (Reaction) 13271 
24.6 Signaling by VEGF (Pathway) 13272 
24.6.1 VEGF ligand-receptor interactions (Pathway) 13275 
24.6.1.1 Homodimerization of VEGF proteins (Reaction) 13277 
24.6.1.2 VEGF binds to VEGFR leading to receptor dimerization (Pathway) 13279 
24.6.1.2.1 VEGFA,B,PLGF bind to VEGFR1 leading to receptor dimerization (Reaction)
13280 
24.6.1.2.2 VEGF-A,C,D bind to VEGFR2 leading to receptor dimerization (Reaction) 13282 
24.6.1.2.3 VEGF-C,D bind to VEGFR3 leading to receptor dimerization (Reaction) 13285 
24.6.2 VEGFA-VEGFR2 Pathway (Pathway) 13287 
24.6.2.1 VEGFR2 autophosphorylates (Reaction) 13288 
24.6.2.2 p-6Y-VEGFR2 binds Src homology 2 domain-containing adapter protein B (SHB)
13291 
(Reaction) 
24.6.2.3 SRC-1 phosphorylates Src homology 2 domain-containing adapter protein B 13292 (Reaction) 
24.6.2.4 Focal adhesion kinase 1 binds p-S-SHB and is recruited to p-6Y-VEGFR2 13293 (Reaction) 
24.6.2.5 Focal adhesion kinase 1 autophosphorylates (Reaction) 13295 
24.6.2.6 SRC-1 binds p-Y397-Focal adhesion kinase 1 (Reaction) 13296 
24.6.2.7 SRC-1 phosphorylate p-Y397-Focal adhesion kinase 1 (Reaction) 13298 
24.6.2.8 Integrin alphaVbeta3 binds p-6Y-VEGFR2 (Reaction) 13299 
24.6.2.9 HSP90AA1 binds p-6Y-VEGFR2 (Reaction) 13301 
24.6.2.10 RHOA:GTP:Mg2+ binds ROCK1,ROCK2 (Reaction) 13302 
24.6.2.11 ROCK1,ROCK2 are activated (Reaction) 13302 
24.6.2.12 Active ROCK1,ROCK2 phosphorylates p-5Y-Focal adhesion kinase 1 on S732
13304 (Reaction) 
24.6.2.13 Proline tyrosine kinase 2-beta binds alphaVbeta3 (Reaction) 13305 
24.6.2.14 SRC-1 phosphorylate proline tyrosine kinase 2-beta (Reaction) 13306 
24.6.2.15 p-Y402-proline tyrosine kinase 2-beta phosphorylates p-5Y,S732-Focal adhesion
13307 kinase 1 on Y407 (Reaction) 
24.6.2.16 Paxillin binds p-6Y,S732-Focal adhesion kinase 1 (Reaction) 13309 
24.6.2.17 FAK1/SRC-1 phosphorylate paxillin on Y31 and Y118 (Reaction) 13310 
24.6.2.18 p130CRK-associated substrate (CAS) binds p-7Y-FAK (Reaction) 13311 
24.6.2.19 FAK/SRC-1 phosphorylate p130CRK-associated substrate (Reaction) 13313 
24.6.2.20 CRK binds p130CAS and or paxillin (Reaction) 13315 
24.6.2.21 DOCK180:ELMO binds CRK (Reaction) 13316 
24.6.2.22 DOCK180:ELMO exchanges GTP for GDP, activating RAC1 (Reaction) 13318 
24.6.2.23 WAVE Regulatory Complex (WRC) interacts with RAC1 and PIP3 and gets 13320 activated (Reaction) 
24.6.2.24 p-6Y-VEGFR2 binds SHC-transforming protein 2 (Reaction) 13320 
24.6.2.25 p-6Y-VEGFR2 binds TSAD (Reaction) 13321 
24.6.2.26 SRC1-1 binds TSAD and is recruited to VEGFR2 (Reaction) 13323 
24.6.2.27 Phosphorylation of SRC-1 (Reaction) 13324 
24.6.2.28 AXL binds SRC-1 (Reaction) 13325 
24.6.2.29 AXL autophosphorylates on Y772 and Y814 (Reaction) 13326 
24.6.2.30 p-AXL binds the p85-subunit of PI3K (Reaction) 13328 
24.6.2.31 p-6Y-VEGFR2 binds the p85-subunit of PI3K (Reaction) 13329 
24.6.2.32 VEGFA dimer:p-6Y-VEGFR2 dimer:PI3K phosphorylates PIP2 to PIP3 13331 (Reaction) 
24.6.2.33 PIP3 stimulates Vav (Reaction) 13332 
24.6.2.34 Src kinases phosphorylate VAV (Reaction) 13333 
24.6.2.35 VAV exchanges GTP for GDP on RAC1, activating it (Reaction) 13334 
24.6.2.36 VEGFR2 mediated vascular permeability (Pathway) 13336 
24.6.2.36.1 RAC1 binds PAK1-3 (Reaction) 13337 
24.6.2.36.2 PAK1-3 dimer disassociates (Reaction) 13338 
24.6.2.36.3 PAK1-3 autophosphorylates (Reaction) 13339 
24.6.2.36.4 PAK1-3 phosphorylates VE-cadherin (Reaction) 13341 
24.6.2.36.5 PIP3 recruits PDPK1 to the membrane (Reaction) 13342 
24.6.2.36.6 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13342 
24.6.2.36.7 AKT binds PDPK1 (Reaction) 13343 
24.6.2.36.8 PDPK1 phosphorylates AKT at T308 (Reaction) 13343 
24.6.2.36.9 eNOS:Caveolin-1 complex binds to CaM (Reaction) 13343 
24.6.2.36.10 HSP90 binds eNOS:Caveolin-1:CaM complex (Reaction) 13343 
24.6.2.36.11 Caveolin-1 dissociates from eNOS:CaM:HSP90 complex (Reaction) 13344 
24.6.2.36.12 AKT1 binds eNOS complex via HSP90 (Reaction) 13344 
24.6.2.36.13 AKT1 phosphorylates eNOS (Reaction) 13344 
24.6.2.36.14 The cofactor BH4 is required for electron transfer in the eNOS catalytic cycle
13345 (Reaction) 
24.6.2.36.15 NO biosynthesis (Reaction) 13345 
24.6.2.37 NADPH oxidase 2 (NOX2) complex binds RAC1 (Reaction) 13346 
24.6.2.38 NADPH oxidase 2 generates superoxide from oxygen (Reaction) 13347 
24.6.2.39 p-6Y-VEGFR2 binds NCK (Reaction) 13348 
24.6.2.40 p-6Y-VEGFR2 binds FYN (Reaction) 13350 
24.6.2.41 FYN autophosphorylates (Reaction) 13351 
24.6.2.42 p-Y420-FYN phosphorylated on S21 (Reaction) 13352 
24.6.2.43 PAK2 binds NCK (Reaction) 13354 
24.6.2.44 VEGF induces CDC42 activation by unknown mechanism (BlackBoxEvent) 13355 
24.6.2.45 CDC42:GTP binds PAK2 (Reaction) 13356 
24.6.2.46 PAK2 autophorylates (Reaction) 13358 
24.6.2.47 FYN phosphorylates PAK2 (Reaction) 13359 
24.6.2.48 p38 MAPK activation by VEGFR (BlackBoxEvent) 13360 
24.6.2.49 p38 phosphorylates MAPK2/3 (Reaction) 13362 
24.6.2.50 p-MAPK2/3 phosphorylates HSP27 (BlackBoxEvent) 13364 
24.6.2.51 VEGFR2 mediated cell proliferation (Pathway) 13365 
24.6.2.51.1 p-6Y-VEGFR2 binds PLCG1 (Reaction) 13366 
24.6.2.51.2 SFKs phosphorylate PLCG1 (Reaction) 13368 
24.6.2.51.3 PLCG1 disassociates from VEGFR2 and translocate to PM (Reaction) 13369 
24.6.2.51.4 Active PLCG1 hydrolyses PIP2 (Reaction) 13371 
24.6.2.51.5 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 13371 channel (Reaction) 
24.6.2.51.6 Release of calcium from intracellular stores by IP3 receptor activation 13371 (Reaction) 
24.6.2.51.7 Calcium binds calmodulin (Reaction) 13371 
24.6.2.51.8 PDK1 phosphorylates PKC (Reaction) 13372 
24.6.2.51.9 PKC autophosphorylates (Reaction) 13373 
24.6.2.51.10 DAG and Ca+2 bind to PKC and tether it to membrane (Reaction) 13375 
24.6.2.51.11 PKC phosphorylates sphingosine kinase 1 (Reaction) 13376 
24.6.2.51.12 p-SPHK1 phosphorylates sphingosine to sphingosine 1-phosphate 13377 (Reaction) 
24.6.2.51.13 RAF/MAP kinase cascade (Pathway) 13379 
24.6.2.51.13.1 RAF activation (Pathway) 13379 
24.6.2.51.13.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13379 
24.6.2.51.13.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13379 
24.6.2.51.13.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13380 
24.6.2.51.13.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13380 
24.6.2.51.13.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction)
13380 
24.6.2.51.13.2 MEK activation (Pathway) 13380 
24.6.2.51.13.2.1 Activated RAF1 complex binds MEK (Reaction) 13381 
24.6.2.51.13.2.2 RAF phosphorylates MEK (Pathway) 13381 
24.6.2.51.13.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13381 
24.6.2.51.13.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13381 
24.6.2.51.13.3 ERK activation (Pathway) 13382 
24.6.2.51.13.3.1 ERK1 activation (Pathway) 13382 
24.6.2.51.13.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13382 
24.6.2.51.13.3.1.2 MEK1 binds ERK-1 (Reaction) 13382 
24.6.2.51.13.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13383 
24.6.2.51.13.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13383 
24.6.2.51.13.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13383 
24.6.2.51.13.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13383 
24.6.2.51.13.3.2 ERK2 activation (Pathway) 13384 
24.6.2.51.13.3.2.1 MEK2 binds ERK-2 (Reaction) 13384 
24.6.2.51.13.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13384 
24.6.2.51.13.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13384 
24.6.2.51.13.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13385 
24.6.2.51.13.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13385 
24.6.3 Neurophilin interactions with VEGF and VEGFR (Pathway) 13385 
24.6.3.1 NRP-1 forms a ternary complex with VEGF165 and VEGFR1 (Reaction) 13386 
24.6.3.2 NRP-2 associates with VEGFR1 forming complexes on cell surface (Reaction)13388 
24.7 Signaling by SCF-KIT (Pathway) 13389 
24.7.1 Processing of SCF isoform 1 (Reaction) 13391 
24.7.2 Dimerization of sSCF (Reaction) 13393 
24.7.3 Interaction of KIT and sSCF (Reaction) 13394 
24.7.4 Dimerization of KIT upon SCF binding (Reaction) 13396 
24.7.5 Autophosphorylation of KIT (Reaction) 13398 
24.7.6 Direct recruitment of PI3K to p-KIT (Reaction) 13400 
24.7.7 Synthesis of PIP3 from PIP2 by PI3K (Reaction) 13402 
24.7.8 PIP3 activates AKT signaling (Pathway) 13403 
24.7.8.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 13403 
24.7.8.2 PIP3 recruits AKT to the membrane (Reaction) 13404 
24.7.8.3 PIP3 recruits PDPK1 to the membrane (Reaction) 13404 
24.7.8.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13404 
24.7.8.5 AKT binds PDPK1 (Reaction) 13404 
24.7.8.6 PDPK1 phosphorylates AKT at T308 (Reaction) 13405 
24.7.8.7 AKT phosphorylates targets in the cytosol (Pathway) 13405 
24.7.8.7.1 AKT phosphorylates BAD (Reaction) 13405 
24.7.8.7.2 AKT phosphorylates GSK3 (Reaction) 13405 
24.7.8.7.3 AKT phosphorylates caspase-9 (Reaction) 13406 
24.7.8.7.4 AKT phosphorylates MDM2 (Reaction) 13406 
24.7.8.7.5 AKT phosphorylates IKKalpha (Reaction) 13406 
24.7.8.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 13406 
24.7.8.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 13407 
24.7.8.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 13407 
24.7.8.8 AKT translocates to the nucleus (Reaction) 13407 
24.7.8.9 AKT phosphorylates targets in the nucleus (Pathway) 13407 
24.7.8.9.1 AKT phosphorylates CREB1 (Reaction) 13408 
24.7.8.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 13408 
24.7.8.9.3 AKT can phosphorylate RSK (Reaction) 13408 
24.7.8.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 13408 
24.7.8.10 Negative regulation of the PI3K/AKT network (Pathway) 13409 
24.7.8.10.1 PTEN dephosphorylates PIP3 (Reaction) 13409 
24.7.8.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction) 13409 
24.7.8.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 13409 
24.7.8.11 PDPK1 binds PIP2 (Reaction) 13410 
24.7.8.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 13410 
24.7.8.13 PTEN mRNA translation negatively regulated by microRNAs (BlackBoxEvent)13410 
24.7.9 Phosphorylation and activation of VAV1 (Reaction) 13410 
24.7.10 Activation of RAC1 (Reaction) 13412 
24.7.11 Interaction of Src family kinases with p-KIT (Reaction) 13413 
24.7.12 Phosphorylation of p-KIT on Y900 by Src kinases (Reaction) 13416 
24.7.13 GRB2:SOS interacts with p-KIT (Reaction) 13417 
24.7.14 SHP2 interacts with p-KIT (Reaction) 13419 
24.7.15 Phosphorylation of SHP2 by SFKs (Reaction) 13421 
24.7.16 GRB2 is indirectly recruited to p-KIT through SHP2 (Reaction) 13422 
24.7.17 Indirect recruitment of GAB2 to p-KIT (Reaction) 13423 
24.7.18 Phosphorylation of GAB2 by SFKs (BlackBoxEvent) 13425 
24.7.19 Indirect recruitment of PI3K to KIT via p(Y)-GAB2 (Reaction) 13426 
24.7.20 RAF/MAP kinase cascade (Pathway) 13427 
24.7.20.1 RAF activation (Pathway) 13427 
24.7.20.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13428 
24.7.20.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13428 
24.7.20.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13428 
24.7.20.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13428 
24.7.20.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 13429 
24.7.20.2 MEK activation (Pathway) 13429 
24.7.20.2.1 Activated RAF1 complex binds MEK (Reaction) 13429 
24.7.20.2.2 RAF phosphorylates MEK (Pathway) 13429 
24.7.20.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13430 
24.7.20.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13430 
24.7.20.3 ERK activation (Pathway) 13430 
24.7.20.3.1 ERK1 activation (Pathway) 13430 
24.7.20.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13431 
24.7.20.3.1.2 MEK1 binds ERK-1 (Reaction) 13431 
24.7.20.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13431 
24.7.20.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13431 
24.7.20.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13432 
24.7.20.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13432 
24.7.20.3.2 ERK2 activation (Pathway) 13432 
24.7.20.3.2.1 MEK2 binds ERK-2 (Reaction) 13432 
24.7.20.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13433 
24.7.20.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13433 
24.7.20.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13433 
24.7.20.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13433 
24.7.21 Activation of RAS by p-KIT bound SOS1 (Reaction) 13434 
24.7.22 Interaction of other tyrosine kinases with p-KIT (Reaction) 13435 
24.7.23 Interaction of other adapter proteins with p-KIT (Reaction) 13437 
24.7.24 JAK2 binds to p-KIT (Reaction) 13438 
24.7.25 Phosphorylation of JAK2 (Reaction) 13439 
24.7.26 Recruitment of STATs (Reaction) 13441 
24.7.27 Phosphorylation of STATs (BlackBoxEvent) 13442 
24.7.28 Dimerization of STATs (Reaction) 13443 
24.7.29 Disassociation and translocation of STATs to the nucleus (Reaction) 13445 
24.7.30 Regulation of KIT signaling (Pathway) 13446 
24.7.30.1 PKC alpha interacts with and phosphorylates KIT (Reaction) 13447 
24.7.30.2 Interaction of SHP1 and KIT (Reaction) 13449 
24.7.30.3 SOCS1 as a regulator of KIT signaling (Reaction) 13450 
24.7.30.4 Interaction of APS and p-KIT (Reaction) 13452 
24.7.30.5 Phosphorylation of APS (Reaction) 13453 
24.7.30.6 Recruitment of CBL to KIT (Reaction) 13454 
24.7.30.7 Downregulation of c-Kit signaling by SOCS6 (Reaction) 13456 
24.7.30.8 LNK binds to p-KIT and inhibit downstream signaling (Reaction) 13458 
24.7.31 PTP-RO interacts with p-c-Kit complex (Reaction) 13459 
24.8 Signaling by ERBB2 (Pathway) 13460 
24.8.1 ERBB3 binds neuregulins (Reaction) 13462 
24.8.2 ERBB2 forms heterodimers with ligand-activated ERBB receptors: EGFR, ERBB313464 and ERBB4 (Reaction) 
24.8.3 SRC family kinases phosphorylate ERBB2 (Reaction) 13466 
24.8.4 Trans-autophosphorylation of p-Y877-ERBB2 heterodimers (Reaction) 13467 
24.8.5 Trans-autophosphorylation of ERBB2 heterodimers (Reaction) 13469 
24.8.6 SHC1 events in ERBB2 signaling (Pathway) 13472 
24.8.6.1 SHC1 binds phosphorylated ERBB2 heterodimers (Reaction) 13473 
24.8.6.2 SHC1 phosphorylation by ERBB2 heterodimers (Reaction) 13475 
24.8.6.3 Recruitment of GRB2:SOS1 to p-SHC1 in complex with phosphorylated ERBB2
13476 heterodimers (Reaction) 
24.8.6.4 RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and
13477 p-SHC1:Phosphorylated ERBB2 heterodimers (Reaction) 
24.8.6.5 RAF/MAP kinase cascade (Pathway) 13479 
24.8.6.5.1 RAF activation (Pathway) 13479 
24.8.6.5.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13479 24.8.6.5.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13479 
24.8.6.5.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13480 
24.8.6.5.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13480 
24.8.6.5.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 13480 
24.8.6.5.2 MEK activation (Pathway) 13480 
24.8.6.5.2.1 Activated RAF1 complex binds MEK (Reaction) 13481 
24.8.6.5.2.2 RAF phosphorylates MEK (Pathway) 13481 
24.8.6.5.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13481 
24.8.6.5.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13481 
24.8.6.5.3 ERK activation (Pathway) 13482 
24.8.6.5.3.1 ERK1 activation (Pathway) 13482 
24.8.6.5.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13482 
24.8.6.5.3.1.2 MEK1 binds ERK-1 (Reaction) 13482 
24.8.6.5.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13483 
24.8.6.5.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13483 
24.8.6.5.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13483 
24.8.6.5.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13483 
24.8.6.5.3.2 ERK2 activation (Pathway) 13484 
24.8.6.5.3.2.1 MEK2 binds ERK-2 (Reaction) 13484 
24.8.6.5.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13484 
24.8.6.5.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13484 
24.8.6.5.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13485 
24.8.6.5.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13485 
24.8.7 GRB2 events in ERBB2 signaling (Pathway) 13485 
24.8.7.1 GRB2:SOS1 complex binds phosphorylated EGFR:ERBB2 heterodimer 13486 (Reaction) 
24.8.7.2 RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and
13488 phosphorylated EGFR:ERBB2 heterodimers. (Reaction) 
24.8.7.3 GRB2:SOS1 complex binds phosphorylated ERBB4:ERBB2 heterodimers 13489 (Reaction) 
24.8.7.4 RAS guanyl nucleotide exchange mediated by SOS1 bound to GRB2 in complex
13491 with phosphorylated ERBB4:ERBB2 heterodimers (Reaction) 
24.8.7.5 RAF/MAP kinase cascade (Pathway) 13492 
24.8.7.5.1 RAF activation (Pathway) 13492 
24.8.7.5.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13492 
24.8.7.5.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13493 
24.8.7.5.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13493 
24.8.7.5.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13493 
24.8.7.5.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 13493 
24.8.7.5.2 MEK activation (Pathway) 13494 
24.8.7.5.2.1 Activated RAF1 complex binds MEK (Reaction) 13494 
24.8.7.5.2.2 RAF phosphorylates MEK (Pathway) 13494 
24.8.7.5.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13494 
24.8.7.5.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13495 
24.8.7.5.3 ERK activation (Pathway) 13495 
24.8.7.5.3.1 ERK1 activation (Pathway) 13495 
24.8.7.5.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13495 
24.8.7.5.3.1.2 MEK1 binds ERK-1 (Reaction) 13496 
24.8.7.5.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13496 
24.8.7.5.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13496 
24.8.7.5.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13496 
24.8.7.5.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13497 
24.8.7.5.3.2 ERK2 activation (Pathway) 13497 
24.8.7.5.3.2.1 MEK2 binds ERK-2 (Reaction) 13497 
24.8.7.5.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13497 
24.8.7.5.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13498 
24.8.7.5.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13498 
24.8.7.5.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13498 
24.8.8 PI3K events in ERBB2 signaling (Pathway) 13498 
24.8.8.1 Binding of PI3K subunit p85 (PIK3R1) to ERBB2:P-ERBB3 heterodimer 13499 (Reaction) 
24.8.8.2 Recruitment of PI3K subunit p110 (PIK3CA) by PIK3R1 bound to phosphorylated
13501 heterodimer of ERBB2 and ERBB3. (Reaction) 
24.8.8.3 PIP2 to PIP3 conversion by PI3K bound to phosphorylated heterodimer of ERBB2
13502 and ERBB3 (Reaction) 
24.8.8.4 Binding of p85 subunit of PI3K (PIK3R1) to p-ERBB2:p-ERBB4 CYT-1 13503 heterodimers (Reaction) 
24.8.8.5 Recruitment of PI3K subunit p110 (PIK3CA) by PIK3R1bound to 13504 ERBB2:ERBB4cyt1 heterodimer. (Reaction) 
24.8.8.6 PIP2 to PIP3 conversion by PI3K bound to phosphorylated heterodimer of ERBB2
13506 and ERBB4 CYT1 (Reaction) 
24.8.8.7 Binding of GRB2:GAB1 to p-ERBB2:p-EGFR (Reaction) 13507 
24.8.8.8 Binding of PI3K subunit p85 (PIK3R1) to GRB2:GAB1 in complex with 13508 phosphorylated heterodimer of ERBB2 and EGFR. (Reaction) 
24.8.8.9 Recruitment of catalytic PI3K subunit p110 (PIK3CA) by PIK3R1 bound to 13509 GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR (Reaction) 
24.8.8.10 PIP2 to PIP3 conversion by PI3K bound to GRB2:GAB1 in complex with 13510 phosphorylated heterodimer of ERBB2 and EGFR (Reaction) 
24.8.8.11 PIP3 activates AKT signaling (Pathway) 13511 
24.8.8.11.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 13512 
24.8.8.11.2 PIP3 recruits AKT to the membrane (Reaction) 13512 
24.8.8.11.3 PIP3 recruits PDPK1 to the membrane (Reaction) 13512 
24.8.8.11.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13512 
24.8.8.11.5 AKT binds PDPK1 (Reaction) 13513 
24.8.8.11.6 PDPK1 phosphorylates AKT at T308 (Reaction) 13513 
24.8.8.11.7 AKT phosphorylates targets in the cytosol (Pathway) 13513 
24.8.8.11.7.1 AKT phosphorylates BAD (Reaction) 13513 
24.8.8.11.7.2 AKT phosphorylates GSK3 (Reaction) 13514 
24.8.8.11.7.3 AKT phosphorylates caspase-9 (Reaction) 13514 
24.8.8.11.7.4 AKT phosphorylates MDM2 (Reaction) 13514 24.8.8.11.7.5 AKT phosphorylates IKKalpha (Reaction) 13514 
24.8.8.11.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 13515 
24.8.8.11.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 13515 
24.8.8.11.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 13515 
24.8.8.11.8 AKT translocates to the nucleus (Reaction) 13515 
24.8.8.11.9 AKT phosphorylates targets in the nucleus (Pathway) 13516 
24.8.8.11.9.1 AKT phosphorylates CREB1 (Reaction) 13516 
24.8.8.11.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 13516 
24.8.8.11.9.3 AKT can phosphorylate RSK (Reaction) 13516 
24.8.8.11.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 13517 
24.8.8.11.10 Negative regulation of the PI3K/AKT network (Pathway) 13517 
24.8.8.11.10.1 PTEN dephosphorylates PIP3 (Reaction) 13517 
24.8.8.11.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction)13517 
24.8.8.11.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 13518 
24.8.8.11.11 PDPK1 binds PIP2 (Reaction) 13518 
24.8.8.11.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 13518 
24.8.8.11.13 PTEN mRNA translation negatively regulated by microRNAs 13518 (BlackBoxEvent) 
24.8.9 PLCG1 events in ERBB2 signaling (Pathway) 13519 
24.8.9.1 PLCG1 binds to p-ERBB2:p-EGFR (Reaction) 13519 
24.8.9.2 PLCG1 phosphorylation by p-EGFR:p-ERBB2 (Reaction) 13521 
24.8.9.3 DAG and IP3 signaling (Pathway) 13523 
24.8.9.3.1 Active PLCG1 hydrolyses PIP2 (Reaction) 13523 
24.8.9.3.2 DAG stimulates protein kinase C-delta (Reaction) 13523 
24.8.9.3.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 13523 channel (Reaction) 
24.8.9.3.4 Release of calcium from intracellular stores by IP3 receptor activation 13524 (Reaction) 
24.8.9.3.5 CaM pathway (Pathway) 13524 
24.8.9.3.5.1 Calcium binds calmodulin (Reaction) 13524 
24.8.9.3.5.2 Calmodulin induced events (Pathway) 13524 
24.8.9.3.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 13525 
24.8.9.3.5.2.1.1 PKA activation (Pathway) 13525 
24.8.9.3.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 13525 
24.8.9.3.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers (Reaction)13525 
24.8.9.3.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 13526 
24.8.9.3.5.2.1.3 PKA phosphorylates CREB (Reaction) 13526 
24.8.9.3.5.2.1.4 Dimerisation of CREB (Reaction) 13526 
24.8.9.3.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 13526 
24.8.9.3.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 13527 
24.8.9.3.5.2.2.2 CamKIV enters the nucleus (Reaction) 13527 
24.8.9.3.5.2.2.3 CaMK IV autophosphorylation (Reaction) 13527 
24.8.9.3.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 13527 
24.8.9.3.5.2.2.5 Dimerisation of CREB (Reaction) 13528 
24.8.9.3.5.2.3 Cam-PDE 1 activation (Pathway) 13528 24.8.9.3.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 13528 
24.8.9.3.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 13528 
24.8.9.3.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 13529 
24.8.9.3.5.2.5 PKC phosphorylates GRK2 (Reaction) 13529 
24.8.10 GRB7 events in ERBB2 signaling (Pathway) 13529 
24.8.10.1 GRB7 binds phosphorylated heterodimer of ERBB2 and ERBB3 (Reaction) 13530 
24.8.11 Downregulation of ERBB2:ERBB3 signaling (Pathway) 13531 
24.8.11.1 ERBB3 binds RNF41 ubiquitin ligase (Reaction) 13532 
24.8.11.2 RNF41 ubiquitinates ERBB3 (Reaction) 13533 
24.8.11.3 Self-ubiquitination of RNF41 (Reaction) 13534 
24.8.11.4 Phosphorylation of USP8 by P-AKT (Reaction) 13535 
24.8.11.5 Ubiquitinated RNF41 binds P-USP8 (Reaction) 13537 
24.8.11.6 Deubiquitination of RNF41 by P-USP8 (Reaction) 13538 
24.8.11.7 RNF41 binds neuregulin-activated ERBB3 (Reaction) 13539 
24.8.11.8 RNF41 ubiquitinates activated ERBB3 (Reaction) 13540 
24.8.12 CHIP (STUB1) mediates ubiquitination of ERBB2 (Reaction) 13542 
24.8.13 CUL5 mediates ubiquitination of ERBB2 (Reaction) 13543 
24.8.14 MATK (CSK homologous kinase) binds phosphorylated ERBB2 (Reaction) 13544 
24.9 Signaling by ERBB4 (Pathway) 13546 
24.9.1 ERBB4 binds NRGs or EGF-like ligands (Reaction) 13552 
24.9.2 Homodimerization of ERBB4 (Reaction) 13554 
24.9.3 Trans-autophosphorylation of ERBB4 homodimers (Reaction) 13555 
24.9.4 ERBB4 forms heterodimers with EGFR (Reaction) 13556 
24.9.5 ERBB4 forms heterodimers with ERBB3 (Reaction) 13558 
24.9.6 SHC1 events in ERBB4 signaling (Pathway) 13559 
24.9.6.1 SHC1 binds P-ERBB4 isoform dimers (Reaction) 13560 
24.9.6.2 Phosphorylation of SHC1 by ERBB4 homodimers (Reaction) 13561 
24.9.6.3 Recruitment of GRB2:SOS1 to phosphorylated SHC1 in complex with 13562 phosphorylated ERBB4 homodimers (Reaction) 
24.9.6.4 RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and
13564 p-Y349,350-SHC1:p-ERBB4 (Reaction) 
24.9.6.5 RAF/MAP kinase cascade (Pathway) 13565 
24.9.6.5.1 RAF activation (Pathway) 13565 
24.9.6.5.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13565 
24.9.6.5.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13566 
24.9.6.5.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13566 
24.9.6.5.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13566 
24.9.6.5.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 13566 
24.9.6.5.2 MEK activation (Pathway) 13567 
24.9.6.5.2.1 Activated RAF1 complex binds MEK (Reaction) 13567 
24.9.6.5.2.2 RAF phosphorylates MEK (Pathway) 13567 
24.9.6.5.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13567 
24.9.6.5.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13568 
24.9.6.5.3 ERK activation (Pathway) 13568 
24.9.6.5.3.1 ERK1 activation (Pathway) 13568 24.9.6.5.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13568 
24.9.6.5.3.1.2 MEK1 binds ERK-1 (Reaction) 13569 
24.9.6.5.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13569 
24.9.6.5.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13569 
24.9.6.5.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13569 
24.9.6.5.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13570 
24.9.6.5.3.2 ERK2 activation (Pathway) 13570 
24.9.6.5.3.2.1 MEK2 binds ERK-2 (Reaction) 13570 
24.9.6.5.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13570 
24.9.6.5.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13571 
24.9.6.5.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13571 
24.9.6.5.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13571 
24.9.7 PI3K events in ERBB4 signaling (Pathway) 13571 
24.9.7.1 Binding of p85 subunit of PI3K (PIK3R1) to p-ERBB4cyt1 homodimers (Reaction)
13572 
24.9.7.2 Recruitment of PI3K subunit p110 (PIK3CA) to PI3K subunit p85 (PIK3R1) bound
13574 to p-ERBB4cyt1 homodimers (Reaction) 
24.9.7.3 Conversion of PIP2 into PIP3 by PI3K bound to p-ERBB4cyt1 homodimers 13575 (Reaction) 
24.9.7.4 PIP3 activates AKT signaling (Pathway) 13576 
24.9.7.4.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 13576 
24.9.7.4.2 PIP3 recruits AKT to the membrane (Reaction) 13577 
24.9.7.4.3 PIP3 recruits PDPK1 to the membrane (Reaction) 13577 
24.9.7.4.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13577 
24.9.7.4.5 AKT binds PDPK1 (Reaction) 13577 
24.9.7.4.6 PDPK1 phosphorylates AKT at T308 (Reaction) 13578 
24.9.7.4.7 AKT phosphorylates targets in the cytosol (Pathway) 13578 
24.9.7.4.7.1 AKT phosphorylates BAD (Reaction) 13578 
24.9.7.4.7.2 AKT phosphorylates GSK3 (Reaction) 13578 
24.9.7.4.7.3 AKT phosphorylates caspase-9 (Reaction) 13579 
24.9.7.4.7.4 AKT phosphorylates MDM2 (Reaction) 13579 
24.9.7.4.7.5 AKT phosphorylates IKKalpha (Reaction) 13579 
24.9.7.4.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 13579 
24.9.7.4.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 13580 
24.9.7.4.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 13580 
24.9.7.4.8 AKT translocates to the nucleus (Reaction) 13580 
24.9.7.4.9 AKT phosphorylates targets in the nucleus (Pathway) 13580 
24.9.7.4.9.1 AKT phosphorylates CREB1 (Reaction) 13581 
24.9.7.4.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 13581 
24.9.7.4.9.3 AKT can phosphorylate RSK (Reaction) 13581 
24.9.7.4.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 13581 
24.9.7.4.10 Negative regulation of the PI3K/AKT network (Pathway) 13582 
24.9.7.4.10.1 PTEN dephosphorylates PIP3 (Reaction) 13582 
24.9.7.4.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction) 13582 
24.9.7.4.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 13582 
24.9.7.4.11 PDPK1 binds PIP2 (Reaction) 13583 
24.9.7.4.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 13583 
24.9.7.4.13 PTEN mRNA translation negatively regulated by microRNAs (BlackBoxEvent)
13583 
24.9.8 Nuclear signaling by ERBB4 (Pathway) 13583 
24.9.8.1 Cleavage of P-ERBB4jmA isoforms by ADAM17 (Reaction) 13585 
24.9.8.2 Cleavage of ERBB4m80 by gamma-scretase complex (Reaction) 13586 
24.9.8.3 Translocation of ERBB4s80 to the nucleus (Reaction) 13588 
24.9.8.4 ERBB4s80 binds TAB2:NCOR1 complex (Reaction) 13589 
24.9.8.5 ERBB4:TAB2:NCOR1 complex translocates to the nucleus (Reaction) 13590 
24.9.8.6 Transcription of GFAP and S100B (BlackBoxEvent) 13592 
24.9.8.7 WWOX binds ERBB4s80 (Reaction) 13593 
24.9.8.8 ERBB4s80 binds YAP1 (Reaction) 13595 
24.9.8.9 Translocation of ERBB4s80:YAP1 complex to the nucleus (Reaction) 13596 
24.9.8.10 ERBB4s80 binds STAT5A (Reaction) 13598 
24.9.8.11 ERBB4s80:STAT5A complex translocates to the nucleus (Reaction) 13599 
24.9.8.12 Transcription of beta-casein (CSN2) (BlackBoxEvent) 13600 
24.9.8.13 ERBB4s80 forms a complex with estrogen receptor ESR1 (Reaction) 13602 
24.9.8.14 Transcription of NR3C3 and CXCL12 (BlackBoxEvent) 13603 
24.9.8.15 Translocation of cytosolic ERBB4s80 to mitochondrial matrix (Reaction) 13605 
24.9.8.16 Prolactin receptor signaling (Pathway) 13606 
24.9.8.16.1 PRLR associates with JAK2 (Reaction) 13606 
24.9.8.16.2 PRLR:JAK2 dimerizes (Reaction) 13606 
24.9.8.16.3 Prolactin receptor ligands bind the prolactin receptor (Reaction) 13607 
24.9.8.16.4 PRLR activation (BlackBoxEvent) 13607 
24.9.8.16.5 SH2B binds JAK2 (Reaction) 13607 
24.9.8.16.6 JAK2 phosphorylation (BlackBoxEvent) 13608 
24.9.8.16.7 Tyrosine phosphorylation of PRLR (BlackBoxEvent) 13608 
24.9.8.16.8 PRLR binds STAT5 (Reaction) 13608 
24.9.8.16.9 PRLR-bound STAT5 is phosphorylated (Reaction) 13609 
24.9.8.16.10 PRLR binds SHP2 (PTPN11) (Reaction) 13609 
24.9.8.16.11 SHP2 is phosphorylated (Reaction) 13609 
24.9.8.16.12 PRLR is phosphorylated at Ser-349 (BlackBoxEvent) 13610 
24.9.8.16.13 PRLR binds SCF beta-TrCP complex (Reaction) 13610 
24.9.8.16.14 Prolactin receptor is internalized (BlackBoxEvent) 13610 
24.9.9 Downregulation of ERBB4 signaling (Pathway) 13611 
24.9.9.1 ERBB4 binds WWP1/ITCH ubiquitin ligases (Reaction) 13612 
24.9.9.2 ERBB4 ubiquitination by WWP1/ITCH (Reaction) 13613 
24.9.9.3 NEDD4 binds ERBB4jmAcyt1s80 dimer (Reaction) 13614 
24.9.9.4 NEDD4 ubiquitinates ERBB4jmAcyt1s80 dimer (Reaction) 13615 
24.10 DAG and IP3 signaling (Pathway) 13617 
24.10.1 Active PLCG1 hydrolyses PIP2 (Reaction) 13617 
24.10.2 DAG stimulates protein kinase C-delta (Reaction) 13617 
24.10.3 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel13617 (Reaction) 
24.10.4 Release of calcium from intracellular stores by IP3 receptor activation (Reaction)13618 
24.10.5 CaM pathway (Pathway) 13618 
24.10.5.1 Calcium binds calmodulin (Reaction) 13618 
24.10.5.2 Calmodulin induced events (Pathway) 13618 
24.10.5.2.1 PKA-mediated phosphorylation of CREB (Pathway) 13619 
24.10.5.2.1.1 PKA activation (Pathway) 13619 
24.10.5.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 13619 
24.10.5.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers (Reaction) 13619 
24.10.5.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction) 13620 
24.10.5.2.1.3 PKA phosphorylates CREB (Reaction) 13620 
24.10.5.2.1.4 Dimerisation of CREB (Reaction) 13620 
24.10.5.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 13620 
24.10.5.2.2.1 Calmodulin binds CaMK IV (Reaction) 13621 
24.10.5.2.2.2 CamKIV enters the nucleus (Reaction) 13621 
24.10.5.2.2.3 CaMK IV autophosphorylation (Reaction) 13621 
24.10.5.2.2.4 CaMK IV phosphorylates CREB (Reaction) 13621 
24.10.5.2.2.5 Dimerisation of CREB (Reaction) 13622 
24.10.5.2.3 Cam-PDE 1 activation (Pathway) 13622 
24.10.5.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 13622 
24.10.5.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 13622 
24.10.5.2.4 Inhibition of GRK2 by calmodulin (Reaction) 13623 
24.10.5.2.5 PKC phosphorylates GRK2 (Reaction) 13623 
24.11 PIP3 activates AKT signaling (Pathway) 13623 
24.11.1 PI3K phosphorylates PIP2 to PIP3 (Reaction) 13623 
24.11.2 PIP3 recruits AKT to the membrane (Reaction) 13624 
24.11.3 PIP3 recruits PDPK1 to the membrane (Reaction) 13624 
24.11.4 TORC2 (mTOR) phosphorylates AKT at S473 (Reaction) 13624 
24.11.5 AKT binds PDPK1 (Reaction) 13624 
24.11.6 PDPK1 phosphorylates AKT at T308 (Reaction) 13625 
24.11.7 AKT phosphorylates targets in the cytosol (Pathway) 13625 
24.11.7.1 AKT phosphorylates BAD (Reaction) 13625 
24.11.7.2 AKT phosphorylates GSK3 (Reaction) 13625 
24.11.7.3 AKT phosphorylates caspase-9 (Reaction) 13626 
24.11.7.4 AKT phosphorylates MDM2 (Reaction) 13626 
24.11.7.5 AKT phosphorylates IKKalpha (Reaction) 13626 
24.11.7.6 AKT phosphorylates p21Cip1 and p27Kip1 (Reaction) 13626 
24.11.7.7 AKT phosphorylates TSC2, inhibiting it (Reaction) 13627 
24.11.7.8 AKT phosphorylates AKT1S1 (PRAS40) (Reaction) 13627 
24.11.8 AKT translocates to the nucleus (Reaction) 13627 
24.11.9 AKT phosphorylates targets in the nucleus (Pathway) 13627 
24.11.9.1 AKT phosphorylates CREB1 (Reaction) 13628 
24.11.9.2 AKT can phosphorylate forkhead box transcription factors (Reaction) 13628 
24.11.9.3 AKT can phosphorylate RSK (Reaction) 13628 
24.11.9.4 AKT can phosphorylate NR4A1 (NUR77) (Reaction) 13628 
24.11.10 Negative regulation of the PI3K/AKT network (Pathway) 13629 
24.11.10.1 PTEN dephosphorylates PIP3 (Reaction) 13629 
24.11.10.2 THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation (Reaction) 13629 24.11.10.3 PHLPP dephosphorylates S473 in AKT (Reaction) 13629 
24.11.11 PDPK1 binds PIP2 (Reaction) 13630 
24.11.12 MIR26A microRNAs bind PTEN mRNA (Reaction) 13630 
24.11.13 PTEN mRNA translation negatively regulated by microRNAs (BlackBoxEvent) 13630 
24.12 RAF/MAP kinase cascade (Pathway) 13631 
24.12.1 RAF activation (Pathway) 13631 
24.12.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 13631 
24.12.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 13631 
24.12.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 13632 
24.12.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 13632 
24.12.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 13632 
24.12.2 MEK activation (Pathway) 13632 
24.12.2.1 Activated RAF1 complex binds MEK (Reaction) 13633 
24.12.2.2 RAF phosphorylates MEK (Pathway) 13633 
24.12.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 13633 
24.12.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 13633 
24.12.3 ERK activation (Pathway) 13634 
24.12.3.1 ERK1 activation (Pathway) 13634 
24.12.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 13634 
24.12.3.1.2 MEK1 binds ERK-1 (Reaction) 13634 
24.12.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 13635 
24.12.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 13635 
24.12.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 13635 
24.12.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 13635 
24.12.3.2 ERK2 activation (Pathway) 13636 
24.12.3.2.1 MEK2 binds ERK-2 (Reaction) 13636 
24.12.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 13636 
24.12.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 13636 
24.12.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 13637 
24.12.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 13637 
24.13 Signaling by Rho GTPases (Pathway) 13637 
24.13.1 Rho GTPase cycle (Pathway) 13640 
24.13.1.1 GEFs activate Rho GTPase:GDP (Reaction) 13642 
24.13.1.2 Rho GTPase:GTP activates downstream effectors (Reaction) 13644 
24.13.1.3 GAPs inactivate Rho GTPase:GTP by hydrolysis (Reaction) 13646 
24.13.1.4 GDIs block activation of Rho GTPase:GDP (Reaction) 13648 
24.13.1.5 Dissociation of Rho GTP:GDP from GDI complex (Reaction) 13650 
24.14 Signaling by BMP (Pathway) 13651 
24.14.1 The ligand trap binds the ligand BMP2, blocking BMP signalling (Reaction) 13654 
24.14.2 Formation of a heteromeric BMP receptor complex (Reaction) 13655 
24.14.3 BMP2 binds to the receptor complex (Reaction) 13656 
24.14.4 Type II receptor phosphorylates type I receptor (Reaction) 13657 
24.14.5 An anchoring protein, Endofin, recruits R-Smad1/5/8 (Reaction) 13658 
24.14.6 Ubiquitin-dependent degradation controls basal levels of R-Smad1/5/8 13659 (BlackBoxEvent) 
24.14.7 I-Smad binds to type I receptor, preventing Smad1/5/8 from being activated 13661 (Reaction) 
24.14.8 Activated type I receptor phosphorylates R-Smad1/5/8 directly (Reaction) 13662 
24.14.9 Phospho-R-Smad1/5/8 dissociates from the receptor complex (Reaction) 13663 
24.14.10 I-Smad competes with Co-Smad for R-Smad1/5/8 (Reaction) 13665 
24.14.11 Phospho-R-Smad1/5/8 forms a complex with Co-Smad (Reaction) 13666 
24.14.12 The phospho-R-Smad1/5/8:Co-Smad transfers to the nucleus (Reaction) 13667 
24.14.13 Ubiquitin-dependent degradation of the Smad complex terminates BMP2 signalling
13669 (BlackBoxEvent) 
24.14.14 SKI complexes with the Smad complex, suppressing BMP2 signalling (Reaction)13670 
24.14.15 I-Smad competes with R-Smad1/5/8 for type I receptor (Reaction) 13672 
24.15 Signaling by TGF-beta Receptor Complex (Pathway) 13673 
24.15.1 TGF-beta receptor signaling activates SMADs (Pathway) 13673 
24.15.1.1 Latent TGF-beta-1 is cleaved by furin (Reaction) 13673 
24.15.1.2 Secretion and activation of the latent large complex of TGF-beta-1 (Reaction)13674 
24.15.1.3 Dimeric TGF-beta-1 binds to the receptor (Reaction) 13674 
24.15.1.4 TGFBR2 recruits TGFBR1 (Reaction) 13674 
24.15.1.5 TGFBR2 phosphorylates TGFBR1 (Reaction) 13675 
24.15.1.6 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 (Reaction) 13675 
24.15.1.7 Activated type I receptor phosphorylates SMAD2/3 directly (Reaction) 13675 
24.15.1.8 Phosphorylated SMAD2/3 dissociates from TGFBR (Reaction) 13676 
24.15.1.9 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 (Reaction)13676 
24.15.1.10 Downregulation of TGF-beta receptor signaling (Pathway) 13677 
24.15.1.10.1 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1) (Reaction)
13677 
24.15.1.10.2 STRAP binds phosphorylated TGF-beta receptor complex (Reaction) 13677 
24.15.1.10.3 STRAP stabilizes interaction of activated TGF-beta receptor complex with
13678 SMAD7 (Reaction) 
24.15.1.10.4 BAMBI interferes with the interaction of type I receptor with type II receptor
13678 (Reaction) 
24.15.1.10.5 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR (Reaction) 13679 
24.15.1.10.6 PP1 dephosphorylates TGFBR1 (Reaction) 13679 
24.15.1.10.7 SMAD7 binds to SMURF2 (Reaction) 13679 
24.15.1.10.8 SMAD7:SMURF2 complex translocates to the cytosol (Reaction) 13680 
24.15.1.10.9 SMAD7 binds to SMURF1 (Reaction) 13680 
24.15.1.10.10 SMAD7:SMURF1 complex binds XPO1 (CRM1) (Reaction) 13680 
24.15.1.10.11 SMAD7:SMURF1 complex is exported to the cytosol (Reaction) 13681 
24.15.1.10.12 NEDD4L ubiquitin ligase binds SMAD7 (Reaction) 13681 
24.15.1.10.13 SMAD7:NEDD4L complex translocates to the cytosol (Reaction) 13681 
24.15.1.10.14 SMAD7:SMURF complex binds to phosphorylated TGFBR1 (Reaction)13682 
24.15.1.10.15 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and SMAD7 13682 (Reaction) 
24.15.1.10.16 Degradation of TGF-beta receptor complex (BlackBoxEvent) 13682 
24.15.1.10.17 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1 (Reaction)13683 
24.15.1.10.18 UCHL5 or USP15 deubiquitinates TGFBR1 (Reaction) 13683 
24.15.1.10.19 SMURF2 binds SMAD2 (Reaction) 13684 24.15.1.10.20 SMURF2 ubiquitinates SMAD2 (Reaction) 13684 
24.15.1.10.21 Degradation of ubiquitinated SMAD2 (BlackBoxEvent) 13684 
24.15.1.10.22 SMAD3 binds STUB1 (CHIP) (Reaction) 13685 
24.15.1.10.23 STUB1 (CHIP) ubiquitinates SMAD3 (Reaction) 13685 
24.15.1.10.24 Degradation of ubiquitinated SMAD3 (BlackBoxEvent) 13685 
24.15.1.10.25 PMEPA1 sequesters phosphorylated SMAD2/3 (Reaction) 13686 
24.15.1.10.26 PMEPA1 sequesters unphosphorylated SMAD2/3 (Reaction) 13686 
24.15.1.10.27 MTMR4 binds phosphorylated SMAD2/3 (Reaction) 13686 
24.15.1.10.28 MTMR4 dephosphorylates SMAD2/3 (Reaction) 13687 
24.15.1.11 CBL binds TGFBR2 (Reaction) 13687 
24.15.1.12 CBL neddylates TGFBR2 (Reaction) 13687 
24.15.2 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) 13688 (Pathway) 
24.15.2.1 TGFBR1 is recruited to tight junctions by PARD6A (Reaction) 13688 
24.15.2.2 TGFBR2 is recruited to tight junctions after TGF-beta stimulation (Reaction) 13688 
24.15.2.3 TGFBR2 phosphorylates TGFBR1 and PARD6A (Reaction) 13689 
24.15.2.4 SMURF1 binds phosphorylated PARD6A (Reaction) 13689 
24.15.2.5 SMURF1 ubiquitinates RHOA (Reaction) 13689 
24.15.2.6 Disassembly of tight junctions (BlackBoxEvent) 13690 
24.15.3 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (Pathway) 13690 
24.15.3.1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (Pathway) 13690 
24.15.3.1.1 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 (Reaction)
13691 
24.15.3.1.2 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction) 13691 
24.15.3.1.3 Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or CDK913692 (Reaction) 
24.15.3.1.4 WWTR1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 13692 
24.15.3.1.5 WWTR1:SMAD translocates to the nucleus (Reaction) 13692 
24.15.3.1.6 WWTR1:SMAD stimulates transcription of SMAD7 (BlackBoxEvent) 13693 
24.15.3.1.7 WWTR1:SMAD stimulates transcription of SERPINE1 while TGIF:SMAD and
13693 SMAD7 inhibit it (BlackBoxEvent) 
24.15.3.1.8 RNF111 binds SMAD7 (Reaction) 13694 
24.15.3.1.9 RNF111 ubiquitinates SMAD7 (Reaction) 13694 
24.15.3.1.10 Degradation of Ub-SMAD7 (BlackBoxEvent) 13694 
24.15.3.1.11 SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5 and13695 DP1/2 (Reaction) 
24.15.3.1.12 MYC trancscription is negatively regulated by 13695 SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex (BlackBoxEvent) 
24.15.3.1.13 SMAD2/3:SMAD4 heterotrimer binds SP1 (Reaction) 13695 
24.15.3.1.14 SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B 13696 (BlackBoxEvent) 
24.15.3.1.15 MEN1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 13696 
24.15.3.1.16 SMAD2/3:SMAD4 complex positively regulates JUNB transcription 13696 (BlackBoxEvent) 
24.15.3.2 Downregulation of SMAD2/3:SMAD4 transcriptional activity (Pathway) 13697 
24.15.3.2.1 SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling (Reaction)
13697 24.15.3.2.2 SMAD2/3 activation induces binding of RNF111/SMURF2 to SKI/SKIL 13697 (Reaction) 
24.15.3.2.3 Ubiquitination of SKI/SKIL by RNF111/SMURF2 (Reaction) 13698 
24.15.3.2.4 Degradation of ubiquitinated SKI/SKIL (BlackBoxEvent) 13698 
24.15.3.2.5 TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus (Reaction)13698 
24.15.3.2.6 TRIM33 monoubiquitinates SMAD4 (Reaction) 13699 
24.15.3.2.7 Ubiquitinated SMAD4 translocates from the nucleus to the cytosol (Reaction)13699 
24.15.3.2.8 USP9X (FAM) binds to ubiquitinated SMAD4 (Reaction) 13699 
24.15.3.2.9 USP9X (FAM) deubiquitinates SMAD4 (Reaction) 13700 
24.15.3.2.10 NEDD4L binds phosphorylated linker region of SMAD2/3 (Reaction) 13700 
24.15.3.2.11 NEDD4L ubiquitinates SMAD2/3 (Reaction) 13700 
24.15.3.2.12 Degradation of SMAD2/3:SMAD4 complex (BlackBoxEvent) 13701 
24.15.3.2.13 SMURF2 binds SMAD3 phosphorylated in the linker region (Reaction) 13701 
24.15.3.2.14 SMURF2 monoubiquitinates SMAD3 (Reaction) 13701 
24.15.3.2.15 TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer (Reaction) 13702 
24.15.3.2.16 PARP1 binds SMAD2/3:SMAD4 heterotrimer (Reaction) 13702 
24.15.3.2.17 PARP1 ADP-ribosylates SMAD3 and SMAD4 (Reaction) 13702 
24.15.3.2.18 PPM1A protein phosphatase binds phosphorylated SMAD2/3 (Reaction)13703 
24.15.3.2.19 PPM1A dephosphorylates nuclear SMAD2/3 (Reaction) 13703 
24.15.3.2.20 Dephosphorylated SMAD2/3 translocates to the cytosol (Reaction) 13703 
24.15.3.2.21 Ubiquitin-dependent degradation of the SMAD complex terminates 13704 TGF-beta signaling (BlackBoxEvent) 
24.16 Signaling by NOTCH (Pathway) 13704 
24.16.1 Pre-NOTCH Expression and Processing (Pathway) 13707 
24.16.1.1 Pre-NOTCH Transcription and Translation (Pathway) 13712 
24.16.1.1.1 CCND1:CREBBP binds NOTCH1 promoter (Reaction) 13715 
24.16.1.1.2 E2F1/3:DP1/2 binds NOTCH1 promoter (Reaction) 13717 
24.16.1.1.3 NOTCH1 gene transcription (BlackBoxEvent) 13718 
24.16.1.1.4 NOTCH2 gene transcription (BlackBoxEvent) 13722 
24.16.1.1.5 NOTCH3 gene transcription (BlackBoxEvent) 13724 
24.16.1.1.6 NOTCH4 gene transcription (BlackBoxEvent) 13725 
24.16.1.1.7 TP53 binds promoters of MIR34 genes (Reaction) 13727 
24.16.1.1.8 p53 positively regulates transcription of MIR34 microRNAs (BlackBoxEvent)13729 
24.16.1.1.9 MIR34 microRNAs bind 3'UTR of NOTCH1 mRNA (Reaction) 13731 
24.16.1.1.10 MIR200B/C microRNAs bind NOTCH1 mRNA (Reaction) 13732 
24.16.1.1.11 MIR449 microRNAs bind 3'UTR of NOTCH1 mRNA (Reaction) 13734 
24.16.1.1.12 MIR34 microRNAs bind 3'UTR of NOTCH2 mRNA (Reaction) 13735 
24.16.1.1.13 MIR150 microRNA binds 3'UTR of NOTCH3 mRNA (Reaction) 13736 
24.16.1.1.14 MIR206 microRNA binds 3'UTR of NOTCH3 mRNA (Reaction) 13737 
24.16.1.1.15 MIR181C microRNA binds 3'UTR of NOTCH4 mRNA (Reaction) 13738 
24.16.1.1.16 MIR302A microRNA binds 3'UTR of NOTCH4 mRNA (Reaction) 13739 
24.16.1.1.17 NOTCH1 mRNA translation controlled by miRNAs (BlackBoxEvent) 13741 
24.16.1.1.18 NOTCH2 mRNA translation controlled by miRNAs (BlackBoxEvent) 13743 
24.16.1.1.19 NOTCH3 mRNA translation controlled by miRNAs (BlackBoxEvent) 13744 
24.16.1.1.20 NOTCH4 mRNA translation controlled by miRNAs (BlackBoxEvent) 13746 
24.16.1.2 Pre-NOTCH Processing in the Endoplasmic Reticulum (Pathway) 13747 
24.16.1.2.1 Fucosylation of Pre-NOTCH by POFUT1 (Reaction) 13749 
24.16.1.2.2 Glucosylation of Pre-NOTCH by POGLUT1 (Reaction) 13752 
24.16.1.3 Pre-NOTCH Processing in Golgi (Pathway) 13754 
24.16.1.3.1 Transport of NOTCH precursor to Golgi (BlackBoxEvent) 13757 
24.16.1.3.2 NOTCH precursor cleaved to form mature NOTCH (Reaction) 13760 
24.16.1.3.3 Glycosylation of Pre-NOTCH by FRINGE (Reaction) 13762 
24.16.1.3.4 Galactosylation of Pre-NOTCH (Reaction) 13765 
24.16.1.3.5 Sialylation of Pre-NOTCH (Reaction) 13767 
24.16.1.3.6 Fringe-modified Pre-NOTCH is cleaved by FURIN (Reaction) 13769 
24.16.1.3.7 Mature NOTCH heterodimer traffics to the plasma membrane 13770 (BlackBoxEvent) 
24.16.1.3.8 Transport of fringe-modified NOTCH to plasma membrane (BlackBoxEvent)13772 
24.16.2 Signaling by NOTCH1 (Pathway) 13773 
24.16.2.1 Activated NOTCH1 Transmits Signal to the Nucleus (Pathway) 13780 
24.16.2.1.1 NOTCH1 binds DLL1 (Reaction) 13785 
24.16.2.1.2 NOTCH1 binds DLL4 (Reaction) 13787 
24.16.2.1.3 NOTCH1 binds JAG1 (Reaction) 13789 
24.16.2.1.4 NOTCH1 binds JAG2 (Reaction) 13790 
24.16.2.1.5 Ubiquitination of DLL/JAG ligands upon binding to NOTCH1 (Reaction) 13792 
24.16.2.1.6 Complex of NOTCH1 with its ligand is cleaved to produce NEXT1 (Reaction)
13794 
24.16.2.1.7 NEXT1 is cleaved to produce NICD1 (Reaction) 13797 
24.16.2.1.8 NICD1 traffics to nucleus (Reaction) 13799 
24.16.2.1.9 DTX binds NOTCH1 (Reaction) 13801 
24.16.2.1.10 Contactin-1 (CNTN1) binds NOTCH1 (Reaction) 13803 
24.16.2.1.11 Cleavage of CNTN1:NOTCH1 complex releases NICD1 (BlackBoxEvent)13805 
24.16.2.1.12 NOTCH1 binds DNER (Reaction) 13807 
24.16.2.1.13 Cleavage of DNER:NOTCH1 complex releases NICD1 (BlackBoxEvent)13809 
24.16.2.1.14 DTX recruits beta-arrestin (ARRB) to NOTCH (Reaction) 13811 
24.16.2.1.15 ARRB mediates NOTCH1 ubiquitination (BlackBoxEvent) 13813 
24.16.2.1.16 ITCH binds DTX (Reaction) 13814 
24.16.2.1.17 ITCH ubiquitinates DTX (Reaction) 13816 
24.16.2.1.18 NOTCH1 binds DLL/JAG ligand in cis (Reaction) 13817 
24.16.2.1.19 NOTCH1 binds DLK1 (Reaction) 13819 
24.16.2.1.20 NOTCH1 associates with negative regulators NUMB and ITCH (Reaction)
13821 
24.16.2.1.21 Ubiquitination of NOTCH1 by ITCH in the absence of ligand (Reaction) 13823 
24.16.2.2 NOTCH1 Intracellular Domain Regulates Transcription (Pathway) 13825 
24.16.2.2.1 NICD1 displaces co-repressor complex from RBPJ (CSL) (Reaction) 13828 
24.16.2.2.2 NICD1 in complex with RBPJ (CSL) recruits MAML (Reaction) 13831 
24.16.2.2.3 NOTCH1 Coactivator Complex binds HES1 promoter (Reaction) 13833 
24.16.2.2.4 NOTCH1 stimulates HES1 transcription (BlackBoxEvent) 13834 
24.16.2.2.5 HES1 binds TLE (Reaction) 13836 
24.16.2.2.6 NOTCH1 Coactivator Complex binds MYC promoter (Reaction) 13838 
24.16.2.2.7 NOTCH1 stimulates MYC transcription (BlackBoxEvent) 13839 
24.16.2.2.8 NOTCH1 Coactivator Complex binds HES5 promoter (Reaction) 13840 24.16.2.2.9 NOTCH1 stimulates HES5 transcription (BlackBoxEvent) 13841 
24.16.2.2.10 NOTCH1 Coactivator Complex binds promoters of HEY genes (Reaction)13843 
24.16.2.2.11 NOTCH1 stimulates HEY transcription (BlackBoxEvent) 13845 
24.16.2.2.12 MAML in complex with NICD1 recruits CDK8 (Reaction) 13847 
24.16.2.2.13 NICD1 is phosphorylated by CDK8 (Reaction) 13849 
24.16.2.2.14 Phosphorylated NICD1 binds FBXW7 (Reaction) 13850 
24.16.2.2.15 Ubiquitination of NICD1 by FBWX7 (Reaction) 13852 
24.16.2.2.16 NICD1 binds HIF1A (Reaction) 13854 
24.16.3 Signaling by NOTCH2 (Pathway) 13856 
24.16.3.1 NOTCH2 Activation and Transmission of Signal to the Nucleus (Pathway) 13861 
24.16.3.1.1 DLL1 binds NOTCH2 (Reaction) 13863 
24.16.3.1.2 JAG1 binds NOTCH2 (Reaction) 13865 
24.16.3.1.3 JAG2 binds NOTCH2 (Reaction) 13867 
24.16.3.1.4 DLL4 binds NOTCH2 (Reaction) 13869 
24.16.3.1.5 Ubiquitination of DLL/JAG ligands upon binding to NOTCH2 (Reaction) 13870 
24.16.3.1.6 NOTCH2-ligand complex is cleaved to produce NEXT2 (Reaction) 13874 
24.16.3.1.7 NEXT2 is cleaved to produce NICD2 (Reaction) 13876 
24.16.3.1.8 NICD2 traffics to the nucleus (Reaction) 13878 
24.16.3.1.9 NOTCH2 binds CNTN1 (Reaction) 13879 
24.16.3.1.10 Gamma-secretase cleaves CNTN1:NOTCH2 to release NICD2 13881 (BlackBoxEvent) 
24.16.3.1.11 NOTCH2 binds MDK (Reaction) 13884 
24.16.3.2 NOTCH2 intracellular domain regulates transcription (Pathway) 13885 
24.16.3.2.1 NICD2 binds RBPJ and MAML in the nucleus (Reaction) 13888 
24.16.3.2.2 NOTCH2 coactivator complex binds HES1 promoter (Reaction) 13889 
24.16.3.2.3 NOTCH2 stimulates HES1 transcription (BlackBoxEvent) 13891 
24.16.3.2.4 NOTCH2 coactivator complex binds HES5 promoter (Reaction) 13893 
24.16.3.2.5 NOTCH2 stimulates transcription of HES5 (BlackBoxEvent) 13894 
24.16.3.2.6 NOTCH2 coactivator complex binds FCER2 promoter (Reaction) 13896 
24.16.3.2.7 NOTCH2 stimulates transcription of FCER2 (CD23A) (BlackBoxEvent) 13897 
24.16.3.2.8 NOTCH2 coactivator complex and phosphorylated CREB1 bind GZMB 13899 promoter (Reaction) 
24.16.3.2.9 NOTCH2 stimulates GZMB transcription (BlackBoxEvent) 13901 
24.16.4 Signaling by NOTCH3 (Pathway) 13903 
24.16.4.1 Notch 3 heterodimer binds with a Notch ligand in the extracellular space 13905 (Reaction) 
24.16.4.2 Notch 3-ligand complex is cleaved to produce NEXT3 (Reaction) 13906 
24.16.4.3 NEXT3 is cleaved to produce NICD3 (Reaction) 13907 
24.16.4.4 NICD3 traffics to the nucleus (Reaction) 13908 
24.16.5 Signaling by NOTCH4 (Pathway) 13909 
24.16.5.1 Notch 4 heterodimer binds with a Notch ligand in the extracellular space 13911 (Reaction) 
24.16.5.2 Notch 4-ligand complex is cleaved to produce NEXT4 (Reaction) 13912 
24.16.5.3 NEXT4 is cleaved to produce NICD4 (Reaction) 13913 
24.16.5.4 NICD4 traffics to the nucleus (Reaction) 13914 
24.17 Signaling by GPCR (Pathway) 13915 
24.17.1 GPCR ligand binding (Pathway) 13917 
24.17.1.1 Class A/1 (Rhodopsin-like receptors) (Pathway) 13918 
24.17.1.1.1 Peptide ligand-binding receptors (Pathway) 13919 
24.17.1.1.1.1 Angiotensin II binds to angiotensin II receptor (types 1 and 2) (Reaction)
13921 
24.17.1.1.1.2 Apelin receptor binds to apelin (Reaction) 13922 
24.17.1.1.1.3 Bombesin-like receptors bind bombesin homologues (Reaction) 13924 
24.17.1.1.1.4 Bradykinin receptors B1 and B2 bind to bradykinin (Reaction) 13925 
24.17.1.1.1.5 GPR77 binds anaphylatoxins and thier desArginated derivatives 13927 (Reaction) 
24.17.1.1.1.6 C5a receptor binds C5a anaphylatoxin (Reaction) 13928 
24.17.1.1.1.7 C3a receptor binds anaphylatoxin C3a (Reaction) 13929 
24.17.1.1.1.8 DARC is a non-specific receptor for many chemokines (Reaction) 13931 
24.17.1.1.1.9 G protein-coupled estrogen receptor 1 binds estrogen non-classically 13932 (Reaction) 
24.17.1.1.1.10 GPCR neuropeptide receptor binds neuropeptides B and W (Reaction)13933 
24.17.1.1.1.11 Nociceptin receptor binds to nociceptin (Reaction) 13935 
24.17.1.1.1.12 Opioid receptors bind opioid peptides (Reaction) 13936 
24.17.1.1.1.13 Chemokine receptors bind chemokines (Pathway) 13939 
24.17.1.1.1.13.1 Receptor CCR10 binds CCL27 and 28 ligands (Reaction) 13939 
24.17.1.1.1.13.2 Receptor CCR6 binds CCL20 ligand (Reaction) 13941 
24.17.1.1.1.13.3 Receptor CCR7 binds CCL19 and 21 ligands (Reaction) 13942 
24.17.1.1.1.13.4 Receptor CCR9 binds CCL25 ligand (Reaction) 13944 
24.17.1.1.1.13.5 Receptor CX3C1 binds CX3CL1 (Reaction) 13945 
24.17.1.1.1.13.6 Receptor CXC1 binds to the ligands lymphotactin and cytokine SCM-1
13946 beta (Reaction) 
24.17.1.1.1.13.7 Receptor CXCR1 binds CXCL6 and CXCL8 ligands (Reaction) 13948 
24.17.1.1.1.13.8 Receptor CXCR2 binds ligands CXCL1 to 7 (Reaction) 13949 
24.17.1.1.1.13.9 Receptor CXCR3 binds ligands CXCL9 to 11 (Reaction) 13951 
24.17.1.1.1.13.10 Receptors CXCR4 and 7 bind CXCL12 ligand (Reaction) 13953 
24.17.1.1.1.13.11 CXCR5 binds CXCL13 (Reaction) 13955 
24.17.1.1.1.13.12 Receptor CXCR6 binds CXCL16 ligand (Reaction) 13956 
24.17.1.1.1.13.13 Receptors CCR1, 2 and 8 bind CCL16 ligand (Reaction) 13957 
24.17.1.1.1.13.14 Receptors CCR3, 4 and 5 bind CCL5 ligand (Reaction) 13959 
24.17.1.1.1.13.15 Receptor CCBP2 binds most inflammatory CC chemokines 13960 (Reaction) 
24.17.1.1.1.13.16 Receptor CCR11 binds CCL19, CCL21 & CCL25 (Reaction) 13961 
24.17.1.1.1.13.17 CCRL2 binds CCL19 (Reaction) 13962 
24.17.1.1.1.14 Somatostatin receptors bind somatostatin (Reaction) 13964 
24.17.1.1.1.15 Tachykinin receptors bind tachykinins (Pathway) 13965 
24.17.1.1.1.15.1 Tachykinin receptor 1 (NK1) binds to substance P (Reaction) 13967 
24.17.1.1.1.15.2 Tachykinin receptor 2 (NK2) binds to nuerokinin A (Reaction) 13968 
24.17.1.1.1.15.3 Tachykinin receptor 3 (NK3) binds to neurokinin B (Reaction) 13969 
24.17.1.1.1.16 Vasopressin-like receptors (Pathway) 13971 
24.17.1.1.1.16.1 Vasopressin receptor type 1 bind vasopressin (Reaction) 13972 
24.17.1.1.1.16.2 Vasopressin receptor type 2 bind vasopressin (Reaction) 13973 
24.17.1.1.1.16.3 Oxytocin receptor bind oxytocin (Reaction) 13975 
24.17.1.1.1.17 Cholecystokinin receptors bind cholecystokinin (Reaction) 13976 
24.17.1.1.1.18 Endothelin receptors bind endothelin (Reaction) 13978 
24.17.1.1.1.19 Melanocortin receptors bind melanocortins (Reaction) 13979 
24.17.1.1.1.20 ACTH specifically binds with melanocortin receptor 2 (Reaction) 13980 
24.17.1.1.1.21 Prolactin-releasing hormone receptor binds PRH (Reaction) 13982 
24.17.1.1.1.22 Neuropeptide Y receptors can bind neuropeptide Y-related peptides 13983 (Reaction) 
24.17.1.1.1.23 Neurotensin receptors can bind neurotensins (Reaction) 13985 

24.17.1.1.1.24 Galanin receptors can bind galanin (Reaction) 13986 
24.17.1.1.1.25 The Kiss receptor GPR54 binds kisspeptin (Reaction) 13988 
24.17.1.1.1.26 Proteinase-activated receptors can bind thrombin (Reaction) 13990 
24.17.1.1.1.27 Orexin and neuropeptides FF and QRFP bind to their respective 13991 receptors (Pathway) 
24.17.1.1.1.27.1 Orexin 1 receptor can bind orexin-A neuropeptide (Reaction) 13992 
24.17.1.1.1.27.2 Orexin 2 receptor can bind orexin-B neuropeptide (Reaction) 13994 
24.17.1.1.1.27.3 Two NPFF receptors can bind neuropeptide FF (Reaction) 13995 
24.17.1.1.1.27.4 The orphan QRFP receptor can bind neuropeptide QRFP (Reaction)
13997 
24.17.1.1.1.28 MLNR (GPR38) is a receptor for motilin (Reaction) 13998 
24.17.1.1.1.29 Formyl peptide receptors bind formyl peptides and many other ligands14000 (Pathway) 
24.17.1.1.1.29.1 FPR is a receptor for formyl peptides (Reaction) 14001 
24.17.1.1.1.29.2 FPRL1 receptor binds a wide range of ligands (Reaction) 14002 
24.17.1.1.1.29.3 FPRL2 receptor binds a wide range of ligands (Reaction) 14004 
24.17.1.1.1.30 Thyrotropin-releasing hormone receptor binds thyrotropin (Reaction) 14005 
24.17.1.1.1.31 Neuropeptide S receptor binds neuropeptide S (Reaction) 14006 
24.17.1.1.1.32 Prokineticin receptors bind prokineticin (Reaction) 14008 
24.17.1.1.1.33 Relaxin receptors (Pathway) 14009 
24.17.1.1.1.33.1 Relaxin receptor 1 binds relaxin 2 and 3 (Reaction) 14011 
24.17.1.1.1.33.2 Relaxin receptor 2 binds relaxin 2 and INSL3 (Reaction) 14012 
24.17.1.1.1.33.3 Relaxin 3 receptor 1 binds relaxin 3 (Reaction) 14014 
24.17.1.1.1.33.4 Relaxin 3 receptor 2 binds relaxin 3 and INSL5 (Reaction) 14015 
24.17.1.1.1.34 Urotensin-2 receptor binds urotensin-2 and 2B (Reaction) 14016 
24.17.1.1.1.35 GHSR is a receptor for ghrelin (Reaction) 14018 
24.17.1.1.1.36 Melanin-concentrating hormone receptors bind MCH (Reaction) 14020 
24.17.1.1.1.37 Neuromedin-U receptors bind neuromedins U, S (Reaction) 14021 
24.17.1.1.1.38 NMUR2 binds neuromedin-S (Reaction) 14023 
24.17.1.1.1.39 GPR37 binds prosaptide (Reaction) 14024 
24.17.1.1.1.40 GPR37L binds prosaposin (Reaction) 14025 
24.17.1.1.2 Amine ligand-binding receptors (Pathway) 14026 
24.17.1.1.2.1 Muscarinic acetylcholine receptors (Pathway) 14028 
24.17.1.1.2.1.1 M2 and M4 receptors bind acetylcholine (Reaction) 14029 
24.17.1.1.2.1.2 M1, M3 and M5 receptors bind acetylcholine (Reaction) 14030 
24.17.1.1.2.2 Adrenoceptors (Pathway) 14032 24.17.1.1.2.2.1 Alpha-1 adrenoceptors bind catecholamines (Reaction) 14033 
24.17.1.1.2.2.2 Alpha-2 adrenoceptors bind catecholamines (Reaction) 14034 
24.17.1.1.2.2.3 Beta adrenoceptors bind catecholamines (Reaction) 14034 
24.17.1.1.2.3 Dopamine receptors (Pathway) 14036 
24.17.1.1.2.3.1 D1-like dopamine receptors bind to dopamine (Reaction) 14037 
24.17.1.1.2.3.2 D2-like dopamine receptors bind to dopamine (Reaction) 14038 
24.17.1.1.2.4 Histamine receptors (Pathway) 14040 
24.17.1.1.2.4.1 H1 receptor binds histamine (Reaction) 14041 
24.17.1.1.2.4.2 H2 receptor binds histamine (Reaction) 14042 
24.17.1.1.2.4.3 H3 and H4 receptors binds histamine (Reaction) 14043 
24.17.1.1.2.5 Serotonin receptors (Pathway) 14045 
24.17.1.1.2.5.1 5-HT1 and 5A receptors can bind serotonin (Reaction) 14046 
24.17.1.1.2.5.2 5-HT2 receptor can bind serotonin (Reaction) 14048 
24.17.1.1.2.5.3 5-HT4, 6 and 7 receptors can bind serotonin (Reaction) 14049 
24.17.1.1.2.6 Trace amine-associated receptors can bind trace amines (Reaction) 14051 
24.17.1.1.3 Hormone ligand-binding receptors (Pathway) 14053 
24.17.1.1.3.1 Follicle-stimulating hormone receptor can bind FSH (Reaction) 14054 
24.17.1.1.3.2 Gonadotropin-releasing hormone receptors can bind GNRH I and II 14055 (Reaction) 
24.17.1.1.3.3 Luteinizing hormone receptor can bind LH (Reaction) 14057 
24.17.1.1.3.4 Thyroid-stimulating hormone receptor can bind TSH (Reaction) 14058 
24.17.1.1.4 Eicosanoid ligand-binding receptors (Pathway) 14059 
24.17.1.1.4.1 Prostanoid ligand receptors (Pathway) 14061 
24.17.1.1.4.1.1 EP1 receptor can bind PGE2 (Reaction) 14062 
24.17.1.1.4.1.2 EP2 and EP4 receptors can bind PGE2 (Reaction) 14063 
24.17.1.1.4.1.3 EP3 receptor can bind PGE2 (Reaction) 14065 
24.17.1.1.4.1.4 FP receptor can bind PGF2-alpha (Reaction) 14066 
24.17.1.1.4.1.5 IP receptor can bind prostacyclin (Reaction) 14067 
24.17.1.1.4.1.6 TP receptor can bind thromboxane (Reaction) 14069 
24.17.1.1.4.1.7 DP1 receptor can bind PGD2 (Reaction) 14069 
24.17.1.1.4.1.8 DP2 receptor can bind PGD2 (Reaction) 14070 
24.17.1.1.4.2 Leukotriene receptors (Pathway) 14072 
24.17.1.1.4.2.1 BLT receptors can bind LTB4 (Reaction) 14073 
24.17.1.1.4.2.2 CysLT receptors can bind cysteinyl leukotrienes (Reaction) 14074 
24.17.1.1.4.2.3 UDP/CysLT receptor can bind cysteinyl leukotrienes (Reaction) 14076 
24.17.1.1.4.3 Oxoeicosanoid receptor can bind oxoeicosanoid (Reaction) 14077 
24.17.1.1.5 Nucleotide-like (purinergic) receptors (Pathway) 14078 
24.17.1.1.5.1 P2Y receptors (Pathway) 14080 
24.17.1.1.5.1.1 P2Y1 receptor can bind to ADP (Reaction) 14081 
24.17.1.1.5.1.2 P2Y2 receptor binds ATP and UTP (Reaction) 14082 
24.17.1.1.5.1.3 P2Y4 receptor can bind to UTP (Reaction) 14083 
24.17.1.1.5.1.4 P2Y5 receptor can bind to LPA (Reaction) 14084 
24.17.1.1.5.1.5 P2Y6 receptor can bind to UDP (Reaction) 14086 
24.17.1.1.5.1.6 P2Y9 receptor can bind to LPA (Reaction) 14087 
24.17.1.1.5.1.7 P2Y10 receptor can bind to LPA (Reaction) 14088 
24.17.1.1.5.1.8 P2Y11 receptor can bind to ATP (Reaction) 14090 
24.17.1.1.5.1.9 P2Y12 receptor can bind to ADP (Reaction) 14091 
24.17.1.1.5.1.10 P2Y13 receptor can bind ADP (Reaction) 14092 
24.17.1.1.5.1.11 P2Y14 receptor can bind to UDP-glucose (Reaction) 14093 
24.17.1.1.5.1.12 The UDP/CysLT (P2Y17) receptor can bind UTP (Reaction) 14095 
24.17.1.1.5.2 Adenosine P1 receptors (Pathway) 14096 
24.17.1.1.5.2.1 A1 and A3 receptors bind adenosine (Reaction) 14097 
24.17.1.1.5.2.2 A2a and A2b receptors bind adenosine (Reaction) 14098 
24.17.1.1.6 Hydroxycarboxylic acid-binding receptors (Pathway) 14100 
24.17.1.1.6.1 HCAR2 binds HCAR2 ligands (Reaction) 14101 
24.17.1.1.6.2 HCAR1 binds LACT (Reaction) 14102 
24.17.1.1.6.3 HCAR3 binds HCAR3 ligands (Reaction) 14103 
24.17.1.1.7 Cannabinoid receptors can bind cannabinoids (Reaction) 14105 
24.17.1.1.8 PAF receptor binds platelet activating factor (Reaction) 14107 
24.17.1.1.9 Melatonin receptors can bind melatonin (Reaction) 14108 
24.17.1.1.10 Lysosphingolipid and LPA receptors (Pathway) 14109 
24.17.1.1.10.1 LPA-binding receptors bind LPA (Reaction) 14111 
24.17.1.1.10.2 S1P-binding receptors bind S1P (Reaction) 14112 
24.17.1.1.11 Opsins (Pathway) 14115 
24.17.1.1.11.1 Light stimulates opsin receptors (Reaction) 14116 
24.17.1.1.11.2 Melanospin is stimulated by light (Reaction) 14119 
24.17.1.1.12 Free fatty acid receptors (Pathway) 14120 
24.17.1.1.12.1 Receptor FFAR1 binds free fatty acids (Reaction) 14121 
24.17.1.1.12.2 Receptor FFAR2 binds carboxylates (Reaction) 14122 
24.17.1.1.12.3 Receptor FFAR3 binds carboxylates (Reaction) 14124 
24.17.1.1.12.4 GPR120 is a receptor for unsaturated long-chain free fatty acids 14125 (Reaction) 
24.17.1.1.12.5 GPR31 is a receptor for 12(S)-HETE (Reaction) 14127 
24.17.1.1.13 GPR4, GPR65, GPR132 and OGR1 are pH sensing receptors (Reaction)14128 
24.17.1.1.14 HCAR2 binds HCAR2 ligands (Reaction) 14130 
24.17.1.1.15 G-protein coupled bile acid receptor binds lithocholic acid (Reaction) 14130 
24.17.1.1.16 N-arachidonyl glycine receptor GPR18 binds N-arachidonyl glycine 14131 (Reaction) 
24.17.1.1.17 Zinc is an agonist of GPR39 (Reaction) 14132 
24.17.1.1.18 OXGR1 binds 2OG (Reaction) 14133 
24.17.1.1.19 SUCNR1 binds SUCCA (Reaction) 14134 
24.17.1.2 Class B/2 (Secretin family receptors) (Pathway) 14136 
24.17.1.2.1 Calcitonin-like ligand receptors (Pathway) 14137 
24.17.1.2.1.1 Calcitonin receptor binds calcitonin (Reaction) 14138 
24.17.1.2.1.2 Amylin receptors can bind Amylin (Reaction) 14140 
24.17.1.2.1.3 CGRP receptor can bind calcitonin gene-related peptides (Reaction) 14141 
24.17.1.2.1.4 The adrenomedullin receptor can bind adrenomedullin and intermedin 14143 (Reaction) 
24.17.1.2.2 Corticotropin-releasing hormone receptor can bind CRH (Reaction) 14144 
24.17.1.2.3 Glucagon-type ligand receptors (Pathway) 14146 
24.17.1.2.3.1 GIP receptor binds gastric inhibitory peptide (Reaction) 14147 
24.17.1.2.3.2 Glucagon binds to Glucagon receptor (Reaction) 14148 
24.17.1.2.3.3 Glucagon-like Peptide-1 Receptor (GLP1R) binds Glucagon-like peptide-1
14149 (Reaction) 
24.17.1.2.3.4 Glucagon-like receptor 2 binds GLP2 (Reaction) 14149 
24.17.1.2.3.5 GHRH receptor binds GHRH (Reaction) 14151 
24.17.1.2.3.6 The PACAP receptor binds PACAP (Reaction) 14152 
24.17.1.2.3.7 Secretin receptor binds secretin (Reaction) 14154 
24.17.1.2.4 Parathyroid hormone receptor can bind parathyroid hormone (Reaction) 14155 
24.17.1.2.5 Patched binds Smoothened (Reaction) 14157 
24.17.1.2.6 Frizzled receptors bind Wnts (Reaction) 14161 
24.17.1.2.7 EGF-TM7 receptors bind chondroitin sulphate (Reaction) 14164 
24.17.1.2.8 CD97 binds CD55 (Reaction) 14165 
24.17.1.3 Class C/3 (Metabotropic glutamate/pheromone receptors) (Pathway) 14167 
24.17.1.3.1 Metabotropic glutamate receptors bind glutamate (Reaction) 14168 
24.17.1.3.2 Calcium-sensing receptor binds calcium (Reaction) 14170 
24.17.1.3.3 GPRC6A can bind L-alpha amino acids and calcium (Reaction) 14171 
24.17.1.3.4 GABAB heterodimeric receptor binds GABA (Reaction) 14172 
24.17.1.3.5 T1R1/T1R3 dimer is the umami taste receptor (Reaction) 14173 
24.17.1.3.6 T1R2/T1R3 dimer is a sweet taste receptor (Reaction) 14174 
24.17.1.3.7 T2Rs bind bitter-tasting compounds (Reaction) 14175 
24.17.2 GPCR downstream signaling (Pathway) 14177 
24.17.2.1 G alpha (s) signalling events (Pathway) 14178 
24.17.2.1.1 Liganded Gs-activating GPCRs bind inactive heterotrimeric Gs (Reaction)14179 
24.17.2.1.2 Liganded Gs-activating GPCR acts as a GEF for Gs (Reaction) 14182 
24.17.2.1.3 The Ligand:GPCR:Gs complex dissociates (Reaction) 14183 
24.17.2.1.4 G alpha (s) activates adenylate cyclase (Reaction) 14185 
24.17.2.1.5 Adenylate cyclase converts ATP to 3',5'-cyclic AMP (cAMP) and 14185 pyrophosphate (Reaction) 
24.17.2.1.6 cAMP degradation by Phosphodiesterases (Reaction) 14187 
24.17.2.1.7 G alpha (s) auto-inactivates by hydrolysing GTP to GDP (Reaction) 14189 
24.17.2.1.8 Inactive G alpha (s) reassociates with G beta:gamma (Reaction) 14190 
24.17.2.2 G alpha (i) signalling events (Pathway) 14191 
24.17.2.2.1 Liganded Gi-activating GPCRs bind inactive heterotrimeric G-protein Gi 14192 (Reaction) 
24.17.2.2.2 Liganded Gi-activating GPCR acts as a GEF for Gi (Reaction) 14195 
24.17.2.2.3 The Ligand:GPCR:Gi complex dissociates (Reaction) 14196 
24.17.2.2.4 G alpha (i) inhibits adenylate cyclase (Reaction) 14198 
24.17.2.2.5 Adenylate cyclase converts ATP to 3',5'-cyclic AMP (cAMP) and 14198 pyrophosphate (Reaction) 
24.17.2.2.6 Opsins that act as GEFs for G alpha-t (Reaction) 14198 
24.17.2.2.7 G alpha (i) auto-inactivates by hydrolysing GTP to GDP (Reaction) 14200 
24.17.2.2.8 Inactive G alpha (i) reassociates with G beta:gamma (Reaction) 14202 
24.17.2.3 G alpha (z) signalling events (Pathway) 14203 
24.17.2.3.1 Liganded Gz-activating GPCRs bind inactive heterotrimeric G-protein Gz (Reaction) 
24.17.2.3.2 Liganded Gz-activating GPCR acts as a GEF for Gz (Reaction) 14206 
24.17.2.3.3 The Ligand:GPCR:Gz complex dissociates (Reaction) 14207 
24.17.2.3.4 G alpha (z) inhibits adenylate cyclase (Reaction) 14209 
24.17.2.3.5 Adenylate cyclase converts ATP to 3',5'-cyclic AMP (cAMP) and 14210 pyrophosphate (Reaction) 
24.17.2.3.6 Gz is a substrate for PKC (Reaction) 14210 
24.17.2.3.7 G alpha (z) auto-inactivates by hydrolysing GTP to GDP (Reaction) 14213 
24.17.2.3.8 Inactive G alpha (z) reassociates with G beta:gamma (Reaction) 14215 
24.17.2.4 G alpha (q) signalling events (Pathway) 14216 
24.17.2.4.1 Liganded Gq-activating GPCRs bind inactive heterotrimeric Gq (Reaction)14217 
24.17.2.4.2 Liganded Gq/11-activating GPCRs act as GEFs for Gq/11 (Reaction) 14219 
24.17.2.4.3 The Ligand:GPCR:Gq complex dissociates (Reaction) 14221 
24.17.2.4.4 GRK2 sequesters activated Gq (Reaction) 14222 
24.17.2.4.5 GRK5 sequesters activated Gq (Reaction) 14224 
24.17.2.4.6 G alpha (q) binds to Trio family RhoGEFs (Reaction) 14226 
24.17.2.4.7 PLC beta is activated by G alpha (q) (Reaction) 14227 
24.17.2.4.8 G alpha (q) inhibits PI3K alpha (Reaction) 14230 
24.17.2.4.9 PLC beta-mediated PIP2 hydrolysis (Reaction) 14231 
24.17.2.4.10 Effects of PIP2 hydrolysis (Pathway) 14233 
24.17.2.4.10.1 Binding of IP3 to IP3 receptor (Reaction) 14233 
24.17.2.4.10.2 Transport of Ca++ from platelet dense tubular system to cytoplasm 14234 (Reaction) 
24.17.2.4.10.3 Calcium and Diacylglycerol activate CalDAG-GEFs (RasGRPs) 14234 (Reaction) 
24.17.2.4.10.4 Activation of Protein Kinase C novel isoforms (Reaction) 14235 
24.17.2.4.10.5 DAG activation of TRPC channels (Reaction) 14235 
24.17.2.4.10.6 Arachidonate production from DAG (Pathway) 14235 
24.17.2.4.10.6.1 DAG is metabolized by DAGL to 2-AG (Reaction) 14236 
24.17.2.4.10.6.2 2-AG hydrolysis to arachidonate by MAGL (Reaction) 14236 
24.17.2.4.10.7 DAG kinase produces phosphatidic acid from DAG (Reaction) 14237 
24.17.2.4.11 G alpha (q) auto-inactivates by hydrolysing GTP to GDP (Reaction) 14237 
24.17.2.4.12 Inactive G alpha (q) reassociates with G beta:gamma (Reaction) 14239 
24.17.2.5 G alpha (12/13) signalling events (Pathway) 14240 
24.17.2.5.1 Liganded G12/13-activating GPCRs bind inactive heterotrimeric G-protein14242 G12/13 (Reaction) 
24.17.2.5.2 Liganded G12/13-activating GPCR acts as a GEF for G12/13 (Reaction) 14243 
24.17.2.5.3 The Ligand:GPCR:G12/13 complex dissociates (Reaction) 14244 
24.17.2.5.4 G alpha (13) activates Rho guanine nucleotide exchange factor 1 14246 (p115-RhoGEF) (Reaction) 
24.17.2.5.5 p115-RhoGEF activation of Rac1 (Reaction) 14247 
24.17.2.5.6 Rac1 activation of PI3K (Reaction) 14248 
24.17.2.5.7 GEFs activate RhoA,B,C (Reaction) 14249 
24.17.2.5.8 ROCK activation by Rho (Reaction) 14250 
24.17.2.5.9 LARG activation by G alpha 12/13 (Reaction) 14205
14251 
24.17.2.5.10 LARG binds plexin B1 (Reaction) 14252 
24.17.2.5.11 G alpha (12/13) auto-inactivates by hydrolysing GTP to GDP (Reaction) 14254 
24.17.2.5.12 Inactive G alpha (12/13) reassociates with G beta:gamma (Reaction) 14255 
24.17.2.6 G-protein beta:gamma signalling (Pathway) 14256 
24.17.2.6.1 G beta:gamma signalling through PI3Kgamma (Pathway) 14257 
24.17.2.6.1.1 Gbeta:gamma recruits PI3K gamma (Reaction) 14258 
24.17.2.6.1.2 G beta:gamma activated PI3Kgamma converts PIP2 to PIP3 (Reaction)14260 
24.17.2.6.1.3 PIP3 recruits PDK1 and AKT to the membrane (Reaction) 14261 
24.17.2.6.1.4 PIP3 binds to RhoA and activates it (Reaction) 14262 
24.17.2.6.2 G beta:gamma signalling through PLC beta (Pathway) 14262 
24.17.2.6.2.1 Gbeta:gamma activation of PLC beta (Reaction) 14263 
24.17.2.6.2.2 PLC beta-mediated PIP2 hydrolysis (Reaction) 14264 
24.17.2.7 Olfactory Signaling Pathway (Pathway) 14267 
24.17.2.7.1 G Protein trimer formation (olfactory) (Reaction) 14269 
24.17.2.7.2 Olfactory Receptor - G Protein olfactory trimer complex formation (Reaction)
14271 
24.17.3 Opioid Signalling (Pathway) 14272 
24.17.3.1 Opioid binds MOR (Reaction) 14274 
24.17.3.2 G-protein activation (Pathway) 14275 
24.17.3.2.1 The high affinity receptor complex binds to G-protein (Reaction) 14276 
24.17.3.2.2 The receptor:G-protein complex releases GDP (Reaction) 14278 
24.17.3.2.3 The receptor:G-protein complex binds GTP (Reaction) 14279 
24.17.3.2.4 The receptor:G-protein complex dissociates (Reaction) 14280 
24.17.3.2.5 G-protein alpha subunit is inactivated (Reaction) 14281 
24.17.3.2.6 G-protein beta-gamma subunits rebind the alpha-GDP subunit (Reaction)14283 
24.17.3.3 Opioid dissociates from MOR (Reaction) 14284 
24.17.3.4 G-protein mediated events (Pathway) 14285 
24.17.3.4.1 PLC beta mediated events (Pathway) 14286 
24.17.3.4.1.1 Activation of PLC beta-1/4 (Reaction) 14287 
24.17.3.4.1.2 PIP2 hydrolysis (Reaction) 14290 
24.17.3.4.1.3 Inactivation of PLC beta (Reaction) 14291 
24.17.3.4.1.4 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+14292 channel (Reaction) 
24.17.3.4.1.5 Release of calcium from intracellular stores by IP3 receptor activation 14293 (Reaction) 
24.17.3.4.1.6 Ca-dependent events (Pathway) 14293 
24.17.3.4.1.6.1 phospho-PLA2 pathway (Pathway) 14294 
24.17.3.4.1.6.1.1 Phosphorylation of cPLA2 by ERK-2 (Reaction) 14295 
24.17.3.4.1.6.1.2 Phospho-cPLA2 translocates to membranes when intracellular 14297 calcium levels increase (Reaction) 
24.17.3.4.1.6.1.3 Hydrolysis of phosphatidylcholine (Reaction) 14298 
24.17.3.4.1.6.2 CaM pathway (Pathway) 14299 
24.17.3.4.1.6.2.1 Calcium binds calmodulin (Reaction) 14299 
24.17.3.4.1.6.2.2 Calmodulin induced events (Pathway) 14299 
24.17.3.4.1.6.2.2.1 PKA-mediated phosphorylation of CREB (Pathway) 14299 
24.17.3.4.1.6.2.2.1.1 PKA activation (Pathway) 14299 24.17.3.4.1.6.2.2.1.1.1 Adenylate cyclase produces cAMP (Reaction) 14300 
24.17.3.4.1.6.2.2.1.1.2 cAMP induces dissociation of inactive PKA tetramers 14300 (Reaction) 
24.17.3.4.1.6.2.2.1.2 PKA catalytic subunit translocates to the nucleus (Reaction)14300 
24.17.3.4.1.6.2.2.1.3 PKA phosphorylates CREB (Reaction) 14301 
24.17.3.4.1.6.2.2.1.4 Dimerisation of CREB (Reaction) 14301 
24.17.3.4.1.6.2.2.2 CaMK IV-mediated phosphorylation of CREB (Pathway) 14301 
24.17.3.4.1.6.2.2.2.1 Calmodulin binds CaMK IV (Reaction) 14301 
24.17.3.4.1.6.2.2.2.2 CamKIV enters the nucleus (Reaction) 14302 
24.17.3.4.1.6.2.2.2.3 CaMK IV autophosphorylation (Reaction) 14302 
24.17.3.4.1.6.2.2.2.4 CaMK IV phosphorylates CREB (Reaction) 14302 
24.17.3.4.1.6.2.2.2.5 Dimerisation of CREB (Reaction) 14302 
24.17.3.4.1.6.2.2.3 Cam-PDE 1 activation (Pathway) 14303 
24.17.3.4.1.6.2.2.3.1 Calmodulin activates Cam-PDE 1 (Reaction) 14303 
24.17.3.4.1.6.2.2.3.2 cAMP hydrolysis by Cam-PDE 1 (Reaction) 14303 
24.17.3.4.1.6.2.2.4 Inhibition of GRK2 by calmodulin (Reaction) 14303 
24.17.3.4.1.6.2.2.5 PKC phosphorylates GRK2 (Reaction) 14304 
24.17.3.4.2 Adenylate cyclase activating pathway (Pathway) 14304 
24.17.3.4.2.1 Galpha-olf:GTP binds to adenylate cyclase and activates it (Reaction) 14305 
24.17.3.4.2.2 Adenylate cyclase converts ATP into cyclic AMP (Reaction) 14306 
24.17.3.4.2.3 Adenylaye cyclase increases the GTPase activity of G alpha-olf (Reaction)14307 
24.17.3.4.2.4 The G alpha-olf:GDP:Adenylate cyclase complex dissociates (Reaction)
14309 
24.17.3.4.3 Adenylate cyclase inhibitory pathway (Pathway) 14310 
24.17.3.4.3.1 G alpha (i) inhibits adenylate cyclase (Reaction) 14310 
24.17.3.4.3.2 G alpha-olf:GTP binds to Gi alpha1:GTP:adenylate cyclase complex 14310 (Reaction) 
24.17.3.4.3.3 Adenylate cyclase increases the GTPase activity of G alpha-olf (Reaction)14311 
24.17.3.4.3.4 Adenylate cyclase increases the GTPase activity of Gi alpha (Reaction)14311 
24.17.3.4.3.5 Dissociation of the Gi alpha:G olf complex (Reaction) 14311 
24.17.3.5 DARPP-32 events (Pathway) 14312 
24.17.3.5.1 PKA phosphorylates PDE4B (Reaction) 14314 
24.17.3.5.2 cAMP hydrolysis by PDE 4 (Reaction) 14315 
24.17.3.5.3 cAMP induces dissociation of inactive PKA tetramers (Reaction) 14316 
24.17.3.5.4 PKA phosphorylates DARPP-32 on Thr34 (Reaction) 14317 
24.17.3.5.5 DARPP-32 phosphorylated on T34 binds to PP1, inhibiting its function 14318 (Reaction) 
24.17.3.5.6 CDK5 phosphorylates DARPP-32 on Thr75 (Reaction) 14319 
24.17.3.5.7 DARPP-32 phosphorylated on Thr75 binds to PKA, inhibiting its function 14321 (Reaction) 
24.17.3.5.8 DARPP-32 is dephosphorylated on Thr75 by PP2A (Reaction) 14322 
24.17.3.5.9 Inactive catalytic PP2B is activated by the binding of calmodulin (Reaction)14323 
24.17.3.5.10 PPP3 complex dephosphorylates DARPP-32 on Thr34 (Reaction) 14325 
24.17.4 Gastrin-CREB signalling pathway via PKC and MAPK (Pathway) 14326 
24.17.4.1 Gastrin binds to CCK-B receptor (Reaction) 14328 
24.17.4.2 G alpha (q) signalling events (Pathway) 14329 24.17.4.2.1 Liganded Gq-activating GPCRs bind inactive heterotrimeric Gq (Reaction)14329 
24.17.4.2.2 Liganded Gq/11-activating GPCRs act as GEFs for Gq/11 (Reaction) 14329 
24.17.4.2.3 The Ligand:GPCR:Gq complex dissociates (Reaction) 14330 
24.17.4.2.4 GRK2 sequesters activated Gq (Reaction) 14330 
24.17.4.2.5 GRK5 sequesters activated Gq (Reaction) 14330 
24.17.4.2.6 G alpha (q) binds to Trio family RhoGEFs (Reaction) 14330 
24.17.4.2.7 PLC beta is activated by G alpha (q) (Reaction) 14331 
24.17.4.2.8 G alpha (q) inhibits PI3K alpha (Reaction) 14331 
24.17.4.2.9 PLC beta-mediated PIP2 hydrolysis (Reaction) 14331 
24.17.4.2.10 Effects of PIP2 hydrolysis (Pathway) 14331 
24.17.4.2.10.1 Binding of IP3 to IP3 receptor (Reaction) 14332 
24.17.4.2.10.2 Transport of Ca++ from platelet dense tubular system to cytoplasm 14332 (Reaction) 
24.17.4.2.10.3 Calcium and Diacylglycerol activate CalDAG-GEFs (RasGRPs) 14332 (Reaction) 
24.17.4.2.10.4 Activation of Protein Kinase C novel isoforms (Reaction) 14332 
24.17.4.2.10.5 DAG activation of TRPC channels (Reaction) 14333 
24.17.4.2.10.6 Arachidonate production from DAG (Pathway) 14333 
24.17.4.2.10.6.1 DAG is metabolized by DAGL to 2-AG (Reaction) 14333 
24.17.4.2.10.6.2 2-AG hydrolysis to arachidonate by MAGL (Reaction) 14333 
24.17.4.2.10.7 DAG kinase produces phosphatidic acid from DAG (Reaction) 14334 
24.17.4.2.11 G alpha (q) auto-inactivates by hydrolysing GTP to GDP (Reaction) 14334 
24.17.4.2.12 Inactive G alpha (q) reassociates with G beta:gamma (Reaction) 14334 
24.17.4.3 EGFR Transactivation by Gastrin (Pathway) 14334 
24.17.4.3.1 Diacylgycerol activates Protein kinase C, alpha type (Reaction) 14336 
24.17.4.3.2 Activated PKC-alpha can activate MMP3 (BlackBoxEvent) 14336 
24.17.4.3.3 Active MMP3 can cleave pro-HBEGF to form active HBEGF (Reaction) 14337 
24.17.4.3.4 Mature HBEGF binds to EGFR, triggering dimerisation and 14339 autophosphorylation of the receptor (BlackBoxEvent) 
24.17.4.3.5 GRB2:SOS1 binds to HBEGF:p-Y-EGFR (Reaction) 14340 
24.17.4.3.6 SOS1-mediated nucleotide exchange of RAS (HB-EFG-initiated) (Reaction)14341 
24.17.4.4 RAF/MAP kinase cascade (Pathway) 14343 
24.17.4.4.1 RAF activation (Pathway) 14343 
24.17.4.4.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 14343 
24.17.4.4.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 14343 
24.17.4.4.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 14344 
24.17.4.4.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 14344 
24.17.4.4.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 14344 
24.17.4.4.2 MEK activation (Pathway) 14344 
24.17.4.4.2.1 Activated RAF1 complex binds MEK (Reaction) 14345 
24.17.4.4.2.2 RAF phosphorylates MEK (Pathway) 14345 
24.17.4.4.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 14345 
24.17.4.4.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 14345 
24.17.4.4.3 ERK activation (Pathway) 14346 
24.17.4.4.3.1 ERK1 activation (Pathway) 14346 
24.17.4.4.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 14346 
24.17.4.4.3.1.2 MEK1 binds ERK-1 (Reaction) 14346 
24.17.4.4.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 14347 
24.17.4.4.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 14347 
24.17.4.4.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 14347 
24.17.4.4.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 14347 
24.17.4.4.3.2 ERK2 activation (Pathway) 14348 
24.17.4.4.3.2.1 MEK2 binds ERK-2 (Reaction) 14348 
24.17.4.4.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 14348 
24.17.4.4.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 14348 
24.17.4.4.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 14349 
24.17.4.4.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 14349 
24.17.4.5 ERK1/2/5 activate RSK1/2/3 (Reaction) 14349 
24.17.4.6 RSK1/2/3 phosphorylates CREB at Serine 133 (Reaction) 14349 
24.18 Signaling by Wnt (Pathway) 14350 
24.18.1 WNT ligand biogenesis and trafficking (Pathway) 14352 
24.18.1.1 N-linked glycosylation of WNTs (BlackBoxEvent) 14352 
24.18.1.2 PORCN palmitoleoylates N-glycosyl WNTs (Reaction) 14353 
24.18.1.3 WNT ligands traffic to the Golgi (BlackBoxEvent) 14353 
24.18.1.4 WLS binds WNT ligands in the Golgi (Reaction) 14353 
24.18.1.5 WNT ligands traffic to the plasma membrane (BlackBoxEvent) 14354 
24.18.1.6 secretion of WNT ligands (Reaction) 14354 
24.18.1.7 WLS is endocytosed to the early endosome (BlackBoxEvent) 14354 
24.18.1.8 Retromer associates with WLS (Reaction) 14355 
24.18.1.9 Retromer recycles WLS to the Golgi (BlackBoxEvent) 14355 
24.18.1.10 WLS dissociates from retromer (BlackBoxEvent) 14355 
24.18.2 Degradation of beta-catenin by the destruction complex (Pathway) 14356 
24.18.2.1 expression of AMER1 gene (BlackBoxEvent) 14356 
24.18.2.2 expression of AXIN1 gene (BlackBoxEvent) 14356 
24.18.2.3 APC is K63-polyubiquitinated (Reaction) 14357 
24.18.2.4 Assembly of the destruction complex (Reaction) 14357 
24.18.2.5 AXIN is phosphorylated in the destruction complex (Reaction) 14358 
24.18.2.6 Association of beta-catenin with the destruction complex (Reaction) 14358 
24.18.2.7 Beta-catenin phosphorylation cascade (Pathway) 14358 
24.18.2.7.1 Phosphorylation of beta-catenin at Ser45 by CK1 alpha (Reaction) 14359 
24.18.2.7.2 Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Reaction) 14359 
24.18.2.7.3 Phosphorylation of phospho- (Ser45, Thr41) beta-catenin at Ser37 by GSK-3
14359 (Reaction) 
24.18.2.7.4 Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3 14360 (Reaction) 
24.18.2.8 Phosphorylation of APC component of the destruction complex (Reaction) 14360 
24.18.2.9 Dissociation of beta-catenin from Axin and association of beta catenin with 14360 phospho-(20 aa) APC in the detruction complex (Reaction) 
24.18.2.10 Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase14361 
complex (Reaction) 24.18.2.11 Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1) 14361 (Reaction) 
24.18.2.12 Degradation of ubiquitinated beta catenin by the proteasome (BlackBoxEvent)14361 
24.18.2.13 repression of WNT target genes (Pathway) 14362 
24.18.2.13.1 TLE oligomerizes (Reaction) 14362 
24.18.2.13.2 TLE recruits HDAC1 to WNT promoters (Reaction) 14362 
24.18.2.13.3 TLE forms non-functional complexes with AES (Reaction) 14363 
24.18.2.13.4 TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes (Reaction) 14363 
24.18.2.13.5 transcription of canonical WNT targets is repressed by the TLE:HDAC and
14364 TCF/CTBP complexes (BlackBoxEvent) 
24.18.3 TCF dependent signaling in response to WNT (Pathway) 14364 
24.18.3.1 WNT binds to FZD and LRP5/6 (Reaction) 14364 
24.18.3.2 WNT mediated activation of DVL (Pathway) 14365 
24.18.3.2.1 CSNK2-mediated phosphorylation of DVL (Reaction) 14365 
24.18.3.2.2 WNT signaling stimulates CSNK1-dependent phosphorylation of DVL 14365 (Reaction) 
24.18.3.2.3 Phosphorylated DVL recruits PIP5K1B to the plasma membrane (Reaction)14366 
24.18.3.2.4 DVL-associated PIP5K1B phosphorylates PI4P to PI(4,5)P2 (Reaction) 14366 
24.18.3.3 FZD recruits DVL to the receptor complex (Reaction) 14367 
24.18.3.4 disassembly of the destruction complex and recruitment of AXIN to the 14367 membrane (Pathway) 
24.18.3.4.1 FRAT proteins bind GSK3beta (Reaction) 14367 
24.18.3.4.2 PP2A dephosphorylates AXIN in the destruction complex (BlackBoxEvent)14368 
24.18.3.4.3 DVL recruits GSK3beta:AXIN1 to the receptor complex (Reaction) 14368 
24.18.3.4.4 phosphorylation of LRP5/6 cytoplasmic domain by membrane-associated14368 GSK3beta (Reaction) 
24.18.3.4.5 phosphorylation of LRP5/6 cytoplasmic domain by CSNKI (Reaction) 14369 
24.18.3.4.6 WNT3A stimulates the caveolin-dependent internalization of FZD5:p-LRP614369 (BlackBoxEvent) 
24.18.3.4.7 beta-catenin is released from the destruction complex (Reaction) 14370 
24.18.3.5 beta-catenin translocates to the nucleus (BlackBoxEvent) 14370 
24.18.3.6 formation of the beta-catenin:TCF transactivating complex (Pathway) 14370 
24.18.3.6.1 binding of TCF/LEF:CTNNB1 to target gene promoters (Pathway) 14371 
24.18.3.6.1.1 TCF7L1/TCF7L2/LEF1:CTNNB1 bind the MYC gene (Reaction) 14371 
24.18.3.6.1.2 TCF7L1/TCF7L2/LEF1:CTNNB1 promote transcription of the MYC gene
14371 (BlackBoxEvent) 
24.18.3.6.1.3 TCF/LEF:CTNNB1 bind the AXIN2 gene (Reaction) 14372 
24.18.3.6.1.4 TCF/LEF:CTNNB1 promote transcription of AXIN2 (BlackBoxEvent) 14372 
24.18.3.6.2 beta-catenin displaces TLE:HDAC1 from TCF/LEF (Reaction) 14372 
24.18.3.6.3 beta-catenin:TCF associates with BCL9 and PYGO (Reaction) 14373 
24.18.3.6.4 beta-catenin recruits CBP/p300 (Reaction) 14373 
24.18.3.6.5 beta-catenin recruits CDC73 and LEO1 (Reaction) 14374 
24.18.3.6.6 beta-catenin recruits SMARCA4 (Reaction) 14374 
24.18.3.6.7 Recruitment of SET1 methyltransferase complex (Reaction) 14374 
24.18.3.6.8 SET1 complex trimethylates H3K4 at the MYC gene (Reaction) 14375 
24.18.3.6.9 beta-catenin recruits TRRAP/KAT5 HAT components (Reaction) 14375 
24.18.3.6.10 KAT5 HAT complex acetylates TCF4 gene at histone H4 (Reaction) 14376 
24.18.3.7 deactivation of the beta-catenin transactivating complex (Pathway) 14376 
24.18.3.7.1 XIAP binds TLE (Reaction) 14376 
24.18.3.7.2 XIAP monoubiquinates TLE (Reaction) 14377 
24.18.3.7.3 XIAP dissociates from ub-TLE (Reaction) 14377 
24.18.3.7.4 APC promotes disassembly of beta-catenin transactivation complex 14377 (BlackBoxEvent) 
24.18.3.7.5 beta-catenin is replaced by repression complexes at the promoter 14378 (BlackBoxEvent) 
24.18.3.7.6 CBY1 binds beta-catenin (Reaction) 14378 
24.18.3.7.7 AKT phosphorylates CBY1 (Reaction) 14378 
24.18.3.7.8 YWHAZ binds p-CBY:CTNNB1 (Reaction) 14379 
24.18.3.7.9 XPO1 binds the beta-catenin:CBY complex (Reaction) 14379 
24.18.3.7.10 YWHAZ and XPO1 mediate the nuclear export of beta-catenin 14379 (BlackBoxEvent) 
24.18.3.7.11 CTNNBIP1 binds beta-catenin (Reaction) 14380 
24.18.3.7.12 CHD8 binds beta-catenin to negatively regulate WNT-dependent gene 14380 expression (Reaction) 
24.18.3.8 degradation of DVL (Pathway) 14380 
24.18.3.8.1 DVL is bound by the CUL3:KLHL12:RBX1 ubiquitin ligase complex (Reaction)
14381 
24.18.3.8.2 DVL is ubiquitinated by CUL3:KLHL12:RBX1 (Reaction) 14381 
24.18.3.8.3 ubiquitinated DVL is degraded by the proteasome (BlackBoxEvent) 14381 
24.18.3.8.4 DVL1 is bound by the HECT ubiquitin ligase HECW1 (Reaction) 14382 
24.18.3.8.5 DVL1 is ubiquitinated by HECW1 (Reaction) 14382 
24.18.3.8.6 ubiquitinated DVL1 is degraded by the proteasome (BlackBoxEvent) 14383 
24.18.3.8.7 DACT1 binds DVL2 (Reaction) 14383 
24.18.3.9 degradation of AXIN (Pathway) 14384 
24.18.3.9.1 Tankyrase binds AXIN (Reaction) 14384 
24.18.3.9.2 Tankyrase ADP-ribosylates AXIN (Reaction) 14384 
24.18.3.9.3 RNF146 binds RibC-AXIN:TNKS complex (Reaction) 14385 
24.18.3.9.4 RNF146 ubiquitinates ADP-ribosylated AXIN (Reaction) 14385 
24.18.3.9.5 Ub-RibC-AXIN is degraded by the proteasome (BlackBoxEvent) 14385 
24.18.3.9.6 SMURF2 binds AXIN (Reaction) 14386 
24.18.3.9.7 AXIN is ubiquitinated by SMURF2 (Reaction) 14386 
24.18.3.9.8 ubiquitinated AXIN is degraded by the proteasome (BlackBoxEvent) 14387 
24.18.3.10 USP34 deubiquitinates AXIN (Reaction) 14387 
24.18.3.11 regulation of FZD by ubiquitination (Pathway) 14388 
24.18.3.11.1 ZNRF3/RNF43 binds the FZD:LRP5/6 receptor complex (Reaction) 14388 
24.18.3.11.2 ZNRF3 ubiquitinates FZD to promote its downregulation (Reaction) 14388 
24.18.3.11.3 USP8 deubiquitinates FZD to potentiate WNT signaling (Reaction) 14389 
24.18.3.11.4 RSPOs bind LGRs (Reaction) 14389 
24.18.3.11.5 RSPO:LGR binds ZNRF3 (Reaction) 14390 
24.18.3.11.6 ZNRF3 autoubiquitinates to promote its internalization (Reaction) 14390 
24.18.3.12 negative regulation of TCF-dependent signaling by WNT ligand antagonists (Pathway) 
24.18.3.12.1 DKK and KRM bind LRP5/6 (Reaction) 14391 
24.18.3.12.2 DKK promotes clathrin-dependent internalization of LRP6 (BlackBoxEvent)
14391 
24.18.3.12.3 SOST binds LRP5/6 (Reaction) 14392 
24.18.3.12.4 WIF1 binds WNTs (Reaction) 14392 
24.18.3.12.5 sFRP binds WNT3A and inhibits WNT:FZD binding (Reaction) 14392 
24.18.3.13 negative regulation of TCF-dependent signaling by DVL-interacting proteins14393 (Pathway) 
24.18.3.13.1 CXXC4 binds DVL to prevent AXIN binding (Reaction) 14393 
24.18.3.13.2 DVL binds CCDC88C (Reaction) 14393 
24.18.3.14 canonical WNT signaling through the atypical receptor RYK (Reaction) 14394 
24.18.4 beta-catenin independent WNT signaling (Pathway) 14394 
24.18.4.1 PCP/CE pathway (Pathway) 14396 
24.18.4.1.1 WNTs bind the FZD receptor to initiate PCP pathway (Reaction) 14397 
24.18.4.1.2 DVL is recruited to the receptor (Reaction) 14400 
24.18.4.1.3 WNT-dependent phosphorylation of DVL (Reaction) 14402 
24.18.4.1.4 ppDVL binds DAAM1 (Reaction) 14404 
24.18.4.1.5 DAAM1 recruits GTP-bound RHO A (Reaction) 14405 
24.18.4.1.6 ppDVL recruits RAC (Reaction) 14407 
24.18.4.1.7 DAAM1 recruits PFN1 (Reaction) 14409 
24.18.4.1.8 RYK binds WNT5A and VANGL2 (Reaction) 14410 
24.18.4.1.9 WNT5A binds ROR2 and VANGL2 (Reaction) 14412 
24.18.4.1.10 VANGL2 is phosphorylated in response to WNT5A (Reaction) 14414 
24.18.4.1.11 Asymmetric localization of PCP proteins (Pathway) 14416 
24.18.4.1.11.1 SCRIB is required for asymmetric membrane localization of VANGL214418 (Reaction) 
24.18.4.1.11.2 VANGL2 is required for asymmetric membrane localization of FZD3 14420 (Reaction) 
24.18.4.1.11.3 WNT5A binding to FZD promotes PRICKLE1 degradation (Reaction) 14422 
24.18.4.1.11.4 DVL2 is phosphorylated after WNT5A binding to FZD (Reaction) 14423 
24.18.4.1.11.5 SMURF1/2 are recruited to the DVL2:PARD6A complex (Reaction) 14425 
24.18.4.1.11.6 SMURF1/2 ubiquitinates PRICKLE1 (Reaction) 14426 
24.18.4.1.11.7 PRICKLE1 is degraded by the proteasome (BlackBoxEvent) 14428 
24.18.4.1.12 WNT5A-dependent internalization of FZD4 (Pathway) 14429 
24.18.4.1.12.1 WNT5A binds FZD4 (Reaction) 14430 
24.18.4.1.12.2 WNT5A-FZD4 recruits DVL2 (Reaction) 14431 
24.18.4.1.12.3 DVL2 is phosphorylated by PKC (Reaction) 14432 
24.18.4.1.12.4 p-DVL2 recruits AP-2 and beta-arrestin 2 to promote clathrin-mediated14433 endocytosis (Reaction) 
24.18.4.1.12.5 WNT5A:FZD4 is endocytosed (BlackBoxEvent) 14434 
24.18.4.1.13 WNT5A-dependent internalization of FZD2, FZD5 and ROR2 (Pathway) 14435 
24.18.4.1.13.1 WNT5A binds FZD and ROR receptors (Reaction) 14436 
24.18.4.1.13.2 FZD2, FZD5 and ROR2 are internalized in a WNT5A and 14438 clathrin-dependent manner (BlackBoxEvent) 
24.18.4.2 Ca2+ pathway (Pathway) 
14390
14439 
24.18.4.2.1 WNT5A and WNT11 bind FZD receptors to initiate Ca2+ signaling (Reaction)
14440 
24.18.4.2.2 FZD recruits trimeric G-proteins (Reaction) 14443 
24.18.4.2.3 WNT:FZD complex promotes G-protein nucleotide exchange (Reaction) 14445 
24.18.4.2.4 G-protein subunits dissociate from WNT:FZD complex (Reaction) 14446 
24.18.4.2.5 Gbeta:gamma activation of PLC beta (Reaction) 14447 
24.18.4.2.6 PLC beta-mediated PIP2 hydrolysis (Reaction) 14447 
24.18.4.2.7 translocation and activation of PKC alpha in response to WNT signaling 14448 (Reaction) 
24.18.4.2.8 IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ 14450 channel (Reaction) 
24.18.4.2.9 Activation of Calcineurin (Reaction) 14450 
24.18.4.2.10 Calcineurin binds and dephosphorylates NFAT1 in response to WNT/Ca2+
14450 signaling (Reaction) 
24.18.4.2.11 translocation of NFATC1:CaN:CaM to nucleus (BlackBoxEvent) 14452 
24.18.4.2.12 decreasing cGMP concentration promotes intracellular Ca2+ release in 14453 response to WNT (Reaction) 
24.18.4.2.13 G alpha t2 binds and activates PDE6 (Reaction) 14455 
24.18.4.2.14 PDE6 hydrolyses cGMP to GMP (Reaction) 14457 
24.18.4.2.15 active calmodulin binds CAMK2 (Reaction) 14459 
24.18.4.2.16 PRKG is activated by binding to high levels of cGMP in the absence of WNT
14460 signaling (Reaction) 
24.18.4.2.17 autophosphorylation and activation of CAMK2 (Reaction) 14462 
24.18.4.2.18 dissociation of CaM and CAMK2 autophosphorylation (Reaction) 14463 
24.18.4.2.19 CAMK2 binds MAP3K7 (Reaction) 14464 
24.18.4.2.20 activation of MAP3K7 in response to WNT (BlackBoxEvent) 14466 
24.18.4.2.21 activation of NLK (Reaction) 14467 
24.18.4.2.22 NLK translocates to nucleus (BlackBoxEvent) 14469 
24.18.4.2.23 NLK phosphorylates TCF/LEF (Reaction) 14470 
24.18.4.2.24 miR-92b binds 3'UTR of NLK mRNA (BlackBoxEvent) 14471 
24.18.4.2.25 NLK mRNA translation controlled by miR-92b (BlackBoxEvent) 14472 
24.18.4.2.26 transcription of canonical WNT targets is negatively regulated by 14474 NLK-dependent phosphorylation of TCF/LEF (BlackBoxEvent) 
24.19 Signaling by Hippo (Pathway) 14476 
24.19.1 Phosphorylation of STK3 (MST2) and SAV1 by STK3 (Reaction) 14480 
24.19.2 Phosphorylation of STK4 (MST1) and SAV1 by STK4 (Reaction) 14481 
24.19.3 Cleavage of p-STK3 (p-MST2) by caspase 3 (Reaction) 14483 
24.19.4 Cleavage of p-STK4 (p-MST1) by caspase 3 (Reaction) 14484 
24.19.5 KIBRA (WWC1) binds LATS proteins (Reaction) 14485 
24.19.6 NPHP4 protein binds LATS proteins (Reaction) 14487 
24.19.7 Phosphorylation of LATS1 and 2 by p-STK3 (p-MST2) (Reaction) 14488 
24.19.8 Phosphorylation of LATS1 and 2 by p-STK3 (MST2)/N (Reaction) 14489 
24.19.9 Phosphorylation of LATS1 and 2 by p-STK4 (p-MST1) (Reaction) 14491 
24.19.10 Phosphorylation of LATS1 and 2 by p-STK4(MST1)/N (Reaction) 14492 
24.19.11 Phosphorylation of MOB1A and B by p-STK3 (p-MST2) (Reaction) 14493 
24.19.12 Phosphorylation of MOB1A and B by p-STK3(MST2)/N (Reaction) 14495 24.19.13 Phosphorylation of MOB1A and B by p-STK4 (p-MST1) (Reaction) 14496 
24.19.14 Phosphorylation of MOB1A and B by p-STK4(MST1)/N (Reaction) 14497 
24.19.15 Phosphorylated MOB1A proteins associate with LATS proteins (Reaction) 14499 
24.19.16 Translocation of YAP1 to the nucleus (Reaction) 14500 
24.19.17 YAP1 binds ZO-2 (TJP2) (Reaction) 14501 
24.19.18 Translocation of YAP1:ZO-2 (TJP2) to the nucleus (Reaction) 14502 
24.19.19 AMOT proteins bind YAP1 (Reaction) 14504 
24.19.20 Phosphorylation of YAP by LATS1 (Reaction) 14505 
24.19.21 Phosphorylation of YAP by LATS2 (Reaction) 14506 
24.19.22 YWHAB (14-3-3 beta/alpha) dimer binds phosphorylated YAP1 (Reaction) 14508 
24.19.23 Translocation of WWTR1 (TAZ) to the nucleus (Reaction) 14509 
24.19.24 WWTR1 (TAZ) binds ZO-1 (TJP1) (Reaction) 14511 
24.19.25 WWTR1 (TAZ) binds ZO-2 (TJP2) (Reaction) 14512 
24.19.26 AMOT proteins bind WWTR1 (TAZ) (Reaction) 14513 
24.19.27 Phosphorylation of WWTR1 (TAZ) by LATS1 (Reaction) 14515 
24.19.28 Phosphorylation of WWTR1 (TAZ) by LATS2 (Reaction) 14516 
24.19.29 DVL2 binds phosphorylated WWTR1 (TAZ) (Reaction) 14518 
24.19.30 YWHAE (14-3-3 epsilon) dimer binds phosphorylated WWTR1 (TAZ) (Reaction)14519 
24.20 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) (Pathway) 14521 
24.20.1 IGF1,2 binds IGF1R (Reaction) 14522 
24.20.2 IGF1,2:IGF1R autophosphorylates (Reaction) 14524 
24.20.3 IGF1R signaling cascade (Pathway) 14526 
24.20.3.1 SHC-related events triggered by IGF1R (Pathway) 14527 
24.20.3.1.1 IGF1,2:p-Y1161,1165,1166-IGF1R binds SHC1 (Reaction) 14528 
24.20.3.1.2 IGF1R phosphorylates SHC1 (Reaction) 14529 
24.20.3.1.3 SHC-mediated signalling (Pathway) 14531 
24.20.3.1.3.1 GRB2:SOS binds to SHC-P (Reaction) 14531 
24.20.3.1.3.2 SOS mediated nucleotide exchange of RAS (SHC) (Reaction) 14531 
24.20.3.1.3.3 RAF/MAP kinase cascade (Pathway) 14531 
24.20.3.1.3.3.1 RAF activation (Pathway) 14532 
24.20.3.1.3.3.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 14532 
24.20.3.1.3.3.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 14532 
24.20.3.1.3.3.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 14532 
24.20.3.1.3.3.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 14533 
24.20.3.1.3.3.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex 14533 (Reaction) 
24.20.3.1.3.3.2 MEK activation (Pathway) 14533 
24.20.3.1.3.3.2.1 Activated RAF1 complex binds MEK (Reaction) 14533 
24.20.3.1.3.3.2.2 RAF phosphorylates MEK (Pathway) 14534 
24.20.3.1.3.3.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 14534 
24.20.3.1.3.3.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 14534 
24.20.3.1.3.3.3 ERK activation (Pathway) 14534 
24.20.3.1.3.3.3.1 ERK1 activation (Pathway) 14535 
24.20.3.1.3.3.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 14535 
24.20.3.1.3.3.3.1.2 MEK1 binds ERK-1 (Reaction) 14535 24.20.3.1.3.3.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 14535 
24.20.3.1.3.3.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 14536 
24.20.3.1.3.3.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 14536 
24.20.3.1.3.3.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 14536 
24.20.3.1.3.3.3.2 ERK2 activation (Pathway) 14536 
24.20.3.1.3.3.3.2.1 MEK2 binds ERK-2 (Reaction) 14537 
24.20.3.1.3.3.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 14537 
24.20.3.1.3.3.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 14537 
24.20.3.1.3.3.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 14537 
24.20.3.1.3.3.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 14538 
24.20.3.2 IRS-related events triggered by IGF1R (Pathway) 14538 
24.20.3.2.1 IGF1,2:p-Y1161,1165,1166-IGF1R binds IRS1,4 (Reaction) 14539 
24.20.3.2.2 IGF1,2:p-Y1161,1165,1166-IGF1R binds IRS2 (Reaction) 14541 
24.20.3.2.3 IGF1,2:p-Y1161,1165,1166-IGF1R phosphorylates IRS1,2,4 (Reaction) 14542 
24.20.3.2.4 IRS-mediated signalling (Pathway) 14544 
24.20.3.2.4.1 PI3K Cascade (Pathway) 14544 
24.20.3.2.4.1.1 PI3K activation (Reaction) 14544 
24.20.3.2.4.1.2 PIP2 conversion to PIP3 (Reaction) 14545 
24.20.3.2.4.1.3 PKB-mediated events (Pathway) 14545 
24.20.3.2.4.1.3.1 PDE3B signalling (Pathway) 14545 
24.20.3.2.4.1.3.1.1 Phosphorylation of PDE3B (Reaction) 14545 
24.20.3.2.4.1.3.1.2 Hydrolysis of cAMP to 5' AMP by Phosphorylated PDE3B 14546 (Reaction) 
24.20.3.2.4.1.3.2 mTOR signalling (Pathway) 14546 
24.20.3.2.4.1.3.2.1 Inhibition of TSC complex formation by PKB (Pathway) 14546 
24.20.3.2.4.1.3.2.1.1 Phosphorylation of TSC2 by PKB (Reaction) 14546 
24.20.3.2.4.1.3.2.1.2 Phosphorylation of complexed TSC2 by PKB (Reaction) 14547 
24.20.3.2.4.1.3.2.2 GTP loading by Rheb (Reaction) 14547 
24.20.3.2.4.1.3.2.3 Formation of active mTORC1 complex (Reaction) 14547 
24.20.3.2.4.1.3.2.4 mTORC1-mediated signalling (Pathway) 14547 
24.20.3.2.4.1.3.2.4.1 S6K1-mediated signalling (Pathway) 14548 
24.20.3.2.4.1.3.2.4.1.1 Activation of S6K1 (Reaction) 14548 
24.20.3.2.4.1.3.2.4.1.2 S6K1 signalling (Pathway) 14548 
24.20.3.2.4.1.3.2.4.1.2.1 Phosphorylation of Ribosomal protein S6 by activated
14548 S6K1 (Reaction) 
24.20.3.2.4.1.3.2.4.1.2.2 Phosphorylation and inactivation of eEF2K by activated
14549 S6K1 (Reaction) 
24.20.3.2.4.1.3.2.4.1.2.3 Phosphorylation and activation of eIF4G by activated
14549 S6K1 (Reaction) 
24.20.3.2.4.1.3.2.4.1.2.4 Phosphorylation and activation of eIF4B by activated14549 S6K1 (Reaction) 
24.20.3.2.4.1.3.2.4.2 Release of eIF4E (Pathway) 14550 
24.20.3.2.4.1.3.2.4.2.1 Phosphorylation of 4E-BP1 by activated mTORC1 14550 (Reaction) 
24.20.3.2.4.1.3.2.4.2.2 Dissociation of phosphorylated 4EBP1 from eIF4E 
(Reaction) 
24.20.3.2.4.1.3.2.5 Energy dependent regulation of mTOR by LKB1-AMPK 14550 (Pathway) 
24.20.3.2.4.1.3.2.5.1 Regulation of AMPK activity via LKB1 (Pathway) 14551 
24.20.3.2.4.1.3.2.5.1.1 LKB1 forms a trimeric complex with STRAD and MO2514551 (Reaction) 
24.20.3.2.4.1.3.2.5.1.2 Activation of cytosolic AMPK by phosphorylation 14551 (Reaction) 
24.20.3.2.4.1.3.2.5.1.3 AMPK is dephosphorylated (Reaction) 14551 
24.20.3.2.4.1.3.2.5.1.4 Phosphorylated AMPK binds AMP (Reaction) 14552 
24.20.3.2.4.1.3.2.5.1.5 AMPK phosphorylates Raptor (Reaction) 14552 
24.20.3.2.4.1.3.2.5.2 Regulation of Rheb GTPase activity by AMPK (Pathway) 14552 
24.20.3.2.4.1.3.2.5.2.1 p-AMPK phosphorylates TSC2 (Reaction) 14552 
24.20.3.2.4.1.3.2.5.2.2 TSC2 activates intrinsic GTPase activity of Rheb 14553 (Reaction) 
24.20.3.2.4.1.4 Activation of PKB (Pathway) 14553 
24.20.3.2.4.1.4.1 PDK1 attachment to plasma membrane (Reaction) 14553 
24.20.3.2.4.1.4.2 PKB attachment to plasma membrane (Reaction) 14553 
24.20.3.2.4.1.4.3 Phosphorylation of AKT2 by PDK1 (Reaction) 14554 
24.20.3.2.4.2 SOS-mediated signalling (Pathway) 14554 
24.20.3.2.4.2.1 GRB2:SOS binds IRS-P (Reaction) 14554 
24.20.3.2.4.2.2 SOS mediated nucleotide exchange of RAS (IRS) (Reaction) 14554 
24.20.3.2.4.2.3 RAF/MAP kinase cascade (Pathway) 14555 
24.20.3.2.4.2.3.1 RAF activation (Pathway) 14555 
24.20.3.2.4.2.3.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 14555 
24.20.3.2.4.2.3.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction)14555 
24.20.3.2.4.2.3.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 14556 
24.20.3.2.4.2.3.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 14556 
24.20.3.2.4.2.3.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex 14556 (Reaction) 
24.20.3.2.4.2.3.2 MEK activation (Pathway) 14556 
24.20.3.2.4.2.3.2.1 Activated RAF1 complex binds MEK (Reaction) 14557 
24.20.3.2.4.2.3.2.2 RAF phosphorylates MEK (Pathway) 14557 
24.20.3.2.4.2.3.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 14557 
24.20.3.2.4.2.3.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 14557 
24.20.3.2.4.2.3.3 ERK activation (Pathway) 14558 
24.20.3.2.4.2.3.3.1 ERK1 activation (Pathway) 14558 
24.20.3.2.4.2.3.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 14558 
24.20.3.2.4.2.3.3.1.2 MEK1 binds ERK-1 (Reaction) 14558 
24.20.3.2.4.2.3.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 14559 
24.20.3.2.4.2.3.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 14559 
24.20.3.2.4.2.3.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 14559 
24.20.3.2.4.2.3.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction)14559 
24.20.3.2.4.2.3.3.2 ERK2 activation (Pathway) 14560 
24.20.3.2.4.2.3.3.2.1 MEK2 binds ERK-2 (Reaction) 14550
14560 
24.20.3.2.4.2.3.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 14560 
24.20.3.2.4.2.3.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 14560 
24.20.3.2.4.2.3.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 14561 
24.20.3.2.4.2.3.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction)14561 
24.21 Signaling by Activin (Pathway) 14561 
24.21.1 Activin A/AB/B binds Activin Receptor ACVR2A/B:ACVR1B (Reaction) 14563 
24.21.2 Activin AB/B binds Activin Receptor ACVR2A/B:ACVR1C (Reaction) 14564 
24.21.3 ACVR2A/B (ActRIIA/B) phosphorylates ACVR1B (ActRIB, ALK4) in response to14566 Activin (Reaction) 
24.21.4 ACVR2A/B (ActRIIA/B) phosphorylates ACVR1C (ActRIC, ALK7) in response to14567 Activin (Reaction) 
24.21.5 Phosphorylation of SMAD2/3 by Activin:Activin Receptor (Reaction) 14569 
24.21.6 Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4 (Reaction) 14570 
24.21.7 The SMAD2/3:SMAD4 complex transfers to the nucleus (Reaction) 14571 
24.21.8 Phospho R-SMAD(SMAD2/3):CO-SMAD(SMAD4):FOXH1 binds Activin Response
14571 Element (Reaction) 
24.21.9 Antagonism of Activin by Follistatin (Pathway) 14571 
24.21.9.1 FSTL3 binds Activin (Reaction) 14573 
24.21.9.2 Follistatin (FST) binds Activin (Reaction) 14574 
24.22 Visual phototransduction (Pathway) 14576 
24.22.1 Retinoid metabolism and transport (Pathway) 14578 
24.22.1.1 PNLIP:CLPS hydrolyses RPALM to atROL and PALM (Reaction) 14579 
24.22.1.2 PLB1 hydrolyses RPALM to atROL (Reaction) 14579 
24.22.1.3 atROL binds to RBP2 (Reaction) 14580 
24.22.1.4 BCMO1:Fe2+ cleaves betaC to atRAL (Reaction) 14582 
24.22.1.5 BCO2:Fe2+ cleaves betaC to APO10al and bION (Reaction) 14583 
24.22.1.6 atRAL binds to RBP2 (Reaction) 14585 
24.22.1.7 RDH11 reduces RBP2:atRAL to RBP2:atROL (Reaction) 14586 
24.22.1.8 AKRs reduce RBP2:atRAL to RBP2:atROL (Reaction) 14587 
24.22.1.9 LRAT esterifies RBP2:atROL and FACYLs to atREs (Reaction) 14589 
24.22.1.10 atREs binds to nascent CM (Reaction) 14590 
24.22.1.11 Cytosolic CMs translocate to extracellular region (Reaction) 14591 
24.22.1.12 Nascent CMs transform into mature CMs (Reaction) 14593 
24.22.1.13 LPL hydrolyses TGs from mature CMs (Reaction) 14594 
24.22.1.14 LDLR transports extracellular CR:atREs to cytosol (Reaction) 14596 
24.22.1.15 CR:atREs binds apoE and HSPG (Reaction) 14598 
24.22.1.16 LRPs transport extracellular CR:atREs:HSPG:apoE to cytosol (Reaction) 14600 
24.22.1.17 NREH hydrolyses atREs to atROL and FAs (Reaction) 14601 
24.22.1.18 NREH hydrolyses atREs (HSPG:apoE) to atROL and FAs (Reaction) 14603 
24.22.1.19 atROL binds RBP1 (parenchymal cell) (Reaction) 14604 
24.22.1.20 Parenchymal atROL translocates to HSCs (BlackBoxEvent) 14605 
24.22.1.21 atROL binds RBP1 (Reaction) 14607 
24.22.1.22 LRAT esterifies RBP1:atROL and FACYLs to atREs (Reaction) 14608 
24.22.1.23 A REH hydrolses atREs to atROL and FAs (BlackBoxEvent) 14609 
24.22.1.24 HSC cytosolic atROL translocates to extracellular region (Reaction) 14611 24.22.1.25 RBP4 binds atROL (Reaction) 14612 
24.22.1.26 RBP4:atROL binds TTR (Reaction) 14613 
24.22.2 The canonical retinoid cycle in rods (twilight vision) (Pathway) 14615 
24.22.2.1 TTR:RBP:atROL binds to STRA6 receptor (Reaction) 14616 
24.22.2.2 STRA6 transports atROL from extracellular region to cytosol (Reaction) 14618 
24.22.2.3 atROL binds RBP1 to form RBP1:atROL (Reaction) 14619 
24.22.2.4 LRAT esterifies RBP1:atROL and FACYLs to atREs (Reaction) 14621 
24.22.2.5 RPE65 isomero-hydrolyses atREs to 11cROL (Reaction) 14622 
24.22.2.6 RDH10,11 oxidise 11cROL to 11cRAL (Reaction) 14624 
24.22.2.7 RDH5 oxidises 11cROL to 11cRAL (Reaction) 14625 
24.22.2.8 11cRAL (RPE) translocates to photoreceptor outer segment (BlackBoxEvent)14627 
24.22.2.9 11cRAL binds to opsin to form 11c-retinyl:RHO (Reaction) 14628 
24.22.2.10 Photons induce isomerization of 11c-retinyl to at-retinyl (Reaction) 14629 
24.22.2.11 ABCA4 mediates atRAL transport (Reaction) 14631 
24.22.2.12 NRPE is a substrate for ABCA4 (Reaction) 14633 
24.22.2.13 NRPE dissociates to atRAL and PE (Reaction) 14635 
24.22.2.14 Biosynthesis of A2E, implicated in retinal degradation (Pathway) 14636 
24.22.2.14.1 atRAL can spontaneously react with PE to form NRPE (Reaction) 14636 
24.22.2.14.2 NRPE condenses with atRAL to form A2PE (Reaction) 14637 
24.22.2.14.3 A2PE hydrolyses to A2E (Reaction) 14637 
24.22.2.14.4 A2E is phagocytosed (Reaction) 14637 
24.22.2.14.5 A2E translocates to RPE cells (Reaction) 14638 
24.22.2.15 atRAL(membrane) diffuses to atRAL(cytosol) (Reaction) 14638 
24.22.2.16 RDH12 reduces atRAL to atROL (Reaction) 14639 
24.22.2.17 RDH8 reduces atRAL to atROL (Reaction) 14641 
24.22.2.18 RBP3 regulates the transport of atROL from ROS to RPE (BlackBoxEvent) 14642 
24.22.3 The retinoid cycle in cones (daylight vision) (Pathway) 14644 
24.22.3.1 RBP3 regulates atROL taken up by Muller cells (BlackBoxEvent) 14646 
24.22.3.2 RLBP1 binds atROL to form RLBP1:atROL (Reaction) 14647 
24.22.3.3 An atROL isomerase isomerises atROL to 11cROL (BlackBoxEvent) 14649 
24.22.3.4 An ARAT esterifies 11cROL to 11c-RE (BlackBoxEvent) 14651 
24.22.3.5 A REH hydrolyses 11cRE to 11cROL (BlackBoxEvent) 14652 
24.22.3.6 11cROL translocates from Muller cells to cone photoreceptor cells 14654 (BlackBoxEvent) 
24.22.3.7 RLBP1 binds 11cROL (Reaction) 14655 
24.22.3.8 11cRDH oxidises 11cROL to 11cRAL (BlackBoxEvent) 14656 
24.22.3.9 11cRAL binds to cone opsins (Reaction) 14658 
24.22.3.10 Photons induce isomerisation of 11c-retinyl to at-retinyl (Reaction) 14659 
24.22.3.11 at-retinyl is hydrolysed from R* to release atRAL (Reaction) 14661 
24.22.3.12 atRAL is reduced to atROL (Reaction) 14662 
24.22.4 The phototransduction cascade (Pathway) 14663 
24.22.4.1 Activation of the phototransduction cascade (Pathway) 14665 
24.22.4.1.1 Photons induce isomerization of 11c-retinyl to at-retinyl (Reaction) 14666 
24.22.4.1.2 MII catalyses GDP/GTP exchange on Gt (Reaction) 14666 
24.22.4.1.3 Gt-GTP dissociates to GNAT1-GTP and GNB1:GNGT1 (Reaction) 14669 
24.22.4.1.4 GNAT1-GTP binds PDE6 and activates it (Reaction) 14670 
24.22.4.1.5 PDE6 hydrolyses cGMP to GMP (Reaction) 14673 
24.22.4.1.6 cGMP:CNG transports Na+ and Ca2+ into the rod outer segment (Reaction)14675 
24.22.4.1.7 NCKX1 exchanges Na+ for Ca2+/K+ (Reaction) 14677 
24.22.4.1.8 cGMP dissociates from CNG channels (Reaction) 14680 
24.22.4.2 Inactivation, recovery and regulation of the phototransduction cascade 14681 (Pathway) 
24.22.4.2.1 METAP1/2 demethylates GNAT1 (Reaction) 14682 
24.22.4.2.2 NMT1/2 transfer MYS to GNAT1 (Reaction) 14684 
24.22.4.2.3 FNTA:FNTB transfers FARN to GNGT1 (Reaction) 14685 
24.22.4.2.4 Unknown NAT N-acylates Gly in GNAT1 (BlackBoxEvent) 14687 
24.22.4.2.5 GRK1 phosphorylates MII to p-MII (Reaction) 14689 
24.22.4.2.6 RCVRN:Ca2+ binds to and inhibits GRK1 (Reaction) 14690 
24.22.4.2.7 SAG binds p-MII to form p-MII:SAG (Reaction) 14692 
24.22.4.2.8 at-retinyl is hydrolysed from p-MII:SAG to release atRAL (Reaction) 14694 
24.22.4.2.9 p-MII:SAG dissociates to p-RHO and SAG (Reaction) 14696 
24.22.4.2.10 PP2A dephosphorylates p-RHO to RHO (Reaction) 14698 
24.22.4.2.11 GNAT1-GTP hydrolyses its bound GTP to GDP (Reaction) 14700 
24.22.4.2.12 PRKCA/Q phosphorylate RGS9-1:GN5B:RGS9BP (Reaction) 14702 
24.22.4.2.13 GNAT1-GDP binds to GNB1:GNGT1 (Reaction) 14704 
24.22.4.2.14 GUCA binds Ca2+ to form GUCA:Ca2+ (Reaction) 14706 
24.22.4.2.15 GUCYs converts GTP to cGMP (Reaction) 14708 
24.22.4.2.16 cGMP binds CNG channel to form cGMP:CNG channel (Reaction) 14710 
24.22.4.2.17 CALM1:Ca2+ binds CNG channel (Reaction) 14711 
24.23 Signaling by Leptin (Pathway) 14713 
24.23.1 Leptin Binds Leptin Receptor (Reaction) 14716 
24.23.2 JAK2 Autophosphorylates in Response to Leptin (Reaction) 14718 
24.23.3 JAK2 Phosphorylates LEPR (Reaction) 14720 
24.23.4 Phosphorylated LEPR Binds SHP2 (PTPN11) (Reaction) 14722 
24.23.5 JAK2 Phosphorylates SHP2 (PTPN11) in Response to Leptin (Reaction) 14724 
24.23.6 Phosphorylated LEPR Binds STAT5 (Reaction) 14726 
24.23.7 JAK2 Phosphorylates STAT5 in Response to Leptin (Reaction) 14728 
24.23.8 Phosphorylated STAT5 Dissociates from Leptin Receptor (Reaction) 14730 
24.23.9 Phosphorylated STAT5 forms dimers (Reaction) 14731 
24.23.10 STAT5 dimers translocate to the nucleus and bind to specific DNA sequences 14732 (BlackBoxEvent) 
24.23.11 Phosphorylated LEPR Binds STAT3 (Reaction) 14732 
24.23.12 JAK2 Phosphoryates STAT3 in Response to Leptin (Reaction) 14734 
24.23.13 Phosphorylated STAT3 Dissociates from Leptin Receptor (Reaction) 14736 
24.23.14 Phosphorylated STAT3 Forms Dimer (Reaction) 14738 
24.23.15 Phosphorylated STAT3 Dimer Translocates to the Nucleus (BlackBoxEvent) 14739 
24.23.16 Phosphorylated LEP:LEPR:JAK2 Binds SH2B1 (Reaction) 14741 
24.23.17 Phosphorylated LEP:LEPR:JAK2:SH2B1 Binds IRS1/2 (Reaction) 14742 
24.23.18 JAK2 Phosphorylates IRS in Response to Leptin (Reaction) 14743 
24.23.19 Phosphorylated LEPR Binds SOCS3 (Reaction) 14745 
24.23.20 RAF/MAP kinase cascade (Pathway) 14746 
24.23.20.1 RAF activation (Pathway) 14747 
24.23.20.1.1 p-RAF binds 14-3-3 beta/alpha (Reaction) 14747 
24.23.20.1.2 Transient dissociation of 14-3-3 upon Ras binding (Reaction) 14747 
24.23.20.1.3 Stabilisation of RAS:RAF by 14-3-3 (Reaction) 14747 
24.23.20.1.4 Stabilisation of RAF by further phosphorylation (Reaction) 14748 
24.23.20.1.5 Phosphorylated human RAF1 binds to RAS:GTP complex (Reaction) 14748 
24.23.20.2 MEK activation (Pathway) 14748 
24.23.20.2.1 Activated RAF1 complex binds MEK (Reaction) 14748 
24.23.20.2.2 RAF phosphorylates MEK (Pathway) 14749 
24.23.20.2.2.1 RAF1 phosphorylates MEK1 (Reaction) 14749 
24.23.20.2.2.2 RAF1 phosphorylates MEK2 (Reaction) 14749 
24.23.20.3 ERK activation (Pathway) 14749 
24.23.20.3.1 ERK1 activation (Pathway) 14750 
24.23.20.3.1.1 Inactivation of MEK1 by p34cdc2 (Reaction) 14750 
24.23.20.3.1.2 MEK1 binds ERK-1 (Reaction) 14750 
24.23.20.3.1.3 MEK1 phosphorylates ERK-1 (Reaction) 14750 
24.23.20.3.1.4 Dissociation of phospho-ERK-1:MEK1 (Reaction) 14751 
24.23.20.3.1.5 Dimerisation of phospho-ERK-1 (Reaction) 14751 
24.23.20.3.1.6 Nuclear translocation of phospho-ERK-1 dimer (Reaction) 14751 
24.23.20.3.2 ERK2 activation (Pathway) 14751 
24.23.20.3.2.1 MEK2 binds ERK-2 (Reaction) 14752 
24.23.20.3.2.2 MEK2 phosphorylates ERK-2 (Reaction) 14752 
24.23.20.3.2.3 Dissociation of phospho-ERK-2:MEK2 (Reaction) 14752 
24.23.20.3.2.4 Dimerisation of phospho-ERK-2 (Reaction) 14752 
24.23.20.3.2.5 Nuclear translocation of phospho-ERK-2 dimer (Reaction) 14753 
24.24 Integrin alphaIIb beta3 signaling (Pathway) 14753 
24.24.1 Activation of Rap1 by cytosolic GEFs (Reaction) 14753 
24.24.2 Activation of Rap1 by membrane-associated GEFs (Reaction) 14754 
24.24.3 Translocation of RIAM to plasma membrane (Reaction) 14754 
24.24.4 Activation of Talin (Reaction) 14755 
24.24.5 Integrin alphaIIb beta3 activation (Reaction) 14755 
24.24.6 Interaction of integrin alphaIIb beta3 with Fibrinogen (Reaction) 14755 
24.24.7 Clustering of Integrin alphaIIb beta3 complexes (Reaction) 14756 
24.24.8 Release of CSK from SRC (Reaction) 14756 
24.24.9 Dephosphorylation of inactive SRC by PTPB1 (Reaction) 14756 
24.24.10 Autophosphorylation of SRC (Reaction) 14757 
24.24.11 Translocation of FADK1 to Focal complexes (Reaction) 14757 
24.24.12 Autophosphorylation of FADK1 at Y397 (Reaction) 14757 
24.24.13 Phosphorylation of pFADK1 by SRC (Reaction) 14758 
24.24.14 GRB2:SOS provides linkage to MAPK signaling for Integrins (Pathway) 14758 
24.24.14.1 Recruitment of GRB2 to p-FADK1 (Reaction) 14758 
24.24.14.2 Interaction of SOS with GRB2 bound to FADK1 (Reaction) 14759 
24.24.15 p130Cas linkage to MAPK signaling for integrins (Pathway) 14759 
24.24.15.1 Recruitment of p130Cas to FADK1 (Reaction) 14759 
24.24.15.2 Phosphorylation of p130Cas by SRC-FADK1 complex (Reaction) 14760 
24.24.15.3 Crk binding to p130cas (Reaction) 14760 
24.24.16 Integrin alpha IIb beta3 T779 phosphorylation blocks SHC binding (Reaction) 14761 
24.24.17 Activated integrin alphaIIb beta3 binds SHC1 (Reaction) 14761 
24.24.18 SHC1 bound to integrin alphaIIb beta3 is phosphorylated somehow 14762 (BlackBoxEvent) 
24.24.19 SHC1 dissociates from integrin alphaIIb beta3 (BlackBoxEvent) 14762 
24.24.20 SYK binds to integrin alphaIIb beta3 (Reaction) 14763 
24.24.21 SYK activation by SRC (Reaction) 14763 
24.25 Signaling by Hedgehog (Pathway) 14763 
24.25.1 Hedgehog ligand biogenesis (Pathway) 14765 
24.25.1.1 Glycosylation of Hh (BlackBoxEvent) 14767 
24.25.1.2 P4HB forms mixed disulphides with Hh precursors (Reaction) 14768 
24.25.1.3 Autoproteolytic cleavage of Hh precursors (Reaction) 14770 
24.25.1.4 HHAT palmitoylates Hh N-terminal fragment (Reaction) 14773 
24.25.1.5 Hh-Np traffics to the plasma membrane (BlackBoxEvent) 14775 
24.25.1.6 Release of Hh-Np from the secreting cell (Pathway) 14776 
24.25.1.6.1 Hh-Np binds to DISP2 (Reaction) 14777 
24.25.1.6.2 Hh-Np binds SCUBE2 in the extracellular region to promote long-range 14780 signalling (Reaction) 
24.25.1.6.3 Hh-Np binds GPC5 (Reaction) 14781 
24.25.1.6.4 NOTUM releases Hh-Np:GPC5 from the plasma membrane (Reaction) 14783 
24.25.1.6.5 Hh-Np is cleaved by ADAM17 to promote ligand shedding (Reaction) 14785 
24.25.1.7 C-terminal Hh fragments are bound by lectins (Reaction) 14787 
24.25.1.8 C-terminal Hh fragments are recruited to SEL1:SYVN1 at the ER membrane14789 (Reaction) 
24.25.1.9 SYVN1 ubiquitinates Hh C-terminal fragments (Reaction) 14790 
24.25.1.10 VCP-catalyzed ATP hydrolysis promotes the translocation of Hh-C into the 14792 cytosol (Reaction) 
24.25.1.11 Hh C-terminal fragments are degraded by the proteasome (BlackBoxEvent)14793 25 Transmembrane transport of small molecules (Pathway) 14795 
25.1 ABC-family proteins mediated transport (Pathway) 14795 
25.1.1 HCO3- transport through ion channel (Reaction) 14796 
25.1.2 ABCA transporters in lipid homeostasis (Pathway) 14798 
25.1.2.1 ABCAs mediate lipid efflux (Reaction) 14799 
25.1.2.2 ABCAs mediate lipid influx (Reaction) 14801 
25.1.2.3 ABCA7:Apo1A-mediated phospholipid efflux (Reaction) 14803 
25.1.2.4 PEX-19 docks ABCD1/D2/D3 to peroximal membrane (Reaction) 14804 
25.1.2.5 ABCD1/D2/D3 mediate long chain fatty acid transport in to peroxisomes 14806 (Reaction) 
25.1.2.6 ABCG5:ABCG8-mediated export of cholesterol and phytosterols (Reaction) 14808 
25.1.2.7 ABCG1-mediated transport of intracellular cholesterol to the cell surface 14808 (Reaction) 
25.1.2.8 ABCG4 may mediate cholesterol efflux (Reaction) 14809 
25.1.3 Mitochondrial ABC transporters (Pathway) 14810 
25.1.3.1 ABC7, mABC1 and mABC2 mediate heme transport (Reaction) 14811 
25.1.3.2 MTABC3 transports porphyrin into mitochondria (Reaction) 14813 
25.1.4 The ABCC family mediates organic anion transport (Reaction) 14814 
25.1.5 ABCA8, B1 and B5 mediate xenobiotic efflux (Reaction) 14815 
25.1.6 ABCA4 mediates atRAL transport (Reaction) 14817 
25.2 SLC-mediated transmembrane transport (Pathway) 14818 
25.2.1 Transport of inorganic cations/anions and amino acids/oligopeptides (Pathway) 14819 
25.2.1.1 Bicarbonate transporters (Pathway) 14821 
25.2.1.1.1 Cl-/HCO3- exchanger transport (Reaction) 14822 
25.2.1.1.2 Na+-coupled HCO3- cotransport (Reaction) 14824 
25.2.1.1.3 Na+-driven Cl-/HCO3- exchanger transport (Reaction) 14827 
25.2.1.2 Sodium/Calcium exchangers (Pathway) 14828 
25.2.1.2.1 Na+/Ca2+ exchanger transport (Reaction) 14829 
25.2.1.2.2 K+-dependent Na+/Ca2+ exchanger transport (Reaction) 14830 
25.2.1.2.3 K+-independent Li+/Ca2+ exchanger transport (Reaction) 14831 
25.2.1.3 Sodium/Proton exchangers (Pathway) 14833 
25.2.1.3.1 Na+/H+ exchanger transport (at cell membrane) (Reaction) 14834 
25.2.1.3.2 Na+/H+ exchanger transport (at early endosome membrane) (Reaction) 14835 
25.2.1.3.3 Na+/H+ exchanger transport (at trans-golgi membrane) (Reaction) 14837 
25.2.1.3.4 Na+/H+ exchanger transport (at late endosome membrane) (Reaction) 14838 
25.2.1.4 Cation-coupled Chloride cotransporters (Pathway) 14839 
25.2.1.4.1 Na+/Cl- cotransport (Reaction) 14841 
25.2.1.4.2 Na+, K+/2Cl- cotransport (Reaction) 14842 
25.2.1.4.3 K+/Cl- cotransport (Reaction) 14843 
25.2.1.5 Multifunctional anion exchangers (Pathway) 14845 
25.2.1.5.1 SLC26A1,2 transport extracellular SO4(2-) to cytosol (Reaction) 14846 
25.2.1.5.2 Group 2 - Cl-/HCO3- exchanger transport (Reaction) 14847 
25.2.1.5.3 Group 3 - Selective Cl- transport (Reaction) 14849 
25.2.1.6 Sodium-coupled phosphate cotransporters (Pathway) 14851 
25.2.1.6.1 Type II Na+/Pi cotransporters (Pathway) 14852 
25.2.1.6.1.1 Electrogenic Na+/Pi cotransport (Reaction) 14853 
25.2.1.6.1.2 Electroneutral Na+/Pi cotransport (Reaction) 14854 
25.2.1.6.2 Type III Na+/Pi cotransport (Reaction) 14856 
25.2.1.7 Amino acid transport across the plasma membrane (Pathway) 14857 
25.2.1.7.1 SLC16A10-mediated uptake of aromatic amino acids (Reaction) 14858 
25.2.1.7.2 SLC38A1 (ATA1)-mediated uptake of neutral amino acids (Reaction) 14860 
25.2.1.7.3 SLC38A2 (ATA2)-mediated uptake of neutral amino acids (Reaction) 14861 
25.2.1.7.4 SLC38A3-mediated uptake of glutamine, histidine, asparagine, and alanine14862 (Reaction) 
25.2.1.7.5 SLC38A4 (ATA3)-mediated uptake of arginine and lysine (Reaction) 14864 
25.2.1.7.6 SLC38A5-mediated uptake of glutamine, histidine, asparagine, and serine 14865 (Reaction) 
25.2.1.7.7 SLC43A1 (LAT3)-mediated uptake of large neutral amino acids (Reaction) 14866 
25.2.1.7.8 SLC43A2 (LAT4)-mediated uptake of large neutral amino acids (Reaction) 14868 
25.2.1.7.9 SLC6A12 (BGT-1)-mediated uptake of GABA and betaine (Reaction) 14869 25.2.1.7.10 SLC6A15-mediated amino acid uptake (Reaction) 14869 
25.2.1.7.11 SLC6A18-mediated glycine uptake (Reaction) 14871 
25.2.1.7.12 SLC6A20-mediated uptake of proline (Reaction) 14872 
25.2.1.7.13 SLC6A6-mediated uptake of taurine and beta-alanine (Reaction) 14873 
25.2.1.7.14 SLC7A5-mediated uptake of neutral amino acids (Reaction) 14875 
25.2.1.7.15 SLC7A8-mediated uptake of neutral amino acids (Reaction) 14876 
25.2.1.7.16 SLC1A4-mediated exchange of extracellular alanine for cytosolic serine, 14878 threonine, or cysteine (Reaction) 
25.2.1.7.17 SLC1A4-mediated exchange of extracellular cysteine for cytosolic alanine,14879 serine, or threonine (Reaction) 
25.2.1.7.18 SLC1A4-mediated exchange of extracellular serine for cytosolic alanine, 14881 threonine, or cysteine (Reaction) 
25.2.1.7.19 SLC1A4-mediated exchange of extracellular threonine for cytosolic alanine,
14882 serine, or cysteine (Reaction) 
25.2.1.7.20 SLC1A5-mediated exchange of alanine and glutamine across the plasma14884 membrane (Reaction) 
25.2.1.7.21 SLC1A5-mediated exchange of glutamine and alanine across the plasma14885 membrane (Reaction) 
25.2.1.7.22 SLC36A1-mediated uptake of glycine, proline, and alanine (Reaction) 14886 
25.2.1.7.23 SLC36A2-mediated uptake of glycine and proline (Reaction) 14888 
25.2.1.7.24 SLC6A14-mediated uptake of basic and neutral amino acids and of 14889 beta-alanine (Reaction) 
25.2.1.7.25 SLC6A19-mediated uptake of neutral amino acids (Reaction) 14891 
25.2.1.7.26 SLC7A1 (CAT-1)-mediated uptake of cationic amino acids (Reaction) 14892 
25.2.1.7.27 SLC7A2, isoform A (CAT-2A)-mediated uptake of cationic amino acids 14894 (Reaction) 
25.2.1.7.28 SLC7A2, isoform B (CAT-2B)-mediated uptake of cationic amino acids 14895 (Reaction) 
25.2.1.7.29 SLC7A3 (CAT-3)-mediated uptake of cationic amino acids (Reaction) 14897 
25.2.1.7.30 SLC7A10-mediated uptake of small neutral amino acids (Reaction) 14898 
25.2.1.7.31 SLC7A11-mediated exchange of extracellular cysteine and cytosolic 14899 glutamate (Reaction) 
25.2.1.7.32 SLC7A6 (y+LAT2)-mediated exchange of extracellular leucine for cytosolic14901 arginine (Reaction) 
25.2.1.7.33 SLC7A7 (y+LAT1)-mediated exchange of extracellular leucine for cytosolic14902 arginine (Reaction) 
25.2.1.7.34 SLC7A9-mediated exchange of extracellular arginine, lysine, or cystine for14903 cytosolic leucine (Reaction) 
25.2.1.8 Glutamate transport (Reaction) 14905 
25.2.1.9 Organic anion transporters (Pathway) 14907 
25.2.1.9.1 Vesicular glutamate transport (Reaction) 14908 
25.2.1.9.2 SLC17A5 cotransports lysosomal Neu5Ac and H+ to cytosol (Reaction) 14910 
25.2.1.9.3 Type I Na+-coupled phosphate co-transport (Reaction) 14910 
25.2.1.9.4 Na+/I- cotransport (influx) by the Na+/I- symporter (Reaction) 14912 
25.2.1.9.5 Passive I- efflux mediated by SMCT1 (Reaction) 14913 
25.2.1.9.6 Na+-dependent monocarboxylate transport by SMCT (Reaction) 14914 
25.2.1.9.7 Sulfate is exported to the cytosol in exchange for dicarboxylate (Reaction) 14916 
25.2.1.9.8 malate [mitochondrial matrix] + orthophosphate [cytosol] malate [cytosol] +14916 orthophosphate [mitochondrial matrix] (Reaction) 
25.2.1.10 Proton-coupled neutral amino acid transporters (Pathway) 14917 
25.2.1.10.1 SLC36A1-mediated uptake of glycine, proline, and alanine (Reaction) 14918 
25.2.1.10.2 SLC36A2-mediated uptake of glycine and proline (Reaction) 14918 
25.2.1.11 Proton/oligonucleotide cotransporters (Pathway) 14918 
25.2.1.11.1 Proton-coupled di- and tri-peptide cotransport (Reaction) 14919 
25.2.1.11.2 Proton-coupled histidine and di-peptide cotransport (Reaction) 14921 
25.2.1.12 Vesicular inhibitory amino acid transport (Reaction) 14922 
25.2.2 Hexose transport (Pathway) 14923 
25.2.2.1 Transport (influx) of fructose by GLUT5 (Reaction) 14924 
25.2.2.2 Transport (influx) of glucose, galactose, and sodium ions by SGLT1 (Reaction)14924 
25.2.2.3 Transport (efflux) of fructose, galactose, and glucose by GLUT2 (Reaction) 14925 
25.2.2.4 Glucose transport (Pathway) 14925 
25.2.2.4.1 GLUT tetramers transport Glc from extracellular region to cytosol (Reaction)14925 
25.2.2.4.2 alpha-D-glucose (cytosol) alpha-D-glucose (extracellular) (Reaction) 14926 
25.2.2.4.3 GLUT1 + ATP GLUT1:ATP (Reaction) 14926 
25.2.2.4.4 GLUT1:ATP GLUT1 + ATP (Reaction) 14927 
25.2.2.4.5 alpha-D-Glucose + ATP => alpha-D-glucose 6-phosphate + ADP (Reaction)14927 
25.2.2.4.6 Regulation of Glucokinase by Glucokinase Regulatory Protein (Pathway) 14928 
25.2.2.4.6.1 glucokinase (GCK1) + glucokinase regulatory protein (GKRP) GCK1:GKRP
14928 complex (Reaction) 
25.2.2.4.6.2 cytosolic GCK1:GKRP complex glucokinase (GCK1) + glucokinase 14928 regulatory protein (GKRP) (Reaction) 
25.2.2.4.6.3 GCK1:GKRP [cytosol] => GCK1:GKRP [nucleoplasm] (Reaction) 14929 
25.2.2.4.6.4 nucleoplasmic GCK1:GKRP complex => glucokinase (GCK1) + glucokinase
14929 regulatory protein (GKRP) (Reaction) 
25.2.2.4.6.5 glucokinase [nucleoplasm] => glucokinase [cytosol] (Reaction) 14930 
25.2.2.4.7 Cytosolic glucose 6-phosphate is exchanged for orthophosphate from the 14930 endoplasmic reticulum lumen by SLC37A4 (Reaction) 
25.2.2.4.8 G6PC hydrolyzes glucose 6-phosphate to form glucose and orthophosphate14931 (liver) (Reaction) 
25.2.2.4.9 G6PC2 hydrolyzes glucose 6-phosphate to form glucose and orthophosphate
14931 (islet) (Reaction) 
25.2.2.4.10 G6PC3 hydrolyzes glucose 6-phosphate to form glucose and orthophosphate
14932 (ubiquitous) (Reaction) 
25.2.2.4.11 Efflux of glucose from the endoplasmic reticulum (BlackBoxEvent) 14932 
25.2.3 Transport of glucose and other sugars, bile salts and organic acids, metal ions and
14933 amine compounds (Pathway) 
25.2.3.1 Facilitative Na+-independent glucose transporters (Pathway) 14934 
25.2.3.1.1 Glucose transport by class I GLUTs (Reaction) 14936 
25.2.3.1.2 Transport (efflux) of fructose, galactose, and glucose by GLUT2 (Reaction)14938 
25.2.3.1.3 Class II GLUTs (Pathway) 14938 
25.2.3.1.3.1 Transport (influx) of fructose by GLUT5 (Reaction) 14939 
25.2.3.1.3.2 GLUT7 and GLUT11 transport glucose and fructose (Reaction) 14939 
25.2.3.1.3.3 GLUT9 transports glucose, fructose and urate (Reaction) 14941 
25.2.3.1.4 Glucose transport by class III GLUTs (Reaction) 14943 

25.2.3.2 Na+-dependent glucose transporters (Pathway) 14945 
25.2.3.2.1 Transport (influx) of glucose, galactose, and sodium ions by SGLT1 (Reaction)
14946 
25.2.3.2.2 SLC5As, NAGLT1 cotransport glucose and Na+ (Reaction) 14946 
25.2.3.2.3 Co-transport (influx) of glucose/mannose and Na+ ions by SGLT4 (Reaction)14948 
25.2.3.3 Inositol transporters (Pathway) 14949 
25.2.3.3.1 Co-transport (influx) of myo-inositol and two Na+ ions by SMIT (Reaction) 14950 
25.2.3.3.2 Co-transport (influx) of myo-inositol/D-chiro-inositol and two Na+ ions by 14951 SGLT6 (Reaction) 
25.2.3.3.3 HMIT co-transports myo-inositol with a proton (Reaction) 14952 
25.2.3.4 SOAT can transport taurolithocholate-3-sulphate (Reaction) 14954 
25.2.3.5 Sodium-coupled sulphate, di- and tri-carboxylate transporters (Pathway) 14955 
25.2.3.5.1 NaS1 co-transports sulphate and a sodium ion (Reaction) 14956 
25.2.3.5.2 NaS2 co-transports sulphate and two sodium ions (Reaction) 14957 
25.2.3.5.3 NaDC1 co-transports dicarboxylic acids and a sodium ion (Reaction) 14959 
25.2.3.5.4 NaDC3 co-transports the dicarboxylic acid succinate and three sodium ion 14960 (Reaction) 
25.2.3.5.5 NACT co-transports trivalent citrate and a sodium ion (Reaction) 14961 
25.2.3.6 MATEs mediate extrusion of xenobiotics (Reaction) 14963 
25.2.3.7 Proton-coupled monocarboxylate transport (Pathway) 14964 
25.2.3.7.1 MCTs mediate proton-coupled transport of monocarboxylates and ketone 14966 bodies (Reaction) 
25.2.3.8 Metal ion SLC transporters (Pathway) 14968 
25.2.3.8.1 NRAMP1 transports divalent metal ions across phagosomal membranes of14970 macrophages (Reaction) 
25.2.3.8.2 DCT1 (NRAMP2) mediates divalent iron uptake across the apical membrane of
14970 enterocytes (Reaction) 
25.2.3.8.3 Ferroportin mediates iron influx across the basolateral membrane of 14972 enterocytes (Reaction) 
25.2.3.8.4 Ferroportin mediates iron efflux on macrophages (Reaction) 14973 
25.2.3.8.5 Zinc transporters (Pathway) 14975 
25.2.3.8.5.1 Zinc efflux and compartmentalization by the SLC30 family (Pathway) 14976 
25.2.3.8.5.1.1 ZnT1 mediates the efflux of zinc from the cell (Reaction) 14977 
25.2.3.8.5.1.2 ZnT2 facilitates zinc vesicular sequestration (Reaction) 14978 
25.2.3.8.5.1.3 ZnT3 transports zinc into synaptic vesicles (Reaction) 14980 
25.2.3.8.5.1.4 ZnT5 transports zinc into secretory granules in pancreatic beta cells 14981 (Reaction) 
25.2.3.8.5.1.5 ZnT6 transports zinc into the golgi apparatus (Reaction) 14982 
25.2.3.8.5.1.6 ZnT7 transports zinc into the golgi apparatus (Reaction) 14982 
25.2.3.8.5.1.7 SLC30A8 transports Zn2+ from cytosol to secretory granule (Reaction)14983 
25.2.3.8.5.2 Zinc influx into cells by the SLC39 gene family (Pathway) 14983 
25.2.3.8.5.2.1 hZIP1-4 mediate zinc uptake by cells (Reaction) 14984 25.2.3.8.5.2.2 hZIP5 mediates zinc uptake by cells (Reaction) 14987 
25.2.3.8.5.2.3 ZIP6 and ZIP14 mediate zinc influx into cells (Reaction) 14988 
25.2.3.8.5.2.4 ZIP7 mediates zinc efflux from the endoplasmic reticulum (Reaction)14990 
25.2.3.8.5.2.5 ZIP8 mediates zinc influx into cells (Reaction) 14991 
25.2.3.8.5.2.6 hZIP10 mediates zinc influx into cells (Reaction) 14993 
25.2.3.8.6 Cellular copper transport is mediated by human copper transporter 1 hCTR1
14994 (Reaction) 
25.2.3.8.7 MagT transporters mediate magnesium uptake into cells (Reaction) 14996 
25.2.3.9 Na+/Cl- dependent neurotransmitter transporters (Pathway) 14997 
25.2.3.9.1 GAT1-3 mediate Na+/Cl- dependent GABA transport (Reaction) 14999 
25.2.3.9.2 SLC6A12 (BGT-1)-mediated uptake of GABA and betaine (Reaction) 14999 
25.2.3.9.3 Uptake of Noradrenaline (Reaction) 14999 
25.2.3.9.4 NAT1 mediates norepinephrine uptake (Reaction) 15000 
25.2.3.9.5 Reuptake of dopamine from the synaptic cleft into neurons (Reaction) 15001 
25.2.3.9.6 Reuptake of serotonin from the synapse (Reaction) 15001 
25.2.3.9.7 GLYT1/2 mediate glycine uptake (Reaction) 15002 
25.2.3.9.8 SLC6A6-mediated uptake of taurine and beta-alanine (Reaction) 15004 
25.2.3.9.9 PROT mediates L-proline uptake (Reaction) 15004 
25.2.3.9.10 SLC6A14-mediated uptake of basic and neutral amino acids and of 15005 beta-alanine (Reaction) 
25.2.3.9.11 SLC6A15-mediated amino acid uptake (Reaction) 15005 
25.2.3.9.12 VMAT1/2 can mediate the transport of biogenic amines (Reaction) 15006 
25.2.3.9.13 SLC6A18-mediated glycine uptake (Reaction) 15007 
25.2.3.9.14 SLC6A19-mediated uptake of neutral amino acids (Reaction) 15007 
25.2.3.9.15 SLC6A20-mediated uptake of proline (Reaction) 15007 
25.2.3.10 Sodium- and chloride-dependent choline transport by CHT (Reaction) 15008 
25.2.3.11 HUT2 and HUT11 mediate urea transport in kidney and erythrocytes respectively
15009 (Reaction) 
25.2.3.12 Rhesus glycoproteins mediate ammonium transport. (Pathway) 15010 
25.2.3.12.1 RhAG mediates ammounium export from red blood cells (Reaction) 15012 
25.2.3.12.2 RhBG mediates ammonium effflux out of kidney collecting duct cells 15013 (Reaction) 
25.2.3.12.3 RhBG mediates ammonium influx into kidney collecting duct cells (Reaction)15015 
25.2.3.12.4 RhCG mediates ammonium influx into kidney collecting duct cells (Reaction)
15016 
25.2.3.12.5 RhCG mediates ammonium efflux out of kidney collecting duct cells 15018 (Reaction) 
25.2.3.13 Cho transports from the extracellular space to the cytosol (Reaction) 15019 
25.2.3.14 Organic cation/anion/zwitterion transport (Pathway) 15019 
25.2.3.14.1 Organic cation transport (Pathway) 15021 
25.2.3.14.1.1 OCT1 transports organic cations into hepatic cells (Reaction) 15022 
25.2.3.14.1.2 OCT1 transports organic cations out of hepatic cells (Reaction) 15023 
25.2.3.14.1.3 OCT2 mediates tubular uptake of organic cations in the kidney (Reaction)
15025 
25.2.3.14.1.4 OCT2 mediates tubular secretion of organic cations in the kidney 15026 (Reaction) 
25.2.3.14.1.5 OCT3 mediates renal clearance of organic cations (Reaction) 15027 
25.2.3.14.1.6 OCT3 mediates renal uptake of organic cations (Reaction) 15029 
25.2.3.14.1.7 OCT4 mediates transport of ergothioneine (Reaction) 15031 
25.2.3.14.1.8 Carnitine transporters mediates sodium-dependent uptake of carnitine 15032 (Reaction) 
25.2.3.14.1.9 ORCTL2 mediates the transport of chloroquine and quinidine with efflux of 15034 
protons (Reaction)  
25.2.3.14.2 Organic anion transport (Pathway)  15035  
25.2.3.14.2.1 OAT1-3 transport organic anions with antiport of dicarboxylic acids  15037  
(Reaction)  

25.2.3.14.2.2 OAT2 and OAT4 mediate transport of sulphate conjugates (Reaction) 15039 
25.2.3.14.2.3 URAT1 regulates urate levels in blood with exchange for organic anions 
15040 (Reaction) 
25.2.4 Transport of vitamins, nucleosides, and related molecules (Pathway) 15042 
25.2.4.1 SLC5A6 transports vitamins from extracellular region to cytosol (Reaction) 15042 
25.2.4.2 Transport of nucleosides and free purine and pyrimidine bases across the plasma 
15044 membrane (Pathway) 
25.2.4.2.1 Concentrative transport (import) of a nucleoside and a sodium ions by solute 
15047 carrier family 28 (sodium-coupled nucleoside transporter), member 1 (Reaction) 
25.2.4.2.2 Concentrative transport (import) of a nucleoside and two sodium ions by solute 
15048 carrier family 28 (sodium-coupled nucleoside transporter), member 3 (Reaction) 
25.2.4.2.3 Concentrative transport (import) of nucleosides plus sodium ions by solute 15049 carrier family 28 (sodium-coupled nucleoside transporter), member 2 (Reaction) 
25.2.4.2.4 Equilibrative transport (export) of nucleosides and free bases by solute carrier 
15051 family 29 (nucleoside transporters), member 1 (Reaction) 
25.2.4.2.5 Equilibrative transport (export) of nucleosides and free bases by solute carrier 
15053 family 29 (nucleoside transporters), member 2 (Reaction) 
25.2.4.2.6 Equilibrative transport (import) of nucleosides and free bases by solute carrier 
15054 family 29 (nucleoside transporters), member 1 (Reaction) 
25.2.4.2.7 Equilibrative transport (import) of nucleosides and free bases by solute carrier 
15055 family 29 (nucleoside transporters), member 2 (Reaction) 
25.2.4.2.8 Equilibrative transport (export) of nucleosides and adenine by solute carrier 15057 family 29 (nucleoside transporters), member 3 (Reaction) 
25.2.4.2.9 Equilibrative transport (import) of nucleosides and adenine by solute carrier 15058 family 29 (nucleoside transporters), member 3 (Reaction) 
25.2.4.2.10 Equilibrative transport (export) of adenosine and biogenic amines by solute 
15059 carrier family 29 (nucleoside transporters), member 4 (Reaction) 
25.2.4.2.11 Equilibrative transport (import) of adenosine and biogenic amines by solute 
15061 carrier family 29 (nucleoside transporters), member 4 (Reaction) 
25.2.4.3 AT1 transports acetyl-CoA into the Golgi lumen (Reaction) 15062 
25.2.4.4 Transport of nucleotide sugars (Pathway) 15064 
25.2.4.4.1 SLC35A1 exchanges CMP-Neu5Ac for CMP (Reaction) 15065 
25.2.4.4.2 SLC35A2 mediates the antiport of UDP-Gal and UDP-GalNAc in exchange for 
15066 UMP (Reaction) 
25.2.4.4.3 SLC35A3 mediates the antiport of UDP-GlcNAc in exchange for UMP 15067 (Reaction) 
25.2.4.4.4 SLC35B2,3 transport cytosolic PAPS to Golgi lumen (Reaction) 15068 
25.2.4.4.5 SLC35B4 mediates the transport of UDP-xylose into the Golgi lumen 15069 (Reaction) 
25.2.4.4.6 SLC35B4 mediates the transport of UDP-N-acetylglucosamine into the Golgi
15071 lumen (Reaction) 
25.2.4.4.7 SLC35C1 mediates the transport of UDP-fucose into the Golgi lumen 15072 (Reaction) 
25.2.4.4.8 UDP-glucuronate transport from the cytosol to ER lumen (Reaction) 15074 
25.2.4.4.9 SLC35D2 exchanges UDP-sugars for UMP (Reaction) 15074 
25.2.4.4.10 SLC35D2 mediates the antiport of GDP-mannose in exchange for GMP 15075 (Reaction) 
25.2.4.5 Transport of fatty acids (Pathway) 15076 
25.2.4.5.1 FATP1, 4 and 6 can mediate the influx of long chain fatty acids into cells 15077 (Reaction) 
25.2.4.6 Transport of organic anions (Pathway) 15079 
25.2.4.6.1 Transport (influx) of bile salts and acids by OATP-A (Reaction) 15080 
25.2.4.6.2 Transport (influx) of glycocholate and taurocholate by OATP-8 (Reaction) 15080 
25.2.4.6.3 Transport (influx) of glycocholate and taurocholate by OATP-C (Reaction) 15081 
25.2.4.6.4 SLCO1B1, SLCO4A1 and SLCO1C1 mediate the transport of thyroid 15081 hormones (Reaction) 
25.2.4.6.5 PGT transports prostaglandins (Reaction) 15083 
25.2.4.6.6 SLCO2B1 has a narrow substrate specificity (Reaction) 15084 
25.2.4.6.7 SLCO3A1 isoform 1 has abroad substrate specificity (Reaction) 15086 
25.2.4.6.8 SLCO4C1 mediates the transport of digoxin (Reaction) 15087 
25.3 Aquaporin-mediated transport (Pathway) 15088 
25.3.1 Passive transport by Aquaporins (Pathway) 15091 
25.3.1.1 Aquaporins passively transport water into cells (Reaction) 15093 
25.3.1.2 Aquaporins passively transport water out of cells (Reaction) 15099 
25.3.1.3 Aquaporin-6 passively transports anions into vesicles (Reaction) 15104 
25.3.1.4 Aquaporin-6 passively transports anions out of vesicles (Reaction) 15106 
25.3.1.5 Aquaporins passively transport glycerol into cells (Reaction) 15107 
25.3.1.6 Aquaporins passively transport glycerol out of cells (Reaction) 15110 
25.3.1.7 Aquaporins passively transport urea into cells (Reaction) 15112 
25.3.1.8 Aquaporins passively transport urea out of cells (Reaction) 15114 
25.3.2 Vasopressin regulates renal water homeostasis via Aquaporins (Pathway) 15115 
25.3.2.1 Vasopressin receptor type 2 bind vasopressin (Reaction) 15117 
25.3.2.2 AVP:AVPR2 Complex binds inactive heterotrimeric G(s) complex (Reaction) 15118 
25.3.2.3 AVP:AVPR2:heterotrimeric G(s) complex exchanges GDP for GTP (Reaction)15119 
25.3.2.4 Heterotrimeric G(s) complex rearranges (Reaction) 15120 
25.3.2.5 G alpha (s) activates adenylate cyclase (Reaction) 15121 
25.3.2.6 Activated Adenylate cyclase catalyses cAMP synthesis (Reaction) 15121 
25.3.2.7 cAMP induces dissociation of inactive PKA tetramers (Reaction) 15122 
25.3.2.8 Phosphorylation of Aquaporin-2 by Protein Kinase A (PKA) (Reaction) 15122 
25.3.2.9 Translocation of Aquaporin-2 from intracellular vesicles to the apical plasma 15124 membrane (BlackBoxEvent) 
25.3.2.10 Aquaporin-1 passively transports water into cell (Reaction) 15125 
25.3.2.11 p-S256-Aquaporin-2 passively transports water into cell (Reaction) 15127 
25.3.2.12 Aquaporin-1 passively transports water out of cell (Reaction) 15129 
25.3.2.13 Aquaporin-3 passively transports water out of cell (Reaction) 15131 
25.3.2.14 Aquaporin-4 passively transports water out of cell (Reaction) 15133 
25.3.3 Transport of glycerol from adipocytes to the liver by Aquaporins (Pathway) 15134 
25.3.3.1 Aquaporin-7 passively transports glycerol out of cell (Reaction) 15136 
25.3.3.2 Aquaporin-9 passively transports glycerol into cell (Reaction) 15137 
25.4 Iron uptake and transport (Pathway) 15139 
25.4.1 Reduction of extracellular Fe3+ (Reaction) 15140 
25.4.2 DCT1 (NRAMP2) mediates divalent iron uptake across the apical membrane of 15142 enterocytes (Reaction) 
25.4.3 Ferroportin mediates iron influx across the basolateral membrane of enterocytes 15142 (Reaction) 
25.4.4 Ferroportin mediates iron efflux on macrophages (Reaction) 15142 
25.4.5 Oxidation of Fe2+ by ceruloplasmin (Reaction) 15143 
25.4.6 Oxidation of Fe2+ by hephaestin (Reaction) 15144 
25.4.7 apo-Transferrin is loaded with two iron ions (Reaction) 15145 
25.4.8 Extracellular ferriheme uptake through the apical membrane of enterocytes 15146 (Reaction) 
25.4.9 The heme ring is cleaved by heme oxygenase (Reaction) 15148 
25.4.10 Export of heme to the blood by FLVCR (Reaction) 15148 
25.4.11 Export of heme to the blood by ABCG2 (Reaction) 15150 
25.4.12 Transferrin endocytosis and recycling (Pathway) 15151 
25.4.12.1 Loaded transferrin binds to TfR1 (Reaction) 15152 
25.4.12.2 Separation of endosome from the plasma membrane (Reaction) 15153 
25.4.12.3 Acidification of Tf:TfR1 containing endosome (Reaction) 15155 
25.4.12.4 Iron separates from the Tf:TfR1 complex (Reaction) 15156 
25.4.12.5 Reduction of Fe3+ in the endosome (Reaction) 15157 
25.4.12.6 Iron diffuses out of the endosome (Reaction) 15158 
25.4.12.7 Recycling of Tf endosome to plasma membrane (Reaction) 15159 
25.4.12.8 apo-Transferrin dissociates from the receptor complex (Reaction) 15161 
25.4.13 Ferritin stores iron (Reaction) 15162 
25.5 Ion channel transport (Pathway) 15163 
25.5.1 Ion transport by P-type ATPases (Pathway) 15164 
25.5.1.1 ATP7A transports cytosolic Cu2+ to extracellular region (Reaction) 15165 
25.5.1.2 ATP7B transports cytosolic Cu2+ to Golgi lumen (Reaction) 15167 
25.5.1.3 ATP2B1-4 transport cytosolic Ca2+ to extracellular region (Reaction) 15168 
25.5.1.4 ATP2A1-3 transport cytosolic Ca2+ to dense tubular network lumen (Reaction)15169 
25.5.1.5 ATP2A1-3 transport cytosolic Ca2+ to ER lumen (Reaction) 15170 
25.5.1.6 ATP2C1/2:Mg2+ transport cytosolic Ca2+ to Golgi lumen (Reaction) 15171 
25.5.1.7 ATP1A:ATP1B:FXYD exchanges Na+ for K+ (Reaction) 15173 
25.5.1.8 ATP4A/12A:ATP4B exchanges K+ for H+ (Reaction) 15175 
25.5.1.9 P-type ATPases type IV transport external-facing APLs to internal side of the 15177 plasma membrane (Reaction) 
25.5.1.10 P-type ATPases type IV transport internal-facing APLs to external side of the15178 plasma membrane (Reaction) 
25.5.2 Ligand-gated ion channel transport (Pathway) 15179 
25.5.2.1 HTR3:5HT transports Na+,K+, and Ca2+ (Reaction) 15180 
25.5.2.2 GABR heteropentamers:GABA transport Cl- from extracellular region to cytosol15182 (Reaction) 
25.5.2.3 GABRR pentamer:GABA transports extracellular Cl- to cytosol (Reaction) 15182 
25.5.2.4 GLRA:GLRB:Gly transports extracellular Cl- to cytosol (Reaction) 15183 
25.5.3 Stimuli-sensing channels (Pathway) 15184 
25.5.3.1 ASICs transport extracellular Na+ to cytosol (Reaction) 15186 
25.5.3.2 SCNN channels transport extracellular Na+ to cytosol (Reaction) 15188 
25.5.3.3 RAF1:SGK:TSC22D3:WPP ubiquitinates SCNN channels (Reaction) 15190 
25.5.3.4 ANOs transport cytosolic Cl- to extracellular region (Reaction) 15192 
25.5.3.5 TPCN1/2 transport lysosomal Ca2+ to cytosol (Reaction) 15194 
25.5.3.6 UNC79:UNC80:NALCN transports cytosolic Na+ to extracellular region (Reaction)15196 
25.5.3.7 CLCN1/2/KA/KB transport cytosolic Cl- to extracellular region (Reaction) 15197 
25.5.3.8 CLCN3 exchanges Cl- for H+ (Reaction) 15200 
25.5.3.9 CLCN4/5/6 exchange Cl- for H+ (Reaction) 15202 
25.5.3.10 CLCN7:OSTM1 exchanges Cl- for H+ (Reaction) 15204 
25.5.3.11 TTYH1 transports cytosolic Cl- to extracellular region (Reaction) 15206 
25.5.3.12 TTYH2/3 transport cytosolic Cl- to extracellular region (Reaction) 15207 
25.5.3.13 BESTs transport cytosolic Cl- to extracellular region (Reaction) 15209 
25.5.3.14 BESTs transport cytosolic HCO3- to extracellular region (Reaction) 15211 
25.5.3.15 RYR tetramers transport sarcoplasmic Ca2+ to cytosol (Reaction) 15213 
25.5.3.16 SLC17A3-1 cotransports extracellular Na+ and Pi to cytosol (Reaction) 15215 
25.5.3.17 SLC17A3-2 transports cytosolic urate to extracellular region (Reaction) 15217 
25.5.3.18 SLC9B1/C2 exchange Na+ for H+ (Reaction) 15219 
25.5.3.19 SLC9B2 exchanges Na+, Li+ for H+ (Reaction) 15220 
25.5.3.20 SLC9C1 exchanges Na+ for H+ (Reaction) 15221 
25.5.3.21 TRP channels (Pathway) 15223 
25.5.3.21.1 TRPs transport extracellular Ca2+ to cytosol (Reaction) 15224 
25.5.3.21.2 TRPM4,5 transport extracellular Na+ to cytosol (Reaction) 15226 26 DNA replication and repair (Pathway) 15228 
26.1 DNA repair (Pathway) 15228 
26.1.1 Base Excision Repair (Pathway) 15229 
26.1.1.1 Base Excision Repair, AP site formation (Pathway) 15230 
26.1.1.1.1 Depyrimidination (Pathway) 15231 
26.1.1.1.1.1 Uracil glycosylase mediated recognition and binding of uracil opposite 15232 guanine (Reaction) 
26.1.1.1.1.2 Cleavage of uracil by Uracil-glycosylase (Reaction) 15233 
26.1.1.1.1.3 TDG glycosylase mediated recognition and binding of thymine opposite15234 guanine (Reaction) 
26.1.1.1.1.4 Cleavage of thymine by TDG glycosylase (Reaction) 15236 
26.1.1.1.1.5 5-methylcytosine G/T mismatch specific DNA glycosylase mediated 15237 recognition and binding of thymine opposite guanine at CpG sequences (Reaction) 
26.1.1.1.1.6 Cleavage of thymine by 5-methylcytosine G/T mismatch specific 15239 glycosylase (Reaction) 
26.1.1.2 Resolution of Abasic Sites (AP sites) (Pathway) 15240 
26.1.1.2.1 Displacement of DNA glycosylase and endonucleolytic cleavage by DNA-lyase
15241 (Reaction) 
26.1.1.2.2 Ligation of DNA at sites of patch replacement (Reaction) 15242 
26.1.2 DNA damage bypass (Pathway) 15243 
26.1.2.1 RAD18 and ubiquitinated PCNA-mediated recruitment of translesion polymerases
15244 (Pathway) 
26.1.2.1.1 Monoubiquitination of PCNA (Reaction) 15245 
26.1.2.1.2 Monoubiquitunated PCNA mediates recruitment of the translesion polymerase
15246 to the DNA damaged site. (Reaction) 
26.1.2.2 Translesion synthesis by DNA polymerases bypassing lesion on DNA template15248 (Pathway) 
26.1.2.2.1 Translesion synthesis by Pol zeta (Pathway) 15249 
26.1.2.2.1.1 Formation of Pol zeta complex (Reaction) 15250 
26.1.2.2.1.2 Binding of Pol zeta complex to a DNA template containing lesions 15251 (Reaction) 
26.1.2.2.1.3 Elongation by Pol zeta complex (Reaction) 15253 
26.1.2.2.2 Translesion synthesis by Pol eta (Pathway) 15254 
26.1.2.2.2.1 Binding of Pol eta to a DNA template containing a lesion (Reaction) 15255 
26.1.2.2.2.2 Insertion of correct bases opposite to the lesion by Pol eta (Reaction) 15256 
26.1.2.2.2.3 Elongation by Pol eta (Reaction) 15257 
26.1.2.2.3 Translesion synthesis by Pol kappa (Pathway) 15258 
26.1.2.2.3.1 REV1-Pol kappa complex formation (Reaction) 15260 
26.1.2.2.3.2 Binding of Pol kappa and REV1 complex to the lesion on the template DNA
15261 strand (Reaction) 
26.1.2.2.3.3 Insertion of correct bases opposite to the lesion by Pol kappa (Reaction)15262 
26.1.2.2.3.4 Elongation by Pol kappa (Reaction) 15263 
26.1.3 DNA Damage Reversal (Pathway) 15265 
26.1.3.1 MGMT mediated DNA Damage Reversal (Reaction) 15265 
26.1.3.2 Reversal of Alkylation Damage By DNA Dioxygenases (Reaction) 15267 
26.1.4 Nucleotide Excision Repair (Pathway) 15268 
26.1.4.1 DNA damage recognition in global genomic repair (Pathway) 15269 
26.1.4.1.1 Nuclear focus formation by interaction of chSNM1A with PIAS1 upon DNA 15270 lesion (Reaction) 
26.1.4.1.2 XP-C binds to RAD23B forming a heterodimer (Reaction) 15271 
26.1.4.1.3 XP-C-RAD23B heterodimer binds to damaged DNA site with lesion (Reaction)15273 
26.1.4.2 Recruitment of repair factors to form the preincision complex (Reaction) 15274 
26.1.4.3 Repair of ~27-30 bp long patch by DNA Pol Epsilon (Reaction) 15276 
26.1.4.4 Ligation of newly synthesized repair patch to incised DNA in GG-NER (Reaction)15278 
26.1.5 Chk1-controlled and DNA-damage induced centrosome duplication (Pathway) 15279 
26.1.5.1 Generation of a DNA double strand break (Reaction) 15280 
26.1.5.2 Activation and association of ATM kinase at the DNA damage sites (Reaction)15281 
26.1.5.3 Phosphorylation of Chk1 by ATM upon DNA damage (Reaction) 15283 26.1.5.4 Association of MRE11 and NBS1 leads to nuclear localization of MRN complex15284 (Reaction) 
26.1.5.5 Phosphorylation of Chk1 by ATR (Reaction) 15286 
26.1.6 Double strand break repair (Pathway) 15288 
26.1.6.1 Homologous recombination repair (Pathway) 15289 
26.1.6.1.1 Homologous recombination repair of replication-dependent double-strand 15290 breaks (Pathway) 
26.1.6.1.1.1 Association between RAD9 and TopBP1 (Reaction) 15291 
26.1.6.1.1.2 Activation of ATR by interaction with RAD9-TopBP1 complex (Reaction)15292 
26.1.6.1.1.3 Formation of the Rad17-RFC alternate clamp-loader complex (Reaction)15293 
26.1.6.1.1.4 Formation of RPA-heterotrimer (Reaction) 15294 
26.1.6.1.1.5 Phosphorylation of RPA2 by CDC2 kinase (Reaction) 15296 
26.1.6.1.1.6 Phosphorylation of Chk1 by ATR (Reaction) 15298 
26.1.6.1.2 Homologous recombination repair (HRR) of replication-independent 15298 double-strand breaks (Pathway) 
26.1.6.1.2.1 ATM mediated response to DNA double-strand break (Pathway) 15299 
26.1.6.1.2.1.1 Generation of a DNA double strand break (Reaction) 15299 
26.1.6.1.2.1.2 Activation and association of ATM kinase at the DNA damage sites 15300 (Reaction) 
26.1.6.1.2.1.3 ATM mediated phosphorylation of repair proteins (Pathway) 15300 
26.1.6.1.2.1.3.1 Phosphorylation of BRCA1 (Reaction) 15301 
26.1.6.1.2.1.3.2 Phosphorylation of Chk1 by ATM upon DNA damage (Reaction) 15303 
26.1.6.1.2.1.3.3 Phosphorylation of Chk2 by ATM upon DNA damage (Reaction) 15303 
26.1.6.1.2.1.3.4 Phosphorylation of c-Abl and Arg by ATM (Reaction) 15304 
26.1.6.1.2.1.3.5 Phosphorylation of RAD51 by tyrosine kinase Abelson family protein
15306 members (Reaction) 
26.1.6.1.2.1.3.6 Rad51 assembly at the DNA-damage sites on the chromatin 15307 (Reaction) 
26.1.6.1.2.1.3.7 Phosphorylation of NBS1 by ATM (Reaction) 15309 
26.1.6.1.2.1.3.8 Phosphorylation of H2AX at S139 by ATM at the site of DSB 15311 (Reaction) 
26.1.6.1.2.2 Recruitment of repair and signaling proteins to double-strand breaks 15312 (Pathway) 
26.1.6.1.2.2.1 Association of 53BP1 with gamma H2AX at double strand break 15313 (Reaction) 
26.1.6.1.2.2.2 Association of gamma-H2AX with MCPH1 (Reaction) 15314 
26.1.6.1.2.2.3 Association of gamma H2AX and NBS1 (Reaction) 15315 
26.1.6.1.2.2.4 Association of MRE11 with RAD50 (Reaction) 15317 
26.1.6.1.2.2.5 Association of MRE11 and NBS1 leads to nuclear localization of MRN
15318 complex (Reaction) 
26.1.6.1.2.3 Processing of DNA double-strand break ends (Pathway) 15318 
26.1.6.1.2.3.1 Formation of RPA-heterotrimer (Reaction) 15319 
26.1.6.1.2.3.2 Binding of RPA heterotrimer to 3' double stranded DNA break (Reaction)15320 
26.1.6.1.2.4 Homologous DNA pairing and strand exchange (Pathway) 15321 
26.1.6.1.2.4.1 Association of RAD51 with BRCA1 (Reaction) 15322 26.1.6.1.2.4.2 Association of RAD51 with BRCA2 (Reaction) 15324 
26.1.6.1.2.4.3 Phosphorylation of RPA2 by CDC2 kinase (Reaction) 15326 
26.1.6.1.2.5 Formation of a multi-protein complex, cohesin (Reaction) 15326 
26.1.6.2 Non-homologous end joining (NHEJ) (Pathway) 15328 
26.1.6.2.1 Association of Ku heterodimer with ends of DNA double-strand breaks 15329 (Reaction) 
26.1.6.2.2 Autophosphorylation of DNA-PKcs (Reaction) 15330 
26.1.6.2.3 Association of DNA-PKcs with Ku-bound ends of DNA double-strand breaks15332 (Reaction) 
26.1.6.2.4 Interaction between two DNA-PK:DNA complexes at opposing ends of DNA15333 DSB (Reaction) 
26.1.6.2.5 Removal of 3'-phosphoglycolate (PG) moiety from DSB ends (Reaction) 15335 
26.1.6.2.6 Association of the XRCC4:DNA ligase IV complex with the DNA-PK:DNA 15336 synaptic complex (Reaction) 
26.1.6.2.7 Removal of repair proteins and ligation of the processed ends of the DNA 15337 double-strand break (Reaction) 
26.1.7 Fanconi Anemia Pathway in DNA repair (Pathway) 15339 
26.1.7.1 Monoubiquitination of FancD2 (Reaction) 15339 
26.1.7.2 Monoubiquitination of FANCI (Reaction) 15341 
26.1.7.3 Phosphorylation of FANCG at S7 (Reaction) 15342 
26.1.7.4 Deubiquitination of FancD2 (Reaction) 15344 
26.1.7.5 BRIP1 (FANCJ) helicase functions in direct unwinding of DNA (Reaction) 15345 
26.2 Telomere maintenance (Pathway) 15346 
26.2.1 Assembly of telomerase and telomere extension (Pathway) 15352 
26.2.1.1 Assembly of telomerase RNP (Reaction) 15353 
26.2.1.2 Recruitment of telomerase RNP to a telomeric chromosome end (Reaction) 15356 
26.2.1.3 Elongation and translocation of the telomeric chromosome end (Reaction) 15359 
26.2.1.4 Elongation and translocation of the extended telomeric chromosome end 15361 (Reaction) 
26.2.1.5 Dissociation of telomerase RNP from the extended chromosomal end (Reaction)15363 
26.2.2 Packaging of telomere ends (Reaction) 15366 27 Innate Immune System (Pathway) 15368 
27.1 Complement Cascade (Pathway) 15369 
27.1.1 Creation of classical C3 convertase (Pathway) 15371 
27.1.1.1 Lectin-mediated initiation of complement cascade (Pathway) 15373 
27.1.1.1.1 MBL or ficolin binds an oligosaccharide pattern on the target cell surface 15374 (Reaction) 
27.1.1.1.2 MASPs activation (Reaction) 15377 
27.1.1.2 Classical antibody-mediated complement activation (Pathway) 15379 
27.1.1.2.1 Antigen bound antibody interacts with C1complement complex (Reaction) 15381 
27.1.1.2.2 Activation of C1r within the C1complement complex (BlackBoxEvent) 15382 
27.1.1.2.3 C1r activates C1s component within C1 complement complex (Reaction) 15384 
27.1.1.3 Proteolytic cleavage of complement factor C4 (BlackBoxEvent) 15386 
27.1.1.4 C4b binds to target cell surface (Reaction) 15388 
27.1.1.5 Formation of C4b:C2 complex (Reaction) 15390 
27.1.1.6 Cleavage of C2 to form classical C3 convertase (Reaction) 15392 
27.1.2 Creation of alternative pathway C3 convertase (Pathway) 15393 
27.1.2.1 Formation of fluid-phase convertase C3 (Pathway) 15395 
27.1.2.1.1 Spontaneous hydrolysis of an internal thioester bond in complement factor C3
15396 (Reaction) 
27.1.2.1.2 Complement factor B binds to the hydrolyzed form of C3 (Reaction) 15398 
27.1.2.1.3 Fluid-phase proteolytic cleavage of factor B (Reaction) 15400 
27.1.2.2 Formation of membrane-bound convertase C3 (Pathway) 15402 
27.1.2.2.1 C3b fragment binds to the target cell surface (Reaction) 15403 
27.1.2.2.2 Complement factor B binds to surface-bound C3b fragment (Reaction) 15405 
27.1.2.2.3 Cleavage of surface-bound factor B (Reaction) 15407 
27.1.3 Cleavage of C3 by surface-bound C3 convertases (Reaction) 15409 
27.1.4 Cleavage of C3 by fluid-phase C3i:factor B (Reaction) 15411 
27.1.5 Formation of classical C5 convertase (Reaction) 15413 
27.1.6 Formation of alternate C5 convertase (Reaction) 15415 
27.1.7 Cleavage of C5 by C5 convertases (Reaction) 15417 
27.1.8 Formation of membrane attack complex (MAC) (Pathway) 15419 
27.1.8.1 Formation of C5b:C6 (Reaction) 15421 
27.1.8.2 Formation of C5b:C6:C7 (Reaction) 15422 
27.1.8.3 C5b:C6:C7 inserts into the target cell membrane (Reaction) 15424 
27.1.8.4 C8 binds to C5b:C6:C7 complement complex (Reaction) 15426 
27.1.8.5 C5b:C6:C7:C8 and C9 bind to form membrane attack complex (MAC) (Reaction)
15427 
27.1.9 Opsonization with C3b or C4b (BlackBoxEvent) 15430 
27.1.10 Anaphylatoxins initiate inflammatory responses (Pathway) 15433 
27.1.10.1 C3a anaphylatoxin binds C3a receptor (Reaction) 15436 
27.1.10.2 C5a anaphylatoxin binds C5a receptor (Reaction) 15438 
27.1.11 Regulation of complement cascades (Pathway) 15440 
27.1.11.1 Complement factor H binds to C3b (Reaction) 15441 
27.1.11.2 Factor H binds to host cell surface (Reaction) 15443 
27.1.11.3 Complement factor H binds to surface-bound C3b (Reaction) 15445 
27.1.11.4 Factor H displaces Bb in Cb:Bb complex (Reaction) 15446 
27.1.11.5 Complement factor I inactivates C3b (Reaction) 15448 
27.1.11.6 Complement factor I inactivates surface-bound C3b (Reaction) 15450 
27.1.11.7 iC3b proteolysis (BlackBoxEvent) 15452 
27.1.11.8 CD59 binds C5b:C6:C7:C8 (Reaction) 15454 
27.1.11.9 Vitronectin binds to C5b-C7 complex (Reaction) 15456 
27.1.11.10 Vitronectin prevents C9 polymerization (Reaction) 15458 
27.1.11.11 CREG(CR1L) binds to surface-bound C3 convertases (Reaction) 15460 
27.1.11.12 CREG (CR1L) causes dissociation of C3 convertases (Reaction) 15462 
27.1.11.13 CREM (CREMP) binds to surface-bound C3b or C4b (Reaction) 15464 
27.1.11.14 Hydrolysis of C4b (Reaction) 15465 
27.2 Toll-like receptors (TLR) cascades (Pathway) 15467 
27.2.1 TLR2 subfamily cascade (Pathway) 15470 
27.2.1.1 TLR2-1 :TLR1-1 binds to triacyl lipopeptide (Reaction) 15471 
27.2.1.2 TLR2-1 : TLR1-2 heterodimer binds to its ligand (Reaction) 15473 
27.2.1.3 MyD88:TIRAP-dependent cascade initiated on plasma membrane (Pathway) 15474 
27.2.1.3.1 Activated TLR homo- or heterodimer recruits adaptors TIRAP(or MAL) and15476 MyD88 (Reaction) 
27.2.1.3.2 IRAK4 recruitment to the activated TLR complexed with ligand, TIRAP and15478 MyD88 (Reaction) 
27.2.1.3.3 Autophosphorylation of chicken IRAK4 (Reaction) 15481 
27.2.1.3.4 IRAK2 binds to the IRAK4 accociated with the complex of the activated TLR :
15483 TIRAP : MyD88 (Reaction) 
27.2.1.3.5 phosphorylation of IRAK2 by activated IRAK4 (Reaction) 15485 
27.2.1.3.6 NFkB and MAPK activation mediated by TRAF6 (Pathway) 15488 
27.2.1.3.6.1 TRAF6 binds to p-IRAK2 complexed with activated TLR (Reaction) 15490 
27.2.1.3.6.2 p-IRAK2- TRAF6 dissociates from the activated chTLR complex (Reaction)15492 
27.2.1.3.6.3 TRAF6 binding to activated IRAK2 stimulates its oligomerization (Reaction)
15494 
27.2.1.3.6.4 Auto ubiquitination of oligo TRAF6 bound to p-IRAK2 (BlackBoxEvent) 15496 
27.2.1.3.6.5 Activated chicken TRAF6 synthesizes free K63bound poly_Ub chains within
15498 the complex p-IRAK2:pUb_oligo TRAF6 (BlackBoxEvent) 
27.2.1.3.6.6 pUb_TRAF6 pIRAK2 recruits TAK1 kinase complex (Reaction) 15500 
27.2.1.3.6.7 Activation of recruited TAK1 within the complex p-IRAK2: 15502 pUb-TRAF6:TAB2/TAB3:TAB1:TAK1 (Reaction) 
27.2.1.3.6.8 TAK1 activates NFkB by phosphorylation and activation of IKKs complex15505 (Pathway) 
27.2.1.3.6.8.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15507 
27.2.1.3.6.8.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to
15510 dissociate from the phospho-IkB (Reaction) 
27.2.1.3.6.8.3 Released NFkB complex migrates to the nucleus and turns on 15512 transcription (Reaction) 
27.2.1.3.6.9 MAPK activation in TLR cascade (Pathway) 15515 
27.2.1.3.6.9.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and 15518 activation (Pathway) 
27.2.1.3.6.9.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15521 
27.2.1.3.6.9.1.2 MKK4 phosphorylates JNK (Reaction) 15524 
27.2.1.3.6.9.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15526 
27.2.1.3.6.9.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15528 
27.2.1.3.6.9.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway)
15530 
27.2.1.3.6.9.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15533 
27.2.1.3.6.9.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15535 
27.2.1.3.6.9.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK 15537 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.1.3.6.9.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15539 
27.2.1.3.6.9.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2
15542 or 3 (Reaction) 
27.2.1.3.6.9.3 ERK activation (Pathway) 15544 
27.2.1.3.6.9.3.1 ERK2 activation (Pathway) 15546 
27.2.1.3.6.9.3.1.1 activated MEK2 binds ERK2 (Reaction) 15547 
27.2.1.3.6.9.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15549 27.2.1.3.6.9.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex 15550 (Reaction) 
27.2.1.3.6.9.3.1.4 Dimerization of activated ERK2 (Reaction) 15552 
27.2.1.3.6.9.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 15554 
27.2.2 TLR3 cascade (Pathway) 15555 
27.2.2.1 viral dsRNA(-) stranded binds to the toll like receptor 3 (TLR3) (Reaction) 15557 
27.2.2.2 viral dsRNA : TRL3 recruits TICAM1 (Reaction) 15558 
27.2.2.3 IKK related kinases bound to dsRNA:TLR3:TICAM1 activate IRF3 (Pathway) 15560 
27.2.2.3.1 Viral dsRNA:TLR3:TICAM1 Complex Activates TBK1 (Pathway) 15563 
27.2.2.3.1.1 TBK1 is recruited to the Viral dsRNA:TLR3:TICAM1 complex (Reaction)15565 
27.2.2.3.1.2 Phosphorylation of IRF3 by TBK1 complexed with activated TLR3 15570 (Reaction) 
27.2.2.3.1.3 Dimerization of Phospho-IRF3 (Reaction) 15572 
27.2.2.3.1.4 Dimerized Phospho-IRF3 is Transported To The Nucleus (Reaction) 15574 
27.2.2.3.2 Viral dsRNA:TLR3:TICAM1 Complex Activates IKBKE_CHICK (Pathway) 15576 
27.2.2.3.2.1 IKK epsilon is recruited to the Viral dsRNA:TLR3:TICAM1 complex 15578 (Reaction) 
27.2.2.3.2.2 Phosphorylation of IRF3 by IKK epsilon(IKBKE) complexed with activated
15582 TLR3. (Reaction) 
27.2.2.3.2.3 Dimerization of Phospho-IRF3 (Reaction) 15585 
27.2.2.3.2.4 Dimerized Phospho-IRF3 is Transported To The Nucleus (Reaction) 15585 
27.2.2.4 NFkB activation mediated by RIP1 complexed with activated TLR3 (Pathway) 15585 
27.2.2.4.1 viral dsRNA:TRL3:TICAM1 activates RIP1 (Reaction) 15587 
27.2.2.4.2 chicken RIP1 facilitates IKKs complex activation (Reaction) 15590 
27.2.2.4.3 activated IKKs phosphorylates IkB alpha causing the NFkB complex to 15593 dissociate from the phospho-IkB (Reaction) 
27.2.2.4.4 Released NFkB complex migrates to the nucleus and turns on transcription15594 (Reaction) 
27.2.2.5 TRAF6 mediated induction of the anti inflammatory cytokines (Pathway) 15594 
27.2.2.5.1 viral dsRNA: TLR3: TICAM1 recruits TRAF6 (Reaction) 15597 
27.2.2.5.2 Auto ubiquitination of the TRAF6 within the complex viral 15599 dsRNA:TLR3:TICAM1:TRAF6 (BlackBoxEvent) 
27.2.2.5.3 Activated chicken TRAF6 synthesizes free K63bound poly_Ub chains within15601 the complex dsRNA :TLR3 :TICAM1 (BlackBoxEvent) 
27.2.2.5.4 TRAF6 recruits TAK1 kinase complex (Reaction) 15603 
27.2.2.5.5 Activation of recruited TAK1 (Reaction) 15605 
27.2.2.5.6 Activated chicken TAK1 dissociates from the activated TLR3 complex 15608 (Reaction) 
27.2.2.5.7 TAK1 activates NFkB by phosphorylation and activation of IKKs complex 15610 (Pathway) 
27.2.2.5.7.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15610 
27.2.2.5.7.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to 15610 dissociate from the phospho-IkB (Reaction) 
27.2.2.5.7.3 Released NFkB complex migrates to the nucleus and turns on transcription
15610 (Reaction) 
27.2.2.5.8 MAPK activation in TLR cascade (Pathway) 15611 
27.2.2.5.8.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and activation
15611 (Pathway) 
27.2.2.5.8.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15611 
27.2.2.5.8.1.2 MKK4 phosphorylates JNK (Reaction) 15611 
27.2.2.5.8.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15612 
27.2.2.5.8.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15612 
27.2.2.5.8.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway) 15612 
27.2.2.5.8.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15612 
27.2.2.5.8.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15613 
27.2.2.5.8.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK complexed
15613 with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.2.5.8.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15613 
27.2.2.5.8.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2 or 3
15614 (Reaction) 
27.2.2.5.8.3 ERK activation (Pathway) 15614 
27.2.2.5.8.3.1 ERK2 activation (Pathway) 15614 
27.2.2.5.8.3.1.1 activated MEK2 binds ERK2 (Reaction) 15614 
27.2.2.5.8.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15615 
27.2.2.5.8.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex (Reaction)15615 
27.2.2.5.8.3.1.4 Dimerization of activated ERK2 (Reaction) 15615 
27.2.2.5.8.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 15615 
27.2.3 TLR4 cascade (Pathway) 15616 
27.2.3.1 Association of LBP with bacterial LPS (Reaction) 15617 
27.2.3.2 LPS binding to CD14 co-receptor (Reaction) 15619 
27.2.3.3 LPS binding to Toll like receptor 4 results in dimerization of the TLR4 associated
15620 with MD2 (Reaction) 
27.2.3.4 MyD88:TIRAP-dependent cascade initiated on plasma membrane (Pathway) 15622 
27.2.3.4.1 Activated TLR homo- or heterodimer recruits adaptors TIRAP(or MAL) and15622 MyD88 (Reaction) 
27.2.3.4.2 IRAK4 recruitment to the activated TLR complexed with ligand, TIRAP and15622 MyD88 (Reaction) 
27.2.3.4.3 Autophosphorylation of chicken IRAK4 (Reaction) 15622 
27.2.3.4.4 IRAK2 binds to the IRAK4 accociated with the complex of the activated TLR :
15623 TIRAP : MyD88 (Reaction) 
27.2.3.4.5 phosphorylation of IRAK2 by activated IRAK4 (Reaction) 15623 
27.2.3.4.6 NFkB and MAPK activation mediated by TRAF6 (Pathway) 15623 
27.2.3.4.6.1 TRAF6 binds to p-IRAK2 complexed with activated TLR (Reaction) 15623 
27.2.3.4.6.2 p-IRAK2- TRAF6 dissociates from the activated chTLR complex (Reaction)15624 
27.2.3.4.6.3 TRAF6 binding to activated IRAK2 stimulates its oligomerization (Reaction)
15624 
27.2.3.4.6.4 Auto ubiquitination of oligo TRAF6 bound to p-IRAK2 (BlackBoxEvent) 15624 
27.2.3.4.6.5 Activated chicken TRAF6 synthesizes free K63bound poly_Ub chains within
15625 the complex p-IRAK2:pUb_oligo TRAF6 (BlackBoxEvent) 
27.2.3.4.6.6 pUb_TRAF6 pIRAK2 recruits TAK1 kinase complex (Reaction) 15625 
27.2.3.4.6.7 Activation of recruited TAK1 within the complex p-IRAK2: pUb-TRAF6:TAB2/TAB3:TAB1:TAK1 (Reaction) 
27.2.3.4.6.8 TAK1 activates NFkB by phosphorylation and activation of IKKs complex15626 (Pathway) 
27.2.3.4.6.8.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15626 
27.2.3.4.6.8.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to
15626 dissociate from the phospho-IkB (Reaction) 
27.2.3.4.6.8.3 Released NFkB complex migrates to the nucleus and turns on 15626 transcription (Reaction) 
27.2.3.4.6.9 MAPK activation in TLR cascade (Pathway) 15627 
27.2.3.4.6.9.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and 15627 activation (Pathway) 
27.2.3.4.6.9.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15627 
27.2.3.4.6.9.1.2 MKK4 phosphorylates JNK (Reaction) 15627 
27.2.3.4.6.9.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15628 
27.2.3.4.6.9.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15628 
27.2.3.4.6.9.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway)
15628 
27.2.3.4.6.9.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15628 
27.2.3.4.6.9.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15629 
27.2.3.4.6.9.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK 15629 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.3.4.6.9.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15629 
27.2.3.4.6.9.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2
15630 or 3 (Reaction) 
27.2.3.4.6.9.3 ERK activation (Pathway) 15630 
27.2.3.4.6.9.3.1 ERK2 activation (Pathway) 15630 
27.2.3.4.6.9.3.1.1 activated MEK2 binds ERK2 (Reaction) 15630 
27.2.3.4.6.9.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15631 
27.2.3.4.6.9.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex 15631 (Reaction) 
27.2.3.4.6.9.3.1.4 Dimerization of activated ERK2 (Reaction) 15631 
27.2.3.4.6.9.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 15631 
27.2.4 TLR5 cascade (Pathway) 15632 
27.2.4.1 Bacterial Flagellin binds TLR5 homodimer (Reaction) 15633 
27.2.4.2 MyD88 cascade initiated on plasma membrane (Pathway) 15635 
27.2.4.2.1 Activated TLR5/TLR15 homodimer recruits MyD88 adaptor (Reaction) 15636 
27.2.4.2.2 IRAK4 binds to activated TLR5 or 15. (Reaction) 15638 
27.2.4.2.3 Autophosphorylation of IRAK4 bound to activated TLR5 or 15 (Reaction) 15640 
27.2.4.2.4 IRAK2 binds to IRAK4 associated with activated TLR : MyD88 complex 15642 (Reaction) 
27.2.4.2.5 Activated IRAK4 bound to activated TLR : MyD88 complex phosphorylates15645 IRAK2 (Reaction) 
27.2.4.2.6 NFkB and MAPK activation mediated by TRAF6 (Pathway) 15647 
27.2.4.2.6.1 TRAF6 binds to p-IRAK2 complexed with activated TLR (Reaction) 15647 
27.2.4.2.6.2 p-IRAK2- TRAF6 dissociates from the activated chTLR complex (Reaction)15648 
15625
27.2.4.2.6.3 TRAF6 binding to activated IRAK2 stimulates its oligomerization (Reaction)
15648 
27.2.4.2.6.4 Auto ubiquitination of oligo TRAF6 bound to p-IRAK2 (BlackBoxEvent) 15648 
27.2.4.2.6.5 Activated chicken TRAF6 synthesizes free K63bound poly_Ub chains within
15649 the complex p-IRAK2:pUb_oligo TRAF6 (BlackBoxEvent) 
27.2.4.2.6.6 pUb_TRAF6 pIRAK2 recruits TAK1 kinase complex (Reaction) 15649 
27.2.4.2.6.7 Activation of recruited TAK1 within the complex p-IRAK2: 15649 pUb-TRAF6:TAB2/TAB3:TAB1:TAK1 (Reaction) 
27.2.4.2.6.8 TAK1 activates NFkB by phosphorylation and activation of IKKs complex15650 (Pathway) 
27.2.4.2.6.8.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15650 
27.2.4.2.6.8.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to
15650 dissociate from the phospho-IkB (Reaction) 
27.2.4.2.6.8.3 Released NFkB complex migrates to the nucleus and turns on 15650 transcription (Reaction) 
27.2.4.2.6.9 MAPK activation in TLR cascade (Pathway) 15651 
27.2.4.2.6.9.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and 15651 activation (Pathway) 
27.2.4.2.6.9.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15651 
27.2.4.2.6.9.1.2 MKK4 phosphorylates JNK (Reaction) 15651 
27.2.4.2.6.9.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15652 
27.2.4.2.6.9.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15652 
27.2.4.2.6.9.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway)
15652 
27.2.4.2.6.9.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15652 
27.2.4.2.6.9.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15653 
27.2.4.2.6.9.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK 15653 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.4.2.6.9.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15653 
27.2.4.2.6.9.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2
15654 or 3 (Reaction) 
27.2.4.2.6.9.3 ERK activation (Pathway) 15654 
27.2.4.2.6.9.3.1 ERK2 activation (Pathway) 15654 
27.2.4.2.6.9.3.1.1 activated MEK2 binds ERK2 (Reaction) 15654 
27.2.4.2.6.9.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15655 
27.2.4.2.6.9.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex 15655 (Reaction) 
27.2.4.2.6.9.3.1.4 Dimerization of activated ERK2 (Reaction) 15655 
27.2.4.2.6.9.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 15655 
27.2.5 TLR7 cascade (Pathway) 15656 
27.2.5.1 TLR7 binds to recognized ligands (Reaction) 15657 
27.2.5.2 MyD88-dependent cascade initiated on endosome membrane (Pathway) 15659 
27.2.5.2.1 Activated TLR7 or 21 recruits MyD88 (Reaction) 15660 
27.2.5.2.2 IRAK4 binds to the activated TLR7 or 21 (Reaction) 15662 
27.2.5.2.3 Autophosphorylation of IRAK4 bound to the activated TLR7 or 21complex. 15665 (Reaction) 
27.2.5.2.4 IRAK2 binds to p-IRAK4:MyD88:activated TLR7 or 21 complex (Reaction) 15667 
27.2.5.2.5 IRAK2 phosphorylation bound to the activated TLR7 (or TLR21) complex (Reaction) 
27.2.5.2.6 NFkB and MAPK activation mediated by TRAF6 upon TLR7 or TLR21 15671 stimulation (Pathway) 
27.2.5.2.6.1 TRAF6 binds to p-IRAK2 complexed with activated TLR7 or TLR21 15672 (Reaction) 
27.2.5.2.6.2 p-IRAK2- TRAF6 dissociates from the activated TRL7 or 21 (Reaction) 15675 
27.2.5.2.6.3 TRAF6 binding to IRAK2 stimulates its oligomerizartion upon TLR7 or 15677 TLR21 stimulation (Reaction) 
27.2.5.2.6.4 Autoubiquitination of oligoTRAF6 bound to p-IRAK2 (BlackBoxEvent) 15679 
27.2.5.2.6.5 Activated TRAF6 synthesizes free K63 linked pUb chains. (BlackBoxEvent)15681 
27.2.5.2.6.6 Activated TRAF6 recruits TAK1 kinase complex upon TLR7 or TLR21 15682 stimulation (Reaction) 
27.2.5.2.6.7 Activation of recruited TAK1 within the complex p-IRAK2: 15684 pUb-TRAF6:TAB2/TAB3:TAB1:TAK1 upon TLR7 or 21 stimulation (Reaction) 
27.2.5.2.6.8 Activated TAK1 leaves endosome membrane (Reaction) 15687 
27.2.5.2.6.9 TAK1 activates NFkB by phosphorylation and activation of IKKs complex15689 (Pathway) 
27.2.5.2.6.9.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15689 
27.2.5.2.6.9.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to
15689 dissociate from the phospho-IkB (Reaction) 
27.2.5.2.6.9.3 Released NFkB complex migrates to the nucleus and turns on 15690 transcription (Reaction) 
27.2.5.2.6.10 MAPK activation in TLR cascade (Pathway) 15690 
27.2.5.2.6.10.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and 15690 activation (Pathway) 
27.2.5.2.6.10.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15690 
27.2.5.2.6.10.1.2 MKK4 phosphorylates JNK (Reaction) 15691 
27.2.5.2.6.10.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15691 
27.2.5.2.6.10.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15691 
27.2.5.2.6.10.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway)
15691 
27.2.5.2.6.10.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15692 
27.2.5.2.6.10.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15692 
27.2.5.2.6.10.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK 15692 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.5.2.6.10.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15693 
27.2.5.2.6.10.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2
15693 or 3 (Reaction) 
27.2.5.2.6.10.3 ERK activation (Pathway) 15693 
27.2.5.2.6.10.3.1 ERK2 activation (Pathway) 15693 
27.2.5.2.6.10.3.1.1 activated MEK2 binds ERK2 (Reaction) 15694 
27.2.5.2.6.10.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15694 
27.2.5.2.6.10.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex 15694 (Reaction) 
27.2.5.2.6.10.3.1.4 Dimerization of activated ERK2 (Reaction) 15694 
27.2.5.2.6.10.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 1566915695 27.2.6 TLR15 cascade (Pathway) 15695 
27.2.6.1 TLR15 binds to recognized ligand (Reaction) 15696 
27.2.6.2 MyD88 cascade initiated on plasma membrane (Pathway) 15698 
27.2.6.2.1 Activated TLR5/TLR15 homodimer recruits MyD88 adaptor (Reaction) 15699 
27.2.6.2.2 IRAK4 binds to activated TLR5 or 15. (Reaction) 15699 
27.2.6.2.3 Autophosphorylation of IRAK4 bound to activated TLR5 or 15 (Reaction) 15699 
27.2.6.2.4 IRAK2 binds to IRAK4 associated with activated TLR : MyD88 complex 15700 (Reaction) 
27.2.6.2.5 Activated IRAK4 bound to activated TLR : MyD88 complex phosphorylates15700 IRAK2 (Reaction) 
27.2.6.2.6 NFkB and MAPK activation mediated by TRAF6 (Pathway) 15700 
27.2.6.2.6.1 TRAF6 binds to p-IRAK2 complexed with activated TLR (Reaction) 15700 
27.2.6.2.6.2 p-IRAK2- TRAF6 dissociates from the activated chTLR complex (Reaction)15701 
27.2.6.2.6.3 TRAF6 binding to activated IRAK2 stimulates its oligomerization (Reaction)
15701 
27.2.6.2.6.4 Auto ubiquitination of oligo TRAF6 bound to p-IRAK2 (BlackBoxEvent) 15701 
27.2.6.2.6.5 Activated chicken TRAF6 synthesizes free K63bound poly_Ub chains within
15702 the complex p-IRAK2:pUb_oligo TRAF6 (BlackBoxEvent) 
27.2.6.2.6.6 pUb_TRAF6 pIRAK2 recruits TAK1 kinase complex (Reaction) 15702 
27.2.6.2.6.7 Activation of recruited TAK1 within the complex p-IRAK2: 15702 pUb-TRAF6:TAB2/TAB3:TAB1:TAK1 (Reaction) 
27.2.6.2.6.8 TAK1 activates NFkB by phosphorylation and activation of IKKs complex15703 (Pathway) 
27.2.6.2.6.8.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15703 
27.2.6.2.6.8.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to
15703 dissociate from the phospho-IkB (Reaction) 
27.2.6.2.6.8.3 Released NFkB complex migrates to the nucleus and turns on 15703 transcription (Reaction) 
27.2.6.2.6.9 MAPK activation in TLR cascade (Pathway) 15704 
27.2.6.2.6.9.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and 15704 activation (Pathway) 
27.2.6.2.6.9.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15704 
27.2.6.2.6.9.1.2 MKK4 phosphorylates JNK (Reaction) 15704 
27.2.6.2.6.9.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15705 
27.2.6.2.6.9.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15705 
27.2.6.2.6.9.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway)
15705 
27.2.6.2.6.9.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15705 
27.2.6.2.6.9.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15706 
27.2.6.2.6.9.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK 15706 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.6.2.6.9.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15706 
27.2.6.2.6.9.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2
15707 or 3 (Reaction) 
27.2.6.2.6.9.3 ERK activation (Pathway) 15707 
27.2.6.2.6.9.3.1 ERK2 activation (Pathway) 15707 
27.2.6.2.6.9.3.1.1 activated MEK2 binds ERK2 (Reaction) 15707 27.2.6.2.6.9.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15708 
27.2.6.2.6.9.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex 15708 (Reaction) 
27.2.6.2.6.9.3.1.4 Dimerization of activated ERK2 (Reaction) 15708 
27.2.6.2.6.9.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 15708 
27.2.7 TLR21 cascade (Pathway) 15709 
27.2.7.1 TLR21homodimer binds to DNA (Reaction) 15710 
27.2.7.2 MyD88-dependent cascade initiated on endosome membrane (Pathway) 15711 
27.2.7.2.1 Activated TLR7 or 21 recruits MyD88 (Reaction) 15712 
27.2.7.2.2 IRAK4 binds to the activated TLR7 or 21 (Reaction) 15712 
27.2.7.2.3 Autophosphorylation of IRAK4 bound to the activated TLR7 or 21complex. 15712 (Reaction) 
27.2.7.2.4 IRAK2 binds to p-IRAK4:MyD88:activated TLR7 or 21 complex (Reaction) 15712 
27.2.7.2.5 IRAK2 phosphorylation bound to the activated TLR7 (or TLR21) complex 15713 (Reaction) 
27.2.7.2.6 NFkB and MAPK activation mediated by TRAF6 upon TLR7 or TLR21 15713 stimulation (Pathway) 
27.2.7.2.6.1 TRAF6 binds to p-IRAK2 complexed with activated TLR7 or TLR21 15713 (Reaction) 
27.2.7.2.6.2 p-IRAK2- TRAF6 dissociates from the activated TRL7 or 21 (Reaction) 15714 
27.2.7.2.6.3 TRAF6 binding to IRAK2 stimulates its oligomerizartion upon TLR7 or 15714 TLR21 stimulation (Reaction) 
27.2.7.2.6.4 Autoubiquitination of oligoTRAF6 bound to p-IRAK2 (BlackBoxEvent) 15714 
27.2.7.2.6.5 Activated TRAF6 synthesizes free K63 linked pUb chains. (BlackBoxEvent)15715 
27.2.7.2.6.6 Activated TRAF6 recruits TAK1 kinase complex upon TLR7 or TLR21 15715 stimulation (Reaction) 
27.2.7.2.6.7 Activation of recruited TAK1 within the complex p-IRAK2: 15715 pUb-TRAF6:TAB2/TAB3:TAB1:TAK1 upon TLR7 or 21 stimulation (Reaction) 
27.2.7.2.6.8 Activated TAK1 leaves endosome membrane (Reaction) 15716 
27.2.7.2.6.9 TAK1 activates NFkB by phosphorylation and activation of IKKs complex15716 (Pathway) 
27.2.7.2.6.9.1 Phosphorylation of IKKs complex by activated TAK1 (Reaction) 15716 
27.2.7.2.6.9.2 activated IKKs phosphorylates IkB alpha causing the NFkB complex to
15716 dissociate from the phospho-IkB (Reaction) 
27.2.7.2.6.9.3 Released NFkB complex migrates to the nucleus and turns on 15717 transcription (Reaction) 
27.2.7.2.6.10 MAPK activation in TLR cascade (Pathway) 15717 
27.2.7.2.6.10.1 Activated TAK1 mediates Jun kinases (JNK) phosphorylation and 15717 activation (Pathway) 
27.2.7.2.6.10.1.1 Phosphorylation of MKK4 by activated TAK1 (Reaction) 15717 
27.2.7.2.6.10.1.2 MKK4 phosphorylates JNK (Reaction) 15718 
27.2.7.2.6.10.1.3 Activated JNK migrates to the nucleoplasm (Reaction) 15718 
27.2.7.2.6.10.1.4 Activation and dimerization of c-JUN in the nucleus (Reaction) 15718 
27.2.7.2.6.10.2 Activated TAK1 mediates p38 MAP kinase phosphorylation (Pathway)
15718 
27.2.7.2.6.10.2.1 Phosphorylation of MKK3/MKK6 by activated TAK1 (Reaction) 15719 27.2.7.2.6.10.2.2 activated MAPK3/MAPK6 migrates to nucleus (Reaction) 15719 
27.2.7.2.6.10.2.3 activated chicken MKK3/MKK6 phosphorylates p38 MAPK 15719 complexed with MAPKAPK2 or MAPKAPK3 (Reaction) 
27.2.7.2.6.10.2.4 Active p38 MAPK phosphorylates MAPKAPK2 or 3 (Reaction) 15720 
27.2.7.2.6.10.2.5 Nuclear export of p38 MAPK mediated by its substrate MAPKAPK2
15720 or 3 (Reaction) 
27.2.7.2.6.10.3 ERK activation (Pathway) 15720 
27.2.7.2.6.10.3.1 ERK2 activation (Pathway) 15720 
27.2.7.2.6.10.3.1.1 activated MEK2 binds ERK2 (Reaction) 15721 
27.2.7.2.6.10.3.1.2 activated MEK2 phosphorylates ERK2 (Reaction) 15721 
27.2.7.2.6.10.3.1.3 Dissociation of phospho ERK2 :phospho MEK2 complex 15721 (Reaction) 
27.2.7.2.6.10.3.1.4 Dimerization of activated ERK2 (Reaction) 15721 
27.2.7.2.6.10.3.1.5 Nuclear translocation of phospho ERK2 dimer (Reaction) 15722 
27.3 RLR (RIG-like receptor) mediated induction of IFN alpha/beta (Pathway) 15722 
27.3.1 dsRNA binds to MDA5 (Reaction) 15724 
27.3.2 Activated MDA5 binds IPS-1 (Reaction) 15727 
27.3.3 TRAF mediated activation of IRF (Pathway) 15729 
27.3.3.1 TRAF3/or TRAF6 interacts with IPS-1 (Reaction) 15732 
27.3.3.2 TRAF3/or TRAF6 ubiquitination within dsRNA:MDA5:IPS1:TRAF3/TRAF6 15734 complex (BlackBoxEvent) 
27.3.3.3 TANK binds polyubiquitinated TRAF3/6 (Reaction) 15736 
27.3.3.4 TBK1/IKK epsilon bind to TANK:TRAF3/TRAF6 complex followed by their 15739 activation (Reaction) 
27.3.3.5 Recruitment of IRF to activated TBK1/IKK epsilon (Reaction) 15741 
27.3.3.6 Phosphorylation and release of IRF3 (Reaction) 15743 
27.3.3.7 Dimerization of Phospho-IRF3 (Reaction) 15745 
27.3.3.8 Dimerized Phospho-IRF3 is Transported To The Nucleus (Reaction) 15746 
27.3.4 Caspase-8 and -10 mediated induction of NF-kB (Pathway) 15746 
27.3.4.1 IPS1 interacts with TRADD, RIP1 and FADD (Reaction) 15748 
27.3.4.2 Caspase 8 or 10 recruitment to IPS1 complex followed by their dimerization 15750 (Reaction) 
27.3.4.3 Recruitment of IKK complex (Reaction) 15754 
27.3.5 TRAF6 mediated NF-kB activation (Pathway) 15756 
27.3.5.1 TRAF6/or TRAF2 interacts with IPS-1 (Reaction) 15758 
27.3.5.2 TRAF6/or TRAF2 ubiquitination within dsRNA:Mda5:Ips1:Traf6/ or Traf2 complex
15760 (BlackBoxEvent) 
27.3.5.3 MEKK1 binds TRAF6 (Reaction) 15763 
27.3.5.4 Phosphorylation of IKKs complex mediated by MEKK1 (Reaction) 15764 
27.3.5.5 activated IKKs phosphorylates IkB alpha causing the NFkB complex to dissociate
15768 from the phospho-IkB (Reaction) 
27.3.6 Negative Regulation of MDA5 signaling (Pathway) 15768 
27.3.6.1 Inhibition of MDA5-IPS1 signaling by Atg5-Atg12 conjugate (Reaction) 15770 
27.3.6.2 NLRC5 binds to CARD domain of Mda5 and prevents IPS1 binding. (Reaction)15771 
27.3.6.3 ITCH homolog downregulates MDA5/IPS1 signaling (Reaction) 15773 
27.3.6.4 NLRX1 inhibits IPS1 signaling (Reaction) 15775 28 Metabolism (Pathway) 15777 
28.1 Carbohydrate metabolism (Pathway) 15778 
28.1.1 Glucose transport (Pathway) 15778 
28.1.1.1 glucose [extracellular] glucose [cytosol] (Reaction) 15779 
28.1.1.2 glucose [cytosol] glucose [extracellular] (Reaction) 15781 
28.1.1.3 glucose + ATP => glucose 6-phosphate + ADP (Reaction) 15782 
28.1.1.4 glucose 6-phosphate [cytosol] => glucose 6-phosphate [endoplasmic reticulum15783 lumen] (Reaction) 
28.1.1.5 glucose 6-phosphate + H2O => glucose + phosphate (Reaction) 15785 
28.1.1.6 Efflux of glucose and orthophosphate from the endoplasmic reticulum 15787 (BlackBoxEvent) 
28.1.2 Glycolysis (Pathway) 15788 
28.1.2.1 glucose 6-phosphate fructose 6-phosphate (Reaction) 15788 
28.1.2.2 fructose 6-phosphate + ATP => fructose 2,6-bisphosphate + ADP (Reaction) 15790 
28.1.2.3 fructose 6-phosphate + ATP => fructose 1,6-bisphosphate + ADP (Reaction) 15791 
28.1.2.4 fructose 1,6-bisphosphate dihydroxyacetone phosphate + glyceraldehyde 15793 3-phosphate (Reaction) 
28.1.2.5 dihydroxyacetone phosphate glyceraldehyde 3-phosphate (Reaction) 15794 
28.1.2.6 glyceraldehyde 3-phosphate + NAD+ + phosphate 1,3-bisphosphoglycerate +15796 NADH + H+ (Reaction) 
28.1.2.7 1,3-bisphosphoglycerate + ADP 3-phosphoglycerate + ATP (Reaction) 15797 
28.1.2.8 3-phosphoglycerate 2-phosphoglycerate (Reaction) 15798 
28.1.2.9 2-phosphoglycerate phosphoenolpyruvate + H2O (Reaction) 15800 
28.1.2.10 phosphoenolpyruvate + ADP => pyruvate + ATP (Reaction) 15801 
28.1.3 Gluconeogenesis (Pathway) 15803 
28.1.3.1 pyruvate + CO2 + ATP => oxaloacetate + ADP + orthophosphate (Reaction) 15805 
28.1.3.2 oxaloacetate + NADH + H+ malate + NAD+ (Reaction) 15807 
28.1.3.3 malate [mitochondrial matrix] + orthophosphate [cytosol] malate [cytosol] + 15809 orthophosphate [mitochondrial matrix] (Reaction) 
28.1.3.4 malate + NAD+ oxaloacetate + NADH + H+ (Reaction) 15810 
28.1.3.5 oxaloacetate + glutamate aspartate + alpha-ketoglutarate (2-oxoglutarate) 15812 (Reaction) 
28.1.3.6 2-oxoglutarate [mitochondrial matrix] + malate [cytosol] 2-oxoglutarate [cytosol] +
15813 malate [mitochondrial matrix] (Reaction) 
28.1.3.7 aspartate [mitochondrial matrix] + glutamate [cytosol] aspartate [cytosol] + 15815 glutamate [mitochondrial matrix] (Reaction) 
28.1.3.8 aspartate + alpha-ketoglutarate (2-oxoglutarate) oxaloacetate + glutamate 15817 (Reaction) 
28.1.3.9 oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [cytosol] (Reaction)15818 
28.1.3.10 oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [mitochondrial 15819 matrix] (Reaction) 
28.1.3.11 phosphoenolpyruvate [mitochondrial matrix] + citrate [cytosol] 15821 phosphoenolpyruvate [cytosol] + citrate [mitochondrial matrix] (Reaction) 
28.1.3.12 phosphoenolpyruvate + H2O 2-phosphoglycerate (Reaction) 
28.1.3.13 2-phosphoglycerate 3-phosphoglycerate (Reaction) 15824 
28.1.3.14 3-phosphoglycerate + ATP 1,3-bisphosphoglycerate + ADP (Reaction) 15826 
28.1.3.15 1,3-bisphosphoglycerate + NADH + H+ glyceraldehyde 3-phosphate + NAD+ +
15827 phosphate (Reaction) 
28.1.3.16 glyceraldehyde 3-phosphate dihydroxyacetone phosphate (Reaction) 15828 
28.1.3.17 dihydroxyacetone phosphate + glyceraldehyde 3-phosphate fructose 15830 1,6-bisphosphate (Reaction) 
28.1.3.18 fructose 2,6-bisphosphate + H2O => fructose 6-phosphate + orthophosphate15831 (Reaction) 
28.1.3.19 fructose 1,6-bisphosphate + H2O => fructose 6-phosphate + orthophosphate15832 (Reaction) 
28.1.3.20 fructose 6-phosphate glucose 6-phosphate (Reaction) 15834 
28.2 Pyruvate metabolism (Pathway) 15835 
28.2.1 pyruvate + NADH + H+ lactate + NAD+ (Reaction) 15836 
28.2.2 lactate + H+ [cytosol] lactate + H+ [extracellular] (Reaction) 15837 
28.2.3 lactate + H+ [extracellular] lactate + H+ [cytosol] (Reaction) 15838 
28.2.4 lactate + NAD+ pyruvate + NADH + H+ (Reaction) 15840 
28.2.5 pyruvate + H+ [cytosol] => pyruvate + H+ [mitochondrial matrix] (Reaction) 15841 
28.2.6 pyruvate + CoASH + NAD+ => acetylCoA + CO2 + NADH + H+ (Reaction) 15843 
28.3 Lipid metabolism (Pathway) 15845 
28.3.1 Sphingolipid metabolism (Pathway) 15845 
28.3.1.1 palmitoyl-CoA + serine => 3-dehydrosphinganine + CoASH + CO2 (Reaction) 15847 
28.3.1.2 3-dehydrosphinganine + NADPH + H+ => sphinganine + NADP+ (Reaction) 15848 
28.3.1.3 sphinganine + stearyl-CoA => dihydroceramide + CoASH (Reaction) 15849 
28.3.1.4 dihydroceramide + NAD(P)H + H+ + O2 => ceramide + NAD(P)+ + H2O 15850 (Reaction) 
28.3.1.5 dihydroceramide + NADPH + H+ + O2 => phytoceramide + NADP+ + H2O 15852 (Reaction) 
28.3.1.6 ceramide + H2O => stearate + sphingosine [endoplasmic reticulum] (Reaction)15853 
28.3.1.7 phytoceramide + H2O => stearate + phytosphingosine (Reaction) 15854 
28.3.1.8 sphinganine (dihydrosphingosine) +ATP => sphinganine 1-phosphate + ADP 15855 (Reaction) 
28.3.2 oxaloacetate + NADH + H+ malate + NAD+ (Reaction) 15856 
28.4 The tricarboxylic acid cycle (Pathway) 15856 
28.4.1 acetyl-CoA + H2O + oxaloacetate => citrate + CoA (Reaction) 15857 
28.4.2 citrate isocitrate (Reaction) 15858 
28.4.3 isocitrate citrate (Reaction) 15859 
28.4.4 isocitrate + NAD+ => 2-oxoglutarate (alpha-ketoglutarate) + CO2 + NADH + H+ 15859 (Reaction) 
28.4.5 2-oxoglutarate (alpha-ketoglutarate) + CoASH + NAD+ => succinylCoA + CO2 + 15861 NADH + H+ (Reaction) 
28.4.6 succinylCoA + GDP + Pi succinate + CoASH + GTP (Reaction) 15863 
28.4.7 succinate + CoASH + GTP succinylCoA + GDP + Pi (Reaction) 15864 
28.4.8 succinylCoA + ADP + Pi succinate + CoASH + ATP (Reaction) 15865 
28.4.9 succinate + CoASH + ATP succinylCoA + ADP + Pi (Reaction) 15867 28.4.10 succinate + FAD fumarate + FADH2 (Reaction) 15868 
28.4.11 fumarate + FADH2 succinate + FAD (Reaction) 15869 
28.4.12 fumarate + H2O malate (Reaction) 15870 
28.4.13 malate fumarate + H2O (Reaction) 15872 
28.4.14 malate + NAD+ oxaloacetate + NADH + H+ (Reaction) 15872 
28.5 Amino acid metabolism (Pathway) 15874 
28.5.1 Arginine metabolism (Pathway) 15874 
28.5.1.1 ATP + aspartate + citrulline argininosuccinate + AMP + pyrophosphate (Reaction)
15876 
28.5.1.2 argininosuccinate fumarate + arginine (Reaction) 15877 
28.5.1.3 arginine + H2O => ornithine + urea (Reaction) 15878 
28.5.1.4 carbamoyl phosphate + ornithine => citrulline + orthophosphate (Reaction) 15880 
28.5.1.5 ornithine (cytosolic) + citrulline (mitochondrial) => ornithine (mitochondrial) + 15881 citrulline (cytosolic) (Reaction) 
28.5.2 oxaloacetate + glutamate aspartate + alpha-ketoglutarate (2-oxoglutarate) (Reaction)
15884 
28.5.3 aspartate + alpha-ketoglutarate (2-oxoglutarate) oxaloacetate + glutamate (Reaction)
15884 
28.5.4 oxaloacetate + glutamate aspartate + alpha-ketoglutarate (2-oxoglutarate) (Reaction)
15885 
28.5.5 aspartate + alpha-ketoglutarate (2-oxoglutarate) oxaloacetate + glutamate (Reaction)
15887 
28.5.6 2-oxoglutarate [mitochondrial matrix] + 2-oxoadipate [cytosol] 2-oxoglutarate [cytosol]
15887 
+ 2-oxoadipate [mitochondrial matrix] (Reaction) 
28.5.7 aspartate [mitochondrial matrix] + glutamate [cytosol] aspartate [cytosol] + glutamate
15889 [mitochondrial matrix] (Reaction) 
28.6 Nucleotide metabolism (Pathway) 15889 
28.6.1 Pyrimidine metabolism (Pathway) 15890 
28.6.1.1 De novo synthesis of UMP (Pathway) 15890 
28.6.1.1.1 L-glutamine + 2 ATP + HCO3- + H2O => carbamoyl phosphate + L-glutamate
15892 
+ 2 ADP + orthophosphate (Reaction) 
28.6.1.1.2 carbamoyl phosphate + L-aspartate N-carbamoyl L-aspartate + 15893 orthophosphate (Reaction) 
28.6.1.1.3 N-carbamoyl L-aspartate + H+ (S)-dihydroorotate + H2O (Reaction) 15895 
28.6.1.1.4 (S)-dihydroorotate + ubiquinone => orotate + ubiquinol (Reaction) 15896 
28.6.1.1.5 orotate + 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) orotidine 15898 5'-monophosphate (OMP) + pyrophosphate (Reaction) 
28.6.1.1.6 orotidine 5'-monophosphate => uridine 5'-monophosphate + CO2 (Reaction)15900 
28.6.2 Purine metabolism (Pathway) 15902 
28.6.2.1 De novo synthesis of IMP (Pathway) 15903 
28.6.2.1.1 Formation of PPAT dimers (Reaction) 15904 
28.6.2.1.2 Formation of PPAT tetramers (Reaction) 15906 
28.6.2.1.3 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) + H2O + L-glutamine 15907 5-phosphoribosylamine + L-glutamate + pyrophosphate (Reaction) 
28.6.2.1.4 5-phosphoribosylamine + glycine + ATP 5-phosphoribosylglycinamide (GAR) +
15909 adenosine 5'-diphosphate + orthophosphate (Reaction) 
28.6.2.1.5 5-phosphoribosylglycinamide (GAR) + 10-formyl-tetrahydrofolate => 15910 5'-phosphoribosylformylglycinamide (FGAR) + tetrahydrofolate (Reaction) 
28.6.2.1.6 5'-phosphoribosylformylglycinamide (FGAR) + L-glutamine + ATP + H2O => 5'-phosphoribosylformylglycinamidine (FGAM) + L-glutamate + ADP + orthophosphate (Reaction) 
28.6.2.1.7 5'-phosphoribosylformylglycinamidine (FGAM) + ATP => 15913 5'-phosphoribosyl-5-aminoimidazole (AIR) + ADP + orthophosphate (Reaction) 
28.6.2.1.8 5'-phosphoribosyl-5-aminoimidazole (AIR) + CO2 15914 5'-phosphoribosyl-5-aminoimidazole-4-carboxylate (CAIR) (Reaction) 
28.6.2.1.9 5'-phosphoribosyl-5-aminoimidazole-4-carboxylate (CAIR) + L-aspartate + ATP15916 
=> 5'-phosphoribosyl-5-aminoimidazole-4-N-succinocarboxamide (SAICAR) + adenosine 
5'-diphosphate + orthophosphate (Reaction) 
28.6.2.1.10 5'-phosphoribosyl-5-aminoimidazole-4-N-succinocarboxamide (SAICAR) 15917 5'-phosphoribosyl-5-aminoimidazole-4-carboxamide (AICAR) + fumarate (Reaction) 
28.6.2.1.11 5'-phosphoribosyl-5-aminoimidazole-4-carboxamide (AICAR) + 15918 10-formyltetrahydrofolate => 5'-phosphoribosyl-5-formaminoimidazole-4-carboxamide (FAICAR) + tetrahydrofolate (Reaction) 
28.6.2.1.12 5'-phosphoribosyl-5-formaminoimidazole-4-carboxamide (FAICAR) inosine15919 5'-monophosphate + H2O (Reaction) 
28.6.2.2 De novo synthesis of AMP (Pathway) 15920 
28.6.2.2.1 inosine 5'-monophosphate (IMP) + L-aspartate + GTP => adenylosuccinate +
15921 GDP + orthophosphate (Reaction) 
28.6.2.2.2 adenylosuccinate => adenosine 5'-monophosphate (AMP) + fumarate 15923 (Reaction) 
28.6.2.3 De novo synthesis of GMP (Pathway) 15925 
28.6.2.3.1 inosine 5'-monophosphate (IMP) + NAD+ + H2O => xanthosine 15925 5'-monophosphate (XMP) + NADH + H+ (Reaction) 
28.6.2.3.2 xanthosine 5'-monophosphate (XMP) + L-glutamine + ATP + H2O => 15927 guanosine 5'-monophosphate (GMP) + L-glutamate + adenosine 5'-monophosphate (AMP) + pyrophosphate (Reaction) 
28.6.2.4 Urate synthesis (Pathway) 15928 
28.6.2.4.1 inosine 5'-monophosphate (IMP) + H2O => inosine + orthophosphate 15929 (Reaction) 
28.6.2.4.2 inosine + orthophosphate hypoxanthine + D-ribose 1-phosphate (Reaction)15931 
28.6.2.4.3 hypoxanthine + H2O + NAD+ => xanthine + NADH + H+ (Reaction) 15932 
28.6.2.4.4 xanthine + H2O + NAD+ => urate + NADH + H+ (Reaction) 15934 
28.7 Heme metabolism (Pathway) 15935 
28.7.1 Heme synthesis (Pathway) 15936 
28.7.1.1 Synthesis of ALAS1 nascent polypeptide (BlackBoxEvent) 15938 
28.7.1.2 Mitochondrial uptake and processing of ALAS1 (BlackBoxEvent) 15939 
28.7.1.3 Synthesis of ALAS2 nascent polypeptide (BlackBoxEvent) 15940 
28.7.1.4 Mitochondrial uptake and processing of ALAS2 (BlackBoxEvent) 15941 
28.7.1.5 succinyl-CoA + glycine => delta-aminolevulinate + CoA SH + CO2 (Reaction) 15942 
28.7.1.6 Transport of delta-aminolevulinate from the mitochondrial matrix to the cytosol15943 (Reaction) 
28.7.1.7 2 delta-aminolevulinate => porphobilinogen + 2 H2O (Reaction) 15944 
28.7.1.8 4 porphobilinogen + H2O => hydroxymethylbilane + 4 NH3 (Reaction) 15945 
28.7.1.9 hydroxymethylbilane => uroporphyrinogen III + H2O (Reaction) 1591215947 
28.7.1.10 hydroxymethylbilane => uroporphyrinogen I + H2O (Reaction) 15948 28.7.1.11 uroporphyrinogen III => coproporphyrinogen III + 4 CO2 (Reaction) 15949 
28.7.1.12 uroporphyrinogen I => coproporphyrinogen I + 4 CO2 (Reaction) 15951 
28.7.1.13 Translocation of coproporphyrinogen III from the cytosol to the mitochondrial15952 intermembrane space (Reaction) 
28.7.1.14 coproporphyrinogen III + 2 O2 => protoporphyrinogen IX + 2 H2O2 + 2 CO2 15953 (Reaction) 
28.7.1.15 2 protoporphyrinogen IX + 3 O2 => 2 protoporphyrin IX + 6 H2O (Reaction) 15955 
28.7.1.16 Transport of protoporphyrin IX from the mitochondrial intermembrane space into
15956 the mitochondrial matrix (Reaction) 
28.7.1.17 protoporphyrin IX + Fe++ => heme + 2 H+ (Reaction) 15957 29 Mus musculus biological processes (Pathway) 15959 
29.1 Circadian Clock (Pathway) 15960 
29.1.1 Expression of Bmal1 (Arntl) (BlackBoxEvent) 15962 
29.1.2 Bmal1 binds Clock,Npas2 forming Bmal1:Clock,Npas2 heterodimer (Reaction) 15964 
29.1.3 Bmal1:Clock,Npas2 heterodimer is phosphorylated and translocates to the nucleus
15966 (BlackBoxEvent) 
29.1.4 Bmal1:Clock,Npas2 activates circadian gene expression (Pathway) 15968 
29.1.4.1 Expression of Avp (Arginine Vasopressin, Vasopressin-neurophysin 2-copeptin)
15969 (BlackBoxEvent) 
29.1.4.2 Expression of Coagulation Factor VII (F7) (BlackBoxEvent) 15970 
29.1.4.3 Expression of Copine-7 (BlackBoxEvent) 15972 
29.1.4.4 Expression of Dbp (BlackBoxEvent) 15973 
29.1.4.5 Expression of Dec1 (Bhlhe40, Bhlhb2) (BlackBoxEvent) 15975 
29.1.4.6 Expression of Dec2 (Bhlhe41, Bhlhb3) (BlackBoxEvent) 15976 
29.1.4.7 Expression of Fox-1 homolog A (BlackBoxEvent) 15978 
29.1.4.8 Expression of Ppara (BlackBoxEvent) 15979 
29.1.4.9 Expression of Tbcel (BlackBoxEvent) 15981 
29.1.4.10 Expression of Nampt (BlackBoxEvent) 15982 
29.1.5 Expression of Cryptochrome-1 (Cry1) (BlackBoxEvent) 15984 
29.1.6 Expression of Cryptochrome-2 (Cry2) (BlackBoxEvent) 15986 
29.1.7 Expression of Period-1 (Per1) (BlackBoxEvent) 15987 
29.1.8 Expression of Period-2 (Per2) (BlackBoxEvent) 15990 
29.1.9 Expression of Nr1d1 (Rev-erba) (BlackBoxEvent) 15992 
29.1.10 Cry proteins stabilize unphosphorylated Bmal1:Clock,Npas2 (Reaction) 15993 
29.1.11 Formation of Cry:Per:Kinase complex (BlackBoxEvent) 15995 
29.1.12 Csnk1e,Csnk1d phosphorylate Cry and Per proteins (Reaction) 15996 
29.1.13 Phosphorylated Cry:Per:Kinase complex translocates to the nucleus 15999 (BlackBoxEvent) 
29.1.14 Cry:Per heterodimer binds Bmal1:Clock,Npas2 heterodimer (Reaction) 16001 
29.1.15 Beta-TrCP (Btrc) binds phosphorylated Per (Reaction) 16003 
29.1.16 Fbxl3 binds phosphorylated Cry proteins (Reaction) 16005 
29.1.17 Cry proteins are ubiquitinylated (BlackBoxEvent) 16006 
29.1.18 Per proteins are ubiquitinylated (BlackBoxEvent) 16008 
29.1.19 Formation of Ror-alpha coactivator complex (Reaction) 16009 
29.1.20 Rora activates circadian gene expression (Pathway) 16010 
29.1.20.1 Expression of Srebf1 (BlackBoxEvent) 16012 
29.1.20.2 Expression of Cpt1a (BlackBoxEvent) 16013 
29.1.20.3 Expression of Bmal1 (Arntl) (BlackBoxEvent) 16015 
29.1.21 Expression of Elovl3 (BlackBoxEvent) 16015 
29.2 Meiotic Recombination (Pathway) 16016 
29.2.1 Prdm9 Binds Recombination Hotspot Motifs in DNA (Reaction) 16018 
29.2.2 Prdm9 Trimethylates Histone H3 at Lysine-4 (Reaction) 16020 
29.2.3 Formation of Double-strand Break in DNA by Spo11 (Reaction) 16021 
29.2.4 Removal of Spo11 and Resection of 5' Ends of DNA (BlackBoxEvent) 16023 
29.2.5 Formation of Meiotic Single-stranded Invasion Complex (BlackBoxEvent) 16025 
29.2.6 Formation of Meiotic Heteroduplex (BlackBoxEvent) 16028 
29.2.7 Formation of Meiotic Holliday Junction (BlackBoxEvent) 16029 
29.2.8 Resolution of Meiotic Holliday Junction (BlackBoxEvent) 16031 
29.3 Meiotic Synapsis (Pathway) 16034 
29.3.1 Formation of Axial/Lateral Elements of Synaptonemal Complex (BlackBoxEvent) 16036 
29.3.2 Telomere clustering at the nuclear membrane (BlackBoxEvent) 16038 
29.3.3 Synapsis (BlackBoxEvent) 16040 
29.3.4 Recruitment of Brca1 to Unsynapsed Regions (Reaction) 16042 
29.3.5 Recruitment of Atr Kinase to Unsynapsed Regions (Reaction) 16044 
29.3.6 Atr Phosphorylates Histone H2A.X at Unsynapsed Regions (Reaction) 16045 
29.4 NoRC negatively regulates rRNA expression (Pathway) 16047 
29.4.1 Transcription of intergenic spacer of the rRNA gene (Reaction) 16048 
29.4.2 Cleavage of intergenic spacer RNA to yield fragments of 150-300 nucleotides 16050 (BlackBoxEvent) 
29.4.3 Ttf-I binds the T0 region (Sal Box) of the rDNA (Reaction) 16051 
29.4.4 Nucleolar Chromatin Remodeling Complex (NoRC) binds intergenic spacer of rRNA
16052 gene (Reaction) 
29.4.5 NoRC:intergenic spacer:Hdac:Dnmt complex deacetylates histone H4 and 16055 dimethylates lysine-9 of histone H3 in main promoter of the rRNA gene (BlackBoxEvent) 
29.4.6 NoRC:intergenic spacer:Hdac:Dnmt complex methylates cytosine in the rRNA genes
16056 (Reaction) 
29.5 Signaling by Leptin (Pathway) 16058 
29.5.1 Leptin Binds Leptin Receptor (Reaction) 16059 
29.5.2 Jak2 Autophosphorylates in Response to Leptin (Reaction) 16061 
29.5.3 Jak2 Phosphorylates Lepr (Reaction) 16062 
29.5.4 Phosphorylated Lepr Binds Shp2 (Reaction) 16064 
29.5.5 Jak2 Phosphorylates Shp2 in Response to Leptin (Reaction) 16065 
29.5.6 Phosphorylated Lepr Binds Stat5 (Reaction) 16066 
29.5.7 Jak2 Phosphorylates Stat5 in Response to Leptin (Reaction) 16067 
29.5.8 Phosphorylated Stat5 Dissociates from Leptin Receptor (Reaction) 16069 
29.5.9 Phosphorylated Stat5 Forms Dimer (Reaction) 16070 
29.5.10 Phosphorylated Stat5 Dimer Translocates to the Nucleus (BlackBoxEvent) 16071 
29.5.11 Phosphorylated Lepr Binds Stat3 (Reaction) 16073 
29.5.12 Jak2 Phosphorylates Stat3 in Response to Leptin (Reaction) 16074 
29.5.13 Phosphorylated Stat3 Dissociates from Leptin Receptor (Reaction) 16076 29.5.14 Phosphorylated Stat3 Forms Dimer (Reaction) 16077 
29.5.15 Phosphorylated Stat3 Dimer Translocates to the Nucleus (BlackBoxEvent) 16079 
29.5.16 Phosphoryated Lep:Lepr:Jak2 Binds Sh2b1 (Reaction) 16080 
29.5.17 Phosphorylated Lep:Lepr:Jak2:Sh2b1 Binds Irs1/2 (Reaction) 16081 
29.5.18 Jak2 Phosphorylates Irs1/2 in Response to Leptin (Reaction) 16083 
29.5.19 Phosphorylated Lepr Binds Socs3 (Reaction) 16084 
29.6 Transcriptional Regulation of Adipocyte Differentiation in 3T3-L1 Pre-adipocytes 16085 (Pathway) 
29.6.1 Expression of Cebpb (BlackBoxEvent) 16087 
29.6.2 Expression of Cebpd (BlackBoxEvent) 16089 
29.6.3 Expression of Klf5 (BlackBoxEvent) 16091 
29.6.4 Expression of Ebf1 (BlackBoxEvent) 16092 
29.6.5 Expression of Pparg (BlackBoxEvent) 16094 
29.6.6 Pparg:Rxra heterodimer binds to PPARG corepressors (Reaction) 16097 
29.6.7 Pparg:Rxra heterodimer binds to fatty acids (Reaction) 16098 
29.6.8 Expression of Cebpa (BlackBoxEvent) 16101 
29.6.9 Maintenance of Pparg expression in differentiated adipocytes (BlackBoxEvent) 16103 







